Psyllid ID: psy3273

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-----
Protein Sequence
MFFIVGTGFLSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS
Secondary Structure (PSIPRED)
cEEEEEEccEEEEEEEEccHHHHHHHHHHHHHHHHHcccccccEEEEEEEEEEccccEEEEEEEEcccccEEEEcccccccccHHHHHHHHHHHHHHHHHHcccEEccccccEEEEcccccEEEEEccccEEccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEcccccEEEEEEEccHHEEEHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEEEcccc
Coil and Loop (DISEMBL)
mffivgtgflsncshvkqgeTLALNERIMLSLVStgiqmvdcpfivcmtyafhtpdKLCFILdlmnggdlhyhlsqhgvfnedEMRFYAAEVILGLEHMHRRYIvyrdlkpanilldehghvrisdlglacdfskkkphasvgks
Flexible Loop (DISEMBL)
MFFIVGTgflsncshVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLglacdfskkkphasvgks
Low Complexity Region (SEG)
MFFIVGTGFLSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS
Disordered region (IsUnstruct)
*FFIVGTGFLSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF************
Disordered Region (DISOPRED)
MFFIVGTGFLSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP***VG**
Disordered Region (DISEMBL)
MFFIVGTGFLSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS***********
Disordered Region (DISPRO)
*FF*VGTGFLSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG**
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MFFIVGTGFLSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	145	2.2.26 [Sep-21-2011]
P26818	688	Beta-adrenergic receptor	yes	N/A	0.855	0.180	0.906	5e-65
P35626	688	Beta-adrenergic receptor	yes	N/A	0.855	0.180	0.898	1e-64
P26817	689	Beta-adrenergic receptor	yes	N/A	0.855	0.179	0.890	9e-64
P21146	689	Beta-adrenergic receptor	no	N/A	0.855	0.179	0.890	1e-63
P25098	689	Beta-adrenergic receptor	no	N/A	0.855	0.179	0.890	1e-63
Q99MK8	689	Beta-adrenergic receptor	yes	N/A	0.855	0.179	0.882	2e-63
P32865	700	G protein-coupled recepto	yes	N/A	0.862	0.178	0.882	4e-63
P26819	688	Beta-adrenergic receptor	no	N/A	0.855	0.180	0.882	5e-63
Q3UYH7	688	Beta-adrenergic receptor	no	N/A	0.855	0.180	0.882	5e-63
O97627	689	Beta-adrenergic receptor	N/A	N/A	0.855	0.179	0.882	5e-63

>sp|P26818|ARBK2_BOVIN Beta-adrenergic receptor kinase 2 OS=Bos taurus GN=ADRBK2 PE=2 SV=1

 Score =  246 bits (627), Expect = 5e-65,   Method: Compositional matrix adjust.
 Identities = 116/128 (90%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG----DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 284

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E EMRFYA E+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 285 QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 345 KKPHASVG 352

Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them.
Bos taurus (taxid: 9913)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1EC: 5

>sp|P35626|ARBK2_HUMAN Beta-adrenergic receptor kinase 2 OS=Homo sapiens GN=ADRBK2 PE=2 SV=2

 Score =  244 bits (623), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 115/128 (89%), Positives = 120/128 (93%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG----DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 284

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E EMRFYA E+ILGLEHMH R++VYRDLKPANILLDEHGH RISDLGLACDFSK
Sbjct: 285 QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHARISDLGLACDFSK 344

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 345 KKPHASVG 352

Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 5

>sp|P26817|ARBK1_RAT Beta-adrenergic receptor kinase 1 OS=Rattus norvegicus GN=Adrbk1 PE=2 SV=1

 Score =  241 bits (616), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 114/128 (89%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 285 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 345 KKPHASVG 352

Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 5

>sp|P21146|ARBK1_BOVIN Beta-adrenergic receptor kinase 1 OS=Bos taurus GN=ADRBK1 PE=1 SV=1

 Score =  241 bits (615), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 114/128 (89%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 285 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 345 KKPHASVG 352

Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them. Key regulator of LPAR1 signaling. Competes with RALA for binding to LPAR1 thus affecting the signaling properties of the receptor. Desensitizes LPAR1 and LPAR2 in a phosphorylation-independent manner.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 5

>sp|P25098|ARBK1_HUMAN Beta-adrenergic receptor kinase 1 OS=Homo sapiens GN=ADRBK1 PE=1 SV=2

 Score =  241 bits (615), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 114/128 (89%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 285 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 345 KKPHASVG 352

Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them. Key regulator of LPAR1 signaling. Competes with RALA for binding to LPAR1 thus affecting the signaling properties of the receptor. Desensitizes LPAR1 and LPAR2 in a phosphorylation-independent manner.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 5

>sp|Q99MK8|ARBK1_MOUSE Beta-adrenergic receptor kinase 1 OS=Mus musculus GN=Adrbk1 PE=2 SV=2

 Score =  240 bits (613), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 113/128 (88%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 285 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344

Query: 136 KKPHASVG 143
           K+PHASVG
Sbjct: 345 KRPHASVG 352

Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 5

>sp|P32865|GPRK1_DROME G protein-coupled receptor kinase 1 OS=Drosophila melanogaster GN=Gprk1 PE=2 SV=2

 Score =  239 bits (610), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 113/128 (88%), Positives = 120/128 (93%), Gaps = 3/128 (2%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGE LALNER ML  VSTGI   DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct: 229 MKQGEMLALNERNMLQAVSTGI---DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 285

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHG+F+EDEM+FYAAEVILGLEHMH+R IVYRDLKPANILLDE+GH+RISDLGLACDFSK
Sbjct: 286 QHGIFSEDEMKFYAAEVILGLEHMHKRCIVYRDLKPANILLDENGHIRISDLGLACDFSK 345

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 346 KKPHASVG 353

Specifically phosphorylates the activated forms of G protein-coupled receptors.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 6

>sp|P26819|ARBK2_RAT Beta-adrenergic receptor kinase 2 OS=Rattus norvegicus GN=Adrbk2 PE=2 SV=1

 Score =  239 bits (609), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 113/128 (88%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGD+HYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG----DCPFIVCMTYAFHTPDKLCFILDLMNGGDMHYHLS 284

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E EMRFYA+E+ILGLEHMH  ++VYRDLKPANILLDE+GHVRISDLGLACDFSK
Sbjct: 285 QHGVFSEKEMRFYASEIILGLEHMHTCFVVYRDLKPANILLDEYGHVRISDLGLACDFSK 344

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 345 KKPHASVG 352

Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 5

>sp|Q3UYH7|ARBK2_MOUSE Beta-adrenergic receptor kinase 2 OS=Mus musculus GN=Adrbk2 PE=2 SV=2

 Score =  239 bits (609), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 113/128 (88%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGD+HYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG----DCPFIVCMTYAFHTPDKLCFILDLMNGGDMHYHLS 284

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E EMRFYA+E+ILGLEHMH  ++VYRDLKPANILLDE+GHVRISDLGLACDFSK
Sbjct: 285 QHGVFSEKEMRFYASEIILGLEHMHTCFVVYRDLKPANILLDEYGHVRISDLGLACDFSK 344

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 345 KKPHASVG 352

Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 5

>sp|O97627|ARBK1_DIDVI Beta-adrenergic receptor kinase 1 OS=Didelphis virginiana GN=ADRBK1 PE=1 SV=1

 Score =  239 bits (609), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 113/128 (88%), Positives = 120/128 (93%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDE GHVRISDLGLACDFSK
Sbjct: 285 QHGVFSESDMRFYAAEIILGLEHMHSRFVVYRDLKPANILLDEFGHVRISDLGLACDFSK 344

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 345 KKPHASVG 352

Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them. Does not act on HTR1B/5-hydroxytryptamine 1B receptor. Key regulator of LPAR1 signaling. Competes with RALA for binding to LPAR1 thus affecting the signaling properties of the receptor. Desensitizes LPAR1 and LPAR2 in a phosphorylation-independent manner.

Didelphis marsupialis virginiana (taxid: 9267)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	145
6175630	690	G protein-coupled receptor kinase type 2	0.862	0.181	0.960	1e-66
156546725	686	PREDICTED: G protein-coupled receptor ki	0.862	0.182	0.945	1e-65
321473913	696	G-protein-coupled receptor kinase [Daphn	0.862	0.179	0.937	1e-65
91088973	639	PREDICTED: similar to G protein-coupled	0.862	0.195	0.945	2e-65
340719091	687	PREDICTED: G protein-coupled receptor ki	0.862	0.181	0.937	6e-65
444510182	1845	Beta-adrenergic receptor kinase 1 [Tupai	0.855	0.067	0.890	6e-65
432091064	1191	Beta-adrenergic receptor kinase 1 [Myoti	0.855	0.104	0.890	6e-65
426369443	973	PREDICTED: beta-adrenergic receptor kina	0.855	0.127	0.890	6e-65
403301214	913	PREDICTED: beta-adrenergic receptor kina	0.855	0.135	0.890	6e-65
307189223	649	G protein-coupled receptor kinase 1 [Cam	0.862	0.192	0.945	6e-65

>gi|6175630|gb|AAF05109.1|AF157046_1 G protein-coupled receptor kinase type 2 [Homarus americanus]

 Score =  257 bits (657), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 123/128 (96%), Positives = 124/128 (96%), Gaps = 3/128 (2%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG   VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG---VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 285

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVFNE EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 286 QHGVFNEQEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 345

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 346 KKPHASVG 353

Source: Homarus americanus

Species: Homarus americanus

Genus: Homarus

Family: Nephropidae

Order: Decapoda

Class: Malacostraca

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|156546725|ref|XP_001604700.1| PREDICTED: G protein-coupled receptor kinase 1-like [Nasonia vitripennis]

 Score =  254 bits (648), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 121/128 (94%), Positives = 124/128 (96%), Gaps = 3/128 (2%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG   VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG---VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 285

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVFNE E++FYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 286 QHGVFNEPEVKFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 345

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 346 KKPHASVG 353

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|321473913|gb|EFX84879.1| G-protein-coupled receptor kinase [Daphnia pulex]

 Score =  254 bits (648), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 120/128 (93%), Positives = 123/128 (96%), Gaps = 3/128 (2%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCF+LDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG---ADCPFIVCMTYAFHTPDKLCFVLDLMNGGDLHYHLS 285

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVFNE EMRFYAAEVILGLEHMHRR+IVYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 286 QHGVFNEQEMRFYAAEVILGLEHMHRRFIVYRDLKPANILLDEHGHVRISDLGLACDFSK 345

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 346 KKPHASVG 353

Source: Daphnia pulex

Species: Daphnia pulex

Genus: Daphnia

Family: Daphniidae

Order: Diplostraca

Class: Branchiopoda

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|91088973|ref|XP_966480.1| PREDICTED: similar to G protein-coupled receptor kinase 1 CG40129-PA [Tribolium castaneum] gi|270011553|gb|EFA08001.1| hypothetical protein TcasGA2_TC005590 [Tribolium castaneum]

 Score =  253 bits (645), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 121/128 (94%), Positives = 123/128 (96%), Gaps = 3/128 (2%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG---QDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 285

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVFNE EM+FYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 286 QHGVFNESEMKFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 345

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 346 KKPHASVG 353

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340719091|ref|XP_003397990.1| PREDICTED: G protein-coupled receptor kinase 1-like [Bombus terrestris] gi|350423291|ref|XP_003493433.1| PREDICTED: G protein-coupled receptor kinase 1-like [Bombus impatiens]

 Score =  251 bits (642), Expect = 6e-65,   Method: Compositional matrix adjust.
 Identities = 120/128 (93%), Positives = 122/128 (95%), Gaps = 3/128 (2%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLS VSTG   VDCPFIVCMTYAF TPDKLCFILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSAVSTG---VDCPFIVCMTYAFQTPDKLCFILDLMNGGDLHYHLS 285

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVFNE EM+FYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 286 QHGVFNEREMKFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 345

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 346 KKPHASVG 353

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|444510182|gb|ELV09517.1| Beta-adrenergic receptor kinase 1 [Tupaia chinensis]

 Score =  251 bits (641), Expect = 6e-65,   Method: Composition-based stats.
 Identities = 114/128 (89%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 218 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 273

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 274 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 333

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 334 KKPHASVG 341

Source: Tupaia chinensis

Species: Tupaia chinensis

Genus: Tupaia

Family: Tupaiidae

Order: Scandentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|432091064|gb|ELK24276.1| Beta-adrenergic receptor kinase 1 [Myotis davidii]

 Score =  251 bits (641), Expect = 6e-65,   Method: Composition-based stats.
 Identities = 114/128 (89%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 187 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 242

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 243 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 302

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 303 KKPHASVG 310

Source: Myotis davidii

Species: Myotis davidii

Genus: Myotis

Family: Vespertilionidae

Order: Chiroptera

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|426369443|ref|XP_004051699.1| PREDICTED: beta-adrenergic receptor kinase 1 [Gorilla gorilla gorilla]

 Score =  251 bits (641), Expect = 6e-65,   Method: Composition-based stats.
 Identities = 114/128 (89%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 513 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 568

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 569 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 628

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 629 KKPHASVG 636

Source: Gorilla gorilla gorilla

Species: Gorilla gorilla

Genus: Gorilla

Family: Hominidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|403301214|ref|XP_003941291.1| PREDICTED: beta-adrenergic receptor kinase 1 [Saimiri boliviensis boliviensis]

 Score =  251 bits (641), Expect = 6e-65,   Method: Composition-based stats.
 Identities = 114/128 (89%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 453 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 508

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 509 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 568

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 569 KKPHASVG 576

Source: Saimiri boliviensis boliviensis

Species: Saimiri boliviensis

Genus: Saimiri

Family: Cebidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|307189223|gb|EFN73671.1| G protein-coupled receptor kinase 1 [Camponotus floridanus]

 Score =  251 bits (641), Expect = 6e-65,   Method: Compositional matrix adjust.
 Identities = 121/128 (94%), Positives = 123/128 (96%), Gaps = 3/128 (2%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG   VDCPFIVCMTYAFHT DKLCFILDLMNGGDLHYHLS
Sbjct: 191 MKQGETLALNERIMLSLVSTG---VDCPFIVCMTYAFHTADKLCFILDLMNGGDLHYHLS 247

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVFNE EM+FYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 248 QHGVFNEPEMKFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 307

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 308 KKPHASVG 315

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	145
ZFIN|ZDB-GENE-030616-382	688	adrbk2 "adrenergic, beta, rece	0.855	0.180	0.906	1.2e-60
UNIPROTKB|F1NTL1	625	ADRBK2 "Uncharacterized protei	0.855	0.198	0.906	1.5e-60
UNIPROTKB|F1MBH7	651	ADRBK2 "Beta-adrenergic recept	0.855	0.190	0.906	1.5e-60
UNIPROTKB|P26818	688	ADRBK2 "Beta-adrenergic recept	0.855	0.180	0.906	1.5e-60
UNIPROTKB|F1PF32	646	ADRBK2 "Uncharacterized protei	0.855	0.191	0.906	1.5e-60
UNIPROTKB|F1RG86	646	ADRBK2 "Uncharacterized protei	0.855	0.191	0.906	1.5e-60
UNIPROTKB|P35626	688	ADRBK2 "Beta-adrenergic recept	0.855	0.180	0.898	3.9e-60
UNIPROTKB|F1N7J3	652	ADRBK1 "Beta-adrenergic recept	0.855	0.190	0.890	4.5e-59
UNIPROTKB|P21146	689	ADRBK1 "Beta-adrenergic recept	0.855	0.179	0.890	4.5e-59
UNIPROTKB|E2R5J6	689	ADRBK1 "Uncharacterized protei	0.855	0.179	0.890	4.5e-59

ZFIN|ZDB-GENE-030616-382 adrbk2 "adrenergic, beta, receptor kinase 2" [Danio rerio (taxid:7955)]

 Score = 621 (223.7 bits), Expect = 1.2e-60, P = 1.2e-60
 Identities = 116/128 (90%), Positives = 122/128 (95%)

Query:    16 VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
             +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct:   229 MKQGETLALNERIMLSLVSTG----DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 284

Query:    76 QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
             QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct:   285 QHGVFSEKDMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344

Query:   136 KKPHASVG 143
             KKPHASVG
Sbjct:   345 KKPHASVG 352

GO:0004672 "protein kinase activity" evidence=IEA;IGI

GO:0004703 "G-protein coupled receptor kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0038032 "termination of G-protein coupled receptor signaling pathway" evidence=IEA

GO:0043009 "chordate embryonic development" evidence=IMP

GO:0007224 "smoothened signaling pathway" evidence=IGI

GO:0055001 "muscle cell development" evidence=IGI;IMP

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

UNIPROTKB|F1NTL1 ADRBK2 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 620 (223.3 bits), Expect = 1.5e-60, P = 1.5e-60
 Identities = 116/128 (90%), Positives = 121/128 (94%)

Query:    16 VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
             +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct:   166 MKQGETLALNERIMLSLVSTG----DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 221

Query:    76 QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
             QHGVF+E EMRFYA E+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct:   222 QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 281

Query:   136 KKPHASVG 143
             KKPHASVG
Sbjct:   282 KKPHASVG 289

GO:0004703 "G-protein coupled receptor kinase activity" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0038032 "termination of G-protein coupled receptor signaling pathway" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1MBH7 ADRBK2 "Beta-adrenergic receptor kinase 2" [Bos taurus (taxid:9913)]

 Score = 620 (223.3 bits), Expect = 1.5e-60, P = 1.5e-60
 Identities = 116/128 (90%), Positives = 121/128 (94%)

Query:    16 VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
             +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct:   192 MKQGETLALNERIMLSLVSTG----DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 247

Query:    76 QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
             QHGVF+E EMRFYA E+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct:   248 QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 307

Query:   136 KKPHASVG 143
             KKPHASVG
Sbjct:   308 KKPHASVG 315

GO:0031623 "receptor internalization" evidence=IEA

GO:0004703 "G-protein coupled receptor kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0038032 "termination of G-protein coupled receptor signaling pathway" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

UNIPROTKB|P26818 ADRBK2 "Beta-adrenergic receptor kinase 2" [Bos taurus (taxid:9913)]

 Score = 620 (223.3 bits), Expect = 1.5e-60, P = 1.5e-60
 Identities = 116/128 (90%), Positives = 121/128 (94%)

Query:    16 VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
             +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct:   229 MKQGETLALNERIMLSLVSTG----DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 284

Query:    76 QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
             QHGVF+E EMRFYA E+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct:   285 QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344

Query:   136 KKPHASVG 143
             KKPHASVG
Sbjct:   345 KKPHASVG 352

GO:0031623 "receptor internalization" evidence=IEA

GO:0004703 "G-protein coupled receptor kinase activity" evidence=IEA

GO:0047696 "beta-adrenergic receptor kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0038032 "termination of G-protein coupled receptor signaling pathway" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

UNIPROTKB|F1PF32 ADRBK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 620 (223.3 bits), Expect = 1.5e-60, P = 1.5e-60
 Identities = 116/128 (90%), Positives = 121/128 (94%)

Query:    16 VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
             +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct:   187 MKQGETLALNERIMLSLVSTG----DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 242

Query:    76 QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
             QHGVF+E EMRFYA E+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct:   243 QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 302

Query:   136 KKPHASVG 143
             KKPHASVG
Sbjct:   303 KKPHASVG 310

GO:0031623 "receptor internalization" evidence=IEA

GO:0004703 "G-protein coupled receptor kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0038032 "termination of G-protein coupled receptor signaling pathway" evidence=IEA

UNIPROTKB|F1RG86 ADRBK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 620 (223.3 bits), Expect = 1.5e-60, P = 1.5e-60
 Identities = 116/128 (90%), Positives = 121/128 (94%)

Query:    16 VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
             +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct:   187 MKQGETLALNERIMLSLVSTG----DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 242

Query:    76 QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
             QHGVF+E EMRFYA E+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct:   243 QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 302

Query:   136 KKPHASVG 143
             KKPHASVG
Sbjct:   303 KKPHASVG 310

GO:0031623 "receptor internalization" evidence=IEA

GO:0004703 "G-protein coupled receptor kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0038032 "termination of G-protein coupled receptor signaling pathway" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

UNIPROTKB|P35626 ADRBK2 "Beta-adrenergic receptor kinase 2" [Homo sapiens (taxid:9606)]

 Score = 616 (221.9 bits), Expect = 3.9e-60, P = 3.9e-60
 Identities = 115/128 (89%), Positives = 120/128 (93%)

Query:    16 VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
             +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct:   229 MKQGETLALNERIMLSLVSTG----DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 284

Query:    76 QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
             QHGVF+E EMRFYA E+ILGLEHMH R++VYRDLKPANILLDEHGH RISDLGLACDFSK
Sbjct:   285 QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHARISDLGLACDFSK 344

Query:   136 KKPHASVG 143
             KKPHASVG
Sbjct:   345 KKPHASVG 352

GO:0005543 "phospholipid binding" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0038032 "termination of G-protein coupled receptor signaling pathway" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0047696 "beta-adrenergic receptor kinase activity" evidence=IEA

GO:0004703 "G-protein coupled receptor kinase activity" evidence=IEA

GO:0031623 "receptor internalization" evidence=IDA

GO:0004672 "protein kinase activity" evidence=TAS

UNIPROTKB|F1N7J3 ADRBK1 "Beta-adrenergic receptor kinase 1" [Bos taurus (taxid:9913)]

 Score = 606 (218.4 bits), Expect = 4.5e-59, P = 4.5e-59
 Identities = 114/128 (89%), Positives = 121/128 (94%)

Query:    16 VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
             +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct:   192 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 247

Query:    76 QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
             QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct:   248 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 307

Query:   136 KKPHASVG 143
             KKPHASVG
Sbjct:   308 KKPHASVG 315

GO:0060048 "cardiac muscle contraction" evidence=IEA

GO:0045988 "negative regulation of striated muscle contraction" evidence=IEA

GO:0031755 "Edg-2 lysophosphatidic acid receptor binding" evidence=IEA

GO:0031623 "receptor internalization" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0007507 "heart development" evidence=IEA

GO:0007217 "tachykinin receptor signaling pathway" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004703 "G-protein coupled receptor kinase activity" evidence=IEA

GO:0003108 "negative regulation of the force of heart contraction by chemical signal" evidence=IEA

GO:0002029 "desensitization of G-protein coupled receptor protein signaling pathway" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0038032 "termination of G-protein coupled receptor signaling pathway" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

UNIPROTKB|P21146 ADRBK1 "Beta-adrenergic receptor kinase 1" [Bos taurus (taxid:9913)]

 Score = 606 (218.4 bits), Expect = 4.5e-59, P = 4.5e-59
 Identities = 114/128 (89%), Positives = 121/128 (94%)

Query:    16 VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
             +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct:   229 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284

Query:    76 QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
             QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct:   285 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344

Query:   136 KKPHASVG 143
             KKPHASVG
Sbjct:   345 KKPHASVG 352

GO:0031694 "alpha-2A adrenergic receptor binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=ISS;IDA

GO:0004703 "G-protein coupled receptor kinase activity" evidence=ISS;IDA

GO:0016020 "membrane" evidence=IC;ISS;IDA

GO:0009966 "regulation of signal transduction" evidence=IMP

GO:0006886 "intracellular protein transport" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007213 "G-protein coupled acetylcholine receptor signaling pathway" evidence=IDA

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0060048 "cardiac muscle contraction" evidence=IMP

GO:0045988 "negative regulation of striated muscle contraction" evidence=IMP

GO:0018105 "peptidyl-serine phosphorylation" evidence=IDA

GO:0003108 "negative regulation of the force of heart contraction by chemical signal" evidence=IMP

GO:0002029 "desensitization of G-protein coupled receptor protein signaling pathway" evidence=ISS;IMP

GO:0007507 "heart development" evidence=ISS

GO:0002026 "regulation of the force of heart contraction" evidence=ISS

GO:0007186 "G-protein coupled receptor signaling pathway" evidence=ISS

GO:0031755 "Edg-2 lysophosphatidic acid receptor binding" evidence=ISS

GO:0002031 "G-protein coupled receptor internalization" evidence=IDA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0007217 "tachykinin receptor signaling pathway" evidence=IEA

GO:0047696 "beta-adrenergic receptor kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0038032 "termination of G-protein coupled receptor signaling pathway" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

UNIPROTKB|E2R5J6 ADRBK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 606 (218.4 bits), Expect = 4.5e-59, P = 4.5e-59
 Identities = 114/128 (89%), Positives = 121/128 (94%)

Query:    16 VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
             +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct:   229 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284

Query:    76 QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
             QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct:   285 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344

Query:   136 KKPHASVG 143
             KKPHASVG
Sbjct:   345 KKPHASVG 352

GO:0005524 "ATP binding" evidence=IEA

GO:0038032 "termination of G-protein coupled receptor signaling pathway" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0004703 "G-protein coupled receptor kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q99MK8	ARBK1_MOUSE	2, ., 7, ., 1, 1, ., 1, 5	0.8828	0.8551	0.1799	yes	N/A
P35626	ARBK2_HUMAN	2, ., 7, ., 1, 1, ., 1, 5	0.8984	0.8551	0.1802	yes	N/A
P32865	GPRK1_DROME	2, ., 7, ., 1, 1, ., 1, 6	0.8828	0.8620	0.1785	yes	N/A
P26818	ARBK2_BOVIN	2, ., 7, ., 1, 1, ., 1, 5	0.9062	0.8551	0.1802	yes	N/A
P28178	PK2_DICDI	2, ., 7, ., 1, 1, ., 1	0.5208	0.6620	0.2004	yes	N/A
P26817	ARBK1_RAT	2, ., 7, ., 1, 1, ., 1, 5	0.8906	0.8551	0.1799	yes	N/A
Q09639	GRK2_CAEEL	2, ., 7, ., 1, 1, ., 1, 6	0.8671	0.8620	0.1768	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	145
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-90
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-84
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-67
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-53
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-44
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-39
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-38
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-37
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-37
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-35
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-34
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-33
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-33
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-33
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-33
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-32
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-31
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-31
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-31
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-31
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-30
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-30
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-29
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-28
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-28
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-28
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-28
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-28
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-28
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-28
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-28
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-27
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-27
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-27
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-27
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-26
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-26
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-25
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-25
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-25
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-24
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-24
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-24
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-23
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-23
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-23
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-23
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-23
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-23
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-22
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-21
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-21
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-20
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-20
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-20
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-19
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-19
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-19
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-18
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-18
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-18
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-18
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-18
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-18
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-17
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-17
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-16
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-15
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-15
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-15
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-14
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-14
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-14
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-13
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-13
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-12
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-12
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-11
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-11
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-10
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-08
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-08
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-07
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-07
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	6e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-06
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-06
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-06
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-06
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-06
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-06
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-06
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-05
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-05
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-05
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-05
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-05
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-05
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-05
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-05
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-05
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-04
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-04
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-04
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-04
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-04
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-04
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-04
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-04
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-04
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-04
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-04
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-04
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-04
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-04
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	0.001
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.001
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.001
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.001
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	0.001
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	0.001
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	0.001
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	0.002
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.002
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.002
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	0.002
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.002
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.003
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	0.003
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	0.003
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	0.004
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	0.004

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  264 bits (676), Expect = 1e-90
 Identities = 115/128 (89%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 34  MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 89

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E EMRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 90  QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 149

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 150 KKPHASVG 157

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  248 bits (635), Expect = 1e-84
 Identities = 116/128 (90%), Positives = 121/128 (94%), Gaps = 4/128 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS
Sbjct: 34  MKQGETLALNERIMLSLVSTG----DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 89

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E EMRFYA E+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 90  QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 149

Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 150 KKPHASVG 157

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  205 bits (523), Expect = 2e-67
 Identities = 68/130 (52%), Positives = 85/130 (65%), Gaps = 10/130 (7%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           ++GE +ALNE+ +L  VS         FIV + YAF T D LC ++ LMNGGDL YH+  
Sbjct: 34  RKGEQMALNEKKILEKVS-------SRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYN 86

Query: 77  HG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
            G   F E    FYAA++I GLEH+H+R IVYRDLKP N+LLD+HG+VRISDLGLA +  
Sbjct: 87  VGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK 146

Query: 135 -KKKPHASVG 143
             KK     G
Sbjct: 147 GGKKIKGRAG 156

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  166 bits (424), Expect = 9e-53
 Identities = 54/125 (43%), Positives = 79/125 (63%), Gaps = 7/125 (5%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           ++     L ER +LS +       + PFIV + YAF T +KL  +L+   GG+L  HLS+
Sbjct: 34  RKEVEHTLTERNILSRI-------NHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK 86

Query: 77  HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
            G F+E+  RFYAAE++L LE++H   I+YRDLKP NILLD  GH++++D GLA + S +
Sbjct: 87  EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146

Query: 137 KPHAS 141
               +
Sbjct: 147 GSRTN 151

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  146 bits (371), Expect = 2e-44
 Identities = 61/116 (52%), Positives = 81/116 (69%), Gaps = 9/116 (7%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           ++GE +ALNE+ +L       + V+  F+V + YA+ T D LC +L LMNGGDL +H+  
Sbjct: 41  RKGEAMALNEKQIL-------EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN 93

Query: 77  HGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            G   F+E+   FYAAE+  GLE +HR  IVYRDLKP NILLD++GH+RISDLGLA
Sbjct: 94  MGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  133 bits (336), Expect = 2e-39
 Identities = 61/116 (52%), Positives = 80/116 (68%), Gaps = 9/116 (7%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           ++GE++ALNE+ +L       + V+  F+V + YA+ T D LC +L LMNGGDL +H+  
Sbjct: 41  RKGESMALNEKQIL-------EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH 93

Query: 77  HGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            G   F E    FYAAE+  GLE +H+  IVYRDLKP NILLD+HGH+RISDLGLA
Sbjct: 94  MGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  132 bits (334), Expect = 3e-39
 Identities = 46/129 (35%), Positives = 69/129 (53%), Gaps = 7/129 (5%)

Query: 14  SHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH 73
             +K+     L E  +L       + +  P IV +   F   DKL  +++   GGDL   
Sbjct: 35  KKIKKDRERILREIKIL-------KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDL 87

Query: 74  LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           L + G  +EDE RFY  +++  LE++H + IV+RDLKP NILLDE GHV+++D GLA   
Sbjct: 88  LKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQL 147

Query: 134 SKKKPHASV 142
              +   + 
Sbjct: 148 DPGEKLTTF 156

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  131 bits (330), Expect = 2e-38
 Identities = 59/116 (50%), Positives = 81/116 (69%), Gaps = 9/116 (7%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           ++GE++ALNE+ +L       + V+  F+V + YA+ T D LC +L +MNGGDL +H+  
Sbjct: 41  RKGESMALNEKQIL-------EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN 93

Query: 77  HGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            G   F E+   FYAAE++ GLE +HR   VYRDLKP NILLD++GH+RISDLGLA
Sbjct: 94  MGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  129 bits (327), Expect = 4e-38
 Identities = 49/122 (40%), Positives = 79/122 (64%), Gaps = 8/122 (6%)

Query: 15  HVKQGET-LALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH 73
            V++G     LNER +L       Q ++ PF+V + Y+F   + +  ++DL+ GGDL YH
Sbjct: 38  CVEKGSVRNVLNERRIL-------QELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYH 90

Query: 74  LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           LSQ   F+E++++F+  E++L LE++H + I++RD+KP NILLDE GHV I+D  +A   
Sbjct: 91  LSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150

Query: 134 SK 135
           + 
Sbjct: 151 TP 152

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  128 bits (323), Expect = 1e-37
 Identities = 42/105 (40%), Positives = 63/105 (60%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +  P IV +  AF   D L  +++   GGDL  +LS+ G  +EDE +  A +++ GLE
Sbjct: 53  RRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLE 112

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 142
           ++H   I++RDLKP NILLDE+G V+I+D GLA    K     + 
Sbjct: 113 YLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT 157

Length = 260

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  127 bits (320), Expect = 5e-37
 Identities = 60/116 (51%), Positives = 78/116 (67%), Gaps = 9/116 (7%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           ++GE +ALNE+ +L       + V+  F+V + YA+ T D LC +L +MNGGDL +H+  
Sbjct: 41  RKGEAMALNEKRIL-------EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN 93

Query: 77  HGVFNEDEMR--FYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            G    DE R  FYAAE+  GLE + R  IVYRDLKP NILLD+ GH+RISDLGLA
Sbjct: 94  MGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  123 bits (312), Expect = 2e-35
 Identities = 46/113 (40%), Positives = 69/113 (61%), Gaps = 11/113 (9%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
           LNE+ +L       Q +  PF+V +  +F     L  +++ + GG+L  HL + G F E 
Sbjct: 49  LNEKRIL-------QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP 101

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
             RFYAA+V+L LE++H   IVYRDLKP N+LLD  G+++I+D G    F+K+
Sbjct: 102 VARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFG----FAKR 150

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  120 bits (302), Expect = 3e-34
 Identities = 50/98 (51%), Positives = 66/98 (67%), Gaps = 4/98 (4%)

Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFNEDEMRFYAAEVILGLEHM 99
           FIV + YAF T   LC ++ +MNGGDL YH+     ++  F E    FY A++I GLEH+
Sbjct: 54  FIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
           H+R I+YRDLKP N+LLD  G+VRISDLGLA +    +
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ 151

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  118 bits (297), Expect = 2e-33
 Identities = 52/108 (48%), Positives = 69/108 (63%), Gaps = 6/108 (5%)

Query: 26  ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEM 85
           ER +L  V        CPF+V + YAF T  KL  ILD +NGG+L  HL Q   F E E+
Sbjct: 54  ERQVLEAVRR------CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV 107

Query: 86  RFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           R Y AE++L L+H+H+  I+YRD+K  NILLD  GHV ++D GL+ +F
Sbjct: 108 RVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 2e-33
 Identities = 45/92 (48%), Positives = 64/92 (69%)

Query: 39  MVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEH 98
           + + PFIV + ++F T   L  + D M+GG+L +HL + G F+ED  +FY AE++L LEH
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEH 111

Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +H+  IVYRDLKP NILLD  GH+ + D GL+
Sbjct: 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLS 143

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  118 bits (297), Expect = 3e-33
 Identities = 54/119 (45%), Positives = 77/119 (64%), Gaps = 3/119 (2%)

Query: 21  TLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF 80
           TL + +R+   +    +  V+ PFIV + YAF T  KL  ILD + GGDL   LS+  +F
Sbjct: 36  TLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 95

Query: 81  NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL---ACDFSKK 136
            E++++FY AE+ L L+H+H   I+YRDLKP NILLDE GH++++D GL   + D  KK
Sbjct: 96  TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  117 bits (296), Expect = 5e-33
 Identities = 42/87 (48%), Positives = 64/87 (73%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  + Y+F T D+LCF+++  NGG+L +HLS+  VF+ED  RFY AE++  L ++H  
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC 114

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            +VYRDLK  N++LD+ GH++I+D GL
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  116 bits (291), Expect = 2e-32
 Identities = 50/117 (42%), Positives = 74/117 (63%), Gaps = 8/117 (6%)

Query: 21  TLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF 80
           T  L ER +L+        V+CPFIV + ++F +P+KL  +L  +NGG+L +HL + G F
Sbjct: 38  THTLAERTVLA-------QVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRF 90

Query: 81  NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
           +    RFY AE++  LE++H+  ++YRDLKP NILLD  GH+ + D GL C  + K 
Sbjct: 91  DLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGL-CKLNMKD 146

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  114 bits (287), Expect = 1e-31
 Identities = 45/106 (42%), Positives = 70/106 (66%), Gaps = 6/106 (5%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
           + E+ +L+L          PF+  +   F T D+L F+++ +NGGDL +H+ + G F+E 
Sbjct: 43  MTEKRVLALAGKH------PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP 96

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
             RFYAAE++LGL+ +H R I+YRDLK  N+LLD  GH++I+D G+
Sbjct: 97  RARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGM 142

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  113 bits (285), Expect = 2e-31
 Identities = 43/87 (49%), Positives = 65/87 (74%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  + YAF T D+LCF+++  NGG+L +HLS+  VF E+  RFY AE++  LE++H R
Sbjct: 55  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 114

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            +VYRD+K  N++LD+ GH++I+D GL
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  112 bits (282), Expect = 5e-31
 Identities = 48/93 (51%), Positives = 66/93 (70%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ V  PFIV + YAF T  KL  IL+ ++GG+L  HL + G+F ED   FY +E+ L L
Sbjct: 54  LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL 113

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
           EH+H++ I+YRDLKP NILLD  GHV+++D GL
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDFGL 146

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  112 bits (282), Expect = 7e-31
 Identities = 56/126 (44%), Positives = 79/126 (62%), Gaps = 8/126 (6%)

Query: 10  LSNCSHVKQGETL--ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG 67
           L   + V++ +T+     ER +L  V         PF+V + YAF T  KL  ILD ++G
Sbjct: 36  LQKAALVQKAKTVEHTRTERNVLEHVR------QSPFLVTLHYAFQTEAKLHLILDYVSG 89

Query: 68  GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDL 127
           G++  HL Q   F+EDE+RFY+ E+IL LEH+H+  IVYRD+K  NILLD  GHV ++D 
Sbjct: 90  GEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDF 149

Query: 128 GLACDF 133
           GL+ +F
Sbjct: 150 GLSKEF 155

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  111 bits (280), Expect = 1e-30
 Identities = 47/93 (50%), Positives = 63/93 (67%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ V  PF+V + Y+F T DKL F+LD +NGG+L +HL +   F E   RFYAAE+   L
Sbjct: 50  LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASAL 109

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
            ++H   I+YRDLKP NILLD  GHV ++D GL
Sbjct: 110 GYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  110 bits (277), Expect = 1e-30
 Identities = 53/124 (42%), Positives = 75/124 (60%), Gaps = 9/124 (7%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           K GE +AL E+ +L       + V+ PFIV + YAF +   LC ++ LMNGGDL YH+  
Sbjct: 34  KSGEKMALLEKEIL-------EKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN 86

Query: 77  HGVFNEDEMR--FYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
            G    +  R   Y+A++  G+ H+H   IVYRD+KP N+LLD+ G+ R+SDLGLA +  
Sbjct: 87  VGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK 146

Query: 135 KKKP 138
             K 
Sbjct: 147 DGKT 150

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  109 bits (273), Expect = 1e-29
 Identities = 43/87 (49%), Positives = 66/87 (75%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  + Y+F T D+LCF+++ +NGG+L +HLS+  VF+ED  RFY AE++  L+++H  
Sbjct: 55  PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            IVYRDLK  N++LD+ GH++I+D GL
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  106 bits (266), Expect = 6e-29
 Identities = 47/91 (51%), Positives = 65/91 (71%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+V + YAF T  KL  ILD +NGG+L  HLSQ   F E E++ Y+ E++L LEH+H+ 
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDF 133
            I+YRD+K  NILLD +GHV ++D GL+ +F
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  105 bits (265), Expect = 1e-28
 Identities = 39/112 (34%), Positives = 66/112 (58%), Gaps = 6/112 (5%)

Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
              E+ +L+      ++   P I+ + Y F   + L F+L+    G+L  ++ ++G  +E
Sbjct: 48  VKIEKEVLT------RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDE 101

Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
              RFYAAE++L LE++H + I++RDLKP NILLD+  H++I+D G A    
Sbjct: 102 KCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  106 bits (265), Expect = 2e-28
 Identities = 45/87 (51%), Positives = 60/87 (68%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+V + Y+F T +KL F+LD +NGG+L +HL +   F E   RFYAAEV   + ++H  
Sbjct: 56  PFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            I+YRDLKP NILLD  GHV ++D GL
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 2e-28
 Identities = 39/97 (40%), Positives = 62/97 (63%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           D P+IV + Y+F   + L  +++ M GGDL   L +  VF E+  RFY AE++L L+ +H
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH 118

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
           +   ++RD+KP NIL+D  GH++++D GL    +K K
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  104 bits (262), Expect = 2e-28
 Identities = 41/107 (38%), Positives = 63/107 (58%), Gaps = 7/107 (6%)

Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            L ER +LS           P++V + Y+F     L  +++ + GGDL   L   G  +E
Sbjct: 40  VLTERDILSQAQ-------SPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE 92

Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
           D  R Y AE++L LE++H   I++RDLKP NIL+D +GH++++D GL
Sbjct: 93  DVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGL 139

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  105 bits (264), Expect = 3e-28
 Identities = 44/105 (41%), Positives = 69/105 (65%), Gaps = 6/105 (5%)

Query: 26  ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEM 85
           ER +L+L        + PF+  +   F T + L F+++ +NGGDL +H+   G F+E   
Sbjct: 45  ERRVLALAW------EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA 98

Query: 86  RFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           RFYAAE+I GL+ +H++ I+YRDLK  N+LLD+ GH++I+D G+ 
Sbjct: 99  RFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMC 143

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  105 bits (263), Expect = 3e-28
 Identities = 52/113 (46%), Positives = 72/113 (63%), Gaps = 6/113 (5%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           K+ E   ++ER +L      ++ V  PF+V + ++F T DKL F+LD +NGG+L YHL +
Sbjct: 36  KKEEKHIMSERNVL------LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR 89

Query: 77  HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
              F E   RFYAAE+   L ++H   IVYRDLKP NILLD  GH+ ++D GL
Sbjct: 90  ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  105 bits (263), Expect = 3e-28
 Identities = 42/88 (47%), Positives = 66/88 (75%), Gaps = 1/88 (1%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH-R 101
           PF+  + Y+F T D+LCF+++  NGG+L +HLS+  VF+ED  RFY AE++  L+++H  
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 114

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGL 129
           + +VYRDLK  N++LD+ GH++I+D GL
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGL 142

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 6e-28
 Identities = 47/119 (39%), Positives = 66/119 (55%), Gaps = 11/119 (9%)

Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ---HGV 79
            L E+ +L+ +       D PF+  +  +F T   LC ++D   GG+L   L Q      
Sbjct: 48  VLTEQEILATL-------DHPFLPTLYASFQTETYLCLVMDYCPGGELF-RLLQRQPGKC 99

Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 138
            +E+  RFYAAEV+L LE++H   IVYRDLKP NILL E GH+ +SD  L+     + P
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  103 bits (259), Expect = 1e-27
 Identities = 47/93 (50%), Positives = 63/93 (67%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ V  PF+V + Y+F T +KL F+LD +NGG+L +HL +   F E   RFYAAE+   L
Sbjct: 50  LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASAL 109

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
            ++H   IVYRDLKP NILLD  GHV ++D GL
Sbjct: 110 GYLHSINIVYRDLKPENILLDSQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  101 bits (255), Expect = 2e-27
 Identities = 46/135 (34%), Positives = 67/135 (49%), Gaps = 15/135 (11%)

Query: 13  CSHVKQGETLALNERIMLSLVSTGIQ-----------MVDCPFIVCMTYAFHTPDKLCFI 61
                +  T AL       +V TG Q             + PFIV +   F     +  +
Sbjct: 12  VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71

Query: 62  LDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH 121
           ++   GG+L   L   G+F+E   RFY A V+L  E++H R I+YRDLKP N+LLD +G+
Sbjct: 72  MEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY 131

Query: 122 VRISDLGLACDFSKK 136
           V++ D G    F+KK
Sbjct: 132 VKLVDFG----FAKK 142

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  102 bits (256), Expect = 4e-27
 Identities = 46/123 (37%), Positives = 76/123 (61%), Gaps = 4/123 (3%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +K+ E L + +   ++   + +  +  PFIV M  +F   +++ F+L+ + GG+L  HL 
Sbjct: 51  LKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           + G F  D  +FY AE++L  E++H + I+YRDLKP N+LLD  GHV+++D G    F+K
Sbjct: 111 KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFG----FAK 166

Query: 136 KKP 138
           K P
Sbjct: 167 KVP 169

Length = 329

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  102 bits (255), Expect = 6e-27
 Identities = 42/87 (48%), Positives = 57/87 (65%), Gaps = 1/87 (1%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+V +   F T D +CF+++   GGDL  H+    VF+E    FYAA V+LGL+++H  
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHEN 120

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            IVYRDLK  N+LLD  G V+I+D GL
Sbjct: 121 KIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 1e-26
 Identities = 34/90 (37%), Positives = 61/90 (67%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P++  + Y+F + D L  +++ +NGGD    +   G   ED  + Y AEV+LG+E +H
Sbjct: 55  ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH 114

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +R I++RD+KP N+L+D+ GH++++D GL+
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLS 144

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  101 bits (253), Expect = 1e-26
 Identities = 40/87 (45%), Positives = 59/87 (67%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  +   F T D+L F+++ +NGGDL YH+ Q G F E    FYAAE+ +GL  +H +
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            I+YRDLK  N++LD  GH++I+D G+
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGM 147

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 98.1 bits (244), Expect = 2e-25
 Identities = 42/87 (48%), Positives = 61/87 (70%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  +   F T D+L F+++ +NGGDL YH+ Q G F E +  FYAAE+ +GL  +HRR
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            I+YRDLK  N++LD  GH++I+D G+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGM 147

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 97.3 bits (242), Expect = 3e-25
 Identities = 38/87 (43%), Positives = 58/87 (66%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  +   F TPD+L F+++ +NGGDL +H+ +   F+E   RFYAAE+   L  +H +
Sbjct: 56  PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            I+YRDLK  N+LLD  GH +++D G+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 96.5 bits (240), Expect = 8e-25
 Identities = 39/87 (44%), Positives = 57/87 (65%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  +   F T D+L F+++ +NGGDL + + +   F+E   RFYAAEV L L  +HR 
Sbjct: 56  PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            ++YRDLK  NILLD  GH +++D G+
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 95.3 bits (237), Expect = 3e-24
 Identities = 36/87 (41%), Positives = 58/87 (66%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+V +   F T  +L F+++ ++GGDL +H+ +     E+  RFY+AE+ L L  +H R
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            I+YRDLK  N+LLD  GH++++D G+
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 91.5 bits (228), Expect = 8e-24
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 2/103 (1%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH-YHLSQHGVFNEDEMRFYAAEVILG 95
           ++ ++ P IV +   F   + L  +++   GG L        G  +EDE+     +++ G
Sbjct: 45  LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEG 104

Query: 96  LEHMHRRYIVYRDLKPANILLDE-HGHVRISDLGLACDFSKKK 137
           LE++H   I++RDLKP NILLD  +G V+++D GL+   +  K
Sbjct: 105 LEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 93.5 bits (232), Expect = 9e-24
 Identities = 39/87 (44%), Positives = 58/87 (66%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  +   F T D+L F+++ +NGGDL Y + Q G F E    FYAAE+ +GL  +H +
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            I+YRDLK  N++LD  GH++I+D G+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGM 147

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 93.7 bits (233), Expect = 1e-23
 Identities = 37/93 (39%), Positives = 59/93 (63%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           D  ++V + Y+F   D L F++D + GGD+   L + G+F ED  RFY AE+   +E +H
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH 118

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           +   ++RD+KP NIL+D  GH++++D GL   F
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 93.0 bits (231), Expect = 3e-23
 Identities = 40/101 (39%), Positives = 63/101 (62%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           D P++V + Y+F     L  I++ + GGDL   L ++  F+ED  RFY AE +L +E +H
Sbjct: 59  DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
           +   ++RD+KP NIL+D  GH+++SD GL+  F K+   A 
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 92.0 bits (228), Expect = 3e-23
 Identities = 38/92 (41%), Positives = 61/92 (66%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           Q  + PF+V +   F T  +L F+++ +NGGDL +H+ +     E+  RFY+AE+ L L 
Sbjct: 51  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
           ++H R I+YRDLK  N+LLD  GH++++D G+
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 91.5 bits (227), Expect = 5e-23
 Identities = 36/89 (40%), Positives = 59/89 (66%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + PF+  +   F T + L F+++ +NGGDL +H+   G F+     FYAAE++ GL+ +H
Sbjct: 54  ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGL 129
            + I+YRDLK  N++LD  GH++I+D G+
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 91.2 bits (226), Expect = 7e-23
 Identities = 39/89 (43%), Positives = 58/89 (65%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + PF+  +   F T + L F+++ +NGGDL +H+     F+     FYAAE+I GL+ +H
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGL 129
            + IVYRDLK  NILLD  GH++I+D G+
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 90.6 bits (225), Expect = 8e-23
 Identities = 41/106 (38%), Positives = 64/106 (60%), Gaps = 7/106 (6%)

Query: 25  NERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDE 84
           NE+ +L  VS        PFI+ + +  H    L  +++ + GG+L  +L   G F+   
Sbjct: 50  NEKRVLKEVSH-------PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNST 102

Query: 85  MRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             FYA+E++  LE++H + IVYRDLKP NILLD+ GH++++D G A
Sbjct: 103 GLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA 148

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 90.5 bits (225), Expect = 2e-22
 Identities = 37/96 (38%), Positives = 59/96 (61%)

Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
            D P++V + Y+F   + L  I++ + GGD+   L +   F E+E RFY AE IL ++ +
Sbjct: 58  ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI 117

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           H+   ++RD+KP N+LLD  GH+++SD GL     K
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 88.2 bits (218), Expect = 1e-21
 Identities = 36/87 (41%), Positives = 57/87 (65%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+V +   F T  +L  +++ +NGGDL +H+ +     E+  RFYAAE+ + L  +H R
Sbjct: 56  PFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            I+YRDLK  N+LLD  GH++++D G+
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 86.5 bits (215), Expect = 2e-21
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 2/92 (2%)

Query: 41  DCPFIVCMTYAFHTPDK--LCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEH 98
             P IV    +    +K  L   L+ ++GG L   L + G   E  +R Y  +++ GL +
Sbjct: 57  QHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAY 116

Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +H   IV+RD+K ANIL+D  G V+++D G A
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCA 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 86.0 bits (214), Expect = 2e-21
 Identities = 34/113 (30%), Positives = 62/113 (54%), Gaps = 13/113 (11%)

Query: 23  ALNE-RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-- 79
           ALNE +I+  L        + P I+    +F    KLC +++  +GGDL   + +     
Sbjct: 46  ALNEVKILKKL--------NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG 97

Query: 80  --FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             F E+++  +  ++ L L+++H R I++RD+KP NI L  +G V++ D G++
Sbjct: 98  KPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 86.2 bits (213), Expect = 1e-20
 Identities = 37/93 (39%), Positives = 59/93 (63%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           D  ++V + Y+F   D L F++D + GGD+   L + G+F ED  RFY AE+   +E +H
Sbjct: 59  DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH 118

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           +   ++RD+KP NIL+D  GH++++D GL   F
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 86.5 bits (214), Expect = 1e-20
 Identities = 32/88 (36%), Positives = 58/88 (65%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PFIV + Y+  + + +  +++ + GGD+   L  +G F+E+    Y +EV L L+++HR 
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            I++RDLKP N+L+   GH++++D GL+
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 5e-20
 Identities = 37/108 (34%), Positives = 60/108 (55%), Gaps = 9/108 (8%)

Query: 24  LNER-IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
           L ER I+ +  S         ++V + YAF   + L   ++ + GGD    L+  GV +E
Sbjct: 49  LTERDILTTTKS--------EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSE 100

Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           D  RFY AE+   ++ +H    ++RDLKP N L+D  GH++++D GL+
Sbjct: 101 DHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 83.1 bits (205), Expect = 1e-19
 Identities = 37/93 (39%), Positives = 58/93 (62%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           D  ++V + Y+F   D L F++D + GGD+   L +  VF E   RFY AE+ L +E +H
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           +   ++RD+KP NIL+D  GH++++D GL   F
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 81.4 bits (201), Expect = 4e-19
 Identities = 39/113 (34%), Positives = 67/113 (59%), Gaps = 8/113 (7%)

Query: 26  ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDE 84
           ER +LS+ ++       P+I  + YAF   D L  +++   GGDL   L+++   F+ED 
Sbjct: 51  ERDILSISNS-------PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM 103

Query: 85  MRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
            +FY AE++L +  +H+   V+RD+KP N+L+D  GH++++D G A   +  K
Sbjct: 104 AQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 79.8 bits (197), Expect = 9e-19
 Identities = 41/112 (36%), Positives = 61/112 (54%), Gaps = 1/112 (0%)

Query: 20  ETLALNERIMLSLVSTGI-QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG 78
           + L L  +I    V   I    + PF+V M  +F T   LC +++ + GGD    L   G
Sbjct: 37  QNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG 96

Query: 79  VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
               D  R Y AE +L LE++H   IV+RDLKP N+L+   GH++++D GL+
Sbjct: 97  ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 78.8 bits (195), Expect = 1e-18
 Identities = 34/126 (26%), Positives = 68/126 (53%), Gaps = 10/126 (7%)

Query: 15  HVKQGETLALNERIMLSLVSTGIQM---------VDCPFIVCMTYAFHTPDKLCFILDLM 65
           H   G+  AL +  +        Q+          + P++V    AF+   ++  +L+ M
Sbjct: 22  HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81

Query: 66  NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRI 124
           +GG L   L + G   E  + + A +++ GL+++H  R+I++RD+KP+N+L++  G V+I
Sbjct: 82  DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKI 141

Query: 125 SDLGLA 130
           +D G++
Sbjct: 142 ADFGIS 147

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 3e-18
 Identities = 36/89 (40%), Positives = 56/89 (62%), Gaps = 1/89 (1%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHM 99
           D  +I  + YAF   + L  ++D   GGDL   LS+      ED  RFY AE++L ++ +
Sbjct: 59  DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLG 128
           H+   V+RD+KP N+LLD++GH+R++D G
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFG 147

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 77.2 bits (191), Expect = 4e-18
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMH 100
           P IV    ++   D+L  +++  +GG L   L +       E ++ +   E++ GLE++H
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSL-KDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 138
              I++RD+K ANILL   G V++ D GL+   S  K 
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 78.5 bits (193), Expect = 4e-18
 Identities = 34/95 (35%), Positives = 56/95 (58%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           D  ++V M Y+F     L  I++ + GGD+   L +    +E+  +FY AE +L ++ +H
Sbjct: 59  DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           +   ++RD+KP N+LLD  GHV++SD GL     K
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 78.1 bits (192), Expect = 5e-18
 Identities = 37/89 (41%), Positives = 56/89 (62%), Gaps = 1/89 (1%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHM 99
           DC +I  + YAF   + L  ++D   GGDL   LS+      ED  RFY AE++L +  +
Sbjct: 59  DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLG 128
           H+ + V+RD+KP N+LLD +GH+R++D G
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 78.2 bits (192), Expect = 6e-18
 Identities = 35/95 (36%), Positives = 56/95 (58%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           D  ++V M Y+F     L  I++ + GGD+   L +     E+E +FY AE +L ++ +H
Sbjct: 59  DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH 118

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           +   ++RD+KP N+LLD  GHV++SD GL     K
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 77.1 bits (190), Expect = 1e-17
 Identities = 34/86 (39%), Positives = 54/86 (62%), Gaps = 1/86 (1%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
            +IV + YAF     L  +++ M GGDL   +S + +  E   RFY AEV+L L+ +H  
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVVLALDAIHSM 161

Query: 103 YIVYRDLKPANILLDEHGHVRISDLG 128
             ++RD+KP N+LLD+ GH++++D G
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 2e-17
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 2/94 (2%)

Query: 52  FHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKP 111
             T D L  IL+    G L   + + G F E  +  Y  +V+ GL ++H + +++RD+K 
Sbjct: 68  IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKA 127

Query: 112 ANILLDEHGHVRISDLGLACDFSK--KKPHASVG 143
           ANIL  + G V+++D G+A   +   K   + VG
Sbjct: 128 ANILTTKDGVVKLADFGVATKLNDVSKDDASVVG 161

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 75.2 bits (185), Expect = 3e-17
 Identities = 33/75 (44%), Positives = 51/75 (68%)

Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           D L   L+L+ GG L   L ++G F E  +R Y  +++LGLE++H R  V+RD+K ANIL
Sbjct: 75  DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANIL 134

Query: 116 LDEHGHVRISDLGLA 130
           +D +G V+++D G+A
Sbjct: 135 VDTNGVVKLADFGMA 149

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 4e-17
 Identities = 26/76 (34%), Positives = 43/76 (56%)

Query: 55  PDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
            + L   ++ M GG +   L  +G   E   R Y  +++ G+E++H   IV+RD+K ANI
Sbjct: 76  DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANI 135

Query: 115 LLDEHGHVRISDLGLA 130
           L D  G+V++ D G +
Sbjct: 136 LRDSAGNVKLGDFGAS 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 73.6 bits (181), Expect = 9e-17
 Identities = 38/113 (33%), Positives = 62/113 (54%), Gaps = 13/113 (11%)

Query: 23  ALNE-RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--- 78
           A+NE RI+ S        V+ P I+    AF   +KLC +++    GDL   +S+     
Sbjct: 46  AVNEIRILAS--------VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR 97

Query: 79  -VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            +  E E+     +++ GL+ +H + I++RDLK ANILL  +  V+I DLG++
Sbjct: 98  KLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGIS 150

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 73.2 bits (179), Expect = 3e-16
 Identities = 35/89 (39%), Positives = 56/89 (62%), Gaps = 1/89 (1%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHM 99
           D  +I  + YAF   + L  ++D   GGDL   LS+      ED  RFY AE+++ ++ +
Sbjct: 59  DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLG 128
           H+ + V+RD+KP NIL+D +GH+R++D G
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 72.0 bits (176), Expect = 1e-15
 Identities = 36/96 (37%), Positives = 59/96 (61%), Gaps = 1/96 (1%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P++V + YAF     L  +++ M GGDL   +S + V  E   RFY AEV+L L+ +H
Sbjct: 101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIH 159

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
               ++RD+KP N+LLD+ GH++++D G     +K+
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 72.0 bits (176), Expect = 1e-15
 Identities = 34/88 (38%), Positives = 57/88 (64%), Gaps = 1/88 (1%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P++V +  AF     L  +++ M GGDL   +S + V  E   +FY AEV+L L+ +H
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTAEVVLALDAIH 159

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLG 128
              +++RD+KP N+LLD+HGH++++D G
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 69.9 bits (172), Expect = 3e-15
 Identities = 26/102 (25%), Positives = 47/102 (46%), Gaps = 9/102 (8%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMR---------FY 88
           + +  P +V +       + L  +L+ M GGDL  +L +         +          +
Sbjct: 51  KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           A ++  G+E++  +  V+RDL   N L+ E   V+ISD GL+
Sbjct: 111 AIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 69.5 bits (171), Expect = 4e-15
 Identities = 39/126 (30%), Positives = 67/126 (53%), Gaps = 12/126 (9%)

Query: 17  KQGETLALNE-RIMLSLVSTGI-QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL 74
           KQ + L +NE  IM       I    D          +   D+L  +++ M+GG L   +
Sbjct: 56  KQNKELIINEILIMKDCKHPNIVDYYDS---------YLVGDELWVVMEYMDGGSLTDII 106

Query: 75  SQHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           +Q+ V  NE ++ +   EV+ GLE++H + +++RD+K  NILL + G V+++D G A   
Sbjct: 107 TQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166

Query: 134 SKKKPH 139
           +K+K  
Sbjct: 167 TKEKSK 172

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 69.4 bits (171), Expect = 5e-15
 Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 2/94 (2%)

Query: 42  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMH 100
            P IV +    HT  KL  + +  +  DL  +L +  G  + + ++    +++ GL + H
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
              I++RDLKP NIL++  G ++++D GLA  F 
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFG 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 69.1 bits (170), Expect = 5e-15
 Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 10/108 (9%)

Query: 27  RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFNEDE 84
           RIM  L        D P IV +       + L  +++ M GGDL  +L ++     +  +
Sbjct: 53  RIMRKL--------DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSD 104

Query: 85  MRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
           +  +A ++  G+E++  +  ++RDL   N L+ E+  V+ISD GL+ D
Sbjct: 105 LLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD 152

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 69.2 bits (170), Expect = 5e-15
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 20/139 (14%)

Query: 15  HVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPDKLCFIL- 62
             + GET+AL +++ L  +  GI           Q    P++V +   F  P    F+L 
Sbjct: 21  DRETGETVAL-KKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF--PHGSGFVLV 77

Query: 63  -DLMNGGDLHYHL--SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            + M   DL   L   +     E +++ Y   ++ G+ +MH   I++RDLKPAN+L+   
Sbjct: 78  MEYM-PSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD 135

Query: 120 GHVRISDLGLACDFSKKKP 138
           G ++I+D GLA  FS+++P
Sbjct: 136 GVLKIADFGLARLFSEEEP 154

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 69.4 bits (168), Expect = 1e-14
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 4/104 (3%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLH---YHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           P IV +   F     L  +++ ++GG L      + + G  +E E  F  A+++  LE++
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 100 HRRYIVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV 142
           H + I++RD+KP NILLD  G  V++ D GLA         +S+
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI 161

Length = 384

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 67.9 bits (167), Expect = 1e-14
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 9/107 (8%)

Query: 27  RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEM 85
           RIM  L        D P +V +       + L  +++ M GGDL  +L ++    +  ++
Sbjct: 53  RIMRKL--------DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDL 104

Query: 86  RFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
             +A ++  G+E++  +  ++RDL   N L+ E+  V+ISD GL+ D
Sbjct: 105 LSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD 151

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 67.6 bits (166), Expect = 3e-14
 Identities = 24/90 (26%), Positives = 43/90 (47%), Gaps = 14/90 (15%)

Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEV-------ILGLEHMHRRY 103
            F     +  + + M   DL        V  +  +    A++       + GLE++H  +
Sbjct: 70  VFGHKSNINLVFEFM-ETDLE------KVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122

Query: 104 IVYRDLKPANILLDEHGHVRISDLGLACDF 133
           I++RDLKP N+L+   G ++++D GLA  F
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSF 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 67.7 bits (165), Expect = 3e-14
 Identities = 33/94 (35%), Positives = 55/94 (58%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +  ++ PF V +  +F     L  +L+ + GG+    L ++  F  D   FYAA+++L  
Sbjct: 85  LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           E++    IVYRDLKP N+LLD+ G ++++D G A
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178

Length = 340

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 66.0 bits (162), Expect = 8e-14
 Identities = 21/66 (31%), Positives = 43/66 (65%), Gaps = 1/66 (1%)

Query: 74  LSQHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
           L    V F E +++ Y  +++ GL+++H   I++RD+K +NIL++  G ++++D GLA  
Sbjct: 90  LDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARP 149

Query: 133 FSKKKP 138
           ++K+  
Sbjct: 150 YTKRNS 155

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 65.6 bits (161), Expect = 9e-14
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 1/92 (1%)

Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEH 98
           +  P IV +       + L  + + M GGDL   L +HG      ++   A ++  G+E+
Sbjct: 58  LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +  +  V+RDL   N L+ E+  V+ISD GL+
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLS 149

Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 65.6 bits (160), Expect = 1e-13
 Identities = 40/124 (32%), Positives = 70/124 (56%), Gaps = 13/124 (10%)

Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD 69
           LS  +  ++ E  A++E  +L+        +D  +I+    +F    KL  +++    GD
Sbjct: 35  LSKMNRREREE--AIDEARVLA-------KLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85

Query: 70  LHYHL-SQHGV-FNEDEM-RFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           LH  L  Q G    ED++ RF+  +++LGL H+H + I++RD+K  N+ LD + +V+I D
Sbjct: 86  LHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGD 144

Query: 127 LGLA 130
           LG+A
Sbjct: 145 LGVA 148

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 65.3 bits (159), Expect = 1e-13
 Identities = 30/83 (36%), Positives = 51/83 (61%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P +VC+     + D +  +L    GG L  H+S+     E+ ++ +AAE+++ L+ +HR 
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 103 YIVYRDLKPANILLDEHGHVRIS 125
            IV RDL P NILLD+ GH++++
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLT 127

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.5 bits (160), Expect = 1e-13
 Identities = 36/113 (31%), Positives = 61/113 (53%), Gaps = 6/113 (5%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL----HYHLSQHGVFNEDEMRFYAAEV 92
           ++ +D P ++    +F   ++L  +L+L + GDL     +   Q  +  E  +  Y  ++
Sbjct: 56  LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG 143
              LEHMH + I++RD+KPAN+ +   G V++ DLGL   FS K    H+ VG
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 65.6 bits (160), Expect = 1e-13
 Identities = 31/81 (38%), Positives = 50/81 (61%), Gaps = 4/81 (4%)

Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           D L   L+ + GG +   L+ +G F E  +R +  +++ GL ++H R I++RD+K ANIL
Sbjct: 79  DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL 138

Query: 116 LDEHGHVRISDLGLACDFSKK 136
           +D  G ++ISD G+    SKK
Sbjct: 139 VDNKGGIKISDFGI----SKK 155

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 2e-13
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 4/90 (4%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMH 100
           P I+ +   F     L  + + M+  DL Y L +       E  ++ Y  +++ GL   H
Sbjct: 58  PNIIKLLDVFRHKGDLYLVFEFMDT-DL-YKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              I++RDLKP N+L++  G ++++D GLA
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLA 145

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 63.9 bits (156), Expect = 4e-13
 Identities = 36/135 (26%), Positives = 66/135 (48%), Gaps = 17/135 (12%)

Query: 8   GFLSNCSHVKQGETLA-----------LNERIMLSLVSTGIQM-VDCPFIVCMTYAFHTP 55
           G +S   H   G+ +A           + ++I+  L    I    + P+IV    AF+  
Sbjct: 15  GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILREL---DILHKCNSPYIVGFYGAFYNN 71

Query: 56  DKLCFILDLMNGGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRY-IVYRDLKPAN 113
             +   ++ M+GG L   L +  G   E  +   A  V+ GL ++H ++ I++RD+KP+N
Sbjct: 72  GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131

Query: 114 ILLDEHGHVRISDLG 128
           IL++  G +++ D G
Sbjct: 132 ILVNSRGQIKLCDFG 146

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 63.3 bits (154), Expect = 8e-13
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 2/90 (2%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGV-FNEDEMRFYAAEVILGLEHMH 100
           P IV    +F     L  ++D   GGDL+  + +Q GV F ED++  +  ++ L L+H+H
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            R I++RD+K  NI L + G +++ D G+A
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIA 148

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 63.0 bits (153), Expect = 1e-12
 Identities = 41/147 (27%), Positives = 73/147 (49%), Gaps = 22/147 (14%)

Query: 4   IVGTGFLSNC---SHVKQGETLAL------------NERIMLSLVSTGIQMV---DCPFI 45
            +GTG  S+C     VK G  +A+             E ++ +L    I+++   + P I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKE-IRLMARLNHPHI 65

Query: 46  V-CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           +  +           F+ + M GG + + LS++G F E  +  Y  +++ GL ++H   I
Sbjct: 66  IRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 105 VYRDLKPANILLDEHGH-VRISDLGLA 130
           ++RD+K AN+L+D  G  +RI+D G A
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 61.9 bits (150), Expect = 2e-12
 Identities = 33/91 (36%), Positives = 57/91 (62%), Gaps = 3/91 (3%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGV-FNEDEMRFYAAEVILGLEHMH 100
           P IV    +F    +L  +++  +GGDL   ++ Q GV F+ED++  +  ++ LGL+H+H
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 101 RRYIVYRDLKPANILLDEHGHV-RISDLGLA 130
            R I++RD+K  NI L ++G V ++ D G+A
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.0 bits (150), Expect = 2e-12
 Identities = 26/76 (34%), Positives = 42/76 (55%)

Query: 53  HTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPA 112
               KL   ++ M GG +   L  +G   E+  R Y  +++ G+ ++H   IV+RD+K A
Sbjct: 76  PEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGA 135

Query: 113 NILLDEHGHVRISDLG 128
           NIL D  G+V++ D G
Sbjct: 136 NILRDSAGNVKLGDFG 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.3 bits (152), Expect = 3e-12
 Identities = 26/90 (28%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 45  IVCMTYAFHTPDKLC----FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           I+ +      P         ++DLM   DLH+ +       E+ +R++  +++ GL+++H
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              +++RDLKP+N+L++E   +RI D G+A
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMA 154

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 62.2 bits (152), Expect = 3e-12
 Identities = 25/99 (25%), Positives = 53/99 (53%), Gaps = 6/99 (6%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAE 91
           ++ +    I+ +      P    F     + +LM   DLH  +       +D ++++  +
Sbjct: 53  LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQ 111

Query: 92  VILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           ++ GL+++H   +++RDLKP+NIL++ +  ++I D GLA
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 61.7 bits (150), Expect = 3e-12
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 5/93 (5%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS----QHGVFNEDEMRFYAAEVILGLEH 98
           P IV     F   D+L  ++DL+ G  L  H +    +   F E+ +     +++L L +
Sbjct: 69  PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128

Query: 99  MHR-RYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +H+ + IV+RDL P NI+L E   V I+D GLA
Sbjct: 129 LHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 3e-12
 Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 6/99 (6%)

Query: 37  IQMV-DC--PFIVCMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFNEDEMRFYAAE 91
           I M+ +C  P IV    ++   DKL  +++   GG L   Y +++ G  +E ++ +   E
Sbjct: 51  ISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRE 109

Query: 92  VILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + GL ++H    ++RD+K ANILL E G V+++D G++
Sbjct: 110 TLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.5 bits (149), Expect = 4e-12
 Identities = 29/87 (33%), Positives = 54/87 (62%), Gaps = 2/87 (2%)

Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRY 103
           IV +    HT + L F+ + M+  DL  ++ QH G  +   +R +  +++ GL ++H ++
Sbjct: 65  IVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123

Query: 104 IVYRDLKPANILLDEHGHVRISDLGLA 130
           I++RDLKP N+L+   G ++++D GLA
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 60.6 bits (147), Expect = 6e-12
 Identities = 40/131 (30%), Positives = 65/131 (49%), Gaps = 11/131 (8%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           K     A NE  +L L+S        P I+     F     L  +++   GG L  ++ +
Sbjct: 40  KDERLAAQNECQVLKLLSH-------PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK 92

Query: 77  HG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHV-RISDLGLACDF 133
               + +ED +  +  +++L L H+H + I++RDLK  NILLD+H  V +I D G++   
Sbjct: 93  RCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152

Query: 134 -SKKKPHASVG 143
            SK K +  VG
Sbjct: 153 SSKSKAYTVVG 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.8 bits (147), Expect = 6e-12
 Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 6/102 (5%)

Query: 37  IQMVDC--PFIVCMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFNEDEMRFYAAEV 92
           I M DC    IV    ++   DKL   ++   GG L   YH++  G  +E ++ + + E 
Sbjct: 58  IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRET 115

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           + GL ++H +  ++RD+K ANILL ++GHV+++D G++   +
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 60.6 bits (147), Expect = 7e-12
 Identities = 28/77 (36%), Positives = 47/77 (61%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
           T + L   L+ + GG +   L  +G F E  +RF+  +V+ GL ++H + I++RDLK  N
Sbjct: 79  TEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADN 138

Query: 114 ILLDEHGHVRISDLGLA 130
           +L+D  G  +ISD G++
Sbjct: 139 LLVDADGICKISDFGIS 155

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 60.4 bits (147), Expect = 7e-12
 Identities = 26/79 (32%), Positives = 45/79 (56%), Gaps = 5/79 (6%)

Query: 56  DKLCFILDLMNGGDLHYHLSQH----GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKP 111
           D+L  ++  ++GG L   + +     G  +E  +     EV+ GLE++H    ++RD+K 
Sbjct: 72  DELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKA 130

Query: 112 ANILLDEHGHVRISDLGLA 130
            NILL E G V+I+D G++
Sbjct: 131 GNILLGEDGSVKIADFGVS 149

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.5 bits (146), Expect = 8e-12
 Identities = 29/96 (30%), Positives = 54/96 (56%), Gaps = 1/96 (1%)

Query: 35  TGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVIL 94
           T +   D P++     ++    KL  I++ + GG     L + G  +E ++     E++ 
Sbjct: 54  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATILREILK 112

Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           GL+++H    ++RD+K AN+LL EHG V+++D G+A
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.5 bits (146), Expect = 9e-12
 Identities = 27/87 (31%), Positives = 56/87 (64%), Gaps = 2/87 (2%)

Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRY 103
           IV +    HT + L  + + ++  DL  ++ +H G  + + ++ +  +++ GL ++H+RY
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123

Query: 104 IVYRDLKPANILLDEHGHVRISDLGLA 130
           I++RDLKP N+L+ + G ++++D GLA
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 60.1 bits (145), Expect = 1e-11
 Identities = 29/96 (30%), Positives = 54/96 (56%), Gaps = 1/96 (1%)

Query: 35  TGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVIL 94
           T +   D P++     ++    KL  I++ + GG     L + G F+E ++     E++ 
Sbjct: 54  TVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA-LDLLRAGPFDEFQIATMLKEILK 112

Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           GL+++H    ++RD+K AN+LL E G V+++D G+A
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.9 bits (146), Expect = 1e-11
 Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 4/97 (4%)

Query: 37  IQMV---DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVI 93
           IQ +     P+I     +F    KL  I++   GG     L + G  +E  + F   EV+
Sbjct: 50  IQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIAFILREVL 108

Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           LGLE++H    ++RD+K ANILL E G V+++D G++
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 58.5 bits (141), Expect = 4e-11
 Identities = 35/113 (30%), Positives = 61/113 (53%), Gaps = 6/113 (5%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH----YHLSQHGVFNEDEMRFYAAEV 92
           ++ ++ P ++    +F   ++L  +L+L + GDL     Y   Q  +  E  +  Y  ++
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVG 143
              +EHMH R +++RD+KPAN+ +   G V++ DLGL   FS K    H+ VG
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 58.5 bits (141), Expect = 5e-11
 Identities = 36/114 (31%), Positives = 62/114 (54%), Gaps = 8/114 (7%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL-----HYHLSQHGVFNEDEMRFYAAE 91
           ++ ++ P ++    +F   ++L  +L+L + GDL     H+   Q  +  E  +  Y  +
Sbjct: 56  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQ 114

Query: 92  VILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVG 143
           +   LEHMH R +++RD+KPAN+ +   G V++ DLGL   FS K    H+ VG
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 58.0 bits (141), Expect = 5e-11
 Identities = 19/70 (27%), Positives = 37/70 (52%), Gaps = 8/70 (11%)

Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + D+M           +    E+E+     + + GLE++H    ++RD+K  NILL+E G
Sbjct: 85  VSDIMK--------ITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG 136

Query: 121 HVRISDLGLA 130
             +++D G++
Sbjct: 137 QAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 58.2 bits (141), Expect = 6e-11
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 1/89 (1%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFNEDEMRFYAAEVILGLEHMHR 101
           P IV +  A+   +KL  +++  +GG L    L       E ++R+   +++  L  +H 
Sbjct: 62  PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
             +++RDLK  NILL   G V+++D G++
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.2 bits (141), Expect = 7e-11
 Identities = 26/87 (29%), Positives = 50/87 (57%), Gaps = 2/87 (2%)

Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRY 103
           IV +    HT   L  + + ++  DL  ++   G   +   +R +  +++ GL + H+R 
Sbjct: 65  IVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR 123

Query: 104 IVYRDLKPANILLDEHGHVRISDLGLA 130
           +++RDLKP N+L+ E G ++++D GLA
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 57.8 bits (139), Expect = 7e-11
 Identities = 25/76 (32%), Positives = 40/76 (52%)

Query: 53  HTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPA 112
                L   ++ M GG +   L  +G   E   R Y  +++ G+ ++H   IV+RD+K A
Sbjct: 76  RAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGA 135

Query: 113 NILLDEHGHVRISDLG 128
           NIL D  G+V++ D G
Sbjct: 136 NILRDSAGNVKLGDFG 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 57.7 bits (139), Expect = 9e-11
 Identities = 25/76 (32%), Positives = 43/76 (56%), Gaps = 1/76 (1%)

Query: 54  TPDK-LCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPA 112
             ++ L   ++ M GG +   L  +G   E+  R Y  +++ G+ ++H   IV+RD+K A
Sbjct: 76  PMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGA 135

Query: 113 NILLDEHGHVRISDLG 128
           NIL D  G+V++ D G
Sbjct: 136 NILRDSVGNVKLGDFG 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 57.5 bits (140), Expect = 1e-10
 Identities = 28/78 (35%), Positives = 45/78 (57%), Gaps = 5/78 (6%)

Query: 56  DKLCFILDLMNGGDLHYHL---SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPA 112
           D+L F+ + M G +L Y L    +   F+E  +R    +++ GL H+H+    +RDLKP 
Sbjct: 71  DELYFVFEYMEG-NL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPE 128

Query: 113 NILLDEHGHVRISDLGLA 130
           N+L+     V+I+D GLA
Sbjct: 129 NLLVSGPEVVKIADFGLA 146

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 57.7 bits (139), Expect = 1e-10
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 4/87 (4%)

Query: 52  FHTPDKLCFILDLMNGGDLHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYR 107
           F + DKL  I++  +GGDL+  + Q    H  F E E+     +++L L+ +H R +++R
Sbjct: 134 FKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHR 193

Query: 108 DLKPANILLDEHGHVRISDLGLACDFS 134
           DLK ANI L   G +++ D G +  +S
Sbjct: 194 DLKSANIFLMPTGIIKLGDFGFSKQYS 220

Length = 478

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 56.6 bits (137), Expect = 2e-10
 Identities = 19/55 (34%), Positives = 39/55 (70%)

Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           F+E +++    +++ GL+++H  +I++RDLK +N+LL + G ++I+D GLA  + 
Sbjct: 105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 56.4 bits (136), Expect = 4e-10
 Identities = 23/70 (32%), Positives = 47/70 (67%), Gaps = 4/70 (5%)

Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           +L+ M+GG L        + +E  +   A +++ G+ ++HRR+IV+RD+KP+N+L++   
Sbjct: 150 LLEFMDGGSL----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK 205

Query: 121 HVRISDLGLA 130
           +V+I+D G++
Sbjct: 206 NVKIADFGVS 215

Length = 353

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 55.4 bits (134), Expect = 5e-10
 Identities = 24/100 (24%), Positives = 46/100 (46%), Gaps = 3/100 (3%)

Query: 43  PFIVCMTYAFH--TPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           P I+ +          +L  + +LM+         +     E  ++ Y  +++  L+HMH
Sbjct: 58  PNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           R  I +RD+KP NIL+ +   ++++D G       K P+ 
Sbjct: 118 RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 55.0 bits (133), Expect = 7e-10
 Identities = 29/77 (37%), Positives = 46/77 (59%), Gaps = 4/77 (5%)

Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNEDEM--RFYAAEVILGLEHMHRRYIVYRDLKPAN 113
           +K+   ++  +GG L   L +HG    DE   R Y  +++ GL ++H   IV+RD+KPAN
Sbjct: 72  EKVYIFMEYCSGGTLE-ELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPAN 129

Query: 114 ILLDEHGHVRISDLGLA 130
           I LD +G +++ D G A
Sbjct: 130 IFLDHNGVIKLGDFGCA 146

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.1 bits (133), Expect = 8e-10
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 9/97 (9%)

Query: 41  DCPFIVCMTYA-FHTPDKLCFI-LDLMNGG-DLHY---HLSQHGVFNEDEMRFYAAEVIL 94
           DCP+IV    A F   D  C+I ++LM+   D  Y   +     V  E+ +   A   + 
Sbjct: 61  DCPYIVKFYGALFREGD--CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118

Query: 95  GLEHMHRRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
            L ++     I++RD+KP+NILLD +G++++ D G++
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.2 bits (133), Expect = 8e-10
 Identities = 23/75 (30%), Positives = 43/75 (57%), Gaps = 1/75 (1%)

Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           D +  ++D+M   DL   + +     E +++    +++ GL  +H+ Y ++RDL PANI 
Sbjct: 93  DFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIF 151

Query: 116 LDEHGHVRISDLGLA 130
           ++  G  +I+D GLA
Sbjct: 152 INSKGICKIADFGLA 166

Length = 335

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 54.7 bits (131), Expect = 1e-09
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 1/96 (1%)

Query: 35  TGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVIL 94
           T +   D P+I     ++    KL  I++ + GG     L + G   E  +     E++ 
Sbjct: 54  TVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA-LDLLKPGPLEETYIATILREILK 112

Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           GL+++H    ++RD+K AN+LL E G V+++D G+A
Sbjct: 113 GLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 54.6 bits (131), Expect = 1e-09
 Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 2/87 (2%)

Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRY 103
           IV +    HT   L  + + ++  DL  +L   G   N   ++ +  +++ GL + HRR 
Sbjct: 66  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124

Query: 104 IVYRDLKPANILLDEHGHVRISDLGLA 130
           +++RDLKP N+L++E G ++++D GLA
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 54.3 bits (130), Expect = 1e-09
 Identities = 34/106 (32%), Positives = 61/106 (57%), Gaps = 7/106 (6%)

Query: 30  LSLVSTGIQMV-DCPF--IVCMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFNEDE 84
            SL+   I MV +C    IV    ++ + +KL   ++   GG L   YH++  G  +E +
Sbjct: 50  FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT--GPLSELQ 107

Query: 85  MRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + +   E + GL ++H +  ++RD+K ANILL ++G V+++D G+A
Sbjct: 108 IAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 54.6 bits (132), Expect = 1e-09
 Identities = 24/67 (35%), Positives = 45/67 (67%), Gaps = 2/67 (2%)

Query: 64  LMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR 123
           LM G DL+ ++ +    ++D ++F   +++ GL+++H   I++RDLKP+NI ++E   ++
Sbjct: 101 LM-GADLN-NIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 158

Query: 124 ISDLGLA 130
           I D GLA
Sbjct: 159 ILDFGLA 165

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 54.4 bits (131), Expect = 2e-09
 Identities = 27/106 (25%), Positives = 45/106 (42%), Gaps = 16/106 (15%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG----------------VFNEDEMR 86
           P IVC+          C + + +  GDLH  L ++                   +  +  
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 87  FYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
             A ++  G+E++   + V+RDL   N L+ E   V+ISD GL+ D
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 54.1 bits (130), Expect = 2e-09
 Identities = 28/87 (32%), Positives = 56/87 (64%), Gaps = 3/87 (3%)

Query: 45  IVCMTYAFHTP-DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY 103
           I+ ++  F +P + + F+ +L+ G DLH  L       +  ++++  +++ GL+++H   
Sbjct: 71  IISLSDIFISPLEDIYFVTELL-GTDLH-RLLTSRPLEKQFIQYFLYQILRGLKYVHSAG 128

Query: 104 IVYRDLKPANILLDEHGHVRISDLGLA 130
           +V+RDLKP+NIL++E+  ++I D GLA
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLA 155

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 53.9 bits (129), Expect = 2e-09
 Identities = 29/104 (27%), Positives = 58/104 (55%), Gaps = 1/104 (0%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P+IV    AF++  ++   ++ M+GG L   L + G   E  +   +  VI GL ++ 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120

Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
            ++ I++RD+KP+NIL++  G +++ D G++        ++ VG
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 164

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.8 bits (129), Expect = 2e-09
 Identities = 26/87 (29%), Positives = 52/87 (59%), Gaps = 2/87 (2%)

Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRY 103
           IV +    HT   L  + + ++  DL  ++   G + +   ++ +  +++ GL + HRR 
Sbjct: 66  IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124

Query: 104 IVYRDLKPANILLDEHGHVRISDLGLA 130
           +++RDLKP N+L++E G ++++D GLA
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 53.5 bits (129), Expect = 3e-09
 Identities = 27/70 (38%), Positives = 42/70 (60%), Gaps = 1/70 (1%)

Query: 69  DLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDL 127
           DL   LS   V F   E++     ++ GL ++HR  I++RD+K ANIL+ + G ++++D 
Sbjct: 104 DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163

Query: 128 GLACDFSKKK 137
           GLA  FS  K
Sbjct: 164 GLARAFSLSK 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 53.1 bits (127), Expect = 3e-09
 Identities = 27/90 (30%), Positives = 50/90 (55%), Gaps = 2/90 (2%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMH 100
           P IV    +F     L  +++  +GGDL   +      +F ED +  +  ++ LG++H+H
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + +++RD+K  NI L ++G V++ D G A
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSA 147

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 53.7 bits (129), Expect = 3e-09
 Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 8/82 (9%)

Query: 58  LCFILDLMNGGDLHYHLSQHG----VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
           +  +LD  N GDL   +         F E E      +V+L + H+H +++++RD+K AN
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173

Query: 114 ILLDEHGHVRISDLGLACDFSK 135
           ILL  +G V++ D G    FSK
Sbjct: 174 ILLCSNGLVKLGDFG----FSK 191

Length = 496

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 52.7 bits (127), Expect = 6e-09
 Identities = 20/59 (33%), Positives = 38/59 (64%)

Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 138
             E +++ Y  +++ G+ ++H  +I++RD+K ANIL+D  G ++I+D GLA  +    P
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 52.7 bits (126), Expect = 6e-09
 Identities = 26/94 (27%), Positives = 51/94 (54%), Gaps = 1/94 (1%)

Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           +V M  ++   D+L  +++ + GG L   +  H   NE+++      V+  L ++H + +
Sbjct: 81  VVDMYNSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQGV 139

Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 138
           ++RD+K  +ILL   G +++SD G     SK+ P
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 52.5 bits (126), Expect = 7e-09
 Identities = 18/51 (35%), Positives = 37/51 (72%)

Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           F+ED ++ +  +++ GL + H++  ++RD+K +NILL+  G ++++D GLA
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.4 bits (126), Expect = 7e-09
 Identities = 24/95 (25%), Positives = 52/95 (54%), Gaps = 4/95 (4%)

Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVF-NEDEMRFYAAEVILGL 96
           VDCP+ V    A      +   +++M+      +  +   G+   ED +   A  ++  L
Sbjct: 57  VDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116

Query: 97  EHMHRRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
           E++H +  +++RD+KP+N+L++ +G V++ D G++
Sbjct: 117 EYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.2 bits (125), Expect = 7e-09
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 16/141 (11%)

Query: 6   GTGFLSNCSHVKQGETLAL-----------NERIMLSLVSTGIQMVDCPFIVCMTYAFHT 54
           GT +L         E L +           NE +  +  +  +  +D P IV    +F  
Sbjct: 14  GTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE 73

Query: 55  PDKLCFILDLMNGGDLHYHLSQHG----VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLK 110
            D  C I +   G DL   L +        +E+++  +  +++LG+ +MH+R I++RDLK
Sbjct: 74  RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLK 133

Query: 111 PANILLDEHGHVRISDLGLAC 131
             NI L ++  ++I D G++ 
Sbjct: 134 AKNIFL-KNNLLKIGDFGVSR 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 52.3 bits (125), Expect = 8e-09
 Identities = 27/87 (31%), Positives = 52/87 (59%), Gaps = 2/87 (2%)

Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRY 103
           IV +    HT   L  + + ++  DL  +L   G + +   ++ +  +++ GL + H+R 
Sbjct: 65  IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123

Query: 104 IVYRDLKPANILLDEHGHVRISDLGLA 130
           I++RDLKP N+L++E G ++++D GLA
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 52.0 bits (125), Expect = 9e-09
 Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 4/94 (4%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV---FNEDEMRFYAAEVILGLEHM 99
           P IVC+        +L  I + ++  DL  +L         + + ++ Y  +++ G+   
Sbjct: 59  PNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           H R +++RDLKP N+L+D  G ++++D GLA  F
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 51.8 bits (124), Expect = 1e-08
 Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 15/137 (10%)

Query: 8   GFLSNCSHVKQGETLALNERIMLSL----VSTGIQMVD------CPFIVCMTYAFHTPDK 57
           G +    H   G T+A+ E I L L     +  I  +D       P+IV    AF     
Sbjct: 15  GSVYKVLHRPTGVTMAMKE-IRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA 73

Query: 58  LCFILDLMNGGD---LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY-IVYRDLKPAN 113
           +   ++ M+ G    L+          ED +R     V+ GL+ +   + I++RD+KP N
Sbjct: 74  VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133

Query: 114 ILLDEHGHVRISDLGLA 130
           +L++ +G V++ D G++
Sbjct: 134 VLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 51.7 bits (124), Expect = 1e-08
 Identities = 25/91 (27%), Positives = 50/91 (54%), Gaps = 1/91 (1%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
             P+IV    AF   + +C  ++ M+ G L     + G    + +   A  V+ GL +++
Sbjct: 61  RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120

Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
             + I++RD+KP+NIL++  G +++ D G++
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 51.6 bits (123), Expect = 1e-08
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 6/96 (6%)

Query: 54  TPDKLCFILDLMNGG---DLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDL 109
             D+L  +L+L NGG   DL     + G    E  + +   E ++GL+H+H    ++RD+
Sbjct: 91  NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDV 150

Query: 110 KPANILLDEHGHVRISDLGLACDF--SKKKPHASVG 143
           K  NILL   G V++ D G++     ++ + + SVG
Sbjct: 151 KGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 51.3 bits (123), Expect = 2e-08
 Identities = 27/92 (29%), Positives = 54/92 (58%), Gaps = 4/92 (4%)

Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV---FNEDEMRFYAAEVILGLEHMHR 101
           IV +    HT +KL  + + M+  DL  ++  HGV    + + ++ +  +++ G+   H 
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
             +++RDLKP N+L+++ G ++++D GLA  F
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAF 150

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.3 bits (123), Expect = 2e-08
 Identities = 34/134 (25%), Positives = 60/134 (44%), Gaps = 21/134 (15%)

Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPD---KLCFIL-------DLMNGGDLHY 72
           AL E  +L ++S      +  +IV +    H  +   K    L       DL    D + 
Sbjct: 47  ALREISLLQMLS------ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNG 100

Query: 73  HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHV-RISDLGLAC 131
                 +     ++ +  +++ G+ H H+  +++RDLKP N+L+D+   + +I+DLGL  
Sbjct: 101 RGPGRPL-PAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Query: 132 DFS---KKKPHASV 142
            FS   K   H  V
Sbjct: 160 AFSIPVKSYTHEIV 173

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 51.2 bits (122), Expect = 2e-08
 Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 17/105 (16%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHG--------------VFNEDEM 85
           P IVC+         +C + + +N GDLH  L   S H                 +  + 
Sbjct: 67  PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126

Query: 86  RFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              A ++  G+E++   + V++DL   NIL+ E  HV+ISDLGL+
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS 171

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 2e-08
 Identities = 20/40 (50%), Positives = 29/40 (72%), Gaps = 4/40 (10%)

Query: 95  GLEHMHRRYIVYRDLKPANILL----DEHGHVRISDLGLA 130
           G+ ++H  ++++RDLKPANIL+     E G V+I DLGLA
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 3e-08
 Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 9/97 (9%)

Query: 43  PFIVCMTYAFHTPDKLCFI---LDLMNGGDLHYHLSQHGVFNEDEMRF--YAAEVILGLE 97
           P IV +    H+ +KL  +   LDL    DL  ++    +   D      Y  +++ G+ 
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDL----DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           + H   +++RDLKP N+L+D  G ++++D GLA  F 
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 50.7 bits (122), Expect = 3e-08
 Identities = 21/57 (36%), Positives = 35/57 (61%), Gaps = 9/57 (15%)

Query: 83  DEMR--FYAAEV-------ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + M+  F  +EV       + G+ H+H  +I++RDLK +N+LL+  G ++I D GLA
Sbjct: 97  ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLA 153

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 50.5 bits (121), Expect = 3e-08
 Identities = 31/133 (23%), Positives = 66/133 (49%), Gaps = 11/133 (8%)

Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD 69
           L+  S  ++    ALNE ++LS       ++  P I+     F   + L   ++  NGG 
Sbjct: 35  LTRLS--EKERRDALNEIVILS-------LLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85

Query: 70  LHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDL 127
           L+  + +    +F E+ + +Y  +++  + ++H+  I++RD+K  NI L + G +++ D 
Sbjct: 86  LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDF 145

Query: 128 GLACDFSKKKPHA 140
           G++     +   A
Sbjct: 146 GISKILGSEYSMA 158

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 50.8 bits (121), Expect = 3e-08
 Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 1/94 (1%)

Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           +V M  ++   D+L  +++ + GG L   +  H   NE+++      V+  L  +H + +
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGV 137

Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 138
           ++RD+K  +ILL   G V++SD G     SK+ P
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 50.8 bits (121), Expect = 3e-08
 Identities = 27/104 (25%), Positives = 58/104 (55%), Gaps = 1/104 (0%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P+IV    AF++  ++   ++ M+GG L   L +     E+ +   +  V+ GL ++ 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120

Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
            ++ I++RD+KP+NIL++  G +++ D G++        ++ VG
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 164

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 4e-08
 Identities = 25/95 (26%), Positives = 49/95 (51%), Gaps = 6/95 (6%)

Query: 55  PDKLCFILDLMNGG---DLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLK 110
            D+L  +++L  GG   DL   L + G    E+ + +   E + GL ++H   +++RD+K
Sbjct: 81  DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK 140

Query: 111 PANILLDEHGHVRISDLGLACDFSKK--KPHASVG 143
             NILL ++  V++ D G++        + +  +G
Sbjct: 141 GQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIG 175

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 50.1 bits (120), Expect = 4e-08
 Identities = 20/40 (50%), Positives = 29/40 (72%), Gaps = 1/40 (2%)

Query: 90  AEVIL-GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG 128
           AE +L GL ++H R I++RD+KP+NILL   G V++ D G
Sbjct: 111 AESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 49.8 bits (119), Expect = 5e-08
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 15/130 (11%)

Query: 17  KQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPDKLCFILDLM 65
             GE +AL ++I L   + G+           + ++ P IV +    HT +KL  + + +
Sbjct: 23  LTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81

Query: 66  NGGDLHYHL--SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR 123
           +  DL   +  S         ++ Y  +++ GL   H   +++RDLKP N+L++  G ++
Sbjct: 82  HQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK 140

Query: 124 ISDLGLACDF 133
           ++D GLA  F
Sbjct: 141 LADFGLARAF 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 6e-08
 Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 8/97 (8%)

Query: 41  DCPFIVCMTYAFHTPD-----KLCFILDLMNGGDLHYHLSQH--GVFNEDEMRFYAAEVI 93
           + P IV +    H P      KL  + + ++  DL  +LS+        + ++    +++
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL 117

Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            G++ +H   IV+RDLKP NIL+   G V+I+D GLA
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 49.5 bits (119), Expect = 7e-08
 Identities = 20/62 (32%), Positives = 39/62 (62%), Gaps = 1/62 (1%)

Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG 128
           DLH  + +  +  +   R+   +++  L+++H   +++RDLKP+NILL+    V+++D G
Sbjct: 94  DLHAVI-RANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG 152

Query: 129 LA 130
           LA
Sbjct: 153 LA 154

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 49.7 bits (119), Expect = 7e-08
 Identities = 22/68 (32%), Positives = 45/68 (66%), Gaps = 1/68 (1%)

Query: 63  DLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHV 122
           +LM+  DLH  +      ++D  +++  +++ GL+++H   +++RDLKP+N+LL+ +  +
Sbjct: 89  ELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDL 147

Query: 123 RISDLGLA 130
           +I D GLA
Sbjct: 148 KICDFGLA 155

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 1e-07
 Identities = 17/49 (34%), Positives = 30/49 (61%)

Query: 82  EDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            D +R Y  +++  + + H   I++RD+KP NIL+ E G +++ D G A
Sbjct: 99  PDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 48.7 bits (117), Expect = 1e-07
 Identities = 25/92 (27%), Positives = 45/92 (48%), Gaps = 1/92 (1%)

Query: 39  MVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEH 98
           M D P  + + Y+  T      I+D +  GDL   L + G  +E E++    +++  L  
Sbjct: 65  MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALND 124

Query: 99  MHRRYIVYRDLKPANILLDEH-GHVRISDLGL 129
           +H+  I++ D+K  N+L D     + + D GL
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL 156

Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 49.0 bits (117), Expect = 1e-07
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 1/96 (1%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV M  ++   D+L  +++ + GG L   +  H   NE+++      V+  L  +H +
Sbjct: 76  PNIVEMYSSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 138
            +++RD+K  +ILL   G V++SD G     SK+ P
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.0 bits (114), Expect = 2e-07
 Identities = 25/91 (27%), Positives = 52/91 (57%), Gaps = 3/91 (3%)

Query: 43  PFIVCMTYAFHTPDKLCFI-LDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHM 99
           P IV    ++   D L +I +    GGDL++ L +    +  E+++  +  ++ + L+++
Sbjct: 59  PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           H ++I++RDLK  N+ L     +++ DLG+A
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIA 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 48.1 bits (115), Expect = 2e-07
 Identities = 19/74 (25%), Positives = 39/74 (52%)

Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           + L  +++L   G L  +L +       +++  A +V +G+ ++  ++ V+RDL   N+L
Sbjct: 68  EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVL 127

Query: 116 LDEHGHVRISDLGL 129
           L      +ISD G+
Sbjct: 128 LVNRHQAKISDFGM 141

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 48.3 bits (115), Expect = 2e-07
 Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 4/90 (4%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           D P+I+    AF   +++    + M+GG L      +    E  +   A  V+ GL ++ 
Sbjct: 57  DSPYIIGFYGAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLW 112

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              I++RD+KP+N+L++  G V++ D G++
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVS 142

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 48.0 bits (114), Expect = 2e-07
 Identities = 24/64 (37%), Positives = 41/64 (64%), Gaps = 1/64 (1%)

Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL   L +H   +ED ++F   +++ GL+++H   I++RDLKP N+ ++E   ++I D
Sbjct: 103 GTDLG-KLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILD 161

Query: 127 LGLA 130
            GLA
Sbjct: 162 FGLA 165

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 48.1 bits (114), Expect = 2e-07
 Identities = 24/91 (26%), Positives = 50/91 (54%), Gaps = 1/91 (1%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH-YHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           + P+IV +  AF+   KL  +++   GG +    L       E +++    +++  L+++
Sbjct: 67  NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL 126

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           H   I++RDLK  N+LL   G ++++D G++
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 47.7 bits (113), Expect = 3e-07
 Identities = 17/56 (30%), Positives = 33/56 (58%)

Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
             ED + +   E++ GL H+H   +++RD+K  N+LL E+  V++ D G++    +
Sbjct: 118 LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 47.7 bits (113), Expect = 3e-07
 Identities = 27/94 (28%), Positives = 52/94 (55%), Gaps = 1/94 (1%)

Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           +V M  ++   ++L  +++ + GG L   +SQ  + NE+++      V+  L ++H + +
Sbjct: 80  VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRL-NEEQIATVCESVLQALCYLHSQGV 138

Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 138
           ++RD+K  +ILL   G V++SD G     SK  P
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 47.5 bits (113), Expect = 4e-07
 Identities = 20/49 (40%), Positives = 34/49 (69%), Gaps = 1/49 (2%)

Query: 81  NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLG 128
           NE  + FY  +++ GL+++H   IV+RD+K  N+L++ + G V+ISD G
Sbjct: 106 NEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFG 154

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 4e-07
 Identities = 23/77 (29%), Positives = 44/77 (57%), Gaps = 1/77 (1%)

Query: 57  KLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL 116
           +L  I++   GG +   L + G   E  +     EV++ L+++H+  +++RD+K ANIL+
Sbjct: 76  RLWIIMEYAEGGSVR-TLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134

Query: 117 DEHGHVRISDLGLACDF 133
              G+V++ D G+A   
Sbjct: 135 TNTGNVKLCDFGVAALL 151

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 47.2 bits (112), Expect = 4e-07
 Identities = 18/51 (35%), Positives = 36/51 (70%)

Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            +ED++++   +++ GL+++H   I++RDLKP N+ ++E   ++I D GLA
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 46.9 bits (111), Expect = 5e-07
 Identities = 20/52 (38%), Positives = 33/52 (63%)

Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           + ++    + + GL+ +H   IV+RDLKP NIL+   G V+++D GLA  +S
Sbjct: 108 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.0 bits (111), Expect = 6e-07
 Identities = 20/42 (47%), Positives = 28/42 (66%)

Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
           +V+ GL  +HR  IV+RD+KP N+L+   G V+I D G A D
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVD 358

Length = 507

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 47.0 bits (111), Expect = 6e-07
 Identities = 23/71 (32%), Positives = 47/71 (66%), Gaps = 2/71 (2%)

Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            + +LM G DL+ ++ +    +++ ++F   +++ GL+++H   I++RDLKP+N+ ++E 
Sbjct: 97  LVTNLM-GADLN-NIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED 154

Query: 120 GHVRISDLGLA 130
             +RI D GLA
Sbjct: 155 CELRILDFGLA 165

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 46.6 bits (111), Expect = 7e-07
 Identities = 31/113 (27%), Positives = 54/113 (47%), Gaps = 14/113 (12%)

Query: 40  VDCPFIV-----CMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVI 93
           VD P +V     C++       ++  I  LM  G L  ++  H        +  +  ++ 
Sbjct: 66  VDHPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119

Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
            G+ ++  + +V+RDL   N+L+    HV+I+D GLA   D  +K+ HA  GK
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 46.6 bits (110), Expect = 8e-07
 Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 1/91 (1%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH-YHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           D P IV +  AF+  + L  +++   GG +    L       E ++R    + +  L ++
Sbjct: 60  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           H   I++RDLK  NIL    G ++++D G++
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 46.6 bits (110), Expect = 8e-07
 Identities = 19/82 (23%), Positives = 45/82 (54%), Gaps = 2/82 (2%)

Query: 56  DKLCFILDLMNGGDLHYHL--SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
           D+L  +++    G +   +  ++     E+ + +   E++ GL H+H+  +++RD+K  N
Sbjct: 82  DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQN 141

Query: 114 ILLDEHGHVRISDLGLACDFSK 135
           +LL E+  V++ D G++    +
Sbjct: 142 VLLTENAEVKLVDFGVSAQLDR 163

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 46.8 bits (111), Expect = 9e-07
 Identities = 27/91 (29%), Positives = 43/91 (47%), Gaps = 4/91 (4%)

Query: 43  PFIVCMTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR 101
           P IV +  +   P  L F + + + G  L   L+  G     E      +V+  L   H 
Sbjct: 38  PNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHN 97

Query: 102 RYIVYRDLKPANILLDEHG---HVRISDLGL 129
           + IV+RDLKP NI++ + G   H ++ D G+
Sbjct: 98  QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 46.1 bits (109), Expect = 1e-06
 Identities = 35/112 (31%), Positives = 57/112 (50%), Gaps = 11/112 (9%)

Query: 43  PFIVCMTYAFHTPDK-----LCFILDLMNGG---DLHYHLSQHGV-FNEDEMRFYAAEVI 93
           P +V     F+  DK     L  +L+L NGG   +L   L   G   +E  + +     +
Sbjct: 79  PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138

Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVG 143
           LGL+H+H   I++RD+K  NILL   G V++ D G++   +  + + + SVG
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 190

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 46.1 bits (109), Expect = 1e-06
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 2/75 (2%)

Query: 58  LCFILDLMNGGDLHYHLSQHGVF--NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           L  +++LM+ G+L   L   G    +  ++  ++ +V  G+E++  + +V+RDL   NIL
Sbjct: 73  LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132

Query: 116 LDEHGHVRISDLGLA 130
           + E G  ++SD GLA
Sbjct: 133 VSEDGVAKVSDFGLA 147

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 46.1 bits (110), Expect = 1e-06
 Identities = 19/46 (41%), Positives = 29/46 (63%), Gaps = 5/46 (10%)

Query: 90  AEVILGLEHMHRRY-----IVYRDLKPANILLDEHGHVRISDLGLA 130
            +++L L   H R      +++RDLKPANI LD + +V++ D GLA
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 45.9 bits (109), Expect = 1e-06
 Identities = 27/93 (29%), Positives = 55/93 (59%), Gaps = 3/93 (3%)

Query: 41  DC--PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEH 98
           +C  P+IV    AF++  ++   ++ M+GG L   L + G   E+ +   +  V+ GL +
Sbjct: 55  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY 114

Query: 99  MH-RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +  +  I++RD+KP+NIL++  G +++ D G++
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 45.8 bits (108), Expect = 1e-06
 Identities = 18/44 (40%), Positives = 31/44 (70%)

Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           +++ GL+ +H   +V+RDLKP NIL+   G ++++D GLA  +S
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 45.7 bits (108), Expect = 1e-06
 Identities = 23/87 (26%), Positives = 42/87 (48%), Gaps = 12/87 (13%)

Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNE------------DEMRFYAAEVILGLEHMHRRY 103
           D LC I + M  GDL+  LSQ  + +               + + A ++  G++++    
Sbjct: 90  DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN 149

Query: 104 IVYRDLKPANILLDEHGHVRISDLGLA 130
            V+RDL   N L+  H  ++I+D G++
Sbjct: 150 FVHRDLATRNCLVGNHYTIKIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 45.6 bits (108), Expect = 2e-06
 Identities = 18/49 (36%), Positives = 28/49 (57%)

Query: 82  EDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           E E+       + GL ++H    ++RD+K  NILL E G V+++D G A
Sbjct: 114 EVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA 162

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 45.4 bits (107), Expect = 2e-06
 Identities = 18/51 (35%), Positives = 35/51 (68%)

Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D GLA
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 45.5 bits (107), Expect = 2e-06
 Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 1/99 (1%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV    ++   D+L  +++ + GG L   +++    +E ++     E +  LE +H  
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN 135

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
            +++RD+K  NILL   G V+++D G     + ++   S
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 45.1 bits (106), Expect = 3e-06
 Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 1/99 (1%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV    +F   D+L  +++ + GG L   +++    +E ++     E +  LE +H  
Sbjct: 76  PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHAN 134

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
            +++RD+K  N+LL   G V+++D G     + ++   S
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 44.7 bits (106), Expect = 3e-06
 Identities = 19/50 (38%), Positives = 32/50 (64%)

Query: 81  NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +E  +R Y  +++ G+E  H   I++RD+KP NIL+ + G V++ D G A
Sbjct: 98  DESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 44.8 bits (106), Expect = 4e-06
 Identities = 21/70 (30%), Positives = 39/70 (55%), Gaps = 1/70 (1%)

Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + +LM   DLH  +  +     +  +F+  +++  L+++H   + +RDLKP NIL +   
Sbjct: 82  VFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC 140

Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 141 KLKICDFGLA 150

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 44.6 bits (105), Expect = 4e-06
 Identities = 18/54 (33%), Positives = 34/54 (62%)

Query: 77  HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           H   + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 117 HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 44.3 bits (105), Expect = 5e-06
 Identities = 16/39 (41%), Positives = 28/39 (71%)

Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           GL   H   +++RDLKP N+L++++G ++++D GLA  F
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.1 bits (104), Expect = 5e-06
 Identities = 23/73 (31%), Positives = 43/73 (58%), Gaps = 1/73 (1%)

Query: 58  LCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD 117
           L  I++ +  G L  +L +H + N  ++  +A ++  G+ ++H ++ ++RDL   N+LLD
Sbjct: 83  LQLIMEYVPLGSLRDYLPKHKL-NLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD 141

Query: 118 EHGHVRISDLGLA 130
               V+I D GLA
Sbjct: 142 NDRLVKIGDFGLA 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 44.2 bits (105), Expect = 5e-06
 Identities = 23/72 (31%), Positives = 48/72 (66%), Gaps = 4/72 (5%)

Query: 60  FILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
            + +LM   DL+  + +QH   + D ++++  +++ GL+++H   +++RDLKP+N+LL+ 
Sbjct: 85  IVQELMET-DLYKLIKTQH--LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 141

Query: 119 HGHVRISDLGLA 130
           +  ++I D GLA
Sbjct: 142 NCDLKICDFGLA 153

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.3 bits (104), Expect = 5e-06
 Identities = 23/57 (40%), Positives = 38/57 (66%), Gaps = 5/57 (8%)

Query: 91  EVILGLEHMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDF-SKKKPHASV 142
           +++ G+ ++H  ++++RDLKPANIL+     E G V+I+D+G A  F S  KP A +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 44.3 bits (105), Expect = 5e-06
 Identities = 23/83 (27%), Positives = 45/83 (54%), Gaps = 6/83 (7%)

Query: 53  HTPDKLCF-----ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYR 107
             P    F     + +LM   DLH  +      + D ++ +  +++ GL+++H   I++R
Sbjct: 69  QPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127

Query: 108 DLKPANILLDEHGHVRISDLGLA 130
           D+KP N+L++ +  ++I D GLA
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLA 150

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 43.9 bits (103), Expect = 6e-06
 Identities = 24/99 (24%), Positives = 50/99 (50%), Gaps = 1/99 (1%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV    ++   D+L  +++ + GG L   +++    +E ++     E +  L+ +H  
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN 134

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
            +++RD+K  NILL   G V+++D G     + ++   S
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.9 bits (104), Expect = 7e-06
 Identities = 17/49 (34%), Positives = 33/49 (67%)

Query: 86  RFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           + +  +++ GL+++H   +++RDLKP N+L++    ++I D GLA  FS
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 43.5 bits (103), Expect = 7e-06
 Identities = 21/74 (28%), Positives = 42/74 (56%), Gaps = 1/74 (1%)

Query: 58  LCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL 116
           L  I++ +  G L  +L +H    N   +  +++++  G++++  +  ++RDL   NIL+
Sbjct: 83  LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV 142

Query: 117 DEHGHVRISDLGLA 130
           +    V+ISD GLA
Sbjct: 143 ESEDLVKISDFGLA 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 43.7 bits (103), Expect = 8e-06
 Identities = 25/88 (28%), Positives = 44/88 (50%), Gaps = 11/88 (12%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHGVFNEDE-----------MRFYAAEVILGLEHMHRR 102
           T D LC I + M  GDL+  LS+H      E           + F A ++  G++++   
Sbjct: 90  TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL 149

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
             V+RDL   N L+ ++  ++I+D G++
Sbjct: 150 NFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.9 bits (103), Expect = 8e-06
 Identities = 23/57 (40%), Positives = 38/57 (66%), Gaps = 5/57 (8%)

Query: 91  EVILGLEHMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDF-SKKKPHASV 142
           +++ G+ ++H  ++++RDLKPANIL+     E G V+I+D+G A  F S  KP A +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.5 bits (102), Expect = 8e-06
 Identities = 17/51 (33%), Positives = 33/51 (64%)

Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.5 bits (102), Expect = 9e-06
 Identities = 17/51 (33%), Positives = 33/51 (64%)

Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.5 bits (102), Expect = 1e-05
 Identities = 21/48 (43%), Positives = 29/48 (60%)

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           Y+ +V  G+E +  R  ++RDL   NILL E+  V+I D GLA D  K
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 1e-05
 Identities = 16/36 (44%), Positives = 23/36 (63%)

Query: 96  LEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC 131
           L ++H R I++RD+K  NI LDE  +  + D G AC
Sbjct: 198 LAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAAC 233

Length = 392

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 43.1 bits (102), Expect = 1e-05
 Identities = 16/42 (38%), Positives = 27/42 (64%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           AA++  G+ ++  R  ++RDL   NIL+ E+   +I+D GLA
Sbjct: 109 AAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA 150

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 43.3 bits (102), Expect = 1e-05
 Identities = 23/75 (30%), Positives = 43/75 (57%), Gaps = 7/75 (9%)

Query: 62  LDLMNGGDLHYHLSQHGVFNEDE--MRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
           LDL    DL  H+     F ++   ++ Y  +++ G+ + H   +++RDLKP N+L+D  
Sbjct: 83  LDL----DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138

Query: 120 GH-VRISDLGLACDF 133
            + ++++D GLA  F
Sbjct: 139 TNALKLADFGLARAF 153

Length = 294

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 42.9 bits (101), Expect = 1e-05
 Identities = 17/42 (40%), Positives = 28/42 (66%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           AA++  G+  + R+  ++RDL+ ANIL+ E    +I+D GLA
Sbjct: 108 AAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLA 149

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 43.0 bits (101), Expect = 1e-05
 Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 1/94 (1%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +D P+IV M       +    +++L   G L+  L ++    E  +     +V +G+
Sbjct: 50  MQQLDNPYIVRMI-GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGM 108

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +++     V+RDL   N+LL    + +ISD GL+
Sbjct: 109 KYLEETNFVHRDLAARNVLLVTQHYAKISDFGLS 142

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 43.0 bits (101), Expect = 1e-05
 Identities = 24/95 (25%), Positives = 49/95 (51%), Gaps = 1/95 (1%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV    ++   D+L  +++ + GG L   +++    +E ++     E +  LE +H  
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN 134

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
            +++RD+K  NILL   G V+++D G     + ++
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 42.9 bits (101), Expect = 1e-05
 Identities = 20/65 (30%), Positives = 35/65 (53%)

Query: 66  NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS 125
           NG  L+Y   + G  ++D +     +V  G+E++ R   ++RDL   N L+   G V++S
Sbjct: 83  NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVS 142

Query: 126 DLGLA 130
           D G+ 
Sbjct: 143 DFGMT 147

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 42.8 bits (101), Expect = 2e-05
 Identities = 22/76 (28%), Positives = 45/76 (59%), Gaps = 3/76 (3%)

Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           + +  + + M   DL  ++ + G  +E+  R +  +++ GL+++H   +++RDLKPAN+ 
Sbjct: 89  NSVYIVQEYMET-DLA-NVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVF 146

Query: 116 LDEHGHV-RISDLGLA 130
           ++    V +I D GLA
Sbjct: 147 INTEDLVLKIGDFGLA 162

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.5 bits (100), Expect = 2e-05
 Identities = 21/48 (43%), Positives = 29/48 (60%)

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           Y+ +V  G+E +  R  ++RDL   NILL E+  V+I D GLA D  K
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 42.4 bits (100), Expect = 2e-05
 Identities = 23/78 (29%), Positives = 40/78 (51%), Gaps = 2/78 (2%)

Query: 61  ILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
           + + M  G L  +L   G  V    +   +A +V  G+E++  +  V+RDL   N+L+ E
Sbjct: 78  VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE 137

Query: 119 HGHVRISDLGLACDFSKK 136
               ++SD GLA + S+ 
Sbjct: 138 DLVAKVSDFGLAKEASQG 155

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.3 bits (99), Expect = 2e-05
 Identities = 21/48 (43%), Positives = 29/48 (60%)

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           Y+ +V  G+E +  R  ++RDL   NILL E+  V+I D GLA D  K
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 41.9 bits (99), Expect = 2e-05
 Identities = 25/102 (24%), Positives = 43/102 (42%), Gaps = 10/102 (9%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH----------GVFNEDEMRFYAA 90
           +C  +V +     T      +++LM  GDL  +L             G     +    AA
Sbjct: 67  NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
           E+  G+ ++  +  V+RDL   N ++ E   V+I D G+  D
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRD 168

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.8 bits (98), Expect = 3e-05
 Identities = 26/107 (24%), Positives = 49/107 (45%), Gaps = 19/107 (17%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDE------------------ 84
           P I+ +       D LC I + M  GDL+  LS H + +++E                  
Sbjct: 79  PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYS 138

Query: 85  -MRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            +   A ++  G++++     V+RDL   N L+ E+  ++I+D G++
Sbjct: 139 SLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 41.9 bits (98), Expect = 3e-05
 Identities = 23/88 (26%), Positives = 44/88 (50%), Gaps = 3/88 (3%)

Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
            +  LM  G L  ++ ++       ++  +  ++  G+ ++    +V+RDL   N+L+  
Sbjct: 85  LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS 144

Query: 119 HGHVRISDLGLA--CDFSKKKPHASVGK 144
             HV+I+D GLA   D  + + HA  GK
Sbjct: 145 PNHVKITDFGLARLLDIDETEYHADGGK 172

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 41.9 bits (98), Expect = 4e-05
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 41.4 bits (97), Expect = 4e-05
 Identities = 18/69 (26%), Positives = 39/69 (56%)

Query: 62  LDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH 121
           ++ + GG +   L++ G   E     Y  +++ G+ ++H   +V+RD+K  N++L  +G 
Sbjct: 81  MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI 140

Query: 122 VRISDLGLA 130
           +++ D G A
Sbjct: 141 IKLIDFGCA 149

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 41.7 bits (98), Expect = 4e-05
 Identities = 17/36 (47%), Positives = 24/36 (66%)

Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            +E++H + +++RDLKP NILL   G V I D G A
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160

Length = 932

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 41.2 bits (97), Expect = 5e-05
 Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 7/94 (7%)

Query: 41  DCPFIV-CMTYAFHTPD-KLCFILDLMNG-GDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           DCP+IV C  Y     D  +C  ++LM+   D      Q     ED +      ++  L 
Sbjct: 72  DCPYIVKCYGYFITDSDVFIC--MELMSTCLDKLLKRIQGP-IPEDILGKMTVAIVKALH 128

Query: 98  HMHRRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
           ++  ++ +++RD+KP+NILLD  G+V++ D G++
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 41.1 bits (96), Expect = 5e-05
 Identities = 30/119 (25%), Positives = 60/119 (50%), Gaps = 10/119 (8%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +K     ++ + +M    +  +  +D P+IV M       + L  ++++ +GG L+  LS
Sbjct: 30  LKNENEKSVRDEMMRE--AEIMHQLDNPYIVRMI-GVCEAEALMLVMEMASGGPLNKFLS 86

Query: 76  ----QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
               +  V N  E+     +V +G++++  +  V+RDL   N+LL    + +ISD GL+
Sbjct: 87  GKKDEITVSNVVEL---MHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLS 142

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.9 bits (96), Expect = 7e-05
 Identities = 17/48 (35%), Positives = 32/48 (66%)

Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 118 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 40.5 bits (94), Expect = 9e-05
 Identities = 16/36 (44%), Positives = 25/36 (69%)

Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           GL ++H   +++RD+K  NILL E G V+++D G A
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA 172

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 40.1 bits (94), Expect = 1e-04
 Identities = 21/72 (29%), Positives = 35/72 (48%), Gaps = 2/72 (2%)

Query: 61  ILDLMNGGDLHYHL--SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
           I +LM  G L   L   +  V     +   A +V  G+ ++  +  ++RDL   NIL+ E
Sbjct: 80  ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE 139

Query: 119 HGHVRISDLGLA 130
               +++D GLA
Sbjct: 140 DLVCKVADFGLA 151

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 40.1 bits (94), Expect = 1e-04
 Identities = 21/74 (28%), Positives = 39/74 (52%), Gaps = 7/74 (9%)

Query: 61  ILDLMNGGDLHYHLSQHG----VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL 116
           +++L+ GG L   L +      V    +M   AA    G+E++  +  ++RDL   N L+
Sbjct: 70  VMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAA---GMEYLESKNCIHRDLAARNCLV 126

Query: 117 DEHGHVRISDLGLA 130
            E+  ++ISD G++
Sbjct: 127 GENNVLKISDFGMS 140

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 40.1 bits (94), Expect = 1e-04
 Identities = 16/46 (34%), Positives = 28/46 (60%)

Query: 85  MRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +  YA+++  G+E++  +  V+RDL   NIL++    V+I D GL 
Sbjct: 110 LLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 40.1 bits (94), Expect = 1e-04
 Identities = 23/84 (27%), Positives = 44/84 (52%), Gaps = 3/84 (3%)

Query: 50  YAFHTPDKLCFIL-DLMNGGDLHYHL--SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVY 106
           YA  T ++  +I+ +LM  G L  +L           ++   AA+V  G+ ++  +  ++
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIH 126

Query: 107 RDLKPANILLDEHGHVRISDLGLA 130
           RDL   N+L+ E+   +++D GLA
Sbjct: 127 RDLAARNVLVGENNICKVADFGLA 150

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 40.0 bits (94), Expect = 1e-04
 Identities = 15/55 (27%), Positives = 29/55 (52%), Gaps = 1/55 (1%)

Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             GV  E  ++    + +  +   H+   ++RD+KP NIL+ + G +++ D G A
Sbjct: 94  PRGV-PEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 40.0 bits (93), Expect = 1e-04
 Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 3/47 (6%)

Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
           GL ++H   +++RD+K  NILL E G V+++D G A   SK  P  S
Sbjct: 133 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA---SKSSPANS 176

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 40.1 bits (93), Expect = 2e-04
 Identities = 24/90 (26%), Positives = 42/90 (46%), Gaps = 13/90 (14%)

Query: 56  DKLCFILDLMNGGDLHYHLSQHGV-------------FNEDEMRFYAAEVILGLEHMHRR 102
           D L  + + M  GDL+  L  HG                + +M   A ++  G+ ++  +
Sbjct: 80  DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACD 132
           + V+RDL   N L+ E+  V+I D G++ D
Sbjct: 140 HFVHRDLATRNCLVGENLLVKIGDFGMSRD 169

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 40.0 bits (93), Expect = 2e-04
 Identities = 19/53 (35%), Positives = 32/53 (60%), Gaps = 5/53 (9%)

Query: 85  MRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
           ++ Y+ ++   L ++H ++I +RDLKP N+L+D + H     L L CDF   K
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT----LKL-CDFGSAK 219

Length = 440

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 39.8 bits (93), Expect = 2e-04
 Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 3/79 (3%)

Query: 61  ILDLMNGGDLHYHL--SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
           +L  M  GDL   +    H    +D + F   +V  G+E++  +  V+RDL   N +LDE
Sbjct: 75  VLPYMKHGDLRNFIRSETHNPTVKDLIGF-GLQVAKGMEYLASKKFVHRDLAARNCMLDE 133

Query: 119 HGHVRISDLGLACDFSKKK 137
              V+++D GLA D   K+
Sbjct: 134 SFTVKVADFGLARDIYDKE 152

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 39.8 bits (93), Expect = 2e-04
 Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 1/43 (2%)

Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDE-HGHVRISDLGLACD 132
           +++  L+ +H   IV+RD+KP NI+  E  G  +I DLG A D
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAAD 305

Length = 566

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 39.4 bits (92), Expect = 2e-04
 Identities = 22/78 (28%), Positives = 36/78 (46%), Gaps = 10/78 (12%)

Query: 61  ILDLMNGGDLHYHL--------SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPA 112
           IL  M  GDLH  L         +        +  +  ++ LG+E++  R  ++RDL   
Sbjct: 85  ILPFMKHGDLHSFLLYSRLGGLPEK--LPLQTLLKFMVDIALGMEYLSNRNFIHRDLAAR 142

Query: 113 NILLDEHGHVRISDLGLA 130
           N +L E   V ++D GL+
Sbjct: 143 NCMLREDMTVCVADFGLS 160

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 39.2 bits (91), Expect = 2e-04
 Identities = 16/53 (30%), Positives = 33/53 (62%)

Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           +++R Y  ++I  +   H+  IV+RD+KP N+L+  +  +++ D G A + S+
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 39.1 bits (91), Expect = 3e-04
 Identities = 12/44 (27%), Positives = 28/44 (63%)

Query: 87  FYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + A ++   +E++ ++  ++RDL   N L+ E+  V+++D GL+
Sbjct: 108 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 151

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.1 bits (91), Expect = 3e-04
 Identities = 20/71 (28%), Positives = 38/71 (53%), Gaps = 1/71 (1%)

Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
            I++ +  G L  +L ++    N  +   YA ++  G++++  R  V+RDL   N+L++ 
Sbjct: 85  LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144

Query: 119 HGHVRISDLGL 129
              V+I D GL
Sbjct: 145 EHQVKIGDFGL 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 38.9 bits (90), Expect = 3e-04
 Identities = 15/43 (34%), Positives = 30/43 (69%)

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           ++A++  G+ ++ R+  ++RDL+ AN+L+ E    +I+D GLA
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA 150

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 38.9 bits (90), Expect = 3e-04
 Identities = 24/83 (28%), Positives = 46/83 (55%), Gaps = 2/83 (2%)

Query: 50  YAFHTPDKLCFILDLMNGGDLHYHLS-QHGVF-NEDEMRFYAAEVILGLEHMHRRYIVYR 107
           YA  + + +  + + M+ G L   L  + G +    ++   AA++  G+ ++ R   V+R
Sbjct: 67  YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126

Query: 108 DLKPANILLDEHGHVRISDLGLA 130
           DL+ ANIL+ E+   +++D GLA
Sbjct: 127 DLRAANILVGENLVCKVADFGLA 149

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 38.9 bits (90), Expect = 3e-04
 Identities = 16/36 (44%), Positives = 24/36 (66%)

Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           GL ++H   +++RD+K  NILL E G V++ D G A
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 38.5 bits (89), Expect = 4e-04
 Identities = 15/43 (34%), Positives = 27/43 (62%)

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA
Sbjct: 114 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 38.5 bits (89), Expect = 4e-04
 Identities = 23/76 (30%), Positives = 42/76 (55%), Gaps = 6/76 (7%)

Query: 61  ILDLMNGGDLHYHL--SQHG---VFNEDEMRF-YAAEVILGLEHMHRRYIVYRDLKPANI 114
           IL  M  GDLH  L  S+ G    +   +M   +  ++  G+E++  +  ++RDL   N 
Sbjct: 84  ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNC 143

Query: 115 LLDEHGHVRISDLGLA 130
           +L+E+ +V ++D GL+
Sbjct: 144 MLNENMNVCVADFGLS 159

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 38.4 bits (89), Expect = 4e-04
 Identities = 20/74 (27%), Positives = 41/74 (55%), Gaps = 1/74 (1%)

Query: 58  LCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL 116
           +C + + M  G L  +L +Q G F+++ +     +V  G+ ++    +++RDL   N L+
Sbjct: 74  ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV 133

Query: 117 DEHGHVRISDLGLA 130
            E+  V++SD G+ 
Sbjct: 134 GENQVVKVSDFGMT 147

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 38.6 bits (90), Expect = 5e-04
 Identities = 19/74 (25%), Positives = 36/74 (48%), Gaps = 1/74 (1%)

Query: 58  LCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL 116
           +  + + M  G L  +L +  G    + +    ++V   +E++     ++RDL   N L+
Sbjct: 74  IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV 133

Query: 117 DEHGHVRISDLGLA 130
            E   V++SD GLA
Sbjct: 134 GEDNVVKVSDFGLA 147

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 38.3 bits (89), Expect = 5e-04
 Identities = 15/40 (37%), Positives = 27/40 (67%)

Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +++ GL ++H + I++RD+K  NI +++   V I DLG A
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAA 204

Length = 357

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 38.1 bits (88), Expect = 7e-04
 Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 1/89 (1%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   F      C IL      DL+ +L+        ++      V+  ++++H  
Sbjct: 143 PSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN 201

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            I++RD+K  NI ++  G V + D G AC
Sbjct: 202 RIIHRDIKAENIFINHPGDVCLGDFGAAC 230

Length = 391

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 37.7 bits (88), Expect = 7e-04
 Identities = 15/42 (35%), Positives = 24/42 (57%)

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
           YA ++  G+ ++  +  ++RDL   NILL     V+I D GL
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGL 143

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 37.7 bits (87), Expect = 8e-04
 Identities = 19/71 (26%), Positives = 36/71 (50%), Gaps = 1/71 (1%)

Query: 61  ILDLMNGGDLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
           +++L+ GGD    L   G      E+         G+E++  ++ ++RDL   N L+ E 
Sbjct: 71  VMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK 130

Query: 120 GHVRISDLGLA 130
             ++ISD G++
Sbjct: 131 NVLKISDFGMS 141

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 37.7 bits (87), Expect = 8e-04
 Identities = 31/135 (22%), Positives = 57/135 (42%), Gaps = 10/135 (7%)

Query: 20  ETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV 79
           E  ++ ERI     ++ ++  +C  +V +            I++LM  GDL  +L     
Sbjct: 46  EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 105

Query: 80  FNED----------EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
             E+          +M   A E+  G+ +++    V+RDL   N ++ E   V+I D G+
Sbjct: 106 EMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 165

Query: 130 ACDFSKKKPHASVGK 144
             D  +   +   GK
Sbjct: 166 TRDIYETDYYRKGGK 180

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 37.7 bits (87), Expect = 9e-04
 Identities = 15/43 (34%), Positives = 28/43 (65%)

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           ++A++  G+  + +R  ++RDL+ ANIL+      +I+D GLA
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 149

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 37.7 bits (88), Expect = 9e-04
 Identities = 15/57 (26%), Positives = 29/57 (50%)

Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
             E  + F   +V+  L+++H +  ++R +K ++ILL   G V +S L  +    K 
Sbjct: 98  LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH 154

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 37.7 bits (87), Expect = 0.001
 Identities = 17/42 (40%), Positives = 28/42 (66%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           AA+V  G+ ++ R   ++RDL+ ANIL+ +    +I+D GLA
Sbjct: 108 AAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLA 149

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 37.6 bits (87), Expect = 0.001
 Identities = 32/135 (23%), Positives = 58/135 (42%), Gaps = 10/135 (7%)

Query: 20  ETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV 79
           E+ +L ERI     ++ ++   C  +V +            +++LM  GDL  +L     
Sbjct: 46  ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP 105

Query: 80  FNED----------EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
             E+          EM   AAE+  G+ +++ +  V+RDL   N ++     V+I D G+
Sbjct: 106 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 165

Query: 130 ACDFSKKKPHASVGK 144
             D  +   +   GK
Sbjct: 166 TRDIYETDYYRKGGK 180

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 37.3 bits (86), Expect = 0.001
 Identities = 27/103 (26%), Positives = 45/103 (43%), Gaps = 16/103 (15%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL------SQHGVFNED----------EMR 86
           P IVC+         L  I    +  DLH  L      S  G  ++D          +  
Sbjct: 68  PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127

Query: 87  FYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
               ++  G+E +   ++V++DL   N+L+ +  +V+ISDLGL
Sbjct: 128 HIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 37.4 bits (87), Expect = 0.001
 Identities = 13/44 (29%), Positives = 29/44 (65%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
           A ++  G+ ++H+R ++++D+   N ++DE   V+I+D  L+ D
Sbjct: 123 AIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRD 166

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 37.1 bits (86), Expect = 0.001
 Identities = 20/75 (26%), Positives = 36/75 (48%), Gaps = 6/75 (8%)

Query: 59  CFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
           C   DL+N         +      +++  ++ +V  G+  +  +  ++RDL   N+LL  
Sbjct: 121 CCYGDLLN----FLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL-T 175

Query: 119 HGHV-RISDLGLACD 132
           HG + +I D GLA D
Sbjct: 176 HGKIVKICDFGLARD 190

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 37.0 bits (85), Expect = 0.001
 Identities = 16/42 (38%), Positives = 29/42 (69%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           AA++  G+ ++ R   ++RDL+ ANIL+ ++   +I+D GLA
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLA 149

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 37.1 bits (86), Expect = 0.001
 Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 12/105 (11%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-------SQHGVFNEDEMRFYAAEVILG 95
           P IV +       +    I++LM GGDL  +L           +    E+     +V  G
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 96  LEHMHRRYIVYRDLKPANILLDEHGH-----VRISDLGLACDFSK 135
             ++ + + ++RDL   N L+ E G+     V+I D GLA D  K
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK 163

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 37.1 bits (86), Expect = 0.002
 Identities = 16/42 (38%), Positives = 26/42 (61%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           A +V  G+ ++  R  V+RDL   N L+ E+  V+I+D GL+
Sbjct: 136 AKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 36.8 bits (85), Expect = 0.002
 Identities = 17/42 (40%), Positives = 24/42 (57%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           A E+ LGL H+H+   ++ DL   N LL     V+I D GL+
Sbjct: 106 ACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 36.8 bits (85), Expect = 0.002
 Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 8/77 (10%)

Query: 61  ILDLMNGGDLHYHL--SQHG--VFN---EDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
           IL  M  GDLH  L  S+ G   F    +  +RF   ++  G+E++  +  ++RDL   N
Sbjct: 85  ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF-MIDIASGMEYLSSKNFIHRDLAARN 143

Query: 114 ILLDEHGHVRISDLGLA 130
            +L+E+  V ++D GL+
Sbjct: 144 CMLNENMTVCVADFGLS 160

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 36.5 bits (84), Expect = 0.002
 Identities = 23/92 (25%), Positives = 40/92 (43%), Gaps = 15/92 (16%)

Query: 56  DKLCFILDLMNGGDLHYHLSQHG----VFNEDE-----------MRFYAAEVILGLEHMH 100
             L  + + M  GDL+  L  HG    +    E           M   A+++  G+ ++ 
Sbjct: 80  RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA 139

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
             + V+RDL   N L+ +   V+I D G++ D
Sbjct: 140 SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 36.5 bits (84), Expect = 0.002
 Identities = 19/79 (24%), Positives = 38/79 (48%)

Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
                  +++    +  ++  ++ +V  G+E +  +  V+RDL   N+L+ E   V+I D
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICD 282

Query: 127 LGLACDFSKKKPHASVGKS 145
            GLA D  +   + S G +
Sbjct: 283 FGLARDIMRDSNYISKGST 301

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 36.4 bits (84), Expect = 0.002
 Identities = 16/42 (38%), Positives = 21/42 (50%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           A EV  GL  +H+   ++ DL   N  L     V+I D GLA
Sbjct: 106 ACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 36.6 bits (84), Expect = 0.003
 Identities = 14/47 (29%), Positives = 30/47 (63%)

Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
           +++  +E++H + +++RD+K  NI L+  G + + D G A  F K++
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321

Length = 501

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 36.1 bits (83), Expect = 0.003
 Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 2/79 (2%)

Query: 58  LCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           L  + + M  G L  +L   G  V   D +  ++ +V   +E++     V+RDL   N+L
Sbjct: 75  LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVL 134

Query: 116 LDEHGHVRISDLGLACDFS 134
           + E    ++SD GL  + S
Sbjct: 135 VSEDNVAKVSDFGLTKEAS 153

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 36.1 bits (83), Expect = 0.003
 Identities = 15/51 (29%), Positives = 33/51 (64%)

Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            +  ++  +AA+V  G++++ ++  ++RDL   NIL+ E+   +I+D GL+
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 36.1 bits (83), Expect = 0.004
 Identities = 19/53 (35%), Positives = 31/53 (58%), Gaps = 5/53 (9%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKK 136
           A +V  G+E++  R  ++RDL   N+L+ E   ++I+D GLA      D+ KK
Sbjct: 140 AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 35.9 bits (83), Expect = 0.004
 Identities = 17/54 (31%), Positives = 31/54 (57%), Gaps = 5/54 (9%)

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKK 136
           +A +V  G+E +  +  ++RDL   N+L+ E   ++I+D GLA      D+ +K
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	145
KOG0595|consensus	429		100.0
KOG0575|consensus	592		100.0
KOG0615|consensus	475		100.0
KOG0598|consensus	357		100.0
KOG0581|consensus	364		100.0
KOG0592|consensus	604		99.97
KOG0605|consensus	550		99.97
KOG0616|consensus	355		99.97
KOG0600|consensus	560		99.97
KOG0593|consensus	396		99.97
KOG0611|consensus	668		99.97
KOG0583|consensus	370		99.97
KOG0198|consensus	313		99.96
KOG0597|consensus	808		99.96
KOG0661|consensus	538		99.96
KOG0659|consensus	318		99.96
KOG0192|consensus	362		99.96
KOG0591|consensus	375		99.96
KOG0658|consensus	364		99.96
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.96
KOG0663|consensus	419		99.96
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.96
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.96
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.95
KOG0594|consensus	323		99.95
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.95
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.95
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.95
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
KOG1187|consensus	361		99.95
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.95
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
KOG0588|consensus	786		99.95
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.95
KOG0578|consensus	550		99.95
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.95
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.95
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.95
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.95
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.95
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.95
KOG0584|consensus	632		99.95
KOG0610|consensus	459		99.95
KOG0585|consensus	576		99.95
KOG0599|consensus	411		99.95
KOG0589|consensus	426		99.95
KOG0582|consensus	516		99.95
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.95
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.95
KOG0580|consensus	281		99.95
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.95
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.95
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.95
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.94
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
KOG0032|consensus	382		99.94
KOG0197|consensus	468		99.94
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.94
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.94
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.94
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.94
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.94
KOG0660|consensus	359		99.94
PHA03212	391	serine/threonine kinase US3; Provisional	99.94
PTZ00267	478	NIMA-related protein kinase; Provisional	99.94
KOG0586|consensus	596		99.94
KOG0694|consensus	694		99.94
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.94
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.94
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.94
KOG4250|consensus	732		99.94
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.94
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.94
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.94
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.94
KOG4236|consensus	888		99.94
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.93
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.93
KOG0194|consensus	474		99.93
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.93
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.93
KOG0608|consensus	1034		99.93
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.93
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.93
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.93
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.93
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.93
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.93
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.93
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.93
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.93
KOG0986|consensus	591		99.93
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.93
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.93
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.93
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.93
KOG0612|consensus	1317		99.93
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.93
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.93
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.92
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.92
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.92
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.92
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.92
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.92
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.92
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.92
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.92
KOG0607|consensus	463		99.92
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.92
KOG0033|consensus	355		99.92
KOG0662|consensus	292		99.92
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.92
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.92
PHA03211	461	serine/threonine kinase US3; Provisional	99.92
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.92
PHA03209	357	serine/threonine kinase US3; Provisional	99.92
PTZ00036	440	glycogen synthase kinase; Provisional	99.92
KOG1026|consensus	774		99.92
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.92
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.92
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.92
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.92
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.91
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.91
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.91
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.91
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.91
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.91
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.91
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.91
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.91
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.91
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.91
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.91
KOG1152|consensus	772		99.91
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.91
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.91
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.91
PTZ00283	496	serine/threonine protein kinase; Provisional	99.91
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.91
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.91
KOG0201|consensus	467		99.91
KOG0667|consensus	586		99.91
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.91
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.91
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.91
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.91
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.91
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.91
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.91
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.91
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.91
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.91
KOG1095|consensus	1025		99.91
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.91
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.91
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.91
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.91
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.91
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.91
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.91
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.91
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.91
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.91
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.91
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.91
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.91
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.91
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.91
PHA02988	283	hypothetical protein; Provisional	99.91
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.91
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.91
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.91
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.91
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.91
KOG1989|consensus	738		99.91
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.91
PHA03207	392	serine/threonine kinase US3; Provisional	99.91
KOG4721|consensus	904		99.91
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.91
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.91
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.91
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.91
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.91
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.91
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.91
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.91
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.91
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.91
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.91
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.9
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.9
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.9
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.9
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.9
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.9
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.9
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.9
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.9
KOG0614|consensus	732		99.9
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.9
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.9
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.9
KOG1094|consensus	807		99.9
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.9
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.9
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.9
KOG0690|consensus	516		99.9
KOG0579|consensus	1187		99.9
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.9
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.9
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.9
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.9
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.9
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.9
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.9
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.9
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.9
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.9
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.9
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.9
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.9
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.9
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.9
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.9
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.9
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.9
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.9
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.9
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.9
KOG0574|consensus	502		99.9
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.9
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.9
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.9
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.9
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.9
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.9
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.9
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.9
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.9
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.9
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.9
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.9
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.9
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.9
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.9
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.9
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.9
KOG4645|consensus	1509		99.9
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.9
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.9
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.9
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.9
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.89
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.89
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.89
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.89
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.89
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.89
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.89
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.89
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.89
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.89
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.89
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.89
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.89
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.89
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.89
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.89
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.89
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.89
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.89
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.89
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.89
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.89
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.89
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.89
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.89
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.89
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.89
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.89
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.89
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.89
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.89
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.89
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.89
KOG4717|consensus	864		99.89
PHA03210	501	serine/threonine kinase US3; Provisional	99.89
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.89
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.89
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.89
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.89
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.88
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.88
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.88
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.88
PLN00009	294	cyclin-dependent kinase A; Provisional	99.88
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.88
KOG0666|consensus	438		99.88
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.88
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.88
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.88
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.88
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.88
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.88
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.88
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.88
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.88
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.88
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.88
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.88
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.88
KOG0193|consensus	678		99.88
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.88
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.88
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.88
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.88
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.88
KOG4279|consensus	1226		99.88
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.88
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.88
KOG0577|consensus	948		99.88
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.87
KOG0604|consensus	400		99.87
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.87
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.87
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.87
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.87
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.87
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.87
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.87
KOG4278|consensus	1157		99.87
KOG0587|consensus	953		99.87
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.87
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.87
PTZ00284	467	protein kinase; Provisional	99.86
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.86
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.86
PHA02882	294	putative serine/threonine kinase; Provisional	99.86
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.86
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.86
KOG1035|consensus	1351		99.86
KOG1151|consensus	775		99.86
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.86
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.86
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.86
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.86
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.85
KOG0576|consensus	829		99.85
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.85
KOG4257|consensus	974		99.85
KOG0984|consensus	282		99.85
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.84
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.84
KOG1025|consensus	1177		99.84
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.84
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.84
KOG0196|consensus	996		99.84
KOG0664|consensus	449		99.84
PRK10345	210	hypothetical protein; Provisional	99.84
KOG1163|consensus	341		99.84
KOG3653|consensus	534		99.83
KOG0696|consensus	683		99.83
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.83
KOG0695|consensus	593		99.83
KOG0199|consensus	1039		99.83
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.83
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
KOG0669|consensus	376		99.82
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.82
KOG2345|consensus	302		99.81
KOG0983|consensus	391		99.8
KOG0603|consensus	612		99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
KOG0596|consensus	677		99.79
KOG0200|consensus	609		99.78
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.78
KOG1006|consensus	361		99.78
smart00090	237	RIO RIO-like kinase.	99.78
KOG1165|consensus	449		99.78
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
KOG2052|consensus	513		99.75
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.75
KOG0668|consensus	338		99.74
KOG0665|consensus	369		99.73
KOG1345|consensus	378		99.73
KOG1164|consensus	322		99.72
KOG1027|consensus	903		99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
KOG0671|consensus	415		99.69
KOG1167|consensus	418		99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG0670|consensus	752		99.65
KOG1166|consensus	974		99.65
KOG1290|consensus	590		99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.6
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.53
KOG0590|consensus	601		99.51
PLN00181	793	protein SPA1-RELATED; Provisional	99.5
KOG1024|consensus	563		99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.39
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.32
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.28
KOG4158|consensus	598		99.24
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.23
KOG0603|consensus	612		99.2
KOG3087|consensus	229		99.16
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.15
KOG3741|consensus	655		99.12
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.06
KOG1023|consensus	484		99.06
KOG1243|consensus	690		99.02
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.96
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.86
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.79
KOG1240|consensus	1431		98.77
KOG0590|consensus	601		98.75
KOG0606|consensus	1205		98.66
KOG0601|consensus	524		98.63
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.6
KOG1266|consensus	458		98.59
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.58
KOG0195|consensus	448		98.41
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.4
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.33
PRK09902	216	hypothetical protein; Provisional	98.24
KOG1033|consensus	516		98.15
KOG0601|consensus	524		98.12
KOG1235|consensus	538		98.11
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.1
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.95
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.42
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.33
PF01636	239	APH: Phosphotransferase enzyme family This family	97.31
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.3
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.21
PLN02876	822	acyl-CoA dehydrogenase	97.14
KOG0606|consensus	1205		96.81
PRK09550	401	mtnK methylthioribose kinase; Reviewed	95.81
KOG0576|consensus	829		95.68
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.57
KOG2268|consensus	465		95.39
KOG2270|consensus	520		94.58
PRK05231	319	homoserine kinase; Provisional	94.54
KOG1035|consensus	1351		94.36
PRK10593	297	hypothetical protein; Provisional	93.97
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	93.97
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	93.74
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	93.64
PRK14559	645	putative protein serine/threonine phosphatase; Pro	93.49
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.38
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	93.3
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.17
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	93.15
COG2334	331	Putative homoserine kinase type II (protein kinase	92.44
COG4248	637	Uncharacterized protein with protein kinase and he	92.41
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	92.28
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	91.79
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	91.5
PRK10271	188	thiK thiamine kinase; Provisional	91.17
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	90.94
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	90.5
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	89.92
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	89.79
PRK06148	1013	hypothetical protein; Provisional	89.71
PLN02236	344	choline kinase	89.68
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	89.4
PRK06149	972	hypothetical protein; Provisional	89.15
KOG2137|consensus	700		87.79
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	86.09
PRK11768	325	serine/threonine protein kinase; Provisional	85.57
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	84.83
KOG2269|consensus	531		83.27
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	82.73
KOG4720|consensus	391		82.03

>KOG0595|consensus

Probab=100.00  E-value=7.7e-36  Score=213.33  Aligned_cols=141  Identities=23%  Similarity=0.342  Sum_probs=128.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|+|++||++++.+++..+|+|++.          .+..+..+++.++|||||.++++.++++.+|+|||||.+|+|.
T Consensus        18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs   97 (429)
T KOG0595|consen   18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLS   97 (429)
T ss_pred             ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHH
Confidence            589999999999999999999997543          3466777899999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC------CCEEEeeeccceecCCCCCcccc
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH------GHVRISDLGLACDFSKKKPHASV  142 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~------~~~~l~dfg~~~~~~~~~~~~~~  142 (145)
                      .++...+.+++.+++.++.|++.|++++|+++|+||||||+|||+...      ..+|++|||+|+.+.++.-..+.
T Consensus        98 ~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tl  174 (429)
T KOG0595|consen   98 DYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETL  174 (429)
T ss_pred             HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHh
Confidence            999999999999999999999999999999999999999999999754      45899999999998877666554

>KOG0575|consensus

Probab=100.00  E-value=4.5e-33  Score=207.08  Aligned_cols=145  Identities=24%  Similarity=0.366  Sum_probs=134.6

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeee-----------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALN-----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      ++|-|||..+|.+++..+|+.+|.|           .++.+.++.++-+.|+|||||+++++|++++++|+|.|+|+.++
T Consensus        25 ~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~s  104 (592)
T KOG0575|consen   25 FLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGS  104 (592)
T ss_pred             eeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCcc
Confidence            4799999999999999999999996           46667788888899999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC-CCcccc-CCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV-GKS  145 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~-~~~  145 (145)
                      |..+++...++.|.+++.++.||+.|+.|||+++|+|||+|..|++++.+..+|++|||+|+.+..+ +.+.++ |||
T Consensus       105 L~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTP  182 (592)
T KOG0575|consen  105 LMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTP  182 (592)
T ss_pred             HHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCC
Confidence            9999998889999999999999999999999999999999999999999999999999999999855 777775 443

>KOG0615|consensus

Probab=100.00  E-value=2.9e-33  Score=200.60  Aligned_cols=141  Identities=22%  Similarity=0.315  Sum_probs=128.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +|.|+||.|-.|...++|+.+|+|.+.               ..+++.+++++|+|||||+++++|+..++.||||||++
T Consensus       180 LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~  259 (475)
T KOG0615|consen  180 LGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVE  259 (475)
T ss_pred             ecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEec
Confidence            699999999999999999999996311               23578889999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC---CCEEEeeeccceecCCCCCcccc
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH---GHVRISDLGLACDFSKKKPHASV  142 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~  142 (145)
                      ||+|.+.+..++.+.+.....++.|++.|+.|+|+.||+||||||+|||+..+   ..+|++|||+|+........++.
T Consensus       260 GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~Tl  338 (475)
T KOG0615|consen  260 GGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTL  338 (475)
T ss_pred             CccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhh
Confidence            99999999999999999999999999999999999999999999999999765   67999999999988766666664

>KOG0598|consensus

Probab=100.00  E-value=9e-33  Score=195.49  Aligned_cols=145  Identities=37%  Similarity=0.661  Sum_probs=131.5

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeee-----------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALN-----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +.|.|+||.|+.++..++++.+|+|           +......+.++++.++||+||+++..|++.+.+|+|+||+.||.
T Consensus        32 viGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGe  111 (357)
T KOG0598|consen   32 VIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGE  111 (357)
T ss_pred             eeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCcc
Confidence            4699999999999999999999995           45556677788899999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee-cCCCCCccc-cCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD-FSKKKPHAS-VGKS  145 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~-~~~~~~~~~-~~~~  145 (145)
                      |..++++++.+++..+..++.+|+.|+.|||+.+|+|||+||+|||+|.++.++++|||+++. ...+...++ +||+
T Consensus       112 Lf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~  189 (357)
T KOG0598|consen  112 LFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTP  189 (357)
T ss_pred             HHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCc
Confidence            999999999999999999999999999999999999999999999999999999999999984 444455555 5653

>KOG0581|consensus

Probab=100.00  E-value=2.1e-32  Score=193.73  Aligned_cols=143  Identities=26%  Similarity=0.387  Sum_probs=130.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCC-EEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD-KLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~-~~~lv~e~~~~~~l~   71 (145)
                      +|.|+.|+|++|++..+++.+|+|.+         ..+.++.++++.++|||||++|+.|..++ .++++||||.+|||.
T Consensus        87 lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd  166 (364)
T KOG0581|consen   87 LGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLD  166 (364)
T ss_pred             cccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHH
Confidence            68999999999999999999999854         33456777889999999999999999998 599999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccccCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGK  144 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  144 (145)
                      ..+...+.+++..+..++.++++|+.|||. +.|+||||||+|+|++..+.+|++|||.|..+.+...+..+||
T Consensus       167 ~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT  240 (364)
T KOG0581|consen  167 DILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGT  240 (364)
T ss_pred             HHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhccccccc
Confidence            999988899999999999999999999995 9999999999999999999999999999988776655555666

>KOG0592|consensus

Probab=99.97  E-value=4.5e-31  Score=194.54  Aligned_cols=135  Identities=31%  Similarity=0.473  Sum_probs=123.7

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +.|-|+|.+|++|+...+++.+|+|.           +.....+.+.|..| +||.|++|+.+|+++..+|+|+||+++|
T Consensus        80 ~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nG  159 (604)
T KOG0592|consen   80 ILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNG  159 (604)
T ss_pred             eeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCC
Confidence            36889999999999999999999953           22344566667777 9999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++.+.+.+++...+.++.+|+.+++|||++|||||||||+|||++.+++++|+|||.|+.+.+
T Consensus       160 dll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  160 DLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             cHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            9999999999999999999999999999999999999999999999999999999999999987654

>KOG0605|consensus

Probab=99.97  E-value=1.1e-30  Score=192.15  Aligned_cols=134  Identities=29%  Similarity=0.510  Sum_probs=123.7

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +.|.||||.||.|+...+|..+|+|.           +.-.+.+.+++...++|+||+++..|++.+++|+||||++||+
T Consensus       148 ~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD  227 (550)
T KOG0605|consen  148 VIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGD  227 (550)
T ss_pred             eeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCcc
Confidence            46899999999999999999999963           3334566677778899999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +.+++...+.+++..++.++.+.+.|+..+|..|++||||||+|+|+|..+.+||+|||++.-+.
T Consensus       228 ~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  228 MMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             HHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999996543

>KOG0616|consensus

Probab=99.97  E-value=1.4e-30  Score=180.33  Aligned_cols=135  Identities=33%  Similarity=0.538  Sum_probs=124.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.|..++...+|..+|+|.           ++-...+..+++.+.||++++++++|.+.+.+|+||||.+||.|
T Consensus        52 lGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGEl  131 (355)
T KOG0616|consen   52 LGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGEL  131 (355)
T ss_pred             eccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccH
Confidence            6899999999999999999999963           22234555678888999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++++++-+.+++..++.++.||+.|++|+|++++++||+||+||++|+.+.+|++|||+|+.+...
T Consensus       132 FS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  132 FSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             HHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            999999999999999999999999999999999999999999999999999999999999977544

>KOG0600|consensus

Probab=99.97  E-value=1.8e-30  Score=190.04  Aligned_cols=135  Identities=26%  Similarity=0.403  Sum_probs=122.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~   69 (145)
                      .|.|.||.||+|++..+|+.||+|.+          ....+++.+++.|+||||+++.+.....  +.+|+|+|||+. +
T Consensus       125 IGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-D  203 (560)
T KOG0600|consen  125 IGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-D  203 (560)
T ss_pred             hcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-h
Confidence            58999999999999999999999753          3456888999999999999999998766  799999999976 8


Q ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          70 LHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        70 l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      |..++.+.+ .+.+.++..++.|++.|+.|+|.+|++|||||.+|||+|..+.+||+|||+|+.+....
T Consensus       204 L~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  204 LSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             hhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            888887654 49999999999999999999999999999999999999999999999999999776554

>KOG0593|consensus

Probab=99.97  E-value=2.8e-31  Score=184.64  Aligned_cols=134  Identities=18%  Similarity=0.329  Sum_probs=120.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|-|+||+|++|+++.+|+.||+|.          .....++...+++++|||+|.+.++|.....+++|+|||+- ++.
T Consensus        10 vGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL   88 (396)
T KOG0593|consen   10 VGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVL   88 (396)
T ss_pred             cccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHH
Confidence            6889999999999999999999962          33445777788999999999999999999999999999977 555


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +.+.. ...++...+..++.|++.|+.|+|+++++||||||+||++...+.+|++|||+|+.+..+
T Consensus        89 ~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   89 HELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            55654 456999999999999999999999999999999999999999999999999999988744

>KOG0611|consensus

Probab=99.97  E-value=2.1e-30  Score=186.65  Aligned_cols=141  Identities=24%  Similarity=0.402  Sum_probs=130.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|.||.|-+|+....|+.||+|-+           .-++++..+++.|+||||+.++++|+.++.+.+||||..+|.|
T Consensus        61 LGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeL  140 (668)
T KOG0611|consen   61 LGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGEL  140 (668)
T ss_pred             hcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccH
Confidence            58999999999999999999999632           2357888899999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCcccc
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV  142 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  142 (145)
                      ++++...+.+++.+...+++||+.++.|+|.++++|+|+|.+||++|.++++|++|||++..+......++.
T Consensus       141 YDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTF  212 (668)
T KOG0611|consen  141 YDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTF  212 (668)
T ss_pred             HHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHh
Confidence            999999999999999999999999999999999999999999999999999999999999988776665553

>KOG0583|consensus

Probab=99.97  E-value=2.1e-29  Score=184.40  Aligned_cols=143  Identities=29%  Similarity=0.429  Sum_probs=125.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-------------HHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-------------MLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.|+.+.+..+++.+|+|...             ...++...++.+. ||||+++++++.+.+.+|+||||+.+
T Consensus        25 lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~g  104 (370)
T KOG0583|consen   25 LGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSG  104 (370)
T ss_pred             ecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCC
Confidence            689999999999999999999986311             2235666778888 99999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-CCEEEeeeccceec-CCCCCccc-cCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDF-SKKKPHAS-VGK  144 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-~~~~l~dfg~~~~~-~~~~~~~~-~~~  144 (145)
                      |+|++++.+.+.+.+..+..++.|++.|+.|+|++|++||||||+|++++.. .++|++|||++... .......+ .|+
T Consensus       105 GdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGs  184 (370)
T KOG0583|consen  105 GDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGS  184 (370)
T ss_pred             ccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCC
Confidence            9999999998899999999999999999999999999999999999999998 99999999999877 34333333 454

>KOG0198|consensus

Probab=99.96  E-value=2.6e-29  Score=178.84  Aligned_cols=134  Identities=27%  Similarity=0.385  Sum_probs=122.6

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHHH--------HHhhhhhcccCCCCceeEeeEEEEcCC--EEEEEEEccCCCCH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERIM--------LSLVSTGIQMVDCPFIVCMTYAFHTPD--KLCFILDLMNGGDL   70 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~~~~l   70 (145)
                      .+|.|+||.||.+...++|+..|+|++..        ++++..++++++|||||+.++......  .++++|||+++|+|
T Consensus        24 ~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL  103 (313)
T KOG0198|consen   24 LLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSL  103 (313)
T ss_pred             cccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcH
Confidence            36899999999999999999999986555        588888999999999999999855444  79999999999999


Q ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-CCCEEEeeeccceecC
Q psy3273          71 HYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-HGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-~~~~~l~dfg~~~~~~  134 (145)
                      .+++...+ .+++..++.+..|++.|+.|+|++|++|+||||+|||++. .+.+|++|||++....
T Consensus       104 ~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen  104 SDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            99999876 7999999999999999999999999999999999999999 6999999999998766

>KOG0597|consensus

Probab=99.96  E-value=1.2e-29  Score=188.49  Aligned_cols=135  Identities=28%  Similarity=0.361  Sum_probs=127.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeee----------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALN----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +.|.|+||+||+++.+.+.+.||+|          +...++++..+++.++||||+.++++|+++.++|+|+||+.+ +|
T Consensus         9 ~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L   87 (808)
T KOG0597|consen    9 MIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DL   87 (808)
T ss_pred             HhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hH
Confidence            4699999999999999999999994          566788999999999999999999999999999999999977 99


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ...+...+.++++.+..+..+++.|+.|+|+++|+|+|+||+||+++..+.+|++|||+|+....+
T Consensus        88 ~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   88 FTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             HHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            999999999999999999999999999999999999999999999999999999999999876544

>KOG0661|consensus

Probab=99.96  E-value=1.5e-29  Score=184.26  Aligned_cols=137  Identities=25%  Similarity=0.405  Sum_probs=121.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhcccCC-CCceeEeeEEEEcCC-EEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGIQMVD-CPFIVCMTYAFHTPD-KLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~-hp~i~~~~~~~~~~~-~~~lv~e~~~~~~l   70 (145)
                      +|-|.||.||+|+...+++.||+|.-.         +-.++.+.+++|+ ||||+++.+++.+.+ .+|+|||||+- +|
T Consensus        18 lGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NL   96 (538)
T KOG0661|consen   18 LGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NL   96 (538)
T ss_pred             hcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hH
Confidence            588999999999999999999996321         2246667788888 999999999999887 99999999966 99


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCc
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH  139 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  139 (145)
                      +++++. +..+++..+..++.||++|+.|+|.+|+.|||+||+|||+.....+|++|||+|+.+.+..+-
T Consensus        97 YqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY  166 (538)
T KOG0661|consen   97 YQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY  166 (538)
T ss_pred             HHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence            999975 466999999999999999999999999999999999999999999999999999988765443

>KOG0659|consensus

Probab=99.96  E-value=3.6e-29  Score=171.18  Aligned_cols=139  Identities=22%  Similarity=0.372  Sum_probs=125.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH----------HHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM----------LSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|.||+||+|++.++|+.||+|++..          ..++.+.+++++||||+.+.++|-..+.+.+|+||++. +|.
T Consensus        10 lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe   88 (318)
T KOG0659|consen   10 LGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLE   88 (318)
T ss_pred             hcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHH
Confidence            6899999999999999999999975332          34677788999999999999999999999999999966 999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccc
Q psy3273          72 YHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS  141 (145)
Q Consensus        72 ~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  141 (145)
                      ..+++. -.+.+..+..++.+++.|+.|+|++.|+|||+||.|++++.++.+|++|||+|+.+.++...+.
T Consensus        89 ~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   89 VVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             HHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            888754 5699999999999999999999999999999999999999999999999999999987655443

>KOG0192|consensus

Probab=99.96  E-value=2.3e-28  Score=177.95  Aligned_cols=133  Identities=25%  Similarity=0.309  Sum_probs=118.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCC-EEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD-KLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~-~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++....+.. +++|.          ...++++...++.++|||||++++++.... .+.+||||+++|+|
T Consensus        49 iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL  127 (362)
T KOG0192|consen   49 LGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSL  127 (362)
T ss_pred             cccCCceeEEEEEeCCcee-EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcH
Confidence            6899999999888875552 44532          447889999999999999999999999887 79999999999999


Q ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCC-ceecCCCCCcEEECCCC-CEEEeeeccceecCC
Q psy3273          71 HYHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRY-IVYRDLKPANILLDEHG-HVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~-iih~~l~~~nil~~~~~-~~~l~dfg~~~~~~~  135 (145)
                      ..++..  ...++......++.+++.|+.|+|+++ |+|+|+|++|+|++... .+|++|||+++....
T Consensus       128 ~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  128 SVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             HHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            999987  578999999999999999999999999 99999999999999997 999999999986654

>KOG0591|consensus

Probab=99.96  E-value=3e-30  Score=178.03  Aligned_cols=144  Identities=26%  Similarity=0.363  Sum_probs=123.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeE-EEEcCCE-EEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTY-AFHTPDK-LCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~-~~~~~~~-~~lv~e~~~~~~   69 (145)
                      .|-|+||.||++.+..+|..+|.|+          ...+-.+..++++|+|||||++++ .|..+.. ++++||+|..|+
T Consensus        27 IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GD  106 (375)
T KOG0591|consen   27 IGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGD  106 (375)
T ss_pred             HcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccC
Confidence            4789999999999999999999864          445567777899999999999999 5665555 999999999999


Q ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh--CC--ceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccc
Q psy3273          70 LHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHR--RY--IVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS  141 (145)
Q Consensus        70 l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~--~~--iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  141 (145)
                      |.++++.    ...++++++..++.|++.|+..+|.  ..  +.||||||.||+++..+.+|++|||+++.+.+......
T Consensus       107 LsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~  186 (375)
T KOG0591|consen  107 LSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAH  186 (375)
T ss_pred             HHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHH
Confidence            9999863    3569999999999999999999998  44  89999999999999999999999999998876544333


Q ss_pred             --cCCC
Q psy3273         142 --VGKS  145 (145)
Q Consensus       142 --~~~~  145 (145)
                        +|||
T Consensus       187 S~VGTP  192 (375)
T KOG0591|consen  187 SLVGTP  192 (375)
T ss_pred             hhcCCC
Confidence              6665

>KOG0658|consensus

Probab=99.96  E-value=3.1e-29  Score=177.45  Aligned_cols=140  Identities=24%  Similarity=0.357  Sum_probs=120.6

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH----HHHhhhhhcccCCCCceeEeeEEEEcC--C---EEEEEEEccCCCCHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI----MLSLVSTGIQMVDCPFIVCMTYAFHTP--D---KLCFILDLMNGGDLH   71 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~hp~i~~~~~~~~~~--~---~~~lv~e~~~~~~l~   71 (145)
                      ++|.|+||.||.+....+++.+|+|.+.    .-.++..++++++|||||++..+|...  +   ...+||||++. +|.
T Consensus        31 liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~  109 (364)
T KOG0658|consen   31 LIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLY  109 (364)
T ss_pred             EEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHH
Confidence            5799999999999999999999998644    345666778899999999998888643  2   35679999977 898


Q ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-CCEEEeeeccceecCCCCCccc
Q psy3273          72 YHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHAS  141 (145)
Q Consensus        72 ~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~  141 (145)
                      ..++.    ...++...+..+.+|+.+|+.|+|..+|+||||||+|+|+|.+ +.+|++|||.|+.+.+++++.+
T Consensus       110 ~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniS  184 (364)
T KOG0658|consen  110 RVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNIS  184 (364)
T ss_pred             HHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCcee
Confidence            88874    4668888999999999999999999999999999999999976 7899999999999888777643

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.96  E-value=1.7e-27  Score=171.93  Aligned_cols=133  Identities=35%  Similarity=0.617  Sum_probs=120.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      ++|.|+||.||+|.+..+++.+++|..           ....++...++.++||||+++++.+..++.+|+||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            479999999999999999999988732           223445567788999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |...+.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||+++..
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            9999988888999999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0663|consensus

Probab=99.96  E-value=1.7e-28  Score=172.55  Aligned_cols=134  Identities=25%  Similarity=0.354  Sum_probs=120.3

Q ss_pred             eeeeeeEEEEEEEcccCCeeeeeHHHHH----------HhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccCCCCH
Q psy3273           3 FIVGTGFLSNCSHVKQGETLALNERIML----------SLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMNGGDL   70 (145)
Q Consensus         3 g~~~~g~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~l   70 (145)
                      +.|.||.||++++.++++.||+|...+-          .++.+++..++|||||.+.++.+..  +.+|+|||||+. +|
T Consensus        85 ~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DL  163 (419)
T KOG0663|consen   85 EEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DL  163 (419)
T ss_pred             ccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hH
Confidence            5689999999999999999999865442          4677778888999999999998755  589999999976 99


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      .+.+.. ..++...++..++.|++.|+.|+|.+.++|||+|++|+++...+.+|++|||+|+.+.++.
T Consensus       164 ksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  164 KSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            998876 4589999999999999999999999999999999999999999999999999999998763

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.96  E-value=1.4e-27  Score=174.80  Aligned_cols=134  Identities=28%  Similarity=0.473  Sum_probs=121.9

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .+|.|+||.||+|.+..+++.+|+|..           ..+..+...++.++||||+++++.+.+++.+|+||||+++++
T Consensus         8 ~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~   87 (363)
T cd05628           8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGD   87 (363)
T ss_pred             EEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCc
Confidence            369999999999999999999998742           234556667888999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |.+++.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++..+.++++|||+++.+.
T Consensus        88 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          88 MMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            99999888889999999999999999999999999999999999999999999999999987553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.9e-27  Score=174.89  Aligned_cols=132  Identities=31%  Similarity=0.551  Sum_probs=120.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++.+..+++.+++|..           ..+..+.+.++.++||||++++++|.+++.+|+||||+++++|
T Consensus         9 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L   88 (377)
T cd05629           9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDL   88 (377)
T ss_pred             EeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcH
Confidence            68999999999999999999999732           2344566778889999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      .+++.....+++..+..++.|++.++.|+|+++++|+||||+||+++..+.++++|||+++.+
T Consensus        89 ~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          89 MTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            999988888999999999999999999999999999999999999999999999999999744

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.95  E-value=3.3e-27  Score=173.94  Aligned_cols=132  Identities=31%  Similarity=0.519  Sum_probs=120.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||++.+..+++.+++|..           ..+..+.+.++.++||||+++++++.+++.+|+||||+++++|
T Consensus         9 LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L   88 (381)
T cd05626           9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDM   88 (381)
T ss_pred             EeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcH
Confidence            69999999999999999999998632           2244566778899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      .+++.....+++..+..++.|++.++.|+|..+++|+||||+||+++..+.++++|||++..+
T Consensus        89 ~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          89 MSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            999988888999999999999999999999999999999999999999999999999998644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0594|consensus

Probab=99.95  E-value=8.2e-28  Score=169.72  Aligned_cols=132  Identities=23%  Similarity=0.363  Sum_probs=117.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHHH----------HhhhhhcccCCCCc-eeEeeEEEEcCC------EEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIML----------SLVSTGIQMVDCPF-IVCMTYAFHTPD------KLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~hp~-i~~~~~~~~~~~------~~~lv~e~   64 (145)
                      .|.|+||.||+|....+|+.||+|++..-          .++.-.+++++|+| |+++++++.+++      .+++|+|+
T Consensus        19 lGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~   98 (323)
T KOG0594|consen   19 LGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEF   98 (323)
T ss_pred             hCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEe
Confidence            58899999999999999999999865543          34455678899999 999999999887      89999999


Q ss_pred             cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          65 MNGGDLHYHLSQHG----VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        65 ~~~~~l~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +.. +|..++....    .++...++.++.|++.|+.|+|+++|+|||+||+|+++++.+.+|++|||+|+.+.
T Consensus        99 ~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~  171 (323)
T KOG0594|consen   99 LDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFS  171 (323)
T ss_pred             ecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence            966 9999997643    57888999999999999999999999999999999999999999999999998765

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.4e-27  Score=173.50  Aligned_cols=134  Identities=29%  Similarity=0.532  Sum_probs=122.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      ..|.|+||.||+|.+..+++.+|+|..           ..+.++...++.++||||++++++|.+++.+|+||||+++++
T Consensus         8 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~   87 (364)
T cd05599           8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGD   87 (364)
T ss_pred             EEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcH
Confidence            369999999999999999999998742           223456777889999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |.+++.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++..+.++++|||++..+.
T Consensus        88 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          88 MMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            99999888889999999999999999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.95  E-value=2.7e-27  Score=170.96  Aligned_cols=133  Identities=36%  Similarity=0.640  Sum_probs=120.3

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +.|.|+||.||++.+..+++.+++|..           ..+..+...++.++||||+++++.|..++..|+||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            479999999999999999999988732           223355667888999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |..++.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||++...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            9998888788999999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.95  E-value=3.6e-27  Score=170.70  Aligned_cols=134  Identities=34%  Similarity=0.603  Sum_probs=122.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+++|..           ..+.++...++.++||||+++++++..++..|++|||+++++|
T Consensus        26 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  105 (329)
T PTZ00263         26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL  105 (329)
T ss_pred             EEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChH
Confidence            68999999999999999999988732           2345666778899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+.+.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus       106 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263        106 FTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99998888899999999999999999999999999999999999999999999999999986643

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.95  E-value=4.2e-27  Score=173.35  Aligned_cols=133  Identities=31%  Similarity=0.543  Sum_probs=120.9

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .+|.|+||.||+|.+..+++.+++|..           ..+..+..+++.++||||+++++.|.+++.+|+||||+++|+
T Consensus         8 ~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~   87 (382)
T cd05625           8 TLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD   87 (382)
T ss_pred             EEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCc
Confidence            369999999999999999999988742           234556677889999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |.+.+.....+++..+..++.|++.++.|+|+.+++|+||||+||+++..+.++++|||++..+
T Consensus        88 L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          88 MMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            9999987778999999999999999999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=5.1e-27  Score=169.85  Aligned_cols=133  Identities=35%  Similarity=0.637  Sum_probs=120.3

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      ++|.|+||.||++.+..+++.+++|..           ..+.++...++.++||||+++.+.+..++..|+||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            469999999999999999999988632           223445567889999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |...+.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++..+.++++|||++...
T Consensus        82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            9999887788999999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG1187|consensus

Probab=99.95  E-value=2.3e-27  Score=173.23  Aligned_cols=134  Identities=22%  Similarity=0.194  Sum_probs=117.9

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCC-EEEEEEEccCCCCHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD-KLCFILDLMNGGDLH   71 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~-~~~lv~e~~~~~~l~   71 (145)
                      +.|.||||.||++..... ..+|+|.        ..-+..+...+.+++|||+++++|+|...+ ..++|+||+++|+|.
T Consensus        82 ~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~  160 (361)
T KOG1187|consen   82 LIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLE  160 (361)
T ss_pred             ceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHH
Confidence            468999999999988876 7777751        233778888899999999999999999988 599999999999999


Q ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhC---CceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQHG--VFNEDEMRFYAAEVILGLEHMHRR---YIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~---~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++....  ++++.+-..++.+++.|+.|||..   .++|+|||++|||+|.+...|++|||+|+....
T Consensus       161 d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  161 DHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE  229 (361)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence            9997644  889999999999999999999964   399999999999999999999999999965543

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.95  E-value=5.3e-27  Score=172.44  Aligned_cols=131  Identities=31%  Similarity=0.540  Sum_probs=120.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+|+|..           ..+.++.++++.++||||+++++.|..++.+|+||||+++++|
T Consensus         9 lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L   88 (376)
T cd05598           9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDM   88 (376)
T ss_pred             EEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcH
Confidence            68999999999999999999999743           2244566778899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      .+++...+.+++..+..++.|++.|+.|+|+.+++|+||+|+||+++..+.++++|||++..
T Consensus        89 ~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          89 MSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            99998878899999999999999999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.4e-27  Score=168.85  Aligned_cols=133  Identities=29%  Similarity=0.482  Sum_probs=120.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+++|..           ..+..+...++.++||||+++++++..++..|++|||+++++|
T Consensus         9 ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L   88 (333)
T cd05600           9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF   88 (333)
T ss_pred             EeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCH
Confidence            68999999999999999999998632           2234556677888999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++.....+++..+..++.|++.++.++|+++++|+||+|+||+++..+.++++|||++....
T Consensus        89 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600          89 RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence            9999887889999999999999999999999999999999999999999999999999997553

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=6.4e-27  Score=168.18  Aligned_cols=132  Identities=36%  Similarity=0.621  Sum_probs=119.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+++|..           ..+..+...++.++||||+++++.+..++..|++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            48899999999999999999988732           2234556678889999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      .+++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++...
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~  143 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLN  143 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence            999988788999999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0588|consensus

Probab=99.95  E-value=4.5e-28  Score=182.34  Aligned_cols=140  Identities=23%  Similarity=0.354  Sum_probs=127.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+.|.|..|++..||+.+|+|.+           ..++++.-+|+-+.|||+++++++|+.+.++|+|.||+++|.|
T Consensus        20 LG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGEL   99 (786)
T KOG0588|consen   20 LGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGEL   99 (786)
T ss_pred             ccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchh
Confidence            68999999999999999999999743           3346777778889999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccc
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS  141 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  141 (145)
                      ++++...+++++.+...+++||+.|+.|+|..+|+|||+||+|+++|...++|++|||+|..-.+++...+
T Consensus       100 Fdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen  100 FDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             HHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence            99999999999999999999999999999999999999999999999998999999999987666554444

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.95  E-value=1.4e-26  Score=167.28  Aligned_cols=133  Identities=35%  Similarity=0.635  Sum_probs=119.0

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +.|.|+||.||++.+..+++.+++|..           .....+...++.++||||+++.+.+..++..|+||||+++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            479999999999999999999988632           222345556788899999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |..++.....+++..+..++.|++.++.|+|+ .+++|+||+|+||+++.++.++++|||++...
T Consensus        82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            99988877889999999999999999999997 79999999999999999999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0578|consensus

Probab=99.95  E-value=6.8e-28  Score=178.35  Aligned_cols=143  Identities=24%  Similarity=0.394  Sum_probs=127.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|+.|.||.|+...+++.||+|.        ++.+-.+...++..+|||||++++.|..++.+|+||||+++|+|.+.
T Consensus       281 igqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDv  360 (550)
T KOG0578|consen  281 IGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDV  360 (550)
T ss_pred             hccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhh
Confidence            6899999999999999999999963        55666777788899999999999999999999999999999998777


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCC--ccccCCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGKS  145 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~  145 (145)
                      +.. ..+++.++..++.+++.|+.|||.++|+|+|||.+||+++.++.+|++|||++..+.....  ...+|||
T Consensus       361 Vt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTP  433 (550)
T KOG0578|consen  361 VTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTP  433 (550)
T ss_pred             hhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCC
Confidence            754 4589999999999999999999999999999999999999999999999999998876543  3346775

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.95  E-value=1.4e-26  Score=167.33  Aligned_cols=133  Identities=38%  Similarity=0.613  Sum_probs=117.7

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH------------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI------------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|+||.||+|.+..+++.+++|...            ........++.++||||+++++.+..++..|+||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            4799999999999999999999887321            1112222467789999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|...+.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++..+.++++|||++...
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            99998888888999999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.95  E-value=1.2e-26  Score=169.80  Aligned_cols=133  Identities=27%  Similarity=0.481  Sum_probs=121.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||++.+..+++.+++|..           ..++.+...+..++||||+++++.+.+++.+|+||||+++++|
T Consensus         9 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L   88 (360)
T cd05627           9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDM   88 (360)
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccH
Confidence            68999999999999999999988632           2344566678889999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++..+.
T Consensus        89 ~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          89 MTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            9999888889999999999999999999999999999999999999999999999999987553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.6e-27  Score=167.95  Aligned_cols=133  Identities=30%  Similarity=0.477  Sum_probs=121.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+++|..           ..+.++...++.++||||+++++++.+++..|++|||+++++|
T Consensus         9 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L   88 (291)
T cd05612           9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL   88 (291)
T ss_pred             eecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCH
Confidence            68999999999999999999988642           2345667778999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++...+.+++.....++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++..+.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          89 FSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            9999888889999999999999999999999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.95  E-value=1.4e-26  Score=167.08  Aligned_cols=133  Identities=38%  Similarity=0.627  Sum_probs=117.8

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH------------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI------------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +.|.|+||.||++.+..+++.+++|...            .+......++.++||||+++++.+..++..|+||||++++
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            4689999999999999999999997421            1122222457789999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|..++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++...
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            99999988788999999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.95  E-value=1.3e-26  Score=167.42  Aligned_cols=133  Identities=38%  Similarity=0.617  Sum_probs=117.3

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH------------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI------------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ..|.|+||.||+|.+..+++.+++|...            .+.+....++.++||||+++++++..++..|++|||++++
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            3689999999999999999988886321            1222223457789999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|...+.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++...
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            99999988778899999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=1.9e-26  Score=169.45  Aligned_cols=133  Identities=27%  Similarity=0.452  Sum_probs=119.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||++.+..+++.+|+|..           ..+.++...++.++||||+++++++.+++.+|+||||+++++|
T Consensus        51 lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L  130 (370)
T cd05621          51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL  130 (370)
T ss_pred             EEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcH
Confidence            68999999999999999999988632           2345666778889999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++... .+++..+..++.|++.|+.|+|+++++|+||+|+||+++..+.++++|||++..+..
T Consensus       131 ~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         131 VNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             HHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            9988653 588999999999999999999999999999999999999999999999999987643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.95  E-value=1.6e-26  Score=166.71  Aligned_cols=133  Identities=36%  Similarity=0.598  Sum_probs=117.3

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH------------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI------------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +.|.|+||.||+|.+..+++.+++|...            .+.+....++.++||||+++++.+...+..|+||||++++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            4699999999999999999999886321            1122223467889999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|...+.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++...
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            99988887778999999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.95  E-value=1.8e-26  Score=167.06  Aligned_cols=132  Identities=29%  Similarity=0.530  Sum_probs=118.0

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|+||.||++.+..+++.+|+|..           ..+..+...++.+ +||||++++++|.+++.+|+||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            479999999999999999999988632           2234455555565 7999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      +|..++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++..
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence            9999888778899999999999999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0584|consensus

Probab=99.95  E-value=1.5e-27  Score=178.30  Aligned_cols=145  Identities=24%  Similarity=0.335  Sum_probs=131.6

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeee------------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCE--EEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALN------------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDK--LCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~--~~lv~e~~~   66 (145)
                      ++|.|+|.+||++.+-.+|-+||..            +.+.+..++..++.|+||||+++|++|.+...  +.+|+|.+.
T Consensus        47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T  126 (632)
T KOG0584|consen   47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT  126 (632)
T ss_pred             hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence            4799999999999999999999884            34667788889999999999999999998765  888999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEEC-CCCCEEEeeeccceecCCCCCccccC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY--IVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVG  143 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--iih~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~  143 (145)
                      .|+|..++.+.+.++.+.+..|++||+.|+.|||++.  |+|||||.+||++. ..+.+||+|+|+|+..........+|
T Consensus       127 SGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIG  206 (632)
T KOG0584|consen  127 SGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIG  206 (632)
T ss_pred             CCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccceecc
Confidence            9999999999999999999999999999999999765  99999999999996 45899999999999888877777889


Q ss_pred             CC
Q psy3273         144 KS  145 (145)
Q Consensus       144 ~~  145 (145)
                      ||
T Consensus       207 TP  208 (632)
T KOG0584|consen  207 TP  208 (632)
T ss_pred             Cc
Confidence            86

>KOG0610|consensus

Probab=99.95  E-value=6.6e-27  Score=168.09  Aligned_cols=132  Identities=33%  Similarity=0.481  Sum_probs=120.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|+|.-|+||.|....++...|+|.           ....+.+.++++.++||.++++|..|+++...|++||||+||+|
T Consensus        85 LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL  164 (459)
T KOG0610|consen   85 LGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDL  164 (459)
T ss_pred             cCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccH
Confidence            6999999999999999999988862           33345666789999999999999999999999999999999999


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          71 HYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ...++.+  ..+++..++.++.+++.|++|||..||++||+||+|||+..++.+-|+||-++...
T Consensus       165 ~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  165 HSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             HHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9998764  56999999999999999999999999999999999999999999999999988654

>KOG0585|consensus

Probab=99.95  E-value=2.8e-27  Score=172.57  Aligned_cols=131  Identities=27%  Similarity=0.431  Sum_probs=116.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee----------------------HHHHHHhhhhhcccCCCCceeEeeEEEEcC--CE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN----------------------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTP--DK   57 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~   57 (145)
                      .|.|.||.|-+|++..+++.+|+|                      ..+..+++..++++|.|||||+|+++.-+.  +.
T Consensus       105 iG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~  184 (576)
T KOG0585|consen  105 IGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDK  184 (576)
T ss_pred             hcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCc
Confidence            589999999999999999999995                      245667888899999999999999999764  68


Q ss_pred             EEEEEEccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          58 LCFILDLMNGGDLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        58 ~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|||+|||..|.+. +.....+ +.+.++..++..++.|++|||..||+||||||+|+|++.++.+|++|||.+...
T Consensus       185 ~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~  260 (576)
T KOG0585|consen  185 LYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEF  260 (576)
T ss_pred             eEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeec
Confidence            99999999988773 2333334 889999999999999999999999999999999999999999999999999866

>KOG0599|consensus

Probab=99.95  E-value=3.5e-28  Score=167.61  Aligned_cols=143  Identities=27%  Similarity=0.467  Sum_probs=125.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------------HHHHHhhhhhcc-cCCCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------------RIMLSLVSTGIQ-MVDCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~-~l~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      +|-|...++.+|....++.+.+.+.                .+.-.++..+++ ...||||+++.++|+++..+++|+|.
T Consensus        25 lgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl  104 (411)
T KOG0599|consen   25 LGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDL  104 (411)
T ss_pred             hcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhh
Confidence            5777888889999999988877741                222234444444 34999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCcccc-C
Q psy3273          65 MNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-G  143 (145)
Q Consensus        65 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~  143 (145)
                      |+.|.|++++.+.-.++++....++.|+..++.|+|.+.|+|+|+||+||+++++.+++++|||+|+.+.+++..+.. |
T Consensus       105 ~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCG  184 (411)
T KOG0599|consen  105 MPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCG  184 (411)
T ss_pred             cccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcC
Confidence            999999999998888999999999999999999999999999999999999999999999999999999998888775 4


Q ss_pred             C
Q psy3273         144 K  144 (145)
Q Consensus       144 ~  144 (145)
                      |
T Consensus       185 T  185 (411)
T KOG0599|consen  185 T  185 (411)
T ss_pred             C
Confidence            4

>KOG0589|consensus

Probab=99.95  E-value=1.1e-27  Score=175.11  Aligned_cols=145  Identities=23%  Similarity=0.337  Sum_probs=128.5

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCE-EEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDK-LCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~-~~lv~e~~~~~~   69 (145)
                      ..|.|+||..+.+++...+..+++|+          +....++...++++.|||||.+.+.|+.++. ++|+|+||+||+
T Consensus        11 ~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~   90 (426)
T KOG0589|consen   11 QVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGD   90 (426)
T ss_pred             hcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCC
Confidence            36899999999999999999888864          3345677788899999999999999998887 999999999999


Q ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC-Cccc-cCCC
Q psy3273          70 LHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS-VGKS  145 (145)
Q Consensus        70 l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~-~~~~  145 (145)
                      +.+.+...  ..++++.+..|+.|++.|+.|+|++.|+|||+|+.||++.++..+++.|||+|+.++++. ...+ +||+
T Consensus        91 l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp  170 (426)
T KOG0589|consen   91 LAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTP  170 (426)
T ss_pred             HHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCC
Confidence            99999754  459999999999999999999999999999999999999999999999999999988775 4444 4553

>KOG0582|consensus

Probab=99.95  E-value=2e-26  Score=167.04  Aligned_cols=133  Identities=22%  Similarity=0.361  Sum_probs=122.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|..++||+|++..+++.||+|         +.+.++++...++.++||||++++.+|..+..+|+||.+|.+||+.+
T Consensus        34 IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ld  113 (516)
T KOG0582|consen   34 IGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLD  113 (516)
T ss_pred             EeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHH
Confidence            578888999999999999999996         35667888888999999999999999999999999999999999999


Q ss_pred             HHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+...  ..+++..+..+..+++.|+.|+|.+|-+|||+|+.|||++.++.++++|||.+..+.
T Consensus       114 Iik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  114 IIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             HHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            99864  349999999999999999999999999999999999999999999999999876553

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.95  E-value=3e-26  Score=165.09  Aligned_cols=134  Identities=32%  Similarity=0.586  Sum_probs=116.5

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcc-cCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQ-MVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|+||.||++.+..+++.+|+|...           ....+...+. ..+||||+++++++..++.+|+||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            4799999999999999999999987321           1112222232 458999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +|..++.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||++....
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            999999887789999999999999999999999999999999999999999999999999997653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.95  E-value=3.2e-26  Score=166.51  Aligned_cols=133  Identities=26%  Similarity=0.423  Sum_probs=118.7

Q ss_pred             eeeeeeeEEEEEEEcccC-CeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQG-ETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~-~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||++.+..++ ..+++|.           ...+..+...++.++||||+++++++..++..|++|||+++++
T Consensus        38 ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~  117 (340)
T PTZ00426         38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGE  117 (340)
T ss_pred             EeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCc
Confidence            689999999999876655 5677752           2234456777889999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |.+++.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++..+.
T Consensus       118 L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        118 FFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999888889999999999999999999999999999999999999999999999999997654

>KOG0580|consensus

Probab=99.95  E-value=1.5e-27  Score=161.15  Aligned_cols=138  Identities=22%  Similarity=0.275  Sum_probs=123.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|-|-||.||.++..+++-.+++|.           ...++++.++.+.|+||||.++|++|.++...|+++||.+.|++
T Consensus        30 LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel  109 (281)
T KOG0580|consen   30 LGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGEL  109 (281)
T ss_pred             ccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchH
Confidence            6789999999999999999999963           23456777778899999999999999999999999999999999


Q ss_pred             HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCc
Q psy3273          71 HYHLS--QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH  139 (145)
Q Consensus        71 ~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  139 (145)
                      +..+.  ....+++.....+..|++.|+.|+|.+.++|||++|+|+|++..+.++++|||.+..-..+...
T Consensus       110 ~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~  180 (281)
T KOG0580|consen  110 YKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRK  180 (281)
T ss_pred             HHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCCce
Confidence            99998  4456999999999999999999999999999999999999999999999999999765544433

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.9e-26  Score=167.75  Aligned_cols=135  Identities=30%  Similarity=0.531  Sum_probs=122.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|++|.||+|.+..+++.+++|..           ..+..+...++.++||||+++++++..++..|+||||+++++|
T Consensus         9 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   88 (350)
T cd05573           9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDL   88 (350)
T ss_pred             EEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCH
Confidence            68999999999999999999998742           2345566778889999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.....+++..+..++.|++.|+.|+|..+++|+||+|+||+++..+.++++|||++..+...
T Consensus        89 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          89 MNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999988788999999999999999999999999999999999999999999999999999866543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.6e-26  Score=165.04  Aligned_cols=134  Identities=29%  Similarity=0.451  Sum_probs=120.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++....+++.+|+|..           ..+.++...++.++||||+++++++.+++.+|+||||+++++|
T Consensus         9 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L   88 (331)
T cd05597           9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDL   88 (331)
T ss_pred             EEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999742           2345566677888999999999999999999999999999999


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++.. ...+++..+..++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++..+..
T Consensus        89 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          89 LTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999975 45689999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.95  E-value=4.1e-26  Score=165.22  Aligned_cols=133  Identities=29%  Similarity=0.512  Sum_probs=117.0

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhccc-CCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQM-VDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|+||.||++.+..+++.+++|...           .+..+...+.. .+||||+++++++..++..|+||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            4799999999999999999998886321           23334444444 48999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|..++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++...
T Consensus        82 ~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          82 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            99998887788999999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=5.4e-26  Score=163.72  Aligned_cols=135  Identities=38%  Similarity=0.647  Sum_probs=118.9

Q ss_pred             CeeeeeeeEEEEEEEc---ccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           1 MFFIVGTGFLSNCSHV---KQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      ..|.|+||.||++.+.   .+++.+++|..          .....+...++.++||||+++++++..++..|+||||+++
T Consensus         3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (318)
T cd05582           3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG   82 (318)
T ss_pred             eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCC
Confidence            3689999999999874   46788887632          2234566678899999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++|.+.+.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++.....
T Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          83 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            99999998777899999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.94  E-value=7.2e-26  Score=164.02  Aligned_cols=135  Identities=29%  Similarity=0.466  Sum_probs=120.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++.+..+++.+++|..           ..+..+...++.++||||+++++++..++..|+||||+++|+|
T Consensus         9 lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L   88 (331)
T cd05624           9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDL   88 (331)
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcH
Confidence            69999999999999999999988732           2244556667888999999999999999999999999999999


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.. ...+++..+..++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++..+...
T Consensus        89 ~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          89 LTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999976 467899999999999999999999999999999999999999999999999999766543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.94  E-value=4.7e-26  Score=164.68  Aligned_cols=135  Identities=27%  Similarity=0.491  Sum_probs=121.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||++.+..+++.+++|.           ...+.++...++.++||||+++++.+..++..|+||||+++++|
T Consensus         9 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   88 (330)
T cd05601           9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL   88 (330)
T ss_pred             EEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCH
Confidence            6899999999999999999998863           22345666777888999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++... ..+++..+..++.|++.++.++|+.+++|+||+|+||+++..+.++++|||++..+...
T Consensus        89 ~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          89 LSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999865 67999999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=5.6e-26  Score=163.85  Aligned_cols=133  Identities=32%  Similarity=0.534  Sum_probs=116.7

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhccc-CCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQM-VDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|+||.||+|.+..+++.+++|...           ....+...++. .+||||++++++|..++.+|+||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            4799999999999999999999887422           12233334443 38999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|...+.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||++...
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            99999988788999999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0032|consensus

Probab=99.94  E-value=4.5e-26  Score=167.13  Aligned_cols=143  Identities=24%  Similarity=0.383  Sum_probs=126.3

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ..|.|.||.++.|....+|+.+|+|.           .....++..+++.+. ||||+.+++.|++.+.+++|||++.||
T Consensus        42 ~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GG  121 (382)
T KOG0032|consen   42 ELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGG  121 (382)
T ss_pred             hhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCc
Confidence            36899999999999999999999852           246778888999998 999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC----CCEEEeeeccceecCCCCCccc-cC
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH----GHVRISDLGLACDFSKKKPHAS-VG  143 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~----~~~~l~dfg~~~~~~~~~~~~~-~~  143 (145)
                      .|.+.+... .+++..+..++.|++.++.|+|+.|++|+|+||+|+++...    ..++++|||+|..+..+..... +|
T Consensus       122 eLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~G  200 (382)
T KOG0032|consen  122 ELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVG  200 (382)
T ss_pred             hHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecC
Confidence            999999765 49999999999999999999999999999999999999643    3799999999998877544444 44


Q ss_pred             C
Q psy3273         144 K  144 (145)
Q Consensus       144 ~  144 (145)
                      +
T Consensus       201 t  201 (382)
T KOG0032|consen  201 T  201 (382)
T ss_pred             C
Confidence            4

>KOG0197|consensus

Probab=99.94  E-value=1.9e-26  Score=169.53  Aligned_cols=137  Identities=20%  Similarity=0.193  Sum_probs=119.1

Q ss_pred             eeeeeeeEEEEEEEcccCC-e-eeeeH----HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGE-T-LALNE----RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS   75 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~-~-~~~~~----~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~   75 (145)
                      +|.|-||.|+.+....+.. . ..+++    .+.+.++++++++|+|+|||++++++..++.+||||||++.|+|.+++.
T Consensus       214 LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr  293 (468)
T KOG0197|consen  214 LGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLR  293 (468)
T ss_pred             hcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhh
Confidence            5899999999999876521 1 12222    3455688899999999999999999999999999999999999999998


Q ss_pred             h--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCC
Q psy3273          76 Q--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  138 (145)
Q Consensus        76 ~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~  138 (145)
                      .  ...++..+.+.++.||++|+.||+++.+|||||..+|||++.+..+|++|||+|+.+.++..
T Consensus       294 ~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  294 TREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             hcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            6  45699999999999999999999999999999999999999999999999999996555443

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=7.2e-26  Score=163.49  Aligned_cols=133  Identities=40%  Similarity=0.680  Sum_probs=117.8

Q ss_pred             CeeeeeeeEEEEEEEc---ccCCeeeeeHH------------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEcc
Q psy3273           1 MFFIVGTGFLSNCSHV---KQGETLALNER------------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~---~~~~~~~~~~~------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      .+|.|+||.||.|...   .+++.+++|..            ..+..+...++.++||||+++++.|..++..|++|||+
T Consensus         3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~   82 (323)
T cd05584           3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL   82 (323)
T ss_pred             eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence            3699999999999874   46778887632            12345666788999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++++|.+++.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||+++..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          83 SGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            99999999988888899999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.94  E-value=9.7e-26  Score=165.66  Aligned_cols=133  Identities=28%  Similarity=0.432  Sum_probs=119.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++.+..+++.+|+|..           ..+..+...++.++||||+++++++.+++..|+||||+++|+|
T Consensus        51 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L  130 (370)
T cd05596          51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL  130 (370)
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcH
Confidence            68999999999999999999998742           2234566778899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ..++.. ..+++..+..++.|++.|+.|+|+.+++|+||+|+||+++..+.++++|||++..+..
T Consensus       131 ~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         131 VNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            998865 3578889999999999999999999999999999999999999999999999976643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=7e-26  Score=163.41  Aligned_cols=133  Identities=31%  Similarity=0.548  Sum_probs=116.6

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhccc-CCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQM-VDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|+||.||+|.+..+++.+++|...           ....+...++. .+||||+++++++...+.+|+||||++++
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            4799999999999999999999887422           12233333443 37999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|..++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++...
T Consensus        82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            99999888788999999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.94  E-value=1.2e-25  Score=159.65  Aligned_cols=134  Identities=43%  Similarity=0.717  Sum_probs=118.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++.+..+++.+++|...           ...++...++.++||||+++.+++.+++..+++|||+++++|
T Consensus         8 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L   87 (285)
T cd05631           8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDL   87 (285)
T ss_pred             EecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcH
Confidence            689999999999999999999987321           233466678889999999999999999999999999999999


Q ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ...+..  ...+++..+..++.|++.++.|+|+.+++|+||+|+||+++....++++|||++..+..
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          88 KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            887754  34588999999999999999999999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.94  E-value=1.1e-25  Score=162.74  Aligned_cols=132  Identities=29%  Similarity=0.524  Sum_probs=117.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|+||.||++....+++.+++|..           ..+..+...+..+ +||||+++++++...+.+|+||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            479999999999999999998888532           2233444555555 7999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      +|...+.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++..+.++++|||++..
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence            9999888778899999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.94  E-value=1.1e-25  Score=165.36  Aligned_cols=133  Identities=29%  Similarity=0.457  Sum_probs=118.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+++|..           ..+.++...++.++||||+++++.+..++.+|+||||+++++|
T Consensus        51 lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L  130 (371)
T cd05622          51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL  130 (371)
T ss_pred             EeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcH
Confidence            68999999999999999999988642           2234566677889999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++.. ..+++..+..++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++..+..
T Consensus       131 ~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         131 VNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            998865 3578889999999999999999999999999999999999999999999999987653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.94  E-value=5.5e-26  Score=161.01  Aligned_cols=134  Identities=43%  Similarity=0.718  Sum_probs=118.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||++.+..+++.+++|...           .+..+...++.++||||+++.+++..++..|++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            488999999999999999999886431           223466678899999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ...+..    ...+++..+..++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++..+..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            887742    34589999999999999999999999999999999999999999999999999976644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.94  E-value=1.2e-25  Score=161.91  Aligned_cols=133  Identities=32%  Similarity=0.536  Sum_probs=116.2

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcc-cCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQ-MVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|+||.||++.+..+++.+|+|...           ....+...++ .++||||+++++++.+++.+|+||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            4799999999999999999999987321           1122233333 359999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|..++.....+++.....++.|++.|+.|+|+++++|+||+|+||+++..+.++++|||++...
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            99999987778899999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0660|consensus

Probab=99.94  E-value=1e-26  Score=164.47  Aligned_cols=133  Identities=23%  Similarity=0.423  Sum_probs=119.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcC-----CEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTP-----DKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~   66 (145)
                      .|.|+||.|+.|.+..+|+.||+|...          .-.++.+.++.++|+||+.+.+++..+     ..+|+|+|+|+
T Consensus        30 iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe  109 (359)
T KOG0660|consen   30 IGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME  109 (359)
T ss_pred             ccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh
Confidence            689999999999999999999998644          224566678889999999999999862     46999999994


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                       .+|.+.++++..+....+..++.|++.|+.|+|+.+++|||+||.|++++.++..|++|||+|+...+
T Consensus       110 -tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  110 -TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             -hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence             49999999888899999999999999999999999999999999999999999999999999998754

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=8.6e-26  Score=167.03  Aligned_cols=131  Identities=22%  Similarity=0.323  Sum_probs=119.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH--HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI--MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV   79 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~   79 (145)
                      +|.|+||.||+|.+..+++.+++|...  ...++...++.++||||++++++|..+...++++|++. ++|..++.....
T Consensus       100 lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~  178 (391)
T PHA03212        100 FTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRN  178 (391)
T ss_pred             EcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCC
Confidence            588999999999999999999998643  35667788999999999999999999999999999995 589888887778


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          80 FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        80 ~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +++..+..++.|++.|+.|+|+.+++|+||||+||+++..+.++++|||+++..
T Consensus       179 l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        179 IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            999999999999999999999999999999999999999999999999998643

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.94  E-value=2.1e-25  Score=168.64  Aligned_cols=134  Identities=26%  Similarity=0.317  Sum_probs=118.4

Q ss_pred             eeeeeeeEEEEEEEccc-CCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQ-GETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~-~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|++|.||.|.+..+ ++.+++|.        ...++.+...++.++||||+++++.+..++.+|+||||+++++|.+
T Consensus        75 lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~  154 (478)
T PTZ00267         75 VGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK  154 (478)
T ss_pred             EEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHH
Confidence            68899999999998887 67777752        2345667778899999999999999999999999999999999998


Q ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          73 HLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+..    ..++++..+..++.|++.++.|+|+++++|+||||+||+++..+.++++|||+++.+..
T Consensus       155 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        155 QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            7753    34688999999999999999999999999999999999999999999999999987654

>KOG0586|consensus

Probab=99.94  E-value=5.7e-26  Score=169.51  Aligned_cols=140  Identities=26%  Similarity=0.357  Sum_probs=129.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|.|+.|-.+++..++..||+|.          ...+.++.++++.++|||||+++.+.+++..+|+||||+.+|.++
T Consensus        64 ig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~  143 (596)
T KOG0586|consen   64 IGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELF  143 (596)
T ss_pred             eccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhH
Confidence            6899999999999999999999974          233567788899999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccc
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS  141 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  141 (145)
                      +++..++.+.+......++|++.+++|+|+..++|+||+++|++++.+.+++|+|||++..+..+...++
T Consensus       144 ~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt  213 (596)
T KOG0586|consen  144 DYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT  213 (596)
T ss_pred             HHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccc
Confidence            9999999999999999999999999999999999999999999999999999999999998877665555

>KOG0694|consensus

Probab=99.94  E-value=1.8e-26  Score=174.00  Aligned_cols=144  Identities=33%  Similarity=0.513  Sum_probs=117.6

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeee-----------HHHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALN-----------ERIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|+||.|+.+....+++.+|+|           +++....+..++... +||+++.++.+|++++++|+||||+.||
T Consensus       375 vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Gg  454 (694)
T KOG0694|consen  375 VLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGG  454 (694)
T ss_pred             EeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCC
Confidence            4799999999999999999999995           222222222222111 8999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC-CCCCccc-cCCC
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHAS-VGKS  145 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~-~~~~~~~-~~~~  145 (145)
                      ++.. +...+.+++..+..++.+++.|++|+|.++|++||+|.+|||+|..+.+||+|||+++.-. .+....+ .|||
T Consensus       455 dm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTp  532 (694)
T KOG0694|consen  455 DLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTP  532 (694)
T ss_pred             cEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCCh
Confidence            9433 3344789999999999999999999999999999999999999999999999999998643 3344333 4553

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.94  E-value=1.5e-25  Score=161.50  Aligned_cols=132  Identities=30%  Similarity=0.582  Sum_probs=115.9

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcc-cCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQ-MVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +.|.|+||.||++.+..+++.+++|...           ....+...+. ..+||||+++++++..++.+|+||||++++
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            4799999999999999999999887322           1222333333 458999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      +|..++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          82 DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            9999998777899999999999999999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.94  E-value=1.1e-25  Score=160.12  Aligned_cols=132  Identities=23%  Similarity=0.325  Sum_probs=117.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||+|.+..+++.+++|...         ...++...++.++||||+++++++.+++..+++||++++ +|.+
T Consensus        13 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~   91 (288)
T cd07871          13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQ   91 (288)
T ss_pred             EecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHH
Confidence            689999999999999999999987432         334666778899999999999999999999999999975 8988


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++... ..+++..+..++.|++.|+.|+|+.+++|+||+|+||+++.++.++++|||++....
T Consensus        92 ~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          92 YLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            88654 457889999999999999999999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.94  E-value=1.8e-25  Score=161.06  Aligned_cols=132  Identities=34%  Similarity=0.611  Sum_probs=116.8

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +.|.|+||.||++.+..+++.+++|..           .....+...++.+ +||||+++++++...+.+|+||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            479999999999999999999988632           1223344445545 7999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      +|...+.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++..+.++++|||++..
T Consensus        82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          82 DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence            9999988877899999999999999999999999999999999999999999999999999865

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.4e-25  Score=162.32  Aligned_cols=132  Identities=36%  Similarity=0.590  Sum_probs=114.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH-----------HHhhhhhcccC---CCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM-----------LSLVSTGIQMV---DCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l---~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|.+..+++.+++|....           ...+.+.+..+   +||||+++++.+..++..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            4889999999999999999999874221           11122233333   799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++|...+.....+++..+..++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++...
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            999999988888999999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG4250|consensus

Probab=99.94  E-value=1.3e-26  Score=175.35  Aligned_cols=143  Identities=22%  Similarity=0.260  Sum_probs=124.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCC------EEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPD------KLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~------~~~lv~e~~~   66 (145)
                      +|.||||.||+.++..+|+.+|+|         .++.+-++.+++++++|||||+++++=++..      .-.++||||.
T Consensus        21 LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~  100 (732)
T KOG4250|consen   21 LGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCS  100 (732)
T ss_pred             hcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecC
Confidence            699999999999999999999996         4566678888899999999999999876543      5788999999


Q ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC----CCCEEEeeeccceecCCCCCc
Q psy3273          67 GGDLHYHLSQH---GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE----HGHVRISDLGLACDFSKKKPH  139 (145)
Q Consensus        67 ~~~l~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~----~~~~~l~dfg~~~~~~~~~~~  139 (145)
                      +|||...+.++   ..+++.+++.++..+..|+.|||.++|+||||||.||++..    ....|++|||.|+.+..++..
T Consensus       101 gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~  180 (732)
T KOG4250|consen  101 GGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLF  180 (732)
T ss_pred             CCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCee
Confidence            99999999754   34999999999999999999999999999999999998742    234799999999999988877


Q ss_pred             ccc-CC
Q psy3273         140 ASV-GK  144 (145)
Q Consensus       140 ~~~-~~  144 (145)
                      +++ ||
T Consensus       181 ~S~vGT  186 (732)
T KOG4250|consen  181 TSLVGT  186 (732)
T ss_pred             eeecCc
Confidence            764 54

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.94  E-value=2.4e-25  Score=161.45  Aligned_cols=133  Identities=25%  Similarity=0.395  Sum_probs=120.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||++.+..++..+++|.         ...+.++.+.++.++||||++++++|..++..+++|||+++++|.+
T Consensus        13 lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   92 (333)
T cd06650          13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ   92 (333)
T ss_pred             ccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHH
Confidence            6889999999999999998888862         2345677778899999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRR-YIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++.....+++..+..++.|++.++.|+|.. +++|+||+|+||+++..+.++++|||++..+.
T Consensus        93 ~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          93 VLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            998877899999999999999999999974 79999999999999999999999999987553

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.94  E-value=2.5e-25  Score=157.39  Aligned_cols=134  Identities=37%  Similarity=0.645  Sum_probs=117.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||++.+..+++.+++|...           ....+.+.++.++||||+++.+.++.+..+|++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            488999999999999999999886422           223456778899999999999999999999999999999999


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ..++...  ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++....++++|||++..+..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            8887543  3588888899999999999999999999999999999999999999999999876643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.94  E-value=2.2e-25  Score=161.50  Aligned_cols=133  Identities=28%  Similarity=0.444  Sum_probs=119.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||++....+++.+++|..           ..+..+...+..++||||+++++.+..++.+|+||||+++|+|
T Consensus         9 lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L   88 (332)
T cd05623           9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDL   88 (332)
T ss_pred             EEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcH
Confidence            69999999999999999998888632           1245566667888999999999999999999999999999999


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++.. ...+++..+..++.|++.++.++|+.+++|+||+|+|++++.++.++++|||++..+.
T Consensus        89 ~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623          89 LTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence            999976 4678999999999999999999999999999999999999999999999999987653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.94  E-value=3.2e-25  Score=160.58  Aligned_cols=134  Identities=22%  Similarity=0.383  Sum_probs=121.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|+||.||++.+..++..+++|.         ...+.++.+.++.++||||+++++++..++..+++|||+++++|.+
T Consensus        13 lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   92 (331)
T cd06649          13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ   92 (331)
T ss_pred             ecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHH
Confidence            5889999999999999999888863         2345667778899999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRR-YIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++.....+++..+..++.|++.++.|+|+. +++|+||+|+||+++..+.++++|||++..+..
T Consensus        93 ~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          93 VLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            998877899999999999999999999985 699999999999999999999999999876544

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4236|consensus

Probab=99.94  E-value=6.8e-26  Score=167.85  Aligned_cols=144  Identities=26%  Similarity=0.399  Sum_probs=127.3

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeee----------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALN----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      ++|+|-||+||-++++++|+.||+|          ....++.+..+++++.||.||.+..-|++.++.++|||.+.| ++
T Consensus       571 vLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DM  649 (888)
T KOG4236|consen  571 VLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DM  649 (888)
T ss_pred             hccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hH
Confidence            4799999999999999999999995          456678889999999999999999999999999999999966 77


Q ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC---CCEEEeeeccceecCCCCCccc-cCC
Q psy3273          71 HYHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH---GHVRISDLGLACDFSKKKPHAS-VGK  144 (145)
Q Consensus        71 ~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~-~~~  144 (145)
                      ..++-+  .+.+++.....++.||+.|++|+|..+|+|+|+||+|+++.+.   -.+|++|||+|+.+...+..+. +||
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGT  729 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGT  729 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCC
Confidence            776643  4679999999999999999999999999999999999999654   4689999999999887776666 465


Q ss_pred             C
Q psy3273         145 S  145 (145)
Q Consensus       145 ~  145 (145)
                      |
T Consensus       730 P  730 (888)
T KOG4236|consen  730 P  730 (888)
T ss_pred             c
Confidence            4

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.94  E-value=1.6e-25  Score=160.13  Aligned_cols=131  Identities=22%  Similarity=0.374  Sum_probs=116.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|+||.||+|.+..+++.+++|...         ...++...++.++||||+++++++.+++..++||||++ +++.+
T Consensus        13 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~   91 (303)
T cd07869          13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQ   91 (303)
T ss_pred             EEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHH
Confidence            689999999999999999999987532         23456677889999999999999999999999999996 47777


Q ss_pred             HHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          73 HLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        73 ~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++.. ...+++..+..++.|++.|+.|+|+.+++|+||+|+||+++..+.++++|||++...
T Consensus        92 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          92 YMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             HHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            7764 356899999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=3.8e-25  Score=160.06  Aligned_cols=134  Identities=40%  Similarity=0.645  Sum_probs=116.8

Q ss_pred             eeeeeeeEEEEEEEc---ccCCeeeeeHH------------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHV---KQGETLALNER------------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~---~~~~~~~~~~~------------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      .|.|+||.||++++.   .+++.+++|..            .....+...++.+ +||||+++++++..++.++++|||+
T Consensus         8 lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (332)
T cd05614           8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYV   87 (332)
T ss_pred             EeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCC
Confidence            689999999998874   46788888632            1234455566777 5899999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++++|.+++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||+++.+..
T Consensus        88 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          88 SGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            9999999998878899999999999999999999999999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.9e-25  Score=156.99  Aligned_cols=133  Identities=44%  Similarity=0.736  Sum_probs=118.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++.+..+++.+++|...           .+.++...++.++||||+++++.+.+++..+++|||+++++|
T Consensus         8 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   87 (285)
T cd05605           8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL   87 (285)
T ss_pred             EecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcH
Confidence            689999999999999999999886422           233466678899999999999999999999999999999999


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ..++...  ..+++..+..++.|++.++.|+|+.+++|+||+|+|++++....++++|||++..+.
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          88 KFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             HHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            8887643  458999999999999999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.93  E-value=5.7e-25  Score=158.82  Aligned_cols=132  Identities=33%  Similarity=0.551  Sum_probs=115.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCC-ceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCP-FIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp-~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|.+..+++.+++|..           .....+...++.++|| +|+++++++...+.+|+||||+++++
T Consensus         8 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~   87 (324)
T cd05587           8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD   87 (324)
T ss_pred             EeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCc
Confidence            68999999999999999999988732           1223444456667665 58899999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |..++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++...
T Consensus        88 L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          88 LMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            9999988788999999999999999999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0194|consensus

Probab=99.93  E-value=1.1e-25  Score=167.18  Aligned_cols=132  Identities=20%  Similarity=0.246  Sum_probs=116.6

Q ss_pred             CeeeeeeeEEEEEEEcccCC---e-eeee-----------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEcc
Q psy3273           1 MFFIVGTGFLSNCSHVKQGE---T-LALN-----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~---~-~~~~-----------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      ++|.|+||.|+++.-...+.   . ||++           .+..+-.++..+++++|||||+++|+...+..+++|||+|
T Consensus       164 kLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~  243 (474)
T KOG0194|consen  164 KLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELC  243 (474)
T ss_pred             eeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEec
Confidence            47999999999998766432   2 5664           2334567777889999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          66 NGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        66 ~~~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      ++|+|.+++...+ .++..+...++.+.+.|+.|||+.+++||||..+|+|++....+|++|||+++.
T Consensus       244 ~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  244 NGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             CCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence            9999999999765 599999999999999999999999999999999999999999999999999864

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.93  E-value=4.8e-25  Score=159.26  Aligned_cols=133  Identities=35%  Similarity=0.589  Sum_probs=115.9

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|+||.||+|.+..+++.+|+|...           ....+...++.+. ||+|+++.+++.+++.+|+||||++++
T Consensus         7 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g   86 (323)
T cd05615           7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGG   86 (323)
T ss_pred             EEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCC
Confidence            3699999999999999999999997321           1223334455554 578889999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|..++.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||++...
T Consensus        87 ~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~  151 (323)
T cd05615          87 DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH  151 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEecccccccc
Confidence            99999988788999999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.93  E-value=2.2e-25  Score=158.03  Aligned_cols=134  Identities=21%  Similarity=0.323  Sum_probs=118.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|++|.||+|.+..+++.+++|.          ...+.++...++.++||||+++++++..++..|+||||++++++.
T Consensus         9 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~   88 (287)
T cd07848           9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE   88 (287)
T ss_pred             ecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHH
Confidence            6889999999999999999888863          233456677788999999999999999999999999999987776


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+......+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++..+..
T Consensus        89 ~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          89 LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            5555556789999999999999999999999999999999999999999999999999986643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0608|consensus

Probab=99.93  E-value=1e-25  Score=169.62  Aligned_cols=132  Identities=30%  Similarity=0.546  Sum_probs=120.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|+|+||-|+.+....+...+|+|-..           -...+.+++.+.+.+-||+||-.|++++.+|+||||++||++
T Consensus       637 iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDm  716 (1034)
T KOG0608|consen  637 IGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDM  716 (1034)
T ss_pred             ecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccH
Confidence            589999999999999999888886322           123455677888999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      .+++..-+.+++..+..++.++..+++..|.-|+|||||||+|||+|.++.+||+|||++.-+
T Consensus       717 MSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  717 MSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             HHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccc
Confidence            999998899999999999999999999999999999999999999999999999999998743

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.93  E-value=6.3e-25  Score=158.60  Aligned_cols=132  Identities=36%  Similarity=0.549  Sum_probs=114.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhh---hhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVS---TGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~---~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      .+|.|++|.||++.+..+++.+++|...           .+..+.   ..++.++||||+++++++..++..|+||||++
T Consensus         6 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   85 (324)
T cd05589           6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAA   85 (324)
T ss_pred             EEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCC
Confidence            3689999999999999999999886321           122222   23467799999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +++|...+.. ..+++.....++.|++.|+.|+|+.+++|+||+|+||+++.++.++++|||++...
T Consensus        86 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          86 GGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            9999877754 56899999999999999999999999999999999999999999999999998653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.93  E-value=1e-24  Score=157.46  Aligned_cols=132  Identities=32%  Similarity=0.542  Sum_probs=115.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|.+..+++.+++|...           ....+...++.+ .||+|+++++++...+.+|+||||+++++
T Consensus         8 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~   87 (323)
T cd05616           8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD   87 (323)
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCC
Confidence            689999999999999999999887321           112222333333 68999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |...+.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++...
T Consensus        88 L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~  151 (323)
T cd05616          88 LMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  151 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence            9999988788999999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.93  E-value=3.8e-25  Score=160.35  Aligned_cols=133  Identities=25%  Similarity=0.296  Sum_probs=110.3

Q ss_pred             eeeeeeeEEEEEEEc-----ccCCeeeeeHH---------HHHHhhhhhcccC-CCCceeEeeEEEEcC-CEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHV-----KQGETLALNER---------IMLSLVSTGIQMV-DCPFIVCMTYAFHTP-DKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~-----~~~~~~~~~~~---------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~-~~~~lv~e~~   65 (145)
                      .|.|+||.||+|...     .+++.+++|..         ..+.++...++.+ +||||+++++++... +.++++|||+
T Consensus        15 lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~   94 (338)
T cd05102          15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFC   94 (338)
T ss_pred             eccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecC
Confidence            689999999999752     34456777542         2345566677777 899999999988764 4689999999


Q ss_pred             CCCCHHHHHHhc--------------------------------------------------------------CCCCHH
Q psy3273          66 NGGDLHYHLSQH--------------------------------------------------------------GVFNED   83 (145)
Q Consensus        66 ~~~~l~~~l~~~--------------------------------------------------------------~~~~~~   83 (145)
                      ++|+|.+++...                                                              .+++..
T Consensus        95 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  174 (338)
T cd05102          95 KYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTME  174 (338)
T ss_pred             CCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHH
Confidence            999999988642                                                              236677


Q ss_pred             HHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          84 EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        84 ~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+..++.|++.|+.|+|+++++|+||||+||+++.+..++++|||+++.+.
T Consensus       175 ~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~  225 (338)
T cd05102         175 DLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY  225 (338)
T ss_pred             HHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccc
Confidence            888899999999999999999999999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.93  E-value=8.3e-25  Score=156.46  Aligned_cols=134  Identities=22%  Similarity=0.288  Sum_probs=113.0

Q ss_pred             eeeeeeeEEEEEEEcc----------------cCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCC
Q psy3273           2 FFIVGTGFLSNCSHVK----------------QGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD   56 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~----------------~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~   56 (145)
                      +|.|+||.||+|....                ++..+++|.         ...+.++.+.++.++||||+++++++...+
T Consensus        13 lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   92 (304)
T cd05096          13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDED   92 (304)
T ss_pred             ecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCC
Confidence            6899999999998643                223566653         223556677788999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC
Q psy3273          57 KLCFILDLMNGGDLHYHLSQHG-------------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD  117 (145)
Q Consensus        57 ~~~lv~e~~~~~~l~~~l~~~~-------------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~  117 (145)
                      ..+++|||+++++|.+++....                   .++...+..++.|++.|+.|+|+.+++|+||+|+||+++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~  172 (304)
T cd05096          93 PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG  172 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEc
Confidence            9999999999999999886431                   256677889999999999999999999999999999999


Q ss_pred             CCCCEEEeeeccceecCC
Q psy3273         118 EHGHVRISDLGLACDFSK  135 (145)
Q Consensus       118 ~~~~~~l~dfg~~~~~~~  135 (145)
                      ..+.++++|||+++.+..
T Consensus       173 ~~~~~kl~DfG~~~~~~~  190 (304)
T cd05096         173 ENLTIKIADFGMSRNLYA  190 (304)
T ss_pred             CCccEEECCCccceeccc
Confidence            999999999999976543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=4.1e-25  Score=159.86  Aligned_cols=131  Identities=22%  Similarity=0.360  Sum_probs=115.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcC-----CEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTP-----DKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~   66 (145)
                      +|.|++|.||++.+..+++.+++|...          .+.++...++.++||||+++++++...     ..+|++|||+.
T Consensus         8 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~   87 (338)
T cd07859           8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME   87 (338)
T ss_pred             EeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC
Confidence            689999999999999999999997432          244566778899999999999998643     25899999995


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                       ++|.+.+.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||+++..
T Consensus        88 -~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          88 -SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             -CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence             589998887778999999999999999999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.93  E-value=6.2e-25  Score=171.71  Aligned_cols=133  Identities=26%  Similarity=0.451  Sum_probs=121.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+++|..           ..+..+...++.++||||+++++.+...+.+|+||||+.+++|
T Consensus        12 LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L   91 (669)
T cd05610          12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDV   91 (669)
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCH
Confidence            68999999999999999999999743           3456666778889999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ..++.....+++..+..++.|++.++.|+|.++++|+||+|+||+++..+.++|+|||+++...
T Consensus        92 ~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~  155 (669)
T cd05610          92 KSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL  155 (669)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence            9999877788999999999999999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.8e-24  Score=151.30  Aligned_cols=134  Identities=26%  Similarity=0.389  Sum_probs=121.2

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH-------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE-------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +.|.|++|.+|.|.+..+++.+++|+             ...+.++.+.++.++||||++++++++.++..++++|++++
T Consensus         9 ~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   88 (263)
T cd06625           9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPG   88 (263)
T ss_pred             eecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCC
Confidence            36889999999999999999998863             23455667778899999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++|.+.+.....+++.....++.|++.++.++|+.+++|+|++|+||+++.+..++++|||.+..+.
T Consensus        89 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          89 GSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             CcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999887789999999999999999999999999999999999999999999999999987553

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.93  E-value=1e-24  Score=151.93  Aligned_cols=133  Identities=17%  Similarity=0.230  Sum_probs=119.0

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      ..|.|+||.||++.+..+++.+++|.         ...+.++.+.++.++||||+++++++..++..+++|||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            36899999999999999999888873         234566777789999999999999999999999999999999999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          72 YHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        72 ~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +++... ..+++..+..++.|++.++.|+|+++++|+|++|+||+++.+..++++|||.+...
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  144 (252)
T cd05084          82 TFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREE  144 (252)
T ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccc
Confidence            998754 45899999999999999999999999999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.93  E-value=6.4e-25  Score=161.58  Aligned_cols=134  Identities=20%  Similarity=0.215  Sum_probs=113.3

Q ss_pred             eeeeeeeEEEEEEE-----cccCCeeeeeHH---------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSH-----VKQGETLALNER---------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~-----~~~~~~~~~~~~---------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +|.|+||.||+|..     ..++..+++|..         ..+.++...++.+ +||||+++++++..++..++||||++
T Consensus        43 LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  122 (375)
T cd05104          43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCC  122 (375)
T ss_pred             ecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhcc
Confidence            68999999999974     334556777532         2345666777788 89999999999999999999999999


Q ss_pred             CCCHHHHHHhcC--------------------------------------------------------------------
Q psy3273          67 GGDLHYHLSQHG--------------------------------------------------------------------   78 (145)
Q Consensus        67 ~~~l~~~l~~~~--------------------------------------------------------------------   78 (145)
                      +|+|.+++....                                                                    
T Consensus       123 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (375)
T cd05104         123 YGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSE  202 (375)
T ss_pred             CCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHH
Confidence            999999885321                                                                    


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          79 -------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        79 -------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                             .+++..+..++.|++.++.|+|+++++|+||+|+|++++....++++|||++..+..
T Consensus       203 ~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         203 ILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             HHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                   366778889999999999999999999999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0986|consensus

Probab=99.93  E-value=1.2e-25  Score=163.57  Aligned_cols=144  Identities=51%  Similarity=0.833  Sum_probs=129.0

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHHH-----------HHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERIM-----------LSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +.|.||||-|+.|+...+|+.+|.|..+.           -..+..+++.+..|.||.+-..|++++.+++|++.|.||+
T Consensus       192 vlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGD  271 (591)
T KOG0986|consen  192 VLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGD  271 (591)
T ss_pred             EEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCc
Confidence            47999999999999999999998853222           2244456778899999999999999999999999999999


Q ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccc-cCC
Q psy3273          70 LHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGK  144 (145)
Q Consensus        70 l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~  144 (145)
                      |.-++.+.+  .+++..+..++.+|..|++++|..+|++||+||+|||+|+.++++++|+|+|..+..+.+.+. +||
T Consensus       272 LkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT  349 (591)
T KOG0986|consen  272 LKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGT  349 (591)
T ss_pred             eeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCc
Confidence            988887654  699999999999999999999999999999999999999999999999999999999988887 665

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.93  E-value=2.2e-24  Score=151.43  Aligned_cols=133  Identities=23%  Similarity=0.321  Sum_probs=121.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|+||.||++.+..+++.+++|.        ...++++...++.++||||+++++++..++..+++|||+++++|.++
T Consensus        17 lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~   96 (267)
T cd06646          17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI   96 (267)
T ss_pred             eecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHH
Confidence            6889999999999999998888863        33455677788899999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +.....+++..+..++.|++.++.|+|+.+++|+|++|+|++++..+.++++|||++..+.
T Consensus        97 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          97 YHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            8877789999999999999999999999999999999999999999999999999997654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.93  E-value=2.4e-24  Score=153.19  Aligned_cols=134  Identities=34%  Similarity=0.525  Sum_probs=121.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.+|.+.+..+++.+++|.           ...+.++.+.++.++||||+++++++..++..|++|||+++++|
T Consensus         9 ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   88 (290)
T cd05580           9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL   88 (290)
T ss_pred             eecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCH
Confidence            5889999999999999999998863           22345566778899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++.....+++.....++.|++.++.++|+++++|+|++|+||+++.++.++++|||++.....
T Consensus        89 ~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          89 FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            99998888899999999999999999999999999999999999999999999999999976543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.93  E-value=4.8e-25  Score=160.90  Aligned_cols=129  Identities=25%  Similarity=0.367  Sum_probs=114.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||++.+..+++.+++|..         ..+.++...++.++||||+++++++..++.+|++|||+++++|..
T Consensus        82 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  161 (353)
T PLN00034         82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG  161 (353)
T ss_pred             ccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccc
Confidence            68999999999999999999998742         345677778899999999999999999999999999999998854


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .    ...++..+..++.|++.++.|+|+++++|+||+++||+++.+..++++|||++..+.
T Consensus       162 ~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        162 T----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             c----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            2    345677888899999999999999999999999999999999999999999997654

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.93  E-value=3.3e-24  Score=151.91  Aligned_cols=135  Identities=69%  Similarity=1.147  Sum_probs=116.0

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhh---hhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVS---TGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~---~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +.|.|+||.||++.+..+++.+++|...           ...++.   ..+...+||||+++.+.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4689999999999999999988886321           111121   12334589999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++|..++.....+++..+..++.|++.++.++|+.+++|+||+|+||+++..+.++++|||++.....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            999999988878899999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0612|consensus

Probab=99.93  E-value=5.5e-26  Score=178.85  Aligned_cols=145  Identities=29%  Similarity=0.455  Sum_probs=130.5

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +.|.|+||-|...+...+++.+|+|.           ...++.+.+++...+.+=|+.+.-.|+++.++|+||||++||+
T Consensus        82 vIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGD  161 (1317)
T KOG0612|consen   82 VIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGD  161 (1317)
T ss_pred             HhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCch
Confidence            36999999999999999999999964           3446677788888899999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCcc---ccCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGKS  145 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~  145 (145)
                      |..++.+...+|+.-+..+...++.|+.-+|+.|.+||||||+|+|+|..+.++++|||.+-.+..+...+   .+|||
T Consensus       162 lltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTP  240 (1317)
T KOG0612|consen  162 LLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTP  240 (1317)
T ss_pred             HHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCC
Confidence            99999988899999999999999999999999999999999999999999999999999998877543332   36775

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.93  E-value=2.7e-24  Score=152.71  Aligned_cols=133  Identities=43%  Similarity=0.719  Sum_probs=118.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++.+..+++.+++|..           ..+..+.+.++.++||||+++.+.+..++..+++|||+++++|
T Consensus         8 lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (285)
T cd05632           8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDL   87 (285)
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccH
Confidence            68999999999999999999988732           1234566778899999999999999999999999999999999


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ..++...  ..+++..+..++.|++.++.|+|+.+++|+|++|+|++++....++++|||++....
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          88 KFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            8887643  468999999999999999999999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.93  E-value=1.9e-24  Score=150.74  Aligned_cols=132  Identities=27%  Similarity=0.396  Sum_probs=119.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|++|.||++.+..+++.+++|.          .....++...++.++||||+++++++..++..+++||++++++|.
T Consensus         7 lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~   86 (260)
T PF00069_consen    7 LGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQ   86 (260)
T ss_dssp             EEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHH
T ss_pred             EEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccc
Confidence            7999999999999999999888862          111223566778889999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +++.....+++..+..++.|++.++.++|+++++|+||+|+||+++..+.++++|||.+...
T Consensus        87 ~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   87 DYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             HHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99987788999999999999999999999999999999999999999999999999999753

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.92  E-value=3.8e-24  Score=153.50  Aligned_cols=133  Identities=23%  Similarity=0.372  Sum_probs=119.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||++.+..++..++++..         ..+.++.+.++.++||||+++++++..++.++++|||+++++|.+
T Consensus         9 lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~   88 (308)
T cd06615           9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ   88 (308)
T ss_pred             ccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHH
Confidence            58899999999999999988877532         234566777889999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++.....+++..+..++.|++.++.|+|+ .+++|+|++|+|++++.++.++++|||++..+.
T Consensus        89 ~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          89 VLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            99887889999999999999999999997 689999999999999999999999999887553

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.92  E-value=1.6e-24  Score=159.44  Aligned_cols=134  Identities=19%  Similarity=0.216  Sum_probs=113.7

Q ss_pred             eeeeeeeEEEEEEEcccC-----CeeeeeHH---------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQG-----ETLALNER---------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~-----~~~~~~~~---------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +|.|+||.||++.+...+     ..+++|..         ..+.++.+.++.+ +||||+++++++...+..+++|||++
T Consensus        46 LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~  125 (374)
T cd05106          46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCC  125 (374)
T ss_pred             ecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhcc
Confidence            689999999999865443     46777632         3355667778888 89999999999999999999999999


Q ss_pred             CCCHHHHHHhc---------------------------------------------------------------------
Q psy3273          67 GGDLHYHLSQH---------------------------------------------------------------------   77 (145)
Q Consensus        67 ~~~l~~~l~~~---------------------------------------------------------------------   77 (145)
                      +|+|.+++...                                                                     
T Consensus       126 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (374)
T cd05106         126 YGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTED  205 (374)
T ss_pred             CCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCC
Confidence            99999988532                                                                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          78 -GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        78 -~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                       ..++...+..++.|++.|+.|+|+++++|+||+|+|++++....++++|||+++.+..
T Consensus       206 ~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~  264 (374)
T cd05106         206 SWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN  264 (374)
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence             1367778899999999999999999999999999999999999999999999976543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.92  E-value=3.3e-24  Score=150.50  Aligned_cols=133  Identities=24%  Similarity=0.361  Sum_probs=120.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|++|.+|++.+..+++.+++|.        ...+.++...++.++||||+++++.+..++..|++|||+++++|.++
T Consensus        17 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~   96 (267)
T cd06645          17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDI   96 (267)
T ss_pred             hCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHH
Confidence            5889999999999999999888863        23455666778899999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +...+.+++.++..++.|++.++.|+|..+++|+|++|+||+++..+.++++|||++..+.
T Consensus        97 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          97 YHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            9888889999999999999999999999999999999999999999999999999987553

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.92  E-value=3.3e-24  Score=150.77  Aligned_cols=132  Identities=15%  Similarity=0.158  Sum_probs=114.5

Q ss_pred             CeeeeeeeEEEEEEEc---ccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHV---KQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~---~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .+|.|+||.||++...   ..+..+++|.         ...+.++...++.++||||+++++++..++..++||||++++
T Consensus        12 ~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   91 (266)
T cd05064          12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG   91 (266)
T ss_pred             eecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCC
Confidence            3689999999999764   3445666642         234556777788899999999999999999999999999999


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          69 DLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        69 ~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      +|.+++... ..+++..+..++.|++.|+.|+|.++++|+|++|+|++++.+..++++|||.+..
T Consensus        92 ~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          92 ALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999998763 5689999999999999999999999999999999999999999999999997754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.92  E-value=3.9e-24  Score=151.94  Aligned_cols=133  Identities=44%  Similarity=0.738  Sum_probs=117.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++.+..+++.+++|..           .....+...++.++|||++.+++.+.+++..|++|||+++++|
T Consensus         8 ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L   87 (285)
T cd05630           8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL   87 (285)
T ss_pred             eecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcH
Confidence            68999999999999999999988632           1233466678899999999999999999999999999999999


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++...  ..+++..+..++.|++.++.|+|+++++|+||+|+|++++..+.++++|||++....
T Consensus        88 ~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          88 KFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            9888543  358899999999999999999999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.92  E-value=2.5e-24  Score=151.05  Aligned_cols=134  Identities=26%  Similarity=0.370  Sum_probs=121.5

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-----------------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEE
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-----------------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILD   63 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e   63 (145)
                      ..|.|++|.+|++.+..+++.+++|..                 ..++++...++.++||||+++++++..++..+++||
T Consensus         7 ~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (267)
T cd06628           7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLE   86 (267)
T ss_pred             eeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEE
Confidence            368899999999999988888888622                 345667778899999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          64 LMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        64 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |+++++|.+++.....+++..+..++.|++.++.++|+++++|+|++|+||+++....++++|||.++.+.
T Consensus        87 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          87 YVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             ecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            99999999999887889999999999999999999999999999999999999999999999999987665

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.92  E-value=2e-24  Score=158.61  Aligned_cols=132  Identities=20%  Similarity=0.324  Sum_probs=117.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCC-----EEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD-----KLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~-----~~~lv~e~~~   66 (145)
                      .|.|+||.||++.+..+++.+++|..          ..+.++...++.++||||+++++++...+     ..|++|||+.
T Consensus         8 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~   87 (372)
T cd07853           8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ   87 (372)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc
Confidence            68999999999999999999999743          23445667788999999999999998876     8999999996


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                       ++|...+.....+++..+..++.|++.|+.|+|+.+++|+||+|+||+++..+.++++|||+++...
T Consensus        88 -~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          88 -SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             -cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence             4888888777789999999999999999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.92  E-value=1.8e-24  Score=155.07  Aligned_cols=132  Identities=22%  Similarity=0.331  Sum_probs=116.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||++.+..+++.+++|...         ...++...++.++||||+++++++..++..+++|||+++ ++.+
T Consensus        14 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~   92 (309)
T cd07872          14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQ   92 (309)
T ss_pred             ecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHH
Confidence            688999999999999999988887432         334566778899999999999999999999999999976 7878


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+... ..++...+..++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++....
T Consensus        93 ~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          93 YMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence            77653 458889999999999999999999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.92  E-value=6e-24  Score=150.45  Aligned_cols=135  Identities=68%  Similarity=1.104  Sum_probs=116.6

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHHH-----------HHhh---hhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERIM-----------LSLV---STGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~~-----------~~~~---~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +.|.|+||.||++.+..+++.+++|....           ...+   ...++..+||||+++.+.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            46899999999999999999999873211           1111   122344689999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++|..++.....+++..+..++.|++.++.|+|+.+++|+|++|+|++++.++.++++|||++..+..
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence            999999888777899999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0607|consensus

Probab=99.92  E-value=3.4e-25  Score=155.64  Aligned_cols=134  Identities=22%  Similarity=0.325  Sum_probs=116.9

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHHH--------HHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERIM--------LSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      ++|.|+|+.|..|....++.++|+|.++.        .-++.+....+ +|+||+.++++|++++.+|+|||.+.||+|.
T Consensus        85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplL  164 (463)
T KOG0607|consen   85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLL  164 (463)
T ss_pred             HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHH
Confidence            47899999999999999999999974332        23444444444 8999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC---CEEEeeeccceecC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG---HVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~---~~~l~dfg~~~~~~  134 (145)
                      +.+..+..+++.++..+...|+.++.|||.+||.|||+||+||+-.+..   -+|++||-++.-+.
T Consensus       165 shI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  165 SHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             HHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence            9999989999999999999999999999999999999999999986554   58999998776543

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.92  E-value=9.7e-24  Score=149.32  Aligned_cols=131  Identities=22%  Similarity=0.350  Sum_probs=115.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|++|.||++.+..+++.+++|..         ..+..+.+.++.++||||+++++.+..++..+++|||++++++..
T Consensus         9 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~   88 (279)
T cd06619           9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDV   88 (279)
T ss_pred             eccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHH
Confidence            68899999999999999999988642         234456667888999999999999999999999999999998855


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +    ..+++..+..++.|++.++.|+|+.+++|+|++|+|++++..+.++++|||++..+...
T Consensus        89 ~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          89 Y----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             h----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            4    35788889999999999999999999999999999999999999999999999765443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0033|consensus

Probab=99.92  E-value=3.9e-26  Score=155.40  Aligned_cols=136  Identities=23%  Similarity=0.344  Sum_probs=120.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|.|..|++|.+..+|+.++.|.+          +.+.+++.+-++|+||||+++.+.....+..|+|+|++.|++|.
T Consensus        19 igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~   98 (355)
T KOG0033|consen   19 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF   98 (355)
T ss_pred             HccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHH
Confidence            58899999999999999999988643          34566666778999999999999999999999999999999998


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC---CCCEEEeeeccceecCCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE---HGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~  137 (145)
                      .-+-....+++..+.-.+.|++.++.|+|.++|+|||++|+|+++.+   ...+|++|||+|..+.++.
T Consensus        99 ~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~  167 (355)
T KOG0033|consen   99 EDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE  167 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence            88776677888999999999999999999999999999999999953   3569999999999887443

>KOG0662|consensus

Probab=99.92  E-value=1.7e-25  Score=146.50  Aligned_cols=135  Identities=21%  Similarity=0.347  Sum_probs=120.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH----------HHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM----------LSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|-|.||+|+++++.++++.+++|.+..          ..++...++.++|.|||+++++..++..+.+|+|+|.. +|.
T Consensus        10 igegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlk   88 (292)
T KOG0662|consen   10 IGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLK   88 (292)
T ss_pred             hcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHH
Confidence            4789999999999999999999975443          24666778899999999999999999999999999955 888


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      .+..+ ++.++...+..++.|++.++.++|++.++|+|++|+|++++.++..|+.|||+++.+.-+-
T Consensus        89 kyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   89 KYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            88765 6789999999999999999999999999999999999999999999999999998775543

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.92  E-value=8.4e-24  Score=149.42  Aligned_cols=133  Identities=47%  Similarity=0.782  Sum_probs=118.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+++|..           ..+..+...++.++|||++++++.+...+..|++|||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            47899999999999999999888632           2234566778899999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++....  .+++..+..++.|++.++.++|.++++|+||+|+||+++.++.++++|||.+..+.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            99987654  68999999999999999999999999999999999999999999999999886543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.92  E-value=9e-24  Score=147.94  Aligned_cols=134  Identities=31%  Similarity=0.504  Sum_probs=120.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.+|+|.+..+++.+++|..           ..+.++...++.++||||+++++.+..+...|+++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            47899999999999998998888632           2355666778899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++.....+++..+..++.|++.++.++|+++++|+|++|+||+++.++.++++|||++.....
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            99998777789999999999999999999999999999999999999999999999999986644

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=4.7e-24  Score=160.43  Aligned_cols=132  Identities=16%  Similarity=0.228  Sum_probs=117.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH--HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhc-C
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI--MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-G   78 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~   78 (145)
                      +|.|++|.||+|.+..+++.+++|...  ...++...++.++||||+++++++..++..+++||++. ++|..++... .
T Consensus       177 Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~  255 (461)
T PHA03211        177 LTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLR  255 (461)
T ss_pred             EccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCC
Confidence            578999999999999999999998532  24467778889999999999999999999999999995 5888887653 5


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          79 VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        79 ~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++..+..++.|++.++.|+|+.+++|+||||+||+++....++|+|||+++.+.
T Consensus       256 ~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        256 PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR  311 (461)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence            68999999999999999999999999999999999999999999999999997654

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.92  E-value=1.2e-23  Score=150.53  Aligned_cols=130  Identities=30%  Similarity=0.511  Sum_probs=118.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|++|.+|++.+..+++.+++|..           ..+.++.+.++.++||||+++++.+..++..+++||++++++|
T Consensus         9 l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L   88 (305)
T cd05609           9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDC   88 (305)
T ss_pred             eecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcH
Confidence            68899999999999999998888632           2334566677889999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      ..++...+.+++.....++.|++.++.|+|+++++|+|++|+||+++..+.++++|||+++
T Consensus        89 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~  149 (305)
T cd05609          89 ATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSK  149 (305)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCcc
Confidence            9999887889999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=3.4e-24  Score=156.75  Aligned_cols=130  Identities=22%  Similarity=0.268  Sum_probs=114.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH--HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHh-cC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER--IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HG   78 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~-~~   78 (145)
                      .|.|++|.||+|.+..+++.+++|..  .....+...++.++||||+++++++..+...++++|++. ++|..++.. ..
T Consensus        74 lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~  152 (357)
T PHA03209         74 LTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSR  152 (357)
T ss_pred             ecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccC
Confidence            58899999999999999999998742  223446667888999999999999999999999999995 488887764 46


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          79 VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        79 ~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      .+++..+..++.|++.|+.|+|.++++|+||+|+||+++....++++|||+++.
T Consensus       153 ~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        153 PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence            689999999999999999999999999999999999999999999999999864

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.92  E-value=4.8e-24  Score=159.89  Aligned_cols=133  Identities=17%  Similarity=0.262  Sum_probs=112.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----HHHhhhhhcccCCCCceeEeeEEEEcC--------CEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----MLSLVSTGIQMVDCPFIVCMTYAFHTP--------DKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~hp~i~~~~~~~~~~--------~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|.+..+++.+|+|...    ...++...++.++||||++++++|...        ..++++|||+++ +
T Consensus        74 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~  152 (440)
T PTZ00036         74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-T  152 (440)
T ss_pred             EEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-c
Confidence            689999999999999999999997532    334577788899999999999887542        257799999975 6


Q ss_pred             HHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC-CEEEeeeccceecCC
Q psy3273          70 LHYHLS----QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG-HVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~-~~~l~dfg~~~~~~~  135 (145)
                      +..++.    ....+++..+..++.|++.|+.|+|+.+++||||||+||+++... .++++|||+|+.+..
T Consensus       153 l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        153 VHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             HHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            766664    245689999999999999999999999999999999999998664 699999999986644

>KOG1026|consensus

Probab=99.92  E-value=8e-25  Score=168.31  Aligned_cols=142  Identities=23%  Similarity=0.288  Sum_probs=123.5

Q ss_pred             eeeeeeeEEEEEEEcc-----cCCeeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVK-----QGETLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-----~~~~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|-|+||.||++..-.     ....||+|         ....|+++++.+..++|||||+++|++..++.+|+|+|||..
T Consensus       494 LGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~  573 (774)
T KOG1026|consen  494 LGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDH  573 (774)
T ss_pred             hcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEeccc
Confidence            5889999999997744     23455553         456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          68 GDLHYHLSQH--------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        68 ~~l~~~l~~~--------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |+|..++...              .++...+.+.++.||+.|+.||.++.++||||.++|+|++....+||+|||+++.+
T Consensus       574 GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdi  653 (774)
T KOG1026|consen  574 GDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDI  653 (774)
T ss_pred             ccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhh
Confidence            9999999632              12678899999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCccccC
Q psy3273         134 SKKKPHASVG  143 (145)
Q Consensus       134 ~~~~~~~~~~  143 (145)
                      -+.+..+..|
T Consensus       654 YssDYYk~~~  663 (774)
T KOG1026|consen  654 YSSDYYKVRG  663 (774)
T ss_pred             hhhhhhcccC
Confidence            7766655443

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.92  E-value=1.8e-23  Score=145.73  Aligned_cols=134  Identities=31%  Similarity=0.443  Sum_probs=120.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|++|.+|++....+++.+++|+             ...+..+...++.++||||+++++++..++..++++||++++
T Consensus         8 ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (258)
T cd06632           8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGG   87 (258)
T ss_pred             eeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCC
Confidence            6899999999999998888888863             234556667788999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++.+...+++..+..++.|++.++.++|+.+++|+|++|+|++++.+..++++|||.+.....
T Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          88 SLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999998777789999999999999999999999999999999999999999999999998876543

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.92  E-value=1.2e-23  Score=155.99  Aligned_cols=134  Identities=21%  Similarity=0.192  Sum_probs=112.5

Q ss_pred             eeeeeeeEEEEEEEcccC-----CeeeeeH---------HHHHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQG-----ETLALNE---------RIMLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~-----~~~~~~~---------~~~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      .|.|+||.||+|.....+     ..+++|.         ...+.++.+.++.++ ||||+++++++...+..|+||||++
T Consensus        45 LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~  124 (400)
T cd05105          45 LGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCF  124 (400)
T ss_pred             ecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecC
Confidence            689999999999875432     3566652         234556777788886 9999999999999999999999999


Q ss_pred             CCCHHHHHHhc---------------------------------------------------------------------
Q psy3273          67 GGDLHYHLSQH---------------------------------------------------------------------   77 (145)
Q Consensus        67 ~~~l~~~l~~~---------------------------------------------------------------------   77 (145)
                      +|+|.+++...                                                                     
T Consensus       125 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (400)
T cd05105         125 YGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQ  204 (400)
T ss_pred             CCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcc
Confidence            99999887532                                                                     


Q ss_pred             ---------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccc
Q psy3273          78 ---------------------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA  130 (145)
Q Consensus        78 ---------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~  130 (145)
                                                 ..+++..+..++.|++.++.|+|..+++|+||+|+|++++....++++|||++
T Consensus       205 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla  284 (400)
T cd05105         205 RSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA  284 (400)
T ss_pred             cCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcc
Confidence                                       13566777889999999999999999999999999999999999999999999


Q ss_pred             eecCC
Q psy3273         131 CDFSK  135 (145)
Q Consensus       131 ~~~~~  135 (145)
                      +.+..
T Consensus       285 ~~~~~  289 (400)
T cd05105         285 RDIMH  289 (400)
T ss_pred             eeccc
Confidence            86543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.92  E-value=1.7e-23  Score=151.26  Aligned_cols=131  Identities=18%  Similarity=0.178  Sum_probs=115.2

Q ss_pred             eeee--eeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIV--GTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~--~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|  +++.||++.+..+++.+|+|...          .++.+...++.++||||++++++|..++..++||||+++++
T Consensus         6 ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~   85 (327)
T cd08227           6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS   85 (327)
T ss_pred             ccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCc
Confidence            4666  78999999999999999997432          34556677888999999999999999999999999999999


Q ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          70 LHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        70 l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      |.+++...  ..+++..+..++.|++.|+.|+|+++++|+|++|+||+++.++.+++.||+.+..
T Consensus        86 l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~  150 (327)
T cd08227          86 AKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS  150 (327)
T ss_pred             HHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhc
Confidence            99988643  4588999999999999999999999999999999999999999999999976543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.92  E-value=2.8e-23  Score=144.94  Aligned_cols=134  Identities=24%  Similarity=0.384  Sum_probs=118.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|++|.+|.+.+..+++.+++|..         +....+...++.++||||+++.+.+.+++..|++|||++++++.+
T Consensus         8 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   87 (255)
T cd08219           8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQ   87 (255)
T ss_pred             eeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHH
Confidence            68899999999999999998888642         334556667889999999999999999999999999999999999


Q ss_pred             HHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          73 HLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++..  ...+++..+..++.|++.++.++|.++++|+|++|+|++++..+.++++|||.+.....
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          88 KIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            8864  34588999999999999999999999999999999999999999999999999876643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.92  E-value=6.9e-24  Score=148.77  Aligned_cols=135  Identities=26%  Similarity=0.378  Sum_probs=120.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH--------------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER--------------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      ++|.|++|.+|.+.+..+++.+++|..              ..+..+.+.++.++||||+++++++...+..++++||++
T Consensus         7 ~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~   86 (268)
T cd06630           7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMA   86 (268)
T ss_pred             eecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccC
Confidence            368999999999999999999888633              234566777889999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC-CEEEeeeccceecCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG-HVRISDLGLACDFSK  135 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~-~~~l~dfg~~~~~~~  135 (145)
                      +++|.+++.....+++..+..++.|++.|+.++|+++++|+||+|+||+++..+ .++++|||.+..+..
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          87 GGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999998777899999999999999999999999999999999999998665 699999999876654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.91  E-value=2e-23  Score=147.66  Aligned_cols=135  Identities=17%  Similarity=0.275  Sum_probs=119.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|++|.+|++.+..+++.+++|..          ..+..+...++.++|||++++++++..+...+++|||++++++.
T Consensus         9 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   88 (286)
T cd07847           9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLN   88 (286)
T ss_pred             ecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHH
Confidence            58899999999999999998888632          23445667788899999999999999999999999999998887


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ..+.....+++..+..++.|++.++.++|+.+++|+|++|+||+++..+.++++|||++..+...
T Consensus        89 ~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          89 ELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             HHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            77766667999999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.3e-23  Score=145.60  Aligned_cols=133  Identities=24%  Similarity=0.374  Sum_probs=120.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|++|.+|++....+++.+++|.        ...+.++...++.++||||+++++.+...+.+|++||++++++|..+
T Consensus        11 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~   90 (262)
T cd06613          11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDI   90 (262)
T ss_pred             ecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence            6889999999999998888888752        44566777788899999999999999999999999999999999998


Q ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          74 LSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        74 l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +... ..+++..+..++.|++.++.++|.++++|+|++|+||+++..+.++++|||.+..+.
T Consensus        91 ~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          91 YQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             HHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhh
Confidence            8765 779999999999999999999999999999999999999999999999999887554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.91  E-value=2.7e-23  Score=144.80  Aligned_cols=135  Identities=25%  Similarity=0.380  Sum_probs=119.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.+|++.+..+++.+++++          ...+..+...++.++||||+++++.+..++..|++|||+++++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (256)
T cd08529           8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLH   87 (256)
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHH
Confidence            5789999999999999999888863          223345556678899999999999999999999999999999999


Q ss_pred             HHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +++...  ..+++..+..++.+++.++.|+|.++++|+|++|+||+++....++++|||++..+...
T Consensus        88 ~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          88 KLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            998764  56889999999999999999999999999999999999999999999999998866543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=1.4e-23  Score=147.70  Aligned_cols=133  Identities=28%  Similarity=0.364  Sum_probs=119.9

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH------------------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEE
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI------------------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFIL   62 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   62 (145)
                      ++|.|++|.||++.+..+++.+++|+..                  .+..+...++.++|||++++++++...+..+++|
T Consensus         8 ~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   87 (272)
T cd06629           8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFL   87 (272)
T ss_pred             eecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEE
Confidence            3789999999999999999988887432                  2345666788999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          63 DLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        63 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ||+++++|.+.+.....+++..+..++.|++.++.++|+.+++|+|++|+||+++..+.++++|||++...
T Consensus        88 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          88 EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             ecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            99999999999987778999999999999999999999999999999999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.91  E-value=1.6e-23  Score=150.68  Aligned_cols=133  Identities=23%  Similarity=0.269  Sum_probs=113.8

Q ss_pred             eeeeeeeEEEEEEEcccCCe----eeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGET----LALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.||++.+..+++.    +++|..         ..+..+...++.++||||+++++++..+ ..++++|++++|
T Consensus        15 lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g   93 (316)
T cd05108          15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFG   93 (316)
T ss_pred             eecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCC
Confidence            68999999999998776654    566532         2344566678899999999999999865 567999999999


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++... ..++......++.|++.|+.|+|+++++|+||+|+||+++.+..++++|||+++.+..
T Consensus        94 ~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          94 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            999998764 4588889999999999999999999999999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.91  E-value=2e-23  Score=147.84  Aligned_cols=134  Identities=21%  Similarity=0.304  Sum_probs=115.3

Q ss_pred             eeeeeeeEEEEEE----EcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEc--CCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCS----HVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHT--PDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~----~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||.+.    +..+++.+++|.        ...+.++...++.++||||+++.+++..  +..+++++||+++
T Consensus        12 lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   91 (284)
T cd05081          12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPY   91 (284)
T ss_pred             ccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCC
Confidence            6899999999997    445778888864        2345667778899999999999998754  3578999999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          68 GDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        68 ~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++|.+++... ..+++.....++.|++.++.|+|.++++|+|++|+||+++.+..++++|||++..+..
T Consensus        92 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          92 GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             CCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            9999998754 4588999999999999999999999999999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=1.1e-23  Score=149.24  Aligned_cols=133  Identities=23%  Similarity=0.367  Sum_probs=117.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.+|++.+..+++.+++|..         ..+.++.+.++.++||||+++++.+..++..|++|||+++++|..
T Consensus         9 ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   88 (286)
T cd06622           9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK   88 (286)
T ss_pred             hcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHH
Confidence            68999999999999999999888632         234456677888999999999999999999999999999999988


Q ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQH---GVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++...   ..+++..+..++.|++.++.|+|. .+++|+||+|+|++++..+.++++|||.+..+.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          89 LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             HHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            88753   368999999999999999999996 599999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.91  E-value=1.3e-23  Score=148.71  Aligned_cols=133  Identities=23%  Similarity=0.385  Sum_probs=114.2

Q ss_pred             eeeeeeeEEEEEEEcc----cCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVK----QGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~----~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +|.|+||.||++....    +++.+++|..         ..+.++...++.++||||+++++++..++..|++|||++++
T Consensus        13 lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~   92 (283)
T cd05090          13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQG   92 (283)
T ss_pred             ccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCC
Confidence            6889999999998643    4456666533         34566777889999999999999999999999999999999


Q ss_pred             CHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273          69 DLHYHLSQH-----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus        69 ~l~~~l~~~-----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      +|.+++...                 ..+++..+..++.|++.++.|+|+++++|+|++|+|++++....++++|||++.
T Consensus        93 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  172 (283)
T cd05090          93 DLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR  172 (283)
T ss_pred             cHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccc
Confidence            999988532                 236788889999999999999999999999999999999999999999999997


Q ss_pred             ecC
Q psy3273         132 DFS  134 (145)
Q Consensus       132 ~~~  134 (145)
                      ...
T Consensus       173 ~~~  175 (283)
T cd05090         173 EIY  175 (283)
T ss_pred             ccc
Confidence            653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.91  E-value=1.8e-23  Score=147.07  Aligned_cols=132  Identities=19%  Similarity=0.173  Sum_probs=109.8

Q ss_pred             eeeeeeeEEEEEEEcc--cCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVK--QGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~--~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++....  ....++++.         ...+.++...++.++||||+++++.+..+...|++|||+++++|
T Consensus         3 lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L   82 (269)
T cd05042           3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDL   82 (269)
T ss_pred             CCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcH
Confidence            6899999999986533  334455542         12334556667889999999999999999999999999999999


Q ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          71 HYHLSQHG-----VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      .+++....     ..++.....++.|++.++.|+|+++++|+|++|+|++++.+..++++|||++...
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          83 KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             HHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEecccccccc
Confidence            99987542     2456778899999999999999999999999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.91  E-value=8.9e-24  Score=151.28  Aligned_cols=130  Identities=20%  Similarity=0.255  Sum_probs=111.6

Q ss_pred             eeeeeeeEEEEEEEcccCCe--eeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGET--LALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~--~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|.+..++..  ++++.         ...+.++...++.+ +||||+++++++..++..|++|||+++++
T Consensus        15 lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   94 (303)
T cd05088          15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN   94 (303)
T ss_pred             ecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCc
Confidence            58899999999998877753  34432         12344566667778 89999999999999999999999999999


Q ss_pred             HHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273          70 LHYHLSQHG----------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus        70 l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      |.+++....                .+++.++..++.|++.++.++|+++++|+|++|+|++++.+..++++|||++.
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~  172 (303)
T cd05088          95 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR  172 (303)
T ss_pred             HHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCc
Confidence            999986432                47888999999999999999999999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.91  E-value=7.4e-24  Score=148.07  Aligned_cols=135  Identities=33%  Similarity=0.565  Sum_probs=121.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.+|++.+..+++.+++|.           ...+.++.+.++.++||||+++++.+..++..++++||+++++|
T Consensus         8 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (258)
T cd05578           8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL   87 (258)
T ss_pred             eccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCH
Confidence            6889999999999999999988862           23445566678899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ..++.....+++..+..++.|++.++.++|.++++|+|++|+||+++.++.++++|||.+......
T Consensus        88 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          88 RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             HHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999987778999999999999999999999999999999999999999999999999998765443

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.91  E-value=2.1e-23  Score=165.19  Aligned_cols=132  Identities=21%  Similarity=0.134  Sum_probs=116.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.||+|.+..+++.+++|..           ..+.++...++.++||||+++++++..++..|++|||+++++|
T Consensus        10 LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL   89 (932)
T PRK13184         10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTL   89 (932)
T ss_pred             EecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCH
Confidence            68999999999999999999999742           2345667778899999999999999999999999999999999


Q ss_pred             HHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          71 HYHLSQH-----------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~~-----------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      .+++...           ...+...+..++.|++.++.|+|+.+++|+||||+||+++..+.++++|||++...
T Consensus        90 ~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i  163 (932)
T PRK13184         90 KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK  163 (932)
T ss_pred             HHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceec
Confidence            9988631           12445667889999999999999999999999999999999999999999999866

>KOG1152|consensus

Probab=99.91  E-value=1.9e-24  Score=161.09  Aligned_cols=143  Identities=20%  Similarity=0.260  Sum_probs=121.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----HH------------HhhhhhcccCC---CCceeEeeEEEEcCCEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----ML------------SLVSTGIQMVD---CPFIVCMTYAFHTPDKLCFIL   62 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----~~------------~~~~~~~~~l~---hp~i~~~~~~~~~~~~~~lv~   62 (145)
                      .|.|+||.|+.|.++.+..+|.+|.+.    ..            -.+..+++.++   ||||+|++++|++++++|++|
T Consensus       569 lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~t  648 (772)
T KOG1152|consen  569 LGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLET  648 (772)
T ss_pred             ccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEe
Confidence            589999999999999999888886322    11            13334455555   999999999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccc
Q psy3273          63 DLMN-GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS  141 (145)
Q Consensus        63 e~~~-~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  141 (145)
                      |.-. +-+|++++.....+.+.+...++.|++.++.++|+.||+|||||-+|+.++..+.+|++|||.|....++.....
T Consensus       649 e~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpfd~f  728 (772)
T KOG1152|consen  649 EVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFDVF  728 (772)
T ss_pred             cCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcCCCccee
Confidence            9754 459999999889999999999999999999999999999999999999999999999999999987766555544


Q ss_pred             cCC
Q psy3273         142 VGK  144 (145)
Q Consensus       142 ~~~  144 (145)
                      +||
T Consensus       729 ~gt  731 (772)
T KOG1152|consen  729 VGT  731 (772)
T ss_pred             eee
Confidence            554

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.91  E-value=1.6e-23  Score=146.96  Aligned_cols=132  Identities=26%  Similarity=0.373  Sum_probs=117.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------------HHHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------------IMLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~   66 (145)
                      .|.|++|.||.+.+..+++.+++|..             ..+.++...++.++||||+++++++..+  ..++++||+++
T Consensus        10 l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~   89 (265)
T cd06652          10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMP   89 (265)
T ss_pred             EecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecC
Confidence            68899999999999999998888632             2455677788999999999999998764  57889999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +++|.+++.+...+++.....++.|++.++.++|+++++|+|++|+||+++..+.++++|||.+...
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          90 GGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            9999999987777899999999999999999999999999999999999999999999999988754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.91  E-value=2.7e-23  Score=145.78  Aligned_cols=134  Identities=18%  Similarity=0.187  Sum_probs=118.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|++|.||++....+++.+++|.       ...+.++.+.++.++||||+++++++..++..+++|||+++++|.+++
T Consensus        14 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   93 (263)
T cd05052          14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL   93 (263)
T ss_pred             cCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHH
Confidence            5789999999999999898888863       234556667788899999999999999999999999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ...  ..+++.....++.|++.++.++|+++++|+|++|+|++++....++++|||.+.....
T Consensus        94 ~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          94 RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             HhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            653  3588999999999999999999999999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.91  E-value=1.4e-23  Score=150.00  Aligned_cols=131  Identities=23%  Similarity=0.335  Sum_probs=116.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|++|.||++.+..+++.+++|+..         ...++...++.++||||+++++++..++..+++|||+++ +|.+
T Consensus        14 lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~   92 (301)
T cd07873          14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQ   92 (301)
T ss_pred             eccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-CHHH
Confidence            688999999999999999999887532         344566778899999999999999999999999999974 8888


Q ss_pred             HHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          73 HLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        73 ~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++.. ...+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++...
T Consensus        93 ~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          93 YLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            8765 356889999999999999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=2.9e-23  Score=157.65  Aligned_cols=133  Identities=27%  Similarity=0.390  Sum_probs=115.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCC--------EEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD--------KLCFILD   63 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~--------~~~lv~e   63 (145)
                      .|.|+||.||+|.+..+++.+|+|..          ....++...+..++||||+++.+.+...+        .+++|||
T Consensus        40 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~E  119 (496)
T PTZ00283         40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLD  119 (496)
T ss_pred             EecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEe
Confidence            68999999999999999999999742          23445666678899999999988876432        3789999


Q ss_pred             ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          64 LMNGGDLHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        64 ~~~~~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |+++|+|.+++..    ...+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++|+|||+++.+.
T Consensus       120 y~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~  194 (496)
T PTZ00283        120 YANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA  194 (496)
T ss_pred             CCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeecc
Confidence            9999999998864    2468999999999999999999999999999999999999999999999999997654

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.91  E-value=5.8e-23  Score=145.41  Aligned_cols=132  Identities=20%  Similarity=0.290  Sum_probs=117.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|++|.+|++.+..++..++++.        ...+..+.+.++.++|||++++++.+..++..|+++||++++++...
T Consensus        13 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~   92 (282)
T cd06643          13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV   92 (282)
T ss_pred             cccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHH
Confidence            5889999999999999888877753        23345566778889999999999999999999999999999999887


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          74 LSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        74 l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +.. ...+++..+..++.|++.++.++|+.+++|+|++|+|++++..+.++++|||++...
T Consensus        93 ~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          93 MLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccc
Confidence            764 467899999999999999999999999999999999999999999999999998654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.91  E-value=3.2e-23  Score=145.34  Aligned_cols=131  Identities=19%  Similarity=0.280  Sum_probs=117.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH--------------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER--------------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||++.. .+++.+++|..              ..+.++...++.++||||+++.+++..++..++++||+++
T Consensus         8 ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (265)
T cd06631           8 LGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPG   86 (265)
T ss_pred             EeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCC
Confidence            68999999999986 46777777632              3356677778899999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++|.+++.+...+++..+..++.|++.++.++|+.+++|+|++|+|++++..+.++++|||.+...
T Consensus        87 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          87 GSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            999999988778899999999999999999999999999999999999999999999999988654

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0201|consensus

Probab=99.91  E-value=1.6e-25  Score=161.81  Aligned_cols=144  Identities=25%  Similarity=0.336  Sum_probs=130.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|+||.||++.+..+++.+|+|         +++.++++...+..+++|||.++|+.|..+..++++||||.+|++.+
T Consensus        21 IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~  100 (467)
T KOG0201|consen   21 IGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLD  100 (467)
T ss_pred             ccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhh
Confidence            689999999999999999999996         56667788888999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCc--cccCCC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASVGKS  145 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~  145 (145)
                      .+.....+++..+..++++++.|+.|+|..+.+|+||++.|+++...+.++++|||++..++.....  ..+||+
T Consensus       101 lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTP  175 (467)
T KOG0201|consen  101 LLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTP  175 (467)
T ss_pred             hhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccccccc
Confidence            9988777789999999999999999999999999999999999998899999999999888765333  336764

>KOG0667|consensus

Probab=99.91  E-value=1.3e-23  Score=157.95  Aligned_cols=134  Identities=24%  Similarity=0.324  Sum_probs=111.5

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH----HHHh---hhhhcccCC------CCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI----MLSL---VSTGIQMVD------CPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~----~~~~---~~~~~~~l~------hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      ++|.|+||.|.+|.+.++++.||+|.+.    ..++   +..+|..|+      --|+|+++++|...+++|||+|.+..
T Consensus       193 ~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~  272 (586)
T KOG0667|consen  193 VLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLST  272 (586)
T ss_pred             EecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhh
Confidence            4799999999999999999999997422    2222   222333333      34999999999999999999998855


Q ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC--CCEEEeeeccceecCC
Q psy3273          68 GDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH--GHVRISDLGLACDFSK  135 (145)
Q Consensus        68 ~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~--~~~~l~dfg~~~~~~~  135 (145)
                       +|+++++.+  ..++...++.+..|++.++.+||..+|||+||||+|||+...  ..+|++|||+|+....
T Consensus       273 -NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  273 -NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             -hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence             999999864  458999999999999999999999999999999999999754  4799999999986543

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.91  E-value=3.3e-23  Score=144.36  Aligned_cols=135  Identities=22%  Similarity=0.277  Sum_probs=120.4

Q ss_pred             CeeeeeeeEEEEEEEccc---CCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQ---GETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .+|.|+||.||+|.....   +..+++|.         ...+..+...++.++||||+++++++..++.++++|||++++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence            368999999999999876   77777752         344556667788899999999999999999999999999999


Q ss_pred             CHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQH---------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++...         ..+++..+..++.|++.++.++|+++++|+|++|+||+++....++++|||.+.....
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999864         6789999999999999999999999999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.91  E-value=4.7e-23  Score=144.82  Aligned_cols=133  Identities=23%  Similarity=0.302  Sum_probs=116.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.||++.+..+++.++++.        ...+.++...++.++||||+++++++..++..++++|++++++|.++
T Consensus        16 lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   95 (268)
T cd06624          16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSAL   95 (268)
T ss_pred             EecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHH
Confidence            6889999999999998888888863        33455667778899999999999999999999999999999999999


Q ss_pred             HHhc-CCC--CHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-CCCEEEeeeccceecC
Q psy3273          74 LSQH-GVF--NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-HGHVRISDLGLACDFS  134 (145)
Q Consensus        74 l~~~-~~~--~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-~~~~~l~dfg~~~~~~  134 (145)
                      +... ..+  ++..+..++.|++.++.|+|.++++|+|++|+||+++. ...++++|||.+..+.
T Consensus        96 l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          96 LRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             HHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            8753 445  78888899999999999999999999999999999976 5689999999987653

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.91  E-value=4.9e-23  Score=144.10  Aligned_cols=134  Identities=18%  Similarity=0.213  Sum_probs=114.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|++|.+|.+..... ..+++|.       ...+.++...++.++||||+++++++...+..+++|||+++++|.+++
T Consensus        12 lg~G~~~~vy~~~~~~~-~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i   90 (256)
T cd05113          12 LGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL   90 (256)
T ss_pred             ecCcccceEEEEEecCC-CcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHH
Confidence            58899999999977543 3355542       223456667788999999999999999999999999999999999998


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          75 SQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ... ..+++..+..++.|++.++.++|.++++|+|++|+|++++.+..++++|||.++....+
T Consensus        91 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          91 REHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            763 46899999999999999999999999999999999999999999999999998765443

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.91  E-value=4.6e-23  Score=147.21  Aligned_cols=133  Identities=20%  Similarity=0.365  Sum_probs=118.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH--------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER--------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|++|.+|++.+..+++.+++|+.        +.+..+...++.++||||+++++.+..++..|+||||+++++|.++
T Consensus        27 lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  106 (297)
T cd06656          27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV  106 (297)
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHH
Confidence            58899999999999999999998642        3345566677889999999999999999999999999999999998


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +.. ..+++..+..++.|++.++.++|+.+++|+|++|+||+++.++.++++|||.+.....
T Consensus       107 ~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656         107 VTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             HHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            864 4578899999999999999999999999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.91  E-value=2.3e-23  Score=146.69  Aligned_cols=131  Identities=20%  Similarity=0.258  Sum_probs=112.7

Q ss_pred             CeeeeeeeEEEEEEEcccCCe--eeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGET--LALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~--~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +.|.|+||.||++....++..  ++++.         ...+..+.+.++++ +||||+++++++..++..|++|||++++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            468999999999999887753  34432         22344566677788 8999999999999999999999999999


Q ss_pred             CHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273          69 DLHYHLSQHG----------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus        69 ~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      +|.+++....                .++...+..++.|++.++.|+|+++++|+|++|+|++++....++++|||++.
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence            9999986432                36788999999999999999999999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.91  E-value=6.5e-23  Score=145.85  Aligned_cols=132  Identities=20%  Similarity=0.292  Sum_probs=117.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|++|.||++.+..+++.++++.        ...+.++...++.++||||+++++.+..++..|++|||++++++...
T Consensus        20 lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   99 (292)
T cd06644          20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAI   99 (292)
T ss_pred             ecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHH
Confidence            6889999999999999999888753        23345566678899999999999999999999999999999999887


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          74 LSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        74 l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +.. ...+++..+..++.|++.++.++|..+++|+|++|+|++++.++.++++|||++...
T Consensus       100 ~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644         100 MLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence            754 456899999999999999999999999999999999999999999999999988653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.91  E-value=3.1e-23  Score=145.72  Aligned_cols=134  Identities=19%  Similarity=0.239  Sum_probs=115.9

Q ss_pred             eeeeeeeEEEEEEEcccCC---eeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE---TLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||++.+..++.   .+++|.         ...+..+...++.++||||+++++++..++..|++|||+++++
T Consensus        12 lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (267)
T cd05066          12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGS   91 (267)
T ss_pred             ecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCC
Confidence            6889999999998875543   455542         2345566677888999999999999999999999999999999


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |.+++... ..++..+...++.|++.++.++|+.+++|+|++|+|++++.+..++++|||.+..+..
T Consensus        92 L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          92 LDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99998764 4688999999999999999999999999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=4.1e-23  Score=144.47  Aligned_cols=132  Identities=28%  Similarity=0.502  Sum_probs=114.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH-----------HHhh-hhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM-----------LSLV-STGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~-----------~~~~-~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|++|.||+|.+..+++.+++|....           ...+ .......+|||++++++++..++..|+++||+++++
T Consensus         4 l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   83 (260)
T cd05611           4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGD   83 (260)
T ss_pred             CCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCC
Confidence            5889999999999999999999874321           1111 112345589999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |.+++.....+++..+..++.|++.++.|+|+.+++|+|++|+||+++....++++|||++...
T Consensus        84 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          84 CASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            9999988778999999999999999999999999999999999999999999999999988654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.91  E-value=2e-23  Score=145.64  Aligned_cols=132  Identities=13%  Similarity=0.077  Sum_probs=113.5

Q ss_pred             eeeeeeeEEEEEEEcccC----------CeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVKQG----------ETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~----------~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      .|.|+||.||++....++          ..+++|.       ...+.++...++.++||||+++++++.. +..+++|||
T Consensus         3 lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~   81 (259)
T cd05037           3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEY   81 (259)
T ss_pred             ccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEc
Confidence            689999999999998776          2344432       2345566677899999999999999988 778999999


Q ss_pred             cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC-------CEEEeeeccceecC
Q psy3273          65 MNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG-------HVRISDLGLACDFS  134 (145)
Q Consensus        65 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~-------~~~l~dfg~~~~~~  134 (145)
                      +++++|.+++.... .++......++.|++.++.|+|+++++|+||+|+|++++...       .++++|||++....
T Consensus        82 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037          82 VKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence            99999999998655 689999999999999999999999999999999999998776       79999999987643

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.91  E-value=4.2e-23  Score=144.19  Aligned_cols=132  Identities=20%  Similarity=0.229  Sum_probs=114.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|+||.||.+.... +..+++|.       ...+..+.+.++.++||||+++++++..++..+++|||+++++|.+++
T Consensus        12 lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~   90 (256)
T cd05114          12 LGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL   90 (256)
T ss_pred             ecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHH
Confidence            5889999999997754 44566652       234556777889999999999999999999999999999999999988


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          75 SQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        75 ~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .. ...+++.....++.|++.++.|+|+++++|+|++|+|++++....++++|||.+....
T Consensus        91 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          91 RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             HhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            64 3468899999999999999999999999999999999999999999999999887553

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1095|consensus

Probab=99.91  E-value=7.9e-24  Score=167.49  Aligned_cols=139  Identities=24%  Similarity=0.269  Sum_probs=121.7

Q ss_pred             eeeeeeeEEEEEEEcccCC-----eeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE-----TLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~-----~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||.+.-.....     .+++|         ++..+.+++..|++++||||+++.|++.+....++++|||++
T Consensus       700 lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~g  779 (1025)
T KOG1095|consen  700 LGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEG  779 (1025)
T ss_pred             eccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhccc
Confidence            6899999999997755332     35554         567788888899999999999999999999999999999999


Q ss_pred             CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCcc
Q psy3273          68 GDLHYHLSQH-------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA  140 (145)
Q Consensus        68 ~~l~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  140 (145)
                      |+|.+++++.       ..+...+++.++.+++.|+.||++..++||||..+|+|++....+|++|||+|+.+-+.+..+
T Consensus       780 GDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr  859 (1025)
T KOG1095|consen  780 GDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYR  859 (1025)
T ss_pred             CcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchhee
Confidence            9999999864       338889999999999999999999999999999999999999999999999999765554443

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.91  E-value=5e-23  Score=144.41  Aligned_cols=134  Identities=23%  Similarity=0.335  Sum_probs=118.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.||++.+..+++.+++|..           ..+..+...++.++||||+++++.+...+..++++||+++++|
T Consensus        10 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   89 (267)
T cd08228          10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDL   89 (267)
T ss_pred             eccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcH
Confidence            68899999999999999999988732           2244566778899999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++..    ...+++..+..++.|++.++.|+|+++++|+|++|+|++++..+.++++|||.+..+..
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          90 SQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             HHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            988752    34588899999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.91  E-value=5.3e-23  Score=144.49  Aligned_cols=133  Identities=26%  Similarity=0.375  Sum_probs=118.2

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-------------HHHHhhhhhcccCCCCceeEeeEEEEc--CCEEEEEEEcc
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-------------IMLSLVSTGIQMVDCPFIVCMTYAFHT--PDKLCFILDLM   65 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~lv~e~~   65 (145)
                      ++|.|++|.+|++.+..++..++++..             ..+.++...++.++||||+++++++..  +...++++|++
T Consensus         9 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~   88 (266)
T cd06651           9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYM   88 (266)
T ss_pred             eecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCC
Confidence            368899999999999999988888632             345567778899999999999999875  36789999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++++|.+.+.....+++.....++.|++.++.++|+++++|+|++|+||+++....++++|||++..+
T Consensus        89 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          89 PGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            99999999987777899999999999999999999999999999999999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.91  E-value=4.2e-23  Score=150.98  Aligned_cols=130  Identities=20%  Similarity=0.332  Sum_probs=110.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCC------EEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD------KLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~------~~~lv~e~~   65 (145)
                      .|.|+||.||++.+..+++.+++|..          ....++...++.++||||+++++++...+      ..|++|||+
T Consensus        29 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~  108 (359)
T cd07876          29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM  108 (359)
T ss_pred             eecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCC
Confidence            68999999999999999999998743          22345666788899999999999997543      579999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++ ++...+.  ..+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||++....
T Consensus       109 ~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876         109 DA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             Cc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            76 5666554  347888899999999999999999999999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.91  E-value=4.8e-23  Score=144.26  Aligned_cols=132  Identities=22%  Similarity=0.305  Sum_probs=112.4

Q ss_pred             eeeeeeeEEEEEEEc--ccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHV--KQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~--~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++...  ..+..+++|.         ...+.++...++.++||||+++++++.. +..+++|||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence            588999999998765  3344566642         2345667778899999999999998864 578999999999999


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++.. ...+++..+..++.|++.++.++|.++++|+||+|+|++++....++++|||++..+.
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  146 (257)
T cd05115          82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALG  146 (257)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCcccccc
Confidence            998875 4568999999999999999999999999999999999999999999999999987553

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.91  E-value=3.9e-23  Score=146.80  Aligned_cols=131  Identities=23%  Similarity=0.355  Sum_probs=116.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|++|.||++.+..+++.+++|+..         ...++.+.++.++||||+++++++.+++..++||||+.+ +|.+
T Consensus        13 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~   91 (291)
T cd07844          13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQ   91 (291)
T ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHH
Confidence            689999999999999999999997532         233467778899999999999999999999999999975 8988


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          73 HLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        73 ~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++... ..+++..+..++.|++.|+.|+|+.+++|+||+|+|++++..+.++++|||++...
T Consensus        92 ~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          92 YMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECcccccccc
Confidence            88653 46899999999999999999999999999999999999999999999999988653

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.91  E-value=3.9e-23  Score=144.45  Aligned_cols=133  Identities=17%  Similarity=0.154  Sum_probs=114.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|++|.||++.... +..+++|.       ...+..+.+.++.++||||+++++++...+..|++||++++++|.+++
T Consensus        12 lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   90 (256)
T cd05059          12 LGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL   90 (256)
T ss_pred             hccCCCceEEEeEecC-CccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHH
Confidence            5889999999998764 44555543       123445667788899999999999999999999999999999999998


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .. ...+++..+..++.|++.++.++|+.+++|+|++|+|++++..+.++++|||.++....
T Consensus        91 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          91 RERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            75 34688999999999999999999999999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.91  E-value=4.6e-23  Score=144.61  Aligned_cols=132  Identities=22%  Similarity=0.284  Sum_probs=113.6

Q ss_pred             eeeeeeeEEEEEEEc----ccCCeeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHV----KQGETLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.|+++...    ..+..+++|         +.+.+.++.+.++.++||||+++++++...+..++|+||+++|
T Consensus         7 ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g   86 (259)
T PF07714_consen    7 IGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGG   86 (259)
T ss_dssp             EEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTE
T ss_pred             EccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccccc
Confidence            689999999999988    344556664         2455666777788899999999999999888899999999999


Q ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          69 DLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        69 ~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|.+++...  ..++......++.|++.|+.|+|+++++|++++++|++++.+..+|++|||++...
T Consensus        87 ~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   87 SLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             BHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999875  67999999999999999999999999999999999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.91  E-value=7.8e-23  Score=143.24  Aligned_cols=133  Identities=26%  Similarity=0.391  Sum_probs=118.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.+|++....+++.+++|.           ...+.++...++.++|||++++++.+..++..+++|||+++++|
T Consensus        10 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (267)
T cd08224          10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDL   89 (267)
T ss_pred             eccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCH
Confidence            5889999999999999999988863           23455666778899999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ..++..    ...+++..+..++.+++.++.++|+.+++|+|++|+|++++.++.++++|||++..+.
T Consensus        90 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          90 SRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             HHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            988863    2448899999999999999999999999999999999999999999999999987554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.91  E-value=5.7e-23  Score=145.97  Aligned_cols=133  Identities=22%  Similarity=0.250  Sum_probs=114.1

Q ss_pred             eeeeeeeEEEEEEEcc-----cCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVK-----QGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-----~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +|.|+||.||.+.+..     ++..+++|.        ...+.++...++.++||||+++++++..++..+++|||++++
T Consensus        13 lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   92 (288)
T cd05093          13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG   92 (288)
T ss_pred             cCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCC
Confidence            6889999999998633     334455543        234566777788999999999999999999999999999999


Q ss_pred             CHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          69 DLHYHLSQHG-------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        69 ~l~~~l~~~~-------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +|.+++...+             .+++..+..++.|++.++.++|+++++|+|++|+||+++....++++|||++..+.
T Consensus        93 ~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  171 (288)
T cd05093          93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY  171 (288)
T ss_pred             CHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCcccccc
Confidence            9999987543             38999999999999999999999999999999999999999999999999987553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.91  E-value=6.9e-23  Score=142.93  Aligned_cols=134  Identities=18%  Similarity=0.288  Sum_probs=119.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.++.+++..+++.+++|+.          ..+.++.+.++.++||||+++++++...+..+++|||+++++|.
T Consensus         8 ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~   87 (256)
T cd08221           8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLY   87 (256)
T ss_pred             ecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHH
Confidence            58899999999999999998888732          23456667888999999999999999999999999999999999


Q ss_pred             HHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++...  ..+++..+..++.|++.++.++|+.+++|+|++|+|++++....++++|||.+.....
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          88 DKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             HHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            999764  4588999999999999999999999999999999999999999999999999876643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=2.8e-23  Score=147.99  Aligned_cols=133  Identities=22%  Similarity=0.293  Sum_probs=113.1

Q ss_pred             eeeeeeeEEEEEEEcccC--------------CeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEE
Q psy3273           2 FFIVGTGFLSNCSHVKQG--------------ETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKL   58 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~--------------~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~   58 (145)
                      +|.|+||.||.|.+..++              ..+++|.         ...+.++.+.++.++|||++++++++..++..
T Consensus        13 lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   92 (295)
T cd05097          13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL   92 (295)
T ss_pred             cCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcc
Confidence            689999999999875432              2356642         23455677788999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEee
Q psy3273          59 CFILDLMNGGDLHYHLSQHG------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD  126 (145)
Q Consensus        59 ~lv~e~~~~~~l~~~l~~~~------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~d  126 (145)
                      +++|||+++++|.+++....            .++...+..++.|++.++.|+|+.+++|+|++|+|++++.+..++++|
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~d  172 (295)
T cd05097          93 CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIAD  172 (295)
T ss_pred             EEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecc
Confidence            99999999999999886432            367788899999999999999999999999999999999999999999


Q ss_pred             eccceecC
Q psy3273         127 LGLACDFS  134 (145)
Q Consensus       127 fg~~~~~~  134 (145)
                      ||++..+.
T Consensus       173 fg~~~~~~  180 (295)
T cd05097         173 FGMSRNLY  180 (295)
T ss_pred             cccccccc
Confidence            99987543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.5e-23  Score=145.31  Aligned_cols=132  Identities=22%  Similarity=0.330  Sum_probs=118.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|++|.||++....+++.+++|.        ...+..+.+.++.++||||+++++.+..+...|++|||+++++|..+
T Consensus        13 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   92 (280)
T cd06611          13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSI   92 (280)
T ss_pred             hcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHH
Confidence            5789999999999998888888863        23345566778899999999999999999999999999999999998


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          74 LSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        74 l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +.. ...+++..+..++.|++.++.|+|+.+++|+|++|+|++++.++.++++|||++...
T Consensus        93 ~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          93 MLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence            875 356899999999999999999999999999999999999999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.91  E-value=5.3e-23  Score=146.18  Aligned_cols=131  Identities=24%  Similarity=0.322  Sum_probs=114.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|++|.||+|.+..+++.+++|...         ...++.+.++.++||||+++++++..++..|++|||+. +++.+
T Consensus        13 ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~   91 (291)
T cd07870          13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQ   91 (291)
T ss_pred             EEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHH
Confidence            689999999999999999988887432         33456677889999999999999999999999999996 57777


Q ss_pred             HHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          73 HLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        73 ~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++.. ...+++..+..++.|++.++.++|+++++|+||+|+||+++..+.++++|||++...
T Consensus        92 ~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          92 YMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            6654 355788888999999999999999999999999999999999999999999988653

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.91  E-value=3.2e-23  Score=146.95  Aligned_cols=134  Identities=21%  Similarity=0.261  Sum_probs=115.9

Q ss_pred             eeeeeeeEEEEEEE----cccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSH----VKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~----~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~   66 (145)
                      .|.|+||.||.|..    ..+++.+++|..         ..+.++...++.++|||++++.+++...  ...+++|||++
T Consensus        12 lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (284)
T cd05079          12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP   91 (284)
T ss_pred             cCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccC
Confidence            68899999999974    456777887642         3456677778899999999999999875  57899999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          67 GGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        67 ~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++|.+++... ..+++.....++.|++.++.++|+++++|+|++|+|++++.++.++++|||++..+..
T Consensus        92 g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            99999998654 4589999999999999999999999999999999999999999999999999976643

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.91  E-value=3.4e-23  Score=147.56  Aligned_cols=133  Identities=22%  Similarity=0.376  Sum_probs=118.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-------------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-------------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +|.|++|.+|++.+..+++.+++|...             .+..+.+.++.++||||+++++++..++..++||||+ ++
T Consensus         8 lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   86 (298)
T cd07841           8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ET   86 (298)
T ss_pred             eeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CC
Confidence            689999999999999999999886432             1234556788899999999999999999999999999 88


Q ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++.... .+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..+..
T Consensus        87 ~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          87 DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999997765 799999999999999999999999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA02988 hypothetical protein; Provisional

Probab=99.91  E-value=5.5e-23  Score=146.07  Aligned_cols=131  Identities=15%  Similarity=0.111  Sum_probs=114.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEc----CCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHT----PDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~   66 (145)
                      .+.|++|.||++..  +++.+++|.           ...+.++...++.++||||+++++++.+    ...++++|||++
T Consensus        28 i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~  105 (283)
T PHA02988         28 IKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT  105 (283)
T ss_pred             EeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence            57889999999987  677888753           2445577788999999999999999876    357899999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +|+|.+++.....++......++.+++.++.++|. .+++|+|++|+|++++.++.++++|||++..+.
T Consensus       106 ~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988        106 RGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             CCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            99999999887788999999999999999999998 488999999999999999999999999987543

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.91  E-value=5.7e-23  Score=144.47  Aligned_cols=133  Identities=20%  Similarity=0.232  Sum_probs=116.0

Q ss_pred             eeeeeeeEEEEEEEcccCC---eeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE---TLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|++|.+|++....++.   .+++|.         ...+..+...++.++||||+++.+++..++..+++|||+++++
T Consensus        12 lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~   91 (269)
T cd05065          12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGA   91 (269)
T ss_pred             ecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCc
Confidence            6899999999999887764   366642         2345566677889999999999999999999999999999999


Q ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          70 LHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        70 l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |.+++.. .+.++......++.|++.++.++|+++++|+|++|+|++++....++++|||++..+.
T Consensus        92 L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          92 LDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9998875 3558899999999999999999999999999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.91  E-value=5e-23  Score=152.75  Aligned_cols=133  Identities=21%  Similarity=0.186  Sum_probs=111.8

Q ss_pred             eeeeeeeEEEEEEEc-----ccCCeeeeeHH---------HHHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHV-----KQGETLALNER---------IMLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~-----~~~~~~~~~~~---------~~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +|.|+||.||+|...     .+++.+++|..         ..+.++...++.+. ||||+++++++...+..++||||++
T Consensus        45 lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~  124 (401)
T cd05107          45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCR  124 (401)
T ss_pred             ccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccC
Confidence            689999999999853     34556777632         23455667788887 9999999999999999999999999


Q ss_pred             CCCHHHHHHhcC--------------------------------------------------------------------
Q psy3273          67 GGDLHYHLSQHG--------------------------------------------------------------------   78 (145)
Q Consensus        67 ~~~l~~~l~~~~--------------------------------------------------------------------   78 (145)
                      +|+|.+++....                                                                    
T Consensus       125 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (401)
T cd05107         125 YGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADI  204 (401)
T ss_pred             CCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhh
Confidence            999999885321                                                                    


Q ss_pred             ------------------------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          79 ------------------------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        79 ------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                                                    .++...+..++.|++.++.|+|..+++|+|++|+|++++....++++|||
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfG  284 (401)
T cd05107         205 ESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFG  284 (401)
T ss_pred             hccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecC
Confidence                                          24556678889999999999999999999999999999999999999999


Q ss_pred             cceecC
Q psy3273         129 LACDFS  134 (145)
Q Consensus       129 ~~~~~~  134 (145)
                      +++.+.
T Consensus       285 la~~~~  290 (401)
T cd05107         285 LARDIM  290 (401)
T ss_pred             cceecc
Confidence            997654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=6.6e-23  Score=143.86  Aligned_cols=134  Identities=26%  Similarity=0.395  Sum_probs=118.8

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-------------HHHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEcc
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-------------IMLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLM   65 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~   65 (145)
                      ++|.|++|.+|++.+..+++.+++|..             ..+.++.+.++.++||||+++++.+.+.  ..+++++|++
T Consensus         9 ~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~   88 (264)
T cd06653           9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYM   88 (264)
T ss_pred             eEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeC
Confidence            368999999999999999998888642             2445667788999999999999998764  5689999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++++|.+.+.+...+++.....++.|++.++.++|+++++|+|++|+||+++..+.++++|||+++.+.
T Consensus        89 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          89 PGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            999999999877778999999999999999999999999999999999999999999999999997653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.91  E-value=2e-23  Score=150.05  Aligned_cols=133  Identities=23%  Similarity=0.348  Sum_probs=110.1

Q ss_pred             eeeeeeeEEEEEEEc--ccCCeeeeeHH------HHHHhhhhhcccCCCCceeEeeEEEEc--CCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHV--KQGETLALNER------IMLSLVSTGIQMVDCPFIVCMTYAFHT--PDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~--~~~~~~~~~~~------~~~~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|+||.||+|.+.  .+++.+++|..      ....++...++.++||||+++++.+..  +...|++||++.+ ++.
T Consensus         9 lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~   87 (317)
T cd07868           9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLW   87 (317)
T ss_pred             cccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHH
Confidence            689999999999975  46677888643      234567778899999999999999864  4578999999865 887


Q ss_pred             HHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC----CCCCEEEeeeccceecCC
Q psy3273          72 YHLSQH---------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD----EHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~----~~~~~~l~dfg~~~~~~~  135 (145)
                      +++...         ..+++..+..++.|++.|+.|+|+.+++|+||+|+||++.    ....++++|||+++.+..
T Consensus        88 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07868          88 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             HHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence            776522         2488899999999999999999999999999999999993    456899999999986643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.91  E-value=1.9e-23  Score=145.93  Aligned_cols=132  Identities=30%  Similarity=0.492  Sum_probs=118.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.+|++.+..+++.+++|..           ..+..+.+.++.++||||+++++.+..++..|+++|++++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            47899999999999999999888732           2344555677888999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      .+++.+...+++.....++.|++.++.++|..+++|+||+|+|++++.++.++++|||++...
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~  143 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVG  143 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence            999988778999999999999999999999999999999999999999999999999988654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG1989|consensus

Probab=99.91  E-value=1.2e-23  Score=162.00  Aligned_cols=132  Identities=22%  Similarity=0.244  Sum_probs=114.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee--------HHHHHHhhhhhcccCC-CCceeEeeEE-EEcC------CEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN--------ERIMLSLVSTGIQMVD-CPFIVCMTYA-FHTP------DKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~-hp~i~~~~~~-~~~~------~~~~lv~e~~   65 (145)
                      +.-|||+.||.|.+.+.+..+|+|        ..+.+.+|.+.++.|+ |||||.+++. ....      -.++++||||
T Consensus        45 LAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC  124 (738)
T KOG1989|consen   45 LAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYC  124 (738)
T ss_pred             EccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhc
Confidence            356999999999999998877775        3556678888888886 9999999993 3221      2588999999


Q ss_pred             CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          66 NGGDLHYHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRY--IVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        66 ~~~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~--iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++|+|-+++..  ...+.+.+++.++.++++|+.+||...  +||||||.+|+|+..++..||||||.++..
T Consensus       125 ~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  125 KGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             cCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            99999999973  355999999999999999999999887  999999999999999999999999999754

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.91  E-value=3.3e-23  Score=145.35  Aligned_cols=133  Identities=25%  Similarity=0.363  Sum_probs=117.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.||++.+..+++.+++|..           ..+.++...++.++||||+++++++..++..+++||++++++|
T Consensus        10 ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   89 (267)
T cd08229          10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL   89 (267)
T ss_pred             hcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCH
Confidence            58899999999999999999888732           2334556677889999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++..    ...+++..+..++.|++.++.|+|+++++|+|++|+||+++.++.++++|||.+..+.
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          90 SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             HHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            998863    3458899999999999999999999999999999999999999999999999887553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=1.7e-23  Score=154.87  Aligned_cols=133  Identities=19%  Similarity=0.295  Sum_probs=115.7

Q ss_pred             eeeeeeeEEEEEEEcc--cCCeeeeeHHH---HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHh
Q psy3273           2 FFIVGTGFLSNCSHVK--QGETLALNERI---MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ   76 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~--~~~~~~~~~~~---~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~   76 (145)
                      +|.|++|.||+|....  +++.+++|...   ...++...++.++||||+++++.+......|++||++. +++.+++..
T Consensus       100 Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~  178 (392)
T PHA03207        100 LTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDR  178 (392)
T ss_pred             ecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHh
Confidence            5889999999997643  45667776432   34567778899999999999999999999999999996 588888876


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          77 HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        77 ~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ...+++..+..++.|++.|+.|+|..+++|+||+|+||+++..+.++++|||+++.+..
T Consensus       179 ~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        179 SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            77899999999999999999999999999999999999999999999999999976543

>KOG4721|consensus

Probab=99.91  E-value=3.2e-24  Score=160.07  Aligned_cols=137  Identities=21%  Similarity=0.251  Sum_probs=123.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHHH-HhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIML-SLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF   80 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~   80 (145)
                      +|+|+.|-|+..+..  ++.||+|++..+ +...+.+++|+||||++|.++|....-+|||||||+.|.|+..++...++
T Consensus       132 lGSGaQGAVF~Grl~--netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~i  209 (904)
T KOG4721|consen  132 LGSGAQGAVFLGRLH--NETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPI  209 (904)
T ss_pred             hccCcccceeeeecc--CceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCcc
Confidence            689999999998764  677888766554 55667899999999999999999999999999999999999999998899


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCcc
Q psy3273          81 NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA  140 (145)
Q Consensus        81 ~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  140 (145)
                      .+..+..|..+|+.++.|||.+.|||||+|.-|||+..+..+|++|||.++.....+...
T Consensus       210 tp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM  269 (904)
T KOG4721|consen  210 TPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM  269 (904)
T ss_pred             CHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhh
Confidence            999999999999999999999999999999999999999999999999998776554443

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=6e-23  Score=147.50  Aligned_cols=133  Identities=35%  Similarity=0.505  Sum_probs=118.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.||.|.+..+++.+++|.           ...+..+.+.++.++||||+++++.+..++..|++||++++++|
T Consensus         9 ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   88 (316)
T cd05574           9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL   88 (316)
T ss_pred             ecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCH
Confidence            5889999999999999999888863           22355666778899999999999999999999999999999999


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++...  ..+++.....++.|++.++.|+|+.+++|+||+|+|++++.++.++++|||++....
T Consensus        89 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          89 FRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             HHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            9998753  468999999999999999999999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.91  E-value=4.5e-23  Score=145.06  Aligned_cols=133  Identities=17%  Similarity=0.143  Sum_probs=111.1

Q ss_pred             CeeeeeeeEEEEEEEcc--cCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVK--QGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~--~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      ..|.|+||.||++....  ++..+++|..         ..+.++...++.++||||+++++.+......+++|||+++++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            36899999999997643  3445566432         234556677889999999999999999999999999999999


Q ss_pred             HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHG-----VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |.+++....     ..++.....++.|++.++.|+|+++++|+|++|+|++++....++++|||.+...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccc
Confidence            999986421     3566677889999999999999999999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.91  E-value=4.7e-23  Score=146.06  Aligned_cols=132  Identities=25%  Similarity=0.362  Sum_probs=110.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH----------HHhhhhhc---ccCCCCceeEeeEEEEc-----CCEEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM----------LSLVSTGI---QMVDCPFIVCMTYAFHT-----PDKLCFILD   63 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~---~~l~hp~i~~~~~~~~~-----~~~~~lv~e   63 (145)
                      .|.|++|.||+|.+..+++.+++|....          ..++...+   +.++||||+++++++..     ....+++||
T Consensus         8 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e   87 (288)
T cd07863           8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFE   87 (288)
T ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEc
Confidence            6899999999999999999999874331          12233333   44589999999999864     346899999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          64 LMNGGDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        64 ~~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++++ ++.+++...  ..+++..+..++.|++.|+.|+|+.+++|+|++|+||+++.++.++++|||++..+.
T Consensus        88 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          88 HVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             cccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            9975 888887653  348999999999999999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.91  E-value=4.5e-23  Score=144.22  Aligned_cols=134  Identities=22%  Similarity=0.267  Sum_probs=114.8

Q ss_pred             CeeeeeeeEEEEEEE--cccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSH--VKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~--~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ..|.|+||.||++..  ..++..+++|..          ..+..+...++.++||||+++++++. ++..+++||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            368999999999964  456677777632          23455566788899999999999876 45678999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++.....+++.....++.|++.++.++|+++++|+|++|+|++++.+..++++|||++..+..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~  147 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA  147 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence            9999998777899999999999999999999999999999999999999999999999999976543

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.91  E-value=9.7e-23  Score=144.69  Aligned_cols=133  Identities=23%  Similarity=0.321  Sum_probs=107.9

Q ss_pred             eeeeeeeEEEEEEEccc-CCeeeeeHHH----------HHHhhhhh---cccCCCCceeEeeEEEEc-----CCEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQ-GETLALNERI----------MLSLVSTG---IQMVDCPFIVCMTYAFHT-----PDKLCFIL   62 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~-~~~~~~~~~~----------~~~~~~~~---~~~l~hp~i~~~~~~~~~-----~~~~~lv~   62 (145)
                      +|.|+||.||+|.+..+ ++.+++|...          ...++.+.   ++.++||||+++++++..     ...++++|
T Consensus         9 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~   88 (290)
T cd07862           9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF   88 (290)
T ss_pred             eccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEE
Confidence            68999999999998654 5777776321          12223333   344589999999999863     45699999


Q ss_pred             EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          63 DLMNGGDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        63 e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |++. ++|.+++...  ..+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus        89 e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T cd07862          89 EHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF  162 (290)
T ss_pred             ccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccC
Confidence            9996 5888888643  4588999999999999999999999999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.91  E-value=6.2e-23  Score=145.18  Aligned_cols=132  Identities=23%  Similarity=0.412  Sum_probs=116.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.||++.+..+++.+++|..          ..+..+...++.++||||+++++++..++..|+||||++ +++.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~   86 (285)
T cd07861           8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLK   86 (285)
T ss_pred             ecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHH
Confidence            58899999999999999999998743          234556667888999999999999999999999999997 5888


Q ss_pred             HHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLSQH---GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +++...   ..+++..+..++.|++.|+.|+|+.+++|+|++|+||+++.++.++++|||++....
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          87 KYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             HHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            887542   458999999999999999999999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=9.8e-23  Score=142.40  Aligned_cols=134  Identities=19%  Similarity=0.252  Sum_probs=115.0

Q ss_pred             CeeeeeeeEEEEEEEcccC---CeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQG---ETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~---~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ..|.|++|.||+|....++   ..+++|.         ...+..+...++.++||||+++++++. .+..+++||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~   80 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG   80 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence            3689999999999775554   5666653         223455667788899999999999876 45689999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++.....+++.....++.|++.++.++|.++++|+||+|+|++++....++++|||.++.+..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA  147 (257)
T ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeec
Confidence            9999998877899999999999999999999999999999999999999999999999999886643

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=6.5e-23  Score=145.35  Aligned_cols=132  Identities=23%  Similarity=0.421  Sum_probs=118.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|++|.||++.+..+++.+++|.         ...+..+...++.++||||+++++.+..++.++++|||+++++|..
T Consensus        13 ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   92 (284)
T cd06620          13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR   92 (284)
T ss_pred             cCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHH
Confidence            5889999999999999998888852         2344566677888999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++...+.+++..+..++.+++.++.|+|. .+++|+|++|+|++++.+..++++|||++...
T Consensus        93 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          93 IYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            88877789999999999999999999996 68999999999999999999999999988654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.91  E-value=3.7e-23  Score=145.55  Aligned_cols=131  Identities=18%  Similarity=0.147  Sum_probs=109.2

Q ss_pred             eeeeeeeEEEEEEEcccC--Ceeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQG--ETLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~--~~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||++......  ..++++         +...+.++...++.++||||+++++.+......|++|||+++++|
T Consensus         3 lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   82 (268)
T cd05086           3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDL   82 (268)
T ss_pred             CCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcH
Confidence            689999999998754433  222332         233455666678889999999999999999999999999999999


Q ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          71 HYHLSQH----GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        71 ~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      .+++...    ...+...+..++.|++.|+.|+|+.+++|+||+|+|++++....++++|||++..
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          83 KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             HHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccc
Confidence            9998753    2356677888999999999999999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.91  E-value=7.8e-23  Score=145.99  Aligned_cols=132  Identities=21%  Similarity=0.383  Sum_probs=117.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|++|.+|++.+..+++.++++.        ...+.++...++.++|||++++++.+..+...|+||||+++++|..+
T Consensus        28 lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~  107 (296)
T cd06654          28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV  107 (296)
T ss_pred             ecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHH
Confidence            5889999999999999999888863        23445566778889999999999999999999999999999999998


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +.. ..+++.++..++.|++.++.++|..+++|+||+|+|++++.++.++++|||.+....
T Consensus       108 ~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654         108 VTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             HHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            864 457889999999999999999999999999999999999999999999999887543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.91  E-value=9.8e-23  Score=142.44  Aligned_cols=135  Identities=27%  Similarity=0.488  Sum_probs=122.3

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      ..|.|++|.+|++.+..+++.+++|.         ...+..+...++.++|||++++++.+..++..++++||+++++|.
T Consensus         8 ~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (264)
T cd06623           8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLA   87 (264)
T ss_pred             eeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHH
Confidence            36889999999999999999988863         334556666778889999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++.....+++.....++.|++.++.++|+ .+++|++++|+||+++..+.++++|||.+..+..
T Consensus        88 ~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          88 DLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             HHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999877889999999999999999999999 9999999999999999999999999999886644

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.90  E-value=9.7e-23  Score=144.14  Aligned_cols=133  Identities=22%  Similarity=0.311  Sum_probs=114.5

Q ss_pred             eeeeeeeEEEEEEEcccC-----CeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQG-----ETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~-----~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|++|.||++.....+     ..+++|..         ..+.++...++.++||||+++++++..++..+++|||+++
T Consensus        13 lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   92 (283)
T cd05048          13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAH   92 (283)
T ss_pred             ccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCC
Confidence            588999999999876655     55666532         2345666778889999999999999999999999999999


Q ss_pred             CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273          68 GDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus        68 ~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      ++|.+++...                ..++...+..++.|++.++.++|.++++|+|++|+|++++.+..++++|||++.
T Consensus        93 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~  172 (283)
T cd05048          93 GDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR  172 (283)
T ss_pred             CcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCccee
Confidence            9999998754                347788889999999999999999999999999999999999999999999987


Q ss_pred             ecC
Q psy3273         132 DFS  134 (145)
Q Consensus       132 ~~~  134 (145)
                      ...
T Consensus       173 ~~~  175 (283)
T cd05048         173 DIY  175 (283)
T ss_pred             ecc
Confidence            653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=4.4e-23  Score=144.48  Aligned_cols=132  Identities=17%  Similarity=0.179  Sum_probs=115.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|++|.||++... +++.+++|..       ..+.++...++.++||||+++++++..++..+++||++++++|.+++
T Consensus        14 lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   92 (261)
T cd05068          14 LGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL   92 (261)
T ss_pred             ecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHH
Confidence            588999999999864 4456777642       23456667788899999999999999999999999999999999998


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          75 SQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        75 ~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ....  .++...+..++.|++.++.++|..+++|+||+|+||+++..+.++++|||++..+.
T Consensus        93 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          93 QGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            7543  58899999999999999999999999999999999999999999999999997664

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.90  E-value=8.9e-23  Score=145.18  Aligned_cols=133  Identities=20%  Similarity=0.280  Sum_probs=115.2

Q ss_pred             eeeeeeeEEEEEEEcccCC----------------eeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE----------------TLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD   56 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~----------------~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~   56 (145)
                      .|.|+||.||++.....+.                .+++|.         ...+..+.+.++.++||||+++++++..++
T Consensus        13 lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   92 (296)
T cd05051          13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDP   92 (296)
T ss_pred             ccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence            6899999999998866543                345542         234455677789999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEe
Q psy3273          57 KLCFILDLMNGGDLHYHLSQHG-----------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS  125 (145)
Q Consensus        57 ~~~lv~e~~~~~~l~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~  125 (145)
                      ..+++||++++++|.+++....           .+++..+..++.|++.++.|+|+++++|+||+|+|++++....++++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~  172 (296)
T cd05051          93 PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIA  172 (296)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEc
Confidence            9999999999999999987654           68899999999999999999999999999999999999999999999


Q ss_pred             eeccceecC
Q psy3273         126 DLGLACDFS  134 (145)
Q Consensus       126 dfg~~~~~~  134 (145)
                      |||.+..+.
T Consensus       173 dfg~~~~~~  181 (296)
T cd05051         173 DFGMSRNLY  181 (296)
T ss_pred             cccceeecc
Confidence            999987653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.90  E-value=9e-23  Score=145.15  Aligned_cols=133  Identities=21%  Similarity=0.236  Sum_probs=114.1

Q ss_pred             eeeeeeeEEEEEEEcc-----cCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVK-----QGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-----~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|++|.+|.+.+..     ++..++++.        ...+.++...++.++||||+++++++...+..+++|||++++
T Consensus        13 lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   92 (291)
T cd05094          13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG   92 (291)
T ss_pred             ecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCC
Confidence            6889999999998643     334455542        245667777889999999999999999999999999999999


Q ss_pred             CHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          69 DLHYHLSQHG----------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        69 ~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      +|.+++....                .+++.....++.|++.++.++|+++++|+||+|+||+++.++.++++|||++..
T Consensus        93 ~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~  172 (291)
T cd05094          93 DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD  172 (291)
T ss_pred             cHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccc
Confidence            9999997532                278889999999999999999999999999999999999999999999999875


Q ss_pred             cC
Q psy3273         133 FS  134 (145)
Q Consensus       133 ~~  134 (145)
                      ..
T Consensus       173 ~~  174 (291)
T cd05094         173 VY  174 (291)
T ss_pred             cC
Confidence            53

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.90  E-value=9.8e-23  Score=144.02  Aligned_cols=132  Identities=19%  Similarity=0.254  Sum_probs=112.7

Q ss_pred             eeeeeeeEEEEEEEcccCCe----eeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGET----LALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~----~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.||++....+++.    +++|.         ...+.++...++.++||||+++++++... ..++++|++++|
T Consensus        15 lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g   93 (279)
T cd05109          15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYG   93 (279)
T ss_pred             cCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCC
Confidence            68899999999998777763    55552         22344556667888999999999998754 577999999999


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          69 DLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        69 ~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +|.+++.. ...+++..+..++.|++.++.|+|+++++|+||+|+||+++.+..++++|||+++.+.
T Consensus        94 ~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          94 CLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            99999876 3568999999999999999999999999999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.90  E-value=1e-22  Score=142.94  Aligned_cols=133  Identities=19%  Similarity=0.226  Sum_probs=115.3

Q ss_pred             eeeeeeeEEEEEEEccc---CCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQ---GETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||++.....   ...+++|.         ...+..+...++.++||||+++++.+..++..+++||++++++
T Consensus        12 lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~   91 (266)
T cd05033          12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGS   91 (266)
T ss_pred             ecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCC
Confidence            68999999999988654   33556642         2234456667889999999999999999999999999999999


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          70 LHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        70 l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |.+++... +.+++..+..++.|++.++.++|+++++|+|++|+|++++.+..++++|||++..+.
T Consensus        92 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          92 LDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99998753 468999999999999999999999999999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.90  E-value=1.1e-22  Score=145.22  Aligned_cols=133  Identities=21%  Similarity=0.392  Sum_probs=118.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|++|.+|++.+..+++.+++|+        ...+.++...++.++||||+++++.+..++.+|+++||+++++|..+
T Consensus        27 lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  106 (296)
T cd06655          27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV  106 (296)
T ss_pred             EecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHH
Confidence            5789999999999999999998863        23445566778899999999999999999999999999999999988


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +.. ..+++.++..++.+++.++.++|+.+++|+|++|+||+++.++.++++|||++..+..
T Consensus       107 ~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655         107 VTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             HHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            865 4589999999999999999999999999999999999999999999999998876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.90  E-value=1.2e-22  Score=141.30  Aligned_cols=133  Identities=17%  Similarity=0.229  Sum_probs=117.9

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +.|.|++|.+|++.+.. ++.+++|.         ...+..+.+.++.++||||+++++++......+++||++++++|.
T Consensus         2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             ccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36899999999999887 88888863         334566777788999999999999999999999999999999999


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +++.. ...++...+..++.+++.++.++|+++++|+|++|+|++++.+..++++|||.+....
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            99865 3568889999999999999999999999999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.90  E-value=1.2e-22  Score=143.83  Aligned_cols=133  Identities=19%  Similarity=0.239  Sum_probs=111.1

Q ss_pred             eeeeeeeEEEEEEEcccCCe----eeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGET----LALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.||++....+++.    +++|..         ..+..+...++.++||||+++++++. +...++++|+++++
T Consensus        15 lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~g   93 (279)
T cd05111          15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLG   93 (279)
T ss_pred             cCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCC
Confidence            68999999999999877764    444321         22333344567889999999999875 45678899999999


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++.. ...+++..+..++.|++.++.|+|+++++|+||+|+|++++.+..++++|||.++.+..
T Consensus        94 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          94 SLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             cHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999975 45689999999999999999999999999999999999999999999999999976543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0614|consensus

Probab=99.90  E-value=4.1e-25  Score=162.81  Aligned_cols=144  Identities=28%  Similarity=0.445  Sum_probs=126.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee-----------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN-----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|+||||.|=..........+|+|           +.+-...+.+++-.+++|+||++|.+|.++.++|++||.|-||.+
T Consensus       428 LGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGEl  507 (732)
T KOG0614|consen  428 LGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGEL  507 (732)
T ss_pred             cccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchh
Confidence            699999999988887766656653           233334566677788999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccc-cCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGKS  145 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~  145 (145)
                      ++.+...+.++..+...++.++++|+.|||+++|++||+||+|++++..+.+|+.|||+|+.+..+...-+ .|||
T Consensus       508 WTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTp  583 (732)
T KOG0614|consen  508 WTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTP  583 (732)
T ss_pred             hhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999987765555 4543

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.90  E-value=9.4e-23  Score=141.79  Aligned_cols=132  Identities=18%  Similarity=0.282  Sum_probs=114.6

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +.|.|++|.||++... ++..+++|.         ...+.++.+.++.++||||+++++++...+..+++|||+++++|.
T Consensus         2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             ccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4689999999999854 566777753         123455667788899999999999999999999999999999999


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +++.. ...+++.....++.+++.++.++|+++++|+|++|+|++++.+..++++|||++...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  143 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQE  143 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceec
Confidence            98865 345789999999999999999999999999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.90  E-value=7.5e-23  Score=144.44  Aligned_cols=134  Identities=20%  Similarity=0.191  Sum_probs=115.9

Q ss_pred             CeeeeeeeEEEEEEEcc-----cCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVK-----QGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~-----~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      .+|.|++|.||+|....     +++.+++|.         ...+.++.+.++.++||||+++++++..+...+++|||++
T Consensus        12 ~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   91 (280)
T cd05049          12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYME   91 (280)
T ss_pred             hccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCC
Confidence            36899999999998754     346677753         3455667778899999999999999999999999999999


Q ss_pred             CCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          67 GGDLHYHLSQHG--------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        67 ~~~l~~~l~~~~--------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      +++|.+++...+              .+++..+..++.|++.++.++|+++++|+|++|+|++++.+..++++|||++..
T Consensus        92 ~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~  171 (280)
T cd05049          92 HGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD  171 (280)
T ss_pred             CCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCccccee
Confidence            999999987542              367888899999999999999999999999999999999999999999999876


Q ss_pred             cC
Q psy3273         133 FS  134 (145)
Q Consensus       133 ~~  134 (145)
                      +.
T Consensus       172 ~~  173 (280)
T cd05049         172 VY  173 (280)
T ss_pred             cc
Confidence            53

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.90  E-value=3.7e-23  Score=143.37  Aligned_cols=130  Identities=26%  Similarity=0.382  Sum_probs=114.5

Q ss_pred             eeeeeEEEEEEEcccCCeeeeeHHHH---HHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCC
Q psy3273           4 IVGTGFLSNCSHVKQGETLALNERIM---LSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF   80 (145)
Q Consensus         4 ~~~~g~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~   80 (145)
                      .|.+|.||.+.+..+++.+++|....   ..++...+....||||+++++++..++..+++|||+++++|.+++.....+
T Consensus         3 ~g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l   82 (237)
T cd05576           3 LGVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNI   82 (237)
T ss_pred             ccccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCC
Confidence            38899999999999999999986543   233333344557999999999999999999999999999999999877779


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          81 NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        81 ~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++..+..++.|++.++.++|..+++|+|++|+|++++.++.++++|||.+...
T Consensus        83 ~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~  135 (237)
T cd05576          83 PEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV  135 (237)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcc
Confidence            99999999999999999999999999999999999999999999999987544

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1094|consensus

Probab=99.90  E-value=8.4e-24  Score=157.94  Aligned_cols=140  Identities=21%  Similarity=0.211  Sum_probs=122.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|-||-|-.|.-.. +..+|+|         .+..+.++++.+.+|+||||++++++|..++.+++|+||+++|+|.+
T Consensus       546 iGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnq  624 (807)
T KOG1094|consen  546 IGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQ  624 (807)
T ss_pred             hcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHH
Confidence            5889999999998765 5666664         45778899999999999999999999999999999999999999999


Q ss_pred             HHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCcccc
Q psy3273          73 HLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV  142 (145)
Q Consensus        73 ~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  142 (145)
                      ++..+  +...-.....++.||+.++.||.+..++|+|+.++|+|++.+..+|++|||+++.+-+++..+.-
T Consensus       625 Fl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq  696 (807)
T KOG1094|consen  625 FLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ  696 (807)
T ss_pred             HHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence            99865  33455666789999999999999999999999999999999999999999999987766655543

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=1e-22  Score=142.16  Aligned_cols=131  Identities=22%  Similarity=0.237  Sum_probs=115.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|++|.||++...  ++.+++|.       ...+..+...++.++||||+++++++...+..+++||++++++|.+++
T Consensus        14 ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~   91 (256)
T cd05039          14 IGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL   91 (256)
T ss_pred             eecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHH
Confidence            688999999999875  67777753       233455666788999999999999999999999999999999999999


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          75 SQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        75 ~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ....  .+++.....++.|++.++.|+|.++++|+||+|+||+++.++.++++|||.+....
T Consensus        92 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          92 RSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence            7654  68999999999999999999999999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.90  E-value=3.6e-23  Score=146.45  Aligned_cols=134  Identities=21%  Similarity=0.382  Sum_probs=119.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.||+|.+..+++.+++|...          .+.++.+.++.++||||+++++++..++..|+++||++++++.
T Consensus         9 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~   88 (286)
T cd07846           9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLD   88 (286)
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHH
Confidence            688999999999999999999887432          2345666788899999999999999999999999999998888


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+......+++.....++.|++.++.|+|+.+++|+|++|+|++++.++.++++|||++..+..
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          89 DLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            8776666689999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.90  E-value=1.6e-23  Score=148.27  Aligned_cols=132  Identities=21%  Similarity=0.341  Sum_probs=116.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|++|.+|++.+..+|+.+++|...          .+..+...++.++||||+++++++.+++..++++||+++ ++.
T Consensus         8 l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~   86 (284)
T cd07839           8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLK   86 (284)
T ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHH
Confidence            588999999999999999998887532          234566678889999999999999999999999999975 787


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .++.+ ...+++..+..++.|++.|+.|+|..+++|+|++|+|++++..+.++++|||++..+.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          87 KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            77764 4668999999999999999999999999999999999999999999999999987653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0690|consensus

Probab=99.90  E-value=2.3e-24  Score=152.01  Aligned_cols=132  Identities=39%  Similarity=0.709  Sum_probs=119.7

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH----HHHH-------HhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE----RIML-------SLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~----~~~~-------~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      ++|.|.||.|..|+.+.+++.+|+|.    +...       ..+...++.++||.+..+...|++.+++|+||||..||.
T Consensus       175 vLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGe  254 (516)
T KOG0690|consen  175 VLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGE  254 (516)
T ss_pred             HhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCce
Confidence            47999999999999999999999852    2222       234455788999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      |+-++.....+++.....+...|+.|+.|+|+++|++||+|.+|+++|.++.+|++|||+++.
T Consensus       255 Lf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  255 LFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             EeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh
Confidence            999999888999999999999999999999999999999999999999999999999999964

>KOG0579|consensus

Probab=99.90  E-value=1.1e-24  Score=164.47  Aligned_cols=144  Identities=22%  Similarity=0.317  Sum_probs=125.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee--------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN--------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|-|+||.||+|....++-..|.|        +.+...-+.++++.|+||+|+++++.|..++.+||+.|||.||-....
T Consensus        40 LGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDai  119 (1187)
T KOG0579|consen   40 LGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAI  119 (1187)
T ss_pred             hcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHH
Confidence            578999999999999887666554        444555667889999999999999999999999999999999999887


Q ss_pred             HH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccc--cCCC
Q psy3273          74 LS-QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGKS  145 (145)
Q Consensus        74 l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~  145 (145)
                      +- -...+.+.++..++.|++.++.|||+..|+|||++..||++..++.++++|||++....+....++  +|||
T Consensus       120 mlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTP  194 (1187)
T KOG0579|consen  120 MLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTP  194 (1187)
T ss_pred             HHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCc
Confidence            65 456799999999999999999999999999999999999999999999999999987766554444  6664

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.90  E-value=2.2e-22  Score=141.77  Aligned_cols=133  Identities=22%  Similarity=0.298  Sum_probs=113.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHHH---Hhhhhhcc-cCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIML---SLVSTGIQ-MVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH   77 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~   77 (145)
                      +|.|+||.||+|.+..+++.++++.....   ..+..... ..+||||+++++.|..++..|+||||+++++|..++...
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~  103 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE  103 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc
Confidence            48899999999999999998888653221   11111111 227999999999999999999999999999999999877


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC-CEEEeeeccceecC
Q psy3273          78 GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG-HVRISDLGLACDFS  134 (145)
Q Consensus        78 ~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~-~~~l~dfg~~~~~~  134 (145)
                      ..+++..+..++.|++.++.++|+.+++|+|++|+|++++... .++++|||.+....
T Consensus       104 ~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390        104 GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            7899999999999999999999999999999999999999887 99999999987654

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.90  E-value=6.1e-23  Score=149.85  Aligned_cols=131  Identities=19%  Similarity=0.334  Sum_probs=111.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCC------EEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD------KLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~------~~~lv~e~~   65 (145)
                      .|.|+||.||+|.+..+++.+++|..          ....++...++.++||||+++++++...+      ..|++|||+
T Consensus        25 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~  104 (355)
T cd07874          25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM  104 (355)
T ss_pred             eeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhh
Confidence            68999999999999999999988743          23334566778899999999999987543      579999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++ ++...+..  .+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||+++....
T Consensus       105 ~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874         105 DA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             cc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            76 66666643  478888999999999999999999999999999999999999999999999976543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.90  E-value=6.5e-23  Score=150.19  Aligned_cols=131  Identities=19%  Similarity=0.324  Sum_probs=111.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcC------CEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTP------DKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~------~~~~lv~e~~   65 (145)
                      +|.|+||.||++.+..+++.+++|..          ....++...++.++||||+++++++...      ...|+||||+
T Consensus        32 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~  111 (364)
T cd07875          32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM  111 (364)
T ss_pred             eecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCC
Confidence            68999999999999999999988743          2234556677889999999999988654      3579999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++ ++...+..  .++...+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||+++....
T Consensus       112 ~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         112 DA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             CC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            76 67666643  478888999999999999999999999999999999999999999999999976543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.90  E-value=1.9e-22  Score=142.48  Aligned_cols=133  Identities=23%  Similarity=0.355  Sum_probs=118.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|++|.+|.+.+..+++.+++|.         ...+.++...++.++||||+++++.+..+...|++|||+++++|.+
T Consensus        12 lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   91 (277)
T cd06640          12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD   91 (277)
T ss_pred             cccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHH
Confidence            5889999999999999998888863         2235566677888999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++.. ..+++..+..++.|++.++.++|+.+++|+|++|+|++++..+.++++|||++..+..
T Consensus        92 ~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          92 LLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            8864 4688899999999999999999999999999999999999999999999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.90  E-value=1.3e-22  Score=143.65  Aligned_cols=133  Identities=20%  Similarity=0.220  Sum_probs=113.8

Q ss_pred             eeeeeeeEEEEEEEcc-----cCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVK-----QGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-----~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.||++....     ++..++++.        ...+.++.+.++.++||||+++++++..++..+++|||++++
T Consensus        13 lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   92 (280)
T cd05092          13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHG   92 (280)
T ss_pred             cCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCC
Confidence            6889999999997532     344555542        345667777889999999999999999999999999999999


Q ss_pred             CHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          69 DLHYHLSQHG---------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        69 ~l~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|.+++....               .+++..+..++.|++.++.|+|+++++|+|++|+||+++.+..++++|||++...
T Consensus        93 ~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  172 (280)
T cd05092          93 DLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI  172 (280)
T ss_pred             CHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEc
Confidence            9999987542               3788899999999999999999999999999999999999999999999998755


Q ss_pred             C
Q psy3273         134 S  134 (145)
Q Consensus       134 ~  134 (145)
                      .
T Consensus       173 ~  173 (280)
T cd05092         173 Y  173 (280)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.90  E-value=1.7e-22  Score=141.85  Aligned_cols=133  Identities=18%  Similarity=0.179  Sum_probs=115.8

Q ss_pred             eeeeeeeEEEEEEEcccCC---eeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE---TLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|++|.||++....+++   .+++|.         ...+..+...++.++|||++++.+++...+..|++||++++++
T Consensus        13 lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   92 (268)
T cd05063          13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGA   92 (268)
T ss_pred             ecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCC
Confidence            6889999999999876654   455542         2334556677889999999999999999999999999999999


Q ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          70 LHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        70 l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |..++.. .+.+++.....++.|++.++.++|+.+++|+|++|+|++++.+..++++|||++....
T Consensus        93 L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          93 LDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999875 3568999999999999999999999999999999999999999999999999987553

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.90  E-value=1.3e-22  Score=145.21  Aligned_cols=134  Identities=20%  Similarity=0.216  Sum_probs=114.3

Q ss_pred             eeeeeeeEEEEEEEc-----ccCCeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHV-----KQGETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      .|.|+||.||++.+.     .++..+++|.         ...+..+.+.++.+ +||||+++++.+...+..|++|||++
T Consensus        43 ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~  122 (302)
T cd05055          43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCC  122 (302)
T ss_pred             eeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCC
Confidence            588999999999763     2344666652         23455677778888 89999999999999999999999999


Q ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          67 GGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        67 ~~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++|.+++....  .+++.+...++.+++.++.|+|+++++|+|++|+||+++....++++|||++..+..
T Consensus       123 ~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  193 (302)
T cd05055         123 YGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN  193 (302)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence            999999987532  389999999999999999999999999999999999999999999999999976543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.90  E-value=2.5e-22  Score=141.91  Aligned_cols=133  Identities=23%  Similarity=0.366  Sum_probs=118.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|+||.||++.+..+++.+++|.         ...+.++...++.++||||+++++.+..++..|+||||+++++|..
T Consensus        12 ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~   91 (277)
T cd06641          12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD   91 (277)
T ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHH
Confidence            5899999999999998998888863         2235566667888999999999999999999999999999999998


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++.. ..+++..+..++.+++.++.++|..+++|+|++|+|++++..+.++++|||++..+..
T Consensus        92 ~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          92 LLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            8764 4688999999999999999999999999999999999999999999999999876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=1.2e-22  Score=143.13  Aligned_cols=133  Identities=21%  Similarity=0.245  Sum_probs=113.2

Q ss_pred             eeeeeeeEEEEEEEcccC-----CeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQG-----ETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~-----~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||++......     ..+++|.         ...+.++...++.++||||+++++++..++..+++|||+++
T Consensus        14 lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   93 (277)
T cd05032          14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAK   93 (277)
T ss_pred             ecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCC
Confidence            688999999999886543     6667653         22344566677889999999999999999999999999999


Q ss_pred             CCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          68 GDLHYHLSQHG----------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        68 ~~l~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++|.+++....          .+++..+..++.|++.++.|+|+++++|+||+|+|++++..+.++++|||+++.+.
T Consensus        94 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~  170 (277)
T cd05032          94 GDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY  170 (277)
T ss_pred             CCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhc
Confidence            99999986432          35677888999999999999999999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.90  E-value=9e-23  Score=144.21  Aligned_cols=133  Identities=14%  Similarity=0.117  Sum_probs=108.1

Q ss_pred             CeeeeeeeEEEEEEEcccC------------------------CeeeeeH--------HHHHHhhhhhcccCCCCceeEe
Q psy3273           1 MFFIVGTGFLSNCSHVKQG------------------------ETLALNE--------RIMLSLVSTGIQMVDCPFIVCM   48 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~------------------------~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~   48 (145)
                      ..|.|+||.||++....++                        ..+++|.        ...+.++...++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            3699999999998754322                        1233331        1233445567788999999999


Q ss_pred             eEEEEcCCEEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC-------
Q psy3273          49 TYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG-------  120 (145)
Q Consensus        49 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~-------  120 (145)
                      ++++..++..++||||+++++|..++.. .+.+++.....++.|++.++.|+|+++++|+||+|+||+++..+       
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~  161 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP  161 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence            9999999999999999999999988865 45688999999999999999999999999999999999996532       


Q ss_pred             CEEEeeeccceec
Q psy3273         121 HVRISDLGLACDF  133 (145)
Q Consensus       121 ~~~l~dfg~~~~~  133 (145)
                      .++++|||.+...
T Consensus       162 ~~kl~d~g~~~~~  174 (274)
T cd05076         162 FIKLSDPGVSFTA  174 (274)
T ss_pred             eeeecCCcccccc
Confidence            4799999987643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.90  E-value=2.2e-22  Score=140.42  Aligned_cols=134  Identities=24%  Similarity=0.365  Sum_probs=118.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.+|.+.+..+++.+++++.          ....++...++.++||||+++.+++..++..++++|++++++|.
T Consensus         8 lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~   87 (256)
T cd08218           8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLY   87 (256)
T ss_pred             eccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHH
Confidence            68899999999999999998888732          23445666788999999999999999999999999999999999


Q ss_pred             HHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +.+...  ..+++..+..++.|++.++.++|+++++|+|++|+|++++.+..++++|||.+..+..
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          88 KKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            988653  3578999999999999999999999999999999999999999999999999976644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.90  E-value=8.9e-23  Score=142.73  Aligned_cols=132  Identities=17%  Similarity=0.171  Sum_probs=116.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|++|.||.+.... +..+++|.        ...+..+...++.++||||+++++++...+..+++|||+++++|.++
T Consensus        14 ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   92 (261)
T cd05148          14 LGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF   92 (261)
T ss_pred             hccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHH
Confidence            5889999999999988 66676653        34456666778899999999999999999999999999999999999


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          74 LSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        74 l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +.+.  ..++...+..++.|++.++.++|.++++|+|++|+|++++.+..++++|||.+..+.
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          93 LRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            9753  458889999999999999999999999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.90  E-value=1.2e-22  Score=141.43  Aligned_cols=134  Identities=22%  Similarity=0.268  Sum_probs=118.7

Q ss_pred             eeeeeeeEEEEEEEcccC----CeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQG----ETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.+|+|.....+    ..+++|.         ...+..+...++.++||||+++++.+..++..+++||+++++
T Consensus         7 lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~   86 (258)
T smart00219        7 LGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGG   86 (258)
T ss_pred             eccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCC
Confidence            588999999999998866    7777753         335556667778889999999999999999999999999999


Q ss_pred             CHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++.....  +++..+..++.|++.++.++|+.+++|+|++|+|++++....++++|||.+.....
T Consensus        87 ~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       87 DLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             CHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999976444  89999999999999999999999999999999999999999999999999976643

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.90  E-value=6e-23  Score=146.68  Aligned_cols=132  Identities=23%  Similarity=0.348  Sum_probs=117.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.+|++.+..+++.+++|.        ...+.++...++.++|||++++++.+..++..|+++||+++++|..+
T Consensus        29 ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~  108 (297)
T cd06659          29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI  108 (297)
T ss_pred             cCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHH
Confidence            5889999999999998998888864        23345566678889999999999999999999999999999999887


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +.. ..+++..+..++.|++.++.++|+.+++|+|++|+||+++.++.++++|||++..+.
T Consensus       109 ~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~  168 (297)
T cd06659         109 VSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  168 (297)
T ss_pred             Hhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence            654 568899999999999999999999999999999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.90  E-value=1.3e-22  Score=144.29  Aligned_cols=133  Identities=20%  Similarity=0.269  Sum_probs=112.5

Q ss_pred             eeeeeeeEEEEEEEcccC-----CeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQG-----ETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~-----~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      .|.|++|.||++......     ..+++|.         ...+.++...++.+ +||||+++++++..++..+++|||++
T Consensus        20 ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~   99 (293)
T cd05053          20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAA   99 (293)
T ss_pred             ecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCC
Confidence            588999999999876433     5556652         12244555667777 89999999999999999999999999


Q ss_pred             CCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccc
Q psy3273          67 GGDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA  130 (145)
Q Consensus        67 ~~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~  130 (145)
                      +++|..++...                ..+++..+..++.|++.++.|+|..+++|+|++|+||+++.++.++++|||.+
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~  179 (293)
T cd05053         100 HGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA  179 (293)
T ss_pred             CCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccc
Confidence            99999998642                34788889999999999999999999999999999999999999999999999


Q ss_pred             eecC
Q psy3273         131 CDFS  134 (145)
Q Consensus       131 ~~~~  134 (145)
                      +.+.
T Consensus       180 ~~~~  183 (293)
T cd05053         180 RDIH  183 (293)
T ss_pred             cccc
Confidence            7654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.90  E-value=1.3e-22  Score=143.70  Aligned_cols=135  Identities=21%  Similarity=0.336  Sum_probs=119.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.+|+|.+..+++.+++|...          .+.++.+.++.++||||+++.+++..++..+++|||++++.+.
T Consensus         9 i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~   88 (288)
T cd07833           9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE   88 (288)
T ss_pred             ecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHH
Confidence            588999999999999999999998543          3456667788899999999999999999999999999987776


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+......+++..+..++.|++.++.++|..+++|+|++|+||+++..+.++++|||.+..+...
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          89 LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            66666667899999999999999999999999999999999999999999999999998765543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.90  E-value=2.4e-22  Score=141.32  Aligned_cols=133  Identities=21%  Similarity=0.356  Sum_probs=114.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccC-CCCceeEeeEEEEcC------CEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTP------DKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~------~~~~lv~e~~~~   67 (145)
                      +|.|+||.||++....+++.+++|.       ...+..+...++.+ +||||+++.+.+...      ..+|++|||+++
T Consensus        14 lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~   93 (272)
T cd06637          14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGA   93 (272)
T ss_pred             eeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCC
Confidence            6889999999999999999888864       23344555566666 799999999998753      468999999999


Q ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          68 GDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        68 ~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++|.+++...  ..+++..+..++.|++.++.|+|+++++|+|++|+|++++....++++|||++..+.
T Consensus        94 ~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          94 GSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999988753  458899999999999999999999999999999999999999999999999987653

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.90  E-value=1.2e-22  Score=145.79  Aligned_cols=133  Identities=22%  Similarity=0.335  Sum_probs=109.1

Q ss_pred             eeeeeeeEEEEEEEcc--cCCeeeeeHHH------HHHhhhhhcccCCCCceeEeeEEEEc--CCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVK--QGETLALNERI------MLSLVSTGIQMVDCPFIVCMTYAFHT--PDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~--~~~~~~~~~~~------~~~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|+||.||+|....  ++..+++|...      ...++...++.++||||+++++++..  +...++++||+++ ++.
T Consensus         9 lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~   87 (317)
T cd07867           9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLW   87 (317)
T ss_pred             eccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHH
Confidence            6899999999999754  55777776432      34567778899999999999999854  5678999999865 777


Q ss_pred             HHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE----CCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQH---------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~----~~~~~~~l~dfg~~~~~~~  135 (145)
                      +.+...         ..+++..+..++.|++.|+.|+|+.+++|+||+|+||++    +..+.++++|||+++.+..
T Consensus        88 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07867          88 HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             HHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence            766421         247888899999999999999999999999999999999    4456899999999986643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.90  E-value=2e-22  Score=142.31  Aligned_cols=132  Identities=20%  Similarity=0.236  Sum_probs=110.6

Q ss_pred             eeeeeeeEEEEEEEcc-----cCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVK-----QGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|++|.||.+....     ++..+++|..         ..+.++...++.++||||+++++++...+..+++|||+++
T Consensus        14 ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~   93 (277)
T cd05062          14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR   93 (277)
T ss_pred             eccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCC
Confidence            6899999999987642     3455666521         2244556678889999999999999999999999999999


Q ss_pred             CCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          68 GDLHYHLSQHG----------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        68 ~~l~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++|.+++....          .++...+..++.|++.++.|+|+++++|+|++|+|++++.+..++++|||++..+
T Consensus        94 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~  169 (277)
T cd05062          94 GDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI  169 (277)
T ss_pred             CCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCcccc
Confidence            99999886421          2466788889999999999999999999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.90  E-value=1.1e-22  Score=147.36  Aligned_cols=133  Identities=20%  Similarity=0.333  Sum_probs=118.8

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH----------------------HHHhhhhhcccCCCCceeEeeEEEEcCCEE
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI----------------------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKL   58 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~   58 (145)
                      +.|.|++|.||++.+..+++.+++|...                      .+.++...++.++||||+++++++..++..
T Consensus        16 ~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   95 (335)
T PTZ00024         16 HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFI   95 (335)
T ss_pred             cccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcE
Confidence            3688999999999999999999887432                      134566678889999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          59 CFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        59 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +++||++. ++|.+++.....+++.....++.|++.++.++|..+++|+||+|+||+++....++++|||.+....
T Consensus        96 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~  170 (335)
T PTZ00024         96 NLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYG  170 (335)
T ss_pred             EEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecc
Confidence            99999996 5899988877789999999999999999999999999999999999999999999999999987654

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=1.7e-22  Score=160.89  Aligned_cols=133  Identities=21%  Similarity=0.293  Sum_probs=113.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEc--CCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHT--PDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|.+..+++.+++|.          ...+..+...++.++||||++++++|..  ...+|+||||+++++
T Consensus        21 LG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGS  100 (1021)
T PTZ00266         21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGD  100 (1021)
T ss_pred             EecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCc
Confidence            6899999999999999998888863          3345567778899999999999999864  357999999999999


Q ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhC-------CceecCCCCCcEEECCC-----------------CC
Q psy3273          70 LHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRR-------YIVYRDLKPANILLDEH-----------------GH  121 (145)
Q Consensus        70 l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~-------~iih~~l~~~nil~~~~-----------------~~  121 (145)
                      |..++..    ...+++..+..++.|++.++.|+|..       +|+|+||+|+||+++..                 ..
T Consensus       101 L~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~i  180 (1021)
T PTZ00266        101 LSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI  180 (1021)
T ss_pred             HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCc
Confidence            9998864    25699999999999999999999984       49999999999999642                 34


Q ss_pred             EEEeeeccceecC
Q psy3273         122 VRISDLGLACDFS  134 (145)
Q Consensus       122 ~~l~dfg~~~~~~  134 (145)
                      ++|+|||++..+.
T Consensus       181 VKLsDFGlAr~l~  193 (1021)
T PTZ00266        181 AKIGDFGLSKNIG  193 (1021)
T ss_pred             eEEccCCcccccc
Confidence            8999999997654

>KOG0574|consensus

Probab=99.90  E-value=7.1e-25  Score=153.35  Aligned_cols=144  Identities=19%  Similarity=0.324  Sum_probs=126.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS   75 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~   75 (145)
                      +|-|+||.|++|.++.+|+.+|+|++-      -+-++..++++|++|++|++|+.|.....+|+|||||..|+..+.+.
T Consensus        41 LGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R  120 (502)
T KOG0574|consen   41 LGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMR  120 (502)
T ss_pred             hcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHH
Confidence            588999999999999999999997533      23345556789999999999999999999999999999999999887


Q ss_pred             -hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC--CCccccCCC
Q psy3273          76 -QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGKS  145 (145)
Q Consensus        76 -~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~  145 (145)
                       ++.++.+.++..++..-+.+++|+|...=+|||||..||+++.++..|++|||++-.+++.  ..+..+|||
T Consensus       121 ~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTP  193 (502)
T KOG0574|consen  121 ARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTP  193 (502)
T ss_pred             HhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCc
Confidence             4578999999999999999999999988899999999999999999999999999888765  444446764

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.90  E-value=1.4e-22  Score=146.57  Aligned_cols=128  Identities=19%  Similarity=0.153  Sum_probs=112.9

Q ss_pred             eeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           3 FIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         3 g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      |.|++|.||.+.+..+++.+++|.          .+.+.++...++.++||||++++++|..++..++++|++.++++..
T Consensus         9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~   88 (328)
T cd08226           9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANS   88 (328)
T ss_pred             cccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHH
Confidence            345999999999999999999863          2345566666778999999999999999999999999999999999


Q ss_pred             HHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccc
Q psy3273          73 HLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA  130 (145)
Q Consensus        73 ~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~  130 (145)
                      ++...  ..+++..+..++.|++.++.|+|+++++|+|++|+||+++..+.+++.||+.+
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~  148 (328)
T cd08226          89 LLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHL  148 (328)
T ss_pred             HHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHH
Confidence            88753  34889999999999999999999999999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.3e-22  Score=142.12  Aligned_cols=133  Identities=21%  Similarity=0.265  Sum_probs=114.8

Q ss_pred             eeeeeeeEEEEEEEcccCC----eeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE----TLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.+|++....+++    .+++|.         ...+.++...++.++||||+++++++.+ ...+++||+++++
T Consensus        15 ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g   93 (279)
T cd05057          15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLG   93 (279)
T ss_pred             ecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCC
Confidence            6889999999999877665    345531         2345566777889999999999999987 7899999999999


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++... ..+++..+..++.|++.++.|+|+++++|+|++|+|++++....++++|||.++.+..
T Consensus        94 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          94 CLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999998763 4689999999999999999999999999999999999999999999999999976543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.90  E-value=1.7e-22  Score=143.03  Aligned_cols=133  Identities=20%  Similarity=0.253  Sum_probs=113.1

Q ss_pred             eeeeeeeEEEEEEEccc-----CCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQ-----GETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~-----~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||++....+     ++.+++|..         ..+..+...++.++||||+++++.+...+..++++||+++
T Consensus        13 lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~   92 (283)
T cd05091          13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSH   92 (283)
T ss_pred             hCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCC
Confidence            58899999999987543     456777532         3345566677889999999999999999999999999999


Q ss_pred             CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273          68 GDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus        68 ~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      ++|..++...                ..+++..+..++.|++.|+.|+|+++++|+|++|+|++++.+..++++|||+++
T Consensus        93 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~  172 (283)
T cd05091          93 SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR  172 (283)
T ss_pred             CcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEeccccccc
Confidence            9999988532                237778888999999999999999999999999999999999999999999987


Q ss_pred             ecC
Q psy3273         132 DFS  134 (145)
Q Consensus       132 ~~~  134 (145)
                      ...
T Consensus       173 ~~~  175 (283)
T cd05091         173 EVY  175 (283)
T ss_pred             ccc
Confidence            553

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.90  E-value=1.3e-22  Score=144.06  Aligned_cols=134  Identities=38%  Similarity=0.638  Sum_probs=116.4

Q ss_pred             eeeeeeeEEEEEEEc---ccCCeeeeeHH------------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHV---KQGETLALNER------------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~---~~~~~~~~~~~------------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      .|.|++|.+|.+.+.   .+++.+++|..            .....+...++.+ +||||+++++.++.+...|++|||+
T Consensus         8 lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (290)
T cd05613           8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI   87 (290)
T ss_pred             eccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecC
Confidence            588999999999885   46777877632            2233455667777 6899999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++++|.+++.....+++..+..++.|++.++.++|+.+++|+|++|+||+++.++.++++|||++..+..
T Consensus        88 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          88 NGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            9999999998777889999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.90  E-value=1.8e-22  Score=144.40  Aligned_cols=133  Identities=20%  Similarity=0.223  Sum_probs=111.5

Q ss_pred             eeeeeeeEEEEEEEcc-------cCCeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVK-------QGETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      +|.|+||.||.+....       .+..+++|.         ...+.++...++.+ +||||+++++.+..++..|++|||
T Consensus        23 lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  102 (304)
T cd05101          23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY  102 (304)
T ss_pred             eeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEec
Confidence            6899999999997532       234566642         22345566667788 899999999999999999999999


Q ss_pred             cCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          65 MNGGDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        65 ~~~~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                      +++++|.+++...                ..++...+..++.|++.++.|+|+++++|+||+|+||+++..+.++++|||
T Consensus       103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g  182 (304)
T cd05101         103 ASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG  182 (304)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCc
Confidence            9999999998753                236677888999999999999999999999999999999999999999999


Q ss_pred             cceecC
Q psy3273         129 LACDFS  134 (145)
Q Consensus       129 ~~~~~~  134 (145)
                      .+..+.
T Consensus       183 ~~~~~~  188 (304)
T cd05101         183 LARDVN  188 (304)
T ss_pred             cceecc
Confidence            997664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.90  E-value=1.7e-22  Score=143.11  Aligned_cols=134  Identities=23%  Similarity=0.343  Sum_probs=114.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-------HHHhhhhhcccC-CCCceeEeeEEEE-----cCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-------MLSLVSTGIQMV-DCPFIVCMTYAFH-----TPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l-~hp~i~~~~~~~~-----~~~~~~lv~e~~~~~   68 (145)
                      .|.|++|.||++.+..+++.+++|...       .+..+.+.++.+ +||||+++++++.     .++..+++|||++++
T Consensus        26 lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~  105 (286)
T cd06638          26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGG  105 (286)
T ss_pred             eccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCC
Confidence            588999999999999999988887432       234455667777 7999999999874     346799999999999


Q ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++..    ...+++..+..++.|++.++.++|+.+++|+|++|+||+++..+.++++|||++..+..
T Consensus       106 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  176 (286)
T cd06638         106 SVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  176 (286)
T ss_pred             CHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence            99987752    24588889999999999999999999999999999999999999999999999876543

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.90  E-value=2.1e-22  Score=140.92  Aligned_cols=133  Identities=18%  Similarity=0.200  Sum_probs=115.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|++|.||++... .+..+++|.       ...+..+...++.++||||+++++.+..++..+++||++++++|.+++
T Consensus        14 lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   92 (261)
T cd05072          14 LGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL   92 (261)
T ss_pred             cCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHH
Confidence            588999999999865 445566652       334566777888999999999999999999999999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ...  ..++...+..++.|++.++.|+|..+++|+|++|+|++++....++++|||.+.....
T Consensus        93 ~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          93 KSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            653  4578888899999999999999999999999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.90  E-value=1.6e-22  Score=142.19  Aligned_cols=135  Identities=18%  Similarity=0.218  Sum_probs=111.7

Q ss_pred             CeeeeeeeEEEEEEEcccCC--eeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcC------CEEEEEE
Q psy3273           1 MFFIVGTGFLSNCSHVKQGE--TLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTP------DKLCFIL   62 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~--~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~------~~~~lv~   62 (145)
                      ..|.|+||.||++....+++  .+++|.          ...+.++...++.++||||+++++.+...      ...+++|
T Consensus         6 ~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~   85 (272)
T cd05075           6 TLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVIL   85 (272)
T ss_pred             ccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEE
Confidence            36899999999999887775  456542          33445566678899999999999986432      2578999


Q ss_pred             EccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          63 DLMNGGDLHYHLSQ------HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        63 e~~~~~~l~~~l~~------~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ||+++++|..++..      ...+++..+..++.|++.++.|+|.++++|+|++|+|++++....++++|||++..+..
T Consensus        86 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  164 (272)
T cd05075          86 PFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN  164 (272)
T ss_pred             EeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCc
Confidence            99999999988742      23478999999999999999999999999999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.90  E-value=2.3e-22  Score=141.75  Aligned_cols=131  Identities=17%  Similarity=0.170  Sum_probs=114.4

Q ss_pred             eeeeeeeEEEEEEEccc-----CCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQ-----GETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~-----~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|....+     .+.+++|.         ...+..+...++.++||||+++++++...+..+++|||+++
T Consensus        13 lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   92 (275)
T cd05046          13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDL   92 (275)
T ss_pred             ecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCC
Confidence            58899999999997653     34556642         23456677788999999999999999999999999999999


Q ss_pred             CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          68 GDLHYHLSQHG---------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        68 ~~l~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      ++|.+++....         .+++.....++.|++.++.|+|+++++|+|++|+|++++..+.++++|||.+..
T Consensus        93 ~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~  166 (275)
T cd05046          93 GDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKD  166 (275)
T ss_pred             CcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccc
Confidence            99999997654         689999999999999999999999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.90  E-value=1.3e-22  Score=144.82  Aligned_cols=132  Identities=18%  Similarity=0.227  Sum_probs=111.3

Q ss_pred             CeeeeeeeEEEEEEEcccCCe--eeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGET--LALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~--~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +.|.|+||.||++....++..  ++++.         ...+..+...++.+ +||||+++++++...+..|+++||++++
T Consensus         9 ~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   88 (297)
T cd05089           9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYG   88 (297)
T ss_pred             eecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCC
Confidence            368999999999998777643  34432         12344566666777 7999999999999999999999999999


Q ss_pred             CHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          69 DLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        69 ~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      +|.+++...                ..+++..+..++.|++.++.++|+++++|+||+|+|++++.+..++++|||++..
T Consensus        89 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  168 (297)
T cd05089          89 NLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG  168 (297)
T ss_pred             cHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCcc
Confidence            999998643                2477889999999999999999999999999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.90  E-value=1.3e-22  Score=144.58  Aligned_cols=133  Identities=23%  Similarity=0.315  Sum_probs=111.6

Q ss_pred             eeeeeeeEEEEEEEcc----------------cCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCC
Q psy3273           2 FFIVGTGFLSNCSHVK----------------QGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD   56 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~----------------~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~   56 (145)
                      +|.|+||.||.+.+..                +...+++|.         ...+..+.+.++.++||||+++++++..++
T Consensus        13 lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   92 (296)
T cd05095          13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSD   92 (296)
T ss_pred             ccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            5899999999986533                223455532         233556677788999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEe
Q psy3273          57 KLCFILDLMNGGDLHYHLSQHG-----------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS  125 (145)
Q Consensus        57 ~~~lv~e~~~~~~l~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~  125 (145)
                      ..+++|||+++++|..++....           .+++..+..++.|++.++.++|+.+++|+|++|+|++++....++++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~  172 (296)
T cd05095          93 PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIA  172 (296)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEec
Confidence            9999999999999999887532           25667889999999999999999999999999999999999999999


Q ss_pred             eeccceecC
Q psy3273         126 DLGLACDFS  134 (145)
Q Consensus       126 dfg~~~~~~  134 (145)
                      |||++..+.
T Consensus       173 dfg~~~~~~  181 (296)
T cd05095         173 DFGMSRNLY  181 (296)
T ss_pred             cCccccccc
Confidence            999997653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.3e-22  Score=141.72  Aligned_cols=134  Identities=25%  Similarity=0.344  Sum_probs=120.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|++|.+|++.+..+++.+++|..         ..+.++...++.++||||+++.+.+..+...|+++|++++++|.+
T Consensus         9 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   88 (274)
T cd06609           9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD   88 (274)
T ss_pred             hcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHH
Confidence            58899999999999999998888632         234556667888999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++... .+++..+..++.|++.++.++|..+++|+|++|+|++++..+.++++|||++..+...
T Consensus        89 ~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          89 LLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             HHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            88764 7899999999999999999999999999999999999999999999999999876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.90  E-value=4e-22  Score=139.04  Aligned_cols=133  Identities=20%  Similarity=0.329  Sum_probs=115.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEc-CCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHT-PDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.+|.+.+..+++.+++|..          ..+.++.+.++.++|||++++.+.+.. +..+|++||++++++|
T Consensus         8 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l   87 (257)
T cd08223           8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDL   87 (257)
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcH
Confidence            57899999999999999988888642          234556667889999999999998875 4578999999999999


Q ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++..  ...+++.++..++.+++.++.++|+.+++|+|++|+||+++....++++|||++..+.
T Consensus        88 ~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          88 YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            998875  3458999999999999999999999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.90  E-value=1.9e-22  Score=143.30  Aligned_cols=133  Identities=20%  Similarity=0.241  Sum_probs=112.7

Q ss_pred             CeeeeeeeEEEEEEEccc-----CCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQ-----GETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~-----~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      ..|.|+||.||++.....     ...++++.         ...+.++...++.++||||+++++.+..++..++++||+.
T Consensus         7 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   86 (290)
T cd05045           7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAK   86 (290)
T ss_pred             cccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecC
Confidence            368999999999987532     23455542         2345567778889999999999999999999999999999


Q ss_pred             CCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCE
Q psy3273          67 GGDLHYHLSQH------------------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHV  122 (145)
Q Consensus        67 ~~~l~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~  122 (145)
                      +++|.+++...                        ..++...+..++.|++.++.++|..+++|+|++|+||+++.++.+
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~  166 (290)
T cd05045          87 YGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKM  166 (290)
T ss_pred             CCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcE
Confidence            99999987632                        236788889999999999999999999999999999999999999


Q ss_pred             EEeeeccceec
Q psy3273         123 RISDLGLACDF  133 (145)
Q Consensus       123 ~l~dfg~~~~~  133 (145)
                      +++|||+++..
T Consensus       167 kl~dfg~~~~~  177 (290)
T cd05045         167 KISDFGLSRDV  177 (290)
T ss_pred             Eeccccccccc
Confidence            99999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.90  E-value=3.2e-22  Score=142.14  Aligned_cols=132  Identities=20%  Similarity=0.236  Sum_probs=110.3

Q ss_pred             eeeeeeeEEEEEEEcc-----cCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVK-----QGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||++....     .+..+++|..         ..+.++...++.++||||+++++++..++..|++|||+++
T Consensus        14 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   93 (288)
T cd05061          14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH   93 (288)
T ss_pred             ecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCC
Confidence            6899999999987642     2346677531         2234455678889999999999999999999999999999


Q ss_pred             CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          68 GDLHYHLSQH----------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        68 ~~l~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++|.+++...          .......+..++.|++.++.|+|+++++|+|++|+||+++.+..++++|||+++.+
T Consensus        94 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~  169 (288)
T cd05061          94 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI  169 (288)
T ss_pred             CCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccc
Confidence            9999999642          12455678889999999999999999999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.90  E-value=3.6e-23  Score=145.75  Aligned_cols=134  Identities=28%  Similarity=0.450  Sum_probs=120.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|++|.+|++....+++.+++|..           ..+..+.+.++.++ ||||+++++++..++..+++||++++++
T Consensus         9 lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (280)
T cd05581           9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGE   88 (280)
T ss_pred             ecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCc
Confidence            68999999999999999999888632           22345556677888 9999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |.+++...+.+++..+..++.|++.++.++|+.+++|+|++|+|++++.++.++++|||.+.....
T Consensus        89 L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          89 LLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999998888899999999999999999999999999999999999999999999999999886644

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.90  E-value=7.8e-23  Score=145.78  Aligned_cols=132  Identities=21%  Similarity=0.354  Sum_probs=117.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH--------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER--------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|++|.||++.+..++..+++|+.        +.+.++...++.++||||+++++.+..++..|++|||+++++|..+
T Consensus        30 lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~  109 (292)
T cd06658          30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI  109 (292)
T ss_pred             ccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHH
Confidence            57899999999999999998888642        2345566677889999999999999999999999999999999887


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +.. ..+++..+..++.|++.++.|+|+.+++|+||+|+|++++.++.++++|||++..+.
T Consensus       110 ~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (292)
T cd06658         110 VTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence            754 468899999999999999999999999999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4645|consensus

Probab=99.90  E-value=3.1e-24  Score=170.87  Aligned_cols=135  Identities=26%  Similarity=0.349  Sum_probs=123.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH----------HHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM----------LSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|.||.||.|.+..+|+..|+||+..          ..++.+.+..++|||+|+++++=...+..+|.||||++|+|.
T Consensus      1243 Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa 1322 (1509)
T KOG4645|consen 1243 IGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLA 1322 (1509)
T ss_pred             cCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHH
Confidence            4778999999999999999999987654          345666677899999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +.+...+..++.....+..|++.|+.|||..||+|||+||.||+++..+.+|++|||.|..+.++
T Consensus      1323 ~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1323 SLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            99988778888888999999999999999999999999999999999999999999999988665

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3.3e-22  Score=141.03  Aligned_cols=134  Identities=22%  Similarity=0.334  Sum_probs=117.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCC---CCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVD---CPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~---hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|++|.+|+|.+..+++.+++|..         ..+.++.+.++.++   |||++++++++..++..+++|||+++++
T Consensus         9 l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06917           9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGS   88 (277)
T ss_pred             eeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCc
Confidence            68899999999999999999888732         23445555666665   9999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.+++.. ..+++..+..++.|++.++.++|..+++|+|++|+|++++..+.++++|||.+..+..+
T Consensus        89 L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          89 VRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             HHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            9988865 47889999999999999999999999999999999999999999999999998776543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.90  E-value=6e-23  Score=149.22  Aligned_cols=131  Identities=20%  Similarity=0.316  Sum_probs=113.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcC------CEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTP------DKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~------~~~~lv~e~~   65 (145)
                      +|.|+||.||+|.+..+++.+++|..          ..+.++...++.++||||+++++++...      ...|++++++
T Consensus        23 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~  102 (343)
T cd07878          23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM  102 (343)
T ss_pred             cccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC
Confidence            68999999999999999999998743          2234567778899999999999988643      3579999988


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                       +++|..++.. ..+++..+..++.|++.|+.|+|+.+++|+||+|+||+++.++.++++|||++....
T Consensus       103 -~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878         103 -GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             -CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence             6688877653 568999999999999999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.90  E-value=2.7e-22  Score=140.29  Aligned_cols=134  Identities=25%  Similarity=0.387  Sum_probs=120.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.+|++....+++.+++|.          ...+..+...++.++||||+++++.+...+..++++||+++++|.
T Consensus         8 lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (264)
T cd06626           8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLE   87 (264)
T ss_pred             eecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHH
Confidence            5889999999999998888888753          334556667788999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++.....+++.....++.+++.++.++|+.+++|+|++|+||+++..+.++++|||.+.....
T Consensus        88 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          88 ELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             HHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            9998777788999999999999999999999999999999999999999999999999876543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.4e-22  Score=141.19  Aligned_cols=134  Identities=19%  Similarity=0.233  Sum_probs=112.3

Q ss_pred             CeeeeeeeEEEEEEEcccC---CeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCE------EEEE
Q psy3273           1 MFFIVGTGFLSNCSHVKQG---ETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDK------LCFI   61 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~---~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~------~~lv   61 (145)
                      .+|.|+||.||.+....++   ..+++|.          ...+..+...++.++||||+++++.+...+.      .+++
T Consensus         6 ~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v   85 (273)
T cd05035           6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVI   85 (273)
T ss_pred             ccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEE
Confidence            3689999999999876533   6677753          2234556667888999999999998866544      8999


Q ss_pred             EEccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          62 LDLMNGGDLHYHLSQH------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        62 ~e~~~~~~l~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +||+++++|..++...      ..+++..+..++.|++.|+.|+|+++++|+|++|+||+++....++++|||+++.+.
T Consensus        86 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  164 (273)
T cd05035          86 LPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY  164 (273)
T ss_pred             EeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeecc
Confidence            9999999999888532      358889999999999999999999999999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.90  E-value=1.2e-22  Score=143.42  Aligned_cols=132  Identities=24%  Similarity=0.352  Sum_probs=117.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|++|.||++.+..+++.+++|..         ..+..+...++.++||||+++++.+..++..|+||||+++++|.+
T Consensus        12 l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   91 (277)
T cd06642          12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD   91 (277)
T ss_pred             hcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHH
Confidence            57899999999999988888888632         245667777889999999999999999999999999999999988


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++.. ..+++..+..++.|++.++.|+|.++++|+|++|+|++++.++.++++|||++..+.
T Consensus        92 ~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          92 LLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             Hhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEcccccccccc
Confidence            8764 568899999999999999999999999999999999999999999999999987654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.4e-22  Score=147.90  Aligned_cols=124  Identities=19%  Similarity=0.183  Sum_probs=100.7

Q ss_pred             eeeeeeeEEEEEEEcc-cCCeeeeeH-------------HHHHHhhhhhcccCCCCceeE-eeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVK-QGETLALNE-------------RIMLSLVSTGIQMVDCPFIVC-MTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-~~~~~~~~~-------------~~~~~~~~~~~~~l~hp~i~~-~~~~~~~~~~~~lv~e~~~   66 (145)
                      .|.|+||.||+|.+.. +++.+++|.             ...+.++.+.++.++|||++. +++.    +..|++|||++
T Consensus        26 IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~  101 (365)
T PRK09188         26 LKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTE  101 (365)
T ss_pred             EeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccC
Confidence            6999999999999876 667777754             234678888899999999984 5542    46899999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCC-CCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDL-KPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l-~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +++|... .   ...   ...++.+++.++.++|+.|++|+|| ||+||+++.++.++++|||+|+.+...
T Consensus       102 G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~  165 (365)
T PRK09188        102 GVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR  165 (365)
T ss_pred             CCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence            9999632 1   111   1457889999999999999999999 999999998889999999999977543

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.89  E-value=2.9e-22  Score=141.61  Aligned_cols=132  Identities=20%  Similarity=0.221  Sum_probs=113.4

Q ss_pred             eeeeeeeEEEEEEEcc-----cCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVK-----QGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|++|.||++....     ++..+++|..         ..+..+...++.++||||+++++++...+..+++|||+++
T Consensus        14 lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g   93 (277)
T cd05036          14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAG   93 (277)
T ss_pred             CCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCC
Confidence            5889999999999977     6677777532         2345566678899999999999999999999999999999


Q ss_pred             CCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC---CEEEeeeccceec
Q psy3273          68 GDLHYHLSQHG-------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG---HVRISDLGLACDF  133 (145)
Q Consensus        68 ~~l~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~---~~~l~dfg~~~~~  133 (145)
                      ++|.+++....       .+++..+..++.|++.++.|+|+++++|+|++|+||+++..+   .++++|||+++.+
T Consensus        94 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~  169 (277)
T cd05036          94 GDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI  169 (277)
T ss_pred             CCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcccccc
Confidence            99999987543       478889999999999999999999999999999999997543   5899999999765

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.89  E-value=2.8e-22  Score=139.90  Aligned_cols=134  Identities=19%  Similarity=0.228  Sum_probs=115.4

Q ss_pred             CeeeeeeeEEEEEEEcc-cCC--eeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVK-QGE--TLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~-~~~--~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|++|.||++.+.. +++  .+++|.         ...+.++...++.++||||+++++.+.. ...+++||+++++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            46899999999999866 333  456642         2344566677889999999999999988 8999999999999


Q ss_pred             CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+.+....  .+++..+..++.|++.++.++|.++++|+|++|+|++++.+..++++|||++..+..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccc
Confidence            9999987653  688999999999999999999999999999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.89  E-value=1.9e-22  Score=141.64  Aligned_cols=134  Identities=22%  Similarity=0.234  Sum_probs=113.0

Q ss_pred             CeeeeeeeEEEEEEEcccC------CeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEcc
Q psy3273           1 MFFIVGTGFLSNCSHVKQG------ETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~------~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      ..|.|++|.||++......      +.+++|.         ...+.++.+.++.++||||+++++++..++..+++||++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            3689999999999886543      4555542         234456667788999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC-----CEEEeeeccceec
Q psy3273          66 NGGDLHYHLSQH-------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG-----HVRISDLGLACDF  133 (145)
Q Consensus        66 ~~~~l~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~-----~~~l~dfg~~~~~  133 (145)
                      ++++|.+++...       ..+++.++..++.|++.++.|+|+.+++|+|++|+|++++...     .++++|||++..+
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~  161 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI  161 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence            999999998642       2377888999999999999999999999999999999998776     8999999998755


Q ss_pred             C
Q psy3273         134 S  134 (145)
Q Consensus       134 ~  134 (145)
                      .
T Consensus       162 ~  162 (269)
T cd05044         162 Y  162 (269)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.89  E-value=4.4e-22  Score=139.36  Aligned_cols=134  Identities=25%  Similarity=0.374  Sum_probs=119.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|++|.+|++....+++.+++|.         ...+.++.+.++.++|||++++++.+..+...|+++|++++++|.+
T Consensus         9 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~   88 (267)
T cd06610           9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLD   88 (267)
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHH
Confidence            5889999999999988888887763         3445666777888999999999999999999999999999999999


Q ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          73 HLSQH---GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++...   ..+++..+..++.|++.++.++|+.+++|+|++|+|++++....++++|||++..+..
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          89 IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            98753   4589999999999999999999999999999999999999999999999999876554

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=3.2e-22  Score=139.90  Aligned_cols=132  Identities=17%  Similarity=0.159  Sum_probs=115.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|++|.||++... +++.+++|.       ...+..+...++.++||||+++++++..+...+++||++++++|.+++
T Consensus        14 ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i   92 (261)
T cd05034          14 LGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL   92 (261)
T ss_pred             eccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHH
Confidence            688999999999865 446666652       234556667788999999999999999989999999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ...  ..++...+..++.+++.++.++|.++++|+|++|+|++++.+..++++|||.+..+.
T Consensus        93 ~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          93 KSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             hccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence            754  358899999999999999999999999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.89  E-value=2.9e-22  Score=140.72  Aligned_cols=133  Identities=14%  Similarity=0.096  Sum_probs=109.5

Q ss_pred             eeeeeeeEEEEEEEcccC------------CeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQG------------ETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFI   61 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~------------~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   61 (145)
                      .|.|++|.||+++.....            ..+++|.        ...+.++...++.++||||+++++++..+...+++
T Consensus         3 lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv   82 (262)
T cd05077           3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMV   82 (262)
T ss_pred             cccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEE
Confidence            689999999999854322            2344542        22344556677889999999999999999999999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCC-------EEEeeeccceec
Q psy3273          62 LDLMNGGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH-------VRISDLGLACDF  133 (145)
Q Consensus        62 ~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~-------~~l~dfg~~~~~  133 (145)
                      |||+++++|..++.. ...+++.....++.|++.|+.|+|+++++|+|++|+||+++..+.       ++++|||.+..+
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~  162 (262)
T cd05077          83 EEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV  162 (262)
T ss_pred             EecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccc
Confidence            999999999888865 456899999999999999999999999999999999999975543       899999988654


Q ss_pred             C
Q psy3273         134 S  134 (145)
Q Consensus       134 ~  134 (145)
                      .
T Consensus       163 ~  163 (262)
T cd05077         163 L  163 (262)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.89  E-value=2.1e-22  Score=146.56  Aligned_cols=132  Identities=25%  Similarity=0.290  Sum_probs=109.3

Q ss_pred             eeeeeeeEEEEEEE-----cccCCeeeeeHH---------HHHHhhhhhcccC-CCCceeEeeEEEEcC-CEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSH-----VKQGETLALNER---------IMLSLVSTGIQMV-DCPFIVCMTYAFHTP-DKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~-----~~~~~~~~~~~~---------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~-~~~~lv~e~~   65 (145)
                      +|.|+||.||+|.+     ..+++.+++|..         ..+.++...++.+ +||||+++++++... ...+++|||+
T Consensus        15 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~   94 (343)
T cd05103          15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC   94 (343)
T ss_pred             ccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEecc
Confidence            68999999999985     345677888632         2344566667777 689999999988654 5789999999


Q ss_pred             CCCCHHHHHHhc-------------------------------------------------------------------C
Q psy3273          66 NGGDLHYHLSQH-------------------------------------------------------------------G   78 (145)
Q Consensus        66 ~~~~l~~~l~~~-------------------------------------------------------------------~   78 (145)
                      ++|+|.+++...                                                                   .
T Consensus        95 ~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (343)
T cd05103          95 KFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKK  174 (343)
T ss_pred             CCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhc
Confidence            999999988642                                                                   1


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          79 VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        79 ~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      .++......++.|++.++.|+|+++++|+||+|+||+++....++++|||++..+
T Consensus       175 ~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  229 (343)
T cd05103         175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI  229 (343)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence            2566777889999999999999999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.89  E-value=1.9e-22  Score=143.47  Aligned_cols=134  Identities=24%  Similarity=0.384  Sum_probs=116.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~   69 (145)
                      .|.|++|.||+|.+..+++.+++|...          ...++...++.++||||+++++++..+  +..|++|||+++ +
T Consensus        13 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~   91 (293)
T cd07843          13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-D   91 (293)
T ss_pred             hcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-C
Confidence            588999999999999999888886432          223466678889999999999999877  899999999975 8


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.+.+... ..+++.....++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++..+..+
T Consensus        92 L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          92 LKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            88888653 45899999999999999999999999999999999999999999999999998866543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.89  E-value=7.8e-23  Score=143.15  Aligned_cols=133  Identities=12%  Similarity=0.073  Sum_probs=111.0

Q ss_pred             eeeeeeeEEEEEEEcccCCe-------eeeeHH--------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGET-------LALNER--------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~-------~~~~~~--------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      .|.|+||.||++.+...+..       +++|..        +.+..+...++.++|||++++++++..++..++||||++
T Consensus         3 lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (258)
T cd05078           3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVK   82 (258)
T ss_pred             CCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCC
Confidence            68999999999998765433       444322        233455566788999999999999999999999999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCC--------EEEeeeccceecC
Q psy3273          67 GGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH--------VRISDLGLACDFS  134 (145)
Q Consensus        67 ~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~--------~~l~dfg~~~~~~  134 (145)
                      +++|..++... ..+++.....++.|++.++.|+|+.+++|+|++|+|++++.+..        ++++|||.+....
T Consensus        83 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078          83 FGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             CCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence            99999999764 45888999999999999999999999999999999999976543        6999999886543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.89  E-value=4.3e-22  Score=140.84  Aligned_cols=134  Identities=27%  Similarity=0.402  Sum_probs=118.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|++|.+|++.+..+++.+++|..          ..+.++...++.++||||+++++++..+...|+|+|++ +++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~   86 (286)
T cd07832           8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLS   86 (286)
T ss_pred             cccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHH
Confidence            58899999999999999998888632          23456667788899999999999999999999999999 99999


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .++.. ...+++..+..++.|++.++.++|+.+++|+|++|+||+++..+.++++|||.+......
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          87 EVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            98864 456899999999999999999999999999999999999999999999999998766443

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.89  E-value=4.6e-22  Score=140.85  Aligned_cols=132  Identities=23%  Similarity=0.251  Sum_probs=111.7

Q ss_pred             eeeeeeeEEEEEE----EcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCS----HVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~----~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~   66 (145)
                      .|.|+||.||.+.    ...+++.+++|..         ..+.++...++.++||||+++++++...  ...+++|||++
T Consensus        12 lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (283)
T cd05080          12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP   91 (283)
T ss_pred             cccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCC
Confidence            6889999998764    3346667777532         2344566788999999999999988653  46899999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +++|.+++... .+++..+..++.|++.++.++|+++++|+|++|+||+++.+..++++|||++..+.
T Consensus        92 ~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          92 LGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             CCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999988753 58999999999999999999999999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.89  E-value=3.9e-22  Score=143.38  Aligned_cols=133  Identities=20%  Similarity=0.214  Sum_probs=111.0

Q ss_pred             eeeeeeeEEEEEEEcc-------cCCeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVK-------QGETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      .|.|++|.||++.+..       ....+++|.         ...+..+...++.+ +||||+++++++..++..|++|||
T Consensus        20 lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   99 (314)
T cd05099          20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEY   99 (314)
T ss_pred             ecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEec
Confidence            6889999999998643       233455542         22344556667777 699999999999999999999999


Q ss_pred             cCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          65 MNGGDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        65 ~~~~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                      +++++|.+++...                ..++..++..++.|++.++.|+|+++++|+|++|+|++++.++.++++|||
T Consensus       100 ~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg  179 (314)
T cd05099         100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFG  179 (314)
T ss_pred             CCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEcccc
Confidence            9999999998653                237788889999999999999999999999999999999999999999999


Q ss_pred             cceecC
Q psy3273         129 LACDFS  134 (145)
Q Consensus       129 ~~~~~~  134 (145)
                      .++.+.
T Consensus       180 ~~~~~~  185 (314)
T cd05099         180 LARGVH  185 (314)
T ss_pred             cccccc
Confidence            997553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=8.4e-22  Score=136.90  Aligned_cols=135  Identities=24%  Similarity=0.378  Sum_probs=121.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.+|++.+..+++.+++|.          ...+.++.+.++.++|||++++.+++..+...+++||++++++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   87 (254)
T cd06627           8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLR   87 (254)
T ss_pred             EcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHH
Confidence            6889999999999999998888853          234556667788899999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +++.....+++.....++.|++.++.++|+.+++|+|++|+||+++..+.++++|||.+......
T Consensus        88 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          88 QIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             HHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            99987788999999999999999999999999999999999999999999999999999876543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.89  E-value=4.8e-22  Score=138.49  Aligned_cols=135  Identities=20%  Similarity=0.348  Sum_probs=120.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS   75 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~   75 (145)
                      .|.|++|.+|++....+++.+++|.      ...+.++...++.++||||+++++.+..+...|+++|++++++|.+++.
T Consensus        11 i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~   90 (256)
T cd06612          11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK   90 (256)
T ss_pred             hcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHH
Confidence            5789999999999999888888864      3345666677889999999999999999999999999999999999987


Q ss_pred             h-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          76 Q-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        76 ~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      . ...+++..+..++.|++.++.++|..+++|+|++|+|++++..+.++++|||++..+...
T Consensus        91 ~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          91 ITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             hCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            5 456899999999999999999999999999999999999999999999999998866543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.89  E-value=4.7e-22  Score=140.56  Aligned_cols=132  Identities=23%  Similarity=0.429  Sum_probs=112.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|+||.||++.+..+++.+++|..          ..+......++.++||||+++++++..++..|++|||++ ++|.
T Consensus         9 ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~   87 (283)
T cd06617           9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLD   87 (283)
T ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHH
Confidence            58899999999999999999998632          222233334567799999999999999999999999996 5787


Q ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRR-YIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~-~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +++..    ...+++..+..++.|++.++.|+|++ +++|+|++|+||+++..+.++++|||++..+.
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          88 KFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            77653    24589999999999999999999997 99999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.89  E-value=3.9e-22  Score=141.01  Aligned_cols=131  Identities=24%  Similarity=0.407  Sum_probs=115.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|++|.+|++.+..+++.+++|+.         .....+...++.++||||+++++.+..++..+++|||+++ ++..
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~   86 (284)
T cd07836           8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKK   86 (284)
T ss_pred             eccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHH
Confidence            57899999999999999999988742         2344566778899999999999999999999999999975 8888


Q ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          73 HLSQH---GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        73 ~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++...   ..+++..+..++.|++.++.++|+.+++|+|++|+|++++..+.++++|||.+...
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~  150 (284)
T cd07836          87 YMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF  150 (284)
T ss_pred             HHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence            77643   35899999999999999999999999999999999999999999999999988654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.89  E-value=6.1e-22  Score=137.94  Aligned_cols=135  Identities=24%  Similarity=0.426  Sum_probs=118.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.+|+|.+..+++.+++|.          ...+..+...++.++|||++++++.+..++..+++||++++++|.
T Consensus         8 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (256)
T cd08220           8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLA   87 (256)
T ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHH
Confidence            6889999999999999998888863          334556677888999999999999999999999999999999999


Q ss_pred             HHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-CCEEEeeeccceecCCC
Q psy3273          72 YHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~  136 (145)
                      +++...  ..+++..+..++.+++.++.++|+++++|+|++|+||+++.. ..++++|||.+..+..+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          88 EYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999753  358999999999999999999999999999999999999855 45799999999866543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.89  E-value=2.9e-22  Score=139.15  Aligned_cols=134  Identities=39%  Similarity=0.630  Sum_probs=120.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.+|.+.+..+++.+++|.           ......+.+.++.++||||+++++.++.++..+++||++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            4789999999999998888888863           22345566678899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++.....+++..+..++.|++.++.++|.++++|+|++|+|++++....++++|||.+.....
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            99998777899999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.89  E-value=1.6e-22  Score=141.58  Aligned_cols=132  Identities=25%  Similarity=0.438  Sum_probs=118.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|++|.+|++.+..+++.+++|.         ...+.++.+.++.++||||+++++.+..++..++++|++++++|.+
T Consensus         9 ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   88 (265)
T cd06605           9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDK   88 (265)
T ss_pred             hcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHH
Confidence            5789999999999999999888862         2234456667788899999999999999999999999999999999


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          73 HLSQH-GVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        73 ~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++... ..+++..+..++.|++.++.++|+ .+++|+|++|+||+++..+.++++|||.+..+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          89 ILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             HHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            99765 778999999999999999999999 99999999999999999999999999988654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=1e-21  Score=139.53  Aligned_cols=132  Identities=26%  Similarity=0.404  Sum_probs=114.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~l   70 (145)
                      +|.|++|.+|.+.+..+++.+++|.         ...+.++.+.++.++||||++++++|...  +.+|++|||+++++|
T Consensus         9 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L   88 (287)
T cd06621           9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL   88 (287)
T ss_pred             eccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCH
Confidence            5889999999999999999888863         23355667788899999999999998653  479999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          71 HYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      .+++..    ...+++..+..++.|++.++.|+|..+++|+|++|+|++++....++++|||++...
T Consensus        89 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          89 DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            887642    345888999999999999999999999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.89  E-value=3.1e-22  Score=145.50  Aligned_cols=134  Identities=25%  Similarity=0.256  Sum_probs=110.8

Q ss_pred             CeeeeeeeEEEEEEEcc-----cCCeeeeeHH---------HHHHhhhhhcccC-CCCceeEeeEEEEcC-CEEEEEEEc
Q psy3273           1 MFFIVGTGFLSNCSHVK-----QGETLALNER---------IMLSLVSTGIQMV-DCPFIVCMTYAFHTP-DKLCFILDL   64 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~-~~~~lv~e~   64 (145)
                      .+|.|+||.||+|....     +++.+++|..         ..+..+...++.+ +||||+++++++... ..++++|||
T Consensus        14 ~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey   93 (337)
T cd05054          14 PLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEY   93 (337)
T ss_pred             ccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEec
Confidence            36899999999997543     4567888642         2233455666777 899999999988654 678999999


Q ss_pred             cCCCCHHHHHHhc-------------------------------------------------------------CCCCHH
Q psy3273          65 MNGGDLHYHLSQH-------------------------------------------------------------GVFNED   83 (145)
Q Consensus        65 ~~~~~l~~~l~~~-------------------------------------------------------------~~~~~~   83 (145)
                      +++++|.+++...                                                             ..++..
T Consensus        94 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  173 (337)
T cd05054          94 CKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLE  173 (337)
T ss_pred             CCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHH
Confidence            9999999988532                                                             256788


Q ss_pred             HHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          84 EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        84 ~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+..++.|++.++.|+|+++++|+|++|+|++++.+..++++|||++..+.
T Consensus       174 ~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~  224 (337)
T cd05054         174 DLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY  224 (337)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcc
Confidence            899999999999999999999999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.89  E-value=2e-22  Score=142.62  Aligned_cols=132  Identities=23%  Similarity=0.375  Sum_probs=116.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.+|++.+..+++.++++...          .+..+.+.++.++||||+++++++..++..+++|||+. ++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~   86 (284)
T cd07860           8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK   86 (284)
T ss_pred             ecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHH
Confidence            578999999999999999999887432          34567778889999999999999999999999999996 5888


Q ss_pred             HHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .++..  ...+++..+..++.|++.++.|+|..+++|+|++|+||+++.++.++++|||++..+.
T Consensus        87 ~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          87 KFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            88764  3568999999999999999999999999999999999999999999999999887543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.89  E-value=7.6e-22  Score=140.16  Aligned_cols=131  Identities=23%  Similarity=0.374  Sum_probs=116.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH--------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER--------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|++|.+|++.+..+++.+++|..        ..+.++...++.++|||++++++++..++..++++||+++++|.++
T Consensus        27 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~  106 (285)
T cd06648          27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI  106 (285)
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHH
Confidence            58899999999999999988888632        2344556678888999999999999999999999999999999998


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +.. ..++...+..++.|++.++.++|+++++|+||+|+|++++.++.++++|||.+...
T Consensus       107 ~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648         107 VTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             HHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence            876 56889999999999999999999999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.89  E-value=6.9e-22  Score=138.32  Aligned_cols=134  Identities=19%  Similarity=0.198  Sum_probs=110.8

Q ss_pred             CeeeeeeeEEEEEEEccc---CCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEE-cCCEEEEEEEccCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQ---GETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFH-TPDKLCFILDLMNG   67 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~-~~~~~~lv~e~~~~   67 (145)
                      +.|.|+||.||+|.....   ...+++|.         ...+..+...++.++||||+++++++. .++..+++|||+++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            368999999999987543   23556643         234445666788999999999999776 45578999999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          68 GDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        68 ~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++|.+++... ...+......++.|++.++.|+|..+++|+|++|+|++++....++++|||+++.+.
T Consensus        82 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          82 GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999998753 446777788899999999999999999999999999999999999999999987553

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.89  E-value=5.1e-22  Score=142.30  Aligned_cols=133  Identities=20%  Similarity=0.212  Sum_probs=110.7

Q ss_pred             eeeeeeeEEEEEEEccc-------CCeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVKQ-------GETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      .|.|+||.||.+.+...       ...+++|.         ...+..+...++.+ +||||+++++++..++..|++|||
T Consensus        26 lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  105 (307)
T cd05098          26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY  105 (307)
T ss_pred             eccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEec
Confidence            58999999999986432       23455542         12234455566777 799999999999999999999999


Q ss_pred             cCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          65 MNGGDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        65 ~~~~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                      +++++|.+++...                ..++..++..++.|++.++.|+|+++++|+|++|+||+++.++.++++|||
T Consensus       106 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg  185 (307)
T cd05098         106 ASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG  185 (307)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCc
Confidence            9999999999753                237788899999999999999999999999999999999999999999999


Q ss_pred             cceecC
Q psy3273         129 LACDFS  134 (145)
Q Consensus       129 ~~~~~~  134 (145)
                      .+..+.
T Consensus       186 ~a~~~~  191 (307)
T cd05098         186 LARDIH  191 (307)
T ss_pred             cccccc
Confidence            987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.89  E-value=8.3e-22  Score=137.66  Aligned_cols=131  Identities=20%  Similarity=0.216  Sum_probs=110.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCCCceeEeeEEEE-cCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDCPFIVCMTYAFH-TPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~hp~i~~~~~~~~-~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|++|.+|++...  +..+++|.      ...+..+...++.++|||++++++++. .++..+++|||+++++|.+++
T Consensus        14 lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   91 (256)
T cd05082          14 IGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL   91 (256)
T ss_pred             ecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHH
Confidence            688999999998764  55556542      234556677788999999999999764 556799999999999999998


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          75 SQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        75 ~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ....  .+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++....
T Consensus        92 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          92 RSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence            7543  47889999999999999999999999999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.89  E-value=8.3e-22  Score=139.17  Aligned_cols=133  Identities=23%  Similarity=0.305  Sum_probs=115.4

Q ss_pred             eeeeeeeEEEEEEEcc----cCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEc--CCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVK----QGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHT--PDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~   66 (145)
                      .|.|++|.||++....    ++..+++|.         ...+..+.+.++.++||||+++++++..  ....+++|||++
T Consensus        12 ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (284)
T cd05038          12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLP   91 (284)
T ss_pred             eccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCC
Confidence            5889999999998643    467777752         3355666777889999999999999887  557999999999


Q ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          67 GGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        67 ~~~l~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +++|.+++.... .++...+..++.|++.++.++|+++++|+|++|+||+++.+..++++|||.+..+.
T Consensus        92 ~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          92 SGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             CCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            999999997643 58999999999999999999999999999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.89  E-value=6.6e-22  Score=140.58  Aligned_cols=133  Identities=24%  Similarity=0.363  Sum_probs=113.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccC-CCCceeEeeEEEEcC-----CEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMV-DCPFIVCMTYAFHTP-----DKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~   68 (145)
                      .|.|++|.+|++....+++.+++|..       ..+..+...++.+ +|||++++++++...     +..|++|||++++
T Consensus        30 l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~  109 (291)
T cd06639          30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGG  109 (291)
T ss_pred             eecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCC
Confidence            57899999999999999998888643       2334455566666 899999999998754     3689999999999


Q ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          69 DLHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        69 ~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +|.+++..    ...+++..+..++.|++.++.++|.++++|+|++|+|++++.++.++++|||++..+.
T Consensus       110 sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         110 SVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             cHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            99988752    3568999999999999999999999999999999999999999999999999887543

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.89  E-value=5e-22  Score=141.69  Aligned_cols=133  Identities=23%  Similarity=0.362  Sum_probs=117.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH--------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER--------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|++|.+|++....+++.+++|+.        ..+.++...++.++||||+++++.+..++..+++|||+++++|..+
T Consensus        28 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  107 (292)
T cd06657          28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI  107 (292)
T ss_pred             cCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHH
Confidence            58899999999999999999988742        2344555677889999999999999999999999999999999887


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +. ...+++..+..++.|++.++.++|+.+++|+|++|+|++++.++.++++|||++..+..
T Consensus       108 ~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657         108 VT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            64 34688999999999999999999999999999999999999999999999998876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.89  E-value=5.4e-22  Score=140.81  Aligned_cols=133  Identities=22%  Similarity=0.234  Sum_probs=113.8

Q ss_pred             eeeeeeeEEEEEEEcc-----cCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVK-----QGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-----~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||++.+..     ++..+++|.         ...+.++...++.++||||+++++++..++..+++|||+++
T Consensus        13 lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   92 (288)
T cd05050          13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAY   92 (288)
T ss_pred             ccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCC
Confidence            5889999999998743     456666653         23355667778899999999999999999999999999999


Q ss_pred             CCHHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEe
Q psy3273          68 GDLHYHLSQH----------------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS  125 (145)
Q Consensus        68 ~~l~~~l~~~----------------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~  125 (145)
                      ++|.+++...                      ..+++..+..++.|++.++.++|.++++|+|++|+|++++.+..++++
T Consensus        93 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~  172 (288)
T cd05050          93 GDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA  172 (288)
T ss_pred             CCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEEC
Confidence            9999998642                      136778889999999999999999999999999999999999999999


Q ss_pred             eeccceecC
Q psy3273         126 DLGLACDFS  134 (145)
Q Consensus       126 dfg~~~~~~  134 (145)
                      |||.+..+.
T Consensus       173 dfg~~~~~~  181 (288)
T cd05050         173 DFGLSRNIY  181 (288)
T ss_pred             ccccceecc
Confidence            999987653

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.89  E-value=1e-21  Score=140.80  Aligned_cols=132  Identities=20%  Similarity=0.227  Sum_probs=114.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.+|++....+++.+++|+.           ..+.++...++.++||||+++.+++..++..|+|+||+.+ ++
T Consensus        23 lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l  101 (307)
T cd06607          23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SA  101 (307)
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CH
Confidence            68899999999999999998888632           2344566678889999999999999999999999999975 77


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+.+.. ...+++..+..++.|++.++.|+|+.+++|+|++|+||+++.++.++++|||++....
T Consensus       102 ~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607         102 SDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            666653 4568999999999999999999999999999999999999999999999999886543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.89  E-value=9.7e-22  Score=137.26  Aligned_cols=135  Identities=24%  Similarity=0.337  Sum_probs=117.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEc--CCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHT--PDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~   69 (145)
                      .|.|++|.+|++.+..+++.++++.          ...+..+...++.++||||+++++.+..  +...+++|||+++++
T Consensus         8 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~   87 (265)
T cd08217           8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGD   87 (265)
T ss_pred             eccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCC
Confidence            5889999999999999999888863          2234456677889999999999998864  457899999999999


Q ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHh-----hCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMH-----RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh-----~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.+++..    ...+++..+..++.|++.++.++|     +.+++|+|++|+||+++..+.++++|||++..+...
T Consensus        88 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~  163 (265)
T cd08217          88 LAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD  163 (265)
T ss_pred             HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence            9998864    356899999999999999999999     889999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.89  E-value=6.3e-22  Score=141.67  Aligned_cols=133  Identities=23%  Similarity=0.306  Sum_probs=112.6

Q ss_pred             eeeeeeeEEEEEEEcccCCe----eeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGET----LALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~----~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|++|.||++.+..+++.    +++|.         ...+.++...++.++||||+++++.+..+ ..++++|++++|
T Consensus        15 lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g   93 (303)
T cd05110          15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHG   93 (303)
T ss_pred             cccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCC
Confidence            68999999999999887764    35541         11344566678889999999999998754 467899999999


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++... ..+++..+..++.|++.++.|+|.++++|+||+|+|++++....++++|||+++.+..
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          94 CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999998764 3588999999999999999999999999999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG4717|consensus

Probab=99.89  E-value=9.7e-23  Score=150.96  Aligned_cols=141  Identities=28%  Similarity=0.395  Sum_probs=122.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH----------HHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM----------LSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|-|.+|-.|++.-+|+.||+|.++.          +-++..-++-++|||||++|++..++..+|+|+|+=.+|+|+
T Consensus        26 lG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~  105 (864)
T KOG4717|consen   26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLF  105 (864)
T ss_pred             hcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHH
Confidence            5889999999999999999999974332          223333456679999999999999999999999999999999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE-CCCCCEEEeeeccceecCCCCCcccc
Q psy3273          72 YHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL-DEHGHVRISDLGLACDFSKKKPHASV  142 (145)
Q Consensus        72 ~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~-~~~~~~~l~dfg~~~~~~~~~~~~~~  142 (145)
                      +++-.+ ..+.+.....++.||+.++.|+|..-++|||+||+|+.+ ..-+.+|++|||++..+.++....+-
T Consensus       106 DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~Ts  178 (864)
T KOG4717|consen  106 DYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTS  178 (864)
T ss_pred             HHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcc
Confidence            998654 569999999999999999999999999999999999976 56689999999999999888766553

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=3e-22  Score=152.33  Aligned_cols=134  Identities=18%  Similarity=0.212  Sum_probs=106.2

Q ss_pred             eeeeeeeEEEEEEEcccCCee-------------------eee-------HHHHHHhhhhhcccCCCCceeEeeEEEEcC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETL-------------------ALN-------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTP   55 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~-------------------~~~-------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~   55 (145)
                      .|.|+||.||.|.........                   +.+       ....+.++...++.++||||+++++++...
T Consensus       156 LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  235 (501)
T PHA03210        156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSE  235 (501)
T ss_pred             ecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEEEEC
Confidence            689999999998764322111                   011       123355677788999999999999999999


Q ss_pred             CEEEEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccc
Q psy3273          56 DKLCFILDLMNGGDLHYHLSQH-----GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA  130 (145)
Q Consensus        56 ~~~~lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~  130 (145)
                      +..|++++++.+ ++..++...     .......+..++.|++.|+.|+|+++++|+||||+||+++..+.++|+|||++
T Consensus       236 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla  314 (501)
T PHA03210        236 ANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA  314 (501)
T ss_pred             CeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCc
Confidence            999999999854 777766432     12335667789999999999999999999999999999999999999999999


Q ss_pred             eecCCC
Q psy3273         131 CDFSKK  136 (145)
Q Consensus       131 ~~~~~~  136 (145)
                      ..+...
T Consensus       315 ~~~~~~  320 (501)
T PHA03210        315 MPFEKE  320 (501)
T ss_pred             eecCcc
Confidence            876543

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.89  E-value=1.5e-21  Score=136.22  Aligned_cols=133  Identities=17%  Similarity=0.240  Sum_probs=115.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|++|.+|++.... ++.+++|.       ...+..+.+.++.++|||++++++++...+..+++|||+++++|.+++
T Consensus        12 ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~   90 (256)
T cd05112          12 IGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL   90 (256)
T ss_pred             ecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHH
Confidence            5889999999998754 55666653       234556677888999999999999999999999999999999999988


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ... ..+++..+..++.|++.++.++|+++++|+|++|+|++++....++++|||.+.....
T Consensus        91 ~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          91 RAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             HhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            753 5688999999999999999999999999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.89  E-value=7.8e-22  Score=140.65  Aligned_cols=133  Identities=21%  Similarity=0.369  Sum_probs=116.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH--------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER--------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.+|++.+..+++.+++|..        ..+..+...++.++|||++++++.+..++..|+|+||+++++|.++
T Consensus        27 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  106 (293)
T cd06647          27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV  106 (293)
T ss_pred             ecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHH
Confidence            58899999999999888888887642        2334555667889999999999999999999999999999999998


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +.. ..++...+..++.|++.++.++|+++++|+|++|+|++++..+.++++|||++..+..
T Consensus       107 ~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647         107 VTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             Hhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            865 3578888899999999999999999999999999999999999999999998875543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.89  E-value=7.6e-22  Score=143.04  Aligned_cols=133  Identities=20%  Similarity=0.213  Sum_probs=111.2

Q ss_pred             eeeeeeeEEEEEEEcccC-------CeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVKQG-------ETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      .|.|+||.||.|.+...+       ..+++|.         ...+.++.+.++++ +||||+++++.+..++..++++||
T Consensus        20 ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   99 (334)
T cd05100          20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEY   99 (334)
T ss_pred             eccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEec
Confidence            689999999999864322       2455542         23445566677788 899999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          65 MNGGDLHYHLSQHG----------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        65 ~~~~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                      +++++|.+++....                .++..+...++.|++.++.|+|.++++|+||+|+||+++.+..++++|||
T Consensus       100 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg  179 (334)
T cd05100         100 ASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG  179 (334)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcc
Confidence            99999999986432                36677888899999999999999999999999999999999999999999


Q ss_pred             cceecC
Q psy3273         129 LACDFS  134 (145)
Q Consensus       129 ~~~~~~  134 (145)
                      +++.+.
T Consensus       180 ~~~~~~  185 (334)
T cd05100         180 LARDVH  185 (334)
T ss_pred             cceecc
Confidence            987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.89  E-value=1.1e-21  Score=141.32  Aligned_cols=132  Identities=20%  Similarity=0.244  Sum_probs=114.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|++|.+|++.+..+++.+++|...           .+..+...++.++|||++++++++..++..+++|||+++ ++
T Consensus        33 lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l  111 (317)
T cd06635          33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SA  111 (317)
T ss_pred             eccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CH
Confidence            688999999999999999988886432           344556677889999999999999999999999999975 77


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+.+.. ...+++..+..++.+++.++.++|.++++|+|++|+||+++.++.++++|||++....
T Consensus       112 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         112 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            776653 4568999999999999999999999999999999999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.89  E-value=6.6e-22  Score=138.79  Aligned_cols=132  Identities=18%  Similarity=0.173  Sum_probs=111.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|++|.||++.+..+.+ +++|..       ..+..+...++.++||||+++++.+. ++..+++|||+++++|.+++
T Consensus        14 lg~g~~~~v~~~~~~~~~~-valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~   91 (262)
T cd05071          14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFL   91 (262)
T ss_pred             cCCCCCCcEEEEEecCCce-EEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHH
Confidence            5789999999998866544 666532       23456677788899999999999875 45689999999999999999


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ...  ..+++..+..++.|++.++.++|+.+++|+|++|+|++++.+..++++|||.+..+..
T Consensus        92 ~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          92 KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             hhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            753  3478889999999999999999999999999999999999999999999999976543

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.5e-22  Score=135.26  Aligned_cols=130  Identities=13%  Similarity=0.135  Sum_probs=101.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------------H-----------------HHhhhhhcccCCCCceeE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------------M-----------------LSLVSTGIQMVDCPFIVC   47 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------------~-----------------~~~~~~~~~~l~hp~i~~   47 (145)
                      .|.|++|.||+|.+. +|+.+++|...                 .                 ...+...++.+.++++..
T Consensus         5 ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~   83 (190)
T cd05147           5 ISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPC   83 (190)
T ss_pred             cccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
Confidence            689999999999997 89999886321                 1                 112555677777777654


Q ss_pred             eeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCceecCCCCCcEEECCCCCEEEee
Q psy3273          48 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM-HRRYIVYRDLKPANILLDEHGHVRISD  126 (145)
Q Consensus        48 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~iih~~l~~~nil~~~~~~~~l~d  126 (145)
                      ........  .++||||++++++.........++...+..++.|++.++.++ |+.+++|+|++|+||+++ ++.++++|
T Consensus        84 p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiD  160 (190)
T cd05147          84 PEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIID  160 (190)
T ss_pred             CcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEE
Confidence            44333222  389999999877765544456789999999999999999999 799999999999999998 47899999


Q ss_pred             eccceecCC
Q psy3273         127 LGLACDFSK  135 (145)
Q Consensus       127 fg~~~~~~~  135 (145)
                      ||+|.....
T Consensus       161 FG~a~~~~~  169 (190)
T cd05147         161 VSQSVEHDH  169 (190)
T ss_pred             ccccccCCC
Confidence            999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.88  E-value=2.2e-21  Score=134.77  Aligned_cols=136  Identities=26%  Similarity=0.335  Sum_probs=122.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~   69 (145)
                      .|.|++|.+|++.+..+++.++++.          ...+.++...++.++||||+++++.+..+  ...++++|++++++
T Consensus         8 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~   87 (260)
T cd06606           8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGS   87 (260)
T ss_pred             eeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCc
Confidence            5889999999999999998888852          34556677778899999999999999988  89999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      |.+++.....+++.....++.|++.++.++|+.+++|+|++|+||+++..+.++++|||.+.......
T Consensus        88 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          88 LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            99999877789999999999999999999999999999999999999999999999999998765543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.88  E-value=1.5e-21  Score=136.67  Aligned_cols=131  Identities=20%  Similarity=0.211  Sum_probs=112.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|+||.||+|... +++.+++|.       ...+.++...++.++||||+++++.+. ++..+++||++++++|.+++
T Consensus        14 ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~   91 (260)
T cd05067          14 LGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFL   91 (260)
T ss_pred             eccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHH
Confidence            689999999999854 456677752       234556777888999999999999874 56789999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ...  ..++...+..++.|++.++.++|+.+++|+|++|+|++++.+..++++|||++....
T Consensus        92 ~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          92 KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            653  358888999999999999999999999999999999999999999999999997665

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=1.3e-21  Score=137.33  Aligned_cols=133  Identities=21%  Similarity=0.336  Sum_probs=115.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccC-CCCceeEeeEEEEcCC------EEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPD------KLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~------~~~lv~e~~~~   67 (145)
                      +|.|++|.+|.+.+..+++.++++.       ...+.++...++.+ +||||+++++++....      .+|++|||+++
T Consensus        14 l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~   93 (275)
T cd06608          14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGG   93 (275)
T ss_pred             ecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCC
Confidence            5789999999999998888888863       23455666667777 7999999999997644      58999999999


Q ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          68 GDLHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        68 ~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++|.+++..    ...+++..+..++.|++.++.|+|+.+++|+|++|+|++++.++.++++|||.+....
T Consensus        94 ~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~  164 (275)
T cd06608          94 GSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD  164 (275)
T ss_pred             CcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence            999988764    3568999999999999999999999999999999999999999999999999887543

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.88  E-value=9.4e-22  Score=143.55  Aligned_cols=131  Identities=20%  Similarity=0.369  Sum_probs=113.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcC------CEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTP------DKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~------~~~~lv~e~~   65 (145)
                      +|.|++|.||.|.+..+++.+++|...          .+.++...++.++||||++++++|..+      ...|+||||+
T Consensus        24 lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~  103 (353)
T cd07850          24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM  103 (353)
T ss_pred             eccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEecc
Confidence            688999999999999999999987532          233566778899999999999998754      3579999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+ ++...+...  ++...+..++.|++.++.++|+++++|+||+|+||+++..+.++++|||++.....
T Consensus       104 ~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850         104 DA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             CC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            65 787777643  88899999999999999999999999999999999999999999999999986644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.88  E-value=2.3e-21  Score=137.94  Aligned_cols=131  Identities=22%  Similarity=0.339  Sum_probs=112.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.+|++.+..+++.+++|...          .+.++.+.++.++||||+++++++..+...|+||||+++ ++.
T Consensus        10 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~   88 (294)
T PLN00009         10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLK   88 (294)
T ss_pred             ecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHH
Confidence            578999999999999999999997542          244566778899999999999999999999999999964 787


Q ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-CCCEEEeeeccceec
Q psy3273          72 YHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-HGHVRISDLGLACDF  133 (145)
Q Consensus        72 ~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-~~~~~l~dfg~~~~~  133 (145)
                      ..+....  ..++..+..++.|++.|+.++|+++++|++++|+|++++. ...++++|||++...
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         89 KHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             HHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            7776433  2578888899999999999999999999999999999985 457899999998754

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.88  E-value=1.8e-21  Score=136.34  Aligned_cols=132  Identities=17%  Similarity=0.171  Sum_probs=111.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|++|.||++....+. .+++|..       ..+.++...++.++|||++++++++. ++..+++|||+++++|.+++
T Consensus        14 ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~   91 (260)
T cd05069          14 LGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFL   91 (260)
T ss_pred             ecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHH
Confidence            588999999999876554 4566531       23455667788999999999998875 45688999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ...  ..+++..+..++.|++.++.|+|+.+++|+|++|+|++++....++++|||.+..+..
T Consensus        92 ~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          92 KEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             hhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            753  3478889999999999999999999999999999999999999999999999976543

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0666|consensus

Probab=99.88  E-value=4.1e-23  Score=144.75  Aligned_cols=134  Identities=22%  Similarity=0.307  Sum_probs=112.5

Q ss_pred             eeeeeeeEEEEEEEcccCC----eeeeeHHHHH----------HhhhhhcccCCCCceeEeeEEEEc-CCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE----TLALNERIML----------SLVSTGIQMVDCPFIVCMTYAFHT-PDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~----~~~~~~~~~~----------~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~   66 (145)
                      .|.|.||-||+|...+++.    .+|+|..+.-          -++....++++|||++++..+|.+ +..+++++||.+
T Consensus        32 Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE  111 (438)
T KOG0666|consen   32 IGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE  111 (438)
T ss_pred             ecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh
Confidence            4788999999997777654    4566543322          355566788899999999999987 789999999997


Q ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC----CCEEEeeeccceecCCC
Q psy3273          67 GGDLHYHLSQH-----GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH----GHVRISDLGLACDFSKK  136 (145)
Q Consensus        67 ~~~l~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~----~~~~l~dfg~~~~~~~~  136 (145)
                      . +|.+.+..+     ..++...+..+++|++.|+.|+|++=++|||+||.||++..+    +++|++|||+++.+.++
T Consensus       112 h-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~p  189 (438)
T KOG0666|consen  112 H-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNP  189 (438)
T ss_pred             h-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcc
Confidence            6 999988643     348999999999999999999999999999999999999765    89999999999988665

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.88  E-value=1.2e-21  Score=136.66  Aligned_cols=129  Identities=22%  Similarity=0.281  Sum_probs=110.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS   75 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~   75 (145)
                      .|.|+||.||++..  +++.+++|.      ...+..+...++.++|||++++++++..+ ..+++|||+++++|.+++.
T Consensus        14 lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~   90 (254)
T cd05083          14 IGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLR   90 (254)
T ss_pred             eccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHH
Confidence            68899999998863  566677753      33455667778899999999999998755 4799999999999999987


Q ss_pred             hcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          76 QHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        76 ~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ...  .+++.....++.|++.++.++|.++++|+|++|+|++++.++.++++|||++...
T Consensus        91 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~  150 (254)
T cd05083          91 TRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG  150 (254)
T ss_pred             hcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence            543  4788899999999999999999999999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.88  E-value=1.4e-21  Score=138.94  Aligned_cols=133  Identities=24%  Similarity=0.407  Sum_probs=112.8

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccC-CCCceeEeeEEEEcCCE-----EEEEEEc
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMV-DCPFIVCMTYAFHTPDK-----LCFILDL   64 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~-----~~lv~e~   64 (145)
                      ++|.|++|.||++.+..+++.+++|...          .+.++...++.+ +||||+++++++...+.     .|++|||
T Consensus         8 ~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~   87 (295)
T cd07837           8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEY   87 (295)
T ss_pred             EecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeec
Confidence            3688999999999999999999997533          233455667777 46999999999987665     8999999


Q ss_pred             cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-CCCEEEeeeccceecC
Q psy3273          65 MNGGDLHYHLSQH-----GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-HGHVRISDLGLACDFS  134 (145)
Q Consensus        65 ~~~~~l~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-~~~~~l~dfg~~~~~~  134 (145)
                      +++ ++..++...     ..+++..+..++.|++.++.|+|+.+++|+|++|+||+++. .+.++++|||++..+.
T Consensus        88 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~  162 (295)
T cd07837          88 LDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS  162 (295)
T ss_pred             cCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecC
Confidence            986 788877542     34799999999999999999999999999999999999998 7899999999987653

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.88  E-value=7.8e-22  Score=141.41  Aligned_cols=132  Identities=22%  Similarity=0.293  Sum_probs=113.4

Q ss_pred             eeeeeeeEEEEEEEcc--cCCeeeeeHHH-----------HHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVK--QGETLALNERI-----------MLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~--~~~~~~~~~~~-----------~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~   66 (145)
                      .|.|++|.+|++.+..  +++.+++|...           ...++...++.++||||+++++++...  +.+++|||+++
T Consensus         8 ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   87 (316)
T cd07842           8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE   87 (316)
T ss_pred             eccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC
Confidence            5889999999999988  88889887433           234566678899999999999999988  88999999997


Q ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC----CCCEEEeeeccceecC
Q psy3273          67 GGDLHYHLSQH-----GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE----HGHVRISDLGLACDFS  134 (145)
Q Consensus        67 ~~~l~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~----~~~~~l~dfg~~~~~~  134 (145)
                      + ++.+.+...     ..+++..+..++.|++.++.|+|+.+++|+||+|+|++++.    .+.++++|||++..+.
T Consensus        88 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~  163 (316)
T cd07842          88 H-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN  163 (316)
T ss_pred             c-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccC
Confidence            5 676666422     25889999999999999999999999999999999999998    8899999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.88  E-value=2e-21  Score=135.03  Aligned_cols=135  Identities=24%  Similarity=0.388  Sum_probs=119.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|++|.+|++.+..+++.+++|..          ..+..+...++.++|||++++.+.+..++..++++|++++++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (258)
T cd08215           8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLS   87 (258)
T ss_pred             eccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHH
Confidence            68899999999999998988888642          23445566778899999999999999999999999999999999


Q ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQH----GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +.+...    ..+++..+..++.+++.++.++|+.+++|+|++|+|++++....++++|||.+......
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          88 QKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             HHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            988753    66899999999999999999999999999999999999999999999999998765443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=8.2e-22  Score=132.80  Aligned_cols=131  Identities=13%  Similarity=0.085  Sum_probs=103.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------------------------------HHHhhhhhcccCCCCceeE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------------------------------MLSLVSTGIQMVDCPFIVC   47 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~l~hp~i~~   47 (145)
                      +|.|++|.||+|.+. +|+.+++|...                                  ..+.+...++.+.|+++..
T Consensus         5 ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (190)
T cd05145           5 ISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPV   83 (190)
T ss_pred             eecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            689999999999987 89999886311                                  1233445567788888855


Q ss_pred             eeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEee
Q psy3273          48 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISD  126 (145)
Q Consensus        48 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~d  126 (145)
                      ...+....  .|+||||++++++.........++......++.|++.++.++|. .|++|+|++|+||+++ ++.++++|
T Consensus        84 p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liD  160 (190)
T cd05145          84 PEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIID  160 (190)
T ss_pred             ceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEE
Confidence            54444333  48999999887554433334567888899999999999999999 9999999999999998 78999999


Q ss_pred             eccceecCCC
Q psy3273         127 LGLACDFSKK  136 (145)
Q Consensus       127 fg~~~~~~~~  136 (145)
                      ||++..+.++
T Consensus       161 FG~a~~~~~~  170 (190)
T cd05145         161 VSQAVELDHP  170 (190)
T ss_pred             cccceecCCC
Confidence            9999877654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.88  E-value=1.8e-21  Score=137.75  Aligned_cols=132  Identities=23%  Similarity=0.369  Sum_probs=112.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccC-CCCceeEeeEEEEc------CCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMV-DCPFIVCMTYAFHT------PDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~------~~~~~lv~e~~~~   67 (145)
                      +|.|+||.+|++.+..+++.+++|.       ...+..+...++.+ +||||+++++++..      .+..|++|||+++
T Consensus        24 lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~  103 (282)
T cd06636          24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGA  103 (282)
T ss_pred             eccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCC
Confidence            6889999999999999999888863       22334445555665 79999999999853      4679999999999


Q ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          68 GDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        68 ~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++|..++...  ..+++..+..++.|++.++.|+|+++++|+|++|+|++++..+.++++|||++...
T Consensus       104 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636         104 GSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             CcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            9999988753  45788888999999999999999999999999999999999999999999998654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.88  E-value=1.5e-21  Score=138.01  Aligned_cols=135  Identities=18%  Similarity=0.220  Sum_probs=114.1

Q ss_pred             CeeeeeeeEEEEEEEccc----CCeeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEc-CCEEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQ----GETLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHT-PDKLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~   66 (145)
                      ++|.|+||.||++.+..+    +..+++|         +...+.++...++.++||||+++++++.. +...++++|+++
T Consensus        13 ~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~   92 (280)
T cd05043          13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMN   92 (280)
T ss_pred             eecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCC
Confidence            368899999999998762    4555554         23345566777889999999999998765 468899999999


Q ss_pred             CCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          67 GGDLHYHLSQH--------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        67 ~~~l~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++|..++...        ..+++.++..++.|++.|+.|+|+++++|+|++|+|++++....++++|||+++.+.+
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~  169 (280)
T cd05043          93 WGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP  169 (280)
T ss_pred             CCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccC
Confidence            99999988643        3488999999999999999999999999999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.88  E-value=1.3e-21  Score=140.42  Aligned_cols=131  Identities=20%  Similarity=0.252  Sum_probs=115.0

Q ss_pred             eeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           4 IVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         4 ~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|++|.++.++...+++.+++|..          ..+.++...++.++||||++++++|..++..+++|||++++++.++
T Consensus        10 ~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~   89 (314)
T cd08216          10 FEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL   89 (314)
T ss_pred             hcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence            456778888888889999998642          3456667778899999999999999999999999999999999999


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          74 LSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        74 l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +...  ..+++..+..++.|++.|+.|+|+++++|+|++|+||+++.++.++++||+.+..+.
T Consensus        90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeec
Confidence            8753  458899999999999999999999999999999999999999999999999886553

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.88  E-value=1.2e-21  Score=136.36  Aligned_cols=134  Identities=28%  Similarity=0.372  Sum_probs=117.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|++|.+|++.+..+++.+++|.          ...+..+...++.++||||+++.+++..++..|+++|++++++|.
T Consensus         8 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   87 (256)
T cd08530           8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLS   87 (256)
T ss_pred             ecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHH
Confidence            5788999999999999998888753          222344556778999999999999999999999999999999999


Q ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .++..    ...+++..+..++.|++.++.++|+.+++|+|++|+|++++....++++|||++.....
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          88 KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            98865    35688899999999999999999999999999999999999999999999998876544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.88  E-value=2.4e-21  Score=135.66  Aligned_cols=132  Identities=18%  Similarity=0.208  Sum_probs=112.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|++|.||.+.... +..+++|.       ...+.++...++.++||||+++.+.+.. ...+++|||+++++|.+++
T Consensus        14 lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~   91 (260)
T cd05073          14 LGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL   91 (260)
T ss_pred             ecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHH
Confidence            6889999999998554 34455642       3345667778899999999999999887 7789999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ...  ...+...+..++.|++.++.++|.++++|+||+|+|++++....++++|||.+..+..
T Consensus        92 ~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          92 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             HhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            753  3477888899999999999999999999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.88  E-value=7.9e-22  Score=139.48  Aligned_cols=132  Identities=23%  Similarity=0.371  Sum_probs=117.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|++|.+|++.+..++..+++|..          ..+..+.+.++.++|||++++++++.+++..|++|||++ ++|.
T Consensus         7 l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~   85 (283)
T cd07835           7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLK   85 (283)
T ss_pred             ecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHH
Confidence            68899999999999999999998743          234456677889999999999999999999999999995 5898


Q ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +++....  .+++..+..++.|++.++.++|+.+++|+|++|+|++++..+.++++|||.+..+.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          86 KYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            8887654  68999999999999999999999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.88  E-value=6.5e-22  Score=141.09  Aligned_cols=133  Identities=22%  Similarity=0.326  Sum_probs=114.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCC----------EEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPD----------KLCFI   61 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~----------~~~lv   61 (145)
                      +|.|++|.||++.+..+++.+++|...          .+..+...++.++|||++++++++.+..          .++++
T Consensus        15 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv   94 (302)
T cd07864          15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLV   94 (302)
T ss_pred             ecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEE
Confidence            588999999999999999988886432          2344566778899999999999987654          79999


Q ss_pred             EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          62 LDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        62 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +||+++ ++...+... ..+++..+..++.|++.++.|+|..+++|+|++|+||+++..+.++++|||.+..+..
T Consensus        95 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  168 (302)
T cd07864          95 FEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS  168 (302)
T ss_pred             EcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccC
Confidence            999976 676766643 4689999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.88  E-value=1.8e-21  Score=136.88  Aligned_cols=132  Identities=17%  Similarity=0.213  Sum_probs=111.4

Q ss_pred             eeeeeeeEEEEEEEccc---CCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQ---GETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|++|.||++.....   ...+++|.         .+.+..+...++.++||||+++++++.. +..|++||++++++
T Consensus        14 lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~   92 (270)
T cd05056          14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGE   92 (270)
T ss_pred             eCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCc
Confidence            58899999999987654   23455542         2345566677889999999999999875 45789999999999


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          70 LHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        70 l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |.+++... ..+++..+..++.+++.++.++|+++++|+|++|+|++++....++++|||++....
T Consensus        93 L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          93 LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            99999764 458999999999999999999999999999999999999999999999999987553

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.88  E-value=1.1e-21  Score=140.63  Aligned_cols=133  Identities=24%  Similarity=0.359  Sum_probs=115.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~   69 (145)
                      .|.|++|.||++.+..+++.+++|...          ...++...++.++||||+++++++...  +..++||||+.+ +
T Consensus        15 ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~   93 (309)
T cd07845          15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-D   93 (309)
T ss_pred             eeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-C
Confidence            588999999999999999999887432          123466778899999999999999765  578999999965 7


Q ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |..++.. ...+++..+..++.|++.++.++|+.+++|+||+|+||+++..+.++++|||.+..+..
T Consensus        94 l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          94 LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            8887764 35689999999999999999999999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.88  E-value=2.3e-21  Score=135.68  Aligned_cols=132  Identities=18%  Similarity=0.166  Sum_probs=112.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|++|.||++... .+..+++|..       ..+.++...++.++|||++++++.+. .+..+++||++++++|.+++
T Consensus        14 ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~   91 (260)
T cd05070          14 LGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFL   91 (260)
T ss_pred             eccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHH
Confidence            588999999999765 4445666532       34556777889999999999999875 45688999999999999988


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ...  ..+++..+..++.+++.++.|+|+++++|+|++|+|++++....++++|||.+..+..
T Consensus        92 ~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          92 KDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            753  4588999999999999999999999999999999999999999999999999976543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0193|consensus

Probab=99.88  E-value=1.6e-22  Score=151.30  Aligned_cols=127  Identities=23%  Similarity=0.250  Sum_probs=112.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee----------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|.||+||++.+--   .||+|          ..+.++.+...+++=+|-||+-++|++..+.. .||+.+|+|.+|+
T Consensus       400 IGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY  475 (678)
T KOG0193|consen  400 IGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLY  475 (678)
T ss_pred             eccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhh
Confidence            5899999999987642   23332          56778888888888899999999999998877 9999999999999


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      ++++- ...++..+...++.|+++|+.|||.++|+|+|+|..||++..+..++|+|||++..
T Consensus       476 ~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  476 THLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             hhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence            99974 45689999999999999999999999999999999999999999999999999864

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.88  E-value=4.7e-21  Score=132.60  Aligned_cols=135  Identities=26%  Similarity=0.418  Sum_probs=121.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|++|.+|++.+..+++.+++|.        ...+.++...++.++|||++++.+.+..++..++++|++++++|.++
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   87 (253)
T cd05122           8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDL   87 (253)
T ss_pred             eccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHH
Confidence            5789999999999998898888863        33455666778899999999999999999999999999999999999


Q ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          74 LSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        74 l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +... ..+++..+..++.|++.++.++|..+++|+|++|+||+++..+.++++|||.+......
T Consensus        88 ~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          88 LKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            8765 57899999999999999999999999999999999999999999999999999876554

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.88  E-value=1.4e-21  Score=142.23  Aligned_cols=131  Identities=21%  Similarity=0.317  Sum_probs=114.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCC------EEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD------KLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~------~~~lv~e~~   65 (145)
                      +|.|++|.||++.+..+++.+++|..          ..+..+...++.++||||+++.+++..+.      .++++||++
T Consensus        23 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~  102 (343)
T cd07880          23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM  102 (343)
T ss_pred             eeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC
Confidence            68999999999999999999998743          23446677889999999999999998654      468999998


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                       +++|..++.. ..+++..+..++.|++.++.++|+.+++|+|++|+|++++..+.++++|||++....
T Consensus       103 -~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880         103 -GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             -CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence             6688877754 568999999999999999999999999999999999999999999999999987653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.88  E-value=1.5e-21  Score=138.54  Aligned_cols=134  Identities=40%  Similarity=0.640  Sum_probs=114.5

Q ss_pred             eeeeeeeEEEEEEEc---ccCCeeeeeHH------------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHV---KQGETLALNER------------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~---~~~~~~~~~~~------------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      +|.|++|.+|++.+.   .+++.+++|..            ..+..+...++.+ +||||+++++.+..+...|+||||+
T Consensus         8 ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (288)
T cd05583           8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYV   87 (288)
T ss_pred             eccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecC
Confidence            688999999998864   35566766521            1233455566777 6999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++++|..++.....+++..+..++.|++.++.++|..+++|+|++|+|++++.+..++++|||++..+..
T Consensus        88 ~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          88 NGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             CCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            9999999988777789999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.88  E-value=2e-21  Score=137.77  Aligned_cols=133  Identities=25%  Similarity=0.423  Sum_probs=119.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|++|.+|++.+..+++.+++|.       ...+..+...++.++|||++++++.+..++..|+++||+++++|.+++
T Consensus        27 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  106 (286)
T cd06614          27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII  106 (286)
T ss_pred             ccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHH
Confidence            5789999999999998888888863       234455667788999999999999999999999999999999999999


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          75 SQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        75 ~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .... .++......++.|++.++.++|..+++|+|++|+|++++.++.++++|||.+....
T Consensus       107 ~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614         107 TQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            8765 79999999999999999999999999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.88  E-value=6.2e-22  Score=143.48  Aligned_cols=132  Identities=22%  Similarity=0.393  Sum_probs=115.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEc----CCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHT----PDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~~   67 (145)
                      .|.|++|.+|++.+..+++.+++|...          .+..+...++.++||||+++.++|..    ....+++|||+. 
T Consensus        13 lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-   91 (334)
T cd07855          13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-   91 (334)
T ss_pred             eecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-
Confidence            588999999999999999999887422          23345677889999999999998864    357899999996 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++|.+++.....+++..+..++.|++.++.|+|.++++|+|++|+||+++.++.++++|||++..+.
T Consensus        92 ~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          92 SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            5898888777779999999999999999999999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG4279|consensus

Probab=99.88  E-value=2e-22  Score=153.50  Aligned_cols=135  Identities=23%  Similarity=0.305  Sum_probs=120.0

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      ++|.|.||+||.+++..+...+++||        ..-+..+...=+.|+|.|||+++|.+-.++.+-|.||-.+||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            47999999999999999999999975        3345566666678899999999999999999999999999999999


Q ss_pred             HHHh-cCCC--CHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-CCCEEEeeeccceecCC
Q psy3273          73 HLSQ-HGVF--NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-HGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~-~~~~--~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-~~~~~l~dfg~~~~~~~  135 (145)
                      ++.+ ++++  ++.+.-.+..||++|+.|+|.+.|+|||||-+|++++. .+.+|++|||-++++..
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            9974 6887  88889999999999999999999999999999999974 57899999999987654

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.88  E-value=3.5e-21  Score=135.97  Aligned_cols=132  Identities=20%  Similarity=0.282  Sum_probs=111.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH---------HHhhhhhcccC-CCCceeEeeEEEEcC--CEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM---------LSLVSTGIQMV-DCPFIVCMTYAFHTP--DKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l-~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~   69 (145)
                      .|.|++|.+|++.+..+++.+++|....         ..++...++.+ +|||++++++++.++  +..+++|||+++ +
T Consensus         7 lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~   85 (282)
T cd07831           7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-N   85 (282)
T ss_pred             ccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-c
Confidence            5889999999999999999888874321         11233445555 599999999999987  899999999975 7


Q ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +.+.+.. ...+++..+..++.|++.++.++|..+++|+|++|+|++++. +.++++|||++..+..
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          86 LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            8777765 456899999999999999999999999999999999999999 9999999999976543

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.88  E-value=1.6e-21  Score=137.79  Aligned_cols=133  Identities=26%  Similarity=0.401  Sum_probs=116.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|++|.+|++....+++.+++|...         ...++...++.++ |||++++++++..++..+++||++ ++++.
T Consensus         7 ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~   85 (283)
T cd07830           7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLY   85 (283)
T ss_pred             eccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHH
Confidence            688999999999999999988886422         1223445567778 999999999999999999999999 77998


Q ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ..+....  .+++..+..++.|++.++.++|+++++|+|++|+|++++..+.++++|||.+.....
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          86 QLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             HHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            8887654  689999999999999999999999999999999999999999999999999976643

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0577|consensus

Probab=99.88  E-value=7.8e-23  Score=153.33  Aligned_cols=132  Identities=19%  Similarity=0.240  Sum_probs=115.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------H---HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------R---IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~---~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|-|+||-||-|++..+.+.||+|.        .   ..+.++..-++.++|||++.+.++|..+...|+|||||-| |.
T Consensus        34 IGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SA  112 (948)
T KOG0577|consen   34 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SA  112 (948)
T ss_pred             hcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cH
Confidence            4779999999999999999999963        1   1223344446778999999999999999999999999965 88


Q ss_pred             HHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLS-QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+.+. ...++.+.++..++.+.+.|+.|+|+.+.||||||..||++...+.+|++|||.|....
T Consensus       113 sDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  113 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             HHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence            88886 45679999999999999999999999999999999999999999999999999997543

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.87  E-value=1e-21  Score=142.53  Aligned_cols=133  Identities=21%  Similarity=0.394  Sum_probs=115.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcC-----CEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTP-----DKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~   66 (145)
                      +|.|++|.+|.+.+..+++.+++|...          ....+...++.++||||+++++++...     ...|+++||+.
T Consensus        13 lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~   92 (337)
T cd07858          13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD   92 (337)
T ss_pred             eccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC
Confidence            688999999999999999999987432          233455677889999999999988654     35899999996


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                       ++|.+++.....+++..+..++.|++.++.++|+++++|+|++|+|++++..+.++++|||++.....
T Consensus        93 -~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          93 -TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             -CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence             58988888778899999999999999999999999999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0604|consensus

Probab=99.87  E-value=3.2e-22  Score=139.53  Aligned_cols=134  Identities=23%  Similarity=0.364  Sum_probs=113.0

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHHHH---Hhhhh-hcccCCCCceeEeeEEEEcC----CEEEEEEEccCCCCHHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERIML---SLVST-GIQMVDCPFIVCMTYAFHTP----DKLCFILDLMNGGDLHY   72 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~l~hp~i~~~~~~~~~~----~~~~lv~e~~~~~~l~~   72 (145)
                      ++|.|-.|.|..|.++.+++.+|+|....-   +++.+ .|.--.|||||+++++|+..    ..+.+|||.++||.|++
T Consensus        69 vLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfs  148 (400)
T KOG0604|consen   69 VLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFS  148 (400)
T ss_pred             hhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHH
Confidence            468899999999999999999999754432   23322 23344899999999999753    46889999999999999


Q ss_pred             HHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC---CCCCEEEeeeccceecC
Q psy3273          73 HLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD---EHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~---~~~~~~l~dfg~~~~~~  134 (145)
                      .++.++.  +.++++..++.||..|++|+|+..|.|||+||+|+|..   .+..+|++|||+|+.-.
T Consensus       149 riq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  149 RIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             HHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            9987655  99999999999999999999999999999999999985   34568999999998554

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.87  E-value=1.9e-21  Score=135.56  Aligned_cols=134  Identities=24%  Similarity=0.404  Sum_probs=117.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.+|++....++..+++|+.          ..+.++...++.++||||+++++.+..++..++++||+++++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (257)
T cd08225           8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLM   87 (257)
T ss_pred             ecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHH
Confidence            57899999999999999988888643          24456667788999999999999999999999999999999999


Q ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC-CEEEeeeccceecCC
Q psy3273          72 YHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG-HVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~-~~~l~dfg~~~~~~~  135 (145)
                      +++....  .+++.....++.|++.++.++|+++++|+|++|+||+++... .++++|||.+.....
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          88 KRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            9887532  478999999999999999999999999999999999998775 469999998876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.87  E-value=1.7e-21  Score=139.26  Aligned_cols=132  Identities=25%  Similarity=0.314  Sum_probs=112.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCC--------EEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPD--------KLCFILD   63 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~--------~~~lv~e   63 (145)
                      +|.|++|.||+|.+..+++.+++|...          ...++...++.++||||+++++++...+        ..+++||
T Consensus        20 lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e   99 (310)
T cd07865          20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFE   99 (310)
T ss_pred             eecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEc
Confidence            688999999999999999999987432          2234556788999999999999987653        4699999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          64 LMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        64 ~~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |+.+ ++...+... ..+++.++..++.|++.++.|+|+++++|+|++|+||+++..+.++++|||++..+.
T Consensus       100 ~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  170 (310)
T cd07865         100 FCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS  170 (310)
T ss_pred             CCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence            9965 787777643 368999999999999999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.87  E-value=8e-21  Score=136.62  Aligned_cols=130  Identities=19%  Similarity=0.248  Sum_probs=113.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.+|++.+..+++.++++..           ..+..+...++.++|||++++.+++..+...|++|||+.+ ++
T Consensus        29 lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l  107 (313)
T cd06633          29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SA  107 (313)
T ss_pred             eccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CH
Confidence            58899999999999999998888632           2234566678899999999999999999999999999965 77


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      .+.+.. ...+++..+..++.|++.++.|+|.++++|+|++|+||+++.++.++++|||++..
T Consensus       108 ~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~  170 (313)
T cd06633         108 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK  170 (313)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence            777654 45689999999999999999999999999999999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.87  E-value=5.7e-21  Score=134.20  Aligned_cols=135  Identities=29%  Similarity=0.389  Sum_probs=112.0

Q ss_pred             eeeeeeeEEEEEEEcc-cCCeeeeeHHH------------------HHHhhhhhc-ccCCCCceeEeeEEEEcCCEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVK-QGETLALNERI------------------MLSLVSTGI-QMVDCPFIVCMTYAFHTPDKLCFI   61 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-~~~~~~~~~~~------------------~~~~~~~~~-~~l~hp~i~~~~~~~~~~~~~~lv   61 (145)
                      .|.|++|.+|++.... +++.+++|...                  .+..+...+ +.++||||+++++.+..++..+++
T Consensus         8 ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   87 (269)
T cd08528           8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIV   87 (269)
T ss_pred             hcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEE
Confidence            5889999999999987 56777765321                  122233333 357999999999999999999999


Q ss_pred             EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          62 LDLMNGGDLHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        62 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |||+++++|.+.+..    ...+++..+..++.|++.++.++|. .+++|+|++|+||+++.+..++++|||.+.....+
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  167 (269)
T cd08528          88 MDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE  167 (269)
T ss_pred             EecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeecccc
Confidence            999999999888742    3458899999999999999999996 78999999999999999999999999999765543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.87  E-value=3.2e-21  Score=139.87  Aligned_cols=132  Identities=23%  Similarity=0.363  Sum_probs=113.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccC-CCCceeEeeEEEEcC--CEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMV-DCPFIVCMTYAFHTP--DKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~--~~~~lv~e~~~~~   68 (145)
                      .|.|++|.+|++.+..+++.+++|..          ..+.++...++.+ +||||+++++++...  ...|+|||++++ 
T Consensus        15 lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-   93 (337)
T cd07852          15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-   93 (337)
T ss_pred             hcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-
Confidence            58899999999999989988888733          2234566678888 999999999998654  368999999975 


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|..++... .+++.....++.|++.++.++|+.+++|+|++|+|++++.++.++++|||++..+..
T Consensus        94 ~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          94 DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            898888654 778888889999999999999999999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.87  E-value=3.1e-21  Score=139.90  Aligned_cols=131  Identities=21%  Similarity=0.345  Sum_probs=112.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhcccCCCCceeEeeEEEEcC-----CEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGIQMVDCPFIVCMTYAFHTP-----DKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~   67 (145)
                      +|.|++|.||++.+..+++.+++|...         ....+...++.++||||+++++++...     ...|+++|++.+
T Consensus        13 lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~   92 (336)
T cd07849          13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET   92 (336)
T ss_pred             EEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc
Confidence            689999999999999999999997432         233456678889999999999987654     358999999965


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                       ++...+.. ..+++..+..++.|++.++.++|+.+++|+||+|+|++++..+.++++|||++....
T Consensus        93 -~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          93 -DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             -CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence             78776643 568999999999999999999999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.87  E-value=3.6e-21  Score=135.97  Aligned_cols=134  Identities=25%  Similarity=0.372  Sum_probs=117.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~   69 (145)
                      .|.|++|.+|++.+..+++.+++|...          .+..+...++.++|||++++++++..+  +..++++||+++ +
T Consensus         7 l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~   85 (287)
T cd07840           7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-D   85 (287)
T ss_pred             eccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-c
Confidence            588999999999999999888886432          244566678889999999999999988  899999999975 8


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +..++... ..+++.....++.|++.++.++|..+++|+|++|+|++++.++.++++|||.+..+...
T Consensus        86 l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          86 LTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            88888654 57899999999999999999999999999999999999999999999999999866543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG4278|consensus

Probab=99.87  E-value=2.6e-22  Score=151.53  Aligned_cols=141  Identities=18%  Similarity=0.176  Sum_probs=126.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee-------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN-------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|=|-||-||...+.+..-.+|+|       +++-+..++..++.++|||+|+++++|..+..+|||+|||.+|+|.+++
T Consensus       275 LGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYL  354 (1157)
T KOG4278|consen  275 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYL  354 (1157)
T ss_pred             cCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHH
Confidence            567889999999999988888885       5667788889999999999999999999999999999999999999999


Q ss_pred             Hh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCcccc
Q psy3273          75 SQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV  142 (145)
Q Consensus        75 ~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  142 (145)
                      ..  ...++...++.++.||..++.||..+.+||||+..+|+|++....+|+.|||+++.++.+......
T Consensus       355 Recnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA  424 (1157)
T KOG4278|consen  355 RECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA  424 (1157)
T ss_pred             HHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence            74  345888888999999999999999999999999999999999999999999999988776655443

>KOG0587|consensus

Probab=99.87  E-value=1e-20  Score=146.35  Aligned_cols=144  Identities=22%  Similarity=0.359  Sum_probs=119.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH-------HHhhhhh-cccCCCCceeEeeEEEEc-----CCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM-------LSLVSTG-IQMVDCPFIVCMTYAFHT-----PDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~~~~   68 (145)
                      .|.|.+|.||+++.+++++..|+|....       .+.+-++ ....+|||++.++++|..     ++.+|+|||||.+|
T Consensus        27 ig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gG  106 (953)
T KOG0587|consen   27 IGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGG  106 (953)
T ss_pred             EeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCc
Confidence            4789999999999999998888853221       1122222 234599999999999864     46899999999999


Q ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccc--cCC
Q psy3273          69 DLHYHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGK  144 (145)
Q Consensus        69 ~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~  144 (145)
                      |..++++.  ...+.+..+..+++.++.++.++|.+.++|+|++-.||++..++.+|+.|||++..+++....++  +|+
T Consensus       107 SVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGt  186 (953)
T KOG0587|consen  107 SVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGT  186 (953)
T ss_pred             cHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCC
Confidence            99999974  35688999999999999999999999999999999999999999999999999999877655544  565


Q ss_pred             C
Q psy3273         145 S  145 (145)
Q Consensus       145 ~  145 (145)
                      |
T Consensus       187 P  187 (953)
T KOG0587|consen  187 P  187 (953)
T ss_pred             c
Confidence            4

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.87  E-value=1.3e-20  Score=135.18  Aligned_cols=133  Identities=20%  Similarity=0.236  Sum_probs=114.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.+|++.+..+++.++++...           .+.++...++.++|||++++.+++..+...+++|||+. +++
T Consensus        23 lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l  101 (308)
T cd06634          23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA  101 (308)
T ss_pred             eeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCH
Confidence            588999999999999999888886421           23345667888999999999999999999999999996 477


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+.+.. ...+++..+..++.|++.++.++|.++++|+|++|+|++++.++.++++|||++.....
T Consensus       102 ~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634         102 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            776653 45689999999999999999999999999999999999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.87  E-value=1.8e-21  Score=140.64  Aligned_cols=134  Identities=20%  Similarity=0.382  Sum_probs=118.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCC-----EEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD-----KLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~-----~~~lv~e~~~   66 (145)
                      .|.|++|.+|+|.+..+++.+++|..          ..+..+...++.++||||+++.+++...+     ..|++|||++
T Consensus         8 ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~   87 (330)
T cd07834           8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME   87 (330)
T ss_pred             ecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh
Confidence            68899999999999999999988632          23455667788899999999999998775     7999999997


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      + +|.+.+.....+++..+..++.|++.++.++|+.+++|+|++|+||+++.++.++++|||.+......
T Consensus        88 ~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          88 T-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             h-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            4 88888887778999999999999999999999999999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00284 protein kinase; Provisional

Probab=99.86  E-value=4.2e-21  Score=144.96  Aligned_cols=130  Identities=22%  Similarity=0.283  Sum_probs=106.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH-------HHhhhhhccc------CCCCceeEeeEEEEcC-CEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM-------LSLVSTGIQM------VDCPFIVCMTYAFHTP-DKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~------l~hp~i~~~~~~~~~~-~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.+..+++.+|+|....       ...+...++.      .+|++++++.++|..+ +.+|++||++ +
T Consensus       137 lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g  215 (467)
T PTZ00284        137 LGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-G  215 (467)
T ss_pred             EEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-C
Confidence            6899999999999999999999984321       1222233333      3556799999999865 5799999988 6


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCC----------------CEEEeeeccc
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHG----------------HVRISDLGLA  130 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~----------------~~~l~dfg~~  130 (145)
                      ++|.+++...+.+++..+..++.|++.|+.|+|. .+++|+||||+||+++..+                .+|++|||.+
T Consensus       216 ~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~  295 (467)
T PTZ00284        216 PCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC  295 (467)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCcc
Confidence            6898988877889999999999999999999998 5999999999999997654                4999999987


Q ss_pred             ee
Q psy3273         131 CD  132 (145)
Q Consensus       131 ~~  132 (145)
                      ..
T Consensus       296 ~~  297 (467)
T PTZ00284        296 CD  297 (467)
T ss_pred             cc
Confidence            54

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.86  E-value=1.1e-20  Score=136.93  Aligned_cols=130  Identities=23%  Similarity=0.392  Sum_probs=112.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEc-CCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHT-PDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||++.+..+++.+++|..          ..+..+...++.++||||+++.++|.. ....|+++|++ +++|
T Consensus        18 ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L   96 (328)
T cd07856          18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDL   96 (328)
T ss_pred             ecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCH
Confidence            57899999999999999999988742          344566778889999999999999876 46789999998 5588


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ..++.. ..+++..+..++.|++.++.++|+.+++|++++|+|++++....++++|||.+...
T Consensus        97 ~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          97 HRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            777653 45788888899999999999999999999999999999999999999999988754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.86  E-value=1e-20  Score=133.10  Aligned_cols=133  Identities=18%  Similarity=0.195  Sum_probs=110.1

Q ss_pred             eeeeeeeEEEEEEEcc---cCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCC------EEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVK---QGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD------KLCFIL   62 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~---~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~------~~~lv~   62 (145)
                      .|.|++|.||++....   +++.+++|.          .+.+.++.+.++.++||||+++++++....      ..++++
T Consensus         7 ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   86 (273)
T cd05074           7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL   86 (273)
T ss_pred             ccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEE
Confidence            5889999999998654   567788763          223445667788999999999999986542      247888


Q ss_pred             EccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          63 DLMNGGDLHYHLSQH------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        63 e~~~~~~l~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ||+++++|..++...      ..++...+..++.|++.++.|+|+++++|+|++|+|++++....++++|||+++...
T Consensus        87 ~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~  164 (273)
T cd05074          87 PFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY  164 (273)
T ss_pred             ecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccccccc
Confidence            999999998877422      247888999999999999999999999999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.86  E-value=8.5e-21  Score=135.42  Aligned_cols=133  Identities=17%  Similarity=0.141  Sum_probs=103.2

Q ss_pred             CeeeeeeeEEEEEEEccc---CCeeeeeHHH-----------HH--------HhhhhhcccCCCCceeEeeEEEEcCC--
Q psy3273           1 MFFIVGTGFLSNCSHVKQ---GETLALNERI-----------ML--------SLVSTGIQMVDCPFIVCMTYAFHTPD--   56 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~---~~~~~~~~~~-----------~~--------~~~~~~~~~l~hp~i~~~~~~~~~~~--   56 (145)
                      +.|.|+||.||+|.+..+   +..++.+...           ..        ......++.++|+|++++++++....  
T Consensus        19 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~   98 (294)
T PHA02882         19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCR   98 (294)
T ss_pred             EEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCC
Confidence            369999999999998777   5555554211           00        01112345679999999999876543  


Q ss_pred             --EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          57 --KLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        57 --~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                        ..++++|++.. ++.+.+......++..+..++.|++.++.|+|+.+++||||||+||+++....++++|||+|+.+.
T Consensus        99 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~  177 (294)
T PHA02882         99 MYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFI  177 (294)
T ss_pred             ceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeec
Confidence              45778887754 676666655557888899999999999999999999999999999999999999999999998764

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.86  E-value=1.4e-20  Score=133.50  Aligned_cols=132  Identities=23%  Similarity=0.344  Sum_probs=110.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|+||.||++.+..+++.+++|...         .+..+...+..+. ||||+++++++..++..+++||++.. ++.
T Consensus        12 lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~   90 (288)
T cd06616          12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLD   90 (288)
T ss_pred             hCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHH
Confidence            588999999999999999999997432         2344555566665 99999999999999999999999865 554


Q ss_pred             HHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLS-----QHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++..     ....+++..+..++.|++.++.|+|. .+++|+|++|+||+++..+.++++|||++..+.
T Consensus        91 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          91 KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            4332     23568999999999999999999997 499999999999999999999999999987553

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.86  E-value=1.2e-20  Score=133.34  Aligned_cols=133  Identities=26%  Similarity=0.358  Sum_probs=112.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhh---cccCCCCceeEeeEEEEcCCE-----EEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTG---IQMVDCPFIVCMTYAFHTPDK-----LCFILD   63 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~---~~~l~hp~i~~~~~~~~~~~~-----~~lv~e   63 (145)
                      .|.|++|.+|++.+..+++.+++|...          .+..+.+.   ++.++|||++++++++...+.     .+++||
T Consensus         7 l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e   86 (287)
T cd07838           7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFE   86 (287)
T ss_pred             ecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEeh
Confidence            588999999999999889988887443          12223222   345679999999999998776     999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          64 LMNGGDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        64 ~~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++.+ ++.+++...  ..+++..+..++.|++.++.++|+.+++|+|++|+|++++..+.++++|||.+..+..
T Consensus        87 ~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          87 HVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             hccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            9975 888888653  3589999999999999999999999999999999999999999999999999877643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG1035|consensus

Probab=99.86  E-value=1e-21  Score=155.97  Aligned_cols=132  Identities=24%  Similarity=0.290  Sum_probs=111.7

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhcccCCCCceeEeeEEEEc-----------------
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGIQMVDCPFIVCMTYAFHT-----------------   54 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~hp~i~~~~~~~~~-----------------   54 (145)
                      ++|.||||.|++++++-.|+.+|+|.+.         .+.++...+++|+|||+|+++..|..                 
T Consensus       486 lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~  565 (1351)
T KOG1035|consen  486 LLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSES  565 (1351)
T ss_pred             HhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhh
Confidence            4799999999999999999999997533         34677788999999999999988753                 


Q ss_pred             --------------------------------------C-----------------------------------------
Q psy3273          55 --------------------------------------P-----------------------------------------   55 (145)
Q Consensus        55 --------------------------------------~-----------------------------------------   55 (145)
                                                            .                                         
T Consensus       566 ~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~  645 (1351)
T KOG1035|consen  566 RSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDT  645 (1351)
T ss_pred             hcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcc
Confidence                                                  0                                         


Q ss_pred             -----------------------CEEEEEEEccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHhhCCceecCCCC
Q psy3273          56 -----------------------DKLCFILDLMNGGDLHYHLSQHGVF-NEDEMRFYAAEVILGLEHMHRRYIVYRDLKP  111 (145)
Q Consensus        56 -----------------------~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~  111 (145)
                                             ..+||=||||+...+.+.+..+... .......++++|+.|+.|+|..|++|||+||
T Consensus       646 ~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP  725 (1351)
T KOG1035|consen  646 SESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKP  725 (1351)
T ss_pred             hhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCc
Confidence                                   1267888999886666666554333 4677889999999999999999999999999


Q ss_pred             CcEEECCCCCEEEeeecccee
Q psy3273         112 ANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus       112 ~nil~~~~~~~~l~dfg~~~~  132 (145)
                      .||+++..+.+|++|||+|+.
T Consensus       726 ~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  726 RNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             ceeEEcCCCCeeecccccchh
Confidence            999999999999999999987

>KOG1151|consensus

Probab=99.86  E-value=1.1e-21  Score=143.44  Aligned_cols=143  Identities=24%  Similarity=0.342  Sum_probs=119.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHHH---------------HHhhhhhcccCCCCceeEeeEEEEcC-CEEEEEEEc
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERIM---------------LSLVSTGIQMVDCPFIVCMTYAFHTP-DKLCFILDL   64 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~hp~i~~~~~~~~~~-~~~~lv~e~   64 (145)
                      ++|.|||.-||+|.+....+++|+|....               .-++-.+-+.|+||-||++|++|..+ +.+|-|+||
T Consensus       470 LLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEY  549 (775)
T KOG1151|consen  470 LLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEY  549 (775)
T ss_pred             HhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeee
Confidence            47999999999999999999999963211               11223344678999999999999755 689999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--CceecCCCCCcEEECCC---CCEEEeeeccceecCCCCCc
Q psy3273          65 MNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR--YIVYRDLKPANILLDEH---GHVRISDLGLACDFSKKKPH  139 (145)
Q Consensus        65 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--~iih~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~  139 (145)
                      |+|.+|.-++..+..++++++..++.||+.++.||...  .|+|-|+||.||++...   +.+|++|||+++.+.+++..
T Consensus       550 ceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~  629 (775)
T KOG1151|consen  550 CEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYN  629 (775)
T ss_pred             cCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccC
Confidence            99999999999889999999999999999999999954  59999999999998543   67999999999987766655


Q ss_pred             cccC
Q psy3273         140 ASVG  143 (145)
Q Consensus       140 ~~~~  143 (145)
                      .+.|
T Consensus       630 ~vdG  633 (775)
T KOG1151|consen  630 SVDG  633 (775)
T ss_pred             cccc
Confidence            4433

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.86  E-value=6.7e-21  Score=138.00  Aligned_cols=132  Identities=22%  Similarity=0.337  Sum_probs=111.8

Q ss_pred             eeeeeeeEEEEEEEccc--CCeeeeeHHH----------HHHhhhhhcccC-CCCceeEeeEEEEcC----CEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVKQ--GETLALNERI----------MLSLVSTGIQMV-DCPFIVCMTYAFHTP----DKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~--~~~~~~~~~~----------~~~~~~~~~~~l-~hp~i~~~~~~~~~~----~~~~lv~e~   64 (145)
                      .|.|+||.||++.+..+  +..+++|...          ...++...++.+ +||||+++++.+...    ...|+++|+
T Consensus         8 lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~   87 (332)
T cd07857           8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEEL   87 (332)
T ss_pred             ccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEec
Confidence            58899999999999888  8888887422          233455566667 699999999875432    458889998


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          65 MNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        65 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +. ++|...+.....+++..+..++.|++.++.++|..+++|+|++|+||+++..+.++++|||.+..+.
T Consensus        88 ~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          88 ME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             cc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            86 5899988877889999999999999999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.86  E-value=1.3e-20  Score=137.21  Aligned_cols=130  Identities=22%  Similarity=0.322  Sum_probs=111.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcC------CEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTP------DKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~------~~~~lv~e~~   65 (145)
                      +|.|++|.+|.+.+..+++.+++|..          ..+.++...++.++||||+++.+++...      ...|++++++
T Consensus        25 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~  104 (345)
T cd07877          25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM  104 (345)
T ss_pred             eeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc
Confidence            68999999999999999999988742          2344566778899999999999988643      3478888877


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                       +++|.+++.. ..+++..+..++.|++.|+.|+|+.+++|+|++|+||+++..+.++++|||++...
T Consensus       105 -~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877         105 -GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             -ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence             6788877754 45899999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=4.7e-21  Score=135.22  Aligned_cols=133  Identities=26%  Similarity=0.372  Sum_probs=117.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.+|.+....+++.+++|...          .+..+...++.++|||++++++++...+..++++|++++ +|.
T Consensus         7 ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~   85 (282)
T cd07829           7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLK   85 (282)
T ss_pred             ccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHH
Confidence            578999999999999999999886322          233455677888999999999999999999999999974 899


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++... ..+++..+..++.+++.++.++|..+++|+|++|+|++++..+.++++|||.+.....
T Consensus        86 ~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          86 KYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             HHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            998765 5799999999999999999999999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.86  E-value=9.6e-21  Score=133.67  Aligned_cols=134  Identities=22%  Similarity=0.356  Sum_probs=117.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.+|++.+..+++.+++|+.          ..+..+...++.++||||+++++.+..++..++++||+++ ++.
T Consensus         7 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~   85 (283)
T cd05118           7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLY   85 (283)
T ss_pred             eecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHH
Confidence            57899999999999989998888632          2344556677888999999999999999999999999976 888


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +.+.. ...+++..+..++.|++.++.++|..+++|+|++|+||+++.+..++++|||.+.....+
T Consensus        86 ~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          86 KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             HHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            87765 457899999999999999999999999999999999999999999999999998766543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.85  E-value=5.6e-21  Score=136.60  Aligned_cols=132  Identities=23%  Similarity=0.348  Sum_probs=112.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcC--------CEEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTP--------DKLCFILD   63 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~--------~~~~lv~e   63 (145)
                      .|.|++|.+|++.+..+++.+++|..          ....++.+.++.++||||+++++.+...        ..+++++|
T Consensus        16 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~   95 (311)
T cd07866          16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP   95 (311)
T ss_pred             eccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEe
Confidence            58899999999999999998888742          1234566778899999999999987543        35799999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          64 LMNGGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        64 ~~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |+.+ ++...+.. ...+++..+..++.|++.++.|+|+.+++|+|++|+||+++..+.++++|||++....
T Consensus        96 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  166 (311)
T cd07866          96 YMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD  166 (311)
T ss_pred             cCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence            9965 67666654 3569999999999999999999999999999999999999999999999999997553

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0576|consensus

Probab=99.85  E-value=1.4e-22  Score=153.08  Aligned_cols=144  Identities=23%  Similarity=0.328  Sum_probs=129.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|.||-||+|++..+++..++|.        ...++++.-+++.++||||+.+++.|...+.+++.||||.+|+|.+.
T Consensus        23 vgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdi  102 (829)
T KOG0576|consen   23 VGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDI  102 (829)
T ss_pred             ecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccce
Confidence            6899999999999999999888864        45567888889999999999999999999999999999999999998


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC--CCccccCCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGKS  145 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~  145 (145)
                      ..-.+++++.++...+++.+.++.|+|+.|=+|||+|-.||++.+.+.+++.|||.+..++..  .....+||+
T Consensus       103 y~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtp  176 (829)
T KOG0576|consen  103 YHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTP  176 (829)
T ss_pred             eeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCc
Confidence            887889999999999999999999999999999999999999999999999999999888654  333335553

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.85  E-value=7.9e-21  Score=132.91  Aligned_cols=132  Identities=25%  Similarity=0.366  Sum_probs=110.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeee---e----------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLAL---N----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~---~----------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|++|.+|++.+...+...++   +          +......+...++.++||||+++++.+...+..++++||++++
T Consensus         8 ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (260)
T cd08222           8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGR   87 (260)
T ss_pred             ecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCC
Confidence            68999999999998876543322   1          1222344556788899999999999999999999999999999


Q ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          69 DLHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        69 ~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +|.+.+..    ...+++.....++.|++.++.++|+.+++|+|++|+|++++. ..++++|||.+..+.
T Consensus        88 ~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          88 DLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             CHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            99988753    346899999999999999999999999999999999999975 569999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4257|consensus

Probab=99.85  E-value=5.2e-21  Score=144.32  Aligned_cols=134  Identities=18%  Similarity=0.253  Sum_probs=115.5

Q ss_pred             eeeeeeeEEEEEEE--cccCCe--eeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSH--VKQGET--LALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~--~~~~~~--~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|-|-||.||.+.-  .+.|+.  ||+|         ..+.+.+++-++++++||||+++.|++.. ...|+|||.++-|
T Consensus       397 iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~G  475 (974)
T KOG4257|consen  397 IGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLG  475 (974)
T ss_pred             hcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccch
Confidence            58889999998854  224443  3442         46677788888999999999999999985 4799999999999


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          69 DLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        69 ~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .|..+++. ...++..+...++.|+..++.|+|+..++||||..+||++.+...+|++|||+++.+...
T Consensus       476 ELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  476 ELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             hHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999985 466999999999999999999999999999999999999999999999999999976544

>KOG0984|consensus

Probab=99.85  E-value=8.1e-21  Score=126.66  Aligned_cols=132  Identities=27%  Similarity=0.462  Sum_probs=112.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.+-+-++..+|...|+|.+.          .+....-.++..+.|++|++|+.+......++.||.|.. ||.
T Consensus        54 lGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sld  132 (282)
T KOG0984|consen   54 LGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLD  132 (282)
T ss_pred             hcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHH
Confidence            588999999999999999999997422          233333344566899999999999999999999999955 887


Q ss_pred             HHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLS----QHGVFNEDEMRFYAAEVILGLEHMHRR-YIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~-~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+..    ....+++..+-+++..++.|+.|||++ .++|||+||+|||++..+++|++|||++-.+.
T Consensus       133 kfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  133 KFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             HHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            7765    346799999999999999999999965 69999999999999999999999999987553

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.84  E-value=1.2e-20  Score=137.30  Aligned_cols=131  Identities=22%  Similarity=0.316  Sum_probs=111.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH--------HHHHhhhhhcccCCCCceeEeeEEEEcC--------------CEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER--------IMLSLVSTGIQMVDCPFIVCMTYAFHTP--------------DKLC   59 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~hp~i~~~~~~~~~~--------------~~~~   59 (145)
                      .|.|++|.||+|.+..+++.+++|+.        ..+.++...++.++||||+++++.+...              ...|
T Consensus        13 Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (342)
T cd07854          13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY   92 (342)
T ss_pred             ecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEE
Confidence            58899999999999999999988642        3355666778899999999999877654              3589


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-CCCEEEeeeccceecC
Q psy3273          60 FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-HGHVRISDLGLACDFS  134 (145)
Q Consensus        60 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-~~~~~l~dfg~~~~~~  134 (145)
                      ++|||+++ +|...+.. ..+++..+..++.|++.|+.|+|..+++|+||+|+|++++. +..++++|||.+..+.
T Consensus        93 lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~  166 (342)
T cd07854          93 IVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD  166 (342)
T ss_pred             EEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecC
Confidence            99999974 88877754 46889999999999999999999999999999999999975 4568999999997653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.84  E-value=8.9e-20  Score=130.05  Aligned_cols=132  Identities=24%  Similarity=0.376  Sum_probs=108.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhc-ccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGI-QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~-~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.+|++.+..+++.+++|...         .+..+...+ +..+||||+++++++.++...|++||++.+ ++.
T Consensus        23 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~  101 (296)
T cd06618          23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLD  101 (296)
T ss_pred             eeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-CHH
Confidence            588999999999999989888886421         111122223 333699999999999999999999999854 777


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +.+.. ...+++.....++.|++.++.|+|+ .+++|+|++|+||+++.+..++++|||.+..+.
T Consensus       102 ~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618         102 KLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            76654 4578999999999999999999997 699999999999999999999999999987553

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG1025|consensus

Probab=99.84  E-value=2.4e-21  Score=149.44  Aligned_cols=137  Identities=20%  Similarity=0.278  Sum_probs=117.8

Q ss_pred             CeeeeeeeEEEEEEEcccCCeee----eeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLA----LNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~----~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      ++|+|+||+||+......|+.+.    +|+         .+-+..++-.+..++|||++++++++..+. +-||++|++.
T Consensus       703 vLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~  781 (1177)
T KOG1025|consen  703 VLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPL  781 (1177)
T ss_pred             eeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhccc
Confidence            47999999999998877776553    332         333445556788999999999999999776 7789999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCC
Q psy3273          68 GDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  138 (145)
Q Consensus        68 ~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~  138 (145)
                      |+|.++++.+ ..+..+..+.|+.||++|+.|+|..+++||||..+|+|+.....+|+.|||+++.+.+.+.
T Consensus       782 G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  782 GCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             chHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            9999999854 5689999999999999999999999999999999999999999999999999997765543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.84  E-value=1.8e-20  Score=136.38  Aligned_cols=131  Identities=23%  Similarity=0.348  Sum_probs=113.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCCE------EEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDK------LCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~------~~lv~e~~   65 (145)
                      .|.|++|.+|++.+..+++.+++|...          .+..+...++.++|||++++.+++..++.      .++++|++
T Consensus        23 ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~  102 (343)
T cd07851          23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM  102 (343)
T ss_pred             eccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC
Confidence            588999999999999999999887532          22346667888999999999998876654      99999998


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                       +++|.+++.. ..+++..+..++.|++.++.++|+.+++|+|++|+|++++..+.++++|||++....
T Consensus       103 -~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851         103 -GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             -CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence             5689888765 468999999999999999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.84  E-value=3.4e-20  Score=134.90  Aligned_cols=129  Identities=21%  Similarity=0.325  Sum_probs=109.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCC------EEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPD------KLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~------~~~lv~e~~   65 (145)
                      .|.|++|.+|++.+..+++.+++|...          .+.++...++.++||||+++++++....      .+|+++|++
T Consensus        23 ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~  102 (342)
T cd07879          23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM  102 (342)
T ss_pred             eeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccc
Confidence            588999999999999999999887432          2345667788899999999999987553      579999998


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      .. ++.....  ..+++..+..++.|++.++.++|+.+++|+|++|+||+++..+.++++|||++...
T Consensus       103 ~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879         103 QT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             cc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            64 6665542  35889999999999999999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0196|consensus

Probab=99.84  E-value=9e-21  Score=145.53  Aligned_cols=136  Identities=21%  Similarity=0.247  Sum_probs=120.7

Q ss_pred             CeeeeeeeEEEEEEEcccCC---eeee---------eHHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGE---TLAL---------NERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~---~~~~---------~~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +.|.|.||-|+...-+..++   .||+         |++..+..++.+|-+.+||||++|.++-......-||+|||++|
T Consensus       636 VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENG  715 (996)
T KOG0196|consen  636 VIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENG  715 (996)
T ss_pred             EEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCC
Confidence            36889999999998877663   4455         35667788888999999999999999999999999999999999


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          69 DLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        69 ~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +|+++++. .+.+...++..+++.|+.|+.||.+.+.+||||..+|||++.+-.+|++|||+++.+.++
T Consensus       716 sLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  716 SLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             cHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            99999985 456888889999999999999999999999999999999999999999999999976443

>KOG0664|consensus

Probab=99.84  E-value=2.1e-22  Score=139.43  Aligned_cols=131  Identities=20%  Similarity=0.357  Sum_probs=113.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCC-----EEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD-----KLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~-----~~~lv~e~~~   66 (145)
                      .|.|+||.||...+..+|+.+++|+.          ...-++.+.+.-.+|.|+...+++.+...     .+|+++|.+.
T Consensus        61 IGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ  140 (449)
T KOG0664|consen   61 IGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ  140 (449)
T ss_pred             ccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH
Confidence            48999999999999999999998642          12234445566779999999999987553     5788999886


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      . +|...+-+...++...+..+..||+.|+.|+|+.+|+||||||.|++++++..+|++|||+++.-
T Consensus       141 S-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  141 S-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             h-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc
Confidence            6 88888888888999999999999999999999999999999999999999999999999999854

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=7.8e-20  Score=124.64  Aligned_cols=125  Identities=16%  Similarity=0.010  Sum_probs=95.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeee--------HHHHHHhhhhhcccC-----CCCceeEeeEEEEcCC---EEE-EEEE
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALN--------ERIMLSLVSTGIQMV-----DCPFIVCMTYAFHTPD---KLC-FILD   63 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l-----~hp~i~~~~~~~~~~~---~~~-lv~e   63 (145)
                      ++|.|++|.||.  +..++.. ++|        ......++...++.+     +||||++++++++++.   .++ +|+|
T Consensus         9 ~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          9 PLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             eecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            479999999996  5555554 354        234567777777777     6899999999999874   434 7899


Q ss_pred             c--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHhhCCceecCCCCCcEEECCC----CCEEEeeeccce
Q psy3273          64 L--MNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL-EHMHRRYIVYRDLKPANILLDEH----GHVRISDLGLAC  131 (145)
Q Consensus        64 ~--~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l-~~lh~~~iih~~l~~~nil~~~~----~~~~l~dfg~~~  131 (145)
                      |  +.+++|.+++... .+++.  ..++.+++.++ .|+|+++|+|+|++|+||+++..    ..++++|++-+.
T Consensus        86 ~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         86 FDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             CCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            9  5578999999763 45555  35677888777 99999999999999999999742    379999944443

>KOG1163|consensus

Probab=99.84  E-value=4.5e-20  Score=125.70  Aligned_cols=140  Identities=19%  Similarity=0.232  Sum_probs=114.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH------HHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI------MLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|+|+||-+|.+....+|+.||+|...      .+..+...-..|+ -+.|+.+..++....+-.+|||.+ |+||.++.
T Consensus        23 iGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLf  101 (341)
T KOG1163|consen   23 IGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLF  101 (341)
T ss_pred             ecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHH
Confidence            589999999999999999999997322      1222222222333 368888899998889999999988 77999988


Q ss_pred             H-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC---CCEEEeeeccceecCCCCCcccc
Q psy3273          75 S-QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH---GHVRISDLGLACDFSKKKPHASV  142 (145)
Q Consensus        75 ~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~  142 (145)
                      . +...++.++++.++.|++..++|+|.++++||||||+|++.+-.   ..+.++|||+|+.+.+......+
T Consensus       102 nfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HI  173 (341)
T KOG1163|consen  102 NFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHI  173 (341)
T ss_pred             HHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccC
Confidence            6 56789999999999999999999999999999999999998743   56889999999988776655544

>KOG3653|consensus

Probab=99.83  E-value=3.1e-20  Score=135.85  Aligned_cols=134  Identities=19%  Similarity=0.174  Sum_probs=113.2

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH-----HHHHHhhhhh--cccCCCCceeEeeEEEEcCC----EEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE-----RIMLSLVSTG--IQMVDCPFIVCMTYAFHTPD----KLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~--~~~l~hp~i~~~~~~~~~~~----~~~lv~e~~~~~~   69 (145)
                      +.|.|.||.||+++-.+  +.||+|.     +.-++.+.++  +-.++|+||+++++.-+..+    .+++|++|.+.|+
T Consensus       217 li~~Grfg~V~KaqL~~--~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGs  294 (534)
T KOG3653|consen  217 LIGRGRFGCVWKAQLDN--RLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGS  294 (534)
T ss_pred             HhhcCccceeehhhccC--ceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCc
Confidence            35889999999998765  8888873     4444444443  34779999999999877655    8999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh---------CCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR---------RYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~---------~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      |.+++..+ ..++.....++..++.|+.|||.         ..|.|||+|.+|+|+..+..+.|+|||+|..+.+..
T Consensus       295 L~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~  370 (534)
T KOG3653|consen  295 LCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGK  370 (534)
T ss_pred             HHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCC
Confidence            99999864 67899999999999999999995         249999999999999999999999999999886543

>KOG0696|consensus

Probab=99.83  E-value=3.3e-21  Score=139.81  Aligned_cols=132  Identities=33%  Similarity=0.558  Sum_probs=113.8

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHHHH-----------HhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERIML-----------SLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|+||.|..+...-+.+.+|+|.....           ..+...++-. +-|.++.+..+|++-+++|+||||+.||
T Consensus       356 VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGG  435 (683)
T KOG0696|consen  356 VLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGG  435 (683)
T ss_pred             EeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCc
Confidence            468999999999999999999888632211           1111112211 5689999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      +|.-.++.-+.+.+..+..++.+|+.++-+||++||++||+|.+|++++.++.+|++|||+++.
T Consensus       436 DLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  436 DLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             hhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence            9999999889999999999999999999999999999999999999999999999999999964

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.83  E-value=6.6e-20  Score=148.52  Aligned_cols=125  Identities=18%  Similarity=0.209  Sum_probs=107.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH----HHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM----LSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH   77 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~   77 (145)
                      .|.|+||.||++....+++.+++|....    ...+.+.+++++||||+++++++.+++..|+||||+++++|.+++.  
T Consensus       698 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--  775 (968)
T PLN00113        698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--  775 (968)
T ss_pred             EccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--
Confidence            6889999999999999999999985432    2334567888999999999999999999999999999999999986  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHh---hCCceecCCCCCcEEECCCCCEEEeeeccc
Q psy3273          78 GVFNEDEMRFYAAEVILGLEHMH---RRYIVYRDLKPANILLDEHGHVRISDLGLA  130 (145)
Q Consensus        78 ~~~~~~~~~~~~~~i~~~l~~lh---~~~iih~~l~~~nil~~~~~~~~l~dfg~~  130 (145)
                       .+++.....++.|++.|+.|+|   +.+++|+|++|+||+++.....++. ++..
T Consensus       776 -~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~  829 (968)
T PLN00113        776 -NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP  829 (968)
T ss_pred             -cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence             3788888999999999999999   6799999999999999987776654 4443

>KOG0695|consensus

Probab=99.83  E-value=2e-20  Score=132.95  Aligned_cols=144  Identities=28%  Similarity=0.510  Sum_probs=119.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhh-cccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTG-IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~-~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+|..|..++..++.+.+|+|.+.           +.+.+... .+--+||.+|-+..+|++++.+++|.||.++|+
T Consensus       258 igrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggd  337 (593)
T KOG0695|consen  258 IGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGD  337 (593)
T ss_pred             ecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcc
Confidence            578899999999999999999996322           22222111 112289999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee-cCCCCCccc-cCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD-FSKKKPHAS-VGKS  145 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~-~~~~~~~~~-~~~~  145 (145)
                      |.-+++.+..+|++.+..+...|..++.|+|++||+++|+|.+|++++..+.+|++|+|+++. +.+++...+ .|||
T Consensus       338 lmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtp  415 (593)
T KOG0695|consen  338 LMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTP  415 (593)
T ss_pred             eeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCC
Confidence            988888888999999999999999999999999999999999999999999999999999975 344444444 4543

>KOG0199|consensus

Probab=99.83  E-value=2.3e-20  Score=142.25  Aligned_cols=142  Identities=15%  Similarity=0.235  Sum_probs=123.0

Q ss_pred             CeeeeeeeEEEEEEEcc-cCC--eeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           1 MFFIVGTGFLSNCSHVK-QGE--TLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~-~~~--~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++|.|.||+|+.+.+.. +|.  .||+|         +...+.++...+-+|+|||++++|++..+ ...-+|+|+++.|
T Consensus       117 ~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplG  195 (1039)
T KOG0199|consen  117 LLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLG  195 (1039)
T ss_pred             HhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccc
Confidence            47999999999998866 333  34443         45567888889999999999999999887 6788999999999


Q ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccccC
Q psy3273          69 DLHYHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG  143 (145)
Q Consensus        69 ~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  143 (145)
                      ||.+.+..  ...+.-..+..++.||+.++.||.+++++|||+..+|+++.....+|++|||+.+.+..++..+.++
T Consensus       196 SLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~  272 (1039)
T KOG0199|consen  196 SLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMA  272 (1039)
T ss_pred             hHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEec
Confidence            99999976  3457788889999999999999999999999999999999999999999999999998887776653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.83  E-value=1.8e-19  Score=123.85  Aligned_cols=130  Identities=36%  Similarity=0.573  Sum_probs=117.5

Q ss_pred             eeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHh
Q psy3273           6 GTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ   76 (145)
Q Consensus         6 ~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~   76 (145)
                      ++|.+|++....+++.+++|.         ...+.++...++.++|||++++.+.+..++..++++|++++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999999898888863         45666777788899999999999999999999999999999999999877


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          77 HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        77 ~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ...++......++.+++.++.++|..+++|++++|+|++++....++++|||.+.....
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~  139 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDP  139 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence            65689999999999999999999999999999999999999999999999999987654

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=1.2e-18  Score=116.91  Aligned_cols=135  Identities=29%  Similarity=0.425  Sum_probs=120.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|++|.+|++....+++.+++|.         ...+.++...++.++||+++++++++...+..++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            4789999999999998888888852         2456677778899999999999999999999999999999899999


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-CCCEEEeeeccceecCCC
Q psy3273          73 HLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-HGHVRISDLGLACDFSKK  136 (145)
Q Consensus        73 ~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~  136 (145)
                      ++... ..++......++.+++.++.++|..+++|+|++|.|++++. ...++++||+.+......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            98765 56889999999999999999999999999999999999998 899999999999766443

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0669|consensus

Probab=99.82  E-value=6.7e-22  Score=135.43  Aligned_cols=132  Identities=25%  Similarity=0.330  Sum_probs=114.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH----------HHhhhhhcccCCCCceeEeeEEEEcC--------CEEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM----------LSLVSTGIQMVDCPFIVCMTYAFHTP--------DKLCFILD   63 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~hp~i~~~~~~~~~~--------~~~~lv~e   63 (145)
                      .|+|.||-|++|++.++++.|+++.+-+          -.++.++++.++|+|++.+.+.|.+.        ..+|+|++
T Consensus        25 igqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~  104 (376)
T KOG0669|consen   25 IGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFD  104 (376)
T ss_pred             cCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHH
Confidence            5889999999999999999988865433          24566778889999999998887643        34999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          64 LMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        64 ~~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +|+. +|...+... -.++..++..++.+++.|+.|+|+..++|||+|+.|++++.++.++++|||+++.+.
T Consensus       105 ~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs  175 (376)
T KOG0669|consen  105 FCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS  175 (376)
T ss_pred             Hhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence            9976 888888764 568999999999999999999999999999999999999999999999999997653

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.82  E-value=8.4e-19  Score=119.60  Aligned_cols=135  Identities=31%  Similarity=0.435  Sum_probs=120.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|++|.+|++....+++.+++|.         ...+..+...++.++|||++++++.+..++..++++|++++++|.+
T Consensus         7 i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   86 (225)
T smart00221        7 LGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFD   86 (225)
T ss_pred             eecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHH
Confidence            5789999999999999888888753         3345566667888899999999999999999999999999999999


Q ss_pred             HHHhcCC-CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          73 HLSQHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        73 ~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++..... +++.....++.+++.++.++|..+++|+|+++.|++++....++++|||.+..+..+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       87 YLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9987665 889999999999999999999999999999999999999999999999999876544

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG2345|consensus

Probab=99.81  E-value=8e-20  Score=124.54  Aligned_cols=133  Identities=21%  Similarity=0.272  Sum_probs=114.9

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcC-----CEEEEEEEccCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTP-----DKLCFILDLMNG   67 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~   67 (145)
                      .+|-|||..|+..+...+++.+|+|.        .+...++.+.-++++|||+++++++...+     ...|++++|...
T Consensus        28 ~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~  107 (302)
T KOG2345|consen   28 LLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKR  107 (302)
T ss_pred             eecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhcc
Confidence            36889999999999999999999863        34445566666788999999999887543     359999999999


Q ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          68 GDLHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRY--IVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        68 ~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~--iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |+|.+.+..    ...+++.+++.++.++..|+.++|...  ..|+|+||.||++..+..+++.|||.++..
T Consensus       108 Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a  179 (302)
T KOG2345|consen  108 GSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA  179 (302)
T ss_pred             ccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence            999998863    235999999999999999999999998  999999999999999999999999998753

>KOG0983|consensus

Probab=99.80  E-value=7.5e-20  Score=126.61  Aligned_cols=132  Identities=23%  Similarity=0.363  Sum_probs=107.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|.-|.|+++....+|..+|+|.          ...+....-.+..-+.|+||+-+++|.++...++.||.|.. .+.
T Consensus       100 lGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~e  178 (391)
T KOG0983|consen  100 LGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAE  178 (391)
T ss_pred             hcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHH
Confidence            5889999999999999999999962          11111221122333689999999999999999999998844 555


Q ss_pred             HHHH-hcCCCCHHHHHHHHHHHHHHHHHHh-hCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLS-QHGVFNEDEMRFYAAEVILGLEHMH-RRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh-~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .++. ...++++..+-.+...++.|+.||- .++++|||+||+||++|..+.+|++|||++-.+.
T Consensus       179 kLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  179 KLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             HHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence            5554 3578999999999999999999998 5689999999999999999999999999987654

>KOG0603|consensus

Probab=99.79  E-value=4.6e-19  Score=133.40  Aligned_cols=134  Identities=22%  Similarity=0.369  Sum_probs=111.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHHH----Hhhhh-hcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHh
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIML----SLVST-GIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ   76 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~   76 (145)
                      .|.|+|+.+-.|.+..+++..++|.+..-    +++.. .+..-+||||+++.+.+.++...|+|||.+.++-+...+..
T Consensus       330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~  409 (612)
T KOG0603|consen  330 LGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS  409 (612)
T ss_pred             cCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHh
Confidence            36789999999999999998888654432    22221 12333899999999999999999999999999988887776


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE-CCCCCEEEeeeccceecCCC
Q psy3273          77 HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL-DEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        77 ~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~-~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ..... .....|+.+++.++.+||..|++|||++|+||++ +..+.++++|||.++...+.
T Consensus       410 ~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  410 KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            55444 6677899999999999999999999999999999 58889999999999877654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=2.8e-18  Score=116.96  Aligned_cols=125  Identities=16%  Similarity=0.167  Sum_probs=102.2

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH----------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE----------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      ++|.|++|.||++..  .+..+++|.                ...+..+...++.+.|++++.+..++...+..+++|||
T Consensus         3 ~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          3 LIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             ccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            368999999999987  455555542                12344556667788999998888887777889999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          65 MNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        65 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      +++++|.+.+.....    ....++.++..++.++|..+++|+|++|.|++++ ...++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999988865322    6778889999999999999999999999999998 78899999998874

>KOG0596|consensus

Probab=99.79  E-value=2.3e-18  Score=128.31  Aligned_cols=134  Identities=19%  Similarity=0.170  Sum_probs=107.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|+||...||++.....+-+.+.+.         ..-+..+.+.+.+| +|.+|+.++++-.+++.+|+|||+ -..+|.
T Consensus       369 iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~-Gd~DL~  447 (677)
T KOG0596|consen  369 IGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC-GDIDLN  447 (677)
T ss_pred             hcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec-ccccHH
Confidence            5899999999999886665544431         22234444555555 789999999999999999999995 466999


Q ss_pred             HHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          72 YHLSQHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        72 ~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      +++..... .+...+..+..|++.++.++|..||+|.|+||.|+++- .+.+||+|||+|..+....
T Consensus       448 kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  448 KILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             HHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence            99986544 45467888999999999999999999999999999874 6799999999998776543

>KOG0200|consensus

Probab=99.78  E-value=2.9e-18  Score=133.06  Aligned_cols=137  Identities=23%  Similarity=0.248  Sum_probs=115.6

Q ss_pred             eeeeeeeEEEEEEEcc---c----CCeeeee---------HHHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVK---Q----GETLALN---------ERIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~---~----~~~~~~~---------~~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      .|.|+||.|+++....   .    ...+|+|         +...+..+.+.++.+ +||||+.+.+++..++.+++|+||
T Consensus       304 lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey  383 (609)
T KOG0200|consen  304 LGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEY  383 (609)
T ss_pred             eecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEe
Confidence            6899999999987532   1    2345553         455666666666666 599999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          65 MNGGDLHYHLSQHG----------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        65 ~~~~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                      ++.|+|..++...+                .+....+..+..||+.|++|+++..++|||+..+|+++..+..+|++|||
T Consensus       384 ~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFG  463 (609)
T KOG0200|consen  384 AEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFG  463 (609)
T ss_pred             ccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEcccc
Confidence            99999999997654                37888999999999999999999999999999999999999999999999


Q ss_pred             cceecCCCCC
Q psy3273         129 LACDFSKKKP  138 (145)
Q Consensus       129 ~~~~~~~~~~  138 (145)
                      +|+...+.+.
T Consensus       464 lar~~~~~~~  473 (609)
T KOG0200|consen  464 LARDHYNKDY  473 (609)
T ss_pred             ceeccCCCCc
Confidence            9997655433

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.78  E-value=9e-19  Score=134.82  Aligned_cols=132  Identities=19%  Similarity=0.266  Sum_probs=95.1

Q ss_pred             eeeeeeeEEEEEEEccc----CCeeeeeHHHHHH----hhhhhcccCCCCceeEeeEE------EEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQ----GETLALNERIMLS----LVSTGIQMVDCPFIVCMTYA------FHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~~l~hp~i~~~~~~------~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.+..+    +..+++|......    .....++...+.++..+...      ...+..+++++||+++
T Consensus       140 LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~  219 (566)
T PLN03225        140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGE  219 (566)
T ss_pred             EeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCC
Confidence            68999999999999998    8888887432100    00011122222233222222      2345689999999999


Q ss_pred             CCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-CCCEEEee
Q psy3273          68 GDLHYHLSQHGV--------------------FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-HGHVRISD  126 (145)
Q Consensus        68 ~~l~~~l~~~~~--------------------~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-~~~~~l~d  126 (145)
                      ++|.+++.....                    .....+..++.|++.++.|+|+++++|+||||+||+++. ...++++|
T Consensus       220 gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~D  299 (566)
T PLN03225        220 STLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIID  299 (566)
T ss_pred             CcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEe
Confidence            999998864321                    112345678999999999999999999999999999985 57899999


Q ss_pred             eccceec
Q psy3273         127 LGLACDF  133 (145)
Q Consensus       127 fg~~~~~  133 (145)
                      ||+|+.+
T Consensus       300 FGlA~~l  306 (566)
T PLN03225        300 LGAAADL  306 (566)
T ss_pred             CCCcccc
Confidence            9999754

>KOG1006|consensus

Probab=99.78  E-value=4.8e-20  Score=127.02  Aligned_cols=131  Identities=24%  Similarity=0.361  Sum_probs=107.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|-|+||+|++-.+..+|+..|+|.+.          .+......++.=+.||||++|+....++..|+.||+|.- |+.
T Consensus        72 iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlD  150 (361)
T KOG1006|consen   72 IGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLD  150 (361)
T ss_pred             hcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHH
Confidence            588999999999999999999996322          122222234455789999999999999999999999954 776


Q ss_pred             HHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          72 YHLS-----QHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        72 ~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      .+..     ....+++..+..+....+.|+.||-. ..++|||+||+|||++..+.+|++|||++-.+
T Consensus       151 klYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  151 KLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            6554     33568888888888889999999984 56999999999999999999999999988644

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=2.5e-18  Score=119.50  Aligned_cols=131  Identities=13%  Similarity=0.077  Sum_probs=100.7

Q ss_pred             eeeeeeeEEEEEE-EcccCCeeeeeHHH--------------------------------HHHhhhhhcccCCCC--cee
Q psy3273           2 FFIVGTGFLSNCS-HVKQGETLALNERI--------------------------------MLSLVSTGIQMVDCP--FIV   46 (145)
Q Consensus         2 ~g~~~~g~~~~~~-~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~l~hp--~i~   46 (145)
                      +|.|++|.||+|. +..+|+.+++|...                                .++.+...++.+.+.  .++
T Consensus        36 Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p  115 (237)
T smart00090       36 ISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVP  115 (237)
T ss_pred             eccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            6889999999998 77789999886322                                123455556666653  344


Q ss_pred             EeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC-ceecCCCCCcEEECCCCCEEEe
Q psy3273          47 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY-IVYRDLKPANILLDEHGHVRIS  125 (145)
Q Consensus        47 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-iih~~l~~~nil~~~~~~~~l~  125 (145)
                      ++++.    ...++|||++++.++.................++.|++.++.++|..+ ++|+|++|+||+++ ...++++
T Consensus       116 ~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~Li  190 (237)
T smart00090      116 KPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVII  190 (237)
T ss_pred             eeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEE
Confidence            55542    235899999999887665544445666677889999999999999999 99999999999998 7889999


Q ss_pred             eeccceecCCCC
Q psy3273         126 DLGLACDFSKKK  137 (145)
Q Consensus       126 dfg~~~~~~~~~  137 (145)
                      |||.+.....+.
T Consensus       191 DFg~a~~~~~~~  202 (237)
T smart00090      191 DVSQSVELDHPM  202 (237)
T ss_pred             EChhhhccCCcc
Confidence            999998765554

>KOG1165|consensus

Probab=99.78  E-value=3.5e-18  Score=121.05  Aligned_cols=140  Identities=20%  Similarity=0.273  Sum_probs=115.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|+|+||.++...+.-+++.||+|-.      -.++.+-..-+.| ..++|+..|-+...+.+=.+|+|++ |.||.++.
T Consensus        36 IGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLF  114 (449)
T KOG1165|consen   36 IGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLF  114 (449)
T ss_pred             cccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHH
Confidence            58999999999999999999999621      1111111111111 6789999998888888888999988 77999988


Q ss_pred             H-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-----CCEEEeeeccceecCCCCCcccc
Q psy3273          75 S-QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-----GHVRISDLGLACDFSKKKPHASV  142 (145)
Q Consensus        75 ~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-----~~~~l~dfg~~~~~~~~~~~~~~  142 (145)
                      . +.+.++.+++..++.|++.-++++|++.+|+|||||+|+|++..     ..+.++|||+|+.+.+++..+.+
T Consensus       115 D~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHI  188 (449)
T KOG1165|consen  115 DLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHI  188 (449)
T ss_pred             HHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccC
Confidence            6 56789999999999999999999999999999999999999754     35899999999999988877765

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.77  E-value=3.9e-18  Score=129.28  Aligned_cols=133  Identities=20%  Similarity=0.179  Sum_probs=98.0

Q ss_pred             eeeeeeeEEEEEEEcc----------------cCCeeeeeHHHHH--------Hh--------------hhhhcccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVK----------------QGETLALNERIML--------SL--------------VSTGIQMVDCP   43 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~----------------~~~~~~~~~~~~~--------~~--------------~~~~~~~l~hp   43 (145)
                      +|.|+||.||++....                .++.+++|.....        .+              +...+..++|.
T Consensus       153 LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~  232 (507)
T PLN03224        153 LGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRN  232 (507)
T ss_pred             eecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcc
Confidence            6899999999987532                3456777653211        11              11122334444


Q ss_pred             c-----eeEeeEEEEc--------CCEEEEEEEccCCCCHHHHHHhcC------------------------CCCHHHHH
Q psy3273          44 F-----IVCMTYAFHT--------PDKLCFILDLMNGGDLHYHLSQHG------------------------VFNEDEMR   86 (145)
Q Consensus        44 ~-----i~~~~~~~~~--------~~~~~lv~e~~~~~~l~~~l~~~~------------------------~~~~~~~~   86 (145)
                      +     +++++++|..        ++..++||||+++++|.+++....                        ..+...+.
T Consensus       233 ~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~  312 (507)
T PLN03224        233 PIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIK  312 (507)
T ss_pred             cchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHH
Confidence            3     4667777653        356899999999999999886321                        13455677


Q ss_pred             HHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          87 FYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        87 ~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .++.|++.++.|+|..+++|+|++|+||+++.+..++++|||++..+.
T Consensus       313 ~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  360 (507)
T PLN03224        313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMC  360 (507)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence            899999999999999999999999999999999999999999997653

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=6.8e-18  Score=114.16  Aligned_cols=123  Identities=15%  Similarity=0.110  Sum_probs=96.8

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH----------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE----------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      +.|.|++|.||++..  .+..+++|.                ...+.++...++.+.|++++...-++...+..+++||+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            468999999999984  344555542                12234566667778888776666666667778999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          65 MNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        65 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +++++|...+.....       .++.+++.++.++|..+++|+|++|.|++++ ...++++|||.+...
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999887754211       6788999999999999999999999999998 788999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=1.2e-17  Score=128.15  Aligned_cols=124  Identities=12%  Similarity=0.074  Sum_probs=100.6

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeee--------------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALN--------------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      ++|.|++|.||++........+..+              ....+.++...++.++|++++.+..++......+++|||++
T Consensus       340 ~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~  419 (535)
T PRK09605        340 LIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIG  419 (535)
T ss_pred             eeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecC
Confidence            3689999999998765443322111              11335667778889999999988888877778899999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +++|.+++.        ....++.+++.++.++|..+++|+|++|+||++ .+..++++|||+++..
T Consensus       420 g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        420 GKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            999988775        345688999999999999999999999999999 5778999999999754

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=2.2e-17  Score=111.82  Aligned_cols=121  Identities=17%  Similarity=0.094  Sum_probs=93.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee------------HHHHHHhhhhhcccCCC-CceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN------------ERIMLSLVSTGIQMVDC-PFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      ++.++||.|+.+..  .++.+..+            ....++++.++++.|+| |++++++++    +..+++|||+.|.
T Consensus        10 l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~   83 (218)
T PRK12274         10 LKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGA   83 (218)
T ss_pred             ecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCc
Confidence            67899999996665  33333321            12246788888999954 889999886    4569999999998


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCC-CCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDL-KPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l-~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+....       ....+..|+..++.++|+.|++|+|+ +|+||+++.++.++++|||++....+
T Consensus        84 ~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         84 AMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             cHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            88654321       11346788999999999999999999 79999999889999999999985543

>KOG2052|consensus

Probab=99.75  E-value=1e-17  Score=122.02  Aligned_cols=131  Identities=27%  Similarity=0.292  Sum_probs=108.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee------HHHHHHhhhhhc--ccCCCCceeEeeEEEEcC----CEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN------ERIMLSLVSTGI--QMVDCPFIVCMTYAFHTP----DKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~--~~l~hp~i~~~~~~~~~~----~~~~lv~e~~~~~~   69 (145)
                      .|.|.||-||++...  |+.||+|      |..++ ++.++-  .+|+|+||..+.+.=..+    .++|+|+||.+.||
T Consensus       219 IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWf-rEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GS  295 (513)
T KOG2052|consen  219 IGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWF-RETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGS  295 (513)
T ss_pred             ecCccccceeecccc--CCceEEEEecccchhhhh-hHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCc
Confidence            588999999999886  5666664      33333 333332  367999999999886654    37999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR--------YIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |++++.. ..++......++..++.|+.+||..        .|.|||||..||++.+++.+.++|+|+|-...+.
T Consensus       296 L~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~  369 (513)
T KOG2052|consen  296 LYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD  369 (513)
T ss_pred             HHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence            9999987 6788999999999999999999953        4899999999999999999999999999776543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.75  E-value=1.1e-17  Score=115.07  Aligned_cols=122  Identities=15%  Similarity=0.154  Sum_probs=96.2

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH--------HH---------HHhhhhhcccCCCCceeEeeEEEEcC--------
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER--------IM---------LSLVSTGIQMVDCPFIVCMTYAFHTP--------   55 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~--------~~---------~~~~~~~~~~l~hp~i~~~~~~~~~~--------   55 (145)
                      ++|-|++|.|+.+..  ++..+++|..        ..         ++++...++.+.||+|+.+.+++...        
T Consensus        38 ~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~  115 (232)
T PRK10359         38 VFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYA  115 (232)
T ss_pred             EecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccccc
Confidence            367899999998655  3556667532        11         45666678889999999999987643        


Q ss_pred             CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          56 DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        56 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +..+++|||++|.+|.++..    .++    ....++..++..+|..|++|+|++|.|+++++++ ++++|||.+...
T Consensus       116 ~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~  184 (232)
T PRK10359        116 HTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCT  184 (232)
T ss_pred             CCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccc
Confidence            35899999999999977632    222    2456889999999999999999999999998877 999999988655

>KOG0668|consensus

Probab=99.74  E-value=2.8e-18  Score=116.33  Aligned_cols=132  Identities=19%  Similarity=0.289  Sum_probs=110.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee-----HHHHHHhhhhhcccCC-CCceeEeeEEEEcCC--EEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN-----ERIMLSLVSTGIQMVD-CPFIVCMTYAFHTPD--KLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~-hp~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|-|.-|+.+.+..+++...+|     ....+.++..++++|. ||||++++++..+..  ...+++|+..+.+..++
T Consensus        46 ~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~l  125 (338)
T KOG0668|consen   46 VGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQL  125 (338)
T ss_pred             HcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHH
Confidence            477888899999999999888775     3455677888888885 999999999988653  47789999988766555


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-CCEEEeeeccceecCCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSKK  136 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~  136 (145)
                      .   +.+....+..++.+++.|+.|+|+.||.|||+||+|++++.. ..++++|.|+|..+-++
T Consensus       126 y---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  126 Y---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             h---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            4   357778899999999999999999999999999999999976 56999999999866443

>KOG0665|consensus

Probab=99.73  E-value=3.7e-18  Score=119.97  Aligned_cols=128  Identities=19%  Similarity=0.311  Sum_probs=105.0

Q ss_pred             eeeeeeEEEEEEEcccCCeeeeeHHHH----------HHhhhhhcccCCCCceeEeeEEEEcCC------EEEEEEEccC
Q psy3273           3 FIVGTGFLSNCSHVKQGETLALNERIM----------LSLVSTGIQMVDCPFIVCMTYAFHTPD------KLCFILDLMN   66 (145)
Q Consensus         3 g~~~~g~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~hp~i~~~~~~~~~~~------~~~lv~e~~~   66 (145)
                      |.|+- .+..|.+...++.+++|+...          -.++...+..++|+||++++.+|....      ..|+|||++.
T Consensus        26 ~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~  104 (369)
T KOG0665|consen   26 GSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD  104 (369)
T ss_pred             CCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh
Confidence            44555 788888888888888864322          234444556779999999999997553      5899999995


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      . +|.+.+.  ..++.+++..+..|++.|++++|+.||+|||+||+||++..++..|+.|||+|+.-.
T Consensus       105 ~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen  105 A-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             h-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence            5 8877776  457889999999999999999999999999999999999999999999999997543

>KOG1345|consensus

Probab=99.73  E-value=1.8e-17  Score=114.73  Aligned_cols=132  Identities=21%  Similarity=0.275  Sum_probs=105.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhh-hcccCCCCceeEeeEE-EEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVST-GIQMVDCPFIVCMTYA-FHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~~~l~hp~i~~~~~~-~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|-|-||.+-.|.++.+...+++|.+       ..+.++-+ ..--=-|.||+.-|++ |++.+.+++++|+++.|+|.+
T Consensus        32 lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~s  111 (378)
T KOG1345|consen   32 LGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRS  111 (378)
T ss_pred             hcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhh
Confidence            58899999999999999999988632       12222211 1111158899987766 888999999999999999977


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC--CCCEEEeeeccceecC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE--HGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~--~~~~~l~dfg~~~~~~  134 (145)
                      -+.. ..+.+.....++.|++.|+.|||+..++|||||.+|||+-.  ..++|++|||..+...
T Consensus       112 nv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  112 NVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             hcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            6654 34678888899999999999999999999999999999843  3589999999987543

>KOG1164|consensus

Probab=99.72  E-value=5.1e-17  Score=117.59  Aligned_cols=130  Identities=19%  Similarity=0.220  Sum_probs=104.7

Q ss_pred             CeeeeeeeEEEEEEEcccC-CeeeeeHHH--------HHHhhhhhcccCC----CCceeEeeEEE-EcCCEEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQG-ETLALNERI--------MLSLVSTGIQMVD----CPFIVCMTYAF-HTPDKLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~~~l~----hp~i~~~~~~~-~~~~~~~lv~e~~~   66 (145)
                      .+|.|+||.||.+.+..++ ..+|+|...        .+..+...+..+.    .++++++.+.+ ..++.-|+||+.+ 
T Consensus        25 ~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-  103 (322)
T KOG1164|consen   25 KIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-  103 (322)
T ss_pred             eccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-
Confidence            3689999999999998875 455554211        2333444444443    36999999999 5788999999977 


Q ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-----CCEEEeeeccce
Q psy3273          67 GGDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-----GHVRISDLGLAC  131 (145)
Q Consensus        67 ~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-----~~~~l~dfg~~~  131 (145)
                      |.+|.++....  +.++..++..++.|++.+++++|+.|++||||||+|+.++..     ..+.+.|||+++
T Consensus       104 G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen  104 GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            77999988543  569999999999999999999999999999999999999855     458999999999

>KOG1027|consensus

Probab=99.71  E-value=4.6e-17  Score=125.90  Aligned_cols=133  Identities=23%  Similarity=0.260  Sum_probs=98.2

Q ss_pred             eeeeeeeE-EEEEEEcccCCeeeeeHH-----HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGF-LSNCSHVKQGETLALNER-----IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~-~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|+.|+ ||+..  -.++.||+|..     ...+++...++.- +||||+++++.-.++...||..|.|+- +|.+++
T Consensus       517 lG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dli  593 (903)
T KOG1027|consen  517 LGYGSNGTVVFRGV--YEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLI  593 (903)
T ss_pred             cccCCCCcEEEEEe--eCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHH
Confidence            35555554 34433  35667777532     2334444444333 899999999999999999999999966 999999


Q ss_pred             HhcCC---CCH-HHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-----CCEEEeeeccceecCCCC
Q psy3273          75 SQHGV---FNE-DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-----GHVRISDLGLACDFSKKK  137 (145)
Q Consensus        75 ~~~~~---~~~-~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-----~~~~l~dfg~~~~~~~~~  137 (145)
                      .....   ... ........|++.|+.+||+.+++|||++|+|||+...     .+++++|||+++++..+.
T Consensus       594 e~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  594 ESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             hccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            76311   111 3446778999999999999999999999999999752     468999999999886553

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=1.1e-16  Score=108.33  Aligned_cols=124  Identities=12%  Similarity=0.061  Sum_probs=93.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH------------------------------HHHhhhhhcccCCCC--ceeEee
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI------------------------------MLSLVSTGIQMVDCP--FIVCMT   49 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~hp--~i~~~~   49 (145)
                      .|.|++|.||++... +++.+++|...                              ....+...+..+.|+  .+++.+
T Consensus        23 i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~  101 (198)
T cd05144          23 IGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPI  101 (198)
T ss_pred             cccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCcee
Confidence            678999999999875 78888887210                              123334445566666  344444


Q ss_pred             EEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecc
Q psy3273          50 YAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL  129 (145)
Q Consensus        50 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~  129 (145)
                      +    .+..+++|||++++++......      .....++.+++.++.++|..+++|+|++|.|++++.+..++++|||.
T Consensus       102 ~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~  171 (198)
T cd05144         102 D----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQ  171 (198)
T ss_pred             e----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCc
Confidence            3    2456899999999888654321      33456788999999999999999999999999999999999999999


Q ss_pred             ceecCCC
Q psy3273         130 ACDFSKK  136 (145)
Q Consensus       130 ~~~~~~~  136 (145)
                      +.....+
T Consensus       172 ~~~~~~~  178 (198)
T cd05144         172 MVSTDHP  178 (198)
T ss_pred             cccCCCc
Confidence            9766554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0671|consensus

Probab=99.69  E-value=2.1e-16  Score=113.30  Aligned_cols=132  Identities=21%  Similarity=0.277  Sum_probs=106.3

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHHHHH-------hhhhhcccCCC--C----ceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERIMLS-------LVSTGIQMVDC--P----FIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~h--p----~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      ++|-|.||.|..|.+..++..+|+|......       .+.+.++.+.+  |    -++.+.++|...++.|+|+|.+ |
T Consensus        96 ~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G  174 (415)
T KOG0671|consen   96 LLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-G  174 (415)
T ss_pred             hhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-C
Confidence            4799999999999999999999986433322       22223344421  2    3578899999999999999988 6


Q ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC--------------------CCCEEEe
Q psy3273          68 GDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE--------------------HGHVRIS  125 (145)
Q Consensus        68 ~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~--------------------~~~~~l~  125 (145)
                      .|+++++..+  .+++...++.+..|++.++.+||+.+++|-|+||+||++.+                    ...++++
T Consensus       175 ~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vI  254 (415)
T KOG0671|consen  175 LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVI  254 (415)
T ss_pred             hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEE
Confidence            6999999753  56999999999999999999999999999999999999832                    1247999


Q ss_pred             eeccceec
Q psy3273         126 DLGLACDF  133 (145)
Q Consensus       126 dfg~~~~~  133 (145)
                      |||.|+.-
T Consensus       255 DFGsAtf~  262 (415)
T KOG0671|consen  255 DFGSATFD  262 (415)
T ss_pred             ecCCccee
Confidence            99999743

>KOG1167|consensus

Probab=99.68  E-value=8.2e-17  Score=116.40  Aligned_cols=130  Identities=18%  Similarity=0.280  Sum_probs=106.6

Q ss_pred             CeeeeeeeEEEEEEEcc---cCCeeeeeHHHH------HHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           1 MFFIVGTGFLSNCSHVK---QGETLALNERIM------LSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .+|.|.|++||++.+..   ..+.+++|.+..      ...+.+.+..+ .+.||+++.+++...++..+|+||++.-.-
T Consensus        43 kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f  122 (418)
T KOG1167|consen   43 KIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRF  122 (418)
T ss_pred             cccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCH
Confidence            37899999999999988   778888864322      22222222222 789999999999999999999999988776


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-CCEEEeeeccceec
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-~~~~l~dfg~~~~~  133 (145)
                      .+++.   .++...+..+++.++.++.++|.+||+|||+||+|++.+.. ++-.|.|||+|..+
T Consensus       123 ~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  123 RDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             HHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence            66664   36688899999999999999999999999999999999855 67899999999743

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=2.1e-15  Score=104.97  Aligned_cols=126  Identities=17%  Similarity=0.088  Sum_probs=92.9

Q ss_pred             ee-eeeeeEEEEEEEcccCCeeeeeH---------------------HHHHHhhhhhcccCCCCce--eEeeEEEEcC-C
Q psy3273           2 FF-IVGTGFLSNCSHVKQGETLALNE---------------------RIMLSLVSTGIQMVDCPFI--VCMTYAFHTP-D   56 (145)
Q Consensus         2 ~g-~~~~g~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~hp~i--~~~~~~~~~~-~   56 (145)
                      +| .||.|+++.++..  ++.++++.                     .....++...++.++|+++  +++++....+ .
T Consensus        39 lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         39 VGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             eecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            45 6888999988775  33444421                     1233456677778888875  6777765433 2


Q ss_pred             ---EEEEEEEccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          57 ---KLCFILDLMNG-GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        57 ---~~~lv~e~~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                         ..++|||++++ .+|.+++.. ..+++..    ..+++.++.++|.+|++|+|++|.||+++.+..++++|||.+..
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence               23599999997 688887754 3455443    46789999999999999999999999999888999999999876


Q ss_pred             cC
Q psy3273         133 FS  134 (145)
Q Consensus       133 ~~  134 (145)
                      ..
T Consensus       192 ~~  193 (239)
T PRK01723        192 RT  193 (239)
T ss_pred             CC
Confidence            54

>KOG0670|consensus

Probab=99.65  E-value=3.2e-16  Score=116.60  Aligned_cols=135  Identities=19%  Similarity=0.264  Sum_probs=109.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---HH----HhhhhhcccC------CCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---ML----SLVSTGIQMV------DCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---~~----~~~~~~~~~l------~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|=|++|..|.+.+-|+.||+|.+.   .+    ..+..++++|      +--|.++++..|....++|+|+|.+.- 
T Consensus       440 ~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Lsl-  518 (752)
T KOG0670|consen  440 TGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSL-  518 (752)
T ss_pred             cccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhc-
Confidence            478889999999999999999996321   11    2233334444      335889999999999999999998844 


Q ss_pred             CHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-CCEEEeeeccceecCCCC
Q psy3273          69 DLHYHLSQHGV---FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK  137 (145)
Q Consensus        69 ~l~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~  137 (145)
                      +|...+...+.   +....+..++.|+..|+..|-.++++|.||+|+|||+... ..+||||||.|.....++
T Consensus       519 NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene  591 (752)
T KOG0670|consen  519 NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE  591 (752)
T ss_pred             hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccc
Confidence            88888886543   7788899999999999999999999999999999999855 568999999998766554

>KOG1166|consensus

Probab=99.65  E-value=3.2e-16  Score=124.68  Aligned_cols=132  Identities=20%  Similarity=0.251  Sum_probs=105.8

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +.|.|+||.||+|...+ ++.+|+|.        .-...+....|+-.--|-|..+...+.-.+.-++|+||.+.|+|.+
T Consensus       705 e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld  783 (974)
T KOG1166|consen  705 EIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLD  783 (974)
T ss_pred             eeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHH
Confidence            46999999999999998 99999972        2222222222221112456666666677777889999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-------CCEEEeeeccceec
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-------GHVRISDLGLACDF  133 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-------~~~~l~dfg~~~~~  133 (145)
                      ++.....+++..+..+..|++.-+..+|..+|||+||||+|+++...       .-++|+|||.|-++
T Consensus       784 ~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  784 LINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             hhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            99987889999999999999999999999999999999999999532       35899999998654

>KOG1290|consensus

Probab=99.65  E-value=2.5e-15  Score=110.92  Aligned_cols=117  Identities=19%  Similarity=0.220  Sum_probs=93.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------------HHHHHhhhhhc-ccCCCCceeEeeEEEEcC----CEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------------RIMLSLVSTGI-QMVDCPFIVCMTYAFHTP----DKLCFIL   62 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~-~~l~hp~i~~~~~~~~~~----~~~~lv~   62 (145)
                      +|-|-|.+||.|.+..+.+.||+|.              +..+++..+.= +..+-..||+|++.|...    .++|||+
T Consensus        86 LGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVf  165 (590)
T KOG1290|consen   86 LGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVF  165 (590)
T ss_pred             ccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEe
Confidence            5788999999999999999999963              33333332210 122335799999999754    4899999


Q ss_pred             EccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHh-hCCceecCCCCCcEEECCC
Q psy3273          63 DLMNGGDLHYHLSQ--HGVFNEDEMRFYAAEVILGLEHMH-RRYIVYRDLKPANILLDEH  119 (145)
Q Consensus        63 e~~~~~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh-~~~iih~~l~~~nil~~~~  119 (145)
                      |++ |-+|..++..  +..++...+..++.|++.|+.||| .+||+|-||||+|+|+...
T Consensus       166 EvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  166 EVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             hhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence            999 5588888863  466999999999999999999999 6899999999999998644

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=2.6e-15  Score=100.51  Aligned_cols=130  Identities=14%  Similarity=0.111  Sum_probs=88.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHHH--------H------------------------HhhhhhcccCCCC--cee
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERIM--------L------------------------SLVSTGIQMVDCP--FIV   46 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~~--------~------------------------~~~~~~~~~l~hp--~i~   46 (145)
                      .+|.|++|.||.|.+. +++.+++|....        .                        ..+...+..+.+.  .++
T Consensus         4 ~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           4 PIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             ccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            3689999999999887 788888873111        0                        0111111122222  234


Q ss_pred             EeeEEEEcCCEEEEEEEccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEE
Q psy3273          47 CMTYAFHTPDKLCFILDLMNGGDLHY-HLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRI  124 (145)
Q Consensus        47 ~~~~~~~~~~~~~lv~e~~~~~~l~~-~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l  124 (145)
                      ++++.    ...+++|||++++.+.. .+... .. ......++.+++.++.++|. .+++|+|++|+|++++ +..+++
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~l  155 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYI  155 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEE
Confidence            44443    24589999999844321 11111 11 15667889999999999999 9999999999999999 889999


Q ss_pred             eeeccceecCCCCC
Q psy3273         125 SDLGLACDFSKKKP  138 (145)
Q Consensus       125 ~dfg~~~~~~~~~~  138 (145)
                      +|||.+.....+..
T Consensus       156 iDfg~a~~~~~~~~  169 (187)
T cd05119         156 IDVPQAVEIDHPNA  169 (187)
T ss_pred             EECcccccccCcch
Confidence            99999987765443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.60  E-value=9.2e-14  Score=98.29  Aligned_cols=132  Identities=28%  Similarity=0.378  Sum_probs=110.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee-----------HHHHHHhhhhhcccCCCC-ceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN-----------ERIMLSLVSTGIQMVDCP-FIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~hp-~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.+|.+.+.   ..++++           ....+.++...++.+.|+ +++++.+.+......+++++++.+++
T Consensus         8 l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~   84 (384)
T COG0515           8 LGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGS   84 (384)
T ss_pred             ecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCc
Confidence            578899999999998   333332           133455555667888888 79999999988888999999999999


Q ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC-CEEEeeeccceecCCC
Q psy3273          70 LHYHLSQHG---VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG-HVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~  136 (145)
                      +...+....   .++......+..|++.++.++|..+++|+|++|+|++++... .+++.|||.+..+...
T Consensus        85 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          85 LEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             HHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            997776554   789999999999999999999999999999999999999888 7999999999865543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.53  E-value=5.7e-14  Score=90.08  Aligned_cols=122  Identities=17%  Similarity=0.086  Sum_probs=96.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH------HHHHhhhhhcccCCC--CceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER------IMLSLVSTGIQMVDC--PFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~h--p~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+++.+|++....  ..+++|..      ..+..+...++.+.+  +++++++.++..++..+++|||+++.++...
T Consensus         6 i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~   83 (155)
T cd05120           6 LKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV   83 (155)
T ss_pred             cccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC
Confidence            5788999999999855  34444321      235566666667766  5889999998888899999999988766443


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhC---CceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRR---YIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                             +......+..++..++..+|..   +++|+|++|.|++++....+++.||+.+..
T Consensus        84 -------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          84 -------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             -------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence                   4455566788899999999974   699999999999999888999999998874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590|consensus

Probab=99.51  E-value=2.6e-14  Score=110.62  Aligned_cols=133  Identities=18%  Similarity=0.179  Sum_probs=105.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----------H---HHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----------M---LSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~---~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      ++|.|++|.++.+...........++..           .   ...+...-..+.|||++.....+......+-.||||+
T Consensus       325 ~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~  404 (601)
T KOG0590|consen  325 VLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCP  404 (601)
T ss_pred             eeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhccc
Confidence            4788999977777776655444443322           1   1111122346799999888777776666666699999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      + +|+.++.+.+.+...++..++.|++.|+.|+|..|+.|+|++++|+++...+.++++|||.+..+.
T Consensus       405 ~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  405 Y-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             H-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence            9 999999887788899999999999999999999999999999999999999999999999987654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.50  E-value=2.3e-14  Score=114.55  Aligned_cols=90  Identities=12%  Similarity=0.177  Sum_probs=71.6

Q ss_pred             ccCCC-CceeEeeEEE-------EcCCEEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecC
Q psy3273          38 QMVDC-PFIVCMTYAF-------HTPDKLCFILDLMNGGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRD  108 (145)
Q Consensus        38 ~~l~h-p~i~~~~~~~-------~~~~~~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~  108 (145)
                      +.+.| +||.+++++|       ..+..++.++|++ +++|.+++.. ...+++.++..++.|++.|+.|+|+++|+|||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            34477 6888899988       2334677888987 5599999975 35699999999999999999999999999999


Q ss_pred             CCCCcEEECCCCCEEEeeec
Q psy3273         109 LKPANILLDEHGHVRISDLG  128 (145)
Q Consensus       109 l~~~nil~~~~~~~~l~dfg  128 (145)
                      |||+||+++..+.++++|||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~  125 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESA  125 (793)
T ss_pred             CCchhEEEcccCcEEEeecc
Confidence            99999999654444444433

>KOG1024|consensus

Probab=99.49  E-value=3.4e-13  Score=97.84  Aligned_cols=136  Identities=13%  Similarity=0.175  Sum_probs=108.5

Q ss_pred             eeeeeeeEEEEEEEcccC-----Ceeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcC-CEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQG-----ETLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTP-DKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~-----~~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~   66 (145)
                      ..-|.||.+|.+..+...     +.+.+|         ++.++.++...+..+.|||+..+.++...+ +.-++++.++.
T Consensus       292 lqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~  371 (563)
T KOG1024|consen  292 LQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATG  371 (563)
T ss_pred             hhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccC
Confidence            356889999999665432     222222         345566666777888999999999997654 56778889998


Q ss_pred             CCCHHHHHH-----h---cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          67 GGDLHYHLS-----Q---HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        67 ~~~l~~~l~-----~---~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      -|+|..++.     +   ...+.-.+...+..|++.|+.|+|+.+++|.||..+|+++++.-++|++|-.+++.+-+.+
T Consensus       372 ~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~D  450 (563)
T KOG1024|consen  372 VGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGD  450 (563)
T ss_pred             cchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCccc
Confidence            899999997     1   1236667788899999999999999999999999999999999999999999999875543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.39  E-value=6.2e-12  Score=94.54  Aligned_cols=92  Identities=16%  Similarity=0.227  Sum_probs=64.6

Q ss_pred             CCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHhhCCceecCCCCCcEEECCC
Q psy3273          42 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVIL-GLEHMHRRYIVYRDLKPANILLDEH  119 (145)
Q Consensus        42 hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~-~l~~lh~~~iih~~l~~~nil~~~~  119 (145)
                      +|++.-..-+....+..+++|||++|.++.+..... ...+..   .+...++. .+..+|..|++|+|++|.|++++.+
T Consensus       217 ~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~---~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~  293 (437)
T TIGR01982       217 DPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRK---ALAENLARSFLNQVLRDGFFHADLHPGNIFVLKD  293 (437)
T ss_pred             CCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHH---HHHHHHHHHHHHHHHhCCceeCCCCcccEEECCC
Confidence            454433333333345679999999999998776432 122222   23333333 3567889999999999999999999


Q ss_pred             CCEEEeeeccceecCCC
Q psy3273         120 GHVRISDLGLACDFSKK  136 (145)
Q Consensus       120 ~~~~l~dfg~~~~~~~~  136 (145)
                      +.++++|||++..+.+.
T Consensus       294 g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       294 GKIIALDFGIVGRLSEE  310 (437)
T ss_pred             CcEEEEeCCCeeECCHH
Confidence            99999999999877543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.32  E-value=2.2e-12  Score=98.64  Aligned_cols=75  Identities=17%  Similarity=0.297  Sum_probs=55.2

Q ss_pred             CCEEEEEEEccCCCCHHHHH--HhcC----CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC----CEEE
Q psy3273          55 PDKLCFILDLMNGGDLHYHL--SQHG----VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG----HVRI  124 (145)
Q Consensus        55 ~~~~~lv~e~~~~~~l~~~l--~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~----~~~l  124 (145)
                      .+..+++|||++|+++.+.-  ...+    .+.+..+..++.|+       ...|++|+|++|.||+++.++    .+++
T Consensus       233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~l  305 (537)
T PRK04750        233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIA  305 (537)
T ss_pred             CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEE
Confidence            34567999999999997642  2222    13334444455554       358999999999999998877    8999


Q ss_pred             eeeccceecCCC
Q psy3273         125 SDLGLACDFSKK  136 (145)
Q Consensus       125 ~dfg~~~~~~~~  136 (145)
                      .|||++..+.+.
T Consensus       306 lDFGivg~l~~~  317 (537)
T PRK04750        306 LDFGIVGSLNKE  317 (537)
T ss_pred             EecceEEECCHH
Confidence            999999877554

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.28  E-value=9.2e-11  Score=79.19  Aligned_cols=90  Identities=14%  Similarity=0.196  Sum_probs=66.7

Q ss_pred             CceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCceecCCCCCcEEECCCCC
Q psy3273          43 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM-HRRYIVYRDLKPANILLDEHGH  121 (145)
Q Consensus        43 p~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~iih~~l~~~nil~~~~~~  121 (145)
                      -++++++++    ..-++|||++.+..+....-....++......+..+++.++..+ |..+++|+|+++.||++. ++.
T Consensus        88 v~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~  162 (197)
T cd05146          88 IPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGK  162 (197)
T ss_pred             CCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCc
Confidence            355666664    45679999997654432222223455566677789999999988 899999999999999996 467


Q ss_pred             EEEeeeccceecCCCC
Q psy3273         122 VRISDLGLACDFSKKK  137 (145)
Q Consensus       122 ~~l~dfg~~~~~~~~~  137 (145)
                      +.++|||.+.....+.
T Consensus       163 v~iIDF~qav~~~hp~  178 (197)
T cd05146         163 VWFIDVSQSVEPTHPH  178 (197)
T ss_pred             EEEEECCCceeCCCCC
Confidence            9999999998775543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG4158|consensus

Probab=99.24  E-value=2.9e-11  Score=88.33  Aligned_cols=89  Identities=25%  Similarity=0.365  Sum_probs=71.7

Q ss_pred             CCCCceeEeeEEEEcC---------------------------CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHH
Q psy3273          40 VDCPFIVCMTYAFHTP---------------------------DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEV   92 (145)
Q Consensus        40 l~hp~i~~~~~~~~~~---------------------------~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i   92 (145)
                      -+|||||++.+.|.++                           ..+|+||...+- +|..++..+ ..+......++.|+
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHH
Confidence            3899999999998751                           248999987744 888877653 34556667788999


Q ss_pred             HHHHHHHhhCCceecCCCCCcEEEC--CC--CCEEEeeeccc
Q psy3273          93 ILGLEHMHRRYIVYRDLKPANILLD--EH--GHVRISDLGLA  130 (145)
Q Consensus        93 ~~~l~~lh~~~iih~~l~~~nil~~--~~--~~~~l~dfg~~  130 (145)
                      ++++.|+|.+|+.|||+|.+||++.  ++  -.+.++|||++
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence            9999999999999999999999984  22  35789999976

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=9.1e-11  Score=77.77  Aligned_cols=95  Identities=19%  Similarity=0.124  Sum_probs=74.3

Q ss_pred             HHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCC
Q psy3273          30 LSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDL  109 (145)
Q Consensus        30 ~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l  109 (145)
                      ..++...++.+.-..|+.+.=++.+.+...|+|||.++..|.+.+...   .    ..++..+-.-+.-||..|++|+|+
T Consensus        46 t~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDL  118 (204)
T COG3642          46 TRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDL  118 (204)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCC
Confidence            345555566666667777777777778888999999998888888754   1    345566666778899999999999


Q ss_pred             CCCcEEECCCCCEEEeeecccee
Q psy3273         110 KPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus       110 ~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      .++|+++.... +.++|||++..
T Consensus       119 TtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642         119 TTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             ccceEEEeCCc-EEEEECCcccc
Confidence            99999997655 99999999973

>KOG0603|consensus

Probab=99.20  E-value=5.5e-12  Score=95.75  Aligned_cols=134  Identities=34%  Similarity=0.535  Sum_probs=106.5

Q ss_pred             eeeeeeeEEEEEEEc---ccCCeeeeeHH----------HHHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHV---KQGETLALNER----------IMLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.++.+...   ..+..+++|..          ..-..+...+..++ ||.++++...|+++...++++++..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            477888887766442   23444444211          11112222333344 99999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |.+...+.....+.+.....+...++.++.++|..+++++|+|++||+++..+.+++.|||.++....
T Consensus        82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh
Confidence            99999998888888999999999999999999999999999999999999999999999999986543

>KOG3087|consensus

Probab=99.16  E-value=1e-09  Score=72.92  Aligned_cols=130  Identities=16%  Similarity=0.143  Sum_probs=89.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      .-+|+.+.++++...  |+...+|+                .....+++..+.++.--.|..+.=+|.+...-.++|||+
T Consensus        15 ikQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~   92 (229)
T KOG3087|consen   15 IKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI   92 (229)
T ss_pred             eeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence            346777777666543  44433331                222344555566666567776666777777777999999


Q ss_pred             CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC---CEEEeeeccceec
Q psy3273          66 NG-GDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG---HVRISDLGLACDF  133 (145)
Q Consensus        66 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~---~~~l~dfg~~~~~  133 (145)
                      ++ .++.+++.+.  ..........++..+-..+.-||.++++|+|+..+||++.+++   .+.++|||++..-
T Consensus        93 ~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   93 DGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             cchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            77 4777777643  2233333367888888899999999999999999999986543   4589999998643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.15  E-value=1.5e-10  Score=76.17  Aligned_cols=117  Identities=15%  Similarity=0.048  Sum_probs=78.7

Q ss_pred             eeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccCCCCc-eeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           3 FIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMVDCPF-IVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         3 g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~hp~-i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +.|..+.+|++...  ++.+++|..       ...+.+...++.+.+.+ +++++....  +..++|||++++.++... 
T Consensus         7 ~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~-   81 (170)
T cd05151           7 KGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE-   81 (170)
T ss_pred             CCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc-
Confidence            45667788887754  445555421       12344444555554433 356665543  335799999999877542 


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHhhCCc-----eecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          75 SQHGVFNEDEMRFYAAEVILGLEHMHRRYI-----VYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        75 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i-----ih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                          .   ........+++.++..+|..++     +|+|++|.|++++ +..++++||+.+..
T Consensus        82 ----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          82 ----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence                0   1112345788899999998875     9999999999998 66899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3741|consensus

Probab=99.12  E-value=7.9e-10  Score=83.17  Aligned_cols=129  Identities=15%  Similarity=0.108  Sum_probs=105.0

Q ss_pred             eEEEEEEEcccCCeeeeeHHH--------HHHhhhhhcccCCCCceeEeeEEEEc----CCEEEEEEEccCC-CCHHHHH
Q psy3273           8 GFLSNCSHVKQGETLALNERI--------MLSLVSTGIQMVDCPFIVCMTYAFHT----PDKLCFILDLMNG-GDLHYHL   74 (145)
Q Consensus         8 g~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~~-~~l~~~l   74 (145)
                      -+-|+|....+|..++++...        ......+.|+++.|+|+|.+.++|.+    +..+++|++|.++ ++|.+..
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            467899999999999887652        23455677899999999999999984    4589999999876 4666654


Q ss_pred             Hh---------------cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          75 SQ---------------HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~~---------------~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      -.               ....++..+..++.|+..++.++|+.|+..+-+.+.+|++....++++...|+...+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            21               123778899999999999999999999999999999999998889999988887665443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.06  E-value=4.3e-09  Score=74.83  Aligned_cols=133  Identities=18%  Similarity=0.192  Sum_probs=80.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee-----------HHHHHHhhhhhcccC---C-------CCceeEeeEEEEc------
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN-----------ERIMLSLVSTGIQMV---D-------CPFIVCMTYAFHT------   54 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l---~-------hp~i~~~~~~~~~------   54 (145)
                      .|.|+++.|+.+.+..+++..+++           +.+.++++.-....+   +       |-.++...+....      
T Consensus        20 i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~   99 (288)
T PF14531_consen   20 IGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPF   99 (288)
T ss_dssp             EEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SE
T ss_pred             cccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcc
Confidence            689999999999999999999984           233333333222221   1       2233333333321      


Q ss_pred             ---C---C-----EEEEEEEccCCCCHHHHHH---hcCCCC----HHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE
Q psy3273          55 ---P---D-----KLCFILDLMNGGDLHYHLS---QHGVFN----EDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL  116 (145)
Q Consensus        55 ---~---~-----~~~lv~e~~~~~~l~~~l~---~~~~~~----~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~  116 (145)
                         .   +     +.+++|+.+. ++|...+.   ......    ...-..+..|++..+.++|..|++|+|++|+|+++
T Consensus       100 ~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll  178 (288)
T PF14531_consen  100 FERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLL  178 (288)
T ss_dssp             EEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE
T ss_pred             eecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEE
Confidence               1   1     2467788774 48877764   222221    11123455888999999999999999999999999


Q ss_pred             CCCCCEEEeeeccceecCC
Q psy3273         117 DEHGHVRISDLGLACDFSK  135 (145)
Q Consensus       117 ~~~~~~~l~dfg~~~~~~~  135 (145)
                      +.++.+.++||+.....+.
T Consensus       179 ~~~G~v~Lg~F~~~~r~g~  197 (288)
T PF14531_consen  179 DQDGGVFLGDFSSLVRAGT  197 (288)
T ss_dssp             -TTS-EEE--GGGEEETTE
T ss_pred             cCCCCEEEcChHHHeecCc
Confidence            9999999999987765543

>KOG1023|consensus

Probab=99.06  E-value=5.4e-10  Score=84.21  Aligned_cols=97  Identities=20%  Similarity=0.203  Sum_probs=88.0

Q ss_pred             cccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCc-eecCCCCCcE
Q psy3273          37 IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYI-VYRDLKPANI  114 (145)
Q Consensus        37 ~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i-ih~~l~~~ni  114 (145)
                      ++.+.|.|+.++.+.+..+...++|.+||..|+|.+.+.. .-.++......+...++.|+.|+|...+ .|+.++..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            3567999999999999999999999999999999999986 4457888888999999999999998776 8999999999


Q ss_pred             EECCCCCEEEeeeccceec
Q psy3273         115 LLDEHGHVRISDLGLACDF  133 (145)
Q Consensus       115 l~~~~~~~~l~dfg~~~~~  133 (145)
                      +++..+.+|++|||+....
T Consensus        81 lvd~~w~lklt~~Gl~~~~   99 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLL   99 (484)
T ss_pred             eeeeeEEEEechhhhcccc
Confidence            9999999999999988655

>KOG1243|consensus

Probab=99.02  E-value=3.2e-09  Score=81.79  Aligned_cols=101  Identities=13%  Similarity=0.225  Sum_probs=84.6

Q ss_pred             HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hCCcee
Q psy3273          28 IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH-RRYIVY  106 (145)
Q Consensus        28 ~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~iih  106 (145)
                      ....+..+.++.++||||+++++.++.++.+|+|+|.+.+  |...+...+   ...+..-+.||+.|+.||| .++++|
T Consensus        54 ~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvH  128 (690)
T KOG1243|consen   54 ELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVH  128 (690)
T ss_pred             HHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeee
Confidence            3445555667888999999999999999999999999865  555665433   5666777899999999997 788999


Q ss_pred             cCCCCCcEEECCCCCEEEeeeccceec
Q psy3273         107 RDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus       107 ~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +++..+.++++..+.-++++|..++..
T Consensus       129 gNv~~~SVfVn~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  129 GNVCKDSVFVNESGEWKLGGLELVSKA  155 (690)
T ss_pred             ccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence            999999999999999999999877543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.96  E-value=7.9e-09  Score=73.14  Aligned_cols=76  Identities=18%  Similarity=0.065  Sum_probs=63.3

Q ss_pred             EEEEEEEccCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-------CCCEEEee
Q psy3273          57 KLCFILDLMNGG-DLHYHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-------HGHVRISD  126 (145)
Q Consensus        57 ~~~lv~e~~~~~-~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-------~~~~~l~d  126 (145)
                      .-++|||++++. +|.+++..  ....+......++.+++..+.-||..|++|+|+++.||+++.       ...+.++|
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID  188 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID  188 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence            578999999886 78888753  234556677788999999999999999999999999999975       45789999


Q ss_pred             ecccee
Q psy3273         127 LGLACD  132 (145)
Q Consensus       127 fg~~~~  132 (145)
                      |+.+..
T Consensus       189 l~r~~~  194 (268)
T PRK15123        189 LHRAQI  194 (268)
T ss_pred             CCcccc
Confidence            998853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=2.8e-09  Score=71.66  Aligned_cols=101  Identities=20%  Similarity=0.173  Sum_probs=62.6

Q ss_pred             HHHhhhhhcccCCCC--ceeEeeEEEEcCCEEEEEEEccC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHhhCC
Q psy3273          29 MLSLVSTGIQMVDCP--FIVCMTYAFHTPDKLCFILDLMN--GGDLHYHLSQHGVFNEDEMRFYAAEVILGLE-HMHRRY  103 (145)
Q Consensus        29 ~~~~~~~~~~~l~hp--~i~~~~~~~~~~~~~~lv~e~~~--~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~-~lh~~~  103 (145)
                      +.+++...|+.+..-  ++++++++-    .-++||||++  +..+..+....  +.......+..+++..+. .+|..|
T Consensus        54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g  127 (188)
T PF01163_consen   54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG  127 (188)
T ss_dssp             HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC
Confidence            445566666666665  467777553    2359999998  65554443321  112334455666666444 467999


Q ss_pred             ceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273         104 IVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus       104 iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++|+|+++.||+++.+ .+.++|||.+.....+
T Consensus       128 ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~~p  159 (188)
T PF01163_consen  128 IVHGDLSEYNILVDDG-KVYIIDFGQAVDSSHP  159 (188)
T ss_dssp             EEESS-STTSEEEETT-CEEE--GTTEEETTST
T ss_pred             ceecCCChhhEEeecc-eEEEEecCcceecCCc
Confidence            9999999999999877 9999999999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=4.9e-08  Score=66.64  Aligned_cols=89  Identities=20%  Similarity=0.155  Sum_probs=71.9

Q ss_pred             eEeeEEEEcC----CEEEEEEEccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC
Q psy3273          46 VCMTYAFHTP----DKLCFILDLMNGG-DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG  120 (145)
Q Consensus        46 ~~~~~~~~~~----~~~~lv~e~~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~  120 (145)
                      ++++.+.+..    ...++|+|.+++. +|.+++......+......++.++...+.-||..|++|+|+++.||+++.+.
T Consensus        76 P~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~  155 (206)
T PF06293_consen   76 PEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDD  155 (206)
T ss_pred             CcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCC
Confidence            4555555542    2468999999874 7888887644466777788999999999999999999999999999998776


Q ss_pred             ---CEEEeeeccceecC
Q psy3273         121 ---HVRISDLGLACDFS  134 (145)
Q Consensus       121 ---~~~l~dfg~~~~~~  134 (145)
                         .+.++||.-++...
T Consensus       156 ~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  156 GQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             CceeEEEEcchhceeCC
Confidence               89999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.79  E-value=5.3e-08  Score=66.44  Aligned_cols=128  Identities=16%  Similarity=0.139  Sum_probs=78.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCC--CceeEeeEEEEcC---CEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDC--PFIVCMTYAFHTP---DKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~h--p~i~~~~~~~~~~---~~~~lv~e~~~~   67 (145)
                      ++.|..+.+|++...+ |+.+++|.         ...+..+...++.+.+  ..+++++.+....   +..+++||++++
T Consensus         6 l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G   84 (223)
T cd05154           6 LSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG   84 (223)
T ss_pred             cCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence            3567788899987754 45555542         2234555555666654  4467777776653   367899999998


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH-----------------------------------------------  100 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-----------------------------------------------  100 (145)
                      .++...+.. ..+++.....++.+++..+..+|                                               
T Consensus        85 ~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (223)
T cd05154          85 RVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW  163 (223)
T ss_pred             EecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence            766543210 12222222223333333333332                                               


Q ss_pred             ---------hCCceecCCCCCcEEECC--CCCEEEeeeccce
Q psy3273         101 ---------RRYIVYRDLKPANILLDE--HGHVRISDLGLAC  131 (145)
Q Consensus       101 ---------~~~iih~~l~~~nil~~~--~~~~~l~dfg~~~  131 (145)
                               ...++|+|+.+.|++++.  ...+.++||+.+.
T Consensus       164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                     234799999999999988  5567899998875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1240|consensus

Probab=98.77  E-value=1.2e-09  Score=88.16  Aligned_cols=93  Identities=16%  Similarity=0.219  Sum_probs=83.4

Q ss_pred             ccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC
Q psy3273          38 QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD  117 (145)
Q Consensus        38 ~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~  117 (145)
                      .-+++||.+.+--+.+++...|+|-+|... +|++.+...+-+...+...++.|++.|+.-+|..|++|+|||.+||++.
T Consensus        76 ~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT  154 (1431)
T KOG1240|consen   76 ALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT  154 (1431)
T ss_pred             HhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe
Confidence            455999999998888888889999999966 9999998766677778888999999999999999999999999999999


Q ss_pred             CCCCEEEeeeccce
Q psy3273         118 EHGHVRISDLGLAC  131 (145)
Q Consensus       118 ~~~~~~l~dfg~~~  131 (145)
                      +=+++.++||...+
T Consensus       155 SWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  155 SWNWLYLTDFASFK  168 (1431)
T ss_pred             eechhhhhcccccC
Confidence            99999999998765

>KOG0590|consensus

Probab=98.75  E-value=1.1e-09  Score=85.23  Aligned_cols=133  Identities=22%  Similarity=0.270  Sum_probs=102.2

Q ss_pred             eeeeeeEEEEEEEcccCC-eeeeeH----------HHHHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           3 FIVGTGFLSNCSHVKQGE-TLALNE----------RIMLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         3 g~~~~g~~~~~~~~~~~~-~~~~~~----------~~~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      |.|+++.+..+....+.+ .++.+.          ......+...-+.+. |+|++++++........++.+++..++++
T Consensus        29 g~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~  108 (601)
T KOG0590|consen   29 GKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSL  108 (601)
T ss_pred             cccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccccc
Confidence            566777777666644332 223321          111122333334455 99999999999999999999999999999


Q ss_pred             HHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHh-hCCceecCCCCCcEEECCCC-CEEEeeeccceecCC
Q psy3273          71 HYHL-SQHG-VFNEDEMRFYAAEVILGLEHMH-RRYIVYRDLKPANILLDEHG-HVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l-~~~~-~~~~~~~~~~~~~i~~~l~~lh-~~~iih~~l~~~nil~~~~~-~~~l~dfg~~~~~~~  135 (145)
                      ...+ .... ..+......+..|+..++.|+| .+++.|++++|+|.+++..+ .++..|||+|..+..
T Consensus       109 f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  109 FSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             ccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            8888 4443 5677778889999999999999 99999999999999999888 999999999987765

>KOG0606|consensus

Probab=98.66  E-value=1.8e-08  Score=81.12  Aligned_cols=99  Identities=29%  Similarity=0.450  Sum_probs=71.2

Q ss_pred             eeeeeEEEEEEEcccCCeeeeeHHHHHHhhh-hhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCH
Q psy3273           4 IVGTGFLSNCSHVKQGETLALNERIMLSLVS-TGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE   82 (145)
Q Consensus         4 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~   82 (145)
                      -|+||.||..++..+.+.+++| .+...... +++...+.|.+|                     |+-...+..-++++-
T Consensus        93 ngAygavylvrh~~trqrfa~k-iNkq~lilRnilt~a~npfvv---------------------gDc~tllk~~g~lPv  150 (1205)
T KOG0606|consen   93 NGAYGAVYLVRHKETRQRFAMK-INKQNLILRNILTFAGNPFVV---------------------GDCATLLKNIGPLPV  150 (1205)
T ss_pred             cCCCCceeeeeccccccchhhc-ccccchhhhccccccCCccee---------------------chhhhhcccCCCCcc
Confidence            4799999999999999998882 22211111 123333444443                     455555555444442


Q ss_pred             HHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          83 DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        83 ~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      ..        +.+++|+|+.+++|+|++|+|.++...+.+|++|||+++.
T Consensus       151 dm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  151 DM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             hh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhh
Confidence            22        7789999999999999999999999999999999999874

>KOG0601|consensus

Probab=98.63  E-value=3.8e-08  Score=74.72  Aligned_cols=136  Identities=17%  Similarity=0.158  Sum_probs=106.4

Q ss_pred             ee--eeeeEEEEEEE--cccCCeeeeeHHH--------HHHhhhhhc--ccC-CCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           3 FI--VGTGFLSNCSH--VKQGETLALNERI--------MLSLVSTGI--QMV-DCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         3 g~--~~~g~~~~~~~--~~~~~~~~~~~~~--------~~~~~~~~~--~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      |.  |.+|.+|...+  ..+++.++.+.-.        ..++..+..  ..+ .|+|.++.+..++.++..++-+|+|. 
T Consensus       123 g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-  201 (524)
T KOG0601|consen  123 GSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-  201 (524)
T ss_pred             ccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-
Confidence            55  88999999988  7788888775411        111111111  111 58899999999999999999999985 


Q ss_pred             CCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHhhCCceecCCCCCcEEECCC-CCEEEeeeccceecCCCCCc
Q psy3273          68 GDLHYHLSQHGV-FNEDEMRFYAAEVIL----GLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPH  139 (145)
Q Consensus        68 ~~l~~~l~~~~~-~~~~~~~~~~~~i~~----~l~~lh~~~iih~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~  139 (145)
                      .++.++...... ++...+.....+...    |+.++|...++|.+++|.|++...+ ..++++|||+...+.++.-.
T Consensus       202 ~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~  279 (524)
T KOG0601|consen  202 ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFS  279 (524)
T ss_pred             chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccc
Confidence            588887765443 788888888888888    9999999999999999999999888 88999999999988766533

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.60  E-value=3.2e-07  Score=60.54  Aligned_cols=60  Identities=25%  Similarity=0.274  Sum_probs=52.7

Q ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          68 GDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        68 ~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |+|.+++.. ...+++.++..++.|++.|+.|+|+.+      ||+||+++.++.+++  ||++.....
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~   61 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP   61 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc
Confidence            588888876 456999999999999999999999998      999999999999998  998876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1266|consensus

Probab=98.59  E-value=4.2e-08  Score=70.51  Aligned_cols=87  Identities=16%  Similarity=0.325  Sum_probs=74.7

Q ss_pred             cCCCCceeEeeEEEEcCC-----EEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCC--ceec
Q psy3273          39 MVDCPFIVCMTYAFHTPD-----KLCFILDLMNGGDLHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRY--IVYR  107 (145)
Q Consensus        39 ~l~hp~i~~~~~~~~~~~-----~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~--iih~  107 (145)
                      .+.|.||+++..+|.+..     ...+++||+..|++.+++++    ...+..+...+|+.||+.|+.|||++.  ++|+
T Consensus       123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg  202 (458)
T KOG1266|consen  123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG  202 (458)
T ss_pred             HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence            458999999999987543     58889999999999999974    345888888999999999999999875  8999


Q ss_pred             CCCCCcEEECCCCCEEEe
Q psy3273         108 DLKPANILLDEHGHVRIS  125 (145)
Q Consensus       108 ~l~~~nil~~~~~~~~l~  125 (145)
                      ++..+.+++...+.+|+.
T Consensus       203 nlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  203 NLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             CcchhheeecCCceEEec
Confidence            999999999977777765

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.58  E-value=7.7e-07  Score=62.64  Aligned_cols=125  Identities=16%  Similarity=0.126  Sum_probs=85.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------------------------------HHHHHhhhhhcccCCCC--ceeEee
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------------------------------RIMLSLVSTGIQMVDCP--FIVCMT   49 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~l~hp--~i~~~~   49 (145)
                      .|.|--+.||.|.+. .|..+++|-                              +...+++-+.|+.|..-  .+++++
T Consensus        99 IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~  177 (304)
T COG0478          99 IGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPI  177 (304)
T ss_pred             cccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcc
Confidence            477888889999887 455555530                              11123333445555444  567776


Q ss_pred             EEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecc
Q psy3273          50 YAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL  129 (145)
Q Consensus        50 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~  129 (145)
                      +    -+.-.+|||++++-.|...-     ++......++..++..+.-.-..|++|+|+++-||+++.++.+.++||-.
T Consensus       178 ~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ  248 (304)
T COG0478         178 A----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQ  248 (304)
T ss_pred             c----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcc
Confidence            6    35567999999886553321     13344445556666666666689999999999999999999999999998


Q ss_pred             ceecCCC
Q psy3273         130 ACDFSKK  136 (145)
Q Consensus       130 ~~~~~~~  136 (145)
                      +.....+
T Consensus       249 ~v~~~hp  255 (304)
T COG0478         249 AVPISHP  255 (304)
T ss_pred             cccCCCC
Confidence            8765444

>KOG0195|consensus

Probab=98.41  E-value=2.6e-07  Score=65.09  Aligned_cols=97  Identities=19%  Similarity=0.263  Sum_probs=78.6

Q ss_pred             HHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCC--ce
Q psy3273          30 LSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRY--IV  105 (145)
Q Consensus        30 ~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~--ii  105 (145)
                      +..+--.++...||||+.+++.+.+...+.++..|++.|||+..+.....  ++..+...++..++.++.|+|+..  +.
T Consensus       234 fneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ip  313 (448)
T KOG0195|consen  234 FNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIP  313 (448)
T ss_pred             hhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhh
Confidence            34444456778999999999999999999999999999999999986543  778888999999999999999865  33


Q ss_pred             ecCCCCCcEEECCCCCE--EEee
Q psy3273         106 YRDLKPANILLDEHGHV--RISD  126 (145)
Q Consensus       106 h~~l~~~nil~~~~~~~--~l~d  126 (145)
                      .-.+....+++|.+...  ...|
T Consensus       314 r~~lns~hvmidedltarismad  336 (448)
T KOG0195|consen  314 RFYLNSKHVMIDEDLTARISMAD  336 (448)
T ss_pred             hhhcccceEEecchhhhheeccc
Confidence            44578888888877544  4444

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.40  E-value=2.8e-06  Score=58.34  Aligned_cols=79  Identities=16%  Similarity=0.318  Sum_probs=56.1

Q ss_pred             ceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEE
Q psy3273          44 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR  123 (145)
Q Consensus        44 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~  123 (145)
                      .++.-.-.+.-....+++|||++|..|.+...    +++    .....+..++.-+|..|+.|+|+.|.|+++.. ..++
T Consensus       104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~  174 (229)
T PF06176_consen  104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIR  174 (229)
T ss_pred             eeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEE
Confidence            34433333444456779999999987755432    222    23345667788999999999999999999874 5599


Q ss_pred             Eeeeccce
Q psy3273         124 ISDLGLAC  131 (145)
Q Consensus       124 l~dfg~~~  131 (145)
                      ++||+..+
T Consensus       175 iID~~~k~  182 (229)
T PF06176_consen  175 IIDTQGKR  182 (229)
T ss_pred             EEECcccc
Confidence            99997664

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.33  E-value=7.2e-06  Score=63.02  Aligned_cols=94  Identities=16%  Similarity=0.277  Sum_probs=66.1

Q ss_pred             CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC
Q psy3273          41 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH  119 (145)
Q Consensus        41 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~  119 (145)
                      +.|++.-..=+++-.+.-.++|||++|..+.+... .....+.+.+.....+..  +..+-..|++|.|..|.|++++.+
T Consensus       224 ~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~  301 (517)
T COG0661         224 DDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSD  301 (517)
T ss_pred             CCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecC
Confidence            55766555555666677889999999988877643 123455444433322222  222234799999999999999999


Q ss_pred             CCEEEeeeccceecCCC
Q psy3273         120 GHVRISDLGLACDFSKK  136 (145)
Q Consensus       120 ~~~~l~dfg~~~~~~~~  136 (145)
                      +++.+.|||+...+.+.
T Consensus       302 g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         302 GRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             CcEEEEcCcceecCCHH
Confidence            99999999999877654

>PRK09902 hypothetical protein; Provisional

Probab=98.24  E-value=2.3e-05  Score=53.59  Aligned_cols=76  Identities=16%  Similarity=0.176  Sum_probs=62.1

Q ss_pred             EEEEEEEccCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCC--EEEeeeccce
Q psy3273          57 KLCFILDLMNG-GDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH--VRISDLGLAC  131 (145)
Q Consensus        57 ~~~lv~e~~~~-~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~--~~l~dfg~~~  131 (145)
                      .-+||+|-+++ .+|.+++...  .+.+...-..+..++...+.-||..|+.|+|+-+.||+++.++.  ++++||.-++
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            47889997764 5888887653  33566666788899999999999999999999999999986666  9999998776


Q ss_pred             e
Q psy3273         132 D  132 (145)
Q Consensus       132 ~  132 (145)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>KOG1033|consensus

Probab=98.15  E-value=4.6e-07  Score=68.28  Aligned_cols=78  Identities=23%  Similarity=0.331  Sum_probs=67.4

Q ss_pred             EEEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          57 KLCFILDLMNGGDLHYHLSQHG---VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        57 ~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ++|+.|++|+..+|.+|+....   .-+....+.+..|+..++.|   ++.+|+|++|.||+...+..+++.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            5899999999999999997443   25666778899999999999   99999999999999998899999999998776


Q ss_pred             CCCC
Q psy3273         134 SKKK  137 (145)
Q Consensus       134 ~~~~  137 (145)
                      ....
T Consensus       407 ~~~~  410 (516)
T KOG1033|consen  407 DKDE  410 (516)
T ss_pred             ccCC
Confidence            5544

>KOG0601|consensus

Probab=98.12  E-value=7.7e-07  Score=67.79  Aligned_cols=92  Identities=20%  Similarity=0.274  Sum_probs=80.2

Q ss_pred             CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-
Q psy3273          41 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-  119 (145)
Q Consensus        41 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-  119 (145)
                      .|++.+.....|......|+=-|||+++++.........+++...+....|++.++.++|+..++|.|++|+||++..+ 
T Consensus       324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~  403 (524)
T KOG0601|consen  324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG  403 (524)
T ss_pred             cccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch
Confidence            7889999988888888888888999999887777555567888889999999999999999999999999999999775 


Q ss_pred             CCEEEeeecccee
Q psy3273         120 GHVRISDLGLACD  132 (145)
Q Consensus       120 ~~~~l~dfg~~~~  132 (145)
                      ...++.||+....
T Consensus       404 ~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  404 FFSKLGDFGCWTR  416 (524)
T ss_pred             hhhhccccccccc
Confidence            7788899888753

>KOG1235|consensus

Probab=98.11  E-value=3.9e-05  Score=59.11  Aligned_cols=87  Identities=15%  Similarity=0.215  Sum_probs=57.3

Q ss_pred             eeEeeEEEEcCCEEEEEEEccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC----C
Q psy3273          45 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE----H  119 (145)
Q Consensus        45 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~----~  119 (145)
                      |++++..+  .+...++|||++|..+.+.-. ....++...+..-..+...-  -+-..|++|+|-.|-||++.+    +
T Consensus       266 VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qIf~~GffHaDPHPGNilv~~~~~~~  341 (538)
T KOG1235|consen  266 VPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QIFKTGFFHADPHPGNILVRPNPEGD  341 (538)
T ss_pred             CCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HHHhcCCccCCCCCCcEEEecCCCCC
Confidence            56665543  346789999999976655432 12334555444333333222  223568999999999999984    5


Q ss_pred             CCEEEeeeccceecCC
Q psy3273         120 GHVRISDLGLACDFSK  135 (145)
Q Consensus       120 ~~~~l~dfg~~~~~~~  135 (145)
                      ..+.+-|||+...+..
T Consensus       342 ~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  342 EEIVLLDHGLYAVISH  357 (538)
T ss_pred             ccEEEEcccccccccH
Confidence            6799999999886644

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.10  E-value=5.1e-05  Score=53.01  Aligned_cols=87  Identities=16%  Similarity=0.161  Sum_probs=58.8

Q ss_pred             ceeEeeEEEEcCCEEEEEEEccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCC
Q psy3273          44 FIVCMTYAFHTPDKLCFILDLMNGGDLHY-HLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGH  121 (145)
Q Consensus        44 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~-~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~  121 (145)
                      .+++.+.+..    -.++||++....... .+.. -++...+......+++..+.-|-. .+++|+|++.=|||+. ++.
T Consensus       131 rvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~  204 (268)
T COG1718         131 RVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE  204 (268)
T ss_pred             CCCCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence            3455555443    348999986531110 1111 122233566667777777777776 8999999999999998 889


Q ss_pred             EEEeeeccceecCCC
Q psy3273         122 VRISDLGLACDFSKK  136 (145)
Q Consensus       122 ~~l~dfg~~~~~~~~  136 (145)
                      +.++|++.|.....+
T Consensus       205 p~iID~~QaV~~~hp  219 (268)
T COG1718         205 PYIIDVSQAVTIDHP  219 (268)
T ss_pred             EEEEECccccccCCC
Confidence            999999999876544

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.95  E-value=0.00021  Score=49.57  Aligned_cols=126  Identities=12%  Similarity=-0.009  Sum_probs=69.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeee-----eHHHHHHhhhhhcccCCCCc--eeEeeEEEEcCCEEEEEEEccCCCC-HH--
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLAL-----NERIMLSLVSTGIQMVDCPF--IVCMTYAFHTPDKLCFILDLMNGGD-LH--   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~hp~--i~~~~~~~~~~~~~~lv~e~~~~~~-l~--   71 (145)
                      +|.|..+.+|++.   .++.+..     ......+++.+.++.+..-.  +++.+++...++...++||+++|.. +.  
T Consensus         9 i~~G~t~~~y~~~---~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~   85 (226)
T TIGR02172         9 TGEGGNGESYTHK---TGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRI   85 (226)
T ss_pred             ecCCCCcceeEec---CCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhh
Confidence            6788888888742   2232222     01223455555555554333  4677888888888899999998853 11  


Q ss_pred             ------------HHHHh-----cC----CCCHHH-HHHHHHH----------HHHH-HHHHh----hCCceecCCCCCcE
Q psy3273          72 ------------YHLSQ-----HG----VFNEDE-MRFYAAE----------VILG-LEHMH----RRYIVYRDLKPANI  114 (145)
Q Consensus        72 ------------~~l~~-----~~----~~~~~~-~~~~~~~----------i~~~-l~~lh----~~~iih~~l~~~ni  114 (145)
                                  ..+..     +.    ..+... ...+..+          +... ..++.    ...++|+|+.|.|+
T Consensus        86 ~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Ni  165 (226)
T TIGR02172        86 ISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNL  165 (226)
T ss_pred             hcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcE
Confidence                        11110     00    011000 0001000          1111 11111    22468999999999


Q ss_pred             EECCCCCEEEeeeccce
Q psy3273         115 LLDEHGHVRISDLGLAC  131 (145)
Q Consensus       115 l~~~~~~~~l~dfg~~~  131 (145)
                      +++.++ +.++||+.+.
T Consensus       166 i~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       166 ITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             EEcCCC-cEEEechhcC
Confidence            998877 9999998775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.42  E-value=0.0081  Score=40.89  Aligned_cols=89  Identities=26%  Similarity=0.262  Sum_probs=63.8

Q ss_pred             ccCCCCceeEeeEEEEcCCEEEEEEEccCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCC
Q psy3273          38 QMVDCPFIVCMTYAFHTPDKLCFILDLMNG------GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKP  111 (145)
Q Consensus        38 ~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~------~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~  111 (145)
                      +...+.+|++++|+.+++-..-+|+|.+.+      .+|.+++.. +.+++ .....   +-.-..++-...|+.+|++|
T Consensus        72 ~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~  146 (199)
T PF10707_consen   72 RGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNP  146 (199)
T ss_pred             cCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHH---HHHHHHHHHHcCCeecCCCc
Confidence            345688999999999999888999988653      367777744 34554 33333   33346677889999999999


Q ss_pred             CcEEECCC---C-CEEEee-eccce
Q psy3273         112 ANILLDEH---G-HVRISD-LGLAC  131 (145)
Q Consensus       112 ~nil~~~~---~-~~~l~d-fg~~~  131 (145)
                      .||++...   . .+.++| ||...
T Consensus       147 ~NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  147 HNIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             ccEEEEecCCCceEEEEEeCCCCcc
Confidence            99999532   2 578888 66544

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.33  E-value=0.002  Score=43.44  Aligned_cols=85  Identities=16%  Similarity=0.196  Sum_probs=65.6

Q ss_pred             CceeEeeEEEEcCCEEEEEEEccCCCCHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHhh---CCceecCCCCCcEEE
Q psy3273          43 PFIVCMTYAFHTPDKLCFILDLMNGGDLHY---HLSQHGVFNEDEMRFYAAEVILGLEHMHR---RYIVYRDLKPANILL  116 (145)
Q Consensus        43 p~i~~~~~~~~~~~~~~lv~e~~~~~~l~~---~l~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~iih~~l~~~nil~  116 (145)
                      +++++++|+|-    -+++.|+...+++..   .+......++.....++.+++..+.+++.   ..+.-.|++++|+-+
T Consensus        20 ~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv   95 (188)
T PF12260_consen   20 EPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGV   95 (188)
T ss_pred             CCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEE
Confidence            59999999983    246789988765542   12222345788888999999999999986   346679999999999


Q ss_pred             CCCCCEEEeeeccce
Q psy3273         117 DEHGHVRISDLGLAC  131 (145)
Q Consensus       117 ~~~~~~~l~dfg~~~  131 (145)
                      +.+++++++|.....
T Consensus        96 ~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   96 NDDGRLKLIDLDDVF  110 (188)
T ss_pred             eCCCcEEEEechhcc
Confidence            999999999987554

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.31  E-value=0.0033  Score=42.87  Aligned_cols=70  Identities=6%  Similarity=-0.124  Sum_probs=39.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee---H--HHHHHhhhhhcccCCCC--ceeEeeEEEE---cCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN---E--RIMLSLVSTGIQMVDCP--FIVCMTYAFH---TPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~~~l~hp--~i~~~~~~~~---~~~~~~lv~e~~~~~~l~   71 (145)
                      ++.|..+.+|...... ++.+...   .  ...+..+...++.+...  -+++++....   .....+++|+++++..+.
T Consensus         5 l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~   83 (239)
T PF01636_consen    5 LSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLD   83 (239)
T ss_dssp             EEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHH
T ss_pred             CCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccccc
Confidence            3456677888888877 5444331   1  23344444444444322  3566666443   334689999999987776


Q ss_pred             H
Q psy3273          72 Y   72 (145)
Q Consensus        72 ~   72 (145)
                      .
T Consensus        84 ~   84 (239)
T PF01636_consen   84 D   84 (239)
T ss_dssp             H
T ss_pred             c
Confidence            6

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.30  E-value=0.0042  Score=43.25  Aligned_cols=30  Identities=23%  Similarity=0.184  Sum_probs=25.8

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      ..++|+|+.+.|++++......++||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            348999999999999987667899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.21  E-value=0.0043  Score=41.52  Aligned_cols=118  Identities=14%  Similarity=0.041  Sum_probs=78.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee------HHHHHHhhhhhcccCCCCce-eEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN------ERIMLSLVSTGIQMVDCPFI-VCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~hp~i-~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      ++-|.+|.||.+.....  .+++|      .+..++.+++.+..++-.++ ++++.+-+..    +.|||+.|.+|....
T Consensus        30 L~KG~~s~Vyl~~~~~~--~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~L~~~~  103 (201)
T COG2112          30 LAKGTTSVVYLGEWRGG--EVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRPLGKLE  103 (201)
T ss_pred             hhcccccEEEEeeccCc--eEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcchhhhh
Confidence            46788999999887644  44443      35556777777777666666 5777765543    559999998887665


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCC-CCcEEECCCCCEEEeeecccee
Q psy3273          75 SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLK-PANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        75 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~-~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      ...   +.+.+    ..+++..--|-..||-|+.++ |...++..+..+-++||-.|+.
T Consensus       104 ~~~---~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         104 IGG---DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hcc---cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            421   33333    334555555667889998876 4445555556999999999873

>PLN02876 acyl-CoA dehydrogenase

Probab=97.14  E-value=0.009  Score=49.00  Aligned_cols=42  Identities=5%  Similarity=0.031  Sum_probs=29.9

Q ss_pred             HHHHhhhhhcccCC-CCce--eEeeEEEEcC---CEEEEEEEccCCCC
Q psy3273          28 IMLSLVSTGIQMVD-CPFI--VCMTYAFHTP---DKLCFILDLMNGGD   69 (145)
Q Consensus        28 ~~~~~~~~~~~~l~-hp~i--~~~~~~~~~~---~~~~lv~e~~~~~~   69 (145)
                      ..+.++...++.+. |+++  ++++.++.+.   +..|+|||++++..
T Consensus        83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876         83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            35667777777775 6666  6777777654   46789999998753

>KOG0606|consensus

Probab=96.81  E-value=0.00035  Score=57.33  Aligned_cols=91  Identities=29%  Similarity=0.434  Sum_probs=79.0

Q ss_pred             CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC
Q psy3273          41 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG  120 (145)
Q Consensus        41 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~  120 (145)
                      .+|.+++..-.|...+..++++++..++++.+.++..++.+..-...+...++.+..++|...+.|++++|.|.+....+
T Consensus       862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g  941 (1205)
T KOG0606|consen  862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG  941 (1205)
T ss_pred             CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC
Confidence            45777777666777788999999999999999998877777777788888899999999999899999999999999999


Q ss_pred             CEEEeeeccce
Q psy3273         121 HVRISDLGLAC  131 (145)
Q Consensus       121 ~~~l~dfg~~~  131 (145)
                      ..++.||+...
T Consensus       942 h~~l~~~~t~~  952 (1205)
T KOG0606|consen  942 HRPLTDFGTLS  952 (1205)
T ss_pred             CcccCcccccc
Confidence            99999998443

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=95.81  E-value=0.58  Score=35.46  Aligned_cols=29  Identities=21%  Similarity=0.367  Sum_probs=24.0

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      ..++|+|+.+.||++..+ .++++|+..+.
T Consensus       223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~  251 (401)
T PRK09550        223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF  251 (401)
T ss_pred             CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence            358999999999999655 68999988664

>KOG0576|consensus

Probab=95.68  E-value=0.0015  Score=51.51  Aligned_cols=130  Identities=15%  Similarity=0.181  Sum_probs=83.4

Q ss_pred             eeeeeeeEEEEEEEcccCCee--eeeHHHHHHhhhhhcccCCCCc-eeEeeEEEEcCCEEEEEEEccCCC-CHHHHH-Hh
Q psy3273           2 FFIVGTGFLSNCSHVKQGETL--ALNERIMLSLVSTGIQMVDCPF-IVCMTYAFHTPDKLCFILDLMNGG-DLHYHL-SQ   76 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~hp~-i~~~~~~~~~~~~~~lv~e~~~~~-~l~~~l-~~   76 (145)
                      |+.++++..++.+...+....  .+....-.+.+.+.+++++||| .+..++-+..++..++.++++..+ +....+ ..
T Consensus       250 fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~s  329 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVS  329 (829)
T ss_pred             HHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChh
Confidence            455667777777766655332  1111223344456688889999 667777778888999999999876 222211 12


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          77 HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        77 ~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .-.+.+.++...++.-..++.++|+.-=+|+|    |++ ......+..+|+....+.+.
T Consensus       330 e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l-~s~~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  330 EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NIL-GSEEEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hHhhhhhhhhhhhhhhcccccccccccccCcc----ccc-ccccccccccccCCcccCcc
Confidence            22345555666677777788888877556666    444 34477888899888776554

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.57  E-value=0.1  Score=39.19  Aligned_cols=71  Identities=21%  Similarity=0.169  Sum_probs=48.9

Q ss_pred             CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          56 DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        56 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      -+.|++|++- ++++...    ..-...+...++++-+.-+.-+.. -.+-|+++...||+++ .+++.++||-+++.
T Consensus       299 ~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            4677788754 5454221    123456666777666554444432 3478999999999999 99999999999984

>KOG2268|consensus

Probab=95.39  E-value=0.02  Score=42.23  Aligned_cols=74  Identities=14%  Similarity=0.257  Sum_probs=52.4

Q ss_pred             CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          55 PDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        55 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      -+.-++|||++.+..|.+.-.   .-+..+   +...++.-+.-+..+|+||+|..-=||+++.+..++++||-......
T Consensus       180 ~~RH~Vvmelv~g~Pl~~v~~---v~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  180 HNRHCVVMELVDGYPLRQVRH---VEDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             ccceeeHHHhhcccceeeeee---cCChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhhccC
Confidence            356789999998877654321   112222   23334444566788999999999999999999999999998664443

>KOG2270|consensus

Probab=94.58  E-value=0.36  Score=36.50  Aligned_cols=98  Identities=11%  Similarity=0.198  Sum_probs=56.5

Q ss_pred             hcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HhhCCceecCCCCCcE
Q psy3273          36 GIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEH-MHRRYIVYRDLKPANI  114 (145)
Q Consensus        36 ~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~-lh~~~iih~~l~~~ni  114 (145)
                      .++.|....|+.+.-+...  .-.+||+++....-..-.-....++...+..+-.+++.-+.- .+.++++|.||+--|+
T Consensus       219 NLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~  296 (520)
T KOG2270|consen  219 NLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL  296 (520)
T ss_pred             HHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence            3444455555554444432  245899998531111111112234444555454455444433 3578999999999998


Q ss_pred             EECCCCCEEEeeeccceecCCC
Q psy3273         115 LLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus       115 l~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.- ++.+.++|.+.|.....+
T Consensus       297 Lyh-dG~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  297 LYH-DGKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             eEE-CCEEEEEEccccccCCCh
Confidence            874 677888998877654433

>PRK05231 homoserine kinase; Provisional

Probab=94.54  E-value=0.031  Score=40.48  Aligned_cols=30  Identities=27%  Similarity=0.406  Sum_probs=25.7

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .+++|+|+.+.|++++.+....++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            479999999999999866556899998775

>KOG1035|consensus

Probab=94.36  E-value=0.1  Score=44.18  Aligned_cols=110  Identities=15%  Similarity=0.100  Sum_probs=75.4

Q ss_pred             HHHHHHhhhhhcccCCCCceeEeeEEEEcCCE----EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q psy3273          26 ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDK----LCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR  101 (145)
Q Consensus        26 ~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~----~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~  101 (145)
                      ++...+.+...+.+..|+|++.++.+-..+..    ..+..+++..-++...+.+-...+..+.+.+..+...++.++|+
T Consensus       225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence            34444445555678899999999888654322    23345788888888888888889999999999999999999998


Q ss_pred             CCceecCCCCC---cEEECCCCCEEEe--eeccceecCC
Q psy3273         102 RYIVYRDLKPA---NILLDEHGHVRIS--DLGLACDFSK  135 (145)
Q Consensus       102 ~~iih~~l~~~---nil~~~~~~~~l~--dfg~~~~~~~  135 (145)
                      ....|.-+..+   +--.+..+.....  ||..+..+..
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d  343 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD  343 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCC
Confidence            86555544443   2222333334444  7776665543

>PRK10593 hypothetical protein; Provisional

Probab=93.97  E-value=0.52  Score=34.10  Aligned_cols=43  Identities=9%  Similarity=0.071  Sum_probs=30.3

Q ss_pred             HHHHhhhhhcccCCC---CceeEeeEEEEc---CCEEEEEEEccCCCCH
Q psy3273          28 IMLSLVSTGIQMVDC---PFIVCMTYAFHT---PDKLCFILDLMNGGDL   70 (145)
Q Consensus        28 ~~~~~~~~~~~~l~h---p~i~~~~~~~~~---~~~~~lv~e~~~~~~l   70 (145)
                      ..+..|...++.|.-   ..++++++++..   .+..++|||++++.++
T Consensus        52 ~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         52 GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence            466667666665532   457888887754   3678999999998655

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=93.97  E-value=0.055  Score=37.50  Aligned_cols=30  Identities=23%  Similarity=0.329  Sum_probs=25.0

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .+++|+|+.+.|++++.....-++||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            458999999999999866556799999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=93.74  E-value=0.071  Score=38.32  Aligned_cols=29  Identities=28%  Similarity=0.329  Sum_probs=25.6

Q ss_pred             CceecCCCCCcEEECCC----CCEEEeeeccce
Q psy3273         103 YIVYRDLKPANILLDEH----GHVRISDLGLAC  131 (145)
Q Consensus       103 ~iih~~l~~~nil~~~~----~~~~l~dfg~~~  131 (145)
                      +++|+|+.+.||+++.+    ..+.++||..|.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            47999999999999874    789999998775

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=93.64  E-value=0.15  Score=35.11  Aligned_cols=29  Identities=28%  Similarity=0.373  Sum_probs=25.5

Q ss_pred             CceecCCCCCcEEECC-CCCEEEeeeccce
Q psy3273         103 YIVYRDLKPANILLDE-HGHVRISDLGLAC  131 (145)
Q Consensus       103 ~iih~~l~~~nil~~~-~~~~~l~dfg~~~  131 (145)
                      +++|+|+.+.|++++. +..+.++||..|.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            5899999999999987 5789999998775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK14559 putative protein serine/threonine phosphatase; Provisional

Probab=93.49  E-value=0.33  Score=38.97  Aligned_cols=83  Identities=11%  Similarity=0.063  Sum_probs=62.2

Q ss_pred             CceeEeeEEEEcCCEEEEEEEccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCC
Q psy3273          43 PFIVCMTYAFHTPDKLCFILDLMNG-GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH  121 (145)
Q Consensus        43 p~i~~~~~~~~~~~~~~lv~e~~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~  121 (145)
                      .||++++++|..++.-++++|+... .+|.+.+.. ...+..+.+.|++|++.-..-+...++...=+.++|+-++.+..
T Consensus       180 ~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~-~~~~~l~~l~Wl~q~~~LW~~l~~~~~~~sll~~~nlrv~~~~~  258 (645)
T PRK14559        180 TEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQD-QTLPTLQILYWLNQMTQLWKALEPWGCCQSLLELENLRVDEDQT  258 (645)
T ss_pred             ccCcchheeecCCCCcEEEeCCCCCCchHHHHhhh-cCCcHHHHHHHHHHHHHHHHHHHhcCeehhccchhheeeCCCce
Confidence            4599999999988877888887643 234333332 24567888999999999999999999888889999999975554


Q ss_pred             EEEee
Q psy3273         122 VRISD  126 (145)
Q Consensus       122 ~~l~d  126 (145)
                      +.+-.
T Consensus       259 ~~l~~  263 (645)
T PRK14559        259 LGLQQ  263 (645)
T ss_pred             ehHhh
Confidence            44433

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.38  E-value=0.3  Score=35.10  Aligned_cols=29  Identities=28%  Similarity=0.356  Sum_probs=24.9

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .+++|+|+.+.|++++. ..+.++||..+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678899998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=93.30  E-value=0.18  Score=36.48  Aligned_cols=30  Identities=33%  Similarity=0.552  Sum_probs=26.4

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .+++|+|+.+.|++++.+....++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            679999999999999887767899999774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.17  E-value=0.51  Score=33.26  Aligned_cols=59  Identities=22%  Similarity=0.265  Sum_probs=40.5

Q ss_pred             EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--CCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          57 KLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR--RYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        57 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~--~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                      .+-++.|.|-....         .    ..-++..-+..+.-.|+  .+.+|+|..|+||+-|+.+.+|+.|=+
T Consensus       128 ~yGvIlE~Cy~~~i---------~----~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~  188 (308)
T PF07387_consen  128 KYGVILERCYKIKI---------N----FSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV  188 (308)
T ss_pred             eeEEEEeeccCccc---------c----hhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence            57788888854322         0    11122222455777783  458999999999999999999999854

The function of this family is unknown.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=93.15  E-value=0.079  Score=37.91  Aligned_cols=30  Identities=30%  Similarity=0.453  Sum_probs=26.1

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .+++|+|+.|.|++++.+....++||..+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            468999999999999987777899998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.44  E-value=0.37  Score=35.54  Aligned_cols=28  Identities=32%  Similarity=0.488  Sum_probs=25.3

Q ss_pred             ceecCCCCCcEEECCCCC-EEEeeeccce
Q psy3273         104 IVYRDLKPANILLDEHGH-VRISDLGLAC  131 (145)
Q Consensus       104 iih~~l~~~nil~~~~~~-~~l~dfg~~~  131 (145)
                      ++|+|+.+.|++++.+.. +.++||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            899999999999998875 8899999775

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=92.41  E-value=0.46  Score=36.51  Aligned_cols=69  Identities=14%  Similarity=0.176  Sum_probs=54.3

Q ss_pred             EEEEEEccCCCCHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEee
Q psy3273          58 LCFILDLMNGGDLHYHLS-------QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD  126 (145)
Q Consensus        58 ~~lv~e~~~~~~l~~~l~-------~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~d  126 (145)
                      .-++|..+++..--..+.       +....++...+...+.++.+...+|..|-.-+|+.++|++++++..+.+.|
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence            567777776642222221       223477888899999999999999999999999999999999999888887

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=92.28  E-value=0.43  Score=34.09  Aligned_cols=29  Identities=31%  Similarity=0.441  Sum_probs=26.3

Q ss_pred             CceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         103 YIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       103 ~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .++|+|+.+.|++.++.+.+.++||.-|.
T Consensus       154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             eeecCCCCccceEEcCCCcEEEEecccCC
Confidence            58999999999999999999999997664

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=91.79  E-value=0.7  Score=31.72  Aligned_cols=76  Identities=16%  Similarity=0.137  Sum_probs=50.8

Q ss_pred             cccCCCCce--eEeeEEEEcC------------------CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q psy3273          37 IQMVDCPFI--VCMTYAFHTP------------------DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL   96 (145)
Q Consensus        37 ~~~l~hp~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l   96 (145)
                      ++.+++.++  ++-++++.-+                  ..+.||-||.+...         .+.    ..-+.++..-+
T Consensus       111 Lke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl  177 (207)
T PF13095_consen  111 LKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDL  177 (207)
T ss_pred             HHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHH
Confidence            344566666  7888887432                  12456777665532         122    23346677788


Q ss_pred             HHHhhCCceecCCCCCcEEECCCCCEEEeeeccc
Q psy3273          97 EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA  130 (145)
Q Consensus        97 ~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~  130 (145)
                      ..+|..||+-+|+++.|..     .-+++|||.+
T Consensus       178 ~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            8999999999999998865     4578899865

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=91.50  E-value=0.16  Score=34.54  Aligned_cols=30  Identities=33%  Similarity=0.581  Sum_probs=20.8

Q ss_pred             CCceecCCCCCcEEE-CCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILL-DEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~-~~~~~~~l~dfg~~~  131 (145)
                      ..+.|+|+.+.||++ .....++++||.-|.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            347899999999999 788999999998775

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK10271 thiK thiamine kinase; Provisional

Probab=91.17  E-value=0.23  Score=33.54  Aligned_cols=27  Identities=22%  Similarity=0.343  Sum_probs=23.4

Q ss_pred             ceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         104 IVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       104 iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .+|+|+.|.|+++..++ ++++|++-+.
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCccc
Confidence            58999999999887665 8899999775

>TIGR02721 ycfN_thiK thiamine kinase

Probab=90.94  E-value=0.21  Score=35.00  Aligned_cols=28  Identities=18%  Similarity=0.323  Sum_probs=24.1

Q ss_pred             CceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         103 YIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       103 ~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .++|+|+.+.|++++.+. +.++||..+.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            479999999999998765 7899998775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=90.50  E-value=0.26  Score=33.28  Aligned_cols=31  Identities=23%  Similarity=0.251  Sum_probs=25.4

Q ss_pred             hCCceecCCCCCcEEECCCC-----CEEEeeeccce
Q psy3273         101 RRYIVYRDLKPANILLDEHG-----HVRISDLGLAC  131 (145)
Q Consensus       101 ~~~iih~~l~~~nil~~~~~-----~~~l~dfg~~~  131 (145)
                      ...++|+|+.+.|+++..+.     .+.++||..+.
T Consensus       119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            34689999999999997443     68999999876

subfamily of choline kinases

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=89.92  E-value=0.31  Score=34.87  Aligned_cols=29  Identities=34%  Similarity=0.470  Sum_probs=24.3

Q ss_pred             CceecCCCCCcEEECCCCC-EEEeeeccce
Q psy3273         103 YIVYRDLKPANILLDEHGH-VRISDLGLAC  131 (145)
Q Consensus       103 ~iih~~l~~~nil~~~~~~-~~l~dfg~~~  131 (145)
                      .++|+|+.+.|++++.++. .-++||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            4899999999999987455 5699999875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=89.79  E-value=0.34  Score=35.54  Aligned_cols=29  Identities=28%  Similarity=0.454  Sum_probs=26.5

Q ss_pred             CceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         103 YIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       103 ~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .++|+|+.+.|++++.....-+.||+.+.
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~  227 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELAT  227 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence            48999999999999988889999999885

>PRK06148 hypothetical protein; Provisional

Probab=89.71  E-value=0.33  Score=41.05  Aligned_cols=31  Identities=26%  Similarity=0.404  Sum_probs=25.4

Q ss_pred             hCCceecCCCCCcEEECCCC--CEE-Eeeeccce
Q psy3273         101 RRYIVYRDLKPANILLDEHG--HVR-ISDLGLAC  131 (145)
Q Consensus       101 ~~~iih~~l~~~nil~~~~~--~~~-l~dfg~~~  131 (145)
                      ..+++|+|+.+.|++++.+.  .+. ++|||-+.
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            35799999999999998764  454 99999775

>PLN02236 choline kinase

Probab=89.68  E-value=0.83  Score=33.78  Aligned_cols=29  Identities=31%  Similarity=0.390  Sum_probs=25.0

Q ss_pred             CceecCCCCCcEEECC-CCCEEEeeeccce
Q psy3273         103 YIVYRDLKPANILLDE-HGHVRISDLGLAC  131 (145)
Q Consensus       103 ~iih~~l~~~nil~~~-~~~~~l~dfg~~~  131 (145)
                      .++|+|+.+.|++++. +..+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            5799999999999976 4679999998775

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=89.40  E-value=0.26  Score=35.68  Aligned_cols=30  Identities=20%  Similarity=0.166  Sum_probs=26.5

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .+++|+|+.++|++++.+..+.++||-.++
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            368999999999999988889999998765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK06149 hypothetical protein; Provisional

Probab=89.15  E-value=0.73  Score=38.90  Aligned_cols=31  Identities=16%  Similarity=0.133  Sum_probs=25.1

Q ss_pred             hCCceecCCCCCcEEECCCC--C---EEEeeeccce
Q psy3273         101 RRYIVYRDLKPANILLDEHG--H---VRISDLGLAC  131 (145)
Q Consensus       101 ~~~iih~~l~~~nil~~~~~--~---~~l~dfg~~~  131 (145)
                      ..+++|+|+.+.|++++.+.  .   ..++|||-+.
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            46799999999999998542  2   4799999765

>KOG2137|consensus

Probab=87.79  E-value=0.44  Score=38.21  Aligned_cols=47  Identities=19%  Similarity=0.454  Sum_probs=39.2

Q ss_pred             HHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          89 AAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        89 ~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ..+++.|+.++|. .+++|+.+.|+++.++..+.-|+..|+.+....+
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~  152 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANG  152 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCC
Confidence            3456688999994 5799999999999999999999999998765444

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=86.09  E-value=0.79  Score=33.66  Aligned_cols=28  Identities=25%  Similarity=0.468  Sum_probs=24.3

Q ss_pred             ceecCCCCCcEEECC-CCCEEEeeeccce
Q psy3273         104 IVYRDLKPANILLDE-HGHVRISDLGLAC  131 (145)
Q Consensus       104 iih~~l~~~nil~~~-~~~~~l~dfg~~~  131 (145)
                      ++|+|+.+.||+++. +..++++||.-|.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            689999999999974 4789999998775

>PRK11768 serine/threonine protein kinase; Provisional

Probab=85.57  E-value=0.6  Score=34.19  Aligned_cols=28  Identities=29%  Similarity=0.234  Sum_probs=23.7

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .+++|+|+.+.|++++ + ...++||+-+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4689999999999995 3 67899998775

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=84.83  E-value=2.5  Score=29.97  Aligned_cols=66  Identities=12%  Similarity=0.263  Sum_probs=43.6

Q ss_pred             eeeEEEEEEEcccCC-eeeee-----HHHHHHhhhhhcccC---CCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           6 GTGFLSNCSHVKQGE-TLALN-----ERIMLSLVSTGIQMV---DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         6 ~~g~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~l---~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .-|.+..|....+|. .+.+|     ...++..+++.+..|   +.-.+++++.+..+.++.|+|+||++.+.+.
T Consensus        25 ~gG~inea~~v~dg~~~~FvK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          25 SGGDINEAWRLRDGTDPFFVKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             CCccccceeEeecCCcceEEEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            346677777776663 44443     234445555444333   4456889999999999999999999875554

>KOG2269|consensus

Probab=83.27  E-value=16  Score=27.69  Aligned_cols=89  Identities=19%  Similarity=0.244  Sum_probs=54.9

Q ss_pred             cCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHH-HHHhhCCceecCCCCCcEEE
Q psy3273          39 MVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY-HLSQHGVFNEDEMRFYAAEVILGL-EHMHRRYIVYRDLKPANILL  116 (145)
Q Consensus        39 ~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~-~l~~~~~~~~~~~~~~~~~i~~~l-~~lh~~~iih~~l~~~nil~  116 (145)
                      .+..|.+|.+..       -.+||.++....+.. .+. .-.+...+....-.|+...+ +..|.+-++|.|++--|++.
T Consensus       346 GlpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK-~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw  417 (531)
T KOG2269|consen  346 GLPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLK-NVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLW  417 (531)
T ss_pred             CCCCCceeeeec-------ceEEEEeecCCCCCCcccc-ccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhhee
Confidence            445677776643       457888774422211 111 12245555555555555554 34467889999999999998


Q ss_pred             CCCCCEEEeeeccceecCCC
Q psy3273         117 DEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus       117 ~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ... .+-++|...+..-..+
T Consensus       418 ~~g-Kvw~IDVsQsvep~HP  436 (531)
T KOG2269|consen  418 TPG-KVWVIDVSQSVEPSHP  436 (531)
T ss_pred             cCC-ceEEEechhccCCCCc
Confidence            765 8888897766544333

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=82.73  E-value=2.4  Score=30.26  Aligned_cols=29  Identities=28%  Similarity=0.251  Sum_probs=24.3

Q ss_pred             CceecCCCCCcEEECCC-----CCEEEeeeccce
Q psy3273         103 YIVYRDLKPANILLDEH-----GHVRISDLGLAC  131 (145)
Q Consensus       103 ~iih~~l~~~nil~~~~-----~~~~l~dfg~~~  131 (145)
                      .++|+|+.+.|+++..+     ..+.+.||..++
T Consensus       216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             EEEcCccCHHhEeEccccccccccceeecccccc
Confidence            48999999999999644     268999998876

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>KOG4720|consensus

Probab=82.03  E-value=5.1  Score=29.55  Aligned_cols=28  Identities=32%  Similarity=0.390  Sum_probs=23.2

Q ss_pred             ceecCCCCCcEEECCC-CCEEEeeeccce
Q psy3273         104 IVYRDLKPANILLDEH-GHVRISDLGLAC  131 (145)
Q Consensus       104 iih~~l~~~nil~~~~-~~~~l~dfg~~~  131 (145)
                      +.|+|+-..||+.++. +.+.++|+.-+.
T Consensus       250 FcHNDLL~~Niiy~~~~~~v~fIDYEYa~  278 (391)
T KOG4720|consen  250 FCHNDLLCGNIIYDSEKGSVEFIDYEYAG  278 (391)
T ss_pred             EeecchhhcceeeccccCcEEEEeecccc
Confidence            5799999999999755 789999987553

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	145
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-65
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-64
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-64
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-64
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-30
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-30
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-25
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-25
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-25
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-25
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-24
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-24
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-24
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-24
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-24
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-24
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-24
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-24
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-24
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-24
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-24
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-24
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-24
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-23
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-23
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-23
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-22
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-22
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-21
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-21
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-20
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-20
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-20
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-19
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-19
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-19
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-19
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-19
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-19
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-19
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-19
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-19
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-19
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-19
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-19
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-19
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-19
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-19
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-19
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-19
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-19
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-19
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-19
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-19
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-19
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-19
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-19
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-19
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-19
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-19
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-19
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-19
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-19
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-19
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-19
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-19
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-19
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-19
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-19
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-19
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-19
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-19
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-19
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-18
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-18
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-18
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-18
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-18
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-18
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-18
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-18
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-18
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-18
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-15
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-14
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-14
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-14
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-14
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-14
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-13
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-13
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-12
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-09
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-06
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-05
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-05
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-05
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-05
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-05
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		8e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-05
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-05
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		8e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-05
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		8e-05
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		8e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-05
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		8e-05
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		8e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-05
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		8e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-04
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-04
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-04
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-04
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-04
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-04
3soa_A	444	Full-Length Human Camkii Length = 444		3e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-04
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-04
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-04
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-04
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-04
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-04
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-04
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-04
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-04
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-04
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-04
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-04
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-04
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-04
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-04
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		9e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-04

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  241 bits (615), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 114/128 (89%), Positives = 121/128 (94%), Gaps = 4/128 (3%)
Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 228 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 283
Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 284 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 343
Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 344 KKPHASVG 351

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  241 bits (615), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 114/128 (89%), Positives = 121/128 (94%), Gaps = 4/128 (3%)
Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284
Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 285 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344
Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 345 KKPHASVG 352

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  241 bits (615), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 114/128 (89%), Positives = 121/128 (94%), Gaps = 4/128 (3%)
Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284
Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 285 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344
Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 345 KKPHASVG 352

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  241 bits (615), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 114/128 (89%), Positives = 121/128 (94%), Gaps = 4/128 (3%)
Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLS
Sbjct: 229 MKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284
Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           QHGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSK
Sbjct: 285 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344
Query: 136 KKPHASVG 143
           KKPHASVG
Sbjct: 345 KKPHASVG 352

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  126 bits (317), Expect = 4e-30,   Method: Composition-based stats.
 Identities = 64/115 (55%), Positives = 78/115 (67%), Gaps = 11/115 (9%)
Query: 19  GETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH---YHLS 75
           GE +ALNE+ +L       + V+  F+V + YA+ T D LC +L LMNGGDL    YH+ 
Sbjct: 227 GEAMALNEKQIL-------EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 279
Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           Q G F E    FYAAE+  GLE +HR  IVYRDLKP NILLD+HGH+RISDLGLA
Sbjct: 280 QAG-FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  126 bits (317), Expect = 4e-30,   Method: Composition-based stats.
 Identities = 64/115 (55%), Positives = 78/115 (67%), Gaps = 11/115 (9%)
Query: 19  GETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH---YHLS 75
           GE +ALNE+ +L       + V+  F+V + YA+ T D LC +L LMNGGDL    YH+ 
Sbjct: 227 GEAMALNEKQIL-------EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 279
Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           Q G F E    FYAAE+  GLE +HR  IVYRDLKP NILLD+HGH+RISDLGLA
Sbjct: 280 QAG-FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  111 bits (277), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 55/119 (46%), Positives = 78/119 (65%), Gaps = 3/119 (2%)
Query: 21  TLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF 80
           TL + +R+   +    +  V+ PF+V + YAF T  KL  ILD + GGDL   LS+  +F
Sbjct: 68  TLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 127
Query: 81  NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL---ACDFSKK 136
            E++++FY AE+ LGL+H+H   I+YRDLKP NILLDE GH++++D GL   A D  KK
Sbjct: 128 TEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKK 186

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  109 bits (272), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 51/112 (45%), Positives = 75/112 (66%)
Query: 21  TLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF 80
           TL + +R+   +    +  V+ PFIV + YAF T  KL  ILD + GGDL   LS+  +F
Sbjct: 64  TLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 123
Query: 81  NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
            E++++FY AE+ L L+H+H   I+YRDLKP NILLDE GH++++D GL+ +
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  109 bits (272), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 51/112 (45%), Positives = 75/112 (66%)
Query: 21  TLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF 80
           TL + +R+   +    +  V+ PFIV + YAF T  KL  ILD + GGDL   LS+  +F
Sbjct: 65  TLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 124
Query: 81  NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
            E++++FY AE+ L L+H+H   I+YRDLKP NILLDE GH++++D GL+ +
Sbjct: 125 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 176

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  108 bits (271), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 51/112 (45%), Positives = 75/112 (66%)
Query: 21  TLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF 80
           TL + +R+   +    +  V+ PFIV + YAF T  KL  ILD + GGDL   LS+  +F
Sbjct: 64  TLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 123
Query: 81  NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
            E++++FY AE+ L L+H+H   I+YRDLKP NILLDE GH++++D GL+ +
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  108 bits (270), Expect = 1e-24,   Method: Composition-based stats.
 Identities = 48/94 (51%), Positives = 65/94 (69%), Gaps = 4/94 (4%)
Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFNEDEMRFYAAEVILGLEHM 99
           FIV + YAF T   LC ++ +MNGGD+ YH+      +  F E    FY A+++ GLEH+
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           H+R I+YRDLKP N+LLD+ G+VRISDLGLA + 
Sbjct: 306 HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  108 bits (270), Expect = 1e-24,   Method: Composition-based stats.
 Identities = 48/94 (51%), Positives = 65/94 (69%), Gaps = 4/94 (4%)
Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFNEDEMRFYAAEVILGLEHM 99
           FIV + YAF T   LC ++ +MNGGD+ YH+      +  F E    FY A+++ GLEH+
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           H+R I+YRDLKP N+LLD+ G+VRISDLGLA + 
Sbjct: 306 HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  108 bits (270), Expect = 1e-24,   Method: Composition-based stats.
 Identities = 48/94 (51%), Positives = 65/94 (69%), Gaps = 4/94 (4%)
Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFNEDEMRFYAAEVILGLEHM 99
           FIV + YAF T   LC ++ +MNGGD+ YH+      +  F E    FY A+++ GLEH+
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           H+R I+YRDLKP N+LLD+ G+VRISDLGLA + 
Sbjct: 306 HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  108 bits (270), Expect = 1e-24,   Method: Composition-based stats.
 Identities = 48/94 (51%), Positives = 65/94 (69%), Gaps = 4/94 (4%)
Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFNEDEMRFYAAEVILGLEHM 99
           FIV + YAF T   LC ++ +MNGGD+ YH+      +  F E    FY A+++ GLEH+
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           H+R I+YRDLKP N+LLD+ G+VRISDLGLA + 
Sbjct: 306 HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 68/96 (70%)
Query: 34  STGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVI 93
           S  +Q    PF+  + YAF T D+LCF+++  NGG+L +HLS+  VF E+  RFY AE++
Sbjct: 59  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 118
Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
             LE++H R +VYRD+K  N++LD+ GH++I+D GL
Sbjct: 119 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 154

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  107 bits (268), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 68/96 (70%)
Query: 34  STGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVI 93
           S  +Q    PF+  + YAF T D+LCF+++  NGG+L +HLS+  VF E+  RFY AE++
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
             LE++H R +VYRD+K  N++LD+ GH++I+D GL
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  107 bits (268), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 68/96 (70%)
Query: 34  STGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVI 93
           S  +Q    PF+  + YAF T D+LCF+++  NGG+L +HLS+  VF E+  RFY AE++
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
             LE++H R +VYRD+K  N++LD+ GH++I+D GL
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  107 bits (268), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 68/96 (70%)
Query: 34  STGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVI 93
           S  +Q    PF+  + YAF T D+LCF+++  NGG+L +HLS+  VF E+  RFY AE++
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
             LE++H R +VYRD+K  N++LD+ GH++I+D GL
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  107 bits (268), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 68/96 (70%)
Query: 34  STGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVI 93
           S  +Q    PF+  + YAF T D+LCF+++  NGG+L +HLS+  VF E+  RFY AE++
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
             LE++H R +VYRD+K  N++LD+ GH++I+D GL
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  107 bits (267), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 68/96 (70%)
Query: 34  STGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVI 93
           S  +Q    PF+  + YAF T D+LCF+++  NGG+L +HLS+  VF E+  RFY AE++
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
             LE++H R +VYRD+K  N++LD+ GH++I+D GL
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  107 bits (267), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 45/96 (46%), Positives = 68/96 (70%)
Query: 34  STGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVI 93
           S  +Q    PF+  + YAF T D+LCF+++  NGG+L +HLS+  VF E+  RFY AE++
Sbjct: 61  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 120
Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
             LE++H R +VYRD+K  N++LD+ GH++I+D GL
Sbjct: 121 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 156

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  106 bits (264), Expect = 5e-24,   Method: Composition-based stats.
 Identities = 42/88 (47%), Positives = 66/88 (75%), Gaps = 1/88 (1%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH-R 101
           PF+  + Y+F T D+LCF+++  NGG+L +HLS+  VF+ED  RFY AE++  L+++H  
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGL 129
           + +VYRDLK  N++LD+ GH++I+D GL
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGL 295

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  106 bits (264), Expect = 5e-24,   Method: Composition-based stats.
 Identities = 42/88 (47%), Positives = 66/88 (75%), Gaps = 1/88 (1%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH-R 101
           PF+  + Y+F T D+LCF+++  NGG+L +HLS+  VF+ED  RFY AE++  L+++H  
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 270
Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGL 129
           + +VYRDLK  N++LD+ GH++I+D GL
Sbjct: 271 KNVVYRDLKLENLMLDKDGHIKITDFGL 298

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  102 bits (254), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 42/88 (47%), Positives = 66/88 (75%), Gaps = 1/88 (1%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH-R 101
           PF+  + Y+F T D+LCF+++  NGG+L +HLS+  VF+ED  RFY AE++  L+++H  
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 128
Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGL 129
           + +VYRDLK  N++LD+ GH++I+D GL
Sbjct: 129 KNVVYRDLKLENLMLDKDGHIKITDFGL 156

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  102 bits (254), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 42/88 (47%), Positives = 66/88 (75%), Gaps = 1/88 (1%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH-R 101
           PF+  + Y+F T D+LCF+++  NGG+L +HLS+  VF+ED  RFY AE++  L+++H  
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 127
Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGL 129
           + +VYRDLK  N++LD+ GH++I+D GL
Sbjct: 128 KNVVYRDLKLENLMLDKDGHIKITDFGL 155

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  102 bits (254), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 42/88 (47%), Positives = 66/88 (75%), Gaps = 1/88 (1%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH-R 101
           PF+  + Y+F T D+LCF+++  NGG+L +HLS+  VF+ED  RFY AE++  L+++H  
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 129
Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGL 129
           + +VYRDLK  N++LD+ GH++I+D GL
Sbjct: 130 KNVVYRDLKLENLMLDKDGHIKITDFGL 157

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  102 bits (253), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 47/92 (51%), Positives = 64/92 (69%)
Query: 42  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR 101
            PF+V + YAF T  KL  ILD +NGG+L  HLSQ   F E E++ Y  E++L LEH+H+
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 177
Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
             I+YRD+K  NILLD +GHV ++D GL+ +F
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  101 bits (252), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 49/104 (47%), Positives = 69/104 (66%)
Query: 26  ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEM 85
           E+ ++S  +  ++ V  PF+V + ++F T DKL F+LD +NGG+L YHL +   F E   
Sbjct: 82  EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA 141
Query: 86  RFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
           RFYAAE+   L ++H   IVYRDLKP NILLD  GH+ ++D GL
Sbjct: 142 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 185

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 44/93 (47%), Positives = 64/93 (68%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ V  PFIV + YAF T  KL  IL+ ++GG+L   L + G+F ED   FY AE+ + L
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
            H+H++ I+YRDLKP NI+L+  GHV+++D GL
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL 167

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 44/93 (47%), Positives = 64/93 (68%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ V  PFIV + YAF T  KL  IL+ ++GG+L   L + G+F ED   FY AE+ + L
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
            H+H++ I+YRDLKP NI+L+  GHV+++D GL
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL 167

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 41/87 (47%), Positives = 61/87 (70%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  +   F T D+L F+++ +NGGDL YH+ Q G F E +  FYAAE+ +GL  +H+R
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            I+YRDLK  N++LD  GH++I+D G+
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGM 166

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ M GGD+  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA 188

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ M GGD+  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA 188

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 46/106 (43%), Positives = 67/106 (63%), Gaps = 7/106 (6%)
Query: 25  NERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDE 84
           +ER+MLS+V+        PFI+ M   F    ++  I+D + GG+L   L +   F    
Sbjct: 55  DERLMLSIVT-------HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV 107
Query: 85  MRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            +FYAAEV L LE++H + I+YRDLKP NILLD++GH++I+D G A
Sbjct: 108 AKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 66/95 (69%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q ++ PF+V + Y+F   + +  ++DL+ GGDL YHL Q+  F E+ ++ +  E+++ L
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMAL 128
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC 131
           +++  + I++RD+KP NILLDEHGHV I+D  +A 
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 40/108 (37%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + Y+F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 40/108 (37%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + Y+F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 40/108 (37%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + Y+F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 40/108 (37%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 75  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 127
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+DE G+++++D G A
Sbjct: 128 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFA 175

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++   GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+++D+ G+++++D GLA
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLA 188

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 43/107 (40%), Positives = 67/107 (62%), Gaps = 6/107 (5%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            + E+ +LSL        + PF+  +   F TPD+L F+++ +NGGDL +H+ +   F+E
Sbjct: 70  TMTEKRILSLAR------NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE 123
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
              RFYAAE+I  L  +H + I+YRDLK  N+LLD  GH +++D G+
Sbjct: 124 ARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM 170

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA 188

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 89  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 141
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 142 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 109 TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 161
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 162 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 89  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 141
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 142 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 89  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 141
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 142 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 89  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 141
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 142 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 89  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 141
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 142 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 81  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 133
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 134 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 181

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 89  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 141
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 142 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 109 TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 161
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 162 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 42/87 (48%), Positives = 59/87 (67%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  M   F T + L F+++ +NGGDL YH+     F+     FYAAE+ILGL+ +H +
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            IVYRDLK  NILLD+ GH++I+D G+
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGM 164

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++   GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+++D+ G+++++D GLA
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLA 188

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 62/93 (66%)
Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           Q V+ PF+V + ++F     L  +L+   GG++  HL + G F+E   RFYAA+++L  E
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           ++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA 189

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 74  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE 126
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 127 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 174

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 42/87 (48%), Positives = 59/87 (67%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  M   F T + L F+++ +NGGDL YH+     F+     FYAAE+ILGL+ +H +
Sbjct: 79  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 138
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            IVYRDLK  NILLD+ GH++I+D G+
Sbjct: 139 GIVYRDLKLDNILLDKDGHIKIADFGM 165

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F E
Sbjct: 109 TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE 161
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 162 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F E
Sbjct: 83  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE 135
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 136 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 183

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 69/108 (63%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+++D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFA 188

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F E
Sbjct: 81  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE 133
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 134 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 181

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++   GG++  HL + G F+E
Sbjct: 89  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE 141
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+++D+ G+++++D G A
Sbjct: 142 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 61/92 (66%)
Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           Q  + PF+V +   F T  +L F+++ +NGGDL +H+ +     E+  RFY+AE+ L L 
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
           ++H R I+YRDLK  N+LLD  GH++++D G+
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 199

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F E
Sbjct: 89  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE 141
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 142 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++   GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+++D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 188

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 61/92 (66%)
Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           Q  + PF+V +   F T  +L F+++ +NGGDL +H+ +     E+  RFY+AE+ L L 
Sbjct: 76  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 135
Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
           ++H R I+YRDLK  N+LLD  GH++++D G+
Sbjct: 136 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 167

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 39/87 (44%), Positives = 58/87 (66%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  +   F T D+L F+++ +NGGDL YH+ Q G F E    FYAAE+ +GL  +  +
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            I+YRDLK  N++LD  GH++I+D G+
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGM 488

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 39/87 (44%), Positives = 58/87 (66%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           PF+  +   F T D+L F+++ +NGGDL YH+ Q G F E    FYAAE+ +GL  +  +
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGL 129
            I+YRDLK  N++LD  GH++I+D G+
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGM 167

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 61/92 (66%)
Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           Q  + PF+V +   F T  +L F+++ +NGGDL +H+ +     E+  RFY+AE+ L L 
Sbjct: 61  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 120
Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
           ++H R I+YRDLK  N+LLD  GH++++D G+
Sbjct: 121 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 152

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 68/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++   GG++  HL + G F+E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+++D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFA 188

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 61/92 (66%)
Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           Q  + PF+V +   F T  +L F+++ +NGGDL +H+ +     E+  RFY+AE+ L L 
Sbjct: 65  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGL 129
           ++H R I+YRDLK  N+LLD  GH++++D G+
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 67/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+V + ++F     L  +++   GG++  HL + G F E
Sbjct: 88  TLNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE 140
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+++D+ G+++++D G A
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 188

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 67/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+  + ++F     L  +++   GG++  HL + G F+E
Sbjct: 89  TLNEKRIL-------QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE 141
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+++D+ G+++++D G A
Sbjct: 142 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 67/108 (62%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+  + ++F     L  +++   GG++  HL + G F+E
Sbjct: 89  TLNEKRIL-------QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE 141
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+++D+ G+++++D G A
Sbjct: 142 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 66/108 (61%), Gaps = 7/108 (6%)
Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
            LNE+ +L       Q V+ PF+  + ++F     L  +++   GG++  HL + G F E
Sbjct: 89  TLNEKRIL-------QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE 141
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              RFYAA+++L  E++H   ++YRDLKP N+++D+ G+++++D G A
Sbjct: 142 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 145
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 146 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 186

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/104 (38%), Positives = 62/104 (59%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +  +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  L
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           E++H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 146 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 92  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 151
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 152 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 192

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 145
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 146 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 186

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 149
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 150 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 190

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 149
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 150 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 190

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 71  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 130
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 131 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 171

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 64  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 123
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 124 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 164

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 125
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 126 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 166

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 126
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 127 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 167

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 61/101 (60%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  LE++
Sbjct: 94  LDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 153
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 154 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 194

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 60/101 (59%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +D PF V + + F   +KL F L     G L  ++ + G F+E   RFY AE++  LE++
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H + I++RDLKP NILL+E  H++I+D G A   S +   A
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 68/126 (53%), Gaps = 7/126 (5%)
Query: 4   IVGTGFLSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILD 63
           I     L+    +K+ ET    E     ++  G    DC +I  + YAF   + L  ++D
Sbjct: 101 IYAMKILNKWEMLKRAETACFREE--RDVLVNG----DCQWITALHYAFQDENHLYLVMD 154
Query: 64  LMNGGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHV 122
              GGDL   LS+      ED  RFY  E++L ++ +H+ + V+RD+KP N+LLD +GH+
Sbjct: 155 YYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHI 214
Query: 123 RISDLG 128
           R++D G
Sbjct: 215 RLADFG 220

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 68/126 (53%), Gaps = 7/126 (5%)
Query: 4   IVGTGFLSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILD 63
           I     L+    +K+ ET    E     ++  G    DC +I  + YAF   + L  ++D
Sbjct: 117 IYAMKILNKWEMLKRAETACFREE--RDVLVNG----DCQWITALHYAFQDENHLYLVMD 170
Query: 64  LMNGGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHV 122
              GGDL   LS+      ED  RFY  E++L ++ +H+ + V+RD+KP N+LLD +GH+
Sbjct: 171 YYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHI 230
Query: 123 RISDLG 128
           R++D G
Sbjct: 231 RLADFG 236

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 60/100 (60%), Gaps = 1/100 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +   + P++V + YAF     L  +++ M GGDL   +S + V  E   RFY AEV+L L
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLAL 186
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
           + +H    ++RD+KP N+LLD+ GH++++D G     +K+
Sbjct: 187 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 226

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 60/100 (60%), Gaps = 1/100 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +   + P++V + YAF     L  +++ M GGDL   +S + V  E   RFY AEV+L L
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLAL 186
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
           + +H    ++RD+KP N+LLD+ GH++++D G     +K+
Sbjct: 187 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 226

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 60/100 (60%), Gaps = 1/100 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +   + P++V + YAF     L  +++ M GGDL   +S + V  E   RFY AEV+L L
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLAL 181
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
           + +H    ++RD+KP N+LLD+ GH++++D G     +K+
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 58/92 (63%), Gaps = 1/92 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +   + P++V +  AF     L  +++ M GGDL   +S + V  E   +FY AEV+L L
Sbjct: 129 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTAEVVLAL 187
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLG 128
           + +H   +++RD+KP N+LLD+HGH++++D G
Sbjct: 188 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 219

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 56/89 (62%), Gaps = 1/89 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHM 99
           D  +I  + YAF   + L  ++D   GGDL   LS+      E+  RFY AE+++ ++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLG 128
           H+ + V+RD+KP NIL+D +GH+R++D G
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLADFG 220

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 62/100 (62%), Gaps = 3/100 (3%)
Query: 37  IQMVDCPFIVCMTYAFHTP--DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVIL 94
           ++ +D P +V +      P  D L  + +L+N G +   +      +ED+ RFY  ++I 
Sbjct: 90  LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-MEVPTLKPLSEDQARFYFQDLIK 148
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           G+E++H + I++RD+KP+N+L+ E GH++I+D G++ +F 
Sbjct: 149 GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/89 (40%), Positives = 55/89 (61%), Gaps = 1/89 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEM-RFYAAEVILGLEHM 99
           D  +I  + +AF   + L  +++   GGDL   LS+ G     EM RFY AE+++ ++ +
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLG 128
           HR   V+RD+KP NILLD  GH+R++D G
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADFG 207

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 56/88 (63%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +     TP  +  +++ ++GG+L  ++ ++G  +E E R    +++ G+++ HR 
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +V+RDLKP N+LLD H + +I+D GL+
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLS 163

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 53/88 (60%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +     TP     +++ ++GG+L  ++ +HG   E E R    +++  +++ HR 
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +V+RDLKP N+LLD H + +I+D GL+
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLS 158

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 53/88 (60%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +     TP     +++ ++GG+L  ++ +HG   E E R    +++  +++ HR 
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +V+RDLKP N+LLD H + +I+D GL+
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLS 158

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 53/94 (56%)
Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           Q+   P I+ +  ++ +   +  + DLM  G+L  +L++    +E E R     ++  + 
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +H   IV+RDLKP NILLD++  +R+SD G +C
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 59/98 (60%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +++++ P IV +     T   L  +++  +GG++  +L  HG   E E R    +++  +
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           ++ H++YIV+RDLK  N+LLD   +++I+D G + +F+
Sbjct: 128 QYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFT 165

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 59/98 (60%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +++++ P IV +     T   L  +++  +GG++  +L  HG   E E R    +++  +
Sbjct: 60  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAV 119
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           ++ H+++IV+RDLK  N+LLD   +++I+D G + +F+
Sbjct: 120 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 157

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 59/98 (60%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +++++ P IV +     T   L  +++  +GG++  +L  HG   E E R    +++  +
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           ++ H+++IV+RDLK  N+LLD   +++I+D G + +F+
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 59/98 (60%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +++++ P IV +     T   L  +++  +GG++  +L  HG   E E R    +++  +
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           ++ H+++IV+RDLK  N+LLD   +++I+D G + +F+
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 70/127 (55%), Gaps = 12/127 (9%)
Query: 15  HVKQGETLAL---NERIMLSLVSTG--------IQMVDCPFIVCMTYAFHTPDKLCFILD 63
           H   G+ +AL   N++++      G        ++++  P I+ +     + D++  +++
Sbjct: 34  HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93
Query: 64  LMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR 123
              G +L  ++ Q    +E E R +  ++I  +E+ HR  IV+RDLKP N+LLDEH +V+
Sbjct: 94  YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVK 152
Query: 124 ISDLGLA 130
           I+D GL+
Sbjct: 153 IADFGLS 159

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 59/98 (60%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +++++ P IV +     T   L  +++  +GG++  +L  HG   E E R    +++  +
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           ++ H+++IV+RDLK  N+LLD   +++I+D G + +F+
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 59/98 (60%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +++++ P IV +     T   L  +++  +GG++  +L  HG   E E R    +++  +
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           ++ H+++IV+RDLK  N+LLD   +++I+D G + +F+
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 70/127 (55%), Gaps = 12/127 (9%)
Query: 15  HVKQGETLAL---NERIMLSLVSTG--------IQMVDCPFIVCMTYAFHTPDKLCFILD 63
           H   G+ +AL   N++++      G        ++++  P I+ +     + D++  +++
Sbjct: 35  HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 94
Query: 64  LMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR 123
              G +L  ++ Q    +E E R +  ++I  +E+ HR  IV+RDLKP N+LLDEH +V+
Sbjct: 95  YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVK 153
Query: 124 ISDLGLA 130
           I+D GL+
Sbjct: 154 IADFGLS 160

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 59/98 (60%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +++++ P IV +     T   L  +++  +GG++  +L  HG   E E R    +++  +
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           ++ H+++IV+RDLK  N+LLD   +++I+D G + +F+
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 70/127 (55%), Gaps = 12/127 (9%)
Query: 15  HVKQGETLAL---NERIMLSLVSTG--------IQMVDCPFIVCMTYAFHTPDKLCFILD 63
           H   G+ +AL   N++++      G        ++++  P I+ +     + D++  +++
Sbjct: 25  HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 84
Query: 64  LMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR 123
              G +L  ++ Q    +E E R +  ++I  +E+ HR  IV+RDLKP N+LLDEH +V+
Sbjct: 85  YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVK 143
Query: 124 ISDLGLA 130
           I+D GL+
Sbjct: 144 IADFGLS 150

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 70/127 (55%), Gaps = 12/127 (9%)
Query: 15  HVKQGETLAL---NERIMLSLVSTG--------IQMVDCPFIVCMTYAFHTPDKLCFILD 63
           H   G+ +AL   N++++      G        ++++  P I+ +     + D++  +++
Sbjct: 29  HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 88
Query: 64  LMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR 123
              G +L  ++ Q    +E E R +  ++I  +E+ HR  IV+RDLKP N+LLDEH +V+
Sbjct: 89  YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVK 147
Query: 124 ISDLGLA 130
           I+D GL+
Sbjct: 148 IADFGLS 154

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 58/94 (61%), Gaps = 1/94 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++++  P I+ +     TP  +  +++   GG+L  ++ +     EDE R +  ++I  +
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           E+ HR  IV+RDLKP N+LLD++ +V+I+D GL+
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS 155

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 58/98 (59%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +++++ P IV +     T   L  I++  +GG++  +L  HG   E E R    +++  +
Sbjct: 65  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 124
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           ++ H++ IV+RDLK  N+LLD   +++I+D G + +F+
Sbjct: 125 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 162

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 58/98 (59%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +++++ P IV +     T   L  I++  +GG++  +L  HG   E E R    +++  +
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           ++ H++ IV+RDLK  N+LLD   +++I+D G + +F+
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 57/97 (58%)
Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           ++++ P IV +     T   L  + +  +GG++  +L  HG   E E R    +++  ++
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ 127
Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           + H+++IV+RDLK  N+LLD   +++I+D G + +F+
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFT 164

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 2/90 (2%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGV-FNEDEMRFYAAEVILGLEHMH 100
           P IV    +F     L  ++D   GGDL   + +Q GV F ED++  +  ++ L L+H+H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            R I++RD+K  NI L + G V++ D G+A
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 55/100 (55%), Gaps = 1/100 (1%)
Query: 35  TGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVIL 94
           T +   D P++     ++    KL  I++ + GG     L + G  +E ++     E++ 
Sbjct: 77  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILK 135
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           GL+++H    ++RD+K AN+LL EHG V+++D G+A   +
Sbjct: 136 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 175

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 55/100 (55%), Gaps = 1/100 (1%)
Query: 35  TGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVIL 94
           T +   D P++     ++    KL  I++ + GG     L + G  +E ++     E++ 
Sbjct: 57  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILK 115
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           GL+++H    ++RD+K AN+LL EHG V+++D G+A   +
Sbjct: 116 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 155

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 55/100 (55%), Gaps = 1/100 (1%)
Query: 35  TGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVIL 94
           T +   D P++     ++    KL  I++ + GG     L + G  +E ++     E++ 
Sbjct: 57  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILK 115
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           GL+++H    ++RD+K AN+LL EHG V+++D G+A   +
Sbjct: 116 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 155

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 55/100 (55%), Gaps = 1/100 (1%)
Query: 35  TGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVIL 94
           T +   D P++     ++    KL  I++ + GG     L + G  +E ++     E++ 
Sbjct: 72  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATILREILK 130
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           GL+++H    ++RD+K AN+LL EHG V+++D G+A   +
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 8/97 (8%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGG---DLHYHLS-----QHGVFNEDEMRFYAAEVIL 94
           P IV    +F   D+L  ++ L++GG   D+  H+      + GV +E  +     EV+ 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC 131
           GLE++H+   ++RD+K  NILL E G V+I+D G++ 
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 8/97 (8%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGG---DLHYHLS-----QHGVFNEDEMRFYAAEVIL 94
           P IV    +F   D+L  ++ L++GG   D+  H+      + GV +E  +     EV+ 
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC 131
           GLE++H+   ++RD+K  NILL E G V+I+D G++ 
Sbjct: 128 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 164

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 49/89 (55%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ M   FH   ++  +L+    G+L+  L +HG F+E     +  E+   L + H R
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 134
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+L+   G ++I+D G + 
Sbjct: 135 KVIHRDIKPENLLMGYKGELKIADFGWSV 163

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 49/89 (55%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ M   FH   ++  +L+    G+L+  L +HG F+E     +  E+   L + H R
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+L+   G ++I+D G + 
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSV 162

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILG 95
           +Q +  P I+ +  AF     +  + D M   DL   +  +  V     ++ Y    + G
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 96  LEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           LE++H+ +I++RDLKP N+LLDE+G ++++D GLA  F
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV       TP  L  I++  +GG+L+  +   G F+EDE RF+  +++ G+ + H  
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVG 143
            I +RDLK  N LLD     R+      CDF   K       P ++VG
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVG 179

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS----QHGVFNEDEMRFYAAEV 92
           ++ ++ P ++    +F   ++L  +L+L + GDL   +     Q  +  E  +  Y  ++
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
              LEHMH R +++RD+KPAN+ +   G V++ DLGL   FS K
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 51/89 (57%), Gaps = 3/89 (3%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           IV +   + +P+ L  ++ L++GG+L   + + G + E +      +V+  + ++HR  I
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 105 VYRDLKPANILL---DEHGHVRISDLGLA 130
           V+RDLKP N+L    DE   + ISD GL+
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLS 170

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 50/89 (56%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   + T      + DLM  G+L  +L++    +E E R     ++  +  +H+ 
Sbjct: 71  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 130
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            IV+RDLKP NILLD+  +++++D G +C
Sbjct: 131 NIVHRDLKPENILLDDDMNIKLTDFGFSC 159

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 53/100 (53%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   + T      + DLM  G+L  +L++    +E E R     ++  +  +H+ 
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 142
            IV+RDLKP NILLD+  +++++D G +C     +   SV
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSV 183

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV       TP  L  +++  +GG+L   +   G F+EDE RF+  ++I G+ + H  
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAM 134
Query: 103 YIVYRDLKPANILLD--EHGHVRISDLGLA-CDFSKKKPHASVG 143
            + +RDLK  N LLD      ++I+D G +       +P ++VG
Sbjct: 135 QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVG 178

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 69/142 (48%), Gaps = 17/142 (11%)
Query: 10  LSNCSHVKQGETLALN-ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG 68
           L    ++++GE +A N +R +++  S     +  P IV       TP  L  +++  +GG
Sbjct: 46  LVAVKYIERGEKIAANVKREIINHRS-----LRHPNIVRFKEVILTPTHLAIVMEYASGG 100
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG 128
           +L   +   G F+EDE RF+  ++I G+ + H   + +RDLK  N LLD     R+    
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK--- 157
Query: 129 LACDFSKKK-------PHASVG 143
             CDF   K       P ++VG
Sbjct: 158 -ICDFGYSKSSVLHSQPKSTVG 178

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 50/89 (56%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   + T      + DLM  G+L  +L++    +E E R     ++  +  +H+ 
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            IV+RDLKP NILLD+  +++++D G +C
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSC 172

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 24/70 (34%), Positives = 46/70 (65%), Gaps = 1/70 (1%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           +LDLM   DLH  +        + +R++  +++ GL++MH   +++RDLKP+N+L++E+ 
Sbjct: 138 VLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC 196
Query: 121 HVRISDLGLA 130
            ++I D G+A
Sbjct: 197 ELKIGDFGMA 206

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 68/138 (49%), Gaps = 16/138 (11%)
Query: 8   GFLSNCSHVKQGETLAL-----------NERIMLSLVSTGIQMVDCPFIVCMTYAFHTPD 56
           G +    HV  G+ +A+            +R+++ L    ++ VDCPF V    A     
Sbjct: 21  GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL-DISMRTVDCPFTVTFYGALFREG 79
Query: 57  KLCFILDLMNGG-DLHYH--LSQHGVFNEDEMRFYAAEVILGLEHMHRRY-IVYRDLKPA 112
            +   ++LM+   D  Y   + +     ED +   A  ++  LEH+H +  +++RD+KP+
Sbjct: 80  DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 139
Query: 113 NILLDEHGHVRISDLGLA 130
           N+L++  G V++ D G++
Sbjct: 140 NVLINALGQVKMCDFGIS 157

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 68/138 (49%), Gaps = 16/138 (11%)
Query: 8   GFLSNCSHVKQGETLAL-----------NERIMLSLVSTGIQMVDCPFIVCMTYAFHTPD 56
           G +    HV  G+ +A+            +R+++ L    ++ VDCPF V    A     
Sbjct: 65  GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL-DISMRTVDCPFTVTFYGALFREG 123
Query: 57  KLCFILDLMNGG-DLHYH--LSQHGVFNEDEMRFYAAEVILGLEHMHRRY-IVYRDLKPA 112
            +   ++LM+   D  Y   + +     ED +   A  ++  LEH+H +  +++RD+KP+
Sbjct: 124 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 183
Query: 113 NILLDEHGHVRISDLGLA 130
           N+L++  G V++ D G++
Sbjct: 184 NVLINALGQVKMCDFGIS 201

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 52/108 (48%), Gaps = 11/108 (10%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV       TP  L  +++  +GG+L   +   G F+EDE RF+  ++I G+ + H  
Sbjct: 74  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 133
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVG 143
            + +RDLK  N LLD     R+      CDF   K       P ++VG
Sbjct: 134 QVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVG 177

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 47/89 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I+D G +C
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSC 157

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 26/91 (28%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   F TP ++  +L+L+ GG+L   + + G ++E +      +++  + ++H  
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 103 YIVYRDLKPANILL---DEHGHVRISDLGLA 130
            IV+RDLKP N+L         ++I+D GL+
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLS 198

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 54/100 (54%), Gaps = 1/100 (1%)
Query: 35  TGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVIL 94
           T +   D  ++     ++    KL  I++ + GG     L + G F+E ++     E++ 
Sbjct: 73  TVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGS-ALDLLRAGPFDEFQIATMLKEILK 131
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           GL+++H    ++RD+K AN+LL E G V+++D G+A   +
Sbjct: 132 GLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 171

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 58/104 (55%), Gaps = 1/104 (0%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P+IV    AF++  ++   ++ M+GG L   L + G   E  +   +  VI GL ++ 
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 140
Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
            ++ I++RD+KP+NIL++  G +++ D G++        ++ VG
Sbjct: 141 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 184

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 1/100 (1%)
Query: 35  TGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVIL 94
           T +   D P+I     ++    KL  I++ + GG     L + G   E  +     E++ 
Sbjct: 69  TVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSA-LDLLKPGPLEETYIATILREILK 127
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           GL+++H    ++RD+K AN+LL E G V+++D G+A   +
Sbjct: 128 GLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 167

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 54/91 (59%), Gaps = 1/91 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P+IV    AF++  ++   ++ M+GG L   L + G   E  +   +  VI GL ++ 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
            ++ I++RD+KP+NIL++  G +++ D G++
Sbjct: 184 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 214

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 54/91 (59%), Gaps = 1/91 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P+IV    AF++  ++   ++ M+GG L   L + G   E  +   +  VI GL ++ 
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
            ++ I++RD+KP+NIL++  G +++ D G++
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 54/91 (59%), Gaps = 1/91 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P+IV    AF++  ++   ++ M+GG L   L + G   E  +   +  VI GL ++ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
            ++ I++RD+KP+NIL++  G +++ D G++
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 58/104 (55%), Gaps = 1/104 (0%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P+IV    AF++  ++   ++ M+GG L   L + G   E  +   +  VI GL ++ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
            ++ I++RD+KP+NIL++  G +++ D G++        ++ VG
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 165

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 58/104 (55%), Gaps = 1/104 (0%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P+IV    AF++  ++   ++ M+GG L   L + G   E  +   +  VI GL ++ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
            ++ I++RD+KP+NIL++  G +++ D G++        ++ VG
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 165

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 54/91 (59%), Gaps = 1/91 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P+IV    AF++  ++   ++ M+GG L   L + G   E  +   +  VI GL ++ 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
            ++ I++RD+KP+NIL++  G +++ D G++
Sbjct: 125 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 155

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 54/91 (59%), Gaps = 1/91 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P+IV    AF++  ++   ++ M+GG L   L + G   E  +   +  VI GL ++ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
            ++ I++RD+KP+NIL++  G +++ D G++
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 54/91 (59%), Gaps = 1/91 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P+IV    AF++  ++   ++ M+GG L   L + G   E  +   +  VI GL ++ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
            ++ I++RD+KP+NIL++  G +++ D G++
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 68/138 (49%), Gaps = 12/138 (8%)
Query: 5   VGTGFLS---NCSHVKQGETLA---LNERIMLSLVSTGIQMVDC---PFIVCMTYAFHTP 55
           +G G  S    C H K  +  A   +++R+  +       +  C   P IV +   FH  
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78
Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
                +++L+NGG+L   + +   F+E E  +   +++  + HMH   +V+RDLKP N+L
Sbjct: 79  LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL 138
Query: 116 L-DEHGH--VRISDLGLA 130
             DE+ +  ++I D G A
Sbjct: 139 FTDENDNLEIKIIDFGFA 156

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 3/98 (3%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFNEDEMRFYAAEVILGLEHMHR 101
           P +V +  AF   +++  I + M+GG+L   ++ +H   +EDE   Y  +V  GL HMH 
Sbjct: 108 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 167
Query: 102 RYIVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK 137
              V+ DLKP NI+        +++ D GL      K+
Sbjct: 168 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 205

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 3/98 (3%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFNEDEMRFYAAEVILGLEHMHR 101
           P +V +  AF   +++  I + M+GG+L   ++ +H   +EDE   Y  +V  GL HMH 
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 102 RYIVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK 137
              V+ DLKP NI+        +++ D GL      K+
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G+++  L +   F+E     Y  E+   L + H +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 54/92 (58%), Gaps = 4/92 (4%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   +     +  IL+L++GG+L   L+Q    +E+E   +  +++ G+ ++H +
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 103 YIVYRDLKPANI-LLDEH---GHVRISDLGLA 130
            I + DLKP NI LLD++    H+++ D GLA
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 47/89 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G+++  L +   F+E     Y  E+   L + H +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I+D G + 
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWSV 161

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 3/104 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++++D P I+ +   F        +++   GG+L   +     FNE +      +V+ G+
Sbjct: 90  LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGV 149
Query: 97  EHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK 137
            ++H+  IV+RDLKP N+LL   ++   ++I D GL+  F  +K
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 3/104 (2%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV       TP  L  +++  +GG+L   +   G F+EDE RF+  ++I G+ + H  
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHASVG 143
            + +RDLK  N LLD     R+         S     +P ++VG
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVG 178

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 52/87 (59%), Gaps = 2/87 (2%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRY 103
           IV +    HT   L  + + ++  DL  +L   G + N   ++ +  +++ GL + HR+ 
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 104 IVYRDLKPANILLDEHGHVRISDLGLA 130
           +++RDLKP N+L++E G ++++D GLA
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLA 147

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDE------MRFYAAEVILGLEH 98
           IV +    HT +KL  + + M+  DL  ++    V N         ++++  +++ GL  
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
            H   I++RDLKP N+L+++ G +++ D GLA  F
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           IV M       D    +++ + G  L  ++  HG  + D    +  +++ G++H H   I
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           V+RD+KP NIL+D +  ++I D G+A   S+
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV +   + +   L  I+ L++GG+L   + + G + E +      +V+  ++++H  
Sbjct: 76  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 135
Query: 103 YIVYRDLKPANIL---LDEHGHVRISDLGLA 130
            IV+RDLKP N+L   LDE   + ISD GL+
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV +   + +   L  I+ L++GG+L   + + G + E +      +V+  ++++H  
Sbjct: 76  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 135
Query: 103 YIVYRDLKPANIL---LDEHGHVRISDLGLA 130
            IV+RDLKP N+L   LDE   + ISD GL+
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV +   + +   L  I+ L++GG+L   + + G + E +      +V+  ++++H  
Sbjct: 76  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 135
Query: 103 YIVYRDLKPANIL---LDEHGHVRISDLGLA 130
            IV+RDLKP N+L   LDE   + ISD GL+
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 66/128 (51%), Gaps = 14/128 (10%)
Query: 18  QGETLALNERIMLS-----LVSTGIQMVDC------PFIVCMTYAFHTPDKLCFILDLMN 66
           QG  +AL +RI L      + ST I+ +        P IV +    H+   L  + + M 
Sbjct: 44  QGRIVAL-KRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102
Query: 67  GGDLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS 125
             DL   L ++     + +++ Y  +++ G+ H H+  I++RDLKP N+L++  G ++++
Sbjct: 103 K-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLA 161
Query: 126 DLGLACDF 133
           D GLA  F
Sbjct: 162 DFGLARAF 169

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 41/75 (54%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV       TP  L  +++  +GG+L   +   G F+EDE RF+  ++I G+ + H  
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 103 YIVYRDLKPANILLD 117
            + +RDLK  N LLD
Sbjct: 135 QVCHRDLKLENTLLD 149

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 66/128 (51%), Gaps = 14/128 (10%)
Query: 18  QGETLALNERIMLS-----LVSTGIQMVDC------PFIVCMTYAFHTPDKLCFILDLMN 66
           QG  +AL +RI L      + ST I+ +        P IV +    H+   L  + + M 
Sbjct: 44  QGRIVAL-KRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102
Query: 67  GGDLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS 125
             DL   L ++     + +++ Y  +++ G+ H H+  I++RDLKP N+L++  G ++++
Sbjct: 103 K-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLA 161
Query: 126 DLGLACDF 133
           D GLA  F
Sbjct: 162 DFGLARAF 169

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 43/79 (54%)
Query: 52  FHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKP 111
           F   D +  +L+L     L     +     E E R+Y  +++LG +++HR  +++RDLK 
Sbjct: 84  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 143
Query: 112 ANILLDEHGHVRISDLGLA 130
            N+ L+E   V+I D GLA
Sbjct: 144 GNLFLNEDLEVKIGDFGLA 162

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV +   + +   L  I+ L++GG+L   + + G + E +      +V+  ++++H  
Sbjct: 76  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 135
Query: 103 YIVYRDLKPANIL---LDEHGHVRISDLGLA 130
            IV+RDLKP N+L   LDE   + ISD GL+
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 46/70 (65%), Gaps = 1/70 (1%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           +LDLM   DLH  +        + +R++  +++ GL++MH   +++RDLKP+N+L++E+ 
Sbjct: 137 VLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC 195
Query: 121 HVRISDLGLA 130
            ++I D G+A
Sbjct: 196 ELKIGDFGMA 205

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 43/79 (54%)
Query: 52  FHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKP 111
           F   D +  +L+L     L     +     E E R+Y  +++LG +++HR  +++RDLK 
Sbjct: 90  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 149
Query: 112 ANILLDEHGHVRISDLGLA 130
            N+ L+E   V+I D GLA
Sbjct: 150 GNLFLNEDLEVKIGDFGLA 168

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 43/79 (54%)
Query: 52  FHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKP 111
           F   D +  +L+L     L     +     E E R+Y  +++LG +++HR  +++RDLK 
Sbjct: 86  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 145
Query: 112 ANILLDEHGHVRISDLGLA 130
            N+ L+E   V+I D GLA
Sbjct: 146 GNLFLNEDLEVKIGDFGLA 164

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 43/79 (54%)
Query: 52  FHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKP 111
           F   D +  +L+L     L     +     E E R+Y  +++LG +++HR  +++RDLK 
Sbjct: 86  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 145
Query: 112 ANILLDEHGHVRISDLGLA 130
            N+ L+E   V+I D GLA
Sbjct: 146 GNLFLNEDLEVKIGDFGLA 164

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 51/94 (54%), Gaps = 1/94 (1%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           +V M  ++   D+L  +++ + GG L   +  H   NE+++      V+  L ++H + +
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQGV 162
Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 138
           ++RD+K  +ILL   G +++SD G     SK+ P
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 196

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 43/79 (54%)
Query: 52  FHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKP 111
           F   D +  +L+L     L     +     E E R+Y  +++LG +++HR  +++RDLK 
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 169
Query: 112 ANILLDEHGHVRISDLGLA 130
            N+ L+E   V+I D GLA
Sbjct: 170 GNLFLNEDLEVKIGDFGLA 188

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 43/79 (54%)
Query: 52  FHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKP 111
           F   D +  +L+L     L     +     E E R+Y  +++LG +++HR  +++RDLK 
Sbjct: 108 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 167
Query: 112 ANILLDEHGHVRISDLGLA 130
            N+ L+E   V+I D GLA
Sbjct: 168 GNLFLNEDLEVKIGDFGLA 186

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 47/89 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK 131
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL  +G ++I+D G + 
Sbjct: 132 RVIHRDIKPENLLLGSNGELKIADFGWSV 160

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 47/89 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK 131
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL  +G ++I+D G + 
Sbjct: 132 RVIHRDIKPENLLLGSNGELKIADFGWSV 160

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +D P I+ +   F        + ++  GG+L   +     F+E +      +V+ G+
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 163
Query: 97  EHMHRRYIVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK 137
            +MH+  IV+RDLKP N+LL+   +  ++RI D GL+  F   K
Sbjct: 164 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 207

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +D P I+ +   F        + ++  GG+L   +     F+E +      +V+ G+
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 145
Query: 97  EHMHRRYIVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK 137
            +MH+  IV+RDLKP N+LL+   +  ++RI D GL+  F   K
Sbjct: 146 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 189

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +D P I+ +   F        + ++  GG+L   +     F+E +      +V+ G+
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 162
Query: 97  EHMHRRYIVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK 137
            +MH+  IV+RDLKP N+LL+   +  ++RI D GL+  F   K
Sbjct: 163 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +D P I+ +   F        + ++  GG+L   +     F+E +      +V+ G+
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 97  EHMHRRYIVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK 137
            +MH+  IV+RDLKP N+LL+   +  ++RI D GL+  F   K
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 70  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 129
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 130 RVIHRDIKPENLLLGSAGELKIADFGWS 157

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 85  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 144
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 145 RVIHRDIKPENLLLGSAGELKIADFGWS 172

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 50/89 (56%), Gaps = 3/89 (3%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           IV +   + +      ++ L++GG+L   + + GV+ E +      +V+  ++++H   I
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 105 VYRDLKPANILL---DEHGHVRISDLGLA 130
           V+RDLKP N+L    +E+  + I+D GL+
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLS 156

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   +     +  + +LM GG+L   + +   F+E E  F    +   +E++H +
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ 140
Query: 103 YIVYRDLKPANIL-LDEHGH---VRISDLGLA 130
            +V+RDLKP+NIL +DE G+   +RI D G A
Sbjct: 141 GVVHRDLKPSNILYVDESGNPECLRICDFGFA 172

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 46/89 (51%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 131
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I+D G + 
Sbjct: 132 RVIHRDIKPENLLLGSAGELKIADFGWSV 160

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 46/89 (51%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I+D G + 
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSV 159

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 94  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 153
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 154 RVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   +     +  + +LM GG+L   + +   F+E E  F    +   +E++H +
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ 140
Query: 103 YIVYRDLKPANIL-LDEHGH---VRISDLGLA 130
            +V+RDLKP+NIL +DE G+   +RI D G A
Sbjct: 141 GVVHRDLKPSNILYVDESGNPECLRICDFGFA 172

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 46/89 (51%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I+D G + 
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSV 156

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 46/89 (51%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 67  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 126
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I+D G + 
Sbjct: 127 RVIHRDIKPENLLLGSAGELKIADFGWSV 155

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 46/89 (51%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I+D G + 
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSV 156

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 46/89 (51%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 68  PNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I+D G + 
Sbjct: 128 KVIHRDIKPENLLLGSAGELKIADFGWSV 156

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 46/89 (51%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I+D G + 
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSV 159

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 46/89 (51%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I+D G + 
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWSV 156

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 94  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 153
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 154 RVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 46/89 (51%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 65  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 124
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I+D G + 
Sbjct: 125 RVIHRDIKPENLLLGSAGELKIADFGWSV 153

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 54/91 (59%), Gaps = 1/91 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           + P+IV    AF++  ++   ++ M+GG L   L +     E+ +   +  V+ GL ++ 
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 101 RRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
            ++ I++RD+KP+NIL++  G +++ D G++
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVS 162

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 46/89 (51%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I+D G + 
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWSV 159

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 28/102 (27%), Positives = 53/102 (51%), Gaps = 3/102 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +D P I+ +   F        + +   GG+L   +     F+E +      +++ G+
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159
Query: 97  EHMHRRYIVYRDLKPANILLDEHG---HVRISDLGLACDFSK 135
            ++H+  IV+RD+KP NILL+      +++I D GL+  FSK
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/125 (24%), Positives = 61/125 (48%), Gaps = 2/125 (1%)
Query: 7   TGFLSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN 66
           TG +     +++      N+RI++ L    ++  DCP+IV     F T   +   ++LM 
Sbjct: 49  TGHVIAVKQMRRSGNKEENKRILMDL-DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMG 107
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY-IVYRDLKPANILLDEHGHVRIS 125
                      G   E  +      ++  L ++  ++ +++RD+KP+NILLDE G +++ 
Sbjct: 108 TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLC 167
Query: 126 DLGLA 130
           D G++
Sbjct: 168 DFGIS 172

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           ++ +   +     +  IL+L++GG+L   L+Q    +E+E   +  +++ G+ ++H + I
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 105 VYRDLKPANI-LLDEH---GHVRISDLGLA 130
            + DLKP NI LLD++    H+++ D GLA
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 57/98 (58%), Gaps = 3/98 (3%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHR 101
           P I+ +   F   + +  +L++ + G+++ +L      F+E+E R +  ++I G+ ++H 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
             I++RDL  +N+LL  + +++I+D GLA     K PH
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQL--KMPH 166

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           ++ +   +     +  IL+L++GG+L   L+Q    +E+E   +  +++ G+ ++H + I
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 105 VYRDLKPANI-LLDEH---GHVRISDLGLA 130
            + DLKP NI LLD++    H+++ D GLA
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 1/89 (1%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV +  A      +   ++L+ GG L   + + G   ED   +Y  + + GLE++H R
Sbjct: 145 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSR 204
Query: 103 YIVYRDLKPANILLDEHG-HVRISDLGLA 130
            I++ D+K  N+LL   G H  + D G A
Sbjct: 205 RILHGDVKADNVLLSSDGSHAALCDFGHA 233

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 1/89 (1%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV +  A      +   ++L+ GG L   + + G   ED   +Y  + + GLE++H R
Sbjct: 126 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSR 185
Query: 103 YIVYRDLKPANILLDEHG-HVRISDLGLA 130
            I++ D+K  N+LL   G H  + D G A
Sbjct: 186 RILHGDVKADNVLLSSDGSHAALCDFGHA 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           ++ +   +     +  IL+L++GG+L   L+Q    +E+E   +  +++ G+ ++H + I
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 105 VYRDLKPANI-LLDEH---GHVRISDLGLA 130
            + DLKP NI LLD++    H+++ D GLA
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           ++ +   +     +  IL+L++GG+L   L+Q    +E+E   +  +++ G+ ++H + I
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 105 VYRDLKPANI-LLDEH---GHVRISDLGLA 130
            + DLKP NI LLD++    H+++ D GLA
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           ++ +   +     +  IL+L++GG+L   L+Q    +E+E   +  +++ G+ ++H + I
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 105 VYRDLKPANI-LLDEH---GHVRISDLGLA 130
            + DLKP NI LLD++    H+++ D GLA
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 14/137 (10%)
Query: 8   GFLSNCSHVKQGETLALN----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDK 57
           G +    HV  G+  A+           ++ +L  +    + VDCPF V    A      
Sbjct: 48  GVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGD 107
Query: 58  LCFILDLMNGG-DLHYH--LSQHGVFNEDEMRFYAAEVILGLEHMHRRY-IVYRDLKPAN 113
           +    +L +   D  Y   + +     ED +   A  ++  LEH+H +  +++RD+KP+N
Sbjct: 108 VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 167
Query: 114 ILLDEHGHVRISDLGLA 130
           +L++  G V+  D G++
Sbjct: 168 VLINALGQVKXCDFGIS 184

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   F     +  IL+L++GG+L   L++     EDE   +  +++ G+ ++H +
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 103 YIVYRDLKPANI-LLDE---HGHVRISDLGLA 130
            I + DLKP NI LLD+   +  +++ D G+A
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   F     +  IL+L++GG+L   L++     EDE   +  +++ G+ ++H +
Sbjct: 75  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 134
Query: 103 YIVYRDLKPANI-LLDE---HGHVRISDLGLA 130
            I + DLKP NI LLD+   +  +++ D G+A
Sbjct: 135 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 166

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   F     +  IL+L++GG+L   L++     EDE   +  +++ G+ ++H +
Sbjct: 89  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 148
Query: 103 YIVYRDLKPANI-LLDE---HGHVRISDLGLA 130
            I + DLKP NI LLD+   +  +++ D G+A
Sbjct: 149 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 180

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 24/88 (27%), Positives = 46/88 (52%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 70  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 129
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I++ G +
Sbjct: 130 RVIHRDIKPENLLLGSAGELKIANFGWS 157

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 1/86 (1%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDL 109
            + T  +L  +     G  L++HL +    F   ++   A +   G++++H + I++RDL
Sbjct: 87  GYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 110 KPANILLDEHGHVRISDLGLACDFSK 135
           K  NI L E   V+I D GLA + S+
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSR 172

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/89 (26%), Positives = 46/89 (51%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +++RD+KP N+LL   G ++I++ G + 
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIANFGWSV 159

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 1/86 (1%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDL 109
            + T  +L  +     G  L++HL +    F   ++   A +   G++++H + I++RDL
Sbjct: 87  GYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 110 KPANILLDEHGHVRISDLGLACDFSK 135
           K  NI L E   V+I D GLA + S+
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSR 172

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 1/95 (1%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           +V M  ++   D+L  +++ + GG L   +  H   NE+++      V+  L  +H + +
Sbjct: 83  VVEMYNSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV 141
Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
           ++RD+K  +ILL   G V++SD G     SK+ P 
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 176

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   +     +  + +LM GG+L   + +   F+E E       +   +E++H +
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 103 YIVYRDLKPANIL-LDEHGH---VRISDLGLA 130
            +V+RDLKP+NIL +DE G+   +RI D G A
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 1/95 (1%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           +V M  ++   D+L  +++ + GG L   +  H   NE+++      V+  L  +H + +
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV 137
Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
           ++RD+K  +ILL   G V++SD G     SK+ P 
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 172

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 1/95 (1%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           +V M  ++   D+L  +++ + GG L   +  H   NE+++      V+  L  +H + +
Sbjct: 90  VVEMYNSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV 148
Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
           ++RD+K  +ILL   G V++SD G     SK+ P 
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 183

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 43/91 (47%), Gaps = 5/91 (5%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV +  A      +   ++L+ GG L   + Q G   ED   +Y  + + GLE++H R
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDF 133
            I++ D+K  N+LL   G          CDF
Sbjct: 170 RILHGDVKADNVLLSSDG-----SRAALCDF 195

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 43/91 (47%), Gaps = 5/91 (5%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV +  A      +   ++L+ GG L   + Q G   ED   +Y  + + GLE++H R
Sbjct: 126 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR 185
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDF 133
            I++ D+K  N+LL   G          CDF
Sbjct: 186 RILHGDVKADNVLLSSDG-----SRAALCDF 211

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 27/95 (28%), Positives = 53/95 (55%), Gaps = 4/95 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ ++ P I+ +   F   D    +L+LM GG+L   +  +    E   + Y  +++L +
Sbjct: 208 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 266
Query: 97  EHMHRRYIVYRDLKPANILL---DEHGHVRISDLG 128
           +++H   I++RDLKP N+LL   +E   ++I+D G
Sbjct: 267 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 301

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 5/94 (5%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +  P IV +  A      +   ++L+ GG L   + Q G   ED   +Y  + + GLE++
Sbjct: 121 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 180
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           H R I++ D+K  N+LL   G          CDF
Sbjct: 181 HTRRILHGDVKADNVLLSSDG-----SRAALCDF 209

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 1/95 (1%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           +V M  ++   D+L  +++ + GG L   +  H   NE+++      V+  L  +H + +
Sbjct: 88  VVEMYNSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV 146
Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
           ++RD+K  +ILL   G V++SD G     SK+ P 
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 181

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 1/95 (1%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           +V M  ++   D+L  +++ + GG L   +  H   NE+++      V+  L  +H + +
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV 191
Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
           ++RD+K  +ILL   G V++SD G     SK+ P 
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 3/104 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +D P I  +   F        + ++  GG+L   +     F+E +      +V+ G+
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 97  EHMHRRYIVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK 137
            + H+  IV+RDLKP N+LL+   +  ++RI D GL+  F   K
Sbjct: 140 TYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +D P I+ +            + +L  GG+L   + +   F+E +      +V  G+
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 97  EHMHRRYIVYRDLKPANILLDEHGH---VRISDLGLACDFSK 135
            +MH+  IV+RDLKP NILL+       ++I D GL+  F +
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 58/121 (47%), Gaps = 4/121 (3%)
Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           K   T   N   +L  V+  ++ +D P I+ +   F        ++++  GG+L   +  
Sbjct: 56  KSSVTTTSNSGALLDEVAV-LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL 114
Query: 77  HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH---VRISDLGLACDF 133
              F+E +      +V+ G  ++H+  IV+RDLKP N+LL+       ++I D GL+  F
Sbjct: 115 RQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF 174
Query: 134 S 134
Sbjct: 175 E 175

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 51/94 (54%), Gaps = 1/94 (1%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           +V M  ++   ++L  +++ + GG L   +SQ    NE+++      V+  L ++H + +
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQGV 162
Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 138
           ++RD+K  +ILL   G V++SD G     SK  P
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 58/121 (47%), Gaps = 4/121 (3%)
Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           K   T   N   +L  V+  ++ +D P I+ +   F        ++++  GG+L   +  
Sbjct: 39  KSSVTTTSNSGALLDEVAV-LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL 97
Query: 77  HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH---VRISDLGLACDF 133
              F+E +      +V+ G  ++H+  IV+RDLKP N+LL+       ++I D GL+  F
Sbjct: 98  RQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF 157
Query: 134 S 134
Sbjct: 158 E 158

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 1/95 (1%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           +V M  ++   D+L  +++ + GG L   +  H   NE+++      V+  L  +H + +
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV 268
Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
           ++RD+K  +ILL   G V++SD G     SK+ P 
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 50/89 (56%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           IV +    H+  KL  + +  +     Y  S +G  + + ++ +  +++ GL   H R +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDF 133
           ++RDLKP N+L++ +G ++++D GLA  F
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAF 151

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   F   D    +L+LM GG+L   +  +    E   + Y  +++L ++++H  
Sbjct: 75  PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133
Query: 103 YIVYRDLKPANILL---DEHGHVRISDLG 128
            I++RDLKP N+LL   +E   ++I+D G
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFG 162

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/72 (31%), Positives = 43/72 (59%), Gaps = 3/72 (4%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL--- 116
            +L+LM GG+L   +  +    E   + Y  +++L ++++H   I++RDLKP N+LL   
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 117 DEHGHVRISDLG 128
           +E   ++I+D G
Sbjct: 151 EEDCLIKITDFG 162

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/72 (31%), Positives = 43/72 (59%), Gaps = 3/72 (4%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL--- 116
            +L+LM GG+L   +  +    E   + Y  +++L ++++H   I++RDLKP N+LL   
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 117 DEHGHVRISDLG 128
           +E   ++I+D G
Sbjct: 151 EEDCLIKITDFG 162

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   F   D    +L+LM GG+L   +  +    E   + Y  +++L ++++H  
Sbjct: 74  PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 132
Query: 103 YIVYRDLKPANILL---DEHGHVRISDLG 128
            I++RDLKP N+LL   +E   ++I+D G
Sbjct: 133 GIIHRDLKPENVLLSSQEEDCLIKITDFG 161

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +D P I+ +            + +L  GG+L   + +   F+E +      +V  G+
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 97  EHMHRRYIVYRDLKPANILLDEHGH---VRISDLGLACDFSK 135
            +MH+  IV+RDLKP NILL+       ++I D GL+  F +
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   F   D    +L+LM GG+L   +  +    E   + Y  +++L ++++H  
Sbjct: 81  PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 139
Query: 103 YIVYRDLKPANILL---DEHGHVRISDLG 128
            I++RDLKP N+LL   +E   ++I+D G
Sbjct: 140 GIIHRDLKPENVLLSSQEEDCLIKITDFG 168

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 82  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 140
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 141 RDNLKISDFGLATVF 155

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 81  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 139
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 140 RDNLKISDFGLATVF 154

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 53/95 (55%), Gaps = 4/95 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ ++ P I+ +   F   D    +L+LM GG+L   +  +    E   + Y  +++L +
Sbjct: 194 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 97  EHMHRRYIVYRDLKPANILL---DEHGHVRISDLG 128
           +++H   I++RDLKP N+LL   +E   ++I+D G
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +D P I+ +            + +L  GG+L   + +   F+E +      +V  G+
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 97  EHMHRRYIVYRDLKPANILLDEHGH---VRISDLGLACDFSK 135
            +MH+  IV+RDLKP NILL+       ++I D GL+  F +
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/72 (29%), Positives = 47/72 (65%), Gaps = 1/72 (1%)
Query: 59  CFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
            +++  + G DL+ ++ +    +++ ++F   +++ GL+++H   I++RDLKP+N+ ++E
Sbjct: 108 VYLVTTLMGADLN-NIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNE 166
Query: 119 HGHVRISDLGLA 130
              +RI D GLA
Sbjct: 167 DSELRILDFGLA 178

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 82  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 140
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 141 RDNLKISDFGLATVF 155

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 82  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 140
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 141 RDNLKISDFGLATVF 155

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 82  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 140
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 141 RDNLKISDFGLATVF 155

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/99 (25%), Positives = 49/99 (49%), Gaps = 1/99 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFNEDEMRFYAAEVILG 95
           +Q  D P +V    ++     L  +++    G +   +  ++    EDE+       + G
Sbjct: 78  MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137
Query: 96  LEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           LE++H    ++RD+K  NILL+  GH +++D G+A   +
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 44/86 (51%), Gaps = 1/86 (1%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDL 109
            + T  +L  +     G  L++HL +    F   ++   A +   G++++H + I++RDL
Sbjct: 75  GYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 134
Query: 110 KPANILLDEHGHVRISDLGLACDFSK 135
           K  NI L E   V+I D GLA   S+
Sbjct: 135 KSNNIFLHEDNTVKIGDFGLATVKSR 160

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 81  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 139
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 140 RDNLKISDFGLATVF 154

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 3/78 (3%)
Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           D+   + + M GG +  H+ +   FNE E      +V   L+ +H + I +RDLKP NIL
Sbjct: 84  DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143
Query: 116 LDEHGH---VRISDLGLA 130
            +       V+I D GL 
Sbjct: 144 CEHPNQVSPVKICDFGLG 161

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 25/84 (29%), Positives = 47/84 (55%), Gaps = 2/84 (2%)
Query: 48  MTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVY 106
           ++Y    P+ L  +++ +  G L   L +H    +   +  Y++++  G+E++  R  V+
Sbjct: 76  VSYGPGRPE-LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 134
Query: 107 RDLKPANILLDEHGHVRISDLGLA 130
           RDL   NIL++   HV+I+D GLA
Sbjct: 135 RDLAARNILVESEAHVKIADFGLA 158

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 81  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 139
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 140 RDNLKISDFGLATVF 154

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 80  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 138
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 139 RDNLKISDFGLATVF 153

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 81  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 139
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 140 RDNLKISDFGLATVF 154

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 82  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 140
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 141 RDNLKISDFGLATVF 155

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 81  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 139
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 140 RDNLKISDFGLATVF 154

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 82  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 140
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 141 RDNLKISDFGLATVF 155

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 81  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 139
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 140 RDNLKISDFGLATVF 154

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 81  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 139
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 140 RDNLKISDFGLATVF 154

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 81  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 139
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 140 RDNLKISDFGLATVF 154

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 81  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 139
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 140 RDNLKISDFGLATVF 154

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 81  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 139
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 140 RDNLKISDFGLATVF 154

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 81  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 139
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 140 RDNLKISDFGLATVF 154

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   +     +  + +L  GG+L   + +   F+E E       +   +E++H +
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 103 YIVYRDLKPANIL-LDEHGH---VRISDLGLA 130
            +V+RDLKP+NIL +DE G+   +RI D G A
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 2/75 (2%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
             L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE
Sbjct: 82  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDE 140
Query: 119 HGHVRISDLGLACDF 133
             +++ISD GLA  F
Sbjct: 141 RDNLKISDFGLATVF 155

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/73 (36%), Positives = 45/73 (61%), Gaps = 2/73 (2%)
Query: 62  LDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE  
Sbjct: 84  LEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDERD 142
Query: 121 HVRISDLGLACDF 133
           +++ISD GLA  F
Sbjct: 143 NLKISDFGLATVF 155

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/73 (36%), Positives = 45/73 (61%), Gaps = 2/73 (2%)
Query: 62  LDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           L+  +GG+L   +    G+   D  RF+  +++ G+ ++H   I +RD+KP N+LLDE  
Sbjct: 83  LEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIGITHRDIKPENLLLDERD 141
Query: 121 HVRISDLGLACDF 133
           +++ISD GLA  F
Sbjct: 142 NLKISDFGLATVF 154

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 44  FIVCMTYAFHTPDK--LCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMH 100
           FIV      + P +  L  +++ +  G L   L +H    +   +  Y++++  G+E++ 
Sbjct: 73  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 132
Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            R  V+RDL   NIL++   HV+I+D GLA
Sbjct: 133 SRRCVHRDLAARNILVESEAHVKIADFGLA 162

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 44  FIVCMTYAFHTPDK--LCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMH 100
           FIV      + P +  L  +++ +  G L   L +H    +   +  Y++++  G+E++ 
Sbjct: 85  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            R  V+RDL   NIL++   HV+I+D GLA
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLA 174

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 44  FIVCMTYAFHTPDK--LCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMH 100
           FIV      + P +  L  +++ +  G L   L +H    +   +  Y++++  G+E++ 
Sbjct: 72  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 131
Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            R  V+RDL   NIL++   HV+I+D GLA
Sbjct: 132 SRRCVHRDLAARNILVESEAHVKIADFGLA 161

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 24/89 (26%), Positives = 50/89 (56%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           IV +    H+  KL  + +  +     Y  S +G  + + ++ +  +++ GL   H R +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 105 VYRDLKPANILLDEHGHVRISDLGLACDF 133
           ++RDLKP N+L++ +G +++++ GLA  F
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAF 151

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 15/98 (15%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDL-------HYHLSQHGVFNEDEMRFYAAEVILG 95
           P ++ +  AF    ++  IL+ ++GG+L        Y +S+  V N      Y  +   G
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN------YMRQACEG 161
Query: 96  LEHMHRRYIVYRDLKPANILLD--EHGHVRISDLGLAC 131
           L+HMH   IV+ D+KP NI+ +  +   V+I D GLA 
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 24/64 (37%), Positives = 39/64 (60%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL   L +H    ED ++F   +++ GL ++H   I++RDLKP N+ ++E   ++I D
Sbjct: 113 GTDLG-KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILD 171
Query: 127 LGLA 130
            GLA
Sbjct: 172 FGLA 175

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 21/72 (29%), Positives = 47/72 (65%), Gaps = 1/72 (1%)
Query: 59  CFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
            +++  + G DL+ ++ +    +++ ++F   +++ GL+++H   I++RDLKP+N+ ++E
Sbjct: 108 VYLVTTLMGADLN-NIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNE 166
Query: 119 HGHVRISDLGLA 130
              +RI D GLA
Sbjct: 167 DSELRILDFGLA 178

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 25/93 (26%), Positives = 47/93 (50%)
Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +D P +V     F   D +  +L++     L     +     E E R++  + I G++
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           ++H   +++RDLK  N+ L++   V+I D GLA
Sbjct: 157 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 25/93 (26%), Positives = 47/93 (50%)
Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +D P +V     F   D +  +L++     L     +     E E R++  + I G++
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           ++H   +++RDLK  N+ L++   V+I D GLA
Sbjct: 157 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 25/93 (26%), Positives = 47/93 (50%)
Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +D P +V     F   D +  +L++     L     +     E E R++  + I G++
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 156
Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           ++H   +++RDLK  N+ L++   V+I D GLA
Sbjct: 157 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 25/93 (26%), Positives = 47/93 (50%)
Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +D P +V     F   D +  +L++     L     +     E E R++  + I G++
Sbjct: 81  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQ 140
Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           ++H   +++RDLK  N+ L++   V+I D GLA
Sbjct: 141 YLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE-DEMR--FYAAEVILGLEHM 99
           P IV    A   P  L  + + ++ G L+  L + G   + DE R    A +V  G+ ++
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 100 HRRY--IVYRDLKPANILLDEHGHVRISDLGLA 130
           H R   IV+RDLK  N+L+D+   V++ D GL+
Sbjct: 154 HNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 186

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+ M    
Sbjct: 46  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERMEPVQ 99
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 128 G 128
           G
Sbjct: 160 G 160

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 1/86 (1%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDL 109
            + T D L  +     G  L+ HL  Q   F   ++   A +   G++++H + I++RD+
Sbjct: 99  GYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDM 158
Query: 110 KPANILLDEHGHVRISDLGLACDFSK 135
           K  NI L E   V+I D GLA   S+
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSR 184

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 19/82 (23%), Positives = 45/82 (54%), Gaps = 2/82 (2%)
Query: 56  DKLCFILDLMNGGDLHYHL--SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
           D+L  +++    G +   +  ++     E+ + +   E++ GL H+H+  +++RD+K  N
Sbjct: 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQN 159
Query: 114 ILLDEHGHVRISDLGLACDFSK 135
           +LL E+  V++ D G++    +
Sbjct: 160 VLLTENAEVKLVDFGVSAQLDR 181

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 38/78 (48%), Gaps = 3/78 (3%)
Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           D+   + + M GG +  H+ +   FNE E      +V   L+ +H + I +RDLKP NIL
Sbjct: 84  DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143
Query: 116 LDEHGHVRISDLGLACDF 133
            +    V    +   CDF
Sbjct: 144 CEHPNQVSPVKI---CDF 158

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFY---AAEVILGLEHMHRRYIVYR 107
            + T  +L  +     G  L++HL  H +  + EM      A +   G++++H + I++R
Sbjct: 71  GYSTKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 128
Query: 108 DLKPANILLDEHGHVRISDLGLACDFSK 135
           DLK  NI L E   V+I D GLA + S+
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSR 156

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFY---AAEVILGLEHMHRRYIVYR 107
            + T  +L  +     G  L++HL  H +  + EM      A +   G++++H + I++R
Sbjct: 91  GYSTKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 148
Query: 108 DLKPANILLDEHGHVRISDLGLACDFSK 135
           DLK  NI L E   V+I D GLA + S+
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSR 176

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 21/72 (29%), Positives = 47/72 (65%), Gaps = 1/72 (1%)
Query: 59  CFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
            +++  + G DL+ ++ +    +++ ++F   +++ GL+++H   I++RDLKP+N+ ++E
Sbjct: 100 VYLVTTLMGADLN-NIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNE 158
Query: 119 HGHVRISDLGLA 130
              +RI D GLA
Sbjct: 159 DCELRILDFGLA 170

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFY---AAEVILGLEHMHRRYIVYR 107
            + T  +L  +     G  L++HL  H +  + EM      A +   G++++H + I++R
Sbjct: 99  GYSTKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 156
Query: 108 DLKPANILLDEHGHVRISDLGLACDFSK 135
           DLK  NI L E   V+I D GLA + S+
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSR 184

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 24/154 (15%)
Query: 1   MFFIVGTGFLSNCSHVKQ---GETLALNERIMLSLVSTGIQMVDC----------PFIVC 47
           + + +GTG    C  +++   G+ L   E    S+     QM+            P IV 
Sbjct: 10  VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 48  MTYAF--HTPDKLCFILDLMNGGDLHYHLS----QHGVFNEDEMRFYAAEVILGLEHMHR 101
                   T   L  +++   GGDL   ++    +    +E+ +     ++ L L+  HR
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 102 R-----YIVYRDLKPANILLDEHGHVRISDLGLA 130
           R      +++RDLKPAN+ LD   +V++ D GLA
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 24/154 (15%)
Query: 1   MFFIVGTGFLSNCSHVKQ---GETLALNERIMLSLVSTGIQMVDC----------PFIVC 47
           + + +GTG    C  +++   G+ L   E    S+     QM+            P IV 
Sbjct: 10  VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 48  MTYAF--HTPDKLCFILDLMNGGDLHYHLS----QHGVFNEDEMRFYAAEVILGLEHMHR 101
                   T   L  +++   GGDL   ++    +    +E+ +     ++ L L+  HR
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 102 R-----YIVYRDLKPANILLDEHGHVRISDLGLA 130
           R      +++RDLKPAN+ LD   +V++ D GLA
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 112 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILD 170
Query: 127 LGLA 130
            GLA
Sbjct: 171 FGLA 174

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 30/166 (18%)
Query: 1   MFFIVGTGFLSNCSHVKQ---GETLALNERIMLSLVSTGIQMVDC----------PFIVC 47
           + + +GTG    C  +++   G+ L   E    S+     QM+            P IV 
Sbjct: 10  VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 48  MTYAF--HTPDKLCFILDLMNGGDLHYHLS----QHGVFNEDEMRFYAAEVILGLEHMHR 101
                   T   L  +++   GGDL   ++    +    +E+ +     ++ L L+  HR
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 102 R-----YIVYRDLKPANILLDEHGHVRISDLGLAC------DFSKK 136
           R      +++RDLKPAN+ LD   +V++ D GLA       DF+K+
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKE 175

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/92 (26%), Positives = 49/92 (53%), Gaps = 1/92 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH-YHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           D P+IV +  A++   KL  +++   GG +    L       E +++    +++  L  +
Sbjct: 66  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 125
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLAC 131
           H + I++RDLK  N+L+   G +R++D G++ 
Sbjct: 126 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA 157

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 39  MVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG----VFNEDEMRFYAAEVIL 94
           M+  P IV +   + +   L  + + M+G DL + + +      V++E     Y  +++ 
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 95  GLEHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLA 130
            L + H   I++RD+KP N+LL   +    V++ D G+A
Sbjct: 142 ALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVA 180

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 18/51 (35%), Positives = 37/51 (72%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           F+E+++++   +++ GL+++H   +V+RDLKP N+ ++E   ++I D GLA
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/92 (26%), Positives = 49/92 (53%), Gaps = 1/92 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH-YHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           D P+IV +  A++   KL  +++   GG +    L       E +++    +++  L  +
Sbjct: 74  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLAC 131
           H + I++RDLK  N+L+   G +R++D G++ 
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA 165

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 18/51 (35%), Positives = 37/51 (72%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           F+E+++++   +++ GL+++H   +V+RDLKP N+ ++E   ++I D GLA
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 191

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 116 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILD 174
Query: 127 LGLA 130
            GLA
Sbjct: 175 FGLA 178

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 3/82 (3%)
Query: 52  FHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKP 111
           F    +   + + + GG +  H+ +   FNE E      +V   L+ +H + I +RDLKP
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKP 139
Query: 112 ANILLDEHGHVRISDLGLACDF 133
            NIL +    V    +   CDF
Sbjct: 140 ENILCESPEKVSPVKI---CDF 158

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHY--HLSQHGVFNE--DEMRFYAAEVILGLEHM 99
           F VC         KL  + + ++     Y   + + GV  E   +M F   +++ GL+ +
Sbjct: 80  FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF---QLLRGLDFL 136
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           H   +V+RDLKP NIL+   G ++++D GLA  +S
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 20/63 (31%), Positives = 41/63 (65%), Gaps = 1/63 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILD 168
Query: 127 LGL 129
            GL
Sbjct: 169 FGL 171

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/100 (25%), Positives = 50/100 (50%), Gaps = 1/100 (1%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV    ++   D+L  +++ + GG L   +++    +E ++     E +  LE +H  
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 142
            +++RD+K  NILL   G V+++D G     + ++   S 
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 61/126 (48%), Gaps = 12/126 (9%)
Query: 19  GETLALN----ERIMLSLVSTGIQMVDC------PFIVCMTYAFHTPDKLCFILDLMNGG 68
           GET AL     E+    + ST I+ +          IV +    HT  +L  + + ++  
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84
Query: 69  DLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDL 127
           DL   L    G       + +  +++ G+ + H R +++RDLKP N+L++  G ++I+D 
Sbjct: 85  DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADF 144
Query: 128 GLACDF 133
           GLA  F
Sbjct: 145 GLARAF 150

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 61/126 (48%), Gaps = 12/126 (9%)
Query: 19  GETLALN----ERIMLSLVSTGIQMVDC------PFIVCMTYAFHTPDKLCFILDLMNGG 68
           GET AL     E+    + ST I+ +          IV +    HT  +L  + + ++  
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84
Query: 69  DLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDL 127
           DL   L    G       + +  +++ G+ + H R +++RDLKP N+L++  G ++I+D 
Sbjct: 85  DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADF 144
Query: 128 GLACDF 133
           GLA  F
Sbjct: 145 GLARAF 150

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 61/126 (48%), Gaps = 12/126 (9%)
Query: 19  GETLALN----ERIMLSLVSTGIQMVDC------PFIVCMTYAFHTPDKLCFILDLMNGG 68
           GET AL     E+    + ST I+ +          IV +    HT  +L  + + ++  
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84
Query: 69  DLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDL 127
           DL   L    G       + +  +++ G+ + H R +++RDLKP N+L++  G ++I+D 
Sbjct: 85  DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADF 144
Query: 128 GLACDF 133
           GLA  F
Sbjct: 145 GLARAF 150

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHY--HLSQHGVFNE--DEMRFYAAEVILGLEHM 99
           F VC         KL  + + ++     Y   + + GV  E   +M F   +++ GL+ +
Sbjct: 80  FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF---QLLRGLDFL 136
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           H   +V+RDLKP NIL+   G ++++D GLA  +S
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHY--HLSQHGVFNE--DEMRFYAAEVILGLEHM 99
           F VC         KL  + + ++     Y   + + GV  E   +M F   +++ GL+ +
Sbjct: 80  FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF---QLLRGLDFL 136
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           H   +V+RDLKP NIL+   G ++++D GLA  +S
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 1/99 (1%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV    ++   D+L  +++ + GG L   +++    +E ++     E +  LE +H  
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 136
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
            +++RD+K  NILL   G V+++D G     + ++   S
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 175

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 1/99 (1%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV    ++   D+L  +++ + GG L   +++    +E ++     E +  LE +H  
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
            +++RD+K  NILL   G V+++D G     + ++   S
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 1/99 (1%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV    ++   D+L  +++ + GG L   +++    +E ++     E +  LE +H  
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
            +++RD+K  NILL   G V+++D G     + ++   S
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 57/120 (47%), Gaps = 7/120 (5%)
Query: 18  QGETLALNERIMLSLVSTGIQMVDCPFIVCM--TYAFHTPDKLCFIL--DLMNGGDLHYH 73
           Q   L  +ER      +  ++ +  P IV    ++      K C +L  +L   G L  +
Sbjct: 60  QDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTY 119
Query: 74  LSQHGVFNEDEMRFYAAEVILGLEHMHRRY--IVYRDLKPANILLD-EHGHVRISDLGLA 130
           L +  V     +R +  +++ GL+ +H R   I++RDLK  NI +    G V+I DLGLA
Sbjct: 120 LKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 42  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 95
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 128 G 128
           G
Sbjct: 156 G 156

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 106 GADLN-NIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 164
Query: 127 LGLA 130
            GLA
Sbjct: 165 FGLA 168

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/104 (25%), Positives = 48/104 (46%), Gaps = 3/104 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +D P I+ +   F     +  +++L  GG+L   +    VF E +      +V+  +
Sbjct: 77  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAV 136
Query: 97  EHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK 137
            + H+  + +RDLKP N L         +++ D GLA  F   K
Sbjct: 137 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 180

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE-DEMR--FYAAEVILGLEHM 99
           P IV    A   P  L  + + ++ G L+  L + G   + DE R    A +V  G+ ++
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 100 HRRY--IVYRDLKPANILLDEHGHVRISDLGLA 130
           H R   IV+R+LK  N+L+D+   V++ D GL+
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 115 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILD 173
Query: 127 LGLA 130
            GLA
Sbjct: 174 FGLA 177

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/104 (25%), Positives = 48/104 (46%), Gaps = 3/104 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +D P I+ +   F     +  +++L  GG+L   +    VF E +      +V+  +
Sbjct: 60  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAV 119
Query: 97  EHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK 137
            + H+  + +RDLKP N L         +++ D GLA  F   K
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 32/43 (74%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           Y  ++I GLE++H + IV++D+KP N+LL   G ++IS LG+A
Sbjct: 114 YFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 115 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILD 173
Query: 127 LGLA 130
            GLA
Sbjct: 174 FGLA 177

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 121 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILD 179
Query: 127 LGLA 130
            GLA
Sbjct: 180 FGLA 183

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/88 (27%), Positives = 46/88 (52%), Gaps = 2/88 (2%)
Query: 43  PFIVCMTYAFHTPDKLCFILD-LMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR 101
           P ++ +   F T +    +L+  +   DL  ++++ G   E   R +  +V+  ++H H 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 102 RYIVYRDLKPANILLD-EHGHVRISDLG 128
           R +V+RD+K  NIL+D   G  ++ D G
Sbjct: 158 RGVVHRDIKDENILIDLRRGCAKLIDFG 185

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 42/76 (55%), Gaps = 3/76 (3%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            + DL+ GG+L   +     ++E +      +++  + H+H+  IV+RDLKP N+LL   
Sbjct: 107 LVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASK 166
Query: 120 ---GHVRISDLGLACD 132
                V+++D GLA +
Sbjct: 167 CKGAAVKLADFGLAIE 182

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/104 (24%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FNEDEMRFYAAEVILG 95
           +  +D   ++ +  AF + + +  +++ ++GG+L   +        E +   +  ++  G
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 96  LEHMHRRYIVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK 137
           + HMH+ YI++ DLKP NIL    +   ++I D GLA  +  ++
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 17  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 75
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 76  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNL 134
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 135 LINTEGAIKLADFGLARAF 153

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 20  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 78
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 79  KLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 137
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 138 LINTEGAIKLADFGLARAF 156

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 20  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 78
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 79  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 137
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 138 LINTEGAIKLADFGLARAF 156

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 19  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 77
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 78  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 136
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 137 LINTEGAIKLADFGLARAF 155

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 20  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 78
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 79  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 137
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 138 LINTEGAIKLADFGLARAF 156

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 17  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 75
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 76  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 135 LINTEGAIKLADFGLARAF 153

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 18  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 76
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 77  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 135
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 136 LINTEGAIKLADFGLARAF 154

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 15/128 (11%)
Query: 19  GETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPDKLCFILDLMNG 67
           GE +AL ++I L   + G+           + ++ P IV +    HT +KL  + + ++ 
Sbjct: 29  GEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 87
Query: 68  GDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS 125
            DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+L++  G ++++
Sbjct: 88  -DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 146
Query: 126 DLGLACDF 133
           D GLA  F
Sbjct: 147 DFGLARAF 154

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 17  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 75
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 76  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 135 LINTEGAIKLADFGLARAF 153

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 24  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 82
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 83  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 141
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 142 LINTEGAIKLADFGLARAF 160

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 21  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 79
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 80  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 138
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 139 LINTEGAIKLADFGLARAF 157

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 16  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 75  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 134 LINTEGAIKLADFGLARAF 152

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 17  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 75
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 76  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 135 LINTEGAIKLADFGLARAF 153

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 16  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 75  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 134 LINTEGAIKLADFGLARAF 152

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 15/128 (11%)
Query: 19  GETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPDKLCFILDLMNG 67
           GE +AL ++I L   + G+           + ++ P IV +    HT +KL  + + ++ 
Sbjct: 28  GEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 86
Query: 68  GDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS 125
            DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+L++  G ++++
Sbjct: 87  -DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 145
Query: 126 DLGLACDF 133
           D GLA  F
Sbjct: 146 DFGLARAF 153

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 17  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 75
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 76  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 135 LINTEGAIKLADFGLARAF 153

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 19  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 77
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 78  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 136
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 137 LINTEGAIKLADFGLARAF 155

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 17  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 75
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 76  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 135 LINTEGAIKLADFGLARAF 153

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 18  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 76
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 77  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 135
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 136 LINTEGAIKLADFGLARAF 154

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 46/74 (62%), Gaps = 1/74 (1%)
Query: 57  KLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL 116
           K  +++  + G DL Y L +    + D + ++  +++ GL+++H   +++RDLKP+N+LL
Sbjct: 119 KDVYLVTHLMGADL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 177
Query: 117 DEHGHVRISDLGLA 130
           +    ++I D GLA
Sbjct: 178 NTTXDLKICDFGLA 191

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 16  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 75  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 134 LINTEGAIKLADFGLARAF 152

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 16  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 75  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 134 LINTEGAIKLADFGLARAF 152

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 24  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 82
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 83  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 141
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 142 LINTEGAIKLADFGLARAF 160

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 17  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 75
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 76  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 135 LINTEGAIKLADFGLARAF 153

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 19  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 77
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 78  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENL 136
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 137 LINTEGAIKLADFGLARAF 155

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 15/128 (11%)
Query: 19  GETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPDKLCFILDLMNG 67
           GE +AL ++I L   + G+           + ++ P IV +    HT +KL  + + ++ 
Sbjct: 29  GEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 87
Query: 68  GDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS 125
            DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+L++  G ++++
Sbjct: 88  -DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLA 146
Query: 126 DLGLACDF 133
           D GLA  F
Sbjct: 147 DFGLARAF 154

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 20/50 (40%), Positives = 32/50 (64%)
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
           DE      +++  L ++H + I++RDLKP NI +DE  +V+I D GLA +
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 20/50 (40%), Positives = 32/50 (64%)
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
           DE      +++  L ++H + I++RDLKP NI +DE  +V+I D GLA +
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 18  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 76
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 77  KLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENL 135
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 136 LINTEGAIKLADFGLARAF 154

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 21  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 79
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 80  KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 138
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 139 LINTEGAIKLADFGLARAF 157

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 20  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 78
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 79  KLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENL 137
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 138 LINTEGAIKLADFGLARAF 156

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 106 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 164
Query: 127 LGLA 130
            GLA
Sbjct: 165 FGLA 168

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 108 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 166
Query: 127 LGLA 130
            GLA
Sbjct: 167 FGLA 170

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 117 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 175
Query: 127 LGLA 130
            GLA
Sbjct: 176 FGLA 179

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 107 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 165
Query: 127 LGLA 130
            GLA
Sbjct: 166 FGLA 169

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 117 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 175
Query: 127 LGLA 130
            GLA
Sbjct: 176 FGLA 179

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 117 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 175
Query: 127 LGLA 130
            GLA
Sbjct: 176 FGLA 179

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 107 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 165
Query: 127 LGLA 130
            GLA
Sbjct: 166 FGLA 169

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 115 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 173
Query: 127 LGLA 130
            GLA
Sbjct: 174 FGLA 177

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 117 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 175
Query: 127 LGLA 130
            GLA
Sbjct: 176 FGLA 179

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/98 (24%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +  P ++ +   +     +  I +L+ GG+L   L++     E+E   +  +++ G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 97  EHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLA 130
            ++H   I + DLKP NI+L +       ++I D GLA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 115 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 173
Query: 127 LGLA 130
            GLA
Sbjct: 174 FGLA 177

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 112 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 170
Query: 127 LGLA 130
            GLA
Sbjct: 171 FGLA 174

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 109 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 167
Query: 127 LGLA 130
            GLA
Sbjct: 168 FGLA 171

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 112 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 170
Query: 127 LGLA 130
            GLA
Sbjct: 171 FGLA 174

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 133 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 191
Query: 127 LGLA 130
            GLA
Sbjct: 192 FGLA 195

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 122 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 180
Query: 127 LGLA 130
            GLA
Sbjct: 181 FGLA 184

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 106 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 164
Query: 127 LGLA 130
            GLA
Sbjct: 165 FGLA 168

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 106 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 164
Query: 127 LGLA 130
            GLA
Sbjct: 165 FGLA 168

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 139 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 197
Query: 127 LGLA 130
            GLA
Sbjct: 198 FGLA 201

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 121 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 179
Query: 127 LGLA 130
            GLA
Sbjct: 180 FGLA 183

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 122 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 180
Query: 127 LGLA 130
            GLA
Sbjct: 181 FGLA 184

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 122 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 180
Query: 127 LGLA 130
            GLA
Sbjct: 181 FGLA 184

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 116 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 174
Query: 127 LGLA 130
            GLA
Sbjct: 175 FGLA 178

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 130 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 188
Query: 127 LGLA 130
            GLA
Sbjct: 189 FGLA 192

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVIL 94
           ++ ++ P IV +    HT +KL  + + ++  DL   +    +       ++ Y  +++ 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           GL   H   +++RDLKP N+L++  G ++++D GLA  F
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 153

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVIL 94
           ++ ++ P IV +    HT +KL  + + ++  DL   +    +       ++ Y  +++ 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           GL   H   +++RDLKP N+L++  G ++++D GLA  F
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 152

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 120 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 178
Query: 127 LGLA 130
            GLA
Sbjct: 179 FGLA 182

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 129 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 187
Query: 127 LGLA 130
            GLA
Sbjct: 188 FGLA 191

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 112 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 170
Query: 127 LGLA 130
            GLA
Sbjct: 171 FGLA 174

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFY---AAEVILGLEHMHRRYIVYR 107
            + T  +L  +     G  L++HL  H +  + EM      A +   G++++H + I++R
Sbjct: 71  GYSTKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 128
Query: 108 DLKPANILLDEHGHVRISDLGLACDFSK 135
           DLK  NI L E   V+I D GLA   S+
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSR 156

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 133 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 191
Query: 127 LGLA 130
            GLA
Sbjct: 192 FGLA 195

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFY---AAEVILGLEHMHRRYIVYR 107
            + T  +L  +     G  L++HL  H +  + EM      A +   G++++H + I++R
Sbjct: 71  GYSTAPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 128
Query: 108 DLKPANILLDEHGHVRISDLGLACDFSK 135
           DLK  NI L E   V+I D GLA   S+
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSR 156

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 62  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 115
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 128 G 128
           G
Sbjct: 176 G 176

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFY---AAEVILGLEHMHRRYIVYR 107
            + T  +L  +     G  L++HL  H +  + EM      A +   G++++H + I++R
Sbjct: 73  GYSTKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 130
Query: 108 DLKPANILLDEHGHVRISDLGLACDFSK 135
           DLK  NI L E   V+I D GLA   S+
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSR 158

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 61  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 114
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 128 G 128
           G
Sbjct: 175 G 175

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFY---AAEVILGLEHMHRRYIVYR 107
            + T  +L  +     G  L++HL  H +  + EM      A +   G++++H + I++R
Sbjct: 76  GYSTKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 133
Query: 108 DLKPANILLDEHGHVRISDLGLACDFSK 135
           DLK  NI L E   V+I D GLA   S+
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSR 161

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 61  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 114
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 128 G 128
           G
Sbjct: 175 G 175

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 130 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 188
Query: 127 LGLA 130
            GLA
Sbjct: 189 FGLA 192

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 130 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 188
Query: 127 LGLA 130
            GLA
Sbjct: 189 FGLA 192

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 62  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 115
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 128 G 128
           G
Sbjct: 176 G 176

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 62  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 115
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 128 G 128
           G
Sbjct: 176 G 176

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 21/48 (43%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+L+D EH  +R+ D GLA
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLA 179

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 69  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 122
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 123 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 182
Query: 128 G 128
           G
Sbjct: 183 G 183

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 129 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 187
Query: 127 LGLA 130
            GLA
Sbjct: 188 FGLA 191

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 19  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 77
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 78  KLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 136
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 137 LINTEGAIKLADFGLARAF 155

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFY---AAEVILGLEHMHRRYIVYR 107
            + T  +L  +     G  L++HL  H +  + EM      A +   G++++H + I++R
Sbjct: 76  GYSTKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 133
Query: 108 DLKPANILLDEHGHVRISDLGLACDFSK 135
           DLK  NI L E   V+I D GLA   S+
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSR 161

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 47  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 100
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 128 G 128
           G
Sbjct: 161 G 161

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 74  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 127
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 128 G 128
           G
Sbjct: 188 G 188

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 20  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 78
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 79  KLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 137
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 138 LINTEGAIKLADFGLARAF 156

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 89  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 142
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 128 G 128
           G
Sbjct: 203 G 203

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 41/76 (53%), Gaps = 3/76 (3%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL--- 116
            + DL+ GG+L   +     ++E +      +++  + H H   IV+RDLKP N+LL   
Sbjct: 80  LVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASK 139
Query: 117 DEHGHVRISDLGLACD 132
            +   V+++D GLA +
Sbjct: 140 SKGAAVKLADFGLAIE 155

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 81  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 134
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 128 G 128
           G
Sbjct: 195 G 195

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 46  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 99
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 128 G 128
           G
Sbjct: 160 G 160

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 47  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 100
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 128 G 128
           G
Sbjct: 161 G 161

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 47  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 100
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 128 G 128
           G
Sbjct: 161 G 161

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 75  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 128
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 128 G 128
           G
Sbjct: 189 G 189

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 89  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 142
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 128 G 128
           G
Sbjct: 203 G 203

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 18/51 (35%), Positives = 35/51 (68%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D GLA
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 178

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 AGLA 172

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 74  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 127
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 128 G 128
           G
Sbjct: 188 G 188

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 75  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 128
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 128 G 128
           G
Sbjct: 189 G 189

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 YGLA 172

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/96 (25%), Positives = 48/96 (50%), Gaps = 1/96 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH-YHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           D P IV +  AF+  + L  +++   GG +    L       E +++    + +  L ++
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 151
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           H   I++RDLK  NIL    G ++++D G++   ++
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 187

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 74  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 127
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 128 G 128
           G
Sbjct: 188 G 188

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 74  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 127
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 128 G 128
           G
Sbjct: 188 G 188

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 75  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 128
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 128 G 128
           G
Sbjct: 189 G 189

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/96 (25%), Positives = 48/96 (50%), Gaps = 1/96 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH-YHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           D P IV +  AF+  + L  +++   GG +    L       E +++    + +  L ++
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 151
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           H   I++RDLK  NIL    G ++++D G++   ++
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 187

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 42  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 95
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 128 G 128
           G
Sbjct: 156 G 156

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 94  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 147
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 128 G 128
           G
Sbjct: 208 G 208

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 17  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 75
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 76  KLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENL 134
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 135 LINTEGAIKLADFGLARAF 153

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 42  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 95
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 128 G 128
           G
Sbjct: 156 G 156

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 45  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 98
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 158
Query: 128 G 128
           G
Sbjct: 159 G 159

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 18/51 (35%), Positives = 35/51 (68%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D GLA
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 178

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/96 (25%), Positives = 48/96 (50%), Gaps = 1/96 (1%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH-YHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           D P IV +  AF+  + L  +++   GG +    L       E +++    + +  L ++
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 151
Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           H   I++RDLK  NIL    G ++++D G++   ++
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 187

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 75  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 128
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 128 G 128
           G
Sbjct: 189 G 189

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFY---AAEVILGLEHMHRRYIVYR 107
            + T  +L  +     G  L++HL  H +  + EM      A +   G++++H + I++R
Sbjct: 98  GYSTKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 155
Query: 108 DLKPANILLDEHGHVRISDLGLACDFSK 135
           DLK  NI L E   V+I D GLA   S+
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSR 183

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFY---AAEVILGLEHMHRRYIVYR 107
            + T  +L  +     G  L++HL  H +  + EM      A +   G++++H + I++R
Sbjct: 99  GYSTKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 156
Query: 108 DLKPANILLDEHGHVRISDLGLACDFSK 135
           DLK  NI L E   V+I D GLA   S+
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSR 184

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG-G 68
           +S+   +  G  + + E ++L  VS+G   V     + +   F  PD    IL+      
Sbjct: 89  ISDWGELPNGTRVPM-EVVLLKKVSSGFSGV-----IRLLDWFERPDSFVLILERPEPVQ 142
Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL   +++ G   E+  R +  +V+  + H H   +++RD+K  NIL+D   G +++ D 
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 128 G 128
           G
Sbjct: 203 G 203

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/57 (40%), Positives = 38/57 (66%), Gaps = 5/57 (8%)
Query: 91  EVILGLEHMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDF-SKKKPHASV 142
           +++ G+ ++H  ++++RDLKPANIL+     E G V+I+D+G A  F S  KP A +
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 41/76 (53%), Gaps = 3/76 (3%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL--- 116
            + DL+ GG+L   +     ++E +      +++  + H H   IV+RDLKP N+LL   
Sbjct: 80  LVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASK 139
Query: 117 DEHGHVRISDLGLACD 132
            +   V+++D GLA +
Sbjct: 140 SKGAAVKLADFGLAIE 155

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 RGLA 172

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 24/100 (24%), Positives = 50/100 (50%), Gaps = 1/100 (1%)
Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P IV    ++   D+L  +++ + GG L   +++    +E ++     E +  LE +H  
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 136
Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 142
            +++R++K  NILL   G V+++D G     + ++   S 
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 176

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL+  L    + N D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 106 VQDLMET-DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTS 163
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 164 DLKICDFGLA 173

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 22/68 (32%), Positives = 34/68 (50%), Gaps = 1/68 (1%)
Query: 67  GGDLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS 125
           G  L  H    G    E ++  Y  + +L L H+H + +V+ D+KPANI L   G  ++ 
Sbjct: 140 GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLG 199
Query: 126 DLGLACDF 133
           D GL  + 
Sbjct: 200 DFGLLVEL 207

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 17/48 (35%), Positives = 33/48 (68%)
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + M +   ++++G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 126 ERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA 173

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 17/48 (35%), Positives = 33/48 (68%)
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + M +   ++++G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 126 ERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA 173

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 131 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 137 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 184

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 130 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 131 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 20  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 78
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 79  KLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 137
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 138 LINTEGAIKLADFGLARAF 156

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 17/48 (35%), Positives = 33/48 (68%)
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + M +   ++++G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 126 ERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA 173

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 45/73 (61%), Gaps = 4/73 (5%)
Query: 62  LDLMNGGDLHYHL-SQHGVF--NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
           ++ + GG L   L S+ G    NE  + FY  +++ GL+++H   IV+RD+K  N+L++ 
Sbjct: 98  MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 157
Query: 119 H-GHVRISDLGLA 130
           + G ++ISD G +
Sbjct: 158 YSGVLKISDFGTS 170

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 19/50 (38%), Positives = 32/50 (64%)
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
           DE      +++  L ++H + I++R+LKP NI +DE  +V+I D GLA +
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKN 165

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +D P+IV M       +    ++++   G L+ +L Q+    +  +     +V +G+
Sbjct: 424 MQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 482
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +++     V+RDL   N+LL    + +ISD GL+
Sbjct: 483 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 516

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +D P+IV M       +    ++++   G L+ +L Q+    +  +     +V +G+
Sbjct: 425 MQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 483
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +++     V+RDL   N+LL    + +ISD GL+
Sbjct: 484 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 517

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 37/59 (62%), Gaps = 1/59 (1%)
Query: 81  NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKP 138
           NE  + FY  +++ GL+++H   IV+RD+K  N+L++ + G ++ISD G +   +   P
Sbjct: 106 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 164

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 41/76 (53%), Gaps = 3/76 (3%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            I DL+ GG+L   +     ++E +      +++  + H H+  +V+RDLKP N+LL   
Sbjct: 98  LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASK 157
Query: 120 ---GHVRISDLGLACD 132
                V+++D GLA +
Sbjct: 158 LKGAAVKLADFGLAIE 173

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/58 (36%), Positives = 36/58 (62%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
           F   E++     ++ GL ++HR  I++RD+K AN+L+   G ++++D GLA  FS  K
Sbjct: 122 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 19/144 (13%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGIQMVD-------CPFIVCMTYAF----HTPD 56
           G +  C H + G+  AL    +L       Q VD        P IVC+   +    H   
Sbjct: 24  GKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKR 80
Query: 57  KLCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
            L  I++ M GG+L   + + G   F E E      ++   ++ +H   I +RD+KP N+
Sbjct: 81  CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENL 140
Query: 115 LL---DEHGHVRISDLGLACDFSK 135
           L    ++   ++++D G A + ++
Sbjct: 141 LYTSKEKDAVLKLTDFGFAKETTQ 164

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/58 (36%), Positives = 36/58 (62%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
           F   E++     ++ GL ++HR  I++RD+K AN+L+   G ++++D GLA  FS  K
Sbjct: 122 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL Y L +    + D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 104 VQDLMET-DL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTX 161
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 162 DLKIXDFGLA 171

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 30/44 (68%)
Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           + + GL+ +H   IV+RDLKP NIL+   G V+++D GLA  +S
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/58 (36%), Positives = 36/58 (62%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
           F   E++     ++ GL ++HR  I++RD+K AN+L+   G ++++D GLA  FS  K
Sbjct: 122 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 19/144 (13%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGIQMVD-------CPFIVCMTYAF----HTPD 56
           G +  C H + G+  AL    +L       Q VD        P IVC+   +    H   
Sbjct: 43  GKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99
Query: 57  KLCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
            L  I++ M GG+L   + + G   F E E      ++   ++ +H   I +RD+KP N+
Sbjct: 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENL 159
Query: 115 LL---DEHGHVRISDLGLACDFSK 135
           L    ++   ++++D G A + ++
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQ 183

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/52 (42%), Positives = 33/52 (63%)
Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 142
           + + GL+ +H   IV+RDLKP NIL+   G V+++D GLA  +S +   A V
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPV 171

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 30/44 (68%)
Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           + + GL+ +H   IV+RDLKP NIL+   G V+++D GLA  +S
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/58 (36%), Positives = 36/58 (62%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
           F   E++     ++ GL ++HR  I++RD+K AN+L+   G ++++D GLA  FS  K
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL Y L +    + D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 104 VQDLMET-DL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTX 161
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 162 DLKICDFGLA 171

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL Y L +    + D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 108 VQDLMET-DL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTX 165
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 166 DLKICDFGLA 175

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/44 (45%), Positives = 30/44 (68%)
Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           + + GL+ +H   IV+RDLKP NIL+   G V+++D GLA  +S
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 21/131 (16%)
Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQ E+ +  +  ++ L    +  V+ P IV +  A   P  +C +++   GG L+  L 
Sbjct: 37  IKQIESESERKAFIVELRQ--LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVL- 91
Query: 76  QHGVFNEDEMRFYAA-----------EVILGLEHMHRRYIVYRDLKPANILLDEHGHV-R 123
            HG    + + +Y A           + +  L  M  + +++RDLKP N+LL   G V +
Sbjct: 92  -HGA---EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK 147
Query: 124 ISDLGLACDFS 134
           I D G ACD  
Sbjct: 148 ICDFGTACDIQ 158

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/95 (26%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFN----EDEMRFYAAEVILGL 96
           DCP+IV    A          ++LM+     ++   + V +    E+ +       +  L
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 97  EHMHRRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
            H+     I++RD+KP+NILLD  G++++ D G++
Sbjct: 139 NHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/76 (28%), Positives = 41/76 (53%), Gaps = 3/76 (3%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            + DL+ GG+L   +     ++E +      +++  + H H+  +V+RDLKP N+LL   
Sbjct: 80  LVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASK 139
Query: 120 ---GHVRISDLGLACD 132
                V+++D GLA +
Sbjct: 140 CKGAAVKLADFGLAIE 155

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/80 (26%), Positives = 50/80 (62%), Gaps = 2/80 (2%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLK 110
           +F   +++  I +LM   DLH  +S   + ++D ++++  + +  ++ +H   +++RDLK
Sbjct: 82  SFENFNEVYIIQELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLK 139
Query: 111 PANILLDEHGHVRISDLGLA 130
           P+N+L++ +  +++ D GLA
Sbjct: 140 PSNLLINSNCDLKVCDFGLA 159

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 59/119 (49%), Gaps = 10/119 (8%)
Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL- 74
           +KQG   A  E +M    +  +  +D P+IV +       + L  ++++  GG LH  L 
Sbjct: 45  LKQGTEKADTEEMMRE--AQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLV 101
Query: 75  ---SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
               +  V N  E+     +V +G++++  +  V+RDL   N+LL    + +ISD GL+
Sbjct: 102 GKREEIPVSNVAEL---LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/64 (32%), Positives = 42/64 (65%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 GGLA 172

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 1/82 (1%)
Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           D+L  +L++ +  DL           E+ ++     ++LG   +H   I++RDLKPAN L
Sbjct: 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL 161
Query: 116 LDEHGHVRISDLGLACDFSKKK 137
           L++   V++ D GLA   + +K
Sbjct: 162 LNQDCSVKVCDFGLARTINSEK 183

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/71 (32%), Positives = 44/71 (61%), Gaps = 2/71 (2%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            + DLM   DL Y L +    + D + ++  +++ GL+++H   +++RDLKP+N+L++  
Sbjct: 123 IVQDLMET-DL-YKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTT 180
Query: 120 GHVRISDLGLA 130
             ++I D GLA
Sbjct: 181 CDLKICDFGLA 191

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/80 (26%), Positives = 50/80 (62%), Gaps = 2/80 (2%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLK 110
           +F   +++  I +LM   DLH  +S   + ++D ++++  + +  ++ +H   +++RDLK
Sbjct: 82  SFENFNEVYIIQELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLK 139
Query: 111 PANILLDEHGHVRISDLGLA 130
           P+N+L++ +  +++ D GLA
Sbjct: 140 PSNLLINSNCDLKVCDFGLA 159

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 40/81 (49%), Gaps = 4/81 (4%)
Query: 69  DLHYHLSQHGVFNE----DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRI 124
           D+       G + E    +++  Y+ +V  G+E +  R  ++RDL   NILL E+  V+I
Sbjct: 181 DVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKI 240
Query: 125 SDLGLACDFSKKKPHASVGKS 145
            D GLA D  K   +   G +
Sbjct: 241 CDFGLARDIYKNPDYVRKGDT 261

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 21/131 (16%)
Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
           +KQ E+ +  +  ++ L    +  V+ P IV +  A   P  +C +++   GG L+  L 
Sbjct: 36  IKQIESESERKAFIVELRQ--LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVL- 90
Query: 76  QHGVFNEDEMRFYAA-----------EVILGLEHMHRRYIVYRDLKPANILLDEHGHV-R 123
            HG    + + +Y A           + +  L  M  + +++RDLKP N+LL   G V +
Sbjct: 91  -HGA---EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK 146
Query: 124 ISDLGLACDFS 134
           I D G ACD  
Sbjct: 147 ICDFGTACDIQ 157

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 8   GFLSNCSHVKQGETLALNERIMLSLVSTGI-----------QMVDCPFIVCMTYAFHTPD 56
           G +    +   GE +AL ++I L   + G+           + ++ P IV +    HT +
Sbjct: 16  GVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74
Query: 57  KLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANI 114
           KL  + + ++  DL   +    +       ++ Y  +++ GL   H   +++RDLKP N+
Sbjct: 75  KLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 115 LLDEHGHVRISDLGLACDF 133
           L++  G ++++D GLA  F
Sbjct: 134 LINTEGAIKLADFGLARAF 152

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/80 (26%), Positives = 50/80 (62%), Gaps = 2/80 (2%)
Query: 51  AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLK 110
           +F   +++  I +LM   DLH  +S   + ++D ++++  + +  ++ +H   +++RDLK
Sbjct: 82  SFENFNEVYIIQELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLK 139
Query: 111 PANILLDEHGHVRISDLGLA 130
           P+N+L++ +  +++ D GLA
Sbjct: 140 PSNLLINSNCDLKVCDFGLA 159

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL Y L +    + D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 104 VQDLMET-DL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTX 161
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 162 DLKICDFGLA 171

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 41/75 (54%), Gaps = 1/75 (1%)
Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           D+L  +L++ +  DL           E  ++     ++LG + +H   I++RDLKPAN L
Sbjct: 105 DELYIVLEIADS-DLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCL 163
Query: 116 LDEHGHVRISDLGLA 130
           L++   V+I D GLA
Sbjct: 164 LNQDCSVKICDFGLA 178

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL+  L    + N D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 108 VQDLMET-DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTX 165
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 166 DLKICDFGLA 175

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL Y L +    + D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 106 VQDLMET-DL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 163
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 164 DLKICDFGLA 173

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL+  L    + N D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 104 VQDLMET-DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 161
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 162 DLKICDFGLA 171

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +D P+IV M       +    ++++   G L+ +L Q+    +  +     +V +G+
Sbjct: 60  MQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 118
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +++     V+RDL   N+LL    + +ISD GL+
Sbjct: 119 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 152

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +D P+IV M       +    ++++   G L+ +L Q+    +  +     +V +G+
Sbjct: 62  MQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +++     V+RDL   N+LL    + +ISD GL+
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 154

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL Y L +    + D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 106 VQDLMET-DL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 163
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 164 DLKICDFGLA 173

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL+  L    + N D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 109 VQDLMET-DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 166
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 167 DLKICDFGLA 176

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +D P+IV M       +    ++++   G L+ +L Q+    +  +     +V +G+
Sbjct: 66  MQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 124
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +++     V+RDL   N+LL    + +ISD GL+
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 158

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL+  L    + N D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 110 VQDLMET-DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 167
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 168 DLKICDFGLA 177

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL+  L    + N D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 101 VQDLMET-DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 158
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 159 DLKICDFGLA 168

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL+  L    + N D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 108 VQDLMET-DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 165
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 166 DLKICDFGLA 175

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +D P+IV M       +    ++++   G L+ +L Q+    +  +     +V +G+
Sbjct: 72  MQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +++     V+RDL   N+LL    + +ISD GL+
Sbjct: 131 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +D P+IV M       +    ++++   G L+ +L Q+    +  +     +V +G+
Sbjct: 66  MQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 124
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +++     V+RDL   N+LL    + +ISD GL+
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 158

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/71 (33%), Positives = 44/71 (61%), Gaps = 2/71 (2%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            + DLM   DL Y L +    + D + ++  +++ GL+++H   +++RDLKP+N+LL+  
Sbjct: 123 IVQDLMET-DL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 180
Query: 120 GHVRISDLGLA 130
             ++I D GLA
Sbjct: 181 CDLKICDFGLA 191

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K   +   G +
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL+  L    + N D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 102 VQDLMET-DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 159
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 160 DLKICDFGLA 169

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL+  L    + N D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 112 VQDLMET-DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 169
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 170 DLKICDFGLA 179

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL+  L    + N D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 104 VQDLMET-DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 161
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 162 DLKICDFGLA 171

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL+  L    + N D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 108 VQDLMET-DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 165
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 166 DLKICDFGLA 175

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL+  L    + N D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 102 VQDLMET-DLYKLLKTQHLSN-DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 159
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 160 DLKICDFGLA 169

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 32/119 (26%), Positives = 59/119 (49%), Gaps = 10/119 (8%)
Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL- 74
           +KQG   A  E +M    +  +  +D P+IV +       + L  ++++  GG LH  L 
Sbjct: 371 LKQGTEKADTEEMMRE--AQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLV 427
Query: 75  ---SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
               +  V N  E+     +V +G++++  +  V+R+L   N+LL    + +ISD GL+
Sbjct: 428 GKREEIPVSNVAEL---LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 58/116 (50%), Gaps = 12/116 (10%)
Query: 39  MVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEH 98
           M+  P I+ +         LC +++   GG L+  LS   +   D +  +A ++  G+ +
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILVNWAVQIARGMNY 120
Query: 99  MHRRYIV---YRDLKPANILL---DEHGH-----VRISDLGLACDFSKKKPHASVG 143
           +H   IV   +RDLK +NIL+    E+G      ++I+D GLA ++ +    ++ G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAG 176

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL Y L +    + D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 108 VQDLMET-DL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 165
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 166 DLKICDFGLA 175

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 44/70 (62%), Gaps = 2/70 (2%)
Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
           + DLM   DL Y L +    + D + ++  +++ GL+++H   +++RDLKP+N+LL+   
Sbjct: 109 VQDLMET-DL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 166
Query: 121 HVRISDLGLA 130
            ++I D GLA
Sbjct: 167 DLKICDFGLA 176

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +D P+IV M       +    ++++   G L+ +L Q+    +  +     +V +G+
Sbjct: 80  MQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 138
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +++     V+RDL   N+LL    + +ISD GL+
Sbjct: 139 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 172

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/73 (30%), Positives = 43/73 (58%), Gaps = 7/73 (9%)
Query: 60  FILDLMNGGDLHYHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD 117
            +++LM+      +LSQ      + + M +   +++ G++H+H   I++RDLKP+NI++ 
Sbjct: 106 IVMELMDA-----NLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 160
Query: 118 EHGHVRISDLGLA 130
               ++I D GLA
Sbjct: 161 SDATLKILDFGLA 173

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +D P+IV M       +    ++++   G L+ +L Q+    +  +     +V +G+
Sbjct: 82  MQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 140
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +++     V+RDL   N+LL    + +ISD GL+
Sbjct: 141 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 174

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +D P+IV M       +    ++++   G L+ +L Q+    +  +     +V +G+
Sbjct: 82  MQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 140
Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +++     V+RDL   N+LL    + +ISD GL+
Sbjct: 141 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 174

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/73 (30%), Positives = 43/73 (58%), Gaps = 7/73 (9%)
Query: 60  FILDLMNGGDLHYHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD 117
            +++LM+      +LSQ      + + M +   +++ G++H+H   I++RDLKP+NI++ 
Sbjct: 106 IVMELMDA-----NLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 160
Query: 118 EHGHVRISDLGLA 130
               ++I D GLA
Sbjct: 161 SDATLKILDFGLA 173

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/54 (33%), Positives = 34/54 (62%)
Query: 77  HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           H   + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 120 HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K   +   G +
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K   +   G +
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K   +   G +
Sbjct: 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/48 (43%), Positives = 28/48 (58%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXK 200

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA 173

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K   +   G +
Sbjct: 155 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K   +   G +
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/54 (33%), Positives = 34/54 (62%)
Query: 77  HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           H   + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 118 HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 171

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K   +   G +
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K   +   G +
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 116 LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA 166

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/48 (35%), Positives = 32/48 (66%)
Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 126 ERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA 173

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K   +   G +
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 38/74 (51%)
Query: 57  KLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL 116
           KL  + +LM          Q  V +   ++++   ++LGL  +H   +V+RDL P NILL
Sbjct: 108 KLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL 167
Query: 117 DEHGHVRISDLGLA 130
            ++  + I D  LA
Sbjct: 168 ADNNDITICDFNLA 181

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/126 (22%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 14  SHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYA--------FHTPDKLCFILDLM 65
           +H + GE + + E I     +    + +   + C+ +          +   +L FI + +
Sbjct: 30  THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89
Query: 66  NGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRI 124
            GG L   + S    +   +   +A ++  G+ ++H   I++RDL   N L+ E+ +V +
Sbjct: 90  KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVV 149
Query: 125 SDLGLA 130
           +D GLA
Sbjct: 150 ADFGLA 155

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/48 (43%), Positives = 28/48 (58%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 191

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/48 (43%), Positives = 28/48 (58%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 200

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K   +   G +
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/73 (28%), Positives = 42/73 (57%), Gaps = 1/73 (1%)
Query: 58  LCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD 117
           L  +++ +  G L  +L +H +    ++  +A ++  G+ ++H ++ ++RDL   N+LLD
Sbjct: 110 LQLVMEYVPLGSLRDYLPRHSI-GLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168
Query: 118 EHGHVRISDLGLA 130
               V+I D GLA
Sbjct: 169 NDRLVKIGDFGLA 181

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/106 (26%), Positives = 56/106 (52%), Gaps = 13/106 (12%)
Query: 42  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHY----HLSQHGVFNEDEMRFYAAEVILGLE 97
           CP ++ +   +    ++  IL+   GG++       L++  + +E+++     +++ G+ 
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE--MVSENDVIRLIKQILEGVY 145
Query: 98  HMHRRYIVYRDLKPANILLDE---HGHVRISDLGLACDFSKKKPHA 140
           ++H+  IV+ DLKP NILL      G ++I D G+    S+K  HA
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM----SRKIGHA 187

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/48 (43%), Positives = 28/48 (58%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 191

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 45/71 (63%), Gaps = 4/71 (5%)
Query: 61  ILDLMNGGDLHYHLS-QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
           + DLM   DL+  L  QH   + D + ++  +++ GL+++H   +++RDLKP+N+LL+  
Sbjct: 108 VQDLMET-DLYKLLKCQH--LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 164
Query: 120 GHVRISDLGLA 130
             ++I D GLA
Sbjct: 165 CDLKICDFGLA 175

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K   +   G +
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 38/74 (51%)
Query: 57  KLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL 116
           KL  + +LM          Q  V +   ++++   ++LGL  +H   +V+RDL P NILL
Sbjct: 108 KLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL 167
Query: 117 DEHGHVRISDLGLA 130
            ++  + I D  LA
Sbjct: 168 ADNNDITICDFNLA 181

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/48 (43%), Positives = 28/48 (58%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 200

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA 173

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/54 (37%), Positives = 31/54 (57%), Gaps = 16/54 (29%)
Query: 96  LEHMHRRYIVY----------------RDLKPANILLDEHGHVRISDLGLACDF 133
           LE +H++Y+VY                RD+KP+NILL+   HV+++D GL+  F
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/56 (33%), Positives = 35/56 (62%), Gaps = 1/56 (1%)
Query: 76  QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHV-RISDLGLA 130
           + G   E+  R +  +++ GL+++H   +++RDLKPAN+ ++    V +I D GLA
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA 173

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/76 (28%), Positives = 41/76 (53%), Gaps = 3/76 (3%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            I DL+ GG+L   +     ++E +      +++  + H H+  +V+R+LKP N+LL   
Sbjct: 87  LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK 146
Query: 120 ---GHVRISDLGLACD 132
                V+++D GLA +
Sbjct: 147 LKGAAVKLADFGLAIE 162

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/64 (31%), Positives = 41/64 (64%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I  
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILG 168
Query: 127 LGLA 130
            GLA
Sbjct: 169 FGLA 172

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 4/108 (3%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEH 98
           VD P  VC          +  I+ LM  G L  ++ +H        +  +  ++  G+ +
Sbjct: 75  VDNPH-VCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 134 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 15/41 (36%), Positives = 28/41 (68%)
Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC 131
           ++  G++++H + +++RDLKP+NI L +   V+I D GL  
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/73 (27%), Positives = 42/73 (57%), Gaps = 4/73 (5%)
Query: 59  CFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD- 117
             + + +N  D       + +  + ++RFY  E++  L++ H + I++RD+KP N+++D 
Sbjct: 111 ALVFEYINNTDFK---QLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDH 167
Query: 118 EHGHVRISDLGLA 130
           +   +R+ D GLA
Sbjct: 168 QQKKLRLIDWGLA 180

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 53/113 (46%), Gaps = 14/113 (12%)
Query: 40  VDCPFI-----VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVI 93
           V  P++     +C+T           +  LM  G L  H+ ++ G     ++  +  ++ 
Sbjct: 76  VGSPYVSRLLGICLTSTVQ------LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIA 129
Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
            G+ ++    +V+RDL   N+L+    HV+I+D GLA   D  + + HA  GK
Sbjct: 130 KGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 182

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 18/48 (37%), Positives = 34/48 (70%), Gaps = 1/48 (2%)
Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++RFY  E++  L++ H + I++RD+KP N+++D +   +R+ D GLA
Sbjct: 138 DIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLA 185

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 21/48 (43%), Positives = 28/48 (58%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA D  K
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/84 (26%), Positives = 41/84 (48%), Gaps = 1/84 (1%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
            I++ +  G L  +L ++    N  +   YA ++  G++++  R  V+RDL   N+L++ 
Sbjct: 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 161
Query: 119 HGHVRISDLGLACDFSKKKPHASV 142
              V+I D GL       K   +V
Sbjct: 162 EHQVKIGDFGLTKAIETDKEXXTV 185

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 21/78 (26%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            + DL+ GG+L   +     ++E +      +++  + + H   IV+R+LKP N+LL   
Sbjct: 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK 164
Query: 120 GH---VRISDLGLACDFS 134
                V+++D GLA + +
Sbjct: 165 AKGAAVKLADFGLAIEVN 182

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 122 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 172

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 125 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 175

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 128 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 178

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/84 (26%), Positives = 41/84 (48%), Gaps = 1/84 (1%)
Query: 60  FILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE 118
            I++ +  G L  +L ++    N  +   YA ++  G++++  R  V+RDL   N+L++ 
Sbjct: 90  LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 149
Query: 119 HGHVRISDLGLACDFSKKKPHASV 142
              V+I D GL       K   +V
Sbjct: 150 EHQVKIGDFGLTKAIETDKEXXTV 173

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 167

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 167

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 21/76 (27%), Positives = 40/76 (52%), Gaps = 3/76 (3%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            + DL+ GG+L   +     ++E +      +++  + + H   IV+R+LKP N+LL   
Sbjct: 82  LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK 141
Query: 120 GH---VRISDLGLACD 132
                V+++D GLA +
Sbjct: 142 AKGAAVKLADFGLAIE 157

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 167

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 21/78 (26%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            + DL+ GG+L   +     ++E +      +++  + + H   IV+R+LKP N+LL   
Sbjct: 82  LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK 141
Query: 120 GH---VRISDLGLACDFS 134
                V+++D GLA + +
Sbjct: 142 AKGAAVKLADFGLAIEVN 159

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 21/78 (26%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            + DL+ GG+L   +     ++E +      +++  + + H   IV+R+LKP N+LL   
Sbjct: 81  LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK 140
Query: 120 GH---VRISDLGLACDFS 134
                V+++D GLA + +
Sbjct: 141 AKGAAVKLADFGLAIEVN 158

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 20/64 (31%), Positives = 41/64 (64%), Gaps = 1/64 (1%)
Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E   ++I D
Sbjct: 110 GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 168
Query: 127 LGLA 130
             LA
Sbjct: 169 FYLA 172

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 18/36 (50%), Positives = 25/36 (69%)
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           G+  +H  + ++RD+K ANILLDE    +ISD GLA
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 18/36 (50%), Positives = 25/36 (69%)
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           G+  +H  + ++RD+K ANILLDE    +ISD GLA
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 17/51 (33%), Positives = 33/51 (64%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            + + M +   +++ G++H+H   I++RDLKP+NI++     ++I D GLA
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 7/101 (6%)
Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVIL-- 94
           ++ +D P I+ +   F     +  +++   GG+L   +       +     Y AE++   
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 95  --GLEHMHRRYIVYRDLKPANILLDE---HGHVRISDLGLA 130
              L + H +++V++DLKP NIL  +   H  ++I D GLA
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 18/36 (50%), Positives = 25/36 (69%)
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           G+  +H  + ++RD+K ANILLDE    +ISD GLA
Sbjct: 139 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 174

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 18/36 (50%), Positives = 25/36 (69%)
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           G+  +H  + ++RD+K ANILLDE    +ISD GLA
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 171

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 15/41 (36%), Positives = 27/41 (65%)
Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC 131
           ++  G++++H + ++ RDLKP+NI L +   V+I D GL  
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 22/86 (25%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 46  VCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           VC+  A      +C + + M  G L  +L +Q G+F  + +     +V  G+ ++    +
Sbjct: 70  VCLEQA-----PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASV 124
Query: 105 VYRDLKPANILLDEHGHVRISDLGLA 130
           ++RDL   N L+ E+  +++SD G+ 
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMT 150

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 45  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRY 103
           +V    A  +P  L  I  L  G  L+  +     V + ++ R  A E++ G+ ++H + 
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 104 IVYRDLKPANILLDEHGHVRISDLGL 129
           I+++DLK  N+  D +G V I+D GL
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGL 175

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 4/108 (3%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEH 98
           VD P  VC          +  I+ LM  G L  ++ +H        +  +  ++  G+ +
Sbjct: 81  VDNPH-VCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 20/53 (37%), Positives = 33/53 (62%), Gaps = 1/53 (1%)
Query: 92  VILGLEHMH-RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
           V+    ++H  + I +RD+KP+NIL+D++G V++SD G +     KK   S G
Sbjct: 160 VLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRG 212

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 39.7 bits (91), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 4/108 (3%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEH 98
           VD P  VC          +  I+ LM  G L  ++ +H        +  +  ++  G+ +
Sbjct: 77  VDNPH-VCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 39.7 bits (91), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 19/49 (38%), Positives = 28/49 (57%)
Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG 128
             ED++ +    +  GLE +H +   +RDLKP NILL + G   + DLG
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 39.3 bits (90), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 4/108 (3%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEH 98
           VD P  VC          +  I  LM  G L  ++ +H        +  +  ++  G+ +
Sbjct: 74  VDNPH-VCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 4/108 (3%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEH 98
           VD P  VC          +  I+ LM  G L  ++ +H        +  +  ++  G+ +
Sbjct: 76  VDNPH-VCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 20/73 (27%), Positives = 42/73 (57%), Gaps = 1/73 (1%)
Query: 58  LCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD 117
           L  +++ +  G L  +L +H +    ++  +A ++  G+ ++H ++ ++R+L   N+LLD
Sbjct: 93  LQLVMEYVPLGSLRDYLPRHSI-GLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLD 151
Query: 118 EHGHVRISDLGLA 130
               V+I D GLA
Sbjct: 152 NDRLVKIGDFGLA 164

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 4/108 (3%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEH 98
           VD P  VC          +  I+ LM  G L  ++ +H        +  +  ++  G+ +
Sbjct: 74  VDNPH-VCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 4/108 (3%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEH 98
           VD P  VC          +  I+ LM  G L  ++ +H        +  +  ++  G+ +
Sbjct: 75  VDNPH-VCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 134 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 4/108 (3%)
Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEH 98
           VD P  VC          +  I+ LM  G L  ++ +H        +  +  ++  G+ +
Sbjct: 78  VDNPH-VCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 137 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 184

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/86 (25%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 46  VCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           VC+  A      +C + + M  G L  +L +Q G+F  + +     +V  G+ ++    +
Sbjct: 70  VCLEQA-----PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 124
Query: 105 VYRDLKPANILLDEHGHVRISDLGLA 130
           ++RDL   N L+ E+  +++SD G+ 
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMT 150

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 147 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 205

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/86 (25%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 46  VCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           VC+  A      +C + + M  G L  +L +Q G+F  + +     +V  G+ ++    +
Sbjct: 68  VCLEQA-----PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 105 VYRDLKPANILLDEHGHVRISDLGLA 130
           ++RDL   N L+ E+  +++SD G+ 
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMT 148

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 15/43 (34%), Positives = 30/43 (69%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           ++A++  G+ ++ R+  ++RDL+ AN+L+ E    +I+D GLA
Sbjct: 114 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA 156

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 128 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 186

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 22/86 (25%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 46  VCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           VC+  A      +C + + M  G L  +L +Q G+F  + +     +V  G+ ++    +
Sbjct: 90  VCLEQA-----PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 144
Query: 105 VYRDLKPANILLDEHGHVRISDLGLA 130
           ++RDL   N L+ E+  +++SD G+ 
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMT 170

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 116 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 20/73 (27%), Positives = 42/73 (57%), Gaps = 1/73 (1%)
Query: 58  LCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD 117
           L  +++ +  G L  +L +H +    ++  +A ++  G+ ++H ++ ++R+L   N+LLD
Sbjct: 93  LQLVMEYVPLGSLRDYLPRHSI-GLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLD 151
Query: 118 EHGHVRISDLGLA 130
               V+I D GLA
Sbjct: 152 NDRLVKIGDFGLA 164

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 124 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 22/86 (25%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 46  VCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
           VC+  A      +C + + M  G L  +L +Q G+F  + +     +V  G+ ++    +
Sbjct: 73  VCLEQA-----PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 127
Query: 105 VYRDLKPANILLDEHGHVRISDLGLA 130
           ++RDL   N L+ E+  +++SD G+ 
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMT 153

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 17/36 (47%), Positives = 27/36 (75%)
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           GL ++H R I++RD+K  NILLDE+   +I+D G++
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 17/36 (47%), Positives = 27/36 (75%)
Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           GL ++H R I++RD+K  NILLDE+   +I+D G++
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 39.3 bits (90), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)
Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGK 144
           +  ++  G+ ++  R +V+RDL   N+L+    HV+I+D GLA      +K+ HA  GK
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	145
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-64
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-58
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-57
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-55
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-47
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-47
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-47
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-47
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-46
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-46
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-46
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-46
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-46
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-45
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-45
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-45
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-44
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-43
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-42
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-42
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-41
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-41
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-28
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-25
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-25
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-24
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-21
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-21
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-21
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-20
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-20
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-20
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-20
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-19
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-19
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-19
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-18
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-18
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-18
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-17
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-17
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-17
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-17
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-16
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-16
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-16
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-16
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-16
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-16
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-16
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-15
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-15
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-15
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-15
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-15
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-15
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-15
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-15
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-15
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-15
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-15
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-15
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-14
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-14
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-14
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-14
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-14
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-14
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-14
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-13
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-13
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-13
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-13
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-13
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-13
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-13
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-13
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-12
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-12
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-12
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-11
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-11
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-10
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-10
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-10
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-10
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-10
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-09
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-09
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-09
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-09
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-09
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-09
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-09
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-09
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-09
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-09
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-09
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-09
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-09
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-09
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-08
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-08
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-08
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-08
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-08
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-08
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-08
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-08
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-08
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-08
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-08
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-08
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-08
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-08
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-08
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-07
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-07
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-07
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-07
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-07
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-07
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-07
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-07
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-07
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-07
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-07
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-06
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-06
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-06
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-06
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-06
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-06
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-06
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-05
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-05
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-04

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  208 bits (530), Expect = 1e-64
 Identities = 114/127 (89%), Positives = 120/127 (94%), Gaps = 4/127 (3%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLSQ
Sbjct: 230 KQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 285

Query: 77  HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
           HGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSKK
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345

Query: 137 KPHASVG 143
           KPHASVG
Sbjct: 346 KPHASVG 352

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  188 bits (478), Expect = 6e-58
 Identities = 62/124 (50%), Positives = 81/124 (65%), Gaps = 9/124 (7%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           ++GE +ALNE+ +L       + V+  F+V + YA+ T D LC +L LMNGGDL +H+  
Sbjct: 225 RKGEAMALNEKQIL-------EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH 277

Query: 77  HG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
            G   F E    FYAAE+  GLE +HR  IVYRDLKP NILLD+HGH+RISDLGLA    
Sbjct: 278 MGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337

Query: 135 KKKP 138
           + + 
Sbjct: 338 EGQT 341

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  184 bits (470), Expect = 4e-57
 Identities = 55/133 (41%), Positives = 78/133 (58%), Gaps = 13/133 (9%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-- 74
           ++G   A+ E+ +L         V   FIV + YAF T   LC ++ +MNGGD+ YH+  
Sbjct: 226 RKGYQGAMVEKKIL-------AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN 278

Query: 75  --SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
               +  F E    FY A+++ GLEH+H+R I+YRDLKP N+LLD+ G+VRISDLGLA +
Sbjct: 279 VDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338

Query: 133 FS--KKKPHASVG 143
               + K     G
Sbjct: 339 LKAGQTKTKGYAG 351

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  175 bits (446), Expect = 7e-55
 Identities = 39/119 (32%), Positives = 72/119 (60%), Gaps = 7/119 (5%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
             E  ++       Q ++ PF+V + Y+F   + +  ++DL+ GGDL YHL Q+  F E+
Sbjct: 63  FKELQIM-------QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE 115

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 142
            ++ +  E+++ L+++  + I++RD+KP NILLDEHGHV I+D  +A    ++    ++
Sbjct: 116 TVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM 174

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  153 bits (390), Expect = 3e-47
 Identities = 40/107 (37%), Positives = 62/107 (57%), Gaps = 7/107 (6%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
             ER ++         +D PF V + + F   +KL F L     G+L  ++ + G F+E 
Sbjct: 78  TRERDVM-------SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             RFY AE++  LE++H + I++RDLKP NILL+E  H++I+D G A
Sbjct: 131 CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 177

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  153 bits (389), Expect = 6e-47
 Identities = 45/107 (42%), Positives = 65/107 (60%), Gaps = 7/107 (6%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
            +ER+ML        +V  PFI+ M   F    ++  I+D + GG+L   L +   F   
Sbjct: 54  NDERLML-------SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP 106

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             +FYAAEV L LE++H + I+YRDLKP NILLD++GH++I+D G A
Sbjct: 107 VAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  153 bits (389), Expect = 6e-47
 Identities = 44/93 (47%), Positives = 63/93 (67%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + V  PFIV + YAF T  KL  IL+ ++GG+L   L + G+F ED   FY AE+ + L 
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           H+H++ I+YRDLKP NI+L+  GHV+++D GL 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  153 bits (388), Expect = 9e-47
 Identities = 48/93 (51%), Positives = 66/93 (70%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
             V+ PFIV + YAF T  KL  ILD + GGDL   LS+  +F E++++FY AE+ L L+
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           H+H   I+YRDLKP NILLDE GH++++D GL+
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  153 bits (388), Expect = 2e-46
 Identities = 49/107 (45%), Positives = 67/107 (62%), Gaps = 6/107 (5%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
             ER +L  +         PF+V + YAF T  KL  ILD +NGG+L  HLSQ   F E 
Sbjct: 106 RTERQVLEHIR------QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH 159

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           E++ Y  E++L LEH+H+  I+YRD+K  NILLD +GHV ++D GL+
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  152 bits (386), Expect = 4e-46
 Identities = 47/93 (50%), Positives = 62/93 (66%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + V  PF+V + ++F T DKL F+LD +NGG+L YHL +   F E   RFYAAE+   L 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           ++H   IVYRDLKP NILLD  GH+ ++D GL 
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  151 bits (384), Expect = 5e-46
 Identities = 44/93 (47%), Positives = 66/93 (70%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           Q    PF+  + YAF T D+LCF+++  NGG+L +HLS+  VF E+  RFY AE++  LE
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           ++H R +VYRD+K  N++LD+ GH++I+D GL 
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  151 bits (384), Expect = 6e-46
 Identities = 39/107 (36%), Positives = 69/107 (64%), Gaps = 7/107 (6%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
           LNE+ +L       Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E 
Sbjct: 89  LNEKRIL-------QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             RFYAA+++L  E++H   ++YRDLKP N+L+D+ G+++++D G A
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  151 bits (383), Expect = 8e-46
 Identities = 46/107 (42%), Positives = 67/107 (62%), Gaps = 6/107 (5%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
           + E+ +LSL        + PF+  M   F T + L F+++ +NGGDL YH+     F+  
Sbjct: 65  MVEKRVLSLA------WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS 118

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              FYAAE+ILGL+ +H + IVYRDLK  NILLD+ GH++I+D G+ 
Sbjct: 119 RATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  149 bits (379), Expect = 4e-45
 Identities = 43/107 (40%), Positives = 67/107 (62%), Gaps = 6/107 (5%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
           + E+ +LSL        + PF+  +   F TPD+L F+++ +NGGDL +H+ +   F+E 
Sbjct: 71  MTEKRILSLAR------NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA 124

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             RFYAAE+I  L  +H + I+YRDLK  N+LLD  GH +++D G+ 
Sbjct: 125 RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  148 bits (377), Expect = 6e-45
 Identities = 42/107 (39%), Positives = 65/107 (60%), Gaps = 6/107 (5%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
           + E+ +L+L          PF+  +   F T D+L F+++ +NGGDL YH+ Q G F E 
Sbjct: 68  MVEKRVLALPG------KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 121

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              FYAAE+ +GL  +  + I+YRDLK  N++LD  GH++I+D G+ 
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  148 bits (376), Expect = 9e-45
 Identities = 39/107 (36%), Positives = 64/107 (59%), Gaps = 6/107 (5%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
             E+ +    S      + PF+V +   F T  +L F+++ +NGGDL +H+ +     E+
Sbjct: 57  QTEKHVFEQAS------NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE 110

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             RFY+AE+ L L ++H R I+YRDLK  N+LLD  GH++++D G+ 
Sbjct: 111 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  149 bits (377), Expect = 1e-44
 Identities = 39/107 (36%), Positives = 64/107 (59%), Gaps = 6/107 (5%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
             E+ +    S      + PF+V +   F T  +L F+++ +NGGDL +H+ +     E+
Sbjct: 100 QTEKHVFEQAS------NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE 153

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             RFY+AE+ L L ++H R I+YRDLK  N+LLD  GH++++D G+ 
Sbjct: 154 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  146 bits (370), Expect = 4e-43
 Identities = 43/94 (45%), Positives = 66/94 (70%), Gaps = 1/94 (1%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           Q    PF+  + Y+F T D+LCF+++  NGG+L +HLS+  VF+ED  RFY AE++  L+
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 262

Query: 98  HMHRRY-IVYRDLKPANILLDEHGHVRISDLGLA 130
           ++H    +VYRDLK  N++LD+ GH++I+D GL 
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  144 bits (365), Expect = 2e-42
 Identities = 37/108 (34%), Positives = 60/108 (55%), Gaps = 8/108 (7%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNE 82
             ER +L          D  +I  + YAF   + L  ++D   GGDL   LS+      E
Sbjct: 122 REERDVL-------VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE 174

Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +  RFY AE+++ ++ +H+ + V+RD+KP NIL+D +GH+R++D G  
Sbjct: 175 EMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  142 bits (360), Expect = 6e-42
 Identities = 36/107 (33%), Positives = 59/107 (55%), Gaps = 8/107 (7%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
             ER ++          + P++V + YAF     L  +++ M GGDL   +S +    E 
Sbjct: 117 WEERDIM-------AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEK 168

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             RFY AEV+L L+ +H    ++RD+KP N+LLD+ GH++++D G  
Sbjct: 169 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  141 bits (358), Expect = 1e-41
 Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 1/94 (1%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGL 96
              D  +I  + +AF   + L  +++   GGDL   LS+ G     +  RFY AE+++ +
Sbjct: 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAI 175

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + +HR   V+RD+KP NILLD  GH+R++D G  
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  143 bits (361), Expect = 6e-41
 Identities = 42/107 (39%), Positives = 65/107 (60%), Gaps = 6/107 (5%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
           + E+ +L+L          PF+  +   F T D+L F+++ +NGGDL YH+ Q G F E 
Sbjct: 389 MVEKRVLALPG------KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 442

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              FYAAE+ +GL  +  + I+YRDLK  N++LD  GH++I+D G+ 
Sbjct: 443 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  118 bits (298), Expect = 1e-33
 Identities = 29/109 (26%), Positives = 45/109 (41%), Gaps = 8/109 (7%)

Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FN 81
            L E           ++   P  V +  A+     L    +L  G  L  H    G    
Sbjct: 103 KLAEVGSHE------KVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP 155

Query: 82  EDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           E ++  Y  + +L L H+H + +V+ D+KPANI L   G  ++ D GL 
Sbjct: 156 EAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL 204

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  117 bits (296), Expect = 2e-33
 Identities = 27/93 (29%), Positives = 50/93 (53%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
             +  P I+ M   FH   ++  +L+    G+L+  L +HG F+E     +  E+   L 
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + H R +++RD+KP N+L+   G ++I+D G +
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWS 161

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  113 bits (285), Expect = 6e-32
 Identities = 25/88 (28%), Positives = 46/88 (52%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L + H +
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RD+KP N+LL   G ++I+D G +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS 156

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  104 bits (262), Expect = 5e-28
 Identities = 20/97 (20%), Positives = 41/97 (42%), Gaps = 9/97 (9%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--------FNEDEMRFYAAEVIL 94
            + +         D++  I + M    +        V             ++     V+ 
Sbjct: 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLN 162

Query: 95  GLEHMH-RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              ++H  + I +RD+KP+NIL+D++G V++SD G +
Sbjct: 163 SFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  100 bits (250), Expect = 3e-26
 Identities = 33/121 (27%), Positives = 58/121 (47%), Gaps = 9/121 (7%)

Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH--GVF 80
           +  E  +L+        +  P IV    +F     L  ++D   GGDL   ++     +F
Sbjct: 70  SRREVAVLA-------NMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF 122

Query: 81  NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
            ED++  +  ++ L L+H+H R I++RD+K  NI L + G V++ D G+A   +     A
Sbjct: 123 QEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182

Query: 141 S 141
            
Sbjct: 183 R 183

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 98.1 bits (245), Expect = 1e-25
 Identities = 27/88 (30%), Positives = 45/88 (51%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
             +V     F   D +  +L+L     L     +     E E R+Y  +++LG +++HR 
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RDLK  N+ L+E   V+I D GLA
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 96.9 bits (242), Expect = 2e-25
 Identities = 27/88 (30%), Positives = 45/88 (51%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
             +V     F   D +  +L+L     L     +     E E R+Y  +++LG +++HR 
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
            +++RDLK  N+ L+E   V+I D GLA
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 94.7 bits (236), Expect = 1e-24
 Identities = 28/122 (22%), Positives = 53/122 (43%), Gaps = 21/122 (17%)

Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAF-------------HTPDKLCFILDLMNGGD 69
            L+E ++L+        ++  ++V    A+                  L   ++    G 
Sbjct: 49  ILSEVMLLA-------SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGT 101

Query: 70  LHYHLSQHGVF-NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG 128
           L+  +    +    DE      +++  L ++H + I++RDLKP NI +DE  +V+I D G
Sbjct: 102 LYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161

Query: 129 LA 130
           LA
Sbjct: 162 LA 163

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 93.9 bits (234), Expect = 3e-24
 Identities = 34/123 (27%), Positives = 59/123 (47%), Gaps = 11/123 (8%)

Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG---- 78
            + E  +L         ++ P ++    +F   ++L  +L+L + GDL   +        
Sbjct: 79  CIKEIDLLK-------QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131

Query: 79  VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 138
           +  E  +  Y  ++   LEHMH R +++RD+KPAN+ +   G V++ DLGL   FS K  
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191

Query: 139 HAS 141
            A 
Sbjct: 192 AAH 194

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 89.1 bits (222), Expect = 1e-22
 Identities = 25/89 (28%), Positives = 56/89 (62%), Gaps = 1/89 (1%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHR 101
           P I+ +   F   + +  +L++ + G+++ +L ++   F+E+E R +  ++I G+ ++H 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
             I++RDL  +N+LL  + +++I+D GLA
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLA 159

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 88.5 bits (219), Expect = 6e-22
 Identities = 19/112 (16%), Positives = 43/112 (38%), Gaps = 16/112 (14%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-----VFNEDEMRFYAAE 91
           ++       +    A    +    + +L + G L   ++ +      V  +  +  +A  
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 92  VILGLEHMHRRYIVYRDLKPANILL-----------DEHGHVRISDLGLACD 132
           ++  +E +H   I++ D+KP N +L           D    + + DLG + D
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 87.3 bits (217), Expect = 7e-22
 Identities = 28/82 (34%), Positives = 53/82 (64%), Gaps = 1/82 (1%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
             D L  + +L+N G +   +      +ED+ RFY  ++I G+E++H + I++RD+KP+N
Sbjct: 109 NEDHLYMVFELVNQGPV-MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167

Query: 114 ILLDEHGHVRISDLGLACDFSK 135
           +L+ E GH++I+D G++ +F  
Sbjct: 168 LLVGEDGHIKIADFGVSNEFKG 189

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 87.4 bits (217), Expect = 1e-21
 Identities = 29/97 (29%), Positives = 57/97 (58%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           ++++ P IV +     T   L  I++  +GG++  +L  HG   E E R    +++  ++
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 128

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           + H++ IV+RDLK  N+LLD   +++I+D G + +F+
Sbjct: 129 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.3 bits (212), Expect = 3e-21
 Identities = 27/77 (35%), Positives = 49/77 (63%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
           TP     +++ ++GG+L  ++ +HG   E E R    +++  +++ HR  +V+RDLKP N
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPEN 141

Query: 114 ILLDEHGHVRISDLGLA 130
           +LLD H + +I+D GL+
Sbjct: 142 VLLDAHMNAKIADFGLS 158

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 85.3 bits (212), Expect = 3e-21
 Identities = 23/77 (29%), Positives = 43/77 (55%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
             +     L+  +GG+L   +       E + + +  +++ G+ ++H   I +RD+KP N
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 135

Query: 114 ILLDEHGHVRISDLGLA 130
           +LLDE  +++ISD GLA
Sbjct: 136 LLLDERDNLKISDFGLA 152

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 85.8 bits (213), Expect = 4e-21
 Identities = 21/89 (23%), Positives = 43/89 (48%), Gaps = 2/89 (2%)

Query: 42  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR 101
              I+ +     T   +  +++     DL+  L +    +  E + Y   ++  +  +H+
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
             IV+ DLKPAN L+ + G +++ D G+A
Sbjct: 146 HGIVHSDLKPANFLIVD-GMLKLIDFGIA 173

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.8 bits (213), Expect = 4e-21
 Identities = 23/77 (29%), Positives = 43/77 (55%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
             +     L+  +GG+L   +       E + + +  +++ G+ ++H   I +RD+KP N
Sbjct: 76  EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 135

Query: 114 ILLDEHGHVRISDLGLA 130
           +LLDE  +++ISD GLA
Sbjct: 136 LLLDERDNLKISDFGLA 152

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 85.9 bits (213), Expect = 5e-21
 Identities = 21/89 (23%), Positives = 43/89 (48%), Gaps = 2/89 (2%)

Query: 42  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR 101
              I+ +     T   +  +++     DL+  L +    +  E + Y   ++  +  +H+
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
             IV+ DLKPAN L+ + G +++ D G+A
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIA 154

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 85.4 bits (211), Expect = 8e-21
 Identities = 21/131 (16%), Positives = 43/131 (32%), Gaps = 10/131 (7%)

Query: 14  SHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPD--KLCFILDLMN----- 66
             +K  +   ++ R +       ++      ++ +             F+   M      
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDL--VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188

Query: 67  -GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS 125
            G  L  H S H             +VI  L  +H   +V+  L+P +I+LD+ G V ++
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 248

Query: 126 DLGLACDFSKK 136
                     +
Sbjct: 249 GFEHLVRDGAR 259

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 85.3 bits (211), Expect = 1e-20
 Identities = 21/89 (23%), Positives = 43/89 (48%), Gaps = 2/89 (2%)

Query: 42  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR 101
              I+ +     T   +  +++     DL+  L +    +  E + Y   ++  +  +H+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
             IV+ DLKPAN L+ + G +++ D G+A
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIA 201

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 83.5 bits (207), Expect = 2e-20
 Identities = 25/138 (18%), Positives = 47/138 (34%), Gaps = 25/138 (18%)

Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPD----------------KLCFILDLMN 66
           A  E   L+        +D   IV     +   D                 L   ++  +
Sbjct: 51  AEREVKALA-------KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCD 103

Query: 67  GGDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRI 124
            G L   + +      ++        ++  G++++H + ++ RDLKP+NI L +   V+I
Sbjct: 104 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163

Query: 125 SDLGLACDFSKKKPHASV 142
            D GL             
Sbjct: 164 GDFGLVTSLKNDGKRTRS 181

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 84.5 bits (209), Expect = 3e-20
 Identities = 27/77 (35%), Positives = 52/77 (67%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
           TP  +  +++ ++GG+L  ++ ++G  +E E R    +++ G+++ HR  +V+RDLKP N
Sbjct: 87  TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPEN 146

Query: 114 ILLDEHGHVRISDLGLA 130
           +LLD H + +I+D GL+
Sbjct: 147 VLLDAHMNAKIADFGLS 163

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 82.8 bits (205), Expect = 3e-20
 Identities = 25/114 (21%), Positives = 45/114 (39%), Gaps = 10/114 (8%)

Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH----G 78
           AL E    +       +     +V    A+   D +    +  NGG L   +S++     
Sbjct: 57  ALREVYAHA------VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS 110

Query: 79  VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
            F E E++    +V  GL ++H   +V+ D+KP+NI +        +      D
Sbjct: 111 YFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 83.6 bits (207), Expect = 4e-20
 Identities = 18/94 (19%), Positives = 44/94 (46%), Gaps = 1/94 (1%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDL-MNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
             V+   I+ +   F        +++   +G DL   + +H   +E    +   +++  +
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            ++  + I++RD+K  NI++ E   +++ D G A
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 83.4 bits (206), Expect = 4e-20
 Identities = 18/112 (16%), Positives = 38/112 (33%), Gaps = 3/112 (2%)

Query: 34  STGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ---HGVFNEDEMRFYAA 90
              +        V           L   + L    +L   +++                 
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171

Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 142
           ++   +E +H + +++RDLKP+NI       V++ D GL     + +   +V
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 82.3 bits (204), Expect = 5e-20
 Identities = 32/131 (24%), Positives = 56/131 (42%), Gaps = 20/131 (15%)

Query: 23  ALNE-RIMLSLVSTGIQMVDCPFIVCMTYAFH--TPDKLCFILDLMNGGDLHYHLSQHG- 78
            ++E  ++  L          P IV         T   L  +++   GGDL   +++   
Sbjct: 52  LVSEVNLLREL--------KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK 103

Query: 79  ---VFNEDEMRFYAAEVILGLEHMHRR-----YIVYRDLKPANILLDEHGHVRISDLGLA 130
                +E+ +     ++ L L+  HRR      +++RDLKPAN+ LD   +V++ D GLA
Sbjct: 104 ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163

Query: 131 CDFSKKKPHAS 141
              +     A 
Sbjct: 164 RILNHDTSFAK 174

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 83.2 bits (206), Expect = 5e-20
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 3/93 (3%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
           TP  L  I++  +GG+L+  +   G F+EDE RF+  +++ G+ + H   I +RDLK  N
Sbjct: 87  TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLEN 146

Query: 114 ILLDEH--GHVRISDLGLACDFSK-KKPHASVG 143
            LLD      ++I D G +       +P ++VG
Sbjct: 147 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 82.6 bits (204), Expect = 1e-19
 Identities = 24/114 (21%), Positives = 46/114 (40%), Gaps = 9/114 (7%)

Query: 38  QMVDCPFIVCM--TYAFHTPDKLCFILDLMNGGDLHYHLSQHG---VFNEDEMRFYAAEV 92
           + ++   IV +       T      I++    G L+  L +        E E      +V
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 93  ILGLEHMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDFSKKKPHASV 142
           + G+ H+    IV+R++KP NI+     D     +++D G A +    +   S+
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 82.0 bits (203), Expect = 1e-19
 Identities = 29/133 (21%), Positives = 47/133 (35%), Gaps = 15/133 (11%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPD----KLCFILDLMNGGDLHY 72
           +Q    A  E  M  L        + P I+ +            +   +L     G L  
Sbjct: 67  QQDREEAQREADMHRLF-------NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWN 119

Query: 73  HL----SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG 128
            +     +     ED++ +    +  GLE +H +   +RDLKP NILL + G   + DLG
Sbjct: 120 EIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179

Query: 129 LACDFSKKKPHAS 141
                      + 
Sbjct: 180 SMNQACIHVEGSR 192

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 82.0 bits (202), Expect = 2e-19
 Identities = 17/64 (26%), Positives = 27/64 (42%)

Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           G  L  H S H             +VI  L  +H   +V+  L+P +I+LD+ G V ++ 
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254

Query: 127 LGLA 130
               
Sbjct: 255 FEHL 258

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 80.6 bits (199), Expect = 4e-19
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 1/94 (1%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
             +  P IV +  A      +   ++L+ GG L   + Q G   ED   +Y  + + GLE
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 164

Query: 98  HMHRRYIVYRDLKPANILLDEHG-HVRISDLGLA 130
           ++H R I++ D+K  N+LL   G    + D G A
Sbjct: 165 YLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 198

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 80.0 bits (198), Expect = 6e-19
 Identities = 29/123 (23%), Positives = 55/123 (44%), Gaps = 6/123 (4%)

Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDL-MNGG 68
           +   S +    T  L   ++   V  G      P ++ +   F T +    +L+  +   
Sbjct: 69  VLGWSPLSDSVTCPLEVALL-WKVGAGGG---HPGVIRLLDWFETQEGFMLVLERPLPAQ 124

Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDL 127
           DL  ++++ G   E   R +  +V+  ++H H R +V+RD+K  NIL+D   G  ++ D 
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184

Query: 128 GLA 130
           G  
Sbjct: 185 GSG 187

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 79.6 bits (197), Expect = 7e-19
 Identities = 29/77 (37%), Positives = 50/77 (64%), Gaps = 1/77 (1%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
           TP  +  +++   GG+L  ++ +     EDE R +  ++I  +E+ HR  IV+RDLKP N
Sbjct: 80  TPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPEN 138

Query: 114 ILLDEHGHVRISDLGLA 130
           +LLD++ +V+I+D GL+
Sbjct: 139 LLLDDNLNVKIADFGLS 155

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 79.4 bits (196), Expect = 1e-18
 Identities = 24/114 (21%), Positives = 46/114 (40%), Gaps = 9/114 (7%)

Query: 38  QMVDCPFIVCM--TYAFHTPDKLCFILDLMNGGDLHYHLSQHG---VFNEDEMRFYAAEV 92
           + ++   IV +       T      I++    G L+  L +        E E      +V
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 93  ILGLEHMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDFSKKKPHASV 142
           + G+ H+    IV+R++KP NI+     D     +++D G A +    +   S+
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 78.2 bits (193), Expect = 2e-18
 Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 3/103 (2%)

Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR- 102
           F             +  + +LM  G L  +L +  V     +R +  +++ GL+ +H R 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 103 -YIVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHASVG 143
             I++RDLK  NI +    G V+I DLGLA         A +G
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG 192

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 78.1 bits (193), Expect = 3e-18
 Identities = 28/91 (30%), Positives = 50/91 (54%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   + T      + DLM  G+L  +L++    +E E R     ++  +  +H+ 
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLACDF 133
            IV+RDLKP NILLD+  +++++D G +C  
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.8 bits (192), Expect = 4e-18
 Identities = 23/91 (25%), Positives = 43/91 (47%), Gaps = 2/91 (2%)

Query: 42  CPFIVCMTYAFHTPDKLCFILDLMNG-GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
              ++ +   F  PD    IL+      DL   +++ G   E+  R +  +V+  + H H
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166

Query: 101 RRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
              +++RD+K  NIL+D   G +++ D G  
Sbjct: 167 NCGVLHRDIKDENILIDLNRGELKLIDFGSG 197

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 77.3 bits (191), Expect = 5e-18
 Identities = 23/78 (29%), Positives = 40/78 (51%), Gaps = 1/78 (1%)

Query: 54  TPDKLCFILDLMNGGDLH-YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPA 112
              K+  +++    G            F   +   Y  ++I GLE++H + IV++D+KP 
Sbjct: 79  EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPG 138

Query: 113 NILLDEHGHVRISDLGLA 130
           N+LL   G ++IS LG+A
Sbjct: 139 NLLLTTGGTLKISALGVA 156

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 77.8 bits (192), Expect = 5e-18
 Identities = 30/96 (31%), Positives = 53/96 (55%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           Q+   P I+ +  ++ +   +  + DLM  G+L  +L++    +E E R     ++  + 
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
            +H   IV+RDLKP NILLD++  +R+SD G +C  
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 77.2 bits (190), Expect = 8e-18
 Identities = 29/106 (27%), Positives = 59/106 (55%), Gaps = 5/106 (4%)

Query: 41  DCPFIVCMTY--AFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEH 98
           + P+IV   +  AF++  ++   ++ M+GG L   L + G   E  +   +  VI GL +
Sbjct: 89  NSPYIV--GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 146

Query: 99  MHRRY-IVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
           +  ++ I++RD+KP+NIL++  G +++ D G++        ++ VG
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 192

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 77.4 bits (190), Expect = 1e-17
 Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 12/108 (11%)

Query: 38  QMVDCPFIVCM------TYAFHTPDKLCFILDLMNGGDLHYHLSQHG---VFNEDEMRFY 88
           + ++ P +V               D     ++   GGDL  +L+Q        E  +R  
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGH---VRISDLGLACDF 133
            +++   L ++H   I++RDLKP NI+L         +I DLG A + 
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 75.4 bits (186), Expect = 2e-17
 Identities = 25/79 (31%), Positives = 41/79 (51%), Gaps = 1/79 (1%)

Query: 54  TPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPA 112
           T  +L  +     G  L++HL +    F   ++   A +   G++++H + I++RDLK  
Sbjct: 90  TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSN 149

Query: 113 NILLDEHGHVRISDLGLAC 131
           NI L E   V+I D GLA 
Sbjct: 150 NIFLHEDNTVKIGDFGLAT 168

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 75.9 bits (187), Expect = 2e-17
 Identities = 32/132 (24%), Positives = 59/132 (44%), Gaps = 17/132 (12%)

Query: 13  CSHVKQGETLAL-----------NERIMLSLVSTGIQMVDCPFIVCMTY--AFHTPDKLC 59
               K G  +A+           N+RI++ L    ++  DCP+IV       F T   + 
Sbjct: 44  MRFRKTGHVIAVKQMRRSGNKEENKRILMDL-DVVLKSHDCPYIV--QCFGTFITNTDVF 100

Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH-RRYIVYRDLKPANILLDE 118
             ++LM            G   E  +      ++  L ++  +  +++RD+KP+NILLDE
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE 160

Query: 119 HGHVRISDLGLA 130
            G +++ D G++
Sbjct: 161 RGQIKLCDFGIS 172

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 76.3 bits (188), Expect = 2e-17
 Identities = 27/96 (28%), Positives = 53/96 (55%), Gaps = 4/96 (4%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + ++ P I+ +   F   D    +L+LM GG+L   +  +    E   + Y  +++L ++
Sbjct: 195 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLA 130
           ++H   I++RDLKP N+LL   +E   ++I+D G +
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 75.5 bits (186), Expect = 2e-17
 Identities = 17/93 (18%), Positives = 35/93 (37%), Gaps = 3/93 (3%)

Query: 53  HTPDKLCFILDLMNGGDLHYHLSQHGV---FNEDEMRFYAAEVILGLEHMHRRYIVYRDL 109
                L   + L    +L   ++                  ++   +E +H + +++RDL
Sbjct: 85  SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDL 144

Query: 110 KPANILLDEHGHVRISDLGLACDFSKKKPHASV 142
           KP+NI       V++ D GL     + +   +V
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 75.0 bits (185), Expect = 3e-17
 Identities = 33/135 (24%), Positives = 66/135 (48%), Gaps = 20/135 (14%)

Query: 13  CSHVKQGETLAL-----------NERIMLSLVSTGIQMVDCPFIVCMTY--AFHTPDKLC 59
             HV  G+ +A+            +R+++ L    ++ VDCPF V  T+  A      + 
Sbjct: 26  MRHVPSGQIMAVKRIRATVNSQEQKRLLMDL-DISMRTVDCPFTV--TFYGALFREGDVW 82

Query: 60  FILDLMNGG---DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY-IVYRDLKPANIL 115
             ++LM+          + +     ED +   A  ++  LEH+H +  +++RD+KP+N+L
Sbjct: 83  ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVL 142

Query: 116 LDEHGHVRISDLGLA 130
           ++  G V++ D G++
Sbjct: 143 INALGQVKMCDFGIS 157

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 75.5 bits (185), Expect = 4e-17
 Identities = 9/79 (11%), Positives = 26/79 (32%), Gaps = 6/79 (7%)

Query: 58  LCFILDLMNG------GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKP 111
              ++   +         L +     G      +    A++I    ++  + +V+    P
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222

Query: 112 ANILLDEHGHVRISDLGLA 130
            N+ +   G + + D+   
Sbjct: 223 DNLFIMPDGRLMLGDVSAL 241

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 74.7 bits (184), Expect = 5e-17
 Identities = 31/114 (27%), Positives = 46/114 (40%), Gaps = 15/114 (13%)

Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY 103
           FI     + H+  +L  I      G L+ +L    +     +R     +  GL H+H   
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLSIASGLAHLHIEI 125

Query: 104 --------IVYRDLKPANILLDEHGHVRISDLGLACDFS------KKKPHASVG 143
                   I +RDLK  NIL+ ++G   I+DLGLA   S          +  VG
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 75.1 bits (185), Expect = 5e-17
 Identities = 28/105 (26%), Positives = 54/105 (51%), Gaps = 4/105 (3%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + V  P I+ +   +     +  IL+L++GG+L   L+Q    +E+E   +  +++ G+ 
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129

Query: 98  HMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDFSKKKP 138
           ++H + I + DLKP NI+L        H+++ D GLA +      
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 74.3 bits (183), Expect = 8e-17
 Identities = 27/96 (28%), Positives = 53/96 (55%), Gaps = 4/96 (4%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + ++ P I+ +   F   D    +L+LM GG+L   +  +    E   + Y  +++L ++
Sbjct: 70  KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLA 130
           ++H   I++RDLKP N+LL   +E   ++I+D G +
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 73.9 bits (182), Expect = 8e-17
 Identities = 26/124 (20%), Positives = 57/124 (45%), Gaps = 9/124 (7%)

Query: 15  HVKQGETLA-----LNERIMLSLVSTGIQMV---DCPFIVCMTYAFHTPDKLCFILDLMN 66
               G  +A     L ++    L+   + ++       +V M  ++   ++L  +++ + 
Sbjct: 66  EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125

Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           GG L   +      NE+++      V+  L ++H + +++RD+K  +ILL   G V++SD
Sbjct: 126 GGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSD 184

Query: 127 LGLA 130
            G  
Sbjct: 185 FGFC 188

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 73.9 bits (182), Expect = 1e-16
 Identities = 26/100 (26%), Positives = 47/100 (47%), Gaps = 4/100 (4%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           +    P I+ +   +     +  + +LM GG+L   + +   F+E E       +   +E
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVE 130

Query: 98  HMHRRYIVYRDLKPANILLDEHGH----VRISDLGLACDF 133
           ++H + +V+RDLKP+NIL  +       +RI D G A   
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 73.4 bits (181), Expect = 1e-16
 Identities = 26/105 (24%), Positives = 53/105 (50%), Gaps = 4/105 (3%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + V    ++ +   +     +  IL+L++GG+L   L+Q    +E+E   +  +++ G+ 
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129

Query: 98  HMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDFSKKKP 138
           ++H + I + DLKP NI+L        H+++ D GLA +      
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 73.5 bits (181), Expect = 1e-16
 Identities = 31/134 (23%), Positives = 59/134 (44%), Gaps = 21/134 (15%)

Query: 13  CSHVKQGETLAL-----------NERIMLSLVSTGIQMVDCPFIVCMTY--AFHTPDKLC 59
             H   G+ +A+            +++++ L    ++  DCP+IV   +  A        
Sbjct: 41  MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL-DVVMRSSDCPYIV--QFYGALFREGDCW 97

Query: 60  FILDLMNGG-DLHY---HLSQHGVFNEDEMRFYAAEVILGLEHMHRRY-IVYRDLKPANI 114
             ++LM+   D  Y   +     V  E+ +       +  L H+     I++RD+KP+NI
Sbjct: 98  ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNI 157

Query: 115 LLDEHGHVRISDLG 128
           LLD  G++++ D G
Sbjct: 158 LLDRSGNIKLCDFG 171

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 73.1 bits (180), Expect = 1e-16
 Identities = 30/124 (24%), Positives = 57/124 (45%), Gaps = 9/124 (7%)

Query: 15  HVKQGETLA-----LNERIMLSLVSTGIQMV---DCPFIVCMTYAFHTPDKLCFILDLMN 66
            V  G+ +A     L ++    L+   I ++     P IV    ++   D+L  +++ + 
Sbjct: 41  DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100

Query: 67  GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISD 126
           GG L   +      +E ++     E +  LE +H   +++RD+K  NILL   G V+++D
Sbjct: 101 GGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTD 159

Query: 127 LGLA 130
            G  
Sbjct: 160 FGFC 163

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 73.2 bits (180), Expect = 2e-16
 Identities = 25/87 (28%), Positives = 42/87 (48%), Gaps = 7/87 (8%)

Query: 46  VCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYI 104
            CM+     P  L  I  L  G  L+  +     V + ++ R  A E++ G+ ++H + I
Sbjct: 97  ACMS-----PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 105 VYRDLKPANILLDEHGHVRISDLGLAC 131
           +++DLK  N+  D    V I+D GL  
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFS 177

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 72.2 bits (178), Expect = 2e-16
 Identities = 26/105 (24%), Positives = 52/105 (49%), Gaps = 4/105 (3%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +  P I+ +   F     +  IL+L++GG+L   L++     EDE   +  +++ G+ 
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122

Query: 98  HMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDFSKKKP 138
           ++H + I + DLKP NI+L      +  +++ D G+A        
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 72.7 bits (179), Expect = 3e-16
 Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 3/95 (3%)

Query: 42  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR 101
            P IV +   FH       +++L+NGG+L   + +   F+E E  +   +++  + HMH 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124

Query: 102 RYIVYRDLKPANILL---DEHGHVRISDLGLACDF 133
             +V+RDLKP N+L    +++  ++I D G A   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 72.2 bits (178), Expect = 3e-16
 Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 2/93 (2%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHR 101
           P IV +    H+   L  + + M   DL   L ++     + +++ Y  +++ G+ H H+
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
             I++RDLKP N+L++  G ++++D GLA  F 
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 72.6 bits (179), Expect = 3e-16
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 2/98 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGL 96
           Q +  P I+ +  AF     +  + D M   DL   +     V     ++ Y    + GL
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           E++H+ +I++RDLKP N+LLDE+G ++++D GLA  F 
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 72.9 bits (179), Expect = 4e-16
 Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 3/99 (3%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFNEDEMRFYAAEVILGLEHMHR 101
           P +V +  AF   +++  I + M+GG+L      +H   +EDE   Y  +V  GL HMH 
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273

Query: 102 RYIVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKP 138
              V+ DLKP NI+        +++ D GL      K+ 
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 71.8 bits (177), Expect = 5e-16
 Identities = 26/93 (27%), Positives = 48/93 (51%), Gaps = 2/93 (2%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHR 101
             IV +    HT  +L  + + ++  DL   L    G       + +  +++ G+ + H 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           R +++RDLKP N+L++  G ++I+D GLA  F 
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 71.6 bits (176), Expect = 5e-16
 Identities = 28/90 (31%), Positives = 52/90 (57%), Gaps = 1/90 (1%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           D P++     ++    KL  I++ + GG     L + G  +E ++     E++ GL+++H
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATILREILKGLDYLH 136

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
               ++RD+K AN+LL EHG V+++D G+A
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVA 166

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 71.6 bits (176), Expect = 6e-16
 Identities = 24/83 (28%), Positives = 43/83 (51%), Gaps = 5/83 (6%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHGV---FNEDEMRFYAAEVILGLEHMHRR--YIVYRD 108
            P  L  + + ++ G L+  L + G     +E      A +V  G+ ++H R   IV+R+
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRN 164

Query: 109 LKPANILLDEHGHVRISDLGLAC 131
           LK  N+L+D+   V++ D GL+ 
Sbjct: 165 LKSPNLLVDKKYTVKVCDFGLSR 187

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 71.5 bits (176), Expect = 6e-16
 Identities = 25/105 (23%), Positives = 49/105 (46%), Gaps = 4/105 (3%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+ 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128

Query: 98  HMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDFSKKKP 138
           ++H   I + DLKP NI+L         ++I D GLA        
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 71.5 bits (176), Expect = 6e-16
 Identities = 27/109 (24%), Positives = 46/109 (42%), Gaps = 3/109 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           Q      ++ +   F   D+   + + M GG +  H+ +   FNE E      +V   L+
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASVG 143
            +H + I +RDLKP NIL    ++   V+I D  L          + + 
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 71.4 bits (176), Expect = 7e-16
 Identities = 23/93 (24%), Positives = 49/93 (52%), Gaps = 2/93 (2%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHR 101
             IV +    H+  KL  + +  +  DL  +        + + ++ +  +++ GL   H 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           R +++RDLKP N+L++ +G +++++ GLA  F 
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 71.0 bits (175), Expect = 9e-16
 Identities = 26/94 (27%), Positives = 49/94 (52%), Gaps = 3/94 (3%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMH 100
           P IV +    HT +KL  + + ++  DL   +    +       ++ Y  +++ GL   H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
              +++RDLKP N+L++  G ++++D GLA  F 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 71.1 bits (175), Expect = 9e-16
 Identities = 25/102 (24%), Positives = 47/102 (46%), Gaps = 6/102 (5%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +    I+ +    H   +L  I +     DL  ++ ++   +   ++ +  ++I G+ 
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVN 146

Query: 98  HMHRRYIVYRDLKPANILLD-----EHGHVRISDLGLACDFS 134
             H R  ++RDLKP N+LL      E   ++I D GLA  F 
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 70.7 bits (174), Expect = 1e-15
 Identities = 24/100 (24%), Positives = 49/100 (49%), Gaps = 3/100 (3%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +  P IV +  +         + DL+ GG+L   +     ++E +      +++  + 
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFS 134
           + H   IV+R+LKP N+LL    +   V+++D GLA + +
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 71.2 bits (175), Expect = 1e-15
 Identities = 24/104 (23%), Positives = 50/104 (48%), Gaps = 3/104 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +  P IV +  +         + DL+ GG+L   +     ++E +      +++  + 
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 142

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP 138
           + H   IV+R+LKP N+LL    +   V+++D GLA + +  + 
Sbjct: 143 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 71.3 bits (175), Expect = 1e-15
 Identities = 30/105 (28%), Positives = 44/105 (41%), Gaps = 9/105 (8%)

Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY 103
           FI        T  +L  + D    G L  +L+++ V  E  ++  A     GL H+H   
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEI 159

Query: 104 --------IVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
                   I +RDLK  NIL+ ++G   I+DLGLA          
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 71.1 bits (175), Expect = 1e-15
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 2/93 (2%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHR 101
             IV +    HT   L  + + ++  DL  +L   G   N   ++ +  +++ GL + HR
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           + +++RDLKP N+L++E G ++++D GLA   S
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKS 151

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 71.3 bits (175), Expect = 1e-15
 Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 3/108 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +D P I+ +   F        + ++  GG+L   +     F+E +      +V+ G+ 
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGIT 140

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASV 142
           +MH+  IV+RDLKP N+LL    +  ++RI D GL+  F   K     
Sbjct: 141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 188

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 70.9 bits (174), Expect = 1e-15
 Identities = 20/97 (20%), Positives = 36/97 (37%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
             P  +     +        +++   G              E E+       + GL ++H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
              +++RD+K  NILL E G V++ D G A   +   
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 208

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 70.9 bits (174), Expect = 1e-15
 Identities = 30/104 (28%), Positives = 42/104 (40%), Gaps = 9/104 (8%)

Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY 103
           FI        +  +L  I D    G L+ +L      +   M   A   + GL H+H   
Sbjct: 96  FIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 104 --------IVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
                   I +RDLK  NIL+ ++G   I+DLGLA  F      
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 70.9 bits (174), Expect = 1e-15
 Identities = 24/104 (23%), Positives = 48/104 (46%), Gaps = 14/104 (13%)

Query: 38  QMVDCPFIVCMTY--------AFHTPDKLCFILDLMNGG---DLHYHLSQHGVFNEDEMR 86
           +      I   TY             D+L  +++    G   DL    ++     E+ + 
Sbjct: 76  KYSHHRNIA--TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL-IKNTKGNTLKEEWIA 132

Query: 87  FYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +   E++ GL H+H+  +++RD+K  N+LL E+  V++ D G++
Sbjct: 133 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 70.5 bits (173), Expect = 1e-15
 Identities = 25/93 (26%), Positives = 46/93 (49%), Gaps = 5/93 (5%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGG---DLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           D P +V    ++     L  +++    G   D+     ++    EDE+       + GLE
Sbjct: 82  DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLE 139

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           ++H    ++RD+K  NILL+  GH +++D G+A
Sbjct: 140 YLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA 172

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 70.7 bits (173), Expect = 2e-15
 Identities = 27/143 (18%), Positives = 53/143 (37%), Gaps = 17/143 (11%)

Query: 5   VGTGFLSNCS-----HVKQGETLAL-------NERIMLSLVSTGIQM---VDCPFIVCMT 49
           +G GF    +     +   GE + +           M++ +   + +    + P IV   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 50  YAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYR 107
             F   ++L  +   M  G              NE  + +    V+  L+++H    V+R
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHR 152

Query: 108 DLKPANILLDEHGHVRISDLGLA 130
            +K ++IL+   G V +S L   
Sbjct: 153 SVKASHILISVDGKVYLSGLRSN 175

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 70.4 bits (173), Expect = 2e-15
 Identities = 22/78 (28%), Positives = 41/78 (52%), Gaps = 1/78 (1%)

Query: 55  PDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
             +L FI + + GG L   + S    +   +   +A ++  G+ ++H   I++RDL   N
Sbjct: 79  DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN 138

Query: 114 ILLDEHGHVRISDLGLAC 131
            L+ E+ +V ++D GLA 
Sbjct: 139 CLVRENKNVVVADFGLAR 156

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 70.3 bits (173), Expect = 2e-15
 Identities = 25/96 (26%), Positives = 52/96 (54%), Gaps = 3/96 (3%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +    IV +   + +      ++ L++GG+L   + + GV+ E +      +V+  ++
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVK 120

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLA 130
           ++H   IV+RDLKP N+L    +E+  + I+D GL+
Sbjct: 121 YLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 70.9 bits (174), Expect = 2e-15
 Identities = 29/105 (27%), Positives = 52/105 (49%), Gaps = 4/105 (3%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P I+ +   F        + +   GG+L   +     F+E +      +++ G+ ++H+ 
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH 165

Query: 103 YIVYRDLKPANILL---DEHGHVRISDLGLACDFSK-KKPHASVG 143
            IV+RD+KP NILL   +   +++I D GL+  FSK  K    +G
Sbjct: 166 NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 70.4 bits (173), Expect = 2e-15
 Identities = 23/106 (21%), Positives = 49/106 (46%), Gaps = 5/106 (4%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFNEDEMRFYAAEVILG 95
               CP ++ +   +    ++  IL+   GG++          + +E+++     +++ G
Sbjct: 84  LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG 143

Query: 96  LEHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP 138
           + ++H+  IV+ DLKP NILL      G ++I D G++        
Sbjct: 144 VYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 70.3 bits (173), Expect = 2e-15
 Identities = 27/98 (27%), Positives = 51/98 (52%), Gaps = 7/98 (7%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV------FNEDEMRFYAAEVILGL 96
             IV +    HT +KL  + + M+  DL  ++    V         + ++++  +++ GL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
              H   I++RDLKP N+L+++ G +++ D GLA  F 
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 70.0 bits (172), Expect = 2e-15
 Identities = 24/93 (25%), Positives = 49/93 (52%), Gaps = 5/93 (5%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGG---DLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           D P+IV +  A++   KL  +++   GG    +   L       E +++    +++  L 
Sbjct: 74  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALN 131

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            +H + I++RDLK  N+L+   G +R++D G++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 69.6 bits (171), Expect = 3e-15
 Identities = 28/99 (28%), Positives = 53/99 (53%), Gaps = 8/99 (8%)

Query: 38  QMVDCPFIVCMTY--AFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEM--RFYAAEV 92
           + +    IV   Y  +F     +   ++ + GG L   L S+ G   ++E    FY  ++
Sbjct: 74  KHLKHKNIV--QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLA 130
           + GL+++H   IV+RD+K  N+L++ + G ++ISD G +
Sbjct: 132 LEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS 170

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 70.1 bits (172), Expect = 3e-15
 Identities = 30/110 (27%), Positives = 56/110 (50%), Gaps = 4/110 (3%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           +++D P I+ +   F        +++   GG+L   +     FNE +      +V+ G+ 
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVT 150

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP-HASVG 143
           ++H+  IV+RDLKP N+LL   ++   ++I D GL+  F  +K     +G
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG 200

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 69.7 bits (171), Expect = 4e-15
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 3/104 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGL 96
             +  P ++ +  AF    ++  IL+ ++GG+L   ++      +E E+  Y  +   GL
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 162

Query: 97  EHMHRRYIVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKP 138
           +HMH   IV+ D+KP NI+    +   V+I D GLA   +  + 
Sbjct: 163 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 69.5 bits (171), Expect = 4e-15
 Identities = 18/89 (20%), Positives = 42/89 (47%), Gaps = 2/89 (2%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHR 101
           P +V +   F    +L  + +  +   + + L ++     E  ++    + +  +   H+
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
              ++RD+KP NIL+ +H  +++ D G A
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFA 149

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 70.0 bits (172), Expect = 4e-15
 Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 3/99 (3%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           +++  P IV +  +         I DL+ GG+L   +     ++E +      +++  + 
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 124

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDF 133
           H H+  +V+R+LKP N+LL    +   V+++D GLA + 
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 69.7 bits (171), Expect = 5e-15
 Identities = 30/110 (27%), Positives = 53/110 (48%), Gaps = 4/110 (3%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +D P I+ +            + +L  GG+L   + +   F+E +      +V  G+ 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP-HASVG 143
           +MH+  IV+RDLKP NILL   ++   ++I D GL+  F +       +G
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 69.4 bits (170), Expect = 5e-15
 Identities = 25/132 (18%), Positives = 51/132 (38%), Gaps = 8/132 (6%)

Query: 17  KQGETLALNE-RIMLSLVSTG--IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY- 72
           ++     + E   M  L      +Q       +    +     +   + +L  G  + + 
Sbjct: 66  EEKNRAIIQEVCFMKKLSGHPNIVQFCSA-ASIGKEESDTGQAEFLLLTELCKGQLVEFL 124

Query: 73  -HLSQHGVFNEDEMRFYAAEVILGLEHMHRR--YIVYRDLKPANILLDEHGHVRISDLGL 129
             +   G  + D +     +    ++HMHR+   I++RDLK  N+LL   G +++ D G 
Sbjct: 125 KKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184

Query: 130 ACDFSKKKPHAS 141
           A   S    ++ 
Sbjct: 185 ATTISHYPDYSW 196

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 68.8 bits (169), Expect = 5e-15
 Identities = 29/104 (27%), Positives = 51/104 (49%), Gaps = 3/104 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +D P I+ +            + +L  GG+L   + +   F+E +      +V  G+ 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP 138
           +MH+  IV+RDLKP NILL   ++   ++I D GL+  F +   
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 68.8 bits (169), Expect = 6e-15
 Identities = 21/104 (20%), Positives = 45/104 (43%), Gaps = 3/104 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FNEDEMRFYAAEVILGL 96
            +     I+ +  +F + ++L  I + ++G D+   ++      NE E+  Y  +V   L
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 97  EHMHRRYIVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKP 138
           + +H   I + D++P NI+        ++I + G A        
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 68.4 bits (168), Expect = 9e-15
 Identities = 19/89 (21%), Positives = 40/89 (44%), Gaps = 2/89 (2%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHR 101
             +V +        +   + + ++   +   L       +   ++ Y  ++I G+   H 
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
             I++RD+KP NIL+ + G V++ D G A
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFA 171

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 68.5 bits (168), Expect = 1e-14
 Identities = 26/96 (27%), Positives = 52/96 (54%), Gaps = 3/96 (3%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
             +  P I+ +   F TP ++  +L+L+ GG+L   + + G ++E +      +++  + 
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVA 162

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLA 130
           ++H   IV+RDLKP N+L         ++I+D GL+
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 67.7 bits (166), Expect = 1e-14
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 8/98 (8%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGG---DL-----HYHLSQHGVFNEDEMRFYAAEV 92
             P IV    +F   D+L  ++ L++GG   D+          + GV +E  +     EV
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + GLE++H+   ++RD+K  NILL E G V+I+D G++
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 67.3 bits (165), Expect = 1e-14
 Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 6/87 (6%)

Query: 55  PDKLCFILDLMNGGDLHYHLSQHGVFNEDE---MRFYAAEVILGLEHMHRR--YIVYRDL 109
                 I   M  G L+  L +   F  D+   ++F A ++  G+  +H     I    L
Sbjct: 81  APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF-ALDMARGMAFLHTLEPLIPRHAL 139

Query: 110 KPANILLDEHGHVRISDLGLACDFSKK 136
              ++++DE    RIS   +   F   
Sbjct: 140 NSRSVMIDEDMTARISMADVKFSFQSP 166

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 67.8 bits (166), Expect = 2e-14
 Identities = 27/108 (25%), Positives = 39/108 (36%), Gaps = 11/108 (10%)

Query: 44  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY 103
           FI            L  I      G L   L  + V + +E+   A  +  GL ++H   
Sbjct: 83  FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDI 141

Query: 104 ----------IVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
                     I +RD+K  N+LL  +    I+D GLA  F   K    
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 67.9 bits (166), Expect = 2e-14
 Identities = 24/143 (16%), Positives = 49/143 (34%), Gaps = 42/143 (29%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG------------------- 78
           + +  P I  +   +     +C +++L +GG L   L+                      
Sbjct: 83  KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 79  ---------------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL- 116
                                V  E  +     ++   L ++H + I +RD+KP N L  
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS 202

Query: 117 -DEHGHVRISDLGLACDFSKKKP 138
            ++   +++ D GL+ +F K   
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNN 225

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 67.3 bits (165), Expect = 2e-14
 Identities = 27/90 (30%), Positives = 46/90 (51%), Gaps = 15/90 (16%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH 100
           DC ++V M Y              + G  L  ++  HG  + D    +  +++ G++H H
Sbjct: 84  DCYYLV-MEY--------------IEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128

Query: 101 RRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              IV+RD+KP NIL+D +  ++I D G+A
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIA 158

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 66.5 bits (163), Expect = 3e-14
 Identities = 26/108 (24%), Positives = 48/108 (44%), Gaps = 3/108 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +D P I+ +   F     +  +++L  GG+L   +    VF E +      +V+  + 
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA 120

Query: 98  HMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASV 142
           + H+  + +RDLKP N L         +++ D GLA  F   K   + 
Sbjct: 121 YCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 66.6 bits (163), Expect = 5e-14
 Identities = 24/99 (24%), Positives = 50/99 (50%), Gaps = 3/99 (3%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHR 101
             ++ +  AF + + +  +++ ++GG+L   +        E +   +  ++  G+ HMH+
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 102 RYIVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKP 138
            YI++ DLKP NIL        ++I D GLA  +  ++ 
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 66.1 bits (162), Expect = 7e-14
 Identities = 18/67 (26%), Positives = 31/67 (46%)

Query: 64  LMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR 123
            ++G  L   +   G           A+    L   H+  I++RD+KPANI++     V+
Sbjct: 97  YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156

Query: 124 ISDLGLA 130
           + D G+A
Sbjct: 157 VMDFGIA 163

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 66.1 bits (162), Expect = 7e-14
 Identities = 27/91 (29%), Positives = 47/91 (51%), Gaps = 3/91 (3%)

Query: 46  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRY 103
           VC T       K+  + + ++  DL  +L +        + ++    + + GL+ +H   
Sbjct: 82  VCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC 140

Query: 104 IVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           IV+RDLKP NIL+   G V+++D GLA  +S
Sbjct: 141 IVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 66.0 bits (161), Expect = 7e-14
 Identities = 23/104 (22%), Positives = 37/104 (35%), Gaps = 10/104 (9%)

Query: 47  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH------ 100
                     +   +++    G L  +LS H        R  A  V  GL ++H      
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSVTRGLAYLHTELPRG 134

Query: 101 ---RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
              +  I +RDL   N+L+   G   ISD GL+   +  +    
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 65.7 bits (161), Expect = 1e-13
 Identities = 25/91 (27%), Positives = 47/91 (51%), Gaps = 3/91 (3%)

Query: 46  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRY 103
           VC         KL  + + ++  DL  +L +        + ++    +++ GL+ +H   
Sbjct: 82  VCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR 140

Query: 104 IVYRDLKPANILLDEHGHVRISDLGLACDFS 134
           +V+RDLKP NIL+   G ++++D GLA  +S
Sbjct: 141 VVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 65.4 bits (160), Expect = 1e-13
 Identities = 24/105 (22%), Positives = 49/105 (46%), Gaps = 7/105 (6%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG----VFNEDEMRFYAAEVI 93
            M+  P IV +   + +   L  + + M+G DL + + +      V++E     Y  +++
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 94  LGLEHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSK 135
             L + H   I++RD+KP  +LL   +    V++   G+A    +
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 65.2 bits (159), Expect = 2e-13
 Identities = 26/121 (21%), Positives = 43/121 (35%), Gaps = 15/121 (12%)

Query: 17  KQGETLALNE-RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
            +  + A  E +++        +  + P ++               ++L     L  ++ 
Sbjct: 58  PECFSFADREVQLL-------RESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE 109

Query: 76  QHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH-----VRISDLGL 129
           Q        E      +   GL H+H   IV+RDLKP NIL+            ISD GL
Sbjct: 110 QKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169

Query: 130 A 130
            
Sbjct: 170 C 170

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 64.6 bits (158), Expect = 2e-13
 Identities = 25/108 (23%), Positives = 50/108 (46%), Gaps = 7/108 (6%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL----HYHLSQHGVFNEDEMRFYAAEVI 93
           + +D P I+ +   F     +  +++   GG+L        ++    +E  +     +++
Sbjct: 75  KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134

Query: 94  LGLEHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP 138
             L + H +++V++DLKP NIL      H  ++I D GLA  F   + 
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 63.9 bits (156), Expect = 4e-13
 Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 9/101 (8%)

Query: 39  MVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRF---YAAEVILG 95
            V+ P IV   Y     + +C +++   GG L+  L                +  +   G
Sbjct: 57  RVNHPNIV-KLYGACL-NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114

Query: 96  LEHMHRRY---IVYRDLKPANILLDEHG-HVRISDLGLACD 132
           + ++H      +++RDLKP N+LL   G  ++I D G ACD
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 63.4 bits (155), Expect = 4e-13
 Identities = 26/109 (23%), Positives = 53/109 (48%), Gaps = 17/109 (15%)

Query: 46  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR--- 102
           VC+         LC +++   GG L+  LS   +  +  + + A ++  G+ ++H     
Sbjct: 74  VCLK-----EPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW-AVQIARGMNYLHDEAIV 127

Query: 103 YIVYRDLKPANILLDEHGH--------VRISDLGLACDFSKKKPHASVG 143
            I++RDLK +NIL+ +           ++I+D GLA ++ +    ++ G
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAG 176

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 64.0 bits (156), Expect = 5e-13
 Identities = 30/135 (22%), Positives = 51/135 (37%), Gaps = 29/135 (21%)

Query: 17  KQGETLALNE-RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 75
                +AL E +++        +  D P ++    +  T   L   L+L    +L   + 
Sbjct: 49  IDFCDIALMEIKLL-------TESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVE 100

Query: 76  QHGVFNEDEMRFYAAE-------VILGLEHMHRRYIVYRDLKPANILLD----------- 117
              V +E+               +  G+ H+H   I++RDLKP NIL+            
Sbjct: 101 SKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160

Query: 118 --EHGHVRISDLGLA 130
             E+  + ISD GL 
Sbjct: 161 GAENLRILISDFGLC 175

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 63.5 bits (155), Expect = 6e-13
 Identities = 26/102 (25%), Positives = 47/102 (46%), Gaps = 9/102 (8%)

Query: 38  QMVDCPFIVCMTYAF----HTPDKLCFILDLMNGGDLHYHLSQ--HGVFNEDEMRFYAAE 91
           Q    P IVC+   +    H    L  I++ M GG+L   + +     F E E      +
Sbjct: 77  QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD 136

Query: 92  VILGLEHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLA 130
           +   ++ +H   I +RD+KP N+L    ++   ++++D G A
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 63.0 bits (154), Expect = 9e-13
 Identities = 23/63 (36%), Positives = 38/63 (60%), Gaps = 1/63 (1%)

Query: 69  DLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDL 127
           DL   LS   V F   E++     ++ GL ++HR  I++RD+K AN+L+   G ++++D 
Sbjct: 109 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 168

Query: 128 GLA 130
           GLA
Sbjct: 169 GLA 171

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 62.7 bits (153), Expect = 9e-13
 Identities = 19/67 (28%), Positives = 29/67 (43%)

Query: 64  LMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR 123
           L+NG DL   L + G            ++   L+  H     +RD+KP NIL+       
Sbjct: 115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAY 174

Query: 124 ISDLGLA 130
           + D G+A
Sbjct: 175 LVDFGIA 181

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 63.2 bits (154), Expect = 1e-12
 Identities = 23/110 (20%), Positives = 48/110 (43%), Gaps = 9/110 (8%)

Query: 38  QMVDCPFIVCMTYAFHT----PDKLCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAE 91
           +   CP IV +   +         L  +++ ++GG+L   +   G   F E E       
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 169

Query: 92  VILGLEHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP 138
           +   ++++H   I +RD+KP N+L      +  ++++D G A + +    
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 63.0 bits (153), Expect = 1e-12
 Identities = 17/43 (39%), Positives = 26/43 (60%), Gaps = 1/43 (2%)

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           Y  E++  L ++H   +VY DLKP NI+L E   +++ DLG  
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAV 228

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 61.6 bits (150), Expect = 2e-12
 Identities = 19/89 (21%), Positives = 38/89 (42%), Gaps = 8/89 (8%)

Query: 56  DKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEHMHRR--YIVYRDLKPA 112
           +    +++ +  GDL++ L  +              ++ LG+E+M  +   IV+RDL+  
Sbjct: 94  NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSP 153

Query: 113 NILLDEHG-----HVRISDLGLACDFSKK 136
           NI L           +++D GL+      
Sbjct: 154 NIFLQSLDENAPVCAKVADFGLSQQSVHS 182

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 60.1 bits (146), Expect = 9e-12
 Identities = 24/112 (21%), Positives = 49/112 (43%), Gaps = 12/112 (10%)

Query: 38  QMVDCPFIVCMTYAFHTPD------KLCFILDLMNGGDLH----YHLSQHGVFNEDEMRF 87
           + +D   IV + Y F++         L  +LD +    ++    ++           ++ 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKP 138
           Y  ++   L ++H   I +RD+KP N+LLD     +++ D G A    + +P
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 60.2 bits (146), Expect = 1e-11
 Identities = 20/79 (25%), Positives = 40/79 (50%), Gaps = 7/79 (8%)

Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL---- 116
           I+        +    +        ++    +++ G+ ++H  ++++RDLKPANIL+    
Sbjct: 109 IIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG 165

Query: 117 DEHGHVRISDLGLACDFSK 135
            E G V+I+D+G A  F+ 
Sbjct: 166 PERGRVKIADMGFARLFNS 184

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 59.8 bits (145), Expect = 1e-11
 Identities = 22/91 (24%), Positives = 43/91 (47%), Gaps = 6/91 (6%)

Query: 45  IVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           +V +       D   F     +L++    D            E  ++     +++G++++
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           H   I++RDLKPAN L+++   V++ D GLA
Sbjct: 173 HSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 59.2 bits (144), Expect = 2e-11
 Identities = 26/138 (18%), Positives = 52/138 (37%), Gaps = 27/138 (19%)

Query: 13  CSHVKQGETLAL----------NE-RIMLSLVSTGIQMVDCPFIVCMTYAFHT----PDK 57
             + +  E  AL           E  +         +   CP IV +   +         
Sbjct: 37  IFNKRTQEKFALKMLQDCPKARREVELHW-------RASQCPHIVRIVDVYENLYAGRKC 89

Query: 58  LCFILDLMNGGDLHYHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           L  +++ ++GG+L   +       F E E       +   ++++H   I +RD+KP N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149

Query: 116 L---DEHGHVRISDLGLA 130
                 +  ++++D G A
Sbjct: 150 YTSKRPNAILKLTDFGFA 167

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 59.7 bits (145), Expect = 2e-11
 Identities = 23/112 (20%), Positives = 50/112 (44%), Gaps = 12/112 (10%)

Query: 38  QMVDCPFIVCMTYAFHTPD------KLCFILDLMNGGDLH----YHLSQHGVFNEDEMRF 87
           ++V  P +V +   F++         L  +L+ +    ++    ++           ++ 
Sbjct: 87  RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKL 145

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKP 138
           Y  +++  L ++H   I +RD+KP N+LLD   G +++ D G A      +P
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 58.8 bits (143), Expect = 2e-11
 Identities = 25/95 (26%), Positives = 46/95 (48%), Gaps = 6/95 (6%)

Query: 39  MVDCPFIVCMTYAFHTPD--KLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +   P I+ +      P       + + +N  D            + ++RFY  E++  L
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKAL 143

Query: 97  EHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLA 130
           ++ H   I++RD+KP N+++D EH  +R+ D GLA
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 58.1 bits (141), Expect = 5e-11
 Identities = 25/92 (27%), Positives = 45/92 (48%), Gaps = 7/92 (7%)

Query: 45  IVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILGLEH 98
           I+ +   F   ++        + +LM   DL   +  Q  V +   ++++   ++LGL  
Sbjct: 91  ILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149

Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +H   +V+RDL P NILL ++  + I D  LA
Sbjct: 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLA 181

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 57.7 bits (140), Expect = 6e-11
 Identities = 25/71 (35%), Positives = 42/71 (59%), Gaps = 2/71 (2%)

Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            ++  M G DL   L +H    ED ++F   +++ GL ++H   I++RDLKP N+ ++E 
Sbjct: 107 LVMPFM-GTDLG-KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 164

Query: 120 GHVRISDLGLA 130
             ++I D GLA
Sbjct: 165 CELKILDFGLA 175

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 57.5 bits (139), Expect = 8e-11
 Identities = 20/71 (28%), Positives = 41/71 (57%), Gaps = 3/71 (4%)

Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            +++LM   +L   +      + + M +   +++ G++H+H   I++RDLKP+NI++   
Sbjct: 144 LVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200

Query: 120 GHVRISDLGLA 130
             ++I D GLA
Sbjct: 201 CTLKILDFGLA 211

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 56.9 bits (138), Expect = 9e-11
 Identities = 22/88 (25%), Positives = 44/88 (50%), Gaps = 1/88 (1%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR 102
           P+IV M       +    ++++   G L+ +L Q+    +  +     +V +G++++   
Sbjct: 78  PYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136

Query: 103 YIVYRDLKPANILLDEHGHVRISDLGLA 130
             V+RDL   N+LL    + +ISD GL+
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLS 164

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 56.6 bits (137), Expect = 2e-10
 Identities = 23/71 (32%), Positives = 45/71 (63%), Gaps = 2/71 (2%)

Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            +  LM G DL+ ++ +     +D ++F   +++ GL+++H   I++RDLKP+N+ ++E 
Sbjct: 111 LVTHLM-GADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 168

Query: 120 GHVRISDLGLA 130
             ++I D GLA
Sbjct: 169 CELKILDFGLA 179

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 56.5 bits (137), Expect = 2e-10
 Identities = 21/71 (29%), Positives = 43/71 (60%), Gaps = 3/71 (4%)

Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            ++  M   DL   +     F+E+++++   +++ GL+++H   +V+RDLKP N+ ++E 
Sbjct: 106 LVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED 162

Query: 120 GHVRISDLGLA 130
             ++I D GLA
Sbjct: 163 CELKILDFGLA 173

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 55.4 bits (134), Expect = 4e-10
 Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 7/101 (6%)

Query: 45  IVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           I+ +      P          + DLM   DL+  L +    + D + ++  +++ GL+++
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 144

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           H   +++RDLKP+N+LL+    ++I D GLA        H 
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 55.6 bits (134), Expect = 4e-10
 Identities = 22/94 (23%), Positives = 44/94 (46%), Gaps = 2/94 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGL 96
           +  D P IV +     T + +  I++L   G+L   L       +   +  YA ++   L
Sbjct: 446 RQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            ++  +  V+RD+   N+L+  +  V++ D GL+
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 55.5 bits (134), Expect = 5e-10
 Identities = 26/91 (28%), Positives = 43/91 (47%), Gaps = 6/91 (6%)

Query: 45  IVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           I+ +       D L F     +L++    DL           E+ ++     ++LG   +
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           H   I++RDLKPAN LL++   V++ D GLA
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 55.0 bits (133), Expect = 6e-10
 Identities = 23/97 (23%), Positives = 46/97 (47%), Gaps = 7/97 (7%)

Query: 38  QMVDCPFIVCM----TYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVI 93
           + +    I+        A      L  +++ +  G L  +L +H      ++  +A ++ 
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAAS--LQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQIC 144

Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            G+ ++H ++ ++RDL   N+LLD    V+I D GLA
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 54.7 bits (132), Expect = 7e-10
 Identities = 20/71 (28%), Positives = 41/71 (57%), Gaps = 3/71 (4%)

Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            +++LM   +L   +      + + M +   +++ G++H+H   I++RDLKP+NI++   
Sbjct: 107 IVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 163

Query: 120 GHVRISDLGLA 130
             ++I D GLA
Sbjct: 164 CTLKILDFGLA 174

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 54.6 bits (132), Expect = 7e-10
 Identities = 23/98 (23%), Positives = 45/98 (45%), Gaps = 7/98 (7%)

Query: 38  QMVDCPFIV----CMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEV 92
           + +    IV        A      L  I++ +  G L  +L +H    +  ++  Y +++
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             G+E++  +  ++RDL   NIL++    V+I D GL 
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 54.5 bits (132), Expect = 7e-10
 Identities = 22/91 (24%), Positives = 43/91 (47%), Gaps = 2/91 (2%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHM 99
           D P IV +     T + +  I++L   G+L   L       +   +  YA ++   L ++
Sbjct: 74  DHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             +  V+RD+   N+L+  +  V++ D GL+
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 54.3 bits (131), Expect = 9e-10
 Identities = 23/98 (23%), Positives = 45/98 (45%), Gaps = 7/98 (7%)

Query: 38  QMVDCPFIV----CMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEV 92
           + +    IV        A      L  I++ +  G L  +L +H    +  ++  Y +++
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             G+E++  +  ++RDL   NIL++    V+I D GL 
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 54.2 bits (131), Expect = 1e-09
 Identities = 23/98 (23%), Positives = 44/98 (44%), Gaps = 7/98 (7%)

Query: 38  QMVDCPFIVCM----TYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEV 92
           + +    IV      T        +  I++ +  G L  +L ++    N  +   YA ++
Sbjct: 78  RNLYHENIVKYKGICTEDGGNG--IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             G++++  R  V+RDL   N+L++    V+I D GL 
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 54.1 bits (131), Expect = 1e-09
 Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 8/81 (9%)

Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNED-----EMRFY-AAEVILGLEHMHRRYIVYRDL 109
           +++  I   M  G+L  HL  +G          E R         GL ++H R I++RD+
Sbjct: 108 NEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDV 165

Query: 110 KPANILLDEHGHVRISDLGLA 130
           K  NILLDE+   +I+D G++
Sbjct: 166 KSINILLDENFVPKITDFGIS 186

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 54.1 bits (131), Expect = 1e-09
 Identities = 27/100 (27%), Positives = 38/100 (38%), Gaps = 17/100 (17%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHGVFNED-----EMRFY----AAEVILGLEHMH---R 101
           TP +   +   M  G +   L                R      +A    GL ++H    
Sbjct: 98  TPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKRQRIALGSAR---GLAYLHDHCD 152

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
             I++RD+K ANILLDE     + D GLA     K  H +
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 54.1 bits (131), Expect = 1e-09
 Identities = 27/83 (32%), Positives = 38/83 (45%), Gaps = 13/83 (15%)

Query: 56  DKLCFILDLMNGGDLHYHLSQHGVFNED----EMRFYAAEVIL----GLEHMHRRYIVYR 107
           D LC +   M  G L   L    +         MR    ++      G+  +H  + ++R
Sbjct: 103 DDLCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRC---KIAQGAANGINFLHENHHIHR 157

Query: 108 DLKPANILLDEHGHVRISDLGLA 130
           D+K ANILLDE    +ISD GLA
Sbjct: 158 DIKSANILLDEAFTAKISDFGLA 180

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 53.9 bits (130), Expect = 1e-09
 Identities = 23/110 (20%), Positives = 52/110 (47%), Gaps = 4/110 (3%)

Query: 38  QMVDCPFIVCMTYAFHTPDK--LCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILG 95
           ++     IV +       +   +  + D M   DLH  + +  +      ++   ++I  
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLH-AVIRANILEPVHKQYVVYQLIKV 121

Query: 96  LEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           ++++H   +++RD+KP+NILL+   HV+++D GL+  F   +   +    
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 53.7 bits (130), Expect = 1e-09
 Identities = 24/109 (22%), Positives = 49/109 (44%), Gaps = 11/109 (10%)

Query: 24  LNE-RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFN 81
           ++E  IM +L        D P IV +       +    I++L   G+L ++L ++     
Sbjct: 61  MSEAVIMKNL--------DHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLK 111

Query: 82  EDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              +  Y+ ++   + ++     V+RD+   NIL+     V++ D GL+
Sbjct: 112 VLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 53.8 bits (130), Expect = 2e-09
 Identities = 26/110 (23%), Positives = 47/110 (42%), Gaps = 12/110 (10%)

Query: 24  LNE-RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDK-LCFILDLMNGGDLHYHLSQHG-VF 80
           L E RI+             P IV +     T  + +  +++L+ GGD    L   G   
Sbjct: 160 LQEARILKQY--------SHPNIVRL-IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARL 210

Query: 81  NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
               +     +   G+E++  +  ++RDL   N L+ E   ++ISD G++
Sbjct: 211 RVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 53.8 bits (130), Expect = 2e-09
 Identities = 22/102 (21%), Positives = 50/102 (49%), Gaps = 7/102 (6%)

Query: 45  IVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHM 99
           I+ +           F     I +LM   DLH  +    + ++D ++++  + +  ++ +
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELM-QTDLH-RVISTQMLSDDHIQYFIYQTLRAVKVL 128

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
           H   +++RDLKP+N+L++ +  +++ D GLA    +     S
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 53.0 bits (128), Expect = 3e-09
 Identities = 27/105 (25%), Positives = 44/105 (41%), Gaps = 10/105 (9%)

Query: 27  RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEM 85
             M SL        D   ++ + Y       +  + +L   G L   L +H G F    +
Sbjct: 73  NAMHSL--------DHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL 123

Query: 86  RFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             YA +V  G+ ++  +  ++RDL   N+LL     V+I D GL 
Sbjct: 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 53.1 bits (128), Expect = 3e-09
 Identities = 21/94 (22%), Positives = 41/94 (43%), Gaps = 2/94 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGL 96
             +D   IV +         L  +   +  G L  H+ QH G      +  +  ++  G+
Sbjct: 70  GSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            ++    +V+R+L   N+LL     V+++D G+A
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 52.6 bits (127), Expect = 3e-09
 Identities = 24/94 (25%), Positives = 43/94 (45%), Gaps = 2/94 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGL 96
             VD P +  +         +  I  LM  G L  ++ +H        +  +  ++  G+
Sbjct: 72  ASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            ++  R +V+RDL   N+L+    HV+I+D GLA
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 52.6 bits (126), Expect = 4e-09
 Identities = 24/92 (26%), Positives = 46/92 (50%), Gaps = 3/92 (3%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEH 98
               +V + YA  + + +  + + M+ G L   L           ++   AA++  G+ +
Sbjct: 320 RHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378

Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + R   V+RDL+ ANIL+ E+   +++D GLA
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLA 410

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 52.1 bits (125), Expect = 6e-09
 Identities = 24/92 (26%), Positives = 46/92 (50%), Gaps = 3/92 (3%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEH 98
               +V + YA  + + +  + + M+ G L   L           ++   AA++  G+ +
Sbjct: 237 RHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295

Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + R   V+RDL+ ANIL+ E+   +++D GLA
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLA 327

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 51.9 bits (125), Expect = 7e-09
 Identities = 23/89 (25%), Positives = 43/89 (48%), Gaps = 2/89 (2%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHR 101
           P+IV +       + L  ++++  GG LH  L           +     +V +G++++  
Sbjct: 70  PYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +  V+RDL   N+LL    + +ISD GL+
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLS 157

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 51.6 bits (124), Expect = 8e-09
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 7/98 (7%)

Query: 38  QMVDCPFIVCM----TYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEV 92
           + +   FIV               L  +++ +  G L   L +H    +   +  Y++++
Sbjct: 79  KALHSDFIVKYRGVSYGPGRQS--LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             G+E++  R  V+RDL   NIL++   HV+I+D GLA
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 51.6 bits (124), Expect = 9e-09
 Identities = 19/71 (26%), Positives = 36/71 (50%), Gaps = 1/71 (1%)

Query: 61  ILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
           I + M  G L   L +  G F+  ++      +  G++++     V+RDL   NIL++ +
Sbjct: 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN 183

Query: 120 GHVRISDLGLA 130
              ++SD GL+
Sbjct: 184 LVCKVSDFGLS 194

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 51.6 bits (124), Expect = 9e-09
 Identities = 23/92 (25%), Positives = 42/92 (45%), Gaps = 3/92 (3%)

Query: 41  DCPFIVCMTYAFHTPDK-LCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEH 98
           D P I+ +     T  K +  + + M  G L   L +H   F   ++      +  G+++
Sbjct: 104 DHPNIIRL-EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162

Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +     V+RDL   NIL++ +   ++SD GL 
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 51.7 bits (124), Expect = 1e-08
 Identities = 16/75 (21%), Positives = 39/75 (52%), Gaps = 2/75 (2%)

Query: 58  LCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
              I + M  G+L  +L +      +   + + A ++   +E++ ++  ++R+L   N L
Sbjct: 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350

Query: 116 LDEHGHVRISDLGLA 130
           + E+  V+++D GL+
Sbjct: 351 VGENHLVKVADFGLS 365

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 51.2 bits (123), Expect = 1e-08
 Identities = 24/94 (25%), Positives = 43/94 (45%), Gaps = 2/94 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGL 96
             VD P +  +         +  I  LM  G L  ++ +H        +  +  ++  G+
Sbjct: 72  ASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            ++  R +V+RDL   N+L+    HV+I+D GLA
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 51.1 bits (123), Expect = 1e-08
 Identities = 23/113 (20%), Positives = 50/113 (44%), Gaps = 15/113 (13%)

Query: 43  PFIVCMTYAFHTPDK-------LCFILDLMNGGDLHYHLSQHGVFN----EDEMRFYAAE 91
           P IV +   F+T  +       L  +++ +    LH     +           ++ +  +
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 92  VILGLEHMHRRY--IVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHAS 141
           +I  +  +H     + +RD+KP N+L++E  G +++ D G A   S  +P+ +
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 51.1 bits (123), Expect = 1e-08
 Identities = 20/71 (28%), Positives = 34/71 (47%), Gaps = 1/71 (1%)

Query: 61  ILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
           + + M  G L   L  H G F   ++      V  G+ ++     V+RDL   N+L+D +
Sbjct: 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN 187

Query: 120 GHVRISDLGLA 130
              ++SD GL+
Sbjct: 188 LVCKVSDFGLS 198

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 51.1 bits (122), Expect = 1e-08
 Identities = 22/89 (24%), Positives = 43/89 (48%), Gaps = 2/89 (2%)

Query: 43  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHR 101
           P+IV +       + L  ++++  GG LH  L           +     +V +G++++  
Sbjct: 396 PYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +  V+R+L   N+LL    + +ISD GL+
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLS 483

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 50.9 bits (122), Expect = 2e-08
 Identities = 17/89 (19%), Positives = 38/89 (42%), Gaps = 6/89 (6%)

Query: 58  LCFILDLMNGGDLH----YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPAN 113
           L  I++ +    LH      +        + +  Y  ++   +  +H   I +RD+KP N
Sbjct: 113 LNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171

Query: 114 ILLD-EHGHVRISDLGLACDFSKKKPHAS 141
           +L++ +   +++ D G A      +P  +
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSEPSVA 200

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 50.8 bits (122), Expect = 2e-08
 Identities = 21/77 (27%), Positives = 37/77 (48%), Gaps = 2/77 (2%)

Query: 58  LCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           L  + + M  G L  +L   G  V   D +  ++ +V   +E++     V+RDL   N+L
Sbjct: 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 321

Query: 116 LDEHGHVRISDLGLACD 132
           + E    ++SD GL  +
Sbjct: 322 VSEDNVAKVSDFGLTKE 338

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 50.3 bits (121), Expect = 2e-08
 Identities = 21/71 (29%), Positives = 36/71 (50%), Gaps = 1/71 (1%)

Query: 61  ILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
           +L  M  GDL   +          ++  +  +V  G+E++  +  V+RDL   N +LDE 
Sbjct: 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES 160

Query: 120 GHVRISDLGLA 130
             V+++D GLA
Sbjct: 161 FTVKVADFGLA 171

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 50.0 bits (120), Expect = 3e-08
 Identities = 21/72 (29%), Positives = 42/72 (58%), Gaps = 3/72 (4%)

Query: 60  FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
            + + M   DL  ++ + G   E+  R +  +++ GL+++H   +++RDLKPAN+ ++  
Sbjct: 99  IVQEYM-ETDLA-NVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE 156

Query: 120 G-HVRISDLGLA 130
              ++I D GLA
Sbjct: 157 DLVLKIGDFGLA 168

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 49.9 bits (120), Expect = 3e-08
 Identities = 21/75 (28%), Positives = 36/75 (48%), Gaps = 2/75 (2%)

Query: 58  LCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           L  + + M  G L  +L   G  V   D +  ++ +V   +E++     V+RDL   N+L
Sbjct: 90  LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 149

Query: 116 LDEHGHVRISDLGLA 130
           + E    ++SD GL 
Sbjct: 150 VSEDNVAKVSDFGLT 164

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 49.6 bits (119), Expect = 4e-08
 Identities = 23/105 (21%), Positives = 45/105 (42%), Gaps = 12/105 (11%)

Query: 37  IQMVDCPFIVCMTYAFHTPDK-LCFILDLMNGGDLHYHLSQHGVFNED----------EM 85
           ++  +C  +V +     +  +    I++LM  GDL  +L        +          +M
Sbjct: 82  MKEFNCHHVVRL-LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 86  RFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              A E+  G+ +++    V+RDL   N ++ E   V+I D G+ 
Sbjct: 141 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 49.3 bits (118), Expect = 6e-08
 Identities = 21/83 (25%), Positives = 35/83 (42%), Gaps = 6/83 (7%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHGVFNED------EMRFYAAEVILGLEHMHRRYIVYR 107
                  IL  M  GDLH  L    +           +  +  ++  G+E++  R  ++R
Sbjct: 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHR 161

Query: 108 DLKPANILLDEHGHVRISDLGLA 130
           DL   N +L E   V ++D GL+
Sbjct: 162 DLAARNCMLAEDMTVCVADFGLS 184

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 49.2 bits (118), Expect = 6e-08
 Identities = 17/75 (22%), Positives = 39/75 (52%), Gaps = 2/75 (2%)

Query: 58  LCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
              I + M  G+L  +L +      +   + + A ++   +E++ ++  ++RDL   N L
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143

Query: 116 LDEHGHVRISDLGLA 130
           + E+  V+++D GL+
Sbjct: 144 VGENHLVKVADFGLS 158

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 49.0 bits (117), Expect = 6e-08
 Identities = 5/42 (11%), Positives = 13/42 (30%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              +    +  HR  +      P+ + +   G V ++     
Sbjct: 135 MQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM 176

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 48.7 bits (117), Expect = 6e-08
 Identities = 17/73 (23%), Positives = 33/73 (45%), Gaps = 1/73 (1%)

Query: 61  ILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
           + + ++ G L  +L  HG      ++     +V  G+  +     ++RDL   N L+D  
Sbjct: 81  VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD 140

Query: 120 GHVRISDLGLACD 132
             V++SD G+   
Sbjct: 141 LCVKVSDFGMTRY 153

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 48.9 bits (117), Expect = 7e-08
 Identities = 23/92 (25%), Positives = 44/92 (47%), Gaps = 3/92 (3%)

Query: 41  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEH 98
               +V + +A  T + +  I + M  G L   L           ++  ++A++  G+  
Sbjct: 241 QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299

Query: 99  MHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           + +R  ++RDL+ ANIL+      +I+D GLA
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLA 331

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 48.7 bits (117), Expect = 7e-08
 Identities = 18/74 (24%), Positives = 38/74 (51%), Gaps = 1/74 (1%)

Query: 58  LCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL 116
           +C + + M  G L  +L    G+F  + +     +V  G+ ++    +++RDL   N L+
Sbjct: 78  ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 137

Query: 117 DEHGHVRISDLGLA 130
            E+  +++SD G+ 
Sbjct: 138 GENQVIKVSDFGMT 151

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 48.8 bits (117), Expect = 9e-08
 Identities = 19/71 (26%), Positives = 37/71 (52%), Gaps = 1/71 (1%)

Query: 61  ILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
           I + M  G L  +L +    F   ++     +V   +E++  +  ++RDL   N L+++ 
Sbjct: 97  ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 156

Query: 120 GHVRISDLGLA 130
           G V++SD GL+
Sbjct: 157 GVVKVSDFGLS 167

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 48.4 bits (116), Expect = 9e-08
 Identities = 24/91 (26%), Positives = 42/91 (46%), Gaps = 6/91 (6%)

Query: 46  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED------EMRFYAAEVILGLEHM 99
           VC+  +     K   IL  M  GDLH +L    +           +  +  ++ LG+E++
Sbjct: 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             R  ++RDL   N +L +   V ++D GL+
Sbjct: 164 SNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.6 bits (116), Expect = 1e-07
 Identities = 21/81 (25%), Positives = 39/81 (48%), Gaps = 3/81 (3%)

Query: 61  ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD--E 118
           +++ + G DL     Q+G F +  +      ++  LE++H    V+ D+K AN+LL    
Sbjct: 130 VMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN 188

Query: 119 HGHVRISDLGLACDFSKKKPH 139
              V ++D GL+  +     H
Sbjct: 189 PDQVYLADYGLSYRYCPNGNH 209

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 48.0 bits (115), Expect = 1e-07
 Identities = 20/74 (27%), Positives = 36/74 (48%), Gaps = 1/74 (1%)

Query: 58  LCFILDLMNGGDLHYHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL 116
              +L  M  GDL   +          ++  +  +V  G++++  +  V+RDL   N +L
Sbjct: 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML 161

Query: 117 DEHGHVRISDLGLA 130
           DE   V+++D GLA
Sbjct: 162 DEKFTVKVADFGLA 175

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 47.8 bits (114), Expect = 2e-07
 Identities = 20/71 (28%), Positives = 35/71 (49%), Gaps = 1/71 (1%)

Query: 61  ILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH 119
           +L  M  GDL   +          ++  +  +V  G++ +  +  V+RDL   N +LDE 
Sbjct: 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 228

Query: 120 GHVRISDLGLA 130
             V+++D GLA
Sbjct: 229 FTVKVADFGLA 239

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 47.6 bits (114), Expect = 2e-07
 Identities = 19/93 (20%), Positives = 34/93 (36%), Gaps = 18/93 (19%)

Query: 56  DKLCFILDLMNGGDLHYHLSQH------------------GVFNEDEMRFYAAEVILGLE 97
                I +    GDL   L +                      + +++  ++ +V  G+ 
Sbjct: 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159

Query: 98  HMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            +  +  ++RDL   NILL      +I D GLA
Sbjct: 160 FLASKNCIHRDLAARNILLTHGRITKICDFGLA 192

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 47.3 bits (113), Expect = 3e-07
 Identities = 18/89 (20%), Positives = 39/89 (43%), Gaps = 16/89 (17%)

Query: 58  LCFILDLMNGGDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHR 101
           L  I++  + G+L  +L                         ++     ++  G+E++  
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +  ++RDL   N+L+ E+  ++I+D GLA
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLA 204

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 47.3 bits (113), Expect = 3e-07
 Identities = 19/87 (21%), Positives = 35/87 (40%), Gaps = 14/87 (16%)

Query: 58  LCFILDLMNGGDLHYHLSQHGVFNEDEMRF--------------YAAEVILGLEHMHRRY 103
           +  I +    GDL   L +     E +  F              ++++V  G+  +  + 
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184

Query: 104 IVYRDLKPANILLDEHGHVRISDLGLA 130
            ++RD+   N+LL      +I D GLA
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLA 211

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 46.8 bits (112), Expect = 3e-07
 Identities = 24/109 (22%), Positives = 43/109 (39%), Gaps = 18/109 (16%)

Query: 39  MVDCPFIVCMTYAFHTPDK-LCFILDLMNGGDLHYHLSQH----------------GVFN 81
            +    IV   Y        L  + + M  GDL+  L  H                G   
Sbjct: 73  NLQHEHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 82  EDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             +M   A+++  G+ ++  ++ V+RDL   N L+  +  V+I D G++
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 46.9 bits (112), Expect = 4e-07
 Identities = 24/89 (26%), Positives = 36/89 (40%), Gaps = 16/89 (17%)

Query: 58  LCFILDLMNGGDLHYHLSQHGVFNED----------------EMRFYAAEVILGLEHMHR 101
           L  I++    G+L  +L                          +  Y+ +V  G+E +  
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
           R  ++RDL   NILL E   V+I D GLA
Sbjct: 167 RKCIHRDLAARNILLSEKNVVKICDFGLA 195

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 46.9 bits (112), Expect = 4e-07
 Identities = 25/110 (22%), Positives = 46/110 (41%), Gaps = 17/110 (15%)

Query: 37  IQMVDCPFIVCMTYAFHTPDK-LCFILDLMNGGDLHYHLSQH---------------GVF 80
           + M+    IV   +   T  + L  + + M  GDL+  L  H               G  
Sbjct: 97  LTMLQHQHIVRF-FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155

Query: 81  NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
              ++   A++V  G+ ++   + V+RDL   N L+ +   V+I D G++
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 46.4 bits (111), Expect = 5e-07
 Identities = 22/79 (27%), Positives = 39/79 (49%), Gaps = 2/79 (2%)

Query: 54  TPDKLCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKP 111
           T + +  I + M  G L   L          +++   AA++  G+  +  R  ++RDL+ 
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA 137

Query: 112 ANILLDEHGHVRISDLGLA 130
           ANIL+ +    +I+D GLA
Sbjct: 138 ANILVSDTLSCKIADFGLA 156

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 46.6 bits (111), Expect = 5e-07
 Identities = 18/91 (19%), Positives = 39/91 (42%), Gaps = 16/91 (17%)

Query: 56  DKLCFILDLMNGGDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHM 99
             L  I++  + G+L  +L                         ++     ++  G+E++
Sbjct: 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219

Query: 100 HRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             +  ++RDL   N+L+ E+  ++I+D GLA
Sbjct: 220 ASQKCIHRDLAARNVLVTENNVMKIADFGLA 250

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 46.0 bits (110), Expect = 6e-07
 Identities = 27/107 (25%), Positives = 46/107 (42%), Gaps = 18/107 (16%)

Query: 41  DCPFIVCMTYAFHTPDK-LCFILDLMNGGDLHYHLSQH----------------GVFNED 83
             P +VC+     T D+ L  I    + GDLH  L                         
Sbjct: 70  QHPNVVCL-LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +     A++  G+E++   ++V++DL   N+L+ +  +V+ISDLGL 
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 45.9 bits (109), Expect = 8e-07
 Identities = 11/53 (20%), Positives = 23/53 (43%), Gaps = 2/53 (3%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPH 139
           A  ++  LE +H    V+ ++   NI +  ++   V ++  G A  +     H
Sbjct: 165 ACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 45.5 bits (108), Expect = 1e-06
 Identities = 25/105 (23%), Positives = 54/105 (51%), Gaps = 15/105 (14%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFNEDEMRFYAAEVIL 94
           ++++D  F        H    +  + +++ G +L   +   +H       ++  + +++L
Sbjct: 89  LKLLDH-FNHKGPNGVH----VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 95  GLEHMHRRY-IVYRDLKPANILLDE------HGHVRISDLGLACD 132
           GL++MHRR  I++ D+KP N+L++          ++I+DLG AC 
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 45.3 bits (106), Expect = 1e-06
 Identities = 13/80 (16%), Positives = 27/80 (33%), Gaps = 2/80 (2%)

Query: 52  FHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY-IVYRDLK 110
           F   D+L  +L+   GG     +    + +    +    ++   L          +RDL 
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189

Query: 111 PANILLDEHGHVRISDLGLA 130
             N+LL +    ++      
Sbjct: 190 WGNVLLKKTSLKKLHYTLNG 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 44.8 bits (106), Expect = 2e-06
 Identities = 15/53 (28%), Positives = 28/53 (52%), Gaps = 2/53 (3%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLD--EHGHVRISDLGLACDFSKKKPH 139
           +  ++  LE++H    V+ D+K +N+LL+      V + D GLA  +  +  H
Sbjct: 158 SLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 44.7 bits (106), Expect = 2e-06
 Identities = 21/78 (26%), Positives = 44/78 (56%), Gaps = 5/78 (6%)

Query: 58  LCFILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
           +C   +L+   +L+  + ++    F+   +R +A  ++  L+ +H+  I++ DLKP NIL
Sbjct: 174 ICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENIL 232

Query: 116 LDEHGH--VRISDLGLAC 131
           L + G   +++ D G +C
Sbjct: 233 LKQQGRSGIKVIDFGSSC 250

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 44.7 bits (106), Expect = 2e-06
 Identities = 20/89 (22%), Positives = 40/89 (44%), Gaps = 16/89 (17%)

Query: 58  LCFILDLMNGGDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHR 101
           L  I++  + G+L  +L                      +  ++   A +V  G+E++  
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +  ++RDL   N+L+ E   ++I+D GLA
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLA 238

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 44.2 bits (105), Expect = 3e-06
 Identities = 22/98 (22%), Positives = 37/98 (37%), Gaps = 23/98 (23%)

Query: 56  DKLCFILDLMNGGDLHYHLSQH-----------------------GVFNEDEMRFYAAEV 92
             +  I +    GDL  +L                           V   +++  +A +V
Sbjct: 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
             G+E +  +  V+RDL   N+L+     V+I D GLA
Sbjct: 182 AKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 43.8 bits (104), Expect = 4e-06
 Identities = 21/89 (23%), Positives = 40/89 (44%), Gaps = 16/89 (17%)

Query: 58  LCFILDLMNGGDLHYHLSQHGVFNEDEMRF----------------YAAEVILGLEHMHR 101
           L   ++    G+L   L +  V   D                    +AA+V  G++++ +
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160

Query: 102 RYIVYRDLKPANILLDEHGHVRISDLGLA 130
           +  ++RDL   NIL+ E+   +I+D GL+
Sbjct: 161 KQFIHRDLAARNILVGENYVAKIADFGLS 189

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 43.4 bits (103), Expect = 6e-06
 Identities = 24/118 (20%), Positives = 47/118 (39%), Gaps = 26/118 (22%)

Query: 38  QMVDCPFIVCMTYAFHTPDK-LCFILDLMNGGDLHYHLSQHGVFNEDEMRF--------- 87
           + V+ P ++ + Y   + D  L  I++    G L   L +        +           
Sbjct: 81  KQVNHPHVIKL-YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139

Query: 88  ---------------YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
                          +A ++  G++++    +V+RDL   NIL+ E   ++ISD GL+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.0 bits (101), Expect = 9e-06
 Identities = 19/43 (44%), Positives = 26/43 (60%)

Query: 88  YAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
           Y+ +V  G+E +  R  ++RDL   NILL E   V+I D GLA
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 42.8 bits (101), Expect = 9e-06
 Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 10/83 (12%)

Query: 58  LCFILDLMNGGDLHYHLSQH-------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLK 110
              +L+LM GGDL   L +              ++   A ++  G +++   + ++RD+ 
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208

Query: 111 PANILLDEHGH---VRISDLGLA 130
             N LL   G     +I D G+A
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMA 231

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 42.7 bits (101), Expect = 1e-05
 Identities = 19/83 (22%), Positives = 36/83 (43%), Gaps = 10/83 (12%)

Query: 58  LCFILDLMNGGDLHYHLSQH-------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLK 110
              +++LM GGDL   L +              ++   A ++  G +++   + ++RD+ 
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167

Query: 111 PANILLDEHGH---VRISDLGLA 130
             N LL   G     +I D G+A
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMA 190

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.4 bits (100), Expect = 2e-05
 Identities = 16/47 (34%), Positives = 28/47 (59%), Gaps = 5/47 (10%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGH-----VRISDLGLA 130
           A ++I  +E++H + ++YRD+KP N L+   G+     + I D  LA
Sbjct: 111 AIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 42.3 bits (100), Expect = 2e-05
 Identities = 14/100 (14%), Positives = 35/100 (35%), Gaps = 11/100 (11%)

Query: 41  DCPFIVCMTYAFHTPDK-LCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEH 98
               +V   Y           + + +  G L  +L ++    N       A ++   +  
Sbjct: 70  SHKHLVLN-YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHF 128

Query: 99  MHRRYIVYRDLKPANILLD--------EHGHVRISDLGLA 130
           +    +++ ++   NILL             +++SD G++
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 41.9 bits (99), Expect = 2e-05
 Identities = 23/97 (23%), Positives = 38/97 (39%), Gaps = 24/97 (24%)

Query: 58  LCFILDLMNGGDLHYHLSQH------------------------GVFNEDEMRFYAAEVI 93
           +C + + M  GDL+  L                              +  E    A +V 
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184

Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            G+ ++  R  V+RDL   N L+ E+  V+I+D GL+
Sbjct: 185 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 41.6 bits (98), Expect = 3e-05
 Identities = 17/56 (30%), Positives = 31/56 (55%), Gaps = 5/56 (8%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDF--SKKKPH 139
           A ++I  +E++H +  ++RD+KP N L+    +   V I D GLA  +  ++   H
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 40.8 bits (96), Expect = 5e-05
 Identities = 12/56 (21%), Positives = 29/56 (51%), Gaps = 5/56 (8%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILL----DEHGH-VRISDLGLACDFSKKKPH 139
           A +++  ++ +H + +VYRD+KP N L+     ++ + + + D G+   +      
Sbjct: 112 AKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 40.8 bits (95), Expect = 5e-05
 Identities = 17/54 (31%), Positives = 27/54 (50%), Gaps = 3/54 (5%)

Query: 89  AAEVILGLEHMHRRYIVYRDLKPANILLDEHGH---VRISDLGLACDFSKKKPH 139
           A ++I  +E +H +  ++RD+KP N L+        V I D GLA  +     H
Sbjct: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 39.7 bits (93), Expect = 1e-04
 Identities = 16/61 (26%), Positives = 29/61 (47%), Gaps = 4/61 (6%)

Query: 80  FNEDEMRFYAAEVILGLEHMHRRY--IVYRDLKPANILLDEHGH--VRISDLGLACDFSK 135
            + +  R +A ++   L  +      I++ DLKP NILL       ++I D G +C   +
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213

Query: 136 K 136
           +
Sbjct: 214 R 214

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 38.5 bits (90), Expect = 3e-04
 Identities = 15/66 (22%), Positives = 30/66 (45%)

Query: 80  FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
           F+ ++++ Y  E++  L ++ +  + + DLKP NILLD+    +           KK   
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193

Query: 140 ASVGKS 145
                +
Sbjct: 194 YRTKST 199

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 38.0 bits (88), Expect = 5e-04
 Identities = 16/62 (25%), Positives = 33/62 (53%), Gaps = 4/62 (6%)

Query: 58  LCFILDLMNGGDLHY--HLSQHGVFNEDEMRFYAAEVILGLEHMHRRY-IVYRDLKPANI 114
           +C + +++ G  L      S +       ++    +V+ GL+++H +  I++ D+KP NI
Sbjct: 120 ICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI 178

Query: 115 LL 116
           LL
Sbjct: 179 LL 180

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	145
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.98
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.98
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.97
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.97
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.96
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.96
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.96
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.96
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.96
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.96
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.96
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.96
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.96
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.96
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.96
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.96
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.96
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.96
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.96
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.95
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.95
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.95
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.95
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.95
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.95
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.95
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.95
3bhy_A	283	Death-associated protein kinase 3; death associate	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.95
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.95
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.95
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.95
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.95
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.95
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.95
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.95
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.95
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.95
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.95
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.95
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.95
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.94
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.94
3niz_A	311	Rhodanese family protein; structural genomics, str	99.94
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.94
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.94
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.94
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.94
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.94
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.94
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.94
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.94
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.94
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.94
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.94
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.94
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.94
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.94
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.94
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.94
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.94
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.94
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.94
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.94
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.94
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.94
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.94
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.94
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.94
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.94
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.94
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.94
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.94
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.94
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.94
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.94
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.94
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.94
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.94
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.94
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.94
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.94
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.94
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.94
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.94
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.94
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.94
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.94
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.94
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.94
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.94
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.94
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.94
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.94
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.94
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.94
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.94
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.94
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.94
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.94
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.94
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.94
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.94
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.94
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.93
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.93
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.93
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.93
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.93
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.93
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.93
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.93
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.93
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.93
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.93
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.93
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.93
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.93
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.93
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.93
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.93
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.93
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.93
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.93
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.93
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.93
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.93
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.93
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.93
3uqc_A	286	Probable conserved transmembrane protein; structur	99.93
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.93
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.93
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.93
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.93
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.93
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.93
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.93
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.93
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.93
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.93
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.93
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.93
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.92
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.92
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.92
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.92
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.92
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.92
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.92
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.92
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.92
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.92
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.92
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.92
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.92
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.92
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.92
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.92
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.92
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.92
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.92
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.92
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.92
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.91
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.91
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.91
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.91
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.91
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.91
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.91
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.91
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.9
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.9
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.9
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.9
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.9
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.84
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.63
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.93
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.89
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.3
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.16
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.97
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.93
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.52
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.22
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.73
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.67
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	94.78
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	94.67
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.53
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	91.61
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	91.29
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	91.07
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.59
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	89.04
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	88.15
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	86.95
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.35
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	84.76
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	84.48
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	83.53
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	82.4
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	82.03

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-37  Score=222.61  Aligned_cols=135  Identities=30%  Similarity=0.443  Sum_probs=126.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+|+|.           ...+.++.++++.++||||++++++|++++.+|+|||||++|+|
T Consensus        40 lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L  119 (311)
T 4aw0_A           40 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL  119 (311)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred             EecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCH
Confidence            6999999999999999999999974           23456788889999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++...+.+++..+..++.|++.|+.|+|+++|+||||||+||+++.++.+||+|||+|+.+...
T Consensus       120 ~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          120 LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999998889999999999999999999999999999999999999999999999999999987543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.7e-37  Score=221.17  Aligned_cols=134  Identities=23%  Similarity=0.366  Sum_probs=124.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.||+|.+..+|+.+|+|.        .+.+.+|..+++.++|||||+++++|++++.+|+|||||++|+|.++
T Consensus        82 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~  161 (346)
T 4fih_A           82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI  161 (346)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHH
T ss_pred             eecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHH
Confidence            6999999999999999999999974        34466788889999999999999999999999999999999999998


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +.. ..+++..+..++.|++.|+.|+|+++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       162 l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          162 VTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             HHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             HHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            875 56999999999999999999999999999999999999999999999999999987654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-36  Score=215.31  Aligned_cols=144  Identities=24%  Similarity=0.308  Sum_probs=126.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEc----CCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHT----PDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|.+..+++.+|+|.          ...+.++..+++.++|||||+++++|++    ++.+|+|||||++
T Consensus        34 iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~g  113 (290)
T 3fpq_A           34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS  113 (290)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             EecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCC
Confidence            6999999999999999999999863          3457788889999999999999999975    3568999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEECC-CCCEEEeeeccceecCCCCCccccCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY--IVYRDLKPANILLDE-HGHVRISDLGLACDFSKKKPHASVGK  144 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--iih~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~  144 (145)
                      |+|.+++.....+++..+..++.|++.|+.|+|+++  |+||||||+|||++. ++.+||+|||+|+..........+||
T Consensus       114 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GT  193 (290)
T 3fpq_A          114 GTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT  193 (290)
T ss_dssp             CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSS
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccC
Confidence            999999998889999999999999999999999998  999999999999975 68999999999975544444444566


Q ss_pred             C
Q psy3273         145 S  145 (145)
Q Consensus       145 ~  145 (145)
                      +
T Consensus       194 p  194 (290)
T 3fpq_A          194 P  194 (290)
T ss_dssp             C
T ss_pred             c
Confidence            4

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.2e-37  Score=220.33  Aligned_cols=135  Identities=23%  Similarity=0.296  Sum_probs=123.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG   78 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~   78 (145)
                      .|.|+||.||+|.+..+|+.+|+|...   ...++..+++.++|||||+++++|++++.+|+|||||++|+|.+++...+
T Consensus        66 lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~  145 (336)
T 4g3f_A           66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG  145 (336)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC
Confidence            699999999999999999999998543   23467788999999999999999999999999999999999999999888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC-CEEEeeeccceecCCC
Q psy3273          79 VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG-HVRISDLGLACDFSKK  136 (145)
Q Consensus        79 ~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~  136 (145)
                      .+++..+..++.|++.|+.|+|+++|+||||||+|||++.++ .+||+|||+|+.+..+
T Consensus       146 ~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          146 CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            999999999999999999999999999999999999999876 6999999999877543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.1e-37  Score=221.03  Aligned_cols=135  Identities=25%  Similarity=0.385  Sum_probs=118.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|+||.||+|.+..+++.+|+|.          .+.+.+|..+++.|+|||||+++++|++++.+|+|||||++|+|.
T Consensus        32 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~  111 (350)
T 4b9d_A           32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLF  111 (350)
T ss_dssp             C------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHH
Confidence            6999999999999999999999973          445678888999999999999999999999999999999999999


Q ss_pred             HHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +++...  ..+++..+..++.|++.|+.|+|+++|+||||||+|||++.++.+||+|||+|+.+.+.
T Consensus       112 ~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          112 KRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             HHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            999754  45799999999999999999999999999999999999999999999999999876543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=222.28  Aligned_cols=134  Identities=23%  Similarity=0.366  Sum_probs=124.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.||+|.+..+|+.+|+|.        .+.+.+|..+++.++|||||+++++|++++.+|+|||||++|+|.++
T Consensus       159 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~  238 (423)
T 4fie_A          159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI  238 (423)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHH
T ss_pred             eccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHH
Confidence            6999999999999999999999974        34567888899999999999999999999999999999999999998


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +.. ..+++..+..++.|++.|+.|+|+++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       239 i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          239 VTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             HHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             Hhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            865 56999999999999999999999999999999999999999999999999999987654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.6e-36  Score=211.66  Aligned_cols=142  Identities=26%  Similarity=0.392  Sum_probs=117.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+|+|.           ...+.+|...++.++||||++++++|++++.+|+||||+ +|+|
T Consensus        21 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L   99 (275)
T 3hyh_A           21 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNEL   99 (275)
T ss_dssp             EEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEH
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCH
Confidence            6999999999999999999999973           234677888899999999999999999999999999999 6799


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccc-cCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGK  144 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~  144 (145)
                      .+.+...+.+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+|++|||+|+...+.....+ +||
T Consensus       100 ~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT  174 (275)
T 3hyh_A          100 FDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS  174 (275)
T ss_dssp             HHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeEC
Confidence            99999888999999999999999999999999999999999999999999999999999987665443333 454

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.9e-36  Score=214.08  Aligned_cols=135  Identities=37%  Similarity=0.623  Sum_probs=117.1

Q ss_pred             eeeeeeeEEEEEEEc---ccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHV---KQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.||+|++.   .+++.+|+|..          ..+.++..+++.++||||++++++|++++.+|+|||||++|
T Consensus        32 lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg  111 (304)
T 3ubd_A           32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG  111 (304)
T ss_dssp             EECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTC
T ss_pred             EecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCC
Confidence            699999999999885   36788888632          24566788899999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          69 DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        69 ~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +|.+++...+.+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+|++|||+|+.....
T Consensus       112 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          112 DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            99999998889999999999999999999999999999999999999999999999999999876443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-34  Score=206.19  Aligned_cols=135  Identities=18%  Similarity=0.238  Sum_probs=113.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCC------------EEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD------------KLCF   60 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~------------~~~l   60 (145)
                      .|.|+||.||+|.+..+++.+|+|.         .+.+.++..+++.++|||||+++++|...+            .+|+
T Consensus        13 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~i   92 (299)
T 4g31_A           13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYI   92 (299)
T ss_dssp             EEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEE
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEE
Confidence            6999999999999999999999973         345667888999999999999999997544            4799


Q ss_pred             EEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          61 ILDLMNGGDLHYHLSQHGV---FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        61 v~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +||||++|+|.+++.....   .++..+..++.|++.|+.|+|+++++||||||+||+++.++.+||+|||+|+.+..+
T Consensus        93 vmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~  171 (299)
T 4g31_A           93 QMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  171 (299)
T ss_dssp             EEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC------
T ss_pred             EEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCC
Confidence            9999999999999986544   455668889999999999999999999999999999999999999999999877554

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.5e-34  Score=221.58  Aligned_cols=145  Identities=68%  Similarity=1.136  Sum_probs=129.5

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHH---hhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----------MLS---LVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~---~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +.|.|+||.||+|++..+|+.+|+|...           ...   .+...++.++|||||+++++|++++.+|+||||++
T Consensus       196 ~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~  275 (689)
T 3v5w_A          196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN  275 (689)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCC
Confidence            3799999999999999999999997421           111   22345678899999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccccCCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS  145 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  145 (145)
                      ||+|.+++...+.+++..+..++.|++.|+.|+|+++|+||||||+|||++.++.+||+|||+|+.+........+||+
T Consensus       276 GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp  354 (689)
T 3v5w_A          276 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH  354 (689)
T ss_dssp             SCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCCCSCCSCG
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCCCCCccCCc
Confidence            9999999998889999999999999999999999999999999999999999999999999999988777766667764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.3e-35  Score=207.11  Aligned_cols=135  Identities=21%  Similarity=0.228  Sum_probs=119.0

Q ss_pred             eeeeeeeEEEEEEEcc-----cCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVK-----QGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-----~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.||+|....     +++.||+|.        .+.+.+|.++++.++|||||++++++.+++.+|+|||||++|
T Consensus        21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G  100 (299)
T 4asz_A           21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG  100 (299)
T ss_dssp             EEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             EeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCC
Confidence            6999999999998753     577888863        456778889999999999999999999999999999999999


Q ss_pred             CHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQH-------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++...             ..+++.+...++.|++.|+.|+|+++++||||||+||+++.+..+|++|||+|+....
T Consensus       101 ~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  180 (299)
T 4asz_A          101 DLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS  180 (299)
T ss_dssp             BHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred             cHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCC
Confidence            999999753             3589999999999999999999999999999999999999999999999999986654


Q ss_pred             C
Q psy3273         136 K  136 (145)
Q Consensus       136 ~  136 (145)
                      .
T Consensus       181 ~  181 (299)
T 4asz_A          181 T  181 (299)
T ss_dssp             G
T ss_pred             C
Confidence            4

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.5e-34  Score=206.30  Aligned_cols=135  Identities=21%  Similarity=0.220  Sum_probs=115.1

Q ss_pred             eeeeeeeEEEEEEEc-----ccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHV-----KQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~-----~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.||+|+..     .+++.||+|.        .+.+.+|..+++.++|||||++++++.+++.+|+|||||++|
T Consensus        49 LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G  128 (329)
T 4aoj_A           49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG  128 (329)
T ss_dssp             EEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             EccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            699999999999864     3678888863        456788899999999999999999999999999999999999


Q ss_pred             CHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          69 DLHYHLSQH---------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        69 ~l~~~l~~~---------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +|.+++...               .++++.+...++.|++.|+.|+|+++++||||||+||+++.+..+||+|||+|+.+
T Consensus       129 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~  208 (329)
T 4aoj_A          129 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI  208 (329)
T ss_dssp             BHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             cHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceec
Confidence            999998643               35889999999999999999999999999999999999999999999999999876


Q ss_pred             CCC
Q psy3273         134 SKK  136 (145)
Q Consensus       134 ~~~  136 (145)
                      ...
T Consensus       209 ~~~  211 (329)
T 4aoj_A          209 YST  211 (329)
T ss_dssp             ---
T ss_pred             cCC
Confidence            443

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.5e-34  Score=204.64  Aligned_cols=135  Identities=21%  Similarity=0.290  Sum_probs=119.7

Q ss_pred             eeeeeeeEEEEEEEc-----ccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHV-----KQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|...     .+++.||+|.         .+.+.++..+++.++|||||++++++.+++.+++|||||++
T Consensus        34 lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~  113 (308)
T 4gt4_A           34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSH  113 (308)
T ss_dssp             EEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSS
T ss_pred             eccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCC
Confidence            699999999999853     4667888863         35677888899999999999999999999999999999999


Q ss_pred             CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273          68 GDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus        68 ~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      |+|.+++...                ..+++.+...++.|++.|+.|+|+++++||||||+|||++.+..+|++|||+|+
T Consensus       114 G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar  193 (308)
T 4gt4_A          114 GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR  193 (308)
T ss_dssp             CBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBC
T ss_pred             CcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccce
Confidence            9999999642                348899999999999999999999999999999999999999999999999998


Q ss_pred             ecCCC
Q psy3273         132 DFSKK  136 (145)
Q Consensus       132 ~~~~~  136 (145)
                      .+...
T Consensus       194 ~~~~~  198 (308)
T 4gt4_A          194 EVYAA  198 (308)
T ss_dssp             GGGGG
T ss_pred             eccCC
Confidence            76543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-33  Score=198.70  Aligned_cols=130  Identities=22%  Similarity=0.221  Sum_probs=113.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee----------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|+||.||+|....   .+|+|          ..+.+.++..+++.++|||||++++++. ++.+|+|||||++|+|.
T Consensus        44 iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~  119 (307)
T 3omv_A           44 IGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLY  119 (307)
T ss_dssp             CCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHH
T ss_pred             EeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHH
Confidence            5999999999997643   35553          3456788889999999999999999875 45789999999999999


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++.. ...+++.+...++.|++.|+.|+|+++++||||||+|||++.++.+||+|||+|+....
T Consensus       120 ~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          120 KHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             HHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            99975 45799999999999999999999999999999999999999999999999999986543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-33  Score=203.15  Aligned_cols=133  Identities=22%  Similarity=0.371  Sum_probs=119.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcC------CEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTP------DKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~------~~~~lv~e~~   65 (145)
                      .|.|+||.||+|.+..+|+.+|+|.+          ..+.++..+++.++||||+++++++...      +.+|+|||||
T Consensus        62 lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~  141 (398)
T 4b99_A           62 IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM  141 (398)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECC
T ss_pred             EecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCC
Confidence            69999999999999999999999742          3345688889999999999999998643      5799999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      + |+|.+++...+.+++..+..++.|++.|+.|+|+++++||||||+||+++..+.+|++|||+|+.+..
T Consensus       142 ~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          142 E-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             S-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            6 68999998888999999999999999999999999999999999999999999999999999987643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.98  E-value=1.1e-31  Score=191.48  Aligned_cols=132  Identities=25%  Similarity=0.241  Sum_probs=113.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccCCCCceeEeeEEEEcCC----EEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD----KLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~----~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|+.  +|+.||+|..       ...+.+...+..++||||+++++++..++    .+|+|||||++|+|
T Consensus        11 iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL   88 (303)
T 3hmm_A           11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL   88 (303)
T ss_dssp             EEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred             EeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcH
Confidence            69999999999986  5888999732       12233445567889999999999998653    68999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR--------YIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.. ..+++.....++.|++.|+.|+|++        +++||||||+|||++.++.+||+|||+|+.....
T Consensus        89 ~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  161 (303)
T 3hmm_A           89 FDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             HHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             HHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence            999976 4688899999999999999999987        8999999999999999999999999999876543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.98  E-value=7.1e-32  Score=206.44  Aligned_cols=143  Identities=24%  Similarity=0.416  Sum_probs=127.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.||+|.+..+|+.+|+|.        ...+.++..+++.++||||++++++|++++.+|++||||++|+|.++
T Consensus       165 lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~  244 (573)
T 3uto_A          165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK  244 (573)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHH
T ss_pred             EeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHH
Confidence            6999999999999999999999862        44567788889999999999999999999999999999999999998


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC--CCEEEeeeccceecCCCCCccc-cCC
Q psy3273          74 LSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHAS-VGK  144 (145)
Q Consensus        74 l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~--~~~~l~dfg~~~~~~~~~~~~~-~~~  144 (145)
                      +.. ...+++..+..++.|++.|+.|||+++++||||||+||+++..  +.+||+|||+|+.+.+...... +||
T Consensus       245 i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT  319 (573)
T 3uto_A          245 VADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT  319 (573)
T ss_dssp             HTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSS
T ss_pred             HHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEEC
Confidence            864 4679999999999999999999999999999999999999854  7899999999998876544433 343

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=2.2e-31  Score=193.27  Aligned_cols=135  Identities=24%  Similarity=0.271  Sum_probs=115.8

Q ss_pred             eeeeeeeEEEEEEEcccC-----Ceeeee---------HHHHHHhhhhhcccCCC-CceeEeeEEEEc-CCEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQG-----ETLALN---------ERIMLSLVSTGIQMVDC-PFIVCMTYAFHT-PDKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~-----~~~~~~---------~~~~~~~~~~~~~~l~h-p~i~~~~~~~~~-~~~~~lv~e~~   65 (145)
                      .|.|+||.||+|.....+     +.||+|         +...+.++...++.++| ||||+++++|.. ++.+|+|||||
T Consensus        72 LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~  151 (353)
T 4ase_A           72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC  151 (353)
T ss_dssp             EEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECC
T ss_pred             EecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcC
Confidence            699999999999986544     456664         23456677778888876 999999999875 46799999999


Q ss_pred             CCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecc
Q psy3273          66 NGGDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL  129 (145)
Q Consensus        66 ~~~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~  129 (145)
                      ++|+|.+++...                ..+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+||+|||+
T Consensus       152 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGl  231 (353)
T 4ase_A          152 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL  231 (353)
T ss_dssp             TTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGG
T ss_pred             CCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchh
Confidence            999999999742                2378899999999999999999999999999999999999999999999999


Q ss_pred             ceecCCC
Q psy3273         130 ACDFSKK  136 (145)
Q Consensus       130 ~~~~~~~  136 (145)
                      |+.+..+
T Consensus       232 ar~~~~~  238 (353)
T 4ase_A          232 ARDIYKD  238 (353)
T ss_dssp             GSCTTTC
T ss_pred             hhhcccC
Confidence            9876543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=7.1e-31  Score=191.19  Aligned_cols=131  Identities=19%  Similarity=0.249  Sum_probs=114.5

Q ss_pred             eeeeeeeEEEEEEEc---ccCCeeeeeH------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHV---KQGETLALNE------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~---~~~~~~~~~~------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|+||.||+|.+.   .+++.+|+|.      .....++.+.++.+ +||||++++++|++++.+|+||||+++++|.
T Consensus        29 lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~  108 (361)
T 4f9c_A           29 IGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFL  108 (361)
T ss_dssp             EEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHH
T ss_pred             EecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHH
Confidence            699999999999875   3567888873      23345566667766 7999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-CCEEEeeeccceecCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-~~~~l~dfg~~~~~~~  135 (145)
                      +.+.   .+++.++..++.|++.|+.|+|++||+||||||+||+++.+ +.+|++|||+|+...+
T Consensus       109 ~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A          109 DILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             HHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             HHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            9884   58999999999999999999999999999999999999876 7899999999986543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.97  E-value=1.1e-29  Score=182.84  Aligned_cols=136  Identities=24%  Similarity=0.357  Sum_probs=124.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+|+|.          ...+.++...++.++||||+++++++.+++..|+||||+++++|.
T Consensus        23 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~  102 (328)
T 3fe3_A           23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVF  102 (328)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHH
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHH
Confidence            6899999999999999999999973          233556777888999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      +++...+.+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+..+.
T Consensus       103 ~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A          103 DYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            999888889999999999999999999999999999999999999999999999999998665443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.97  E-value=4.6e-29  Score=181.68  Aligned_cols=136  Identities=24%  Similarity=0.394  Sum_probs=124.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.+..+++.+|+|.              ...+.++...++.++||||++++++|.+++.+|+||||+++
T Consensus        20 LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~g   99 (361)
T 2yab_A           20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSG   99 (361)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCC
Confidence            6899999999999999999999863              24567788889999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC----CEEEeeeccceecCCCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLACDFSKKK  137 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~----~~~l~dfg~~~~~~~~~  137 (145)
                      ++|.+++.....+++..+..++.|++.|+.|+|+.+++|+||+|+||+++..+    .++++|||++..+..+.
T Consensus       100 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~  173 (361)
T 2yab_A          100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV  173 (361)
T ss_dssp             CBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC
Confidence            99999998888899999999999999999999999999999999999998765    79999999998876543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=1.6e-29  Score=188.09  Aligned_cols=135  Identities=27%  Similarity=0.433  Sum_probs=122.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH-----------HHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM-----------LSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+|+|....           +..+...++.++||||++++++|.+++.+|+||||+++|+|
T Consensus        82 LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L  161 (437)
T 4aw2_A           82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL  161 (437)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBH
T ss_pred             EEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcH
Confidence            6999999999999999999999974321           45666677888999999999999999999999999999999


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.. ...+++..+..++.|++.|+.|+|+.+++|+||||+||+++.++.+||+|||+++.+...
T Consensus       162 ~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          162 LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             HHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            999986 567999999999999999999999999999999999999999999999999999876544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.97  E-value=2.2e-29  Score=184.69  Aligned_cols=136  Identities=29%  Similarity=0.528  Sum_probs=124.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||.|.+..+++.+|+|.           ...+.++...++.++||||++++++|.+.+.+|+||||+.+++|
T Consensus        23 LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L  102 (384)
T 4fr4_A           23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL  102 (384)
T ss_dssp             EECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcH
Confidence            6899999999999999999999973           23445677788999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      ..++.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++..+.++|+|||++..+....
T Consensus       103 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A          103 RYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            9999988889999999999999999999999999999999999999999999999999998775443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.96  E-value=6.5e-29  Score=178.07  Aligned_cols=134  Identities=33%  Similarity=0.508  Sum_probs=122.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+|+|.           ...+.++...++.++||||+++++++.+++.+|+||||+++++|
T Consensus        14 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L   93 (318)
T 1fot_A           14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL   93 (318)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCH
Confidence            6999999999999999999999973           22344566678889999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||++.....
T Consensus        94 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           94 FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             HHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999888899999999999999999999999999999999999999999999999999986643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=4.6e-29  Score=181.20  Aligned_cols=132  Identities=32%  Similarity=0.568  Sum_probs=119.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|.+..+++.+|+|..           .....+...++.+ +||||++++++|.+++.+|+||||+++++
T Consensus        31 lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~  110 (353)
T 3txo_A           31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGD  110 (353)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred             EeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCc
Confidence            69999999999999999999999732           2233445556655 79999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |..++.....+++..+..++.|++.|+.|+|+++++|+||||+||+++.++.++|+|||+++..
T Consensus       111 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          111 LMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999988888999999999999999999999999999999999999999999999999999754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=7e-29  Score=179.21  Aligned_cols=132  Identities=36%  Similarity=0.638  Sum_probs=121.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+|+|..           ....++...++.++||||++++++|.+.+.+|+||||+++++|
T Consensus        13 lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L   92 (337)
T 1o6l_A           13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL   92 (337)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcH
Confidence            69999999999999999999999732           2345566778899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ..++.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||+++..
T Consensus        93 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           93 FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            999988888999999999999999999999999999999999999999999999999999764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.96  E-value=1.5e-28  Score=175.00  Aligned_cols=134  Identities=20%  Similarity=0.302  Sum_probs=123.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|+||.||++.+..+++.+++|.        ...+.++...++.++||||+++++++..++..++||||+++++|.++
T Consensus        18 lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   97 (310)
T 3s95_A           18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGI   97 (310)
T ss_dssp             EECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHH
T ss_pred             ecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHH
Confidence            6899999999999999999999873        44566788889999999999999999999999999999999999999


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          74 LSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        74 l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +.. ...+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus        98 l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           98 IKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             HHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             HHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            986 56799999999999999999999999999999999999999999999999999987643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.96  E-value=4.6e-29  Score=183.61  Aligned_cols=132  Identities=30%  Similarity=0.515  Sum_probs=118.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|++..+++.+|+|...           .+..+...++.+ +||||++++++|.+++.+|+||||+++|+
T Consensus        60 LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~  139 (396)
T 4dc2_A           60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD  139 (396)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCc
Confidence            699999999999999999999986422           233444455444 89999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |..++.....+++..+..++.|++.|+.|+|+++++|+||||+||+++.++.++|+|||+++..
T Consensus       140 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          140 LMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            9999988888999999999999999999999999999999999999999999999999999863

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=6.2e-29  Score=176.09  Aligned_cols=134  Identities=22%  Similarity=0.292  Sum_probs=123.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+++|.           ...+.++...++.++||||+++++++..++..|+||||+++++|
T Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L   98 (294)
T 4eqm_A           19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL   98 (294)
T ss_dssp             EEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             EccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCH
Confidence            6899999999999999999999873           24566777888999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++...+.+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus        99 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           99 SEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99998888899999999999999999999999999999999999999999999999999976543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.96  E-value=4.7e-29  Score=184.30  Aligned_cols=134  Identities=28%  Similarity=0.454  Sum_probs=121.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+|+|...           .+.++...++.++||||++++++|.+++.+|+||||+++|+|
T Consensus        77 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L  156 (410)
T 3v8s_A           77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL  156 (410)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred             EEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            699999999999999999999997432           244666778889999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.. ..+++..+..++.|++.|+.|+|+++++|+||||+||+++..+.++|+|||+++.+...
T Consensus       157 ~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          157 VNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             HHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            998875 46899999999999999999999999999999999999999999999999999876544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.96  E-value=1.9e-28  Score=173.82  Aligned_cols=134  Identities=21%  Similarity=0.381  Sum_probs=122.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|+||.||+|.+..+++.+++|.        ...+.++...++.++||||+++++++..++..|+||||+++++|.++
T Consensus        28 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  107 (297)
T 3fxz_A           28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV  107 (297)
T ss_dssp             EEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHH
T ss_pred             eccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHH
Confidence            6999999999999999999999873        34456677778889999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +... .+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+...
T Consensus       108 ~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A          108 VTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             HHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             Hhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            8764 6899999999999999999999999999999999999999999999999999877544

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=1.9e-28  Score=177.72  Aligned_cols=134  Identities=29%  Similarity=0.542  Sum_probs=123.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+++|..           ..+.++...++.++||||+++++++.+++.+|+||||+++++|
T Consensus        49 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L  128 (350)
T 1rdq_E           49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM  128 (350)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             eecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcH
Confidence            68999999999999999999999742           2344566778899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||+++.+..
T Consensus       129 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence            99998878899999999999999999999999999999999999999999999999999987654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.96  E-value=6.7e-29  Score=183.58  Aligned_cols=136  Identities=26%  Similarity=0.396  Sum_probs=122.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+|+|...           .+..+.+.+..++||||++++++|.+++.+|+||||+++|+|
T Consensus        69 lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L  148 (412)
T 2vd5_A           69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL  148 (412)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcH
Confidence            699999999999999999999997432           234566677888999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          71 HYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        71 ~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      .+++... ..+++..+..++.|++.|+.|+|+++++|+||||+||+++..+.++++|||+++.+....
T Consensus       149 ~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             HHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            9999864 479999999999999999999999999999999999999999999999999998775543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.96  E-value=1.9e-28  Score=175.97  Aligned_cols=135  Identities=21%  Similarity=0.349  Sum_probs=123.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|.+..+++.+++|.              ...+.++...++.++||||+++++++..++..++||||+++
T Consensus        19 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   98 (326)
T 2y0a_A           19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG   98 (326)
T ss_dssp             EECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCC
Confidence            6899999999999999999999863              34567788889999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC----CEEEeeeccceecCCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLACDFSKK  136 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~----~~~l~dfg~~~~~~~~  136 (145)
                      ++|.+++.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++..+    .++++|||++..+...
T Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~  171 (326)
T 2y0a_A           99 GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG  171 (326)
T ss_dssp             CBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT
T ss_pred             CCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC
Confidence            99999998878899999999999999999999999999999999999998766    7999999999877543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.4e-28  Score=176.40  Aligned_cols=136  Identities=18%  Similarity=0.304  Sum_probs=123.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|+||.||+|.+..+++.+++|.       ...+.++...++.++||||+++++++.+.+..++||||+++++|.+++
T Consensus        13 lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l   92 (321)
T 1tki_A           13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI   92 (321)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHH
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHH
Confidence            6899999999999999999998863       345677888889999999999999999999999999999999999999


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC--CCCEEEeeeccceecCCCC
Q psy3273          75 SQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE--HGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        75 ~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~--~~~~~l~dfg~~~~~~~~~  137 (145)
                      ... ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++.  +..++++|||++..+..+.
T Consensus        93 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           93 NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             TSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            754 46999999999999999999999999999999999999986  7899999999998775543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=8.5e-29  Score=179.29  Aligned_cols=133  Identities=34%  Similarity=0.583  Sum_probs=118.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|.+..+++.+|+|...           ....+...++.+ +||||+++++++.+++.+|+||||+++|+
T Consensus        25 lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~  104 (345)
T 1xjd_A           25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD  104 (345)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCc
Confidence            699999999999999999999997321           233444445544 99999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |.+++.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||+++...
T Consensus       105 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A          105 LMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999887889999999999999999999999999999999999999999999999999998643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.96  E-value=1.6e-28  Score=177.83  Aligned_cols=132  Identities=30%  Similarity=0.512  Sum_probs=119.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|.+..+++.+|+|..           ..+..+...++.+ +||||++++++|.+++.+|+||||+++++
T Consensus        17 lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~   96 (345)
T 3a8x_A           17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD   96 (345)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             EEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCc
Confidence            69999999999999999999998642           2344555666665 89999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |..++.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||+++..
T Consensus        97 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           97 LMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            9999988788999999999999999999999999999999999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.96  E-value=2.4e-28  Score=177.82  Aligned_cols=136  Identities=21%  Similarity=0.341  Sum_probs=123.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+++|.          ...+.++...++.++||||+++++++..++..|+||||+++++|.
T Consensus        37 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~  116 (362)
T 2bdw_A           37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF  116 (362)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHH
Confidence            6899999999999999999999863          345667788889999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC---CCEEEeeeccceecCCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH---GHVRISDLGLACDFSKKK  137 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~~  137 (145)
                      +.+.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++..   ..++++|||++..+....
T Consensus       117 ~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          117 EDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             HHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            999887889999999999999999999999999999999999999764   459999999998776443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=2.9e-28  Score=181.69  Aligned_cols=135  Identities=22%  Similarity=0.372  Sum_probs=121.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee----------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+++|          +...+.++...++.++||||+++++++.+++..|+||||+++++|.
T Consensus        19 LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~   98 (444)
T 3soa_A           19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF   98 (444)
T ss_dssp             EEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHH
T ss_pred             eccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHH
Confidence            699999999999999999999885          2345677888899999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC---CCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD---EHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~---~~~~~~l~dfg~~~~~~~~  136 (145)
                      +.+.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++   ....++++|||++..+..+
T Consensus        99 ~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           99 EDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             HHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            9999888899999999999999999999999999999999999998   4578999999999876544

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=2.1e-28  Score=176.66  Aligned_cols=134  Identities=27%  Similarity=0.416  Sum_probs=122.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+|+|..           ..+.++...++.++||||+++++++.+++..++||||+ +|+|
T Consensus        17 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l   95 (336)
T 3h4j_B           17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGEL   95 (336)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEH
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcH
Confidence            69999999999999999999999732           24567777889999999999999999999999999999 6799


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++..+.++++|||++.....+
T Consensus        96 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           96 FDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999988788999999999999999999999999999999999999999999999999999866544

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.96  E-value=2.2e-28  Score=183.63  Aligned_cols=136  Identities=25%  Similarity=0.434  Sum_probs=125.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+|+|..           ..+.++...++.++||||+++++++.+++..|+||||+++++|
T Consensus        24 LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L  103 (476)
T 2y94_A           24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGEL  103 (476)
T ss_dssp             EECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEH
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence            68999999999999999999999732           3456777888999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      .+++...+.+++..+..++.|++.|+.|+|+.+++|+||+|+||+++.++.++++|||++..+..+.
T Consensus       104 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A          104 FDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             HHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            9999887889999999999999999999999999999999999999999999999999998776544

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.96  E-value=2.6e-28  Score=178.37  Aligned_cols=132  Identities=38%  Similarity=0.592  Sum_probs=116.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhh-hcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVST-GIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~-~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|++..+++.+|+|...           ....+.. .++.++||||++++++|.+++.+|+||||+++++
T Consensus        46 lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~  125 (373)
T 2r5t_A           46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGE  125 (373)
T ss_dssp             EECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred             EeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCc
Confidence            689999999999999999999987421           1122222 2577899999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |.+++.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++|+|||+++..
T Consensus       126 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          126 LFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            9999988888999999999999999999999999999999999999999999999999999764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=4.1e-28  Score=176.17  Aligned_cols=132  Identities=32%  Similarity=0.535  Sum_probs=119.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|.+..+++.+|+|..           .....+...++.+ +||||++++++|.+++.+|+||||+++++
T Consensus        28 lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~  107 (353)
T 2i0e_A           28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD  107 (353)
T ss_dssp             EEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCc
Confidence            69999999999999999999999742           2234455556665 89999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |.+++...+.+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||++...
T Consensus       108 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A          108 LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999988788999999999999999999999999999999999999999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.96  E-value=4e-28  Score=174.27  Aligned_cols=135  Identities=24%  Similarity=0.411  Sum_probs=120.2

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH-----HHHHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE-----RIMLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .+|.|+||.||+|.+..+++.+|+|.     .....++...++.+. ||||+++++++.+++..|+||||+++++|.+++
T Consensus        18 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   97 (325)
T 3kn6_A           18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI   97 (325)
T ss_dssp             CSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHH
Confidence            37999999999999999999999974     334556666777776 999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC---CEEEeeeccceecCC
Q psy3273          75 SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG---HVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~---~~~l~dfg~~~~~~~  135 (145)
                      .....+++..+..++.|++.++.|+|+++++|+||+|+||+++..+   .++++|||++.....
T Consensus        98 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           98 KKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             HHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            9888899999999999999999999999999999999999997654   799999999986543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.96  E-value=1e-28  Score=177.21  Aligned_cols=133  Identities=22%  Similarity=0.247  Sum_probs=122.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||+|.+..+++.+++|..         ..+.++...++.++||||+++++++..++..|+||||+++++|.+
T Consensus        15 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (323)
T 3tki_A           15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD   94 (323)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGG
T ss_pred             EecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHH
Confidence            69999999999999999999999742         345677778889999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++..+.
T Consensus        95 ~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           95 RIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             GSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            99877789999999999999999999999999999999999999999999999999998654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=4.4e-28  Score=171.21  Aligned_cols=133  Identities=21%  Similarity=0.339  Sum_probs=119.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+++|..          ..+.++...++.++||||+++++++.+++..++||||+++ ++.
T Consensus        10 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~   88 (292)
T 3o0g_A           10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLK   88 (292)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHH
T ss_pred             ecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHH
Confidence            69999999999999999999999742          4556777888999999999999999999999999999976 555


Q ss_pred             HHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLS-QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ..+. ..+.+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus        89 ~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           89 KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            5554 467899999999999999999999999999999999999999999999999999987653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.96  E-value=6.1e-28  Score=174.94  Aligned_cols=135  Identities=21%  Similarity=0.377  Sum_probs=120.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.||+|.+..+++.+|+|.             ...+.++...++.++||||+++++++..++.+|+||||++++
T Consensus        32 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~  111 (351)
T 3c0i_A           32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGA  111 (351)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSC
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCC
Confidence            6899999999999999999999973             344667778889999999999999999999999999999999


Q ss_pred             CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC---CEEEeeeccceecCCC
Q psy3273          69 DLHYHLSQH----GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG---HVRISDLGLACDFSKK  136 (145)
Q Consensus        69 ~l~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~---~~~l~dfg~~~~~~~~  136 (145)
                      +|.+.+...    ..+++..+..++.|++.++.|+|+++++|+||+|+||+++...   .++++|||++..+...
T Consensus       112 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~  186 (351)
T 3c0i_A          112 DLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES  186 (351)
T ss_dssp             BHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTT
T ss_pred             CHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCC
Confidence            998877532    3589999999999999999999999999999999999997654   4999999999877654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.96  E-value=5.4e-28  Score=184.68  Aligned_cols=137  Identities=45%  Similarity=0.741  Sum_probs=123.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+|+|..           ..+.++...++.++||||+++++++.+++.+|+||||+++|+|
T Consensus       192 LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L  271 (576)
T 2acx_A          192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL  271 (576)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            69999999999999999999999742           2345667778899999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCC
Q psy3273          71 HYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  138 (145)
Q Consensus        71 ~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~  138 (145)
                      .+++....  .+++..+..++.|++.|+.|+|+.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus       272 ~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          272 KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             HHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence            99987643  499999999999999999999999999999999999999999999999999988765433

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.96  E-value=1.7e-27  Score=166.87  Aligned_cols=136  Identities=21%  Similarity=0.294  Sum_probs=124.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|+||.||+|.+..+++.+++|.        ...+.++...++.++||||+++++++..++..++||||+++++|.+.
T Consensus        17 lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   96 (277)
T 3f3z_A           17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFER   96 (277)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             EeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHH
Confidence            6899999999999999998888863        35567788888999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE---CCCCCEEEeeeccceecCCCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~---~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      +.....+++..+..++.|++.++.++|+++++|+||+|+||++   +....++++|||++..+....
T Consensus        97 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           97 VVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             HHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            9888889999999999999999999999999999999999999   677899999999998775543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.96  E-value=4e-28  Score=180.79  Aligned_cols=132  Identities=35%  Similarity=0.632  Sum_probs=117.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+|+|..           ..+.++...++.++||||+++++++..++.+|+||||+++++|
T Consensus       156 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L  235 (446)
T 4ejn_A          156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL  235 (446)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBH
T ss_pred             EeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcH
Confidence            69999999999999999999999732           2234566678899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      ..++.....+++..+..++.|++.|+.|+|+ .+++|+||+|+||+++.++.++|+|||+++..
T Consensus       236 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          236 FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            9999888889999999999999999999998 99999999999999999999999999999754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.96  E-value=7.2e-28  Score=169.06  Aligned_cols=135  Identities=22%  Similarity=0.282  Sum_probs=121.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|++|.||+|.+..+++.+++|.           ...+.++...++.++||||+++++++.+++..+++|||+++++|
T Consensus        17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l   96 (279)
T 3fdn_A           17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV   96 (279)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred             EecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcH
Confidence            6899999999999999999999873           23355677788999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+.+.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++......
T Consensus        97 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           97 YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            999988788999999999999999999999999999999999999999999999999998655443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.96  E-value=1.5e-27  Score=175.19  Aligned_cols=136  Identities=24%  Similarity=0.401  Sum_probs=122.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|+||.||+|.+..+++.+++|.        ...+.++...++.++||||+++++++..++..++||||+++++|.++
T Consensus        59 LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~  138 (387)
T 1kob_A           59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR  138 (387)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHH
T ss_pred             EecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHH
Confidence            6899999999999999999998863        34567788889999999999999999999999999999999999998


Q ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC--CCCEEEeeeccceecCCCC
Q psy3273          74 LSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE--HGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        74 l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~--~~~~~l~dfg~~~~~~~~~  137 (145)
                      +... ..+++..+..++.|++.|+.|+|+++++|+||+|+||+++.  ...++++|||++..+....
T Consensus       139 l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          139 IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             TTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            8754 46999999999999999999999999999999999999974  4679999999998776543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.96  E-value=1.5e-27  Score=179.70  Aligned_cols=136  Identities=24%  Similarity=0.370  Sum_probs=120.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+|+|.          ...+.++...++.++||||++++++|..++.+|+||||+++++|.
T Consensus        45 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~  124 (494)
T 3lij_A           45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF  124 (494)
T ss_dssp             EECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred             EecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHH
Confidence            6899999999999999999998863          334567788899999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC---CCEEEeeeccceecCCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH---GHVRISDLGLACDFSKKK  137 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~~  137 (145)
                      +.+.....+++..+..++.|++.++.|+|+++++|+||+|+||+++..   ..++++|||++..+....
T Consensus       125 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          125 DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            999887889999999999999999999999999999999999999754   459999999998776543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=1.7e-27  Score=170.26  Aligned_cols=135  Identities=18%  Similarity=0.235  Sum_probs=118.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCC----------------
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD----------------   56 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~----------------   56 (145)
                      +|.|+||.||+|.+..+++.+|+|.         .+.+.++...++.++||||++++++|...+                
T Consensus        14 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (332)
T 3qd2_B           14 MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDE   93 (332)
T ss_dssp             EECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccc
Confidence            6899999999999999999999973         345678888899999999999999986543                


Q ss_pred             -----------------------------------------EEEEEEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHH
Q psy3273          57 -----------------------------------------KLCFILDLMNGGDLHYHLSQHGV---FNEDEMRFYAAEV   92 (145)
Q Consensus        57 -----------------------------------------~~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~i   92 (145)
                                                               ..+++|||+++++|.+++.....   .++..+..++.|+
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi  173 (332)
T 3qd2_B           94 STDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQI  173 (332)
T ss_dssp             --------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHH
T ss_pred             cccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHH
Confidence                                                     38999999999999999986533   5566788999999


Q ss_pred             HHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          93 ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        93 ~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +.|+.|+|+++++|+||+|+||+++.++.++++|||++..+...
T Consensus       174 ~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  217 (332)
T 3qd2_B          174 AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  217 (332)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred             HHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence            99999999999999999999999999999999999999877654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.96  E-value=1.8e-27  Score=179.66  Aligned_cols=136  Identities=23%  Similarity=0.351  Sum_probs=121.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------------------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------------------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCF   60 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l   60 (145)
                      +|.|+||.||+|.+..+++.+|+|..                     ..+.++...++.++||||+++++++.+++.+|+
T Consensus        44 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  123 (504)
T 3q5i_A           44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL  123 (504)
T ss_dssp             EEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            68999999999999999999988632                     345567778899999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC---CEEEeeeccceecCCCC
Q psy3273          61 ILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG---HVRISDLGLACDFSKKK  137 (145)
Q Consensus        61 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~---~~~l~dfg~~~~~~~~~  137 (145)
                      ||||+++++|.+.+.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++..+   .++++|||++..+..+.
T Consensus       124 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  203 (504)
T 3q5i_A          124 VTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY  203 (504)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC
Confidence            999999999999998878899999999999999999999999999999999999998664   69999999998776543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.96  E-value=1.5e-27  Score=170.67  Aligned_cols=135  Identities=22%  Similarity=0.377  Sum_probs=124.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|.+..+++.+++|.              ...+.++...++.++||||+++++++..++..++|||++++
T Consensus        20 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   99 (321)
T 2a2a_A           20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG   99 (321)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             eeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCC
Confidence            6899999999999999999999863              34567788888999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC----CEEEeeeccceecCCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLACDFSKK  136 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~----~~~l~dfg~~~~~~~~  136 (145)
                      ++|.+++.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++..+    .++++|||++..+..+
T Consensus       100 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~  172 (321)
T 2a2a_A          100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG  172 (321)
T ss_dssp             CBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcc
Confidence            99999998878899999999999999999999999999999999999998776    7999999999877654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.96  E-value=1.5e-27  Score=174.64  Aligned_cols=132  Identities=19%  Similarity=0.195  Sum_probs=121.4

Q ss_pred             eeee--eeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIV--GTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~--~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|  ++|.||+|.+..+++.+|+|.          ...+.++...++.++||||+++++++..++.+|+||||+++++
T Consensus        33 lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  112 (389)
T 3gni_B           33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS  112 (389)
T ss_dssp             EEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             ccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCC
Confidence            6889  999999999999999999973          3455667788899999999999999999999999999999999


Q ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |.+++...  ..+++..+..++.|++.|+.|+|+++++|+||||+||+++.++.++++|||.+...
T Consensus       113 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          113 AKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             HHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             HHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            99999765  66999999999999999999999999999999999999999999999999988654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.96  E-value=1.1e-27  Score=171.09  Aligned_cols=136  Identities=20%  Similarity=0.246  Sum_probs=120.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCC--EEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD--KLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+++|.         ...+.++...++.++||||+++++++...+  ..++||||+++++|
T Consensus        17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L   96 (319)
T 4euu_A           17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL   96 (319)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBH
T ss_pred             ecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCH
Confidence            6899999999999999999999974         234457777889999999999999998765  78999999999999


Q ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE----CCCCCEEEeeeccceecCCCC
Q psy3273          71 HYHLSQHG---VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        71 ~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~----~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      .+++....   .+++..+..++.|++.++.|+|+.+++|+||+|+||++    +....++++|||+++.+....
T Consensus        97 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~  170 (319)
T 4euu_A           97 YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE  170 (319)
T ss_dssp             HHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC
Confidence            99997543   38999999999999999999999999999999999998    667789999999998775544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.96  E-value=3e-28  Score=177.26  Aligned_cols=132  Identities=26%  Similarity=0.323  Sum_probs=118.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|+||.||+|.+..+++.+|+|..       ..+.++...++.++||||+++++++.+++.+|+||||+++++|.+++
T Consensus        28 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  107 (361)
T 3uc3_A           28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI  107 (361)
T ss_dssp             ESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred             eccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHH
Confidence            68999999999999999999999742       34567777788999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCC--EEEeeeccceec
Q psy3273          75 SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH--VRISDLGLACDF  133 (145)
Q Consensus        75 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~--~~l~dfg~~~~~  133 (145)
                      ...+.+++..+..++.|++.|+.|+|+++++|+||+|+||+++....  ++++|||+++..
T Consensus       108 ~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A          108 CNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            88788999999999999999999999999999999999999986654  999999998743

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.95  E-value=4.4e-28  Score=174.75  Aligned_cols=136  Identities=16%  Similarity=0.249  Sum_probs=123.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      +|.|+||.||+|.+..+++.+++|...                .+.++...++.++||||+++++++..++.+++|||++
T Consensus        32 lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  111 (335)
T 3dls_A           32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKH  111 (335)
T ss_dssp             CSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeC
Confidence            688999999999999999999997432                3445777888999999999999999999999999998


Q ss_pred             CCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          66 NGG-DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        66 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      .+| +|.+++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+..+.
T Consensus       112 ~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  184 (335)
T 3dls_A          112 GSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK  184 (335)
T ss_dssp             TTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             CCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCC
Confidence            776 999999888889999999999999999999999999999999999999999999999999998776544

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=1.3e-27  Score=168.05  Aligned_cols=135  Identities=23%  Similarity=0.320  Sum_probs=123.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|++|.||+|.+..+++.+++|..           ..+.++...++.++||||+++++++..++..+++||++++++|
T Consensus        22 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  101 (284)
T 2vgo_A           22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL  101 (284)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcH
Confidence            68999999999999999999988742           3456677788899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.....+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++......
T Consensus       102 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A          102 YKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            999988788999999999999999999999999999999999999999999999999999766543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.95  E-value=1.7e-27  Score=181.15  Aligned_cols=136  Identities=40%  Similarity=0.691  Sum_probs=122.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+|+|..           ..+..+...++.++||||++++++|.+++.+|+||||+++++|
T Consensus       193 LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L  272 (543)
T 3c4z_A          193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI  272 (543)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBH
T ss_pred             EeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCH
Confidence            79999999999999999999999742           2344566778889999999999999999999999999999999


Q ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          71 HYHLSQH----GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        71 ~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      ..++...    ..+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||+++.+....
T Consensus       273 ~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~  343 (543)
T 3c4z_A          273 RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ  343 (543)
T ss_dssp             HHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             HHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence            9998753    369999999999999999999999999999999999999999999999999998776543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.95  E-value=7.6e-28  Score=172.88  Aligned_cols=133  Identities=37%  Similarity=0.641  Sum_probs=115.8

Q ss_pred             eeeeeeeEEEEEEEc---ccCCeeeeeHH------------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHV---KQGETLALNER------------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~---~~~~~~~~~~~------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +|.|+||.||+|.+.   .+++.+|+|..            ..+.++...++.++||||+++++++..++.+|+||||++
T Consensus        25 lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  104 (327)
T 3a62_A           25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLS  104 (327)
T ss_dssp             EEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCT
T ss_pred             EEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCC
Confidence            699999999999986   68888888632            234556777889999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +++|.+++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++....
T Consensus       105 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A          105 GGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            99999999888889999999999999999999999999999999999999999999999999987543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.95  E-value=9.2e-28  Score=175.46  Aligned_cols=134  Identities=16%  Similarity=0.239  Sum_probs=121.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||+|....+++.+|+|.         ...+.++...++.++||||+++++++..++..|+||||+++++|.+
T Consensus       122 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~  201 (377)
T 3cbl_A          122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT  201 (377)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred             eccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHH
Confidence            6899999999999999999999973         2345567788899999999999999999999999999999999999


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          73 HLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++... ..++...+..++.|++.|+.|+|+.+++|+||+|+||+++.++.++++|||+++....
T Consensus       202 ~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          202 FLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             HHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            99764 4589999999999999999999999999999999999999999999999999986543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.95  E-value=1e-27  Score=173.67  Aligned_cols=135  Identities=22%  Similarity=0.395  Sum_probs=113.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS   75 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~   75 (145)
                      +|.|+||.||+|.+..+++.+++|.      ...+.++...++.++||||+++++++..++..++||||+++++|.+++.
T Consensus        61 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  140 (349)
T 2w4o_A           61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV  140 (349)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT
T ss_pred             EeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHH
Confidence            6899999999999999999999863      3345667778889999999999999999999999999999999999998


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC---CCCEEEeeeccceecCCC
Q psy3273          76 QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE---HGHVRISDLGLACDFSKK  136 (145)
Q Consensus        76 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~  136 (145)
                      ....+++..+..++.|++.++.|+|+.+++|+||+|+||+++.   ...++++|||+++.....
T Consensus       141 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          141 EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            8788999999999999999999999999999999999999975   788999999999866443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.95  E-value=1.6e-27  Score=171.10  Aligned_cols=135  Identities=20%  Similarity=0.213  Sum_probs=120.1

Q ss_pred             eeeeeeeEEEEEEEcccCCe---eeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGET---LALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~---~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||++.+..+++.   +++|.         ...+.++...++.++||||+++++++..++..|+||||+++++
T Consensus        57 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  136 (325)
T 3kul_A           57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGS  136 (325)
T ss_dssp             EEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCB
T ss_pred             EEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCc
Confidence            68999999999999876654   77753         3456678888999999999999999999999999999999999


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.+++... ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||+++.+...
T Consensus       137 L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          137 LDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             HHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999754 57999999999999999999999999999999999999999999999999999876543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.95  E-value=1.6e-27  Score=174.07  Aligned_cols=136  Identities=22%  Similarity=0.398  Sum_probs=117.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|+||.||+|.+..+++.+++|.        ...+.++...++.++||||+++++++..++..++||||+++++|.++
T Consensus        97 lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~  176 (373)
T 2x4f_A           97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR  176 (373)
T ss_dssp             CC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHH
T ss_pred             EecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHH
Confidence            6899999999999999999999863        44567788889999999999999999999999999999999999988


Q ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE--CCCCCEEEeeeccceecCCCC
Q psy3273          74 LSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        74 l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~--~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      +... ..+++.....++.|++.++.|+|+.+++|+||+|+||++  +....++++|||+++.+....
T Consensus       177 l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          177 IIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             HHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            8653 468999999999999999999999999999999999998  556789999999998776543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.95  E-value=4.7e-27  Score=168.36  Aligned_cols=134  Identities=24%  Similarity=0.343  Sum_probs=122.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.||+|.+..+|+.+|+|.        .+.+.++...++.++||||+++++++..++..++||||+++++|.++
T Consensus        53 lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~  132 (321)
T 2c30_A           53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI  132 (321)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHH
T ss_pred             eccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHH
Confidence            6899999999999999999999973        34566778889999999999999999999999999999999999998


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +.. ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++..+...
T Consensus       133 l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  194 (321)
T 2c30_A          133 VSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  194 (321)
T ss_dssp             HTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             HHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC
Confidence            764 46899999999999999999999999999999999999999999999999999877544

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=5.9e-27  Score=164.54  Aligned_cols=136  Identities=21%  Similarity=0.344  Sum_probs=122.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|++|.||+|.+..+++.+++|.          ...+.++...++.++||||+++++++..++..+++||++++++|.
T Consensus        14 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   93 (284)
T 3kk8_A           14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF   93 (284)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             hcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHH
Confidence            6899999999999999999999863          244567777888999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCC---EEEeeeccceecCCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH---VRISDLGLACDFSKKK  137 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~---~~l~dfg~~~~~~~~~  137 (145)
                      +.+.....+++..+..++.|++.++.++|+++++|+||+|+||+++....   ++++|||.+.......
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (284)
T 3kk8_A           94 EDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  162 (284)
T ss_dssp             HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence            99988788999999999999999999999999999999999999976544   9999999998765543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.95  E-value=1.2e-27  Score=179.74  Aligned_cols=135  Identities=25%  Similarity=0.376  Sum_probs=123.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+|+|.           ...+.++...++.++||||+++++++..++..|+|||++.+++|
T Consensus        34 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L  113 (484)
T 3nyv_A           34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL  113 (484)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCH
Confidence            6999999999999999999999974           34566788889999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC---CCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD---EHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~---~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+.+.....+++..+..++.|++.++.|+|+++++|+||+|+||+++   ....++++|||++..+...
T Consensus       114 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          114 FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             HHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            99998888899999999999999999999999999999999999994   5678999999999876544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.95  E-value=5.4e-28  Score=172.30  Aligned_cols=134  Identities=17%  Similarity=0.254  Sum_probs=118.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCC----EEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD----KLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~----~~~lv~e~~~   66 (145)
                      .|.|+||.||+|.+..+++.+++|..           ..+.++...++.++||||+++++++...+    ..|+||||++
T Consensus        20 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~   99 (311)
T 3ork_A           20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD   99 (311)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             EccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCC
Confidence            68999999999999999999999732           34567778889999999999999987654    3599999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++|.+++...+.+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus       100 g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A          100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            999999998888899999999999999999999999999999999999999999999999999976543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.95  E-value=6.4e-27  Score=165.32  Aligned_cols=133  Identities=25%  Similarity=0.316  Sum_probs=122.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+++|.           .+.+.++...++.++||||+++++++..++..+++||++++++|
T Consensus        23 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  102 (294)
T 2rku_A           23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL  102 (294)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             EeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCH
Confidence            6899999999999999999988863           34456677788899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++.....+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++....
T Consensus       103 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A          103 LELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            9999887889999999999999999999999999999999999999999999999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.95  E-value=1.5e-27  Score=172.93  Aligned_cols=133  Identities=25%  Similarity=0.396  Sum_probs=122.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||+|.+..+++.+++|.         ...+.++...++.++||||+++++++..++..++||||+++++|.+
T Consensus        41 lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  120 (360)
T 3eqc_A           41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ  120 (360)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred             ecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHH
Confidence            6899999999999999999999863         3456777888999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRR-YIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++.....+++..+..++.|++.++.|+|+. +++|+||+|+||+++.++.++++|||++..+.
T Consensus       121 ~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          121 VLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             HHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            998878899999999999999999999985 99999999999999999999999999986543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.95  E-value=5.3e-27  Score=164.73  Aligned_cols=135  Identities=22%  Similarity=0.392  Sum_probs=122.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|.+..+++.+++|.              ...+.++...++.++||||+++++++..++..+++||++++
T Consensus        13 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   92 (283)
T 3bhy_A           13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSG   92 (283)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             hcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCC
Confidence            6899999999999999999998863              45567788888999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC----CEEEeeeccceecCCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLACDFSKK  136 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~----~~~l~dfg~~~~~~~~  136 (145)
                      ++|.+++.....+++..+..++.|++.++.++|+.+++|+||+|+||+++..+    .++++|||.+..+...
T Consensus        93 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~  165 (283)
T 3bhy_A           93 GELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG  165 (283)
T ss_dssp             CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCC
Confidence            99999998878899999999999999999999999999999999999998766    7999999999876543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=4.6e-27  Score=171.16  Aligned_cols=136  Identities=26%  Similarity=0.449  Sum_probs=123.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      +|.|++|.||+|.+..+|+.+++|.                ...+.++...++.+ +||||+++++++...+..|+||||
T Consensus       102 lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~  181 (365)
T 2y7j_A          102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL  181 (365)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECC
T ss_pred             EecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEe
Confidence            6899999999999999999999973                23455666677777 899999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          65 MNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        65 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      +++++|.+++.....+++..+..++.|++.++.|+|+.|++|+|++|+||+++.++.++++|||++..+....
T Consensus       182 ~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~  254 (365)
T 2y7j_A          182 MRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE  254 (365)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCc
Confidence            9999999999887889999999999999999999999999999999999999999999999999998776543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.95  E-value=6.1e-27  Score=165.14  Aligned_cols=135  Identities=24%  Similarity=0.307  Sum_probs=120.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEc----CCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHT----PDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.+..++..+++|.          ...+.++...++.++||||+++++++..    +..+++||||+++
T Consensus        34 lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~  113 (290)
T 1t4h_A           34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS  113 (290)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCS
T ss_pred             ccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCC
Confidence            6899999999999999999988752          3446677788899999999999999875    3569999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEEC-CCCCEEEeeeccceecCCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY--IVYRDLKPANILLD-EHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--iih~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++|.+++.....+++..+..++.|++.++.|+|+.+  ++|+||+|+||+++ ..+.++++|||++......
T Consensus       114 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~  185 (290)
T 1t4h_A          114 GTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             CCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence            999999988788999999999999999999999999  99999999999997 7789999999999755443

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=5.8e-27  Score=168.63  Aligned_cols=133  Identities=25%  Similarity=0.316  Sum_probs=122.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++.+..+++.+++|.           .+.+.++...++.++||||+++++++..++..|++|||+++++|
T Consensus        49 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  128 (335)
T 2owb_A           49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL  128 (335)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBH
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCH
Confidence            6899999999999999999988863           34456677788899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+.
T Consensus       129 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          129 LELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999887889999999999999999999999999999999999999999999999999998764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=2.7e-27  Score=168.32  Aligned_cols=134  Identities=17%  Similarity=0.287  Sum_probs=122.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|++|.||+|.+..+++.+++|.          ...+.++...++.++||||+++++++..++..++||||+++++|.
T Consensus        11 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~   90 (311)
T 4agu_A           11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLH   90 (311)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHH
T ss_pred             EeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHH
Confidence            6899999999999999999999873          344567778889999999999999999999999999999999998


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .++.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++..+..
T Consensus        91 ~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           91 ELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             HHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             HHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            8888778899999999999999999999999999999999999999999999999999987653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.95  E-value=1.8e-27  Score=178.96  Aligned_cols=135  Identities=24%  Similarity=0.362  Sum_probs=122.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+|+|.          ...+.++...++.++||||+++++++..++.+|+||||+++++|.
T Consensus        30 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~  109 (486)
T 3mwu_A           30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF  109 (486)
T ss_dssp             EECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             EeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHH
Confidence            6899999999999999999999974          234567778889999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC---CCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD---EHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~---~~~~~~l~dfg~~~~~~~~  136 (145)
                      +.+.....+++..+..++.|++.++.|+|+++++|+||+|+||+++   ....++++|||++..+..+
T Consensus       110 ~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A          110 DEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            9998878899999999999999999999999999999999999995   4457999999999766443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.95  E-value=4.5e-27  Score=165.73  Aligned_cols=135  Identities=20%  Similarity=0.289  Sum_probs=118.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||+|.+..+++.+++|.         ...+.++...++.++||||+++++++...+..++||||+++++|.+
T Consensus        30 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  109 (285)
T 3is5_A           30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLE  109 (285)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHH
T ss_pred             eccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHH
Confidence            6899999999999999999998863         3456677888899999999999999999999999999999999999


Q ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC---CCCCEEEeeeccceecCCC
Q psy3273          73 HLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD---EHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        73 ~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~---~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+..    ...+++..+..++.|++.++.++|+.+++|+||+|+||+++   ....++++|||++..+...
T Consensus       110 ~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          110 RIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD  180 (285)
T ss_dssp             HHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred             HHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence            8853    36799999999999999999999999999999999999994   4578999999999765543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=1.1e-27  Score=178.70  Aligned_cols=134  Identities=18%  Similarity=0.254  Sum_probs=111.7

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcC-----CEEEEEEEcc
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTP-----DKLCFILDLM   65 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~   65 (145)
                      .+|.|+||.||+|.+..+++.+|+|.          ...+.++...++.++||||+++++++...     ..+|+|||++
T Consensus        60 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  139 (458)
T 3rp9_A           60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA  139 (458)
T ss_dssp             C-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC
T ss_pred             EeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc
Confidence            36999999999999999999999973          23456777888999999999999999533     5799999988


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                       +++|...+.....+++..+..++.|++.|+.|+|+.+++|+||||+||+++.++.++|+|||+++.+..
T Consensus       140 -~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          140 -DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             -SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             -ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence             569999998888899999999999999999999999999999999999999999999999999987643

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.95  E-value=8.5e-27  Score=164.75  Aligned_cols=136  Identities=24%  Similarity=0.362  Sum_probs=122.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------------HHHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------------IMLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILD   63 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e   63 (145)
                      +|.|++|.||+|.+..+++.+++|..                 ..+.++...++.+. ||||+++++++..++..++|||
T Consensus        25 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  104 (298)
T 1phk_A           25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD  104 (298)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEe
Confidence            68999999999999999999999742                 23445666677774 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          64 LMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        64 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      ++++++|.+++.....+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..+....
T Consensus       105 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  178 (298)
T 1phk_A          105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE  178 (298)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCc
Confidence            99999999999887889999999999999999999999999999999999999999999999999998765443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=6.2e-27  Score=164.12  Aligned_cols=133  Identities=20%  Similarity=0.317  Sum_probs=121.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.||+|.+..+++.+++|..           ..+.++...++.++||||+++++++..++..+++||++++++|
T Consensus        19 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (278)
T 3cok_A           19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM   98 (278)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEH
T ss_pred             ecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcH
Confidence            68999999999999999999999742           3456677788899999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          71 HYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        71 ~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .+++... ..+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++....
T Consensus        99 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           99 NRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             HHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            9999864 669999999999999999999999999999999999999999999999999998764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=3.5e-27  Score=171.49  Aligned_cols=133  Identities=15%  Similarity=0.170  Sum_probs=111.6

Q ss_pred             eeeeeeeEEEEE-----EEcccCCeeeeeH-----HHHHHhhhhhc---ccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNC-----SHVKQGETLALNE-----RIMLSLVSTGI---QMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~-----~~~~~~~~~~~~~-----~~~~~~~~~~~---~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +|.|+||.||+|     .+..+++.+|+|.     ...+..+...+   +...||||+++++++..++..|+||||++++
T Consensus        73 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g  152 (365)
T 3e7e_A           73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYG  152 (365)
T ss_dssp             EEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSC
T ss_pred             eeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCC
Confidence            689999999999     5777889999873     22233333333   4445999999999999999999999999999


Q ss_pred             CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-----------CCCEEEeeecccee
Q psy3273          69 DLHYHLSQ-----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-----------HGHVRISDLGLACD  132 (145)
Q Consensus        69 ~l~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-----------~~~~~l~dfg~~~~  132 (145)
                      +|.+++..     ...+++..+..++.|++.|+.|+|+++++|+||||+||+++.           ...++|+|||+|+.
T Consensus       153 ~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~  232 (365)
T 3e7e_A          153 TLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID  232 (365)
T ss_dssp             BHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEE
T ss_pred             cHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhh
Confidence            99999973     456999999999999999999999999999999999999988           78999999999976


Q ss_pred             cC
Q psy3273         133 FS  134 (145)
Q Consensus       133 ~~  134 (145)
                      +.
T Consensus       233 ~~  234 (365)
T 3e7e_A          233 MK  234 (365)
T ss_dssp             GG
T ss_pred             hh
Confidence            54

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=4.6e-27  Score=168.06  Aligned_cols=133  Identities=23%  Similarity=0.346  Sum_probs=114.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||+|.+..+++.+++|..         ..+.++...++.++||||+++++++..++..|+||||++ ++|.+
T Consensus        13 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~   91 (317)
T 2pmi_A           13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKK   91 (317)
T ss_dssp             ------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHH
T ss_pred             ECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHH
Confidence            68999999999999999999999742         345677788999999999999999999999999999997 59998


Q ss_pred             HHHhc------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          73 HLSQH------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++...      ..+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus        92 ~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           92 YMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             HHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             HHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            88643      3589999999999999999999999999999999999999999999999999987653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.95  E-value=1.7e-27  Score=168.64  Aligned_cols=134  Identities=25%  Similarity=0.418  Sum_probs=117.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------------------------------HHHHhhhhhcccCCCCceeE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------------------------------IMLSLVSTGIQMVDCPFIVC   47 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~l~hp~i~~   47 (145)
                      .|.|+||.||+|.+..+++.+|+|..                                  +.+.++...++.++||||++
T Consensus        21 lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~  100 (298)
T 2zv2_A           21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVK  100 (298)
T ss_dssp             EEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCC
T ss_pred             EeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCe
Confidence            68999999999999999999998742                                  34567778889999999999


Q ss_pred             eeEEEEc--CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEe
Q psy3273          48 MTYAFHT--PDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS  125 (145)
Q Consensus        48 ~~~~~~~--~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~  125 (145)
                      +++++..  ++..|+||||+++++|.++.. ...+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++
T Consensus       101 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~  179 (298)
T 2zv2_A          101 LVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIA  179 (298)
T ss_dssp             EEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEe
Confidence            9999986  578999999999999877543 4579999999999999999999999999999999999999999999999


Q ss_pred             eeccceecCCC
Q psy3273         126 DLGLACDFSKK  136 (145)
Q Consensus       126 dfg~~~~~~~~  136 (145)
                      |||++..+...
T Consensus       180 Dfg~~~~~~~~  190 (298)
T 2zv2_A          180 DFGVSNEFKGS  190 (298)
T ss_dssp             CCTTCEECSSS
T ss_pred             cCCCccccccc
Confidence            99999876543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.95  E-value=4e-27  Score=167.73  Aligned_cols=133  Identities=22%  Similarity=0.330  Sum_probs=117.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhccc-CCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQM-VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~-l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||+|.+..+++.+++|.        ...+.++...+.. .+||||+++++++..++.+|+||||+++++|.+
T Consensus        21 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  100 (316)
T 2ac3_A           21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS  100 (316)
T ss_dssp             CCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHH
T ss_pred             ecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHH
Confidence            6899999999999999999999974        3345556666665 589999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCC---EEEeeeccceecC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH---VRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~---~~l~dfg~~~~~~  134 (145)
                      ++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++.+..   ++++|||++..+.
T Consensus       101 ~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A          101 HIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             HHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9988788999999999999999999999999999999999999987655   9999999987653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.95  E-value=1.6e-26  Score=162.13  Aligned_cols=135  Identities=22%  Similarity=0.269  Sum_probs=117.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|++|.||+|.+..+++.+++|.          ...+.++...+..+ +||||+++++++..++..++||||+++++|
T Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   98 (289)
T 1x8b_A           19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSL   98 (289)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             hcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcH
Confidence            6899999999999999999999973          22333444455566 999999999999999999999999999999


Q ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-------------------CCCEEEeee
Q psy3273          71 HYHLSQH----GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-------------------HGHVRISDL  127 (145)
Q Consensus        71 ~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-------------------~~~~~l~df  127 (145)
                      .+++...    ..+++..+..++.|++.++.|+|+++++|+||+|+||+++.                   ...++++||
T Consensus        99 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df  178 (289)
T 1x8b_A           99 ADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL  178 (289)
T ss_dssp             HHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCC
T ss_pred             HHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEccc
Confidence            9999754    66999999999999999999999999999999999999983                   447999999


Q ss_pred             ccceecCCC
Q psy3273         128 GLACDFSKK  136 (145)
Q Consensus       128 g~~~~~~~~  136 (145)
                      |.+.....+
T Consensus       179 g~~~~~~~~  187 (289)
T 1x8b_A          179 GHVTRISSP  187 (289)
T ss_dssp             TTCEETTCS
T ss_pred             ccccccCCc
Confidence            999876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.95  E-value=3.7e-27  Score=170.47  Aligned_cols=135  Identities=21%  Similarity=0.296  Sum_probs=117.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----HHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHh
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----MLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ   76 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~   76 (145)
                      +|.|+||.||+|.+..+++.+|+|...    ...++.+.+..+ +||||+++++++.+++..|+||||+++++|.+.+..
T Consensus        30 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~  109 (342)
T 2qr7_A           30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR  109 (342)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH
Confidence            689999999999999999999997432    123344444444 899999999999999999999999999999999988


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC----CCEEEeeeccceecCCC
Q psy3273          77 HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH----GHVRISDLGLACDFSKK  136 (145)
Q Consensus        77 ~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~----~~~~l~dfg~~~~~~~~  136 (145)
                      ...+++..+..++.|++.++.|+|+++++|+||+|+||++...    ..++++|||++..+...
T Consensus       110 ~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A          110 QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            8889999999999999999999999999999999999998543    35999999999876543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.8e-27  Score=182.04  Aligned_cols=130  Identities=12%  Similarity=0.079  Sum_probs=104.6

Q ss_pred             eeeeeEEEEEEEcccCCeeeeeH------------------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           4 IVGTGFLSNCSHVKQGETLALNE------------------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         4 ~~~~g~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      .++.|....++....|+.+++|.                  .+.++++.+.++++ .||||+++++++++++..||||||
T Consensus       244 ~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEy  323 (569)
T 4azs_A          244 AGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEK  323 (569)
T ss_dssp             --------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEEC
T ss_pred             cCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEec
Confidence            34455555555555666665531                  23467788888888 799999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          65 MNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        65 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++|++|.+.+...+++++..   ++.|++.|+.|+|++||+||||||+|||++.++.+||+|||+|+.+..+
T Consensus       324 v~G~~L~d~i~~~~~l~~~~---I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          324 LPGRLLSDMLAAGEEIDREK---ILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             CCSEEHHHHHHTTCCCCHHH---HHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             CCCCcHHHHHHhCCCCCHHH---HHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999888888764   6789999999999999999999999999999999999999999876543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.95  E-value=9.5e-27  Score=166.01  Aligned_cols=134  Identities=23%  Similarity=0.337  Sum_probs=114.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+|+|..           ..+.+.....+..+||||+++++++..++..|+|||++ +++|
T Consensus        65 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L  143 (311)
T 3p1a_A           65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSL  143 (311)
T ss_dssp             EEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             eccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCH
Confidence            69999999999999999999999732           12222222334459999999999999999999999999 6688


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.. ...+++..+..++.|++.|+.|+|+.+++|+||||+||+++.++.++++|||++......
T Consensus       144 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          144 QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            888765 456999999999999999999999999999999999999999999999999999876543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.95  E-value=8.7e-27  Score=163.08  Aligned_cols=134  Identities=25%  Similarity=0.419  Sum_probs=122.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|++|.||.+.+..+++.+++|..           ..+.++...++.++||||+++++++..++..|++||++++++|
T Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (276)
T 2h6d_A           19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGEL   98 (276)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             ecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcH
Confidence            68999999999999999999999742           2445667778899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++.....+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++.....
T Consensus        99 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           99 FDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99998878899999999999999999999999999999999999999999999999999976644

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.95  E-value=4.5e-27  Score=171.53  Aligned_cols=134  Identities=20%  Similarity=0.225  Sum_probs=117.3

Q ss_pred             eeeeeeeEEEEEEEcc-------cCCeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVK-------QGETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      +|.|+||.||+|.+..       ++..+++|.         ...+.++...++.+ +||||+++++++..++.+|+||||
T Consensus        89 LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~  168 (370)
T 2psq_A           89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY  168 (370)
T ss_dssp             ESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             EeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEc
Confidence            6899999999998753       345677752         34466777788888 899999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          65 MNGGDLHYHLSQHG----------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        65 ~~~~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                      +++++|.+++....                .++...+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||
T Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG  248 (370)
T 2psq_A          169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG  248 (370)
T ss_dssp             CTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCS
T ss_pred             CCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEcccc
Confidence            99999999997543                37889999999999999999999999999999999999999999999999


Q ss_pred             cceecCC
Q psy3273         129 LACDFSK  135 (145)
Q Consensus       129 ~~~~~~~  135 (145)
                      +++.+..
T Consensus       249 ~a~~~~~  255 (370)
T 2psq_A          249 LARDINN  255 (370)
T ss_dssp             SCEETTC
T ss_pred             CCcccCc
Confidence            9987654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=2.9e-27  Score=173.83  Aligned_cols=137  Identities=20%  Similarity=0.251  Sum_probs=120.2

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCC--EEEEEEEccCCCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD--KLCFILDLMNGGD   69 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~~~~   69 (145)
                      ++|.|+||.||+|.+..+++.+|+|.         ...+.++...++.++||||+++++++...+  ..++||||+++++
T Consensus        16 ~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~   95 (396)
T 4eut_A           16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS   95 (396)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEE
T ss_pred             EEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCC
Confidence            36999999999999999999999974         234457777889999999999999998765  7899999999999


Q ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE----CCCCCEEEeeeccceecCCCC
Q psy3273          70 LHYHLSQHG---VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        70 l~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~----~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      |.+++....   .+++..+..++.|++.|+.|+|+++++|+||+|+||++    +....++++|||+++.+....
T Consensus        96 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~  170 (396)
T 4eut_A           96 LYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE  170 (396)
T ss_dssp             HHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG
T ss_pred             HHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC
Confidence            999997532   38999999999999999999999999999999999998    666779999999998775543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.95  E-value=2.5e-27  Score=174.48  Aligned_cols=134  Identities=19%  Similarity=0.304  Sum_probs=114.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---HHHHhhhhh-cccCCCCceeEeeEEEEc----CCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---IMLSLVSTG-IQMVDCPFIVCMTYAFHT----PDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-~~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|+||.||+|.+..+++.+|+|..   ....++... ++..+||||++++++|..    ++.+|+||||+++++|.++
T Consensus        70 LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~  149 (400)
T 1nxk_A           70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR  149 (400)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHH
T ss_pred             eeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHH
Confidence            69999999999999999999999743   223333333 355699999999999876    5679999999999999999


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC---CCCEEEeeeccceecCC
Q psy3273          74 LSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE---HGHVRISDLGLACDFSK  135 (145)
Q Consensus        74 l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~---~~~~~l~dfg~~~~~~~  135 (145)
                      +...  ..+++..+..++.|++.|+.|+|+++++|+||+|+||+++.   .+.++|+|||+++....
T Consensus       150 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          150 IQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             HHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             HHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            9864  35999999999999999999999999999999999999987   67899999999987654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.95  E-value=5e-27  Score=166.63  Aligned_cols=134  Identities=22%  Similarity=0.333  Sum_probs=121.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.||+|.+..+++.+++|.        ...+.++...++.++||||+++++++..++..|++||++++++|.++
T Consensus        17 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   96 (304)
T 2jam_A           17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDR   96 (304)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             ccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHH
Confidence            6899999999999999999999873        23456777788999999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE---CCCCCEEEeeeccceecCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~---~~~~~~~l~dfg~~~~~~~  135 (145)
                      +.....+++..+..++.|++.++.++|+.+++|+||+|+||++   +....++++|||++.....
T Consensus        97 l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           97 ILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             HHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9877889999999999999999999999999999999999999   6778899999999875443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.95  E-value=3e-27  Score=172.66  Aligned_cols=134  Identities=19%  Similarity=0.208  Sum_probs=113.3

Q ss_pred             eeeeeeeEEEEEEEc---ccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHV---KQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~---~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||++...   .++..+++|.         ...+.++...++.++||||+++++++..++..++||||+++++
T Consensus        53 lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  132 (373)
T 2qol_A           53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGS  132 (373)
T ss_dssp             EEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             EeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCc
Confidence            699999999999887   4566788863         3456677888999999999999999999999999999999999


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |.+++... ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||+++.+..
T Consensus       133 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             HHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999764 4699999999999999999999999999999999999999999999999999986643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=2.5e-27  Score=175.97  Aligned_cols=134  Identities=21%  Similarity=0.322  Sum_probs=120.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcC-----CEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTP-----DKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~   66 (145)
                      +|.|+||.||+|.+..+++.+|+|..          ..+.++...++.++||||+++++++...     +.+|+|||++.
T Consensus        34 lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~  113 (432)
T 3n9x_A           34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD  113 (432)
T ss_dssp             EEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS
T ss_pred             EeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC
Confidence            69999999999999999999999742          3456777888999999999999999876     57999999986


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                       ++|.+.+.....+++..+..++.|++.|+.|+|+.+++|+||||+||+++.++.++|+|||+++.+...
T Consensus       114 -~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          114 -SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             -EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             -cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence             599999988788999999999999999999999999999999999999999999999999999876543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.95  E-value=5.7e-27  Score=182.27  Aligned_cols=133  Identities=32%  Similarity=0.528  Sum_probs=119.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|.+..+++.+|+|...           ....+...+..+ +||||++++++|++.+.+|+||||+++++
T Consensus       349 LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~  428 (674)
T 3pfq_A          349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD  428 (674)
T ss_dssp             SSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCB
T ss_pred             EccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCc
Confidence            689999999999999999999997422           233444455555 79999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |..++...+.+++..+..++.|++.|+.|+|+.+++|+||||+||+++.++.++|+|||+++...
T Consensus       429 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          429 LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999988889999999999999999999999999999999999999999999999999998643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.95  E-value=1.3e-27  Score=176.95  Aligned_cols=134  Identities=21%  Similarity=0.344  Sum_probs=117.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH----------------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI----------------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      +|.|+||.||+|.+..+++.+|+|...                .+.++...++.++||||+++++++.. +..|+||||+
T Consensus       143 LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~  221 (419)
T 3i6u_A          143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELM  221 (419)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECC
T ss_pred             EeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcC
Confidence            699999999999999999999997422                24567778899999999999999864 5689999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC---CCEEEeeeccceecCCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH---GHVRISDLGLACDFSKK  136 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~  136 (145)
                      ++++|.+++.....+++..+..++.|++.|+.|+|+++++|+||+|+||+++..   ..++++|||+++.+...
T Consensus       222 ~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  295 (419)
T 3i6u_A          222 EGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET  295 (419)
T ss_dssp             TTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--
T ss_pred             CCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC
Confidence            999999998887889999999999999999999999999999999999999654   45999999999866443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.95  E-value=8.7e-27  Score=165.65  Aligned_cols=135  Identities=21%  Similarity=0.231  Sum_probs=118.8

Q ss_pred             eeeeeeeEEEEEEEc-----ccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHV-----KQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.+.     .+++.+++|.         ...+.++...++.++||||+++++++..++..+++|||+++
T Consensus        31 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  110 (314)
T 2ivs_A           31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY  110 (314)
T ss_dssp             EEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             ecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCC
Confidence            689999999999984     3447777763         34566778888999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEE
Q psy3273          68 GDLHYHLSQHGV------------------------FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR  123 (145)
Q Consensus        68 ~~l~~~l~~~~~------------------------~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~  123 (145)
                      ++|.+++.....                        +++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++
T Consensus       111 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~k  190 (314)
T 2ivs_A          111 GSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMK  190 (314)
T ss_dssp             CBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEE
T ss_pred             CCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEE
Confidence            999999976432                        78899999999999999999999999999999999999999999


Q ss_pred             EeeeccceecCCC
Q psy3273         124 ISDLGLACDFSKK  136 (145)
Q Consensus       124 l~dfg~~~~~~~~  136 (145)
                      ++|||++..+...
T Consensus       191 l~Dfg~~~~~~~~  203 (314)
T 2ivs_A          191 ISDFGLSRDVYEE  203 (314)
T ss_dssp             ECCCTTCEECTTT
T ss_pred             Ecccccccccccc
Confidence            9999999876543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.95  E-value=1.1e-26  Score=162.02  Aligned_cols=134  Identities=15%  Similarity=0.143  Sum_probs=118.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|+||.||++... ++..+++|.       ...+.++...++.++||||+++++++..++..++|||++++++|.+++
T Consensus        16 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   94 (268)
T 3sxs_A           16 LGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL   94 (268)
T ss_dssp             EEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             eccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHH
Confidence            689999999999766 455677753       344567777888999999999999999999999999999999999999


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          75 SQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ... ..+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++.....+
T Consensus        95 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           95 RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             HHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             HHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            764 45999999999999999999999999999999999999999999999999999876544

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.95  E-value=1.3e-26  Score=164.06  Aligned_cols=135  Identities=21%  Similarity=0.260  Sum_probs=120.0

Q ss_pred             eeeeeeeEEEEEE----EcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCS----HVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~----~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~   66 (145)
                      +|.|+||.||+|.    +..+++.+++|.         ...+.++...++.++||||+++++++..+  ..++++|||++
T Consensus        29 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~  108 (302)
T 4e5w_A           29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP  108 (302)
T ss_dssp             EEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCT
T ss_pred             cCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCC
Confidence            6899999999999    677888898874         24566777888999999999999999877  67999999999


Q ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          67 GGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        67 ~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +++|.+++.. ...+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++..+...
T Consensus       109 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  179 (302)
T 4e5w_A          109 SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  179 (302)
T ss_dssp             TCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence            9999999954 467999999999999999999999999999999999999999999999999999876544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.95  E-value=6.3e-27  Score=165.09  Aligned_cols=131  Identities=24%  Similarity=0.381  Sum_probs=117.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+ .+++.+++|..          ..+.++...++.++||||+++++++..++..++|||++++ +|.
T Consensus        10 lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~   87 (288)
T 1ob3_A           10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLK   87 (288)
T ss_dssp             EEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHH
T ss_pred             cccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHH
Confidence            68999999999998 67888888642          3455777889999999999999999999999999999976 898


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +++.. ...+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||++..+.
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           88 KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             HHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence            88875 3679999999999999999999999999999999999999999999999999997654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=6.4e-27  Score=166.68  Aligned_cols=134  Identities=19%  Similarity=0.204  Sum_probs=119.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|++|.||+|.+..+++.+++|..           ..+.++...++.++||||+++++++..++..|++||++++++|
T Consensus        42 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  121 (309)
T 2h34_A           42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDL  121 (309)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEH
T ss_pred             EcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCH
Confidence            68999999999999999999999742           4456777788999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++.....
T Consensus       122 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          122 AAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99998878899999999999999999999999999999999999999999999999999876543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.95  E-value=4.9e-27  Score=168.86  Aligned_cols=133  Identities=22%  Similarity=0.229  Sum_probs=119.1

Q ss_pred             eeeeeeeEEEEEEEcc-----cCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVK-----QGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-----~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.+..     +++.+++|.         ...+.++...++.++||||+++++++..++..|+||||+++
T Consensus        55 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  134 (343)
T 1luf_A           55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAY  134 (343)
T ss_dssp             EEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCC
Confidence            6899999999999973     457788863         34567788889999999999999999999999999999999


Q ss_pred             CCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEE
Q psy3273          68 GDLHYHLSQH------------------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR  123 (145)
Q Consensus        68 ~~l~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~  123 (145)
                      ++|.+++...                        ..+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++
T Consensus       135 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~k  214 (343)
T 1luf_A          135 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK  214 (343)
T ss_dssp             CBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             CcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEE
Confidence            9999999753                        4688999999999999999999999999999999999999999999


Q ss_pred             EeeeccceecC
Q psy3273         124 ISDLGLACDFS  134 (145)
Q Consensus       124 l~dfg~~~~~~  134 (145)
                      ++|||++..+.
T Consensus       215 l~Dfg~~~~~~  225 (343)
T 1luf_A          215 IADFGLSRNIY  225 (343)
T ss_dssp             ECCCSCHHHHT
T ss_pred             EeecCCCcccc
Confidence            99999997654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.95  E-value=2.8e-27  Score=167.25  Aligned_cols=134  Identities=20%  Similarity=0.284  Sum_probs=116.8

Q ss_pred             eeeeeeeEEEEEE----EcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCS----HVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~----~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.    +..+++.+++|.        ...+.++...++.++||||+++++++...  ..+++||||+++
T Consensus        18 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   97 (295)
T 3ugc_A           18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY   97 (295)
T ss_dssp             EEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTT
T ss_pred             eeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCC
Confidence            6899999999998    567888898873        34566788889999999999999998654  568999999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          68 GDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        68 ~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++|.+++... ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++..+..
T Consensus        98 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           98 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             CBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             CCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            9999999764 3599999999999999999999999999999999999999999999999999986643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.94  E-value=5.3e-27  Score=168.38  Aligned_cols=134  Identities=22%  Similarity=0.267  Sum_probs=119.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|+||.||+|.+..+++.+|+|..      ..+..+...++.+ +||||+++++++..++..++|||++ +++|.+++
T Consensus        17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~   95 (330)
T 2izr_A           17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLF   95 (330)
T ss_dssp             CCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHH
T ss_pred             eeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHH
Confidence            68999999999999999999999742      2355677778888 9999999999999999999999999 88999999


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCC-----EEEeeeccceecCCC
Q psy3273          75 SQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH-----VRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~-----~~l~dfg~~~~~~~~  136 (145)
                      .. ...+++..+..++.|++.|+.|+|+.+++|+||+|+||+++..+.     ++++|||+++.+..+
T Consensus        96 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           96 DLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             HHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence            86 467999999999999999999999999999999999999987776     999999999877544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.94  E-value=3.1e-27  Score=178.20  Aligned_cols=135  Identities=16%  Similarity=0.174  Sum_probs=122.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|+||.||++....+++.+++|.       ...+.++...++.++||||+++++++..++.+|+||||+++++|.+++
T Consensus       228 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l  307 (495)
T 1opk_A          228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL  307 (495)
T ss_dssp             SGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred             ecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHH
Confidence            5889999999999999999999873       455677888899999999999999999999999999999999999999


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ...  ..+++..+..++.|++.++.|+|+++++|+||+|+||+++.+..++|+|||+++.+...
T Consensus       308 ~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          308 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             HHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             HhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            753  45899999999999999999999999999999999999999999999999999876543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.94  E-value=1.2e-26  Score=165.55  Aligned_cols=132  Identities=24%  Similarity=0.422  Sum_probs=116.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+. +++.+|+|.          ...+.++...++.++||||+++++++.+++..++||||+++ ++.
T Consensus        29 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~  106 (311)
T 3niz_A           29 VGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLK  106 (311)
T ss_dssp             EEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHH
T ss_pred             ccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHH
Confidence            689999999999985 488888863          23456777788999999999999999999999999999975 787


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +.+... ..+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus       107 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A          107 KVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             HHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            777654 4599999999999999999999999999999999999999999999999999987653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.94  E-value=1.4e-26  Score=161.97  Aligned_cols=133  Identities=22%  Similarity=0.249  Sum_probs=121.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|++|.||+|.+..+++.+++|.         ...+.++...++.++||||+++++++..++..|++||++++++|.+
T Consensus        15 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (276)
T 2yex_A           15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD   94 (276)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGG
T ss_pred             eecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHH
Confidence            6899999999999999999999864         2445667777889999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++.....+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||.+..+.
T Consensus        95 ~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           95 RIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             GSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             HHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            98877779999999999999999999999999999999999999999999999999997653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.94  E-value=5.2e-27  Score=169.76  Aligned_cols=134  Identities=25%  Similarity=0.277  Sum_probs=115.8

Q ss_pred             eeeeeeeEEEEEE-----EcccCCeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCC-EEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCS-----HVKQGETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPD-KLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~-----~~~~~~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~-~~~lv~e~~   65 (145)
                      +|.|+||.||+|.     ...+++.+++|.         ...+.++...++.+ +||||+++++++..++ ..+++|||+
T Consensus        30 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~  109 (359)
T 3vhe_A           30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC  109 (359)
T ss_dssp             EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECC
T ss_pred             ecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEec
Confidence            6999999999999     455668888863         23456677777778 8899999999998764 599999999


Q ss_pred             CCCCHHHHHHhcCC------------------------------------------------------------------
Q psy3273          66 NGGDLHYHLSQHGV------------------------------------------------------------------   79 (145)
Q Consensus        66 ~~~~l~~~l~~~~~------------------------------------------------------------------   79 (145)
                      ++++|.+++.....                                                                  
T Consensus       110 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3vhe_A          110 KFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF  189 (359)
T ss_dssp             TTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTTTTC
T ss_pred             CCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccc
Confidence            99999999975432                                                                  


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          80 FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        80 ~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence            88899999999999999999999999999999999999999999999999986643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.94  E-value=4.9e-27  Score=167.96  Aligned_cols=134  Identities=22%  Similarity=0.362  Sum_probs=119.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      +|.|+||.||+|.+..+++.+++|..                ..+.++...++.++||||+++++++..++ .|+||||+
T Consensus        18 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~   96 (322)
T 2ycf_A           18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELM   96 (322)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECC
T ss_pred             EecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecC
Confidence            68999999999999999999999742                13556777888999999999999998765 89999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC---CEEEeeeccceecCCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG---HVRISDLGLACDFSKK  136 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~---~~~l~dfg~~~~~~~~  136 (145)
                      ++++|.+++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++...   .++++|||++..+...
T Consensus        97 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  170 (322)
T 2ycf_A           97 EGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET  170 (322)
T ss_dssp             TTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC
T ss_pred             CCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc
Confidence            9999999998878899999999999999999999999999999999999998655   4999999999876543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.94  E-value=1e-26  Score=162.34  Aligned_cols=132  Identities=17%  Similarity=0.252  Sum_probs=118.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|+||.||+|.+.. ++.+++|.       ...+.++...++.++||||+++++++..++..+++|||+++++|.+++
T Consensus        18 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   96 (269)
T 4hcu_A           18 IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL   96 (269)
T ss_dssp             EEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             ecCCCccEEEEEEecC-CCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHH
Confidence            6899999999999874 55677763       345677888889999999999999999999999999999999999999


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          75 SQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        75 ~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      .. ...+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++....
T Consensus        97 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           97 RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             HTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             HhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence            75 4568999999999999999999999999999999999999999999999999997553

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.94  E-value=1.1e-26  Score=165.66  Aligned_cols=131  Identities=24%  Similarity=0.307  Sum_probs=112.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|..  +++.+++|.          ...+.++...++.++||||+++++++..++..++||||+++++|.
T Consensus        45 lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~  122 (309)
T 3p86_A           45 IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY  122 (309)
T ss_dssp             EEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHH
T ss_pred             eecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHH
Confidence            69999999999976  466677753          334567778889999999999999999999999999999999999


Q ss_pred             HHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLSQHGV---FNEDEMRFYAAEVILGLEHMHRRY--IVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~--iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +++.....   +++..+..++.|++.++.|+|+.+  ++|+||+|+||+++.++.++++|||+++...
T Consensus       123 ~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             HHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99976543   899999999999999999999999  9999999999999999999999999997543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.94  E-value=1.1e-26  Score=163.51  Aligned_cols=132  Identities=12%  Similarity=0.075  Sum_probs=116.9

Q ss_pred             eeeeeeeEEEEEEEcccCC-------eeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE-------TLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~-------~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +|.|+||.||+|.+..+++       .+++|.        .+.+.++...++.++||||+++++++..++..++||||++
T Consensus        16 lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   95 (289)
T 4fvq_A           16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVK   95 (289)
T ss_dssp             EEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCT
T ss_pred             eccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCC
Confidence            6899999999999998874       466652        3445677778899999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCC--------EEEeeeccceec
Q psy3273          67 GGDLHYHLSQHGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH--------VRISDLGLACDF  133 (145)
Q Consensus        67 ~~~l~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~--------~~l~dfg~~~~~  133 (145)
                      +++|.+++..... +++.....++.|++.++.|+|+++++|+||+|+||+++.+..        ++++|||++...
T Consensus        96 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~  171 (289)
T 4fvq_A           96 FGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV  171 (289)
T ss_dssp             TCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTT
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccc
Confidence            9999999986544 899999999999999999999999999999999999987766        999999998654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.94  E-value=9.2e-27  Score=167.23  Aligned_cols=132  Identities=22%  Similarity=0.285  Sum_probs=117.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+++|..          ..+.++...++.++||||+++++++..++..++||||+++ +|.
T Consensus        42 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~  120 (329)
T 3gbz_A           42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLK  120 (329)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHH
T ss_pred             EEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHH
Confidence            68999999999999999999999742          2345677788999999999999999999999999999975 999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC-----CCCCEEEeeeccceecC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-----EHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~-----~~~~~~l~dfg~~~~~~  134 (145)
                      +++.....+++..+..++.|++.++.|+|+++++|+||+|+||+++     ....++++|||++..+.
T Consensus       121 ~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          121 KYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             HHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             HHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9998888899999999999999999999999999999999999994     44559999999997654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.94  E-value=1.2e-26  Score=168.02  Aligned_cols=133  Identities=20%  Similarity=0.243  Sum_probs=119.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+++|..           ..+.++...++.++||||+++++++..++..++||||+. |++
T Consensus        62 lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l  140 (348)
T 1u5q_A           62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA  140 (348)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred             EccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCH
Confidence            68999999999999999999998742           345677778899999999999999999999999999997 578


Q ss_pred             HHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLS-QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+.+. ....+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||++.....
T Consensus       141 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          141 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            77775 456799999999999999999999999999999999999999999999999999976543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=7.9e-27  Score=169.30  Aligned_cols=134  Identities=37%  Similarity=0.627  Sum_probs=119.2

Q ss_pred             eeeeeeeEEEEEEEc---ccCCeeeeeHH------------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHV---KQGETLALNER------------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~---~~~~~~~~~~~------------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      .|.|+||.||+|.+.   .+++.+++|..            ..+.++...++.+ +||||+++++++..++..++||||+
T Consensus        62 lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~  141 (355)
T 1vzo_A           62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI  141 (355)
T ss_dssp             EEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             eccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecC
Confidence            689999999999985   47888888642            2344555666677 6999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++++|.+++.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++|+|||+++.+..
T Consensus       142 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          142 NGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            9999999998878899999999999999999999999999999999999999999999999999987643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.94  E-value=1.2e-26  Score=165.02  Aligned_cols=134  Identities=23%  Similarity=0.342  Sum_probs=115.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-------------HHHhhhhhccc---CCCCceeEeeEEEEcCC-----EEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-------------MLSLVSTGIQM---VDCPFIVCMTYAFHTPD-----KLCF   60 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~---l~hp~i~~~~~~~~~~~-----~~~l   60 (145)
                      +|.|+||.||+|.+..+++.+|+|...             ...++...++.   ++||||+++++++....     ..++
T Consensus        17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~l   96 (308)
T 3g33_A           17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTL   96 (308)
T ss_dssp             ECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEE
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEE
Confidence            689999999999999999999998532             33444444444   45999999999998765     5899


Q ss_pred             EEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          61 ILDLMNGGDLHYHLSQHGV--FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        61 v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +||++. ++|.+++.....  +++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++..+...
T Consensus        97 v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  173 (308)
T 3g33_A           97 VFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ  173 (308)
T ss_dssp             EEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC
T ss_pred             Eehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCC
Confidence            999997 599999986543  999999999999999999999999999999999999999999999999999766543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.94  E-value=1.7e-26  Score=165.02  Aligned_cols=134  Identities=19%  Similarity=0.222  Sum_probs=108.3

Q ss_pred             eeeeeeeEEEEEEEcccCC---eeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEE------EEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGE---TLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKL------CFIL   62 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~---~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~------~lv~   62 (145)
                      +|.|+||.||+|.+..+++   .+++|.          ...+.++...++.++||||+++++++......      +++|
T Consensus        31 lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~  110 (323)
T 3qup_A           31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVIL  110 (323)
T ss_dssp             EEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEE
T ss_pred             ecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEE
Confidence            6999999999999888775   677753          34566777888999999999999999887655      9999


Q ss_pred             EccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          63 DLMNGGDLHYHLSQHG------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        63 e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ||+++++|.+++....      .+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||+++.+..
T Consensus       111 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~  189 (323)
T 3qup_A          111 PFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS  189 (323)
T ss_dssp             ECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccc
Confidence            9999999999986432      589999999999999999999999999999999999999999999999999986644

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.94  E-value=3.4e-26  Score=163.88  Aligned_cols=132  Identities=22%  Similarity=0.204  Sum_probs=114.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCC----EEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD----KLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~----~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|...  ++.+|+|.       ......+...++.++||||+++++++....    .+++||||+++++|
T Consensus        32 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L  109 (322)
T 3soc_A           32 KARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL  109 (322)
T ss_dssp             EECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred             ecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCH
Confidence            689999999999875  67888873       223344666788999999999999998743    48999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC----------CceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR----------YIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~----------~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.. ..+++..+..++.|++.++.|+|+.          +++|+||+|+||+++..+.++++|||+++.+...
T Consensus       110 ~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~  184 (322)
T 3soc_A          110 SDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG  184 (322)
T ss_dssp             HHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTT
T ss_pred             HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccc
Confidence            999976 4589999999999999999999999          9999999999999999999999999999876543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.94  E-value=2.6e-26  Score=164.17  Aligned_cols=134  Identities=22%  Similarity=0.268  Sum_probs=119.3

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      ++|.|+||.||+|.. .+++.+++|.        ...+.++...++.++||||+++++++..++..++||||+++++|.+
T Consensus        46 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  124 (321)
T 2qkw_B           46 LIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR  124 (321)
T ss_dssp             CSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGG
T ss_pred             eeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHH
Confidence            368999999999996 4688888863        4556778888999999999999999999999999999999999999


Q ss_pred             HHHhcC----CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          73 HLSQHG----VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++....    .+++.....++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++.....
T Consensus       125 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             GSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             HHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            886432    488999999999999999999999999999999999999999999999999986543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.94  E-value=2.5e-26  Score=162.88  Aligned_cols=135  Identities=20%  Similarity=0.320  Sum_probs=117.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---HHHHhhhhhc-ccCCCCceeEeeEEEEc----CCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---IMLSLVSTGI-QMVDCPFIVCMTYAFHT----PDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|+||.||+|.+..+++.+|+|..   ....++...+ +.++||||+++++++..    +...++||||+++++|.++
T Consensus        26 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  105 (299)
T 3m2w_A           26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR  105 (299)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHH
T ss_pred             cccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHH
Confidence            68999999999999999999999743   2333444433 66699999999999987    6789999999999999999


Q ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC---CCCEEEeeeccceecCCC
Q psy3273          74 LSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE---HGHVRISDLGLACDFSKK  136 (145)
Q Consensus        74 l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~  136 (145)
                      +....  .+++..+..++.|++.|+.|+|+.+++|+||+|+||+++.   ...++++|||++......
T Consensus       106 l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  173 (299)
T 3m2w_A          106 IQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE  173 (299)
T ss_dssp             HHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTC
T ss_pred             HHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccccc
Confidence            98653  6999999999999999999999999999999999999987   678999999999876543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.94  E-value=1.3e-26  Score=162.56  Aligned_cols=135  Identities=19%  Similarity=0.289  Sum_probs=120.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----HHHHhhhhhcccCCCCceeEeeEEEEc----------------CCEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----IMLSLVSTGIQMVDCPFIVCMTYAFHT----------------PDKLCFI   61 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~hp~i~~~~~~~~~----------------~~~~~lv   61 (145)
                      .|.|++|.||++.+..+++.+++|..    ..+.++...++.++||||+++++++..                ...++++
T Consensus        19 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv   98 (284)
T 2a19_B           19 IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQ   98 (284)
T ss_dssp             EECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEE
T ss_pred             eccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEE
Confidence            68999999999999999999999743    355677778889999999999999865                3458999


Q ss_pred             EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          62 LDLMNGGDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        62 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |||+++++|.+++...  ..+++..+..++.|++.++.++|+.+++|+||+|+||+++.+..++++|||++..+...
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  175 (284)
T 2a19_B           99 MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND  175 (284)
T ss_dssp             ECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCC
T ss_pred             EeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheecccc
Confidence            9999999999999753  57999999999999999999999999999999999999999999999999999877544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=1.4e-26  Score=169.35  Aligned_cols=135  Identities=19%  Similarity=0.274  Sum_probs=115.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----HHHHhhhhhcccCCCCceeEeeEEEEcC----------------------
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----IMLSLVSTGIQMVDCPFIVCMTYAFHTP----------------------   55 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~hp~i~~~~~~~~~~----------------------   55 (145)
                      +|.|+||.||+|.+..+++.+|+|..    ....++...++.++||||++++++|...                      
T Consensus        15 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (383)
T 3eb0_A           15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNN   94 (383)
T ss_dssp             EECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------------------
T ss_pred             EEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccccccccc
Confidence            69999999999999999999999843    3345677788999999999999999543                      


Q ss_pred             ----------------CEEEEEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEE
Q psy3273          56 ----------------DKLCFILDLMNGGDLHYHLS----QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL  115 (145)
Q Consensus        56 ----------------~~~~lv~e~~~~~~l~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil  115 (145)
                                      ..+++||||+++ +|.+.+.    ....+++..+..++.|++.|+.|+|+.+++|+||+|+||+
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil  173 (383)
T 3eb0_A           95 GVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL  173 (383)
T ss_dssp             ---------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEE
T ss_pred             ccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEE
Confidence                            348999999985 7766664    3467999999999999999999999999999999999999


Q ss_pred             EC-CCCCEEEeeeccceecCCCC
Q psy3273         116 LD-EHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus       116 ~~-~~~~~~l~dfg~~~~~~~~~  137 (145)
                      ++ .++.++++|||++..+....
T Consensus       174 ~~~~~~~~kl~Dfg~a~~~~~~~  196 (383)
T 3eb0_A          174 VNSKDNTLKLCDFGSAKKLIPSE  196 (383)
T ss_dssp             EETTTTEEEECCCTTCEECCTTS
T ss_pred             EcCCCCcEEEEECCCCcccCCCC
Confidence            97 57889999999998765443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.94  E-value=1.5e-26  Score=162.54  Aligned_cols=133  Identities=17%  Similarity=0.171  Sum_probs=115.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|+||.||++... +++.+++|.       ...+.++...++.++||||+++++++..++..++||||+++++|.+++
T Consensus        32 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  110 (283)
T 3gen_A           32 LGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL  110 (283)
T ss_dssp             CC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHH
T ss_pred             cCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHH
Confidence            689999999999776 556677753       344667778889999999999999999999999999999999999999


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .. ...+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++.....
T Consensus       111 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A          111 REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             HCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            75 46799999999999999999999999999999999999999999999999999976543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.94  E-value=1.5e-26  Score=164.43  Aligned_cols=135  Identities=21%  Similarity=0.224  Sum_probs=119.3

Q ss_pred             eeeeeeeEEEEEEE-----cccCCeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSH-----VKQGETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~-----~~~~~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +|.|+||.||+|.+     ..+++.+++|.         ...+.++...++.+ +||||+++++++..++..+++||+++
T Consensus        31 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  110 (313)
T 1t46_A           31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC  110 (313)
T ss_dssp             EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             hCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCC
Confidence            68999999999985     44667788763         34566777788888 99999999999999999999999999


Q ss_pred             CCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          67 GGDLHYHLSQHG------------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        67 ~~~l~~~l~~~~------------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                      +++|.+++....                  .+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  190 (313)
T 1t46_A          111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG  190 (313)
T ss_dssp             TEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCG
T ss_pred             CCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEcccc
Confidence            999999997543                  48999999999999999999999999999999999999999999999999


Q ss_pred             cceecCCC
Q psy3273         129 LACDFSKK  136 (145)
Q Consensus       129 ~~~~~~~~  136 (145)
                      ++..+...
T Consensus       191 ~~~~~~~~  198 (313)
T 1t46_A          191 LARDIKND  198 (313)
T ss_dssp             GGSCTTSC
T ss_pred             cccccccc
Confidence            99876544

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=7.9e-27  Score=168.03  Aligned_cols=134  Identities=19%  Similarity=0.294  Sum_probs=116.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.||+|.+..+++.+++|.             ...+.++...++.++||||+++++++.+++..++||||++++
T Consensus        34 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg  113 (345)
T 3hko_A           34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGG  113 (345)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             eeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCC
Confidence            6899999999999999999998873             244566778889999999999999999999999999999999


Q ss_pred             CHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCceecC
Q psy3273          69 DLHYHLSQ----------------------------------------HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRD  108 (145)
Q Consensus        69 ~l~~~l~~----------------------------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~  108 (145)
                      +|.+++..                                        ...+++..+..++.|++.++.|+|+.+++|+|
T Consensus       114 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~D  193 (345)
T 3hko_A          114 HLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRD  193 (345)
T ss_dssp             BHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             cHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            99998841                                        01135677888999999999999999999999


Q ss_pred             CCCCcEEECCCC--CEEEeeeccceecCC
Q psy3273         109 LKPANILLDEHG--HVRISDLGLACDFSK  135 (145)
Q Consensus       109 l~~~nil~~~~~--~~~l~dfg~~~~~~~  135 (145)
                      |+|+||+++.+.  .++++|||++..+..
T Consensus       194 lkp~NIll~~~~~~~~kl~Dfg~a~~~~~  222 (345)
T 3hko_A          194 IKPENFLFSTNKSFEIKLVDFGLSKEFYK  222 (345)
T ss_dssp             CCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred             CChhhEEEecCCCceEEEeeccccccccc
Confidence            999999998665  899999999987643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.94  E-value=4e-26  Score=166.96  Aligned_cols=134  Identities=20%  Similarity=0.235  Sum_probs=117.4

Q ss_pred             eeeeeeeEEEEEEEcccC-------CeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVKQG-------ETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      +|.|+||.||+|.+..++       ..+++|.         ...+.++...++.+ +||||+++++++..++..++||||
T Consensus        77 LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~  156 (382)
T 3tt0_A           77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY  156 (382)
T ss_dssp             EEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             EecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEe
Confidence            689999999999975433       4577752         24456777778888 999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          65 MNGGDLHYHLSQHG----------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        65 ~~~~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                      +++++|.+++....                .+++..+..++.|++.|+.|+|+.+++|+||||+||+++.++.++|+|||
T Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG  236 (382)
T 3tt0_A          157 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG  236 (382)
T ss_dssp             CTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCS
T ss_pred             cCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccC
Confidence            99999999997643                48999999999999999999999999999999999999999999999999


Q ss_pred             cceecCC
Q psy3273         129 LACDFSK  135 (145)
Q Consensus       129 ~~~~~~~  135 (145)
                      +++.+..
T Consensus       237 ~a~~~~~  243 (382)
T 3tt0_A          237 LARDIHH  243 (382)
T ss_dssp             CCCCSSC
T ss_pred             ccccccc
Confidence            9986644

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.7e-26  Score=166.30  Aligned_cols=135  Identities=23%  Similarity=0.238  Sum_probs=117.2

Q ss_pred             eeeeeeeEEEEEEEc-----ccCCeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHV-----KQGETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +|.|+||.||+|.+.     .+++.+++|.         ...+.++...++.+ +||||+++++++..++..++||||++
T Consensus        53 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~  132 (344)
T 1rjb_A           53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC  132 (344)
T ss_dssp             EEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             ecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCC
Confidence            699999999999973     3455677753         33456777778888 99999999999999999999999999


Q ss_pred             CCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEE
Q psy3273          67 GGDLHYHLSQHG-----------------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR  123 (145)
Q Consensus        67 ~~~l~~~l~~~~-----------------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~  123 (145)
                      +++|.+++....                       .+++..+..++.|++.|+.|+|+.+++|+||+|+||+++.++.++
T Consensus       133 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~k  212 (344)
T 1rjb_A          133 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVK  212 (344)
T ss_dssp             TCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEE
T ss_pred             CCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEE
Confidence            999999997542                       278899999999999999999999999999999999999999999


Q ss_pred             EeeeccceecCCC
Q psy3273         124 ISDLGLACDFSKK  136 (145)
Q Consensus       124 l~dfg~~~~~~~~  136 (145)
                      ++|||++..+...
T Consensus       213 L~Dfg~~~~~~~~  225 (344)
T 1rjb_A          213 ICDFGLARDIMSD  225 (344)
T ss_dssp             ECCCGGGSCGGGC
T ss_pred             eCCCccCcccccC
Confidence            9999999866543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=8.4e-27  Score=167.41  Aligned_cols=134  Identities=17%  Similarity=0.285  Sum_probs=118.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+++|.          ...+.++...++.++||||+++++++..++..++||||++++++.
T Consensus        33 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~  112 (331)
T 4aaa_A           33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILD  112 (331)
T ss_dssp             GGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHH
T ss_pred             EeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHH
Confidence            6889999999999999999999973          234556777888999999999999999999999999999998888


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+......+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..+..
T Consensus       113 ~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          113 DLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             HHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             HHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            8877777899999999999999999999999999999999999999999999999999976543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.94  E-value=2.1e-26  Score=165.06  Aligned_cols=131  Identities=20%  Similarity=0.264  Sum_probs=117.0

Q ss_pred             eeeeeeeEEEEEEEcccCCee--eeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETL--ALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~--~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|.+..++..+  ++|.         ...+.++...++.+ +||||+++++++..++..|+|||++++++
T Consensus        33 lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  112 (327)
T 1fvr_A           33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN  112 (327)
T ss_dssp             EECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred             eecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCC
Confidence            689999999999999988755  5542         33456677788888 99999999999999999999999999999


Q ss_pred             HHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          70 LHYHLSQHG----------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        70 l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      |.+++....                .+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..
T Consensus       113 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~  191 (327)
T 1fvr_A          113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG  191 (327)
T ss_dssp             HHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEES
T ss_pred             HHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcc
Confidence            999997543                689999999999999999999999999999999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.94  E-value=5.7e-26  Score=162.73  Aligned_cols=135  Identities=21%  Similarity=0.318  Sum_probs=120.0

Q ss_pred             eeeeeeeEEEEEE----EcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEE--cCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCS----HVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFH--TPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~----~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.    +..+++.+++|.        ...+.++...++.++||||+++++++.  .....++||||+++
T Consensus        31 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~  110 (327)
T 3lxl_A           31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS  110 (327)
T ss_dssp             EEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTT
T ss_pred             ccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCC
Confidence            6899999999999    567888888873        344677888899999999999999987  45679999999999


Q ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          68 GDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        68 ~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++|.+++.. ...+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..+...
T Consensus       111 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          111 GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            999999976 456999999999999999999999999999999999999999999999999999876543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.94  E-value=2.6e-26  Score=162.10  Aligned_cols=134  Identities=22%  Similarity=0.261  Sum_probs=118.8

Q ss_pred             eeeeeeeEEEEEEE--cccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSH--VKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~--~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|..  ..+++.+++|.          ...+.++...++.++||||+++++++ ..+..++|||++++++
T Consensus        25 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~  103 (291)
T 1xbb_A           25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGP  103 (291)
T ss_dssp             EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred             cccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCC
Confidence            68999999999954  55667787763          34566777888999999999999999 5667899999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.+++.....+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..+...
T Consensus       104 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A          104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             HHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            9999998888999999999999999999999999999999999999999999999999999876544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.94  E-value=5.9e-26  Score=161.59  Aligned_cols=135  Identities=21%  Similarity=0.351  Sum_probs=118.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS   75 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~   75 (145)
                      +|.|+||.||+|.+..+++.+++|.      ...+.++...++.++||||+++++++..++..|++|||+++++|.+++.
T Consensus        37 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~  116 (314)
T 3com_A           37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR  116 (314)
T ss_dssp             CC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHH
Confidence            6889999999999999999999974      3445667778889999999999999999999999999999999999987


Q ss_pred             -hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          76 -QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        76 -~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                       ....+++..+..++.|++.++.++|..+++|+||+|+||+++.++.++++|||++..+...
T Consensus       117 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          117 LRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             HHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence             4567999999999999999999999999999999999999999999999999999876543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.94  E-value=8e-27  Score=164.18  Aligned_cols=135  Identities=17%  Similarity=0.180  Sum_probs=122.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|++|.||+|.+..+++.+++|.       ...+.++...++.++||||+++++++..++..++|||++++++|.+++
T Consensus        21 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~  100 (288)
T 3kfa_A           21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL  100 (288)
T ss_dssp             SGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred             cCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHH
Confidence            5889999999999999999999863       455667788889999999999999999999999999999999999999


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ...  ..+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++......
T Consensus       101 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A          101 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             HHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             HhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            763  45899999999999999999999999999999999999999999999999999765543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.94  E-value=6.7e-26  Score=161.49  Aligned_cols=132  Identities=22%  Similarity=0.319  Sum_probs=116.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEE----cCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFH----TPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~----~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|.+..+++.+++|.        ...+.++...++.++||||+++++++.    .....+++|||+++++
T Consensus        37 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~  116 (317)
T 2buj_A           37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT  116 (317)
T ss_dssp             EEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCB
T ss_pred             ecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCc
Confidence            6899999999999999999999973        445667778889999999999999987    3458999999999999


Q ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |.+++..    ...+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++...
T Consensus       117 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          117 LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             HHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9998875    466999999999999999999999999999999999999999999999999987654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.94  E-value=4.1e-26  Score=160.91  Aligned_cols=135  Identities=22%  Similarity=0.289  Sum_probs=120.6

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      ++|.|+||.||+|.+..+++.+++|.        ...+.++...++.++||||+++++++..++..+++||++++++|.+
T Consensus        29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  108 (295)
T 2clq_A           29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA  108 (295)
T ss_dssp             EEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHH
T ss_pred             EEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHH
Confidence            36999999999999999999999873        4456677788899999999999999999999999999999999999


Q ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-CCCEEEeeeccceecCC
Q psy3273          73 HLSQH---GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-HGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-~~~~~l~dfg~~~~~~~  135 (145)
                      ++...   ..+++..+..++.|++.++.++|+.+++|+||+|+||+++. .+.++++|||++..+..
T Consensus       109 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          109 LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             HHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             HHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            99754   24678888999999999999999999999999999999987 78999999999987654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.94  E-value=2.8e-26  Score=165.24  Aligned_cols=136  Identities=24%  Similarity=0.397  Sum_probs=114.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----HHHHhhhhhcccCCCCceeEeeEEEEc----CCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----IMLSLVSTGIQMVDCPFIVCMTYAFHT----PDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|+||.||+|.+..+++.+|+|..    ...++....++.++||||+++++++..    +...++||||+++++|.++
T Consensus        37 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~  116 (336)
T 3fhr_A           37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR  116 (336)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHH
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHH
Confidence            69999999999999999999999742    233334445667799999999999976    4568999999999999999


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC---CCCEEEeeeccceecCCCC
Q psy3273          74 LSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE---HGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        74 l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~  137 (145)
                      +...  ..+++..+..++.|++.++.|+|+++++|+||+|+||+++.   ...++++|||++.......
T Consensus       117 l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~  185 (336)
T 3fhr_A          117 IQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA  185 (336)
T ss_dssp             HHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc
Confidence            9865  36999999999999999999999999999999999999975   3459999999998765443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=5.4e-26  Score=166.46  Aligned_cols=132  Identities=20%  Similarity=0.320  Sum_probs=108.6

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCC-CCceeEeeEEEEcCC--EEEEEEEccCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVD-CPFIVCMTYAFHTPD--KLCFILDLMNG   67 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~-hp~i~~~~~~~~~~~--~~~lv~e~~~~   67 (145)
                      .+|.|+||.||+|.+..+++.+|+|..          ....++...++.+. ||||+++++++..++  .+|+||||++ 
T Consensus        16 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-   94 (388)
T 3oz6_A           16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-   94 (388)
T ss_dssp             C-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-
T ss_pred             EeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-
Confidence            368999999999999999999999742          22345556667776 999999999998654  7999999997 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++|...+.. ..+++.....++.|++.|+.|+|+.+++|+||||+||+++.++.++++|||+|+.+.
T Consensus        95 ~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           95 TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            589888875 578999999999999999999999999999999999999999999999999998764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.94  E-value=3.9e-26  Score=160.67  Aligned_cols=134  Identities=25%  Similarity=0.461  Sum_probs=109.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+++|..          ..+.++...++.++||||+++++++..++..++||||+++ +|.
T Consensus        15 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~   93 (290)
T 3fme_A           15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLD   93 (290)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHH
T ss_pred             cCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chH
Confidence            68999999999999999999999732          2233444457788999999999999999999999999975 887


Q ss_pred             HHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLS----QHGVFNEDEMRFYAAEVILGLEHMHRR-YIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~-~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +++.    ....+++..+..++.|++.++.|+|++ +++|+||+|+||+++..+.++++|||++..+...
T Consensus        94 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           94 KFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD  163 (290)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence            7664    346799999999999999999999998 9999999999999999999999999999765443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.94  E-value=5.5e-26  Score=163.32  Aligned_cols=135  Identities=21%  Similarity=0.235  Sum_probs=116.6

Q ss_pred             eeeeeeeEEEEEEEc-------ccCCeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHV-------KQGETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      +|.|+||.||+|.+.       .+++.+++|.         ...+.++...++.+ +||||+++++++..++..|+||||
T Consensus        43 lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~  122 (334)
T 2pvf_A           43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY  122 (334)
T ss_dssp             EEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEEC
T ss_pred             EeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEEC
Confidence            689999999999986       4567788863         33455667777888 999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          65 MNGGDLHYHLSQHG----------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        65 ~~~~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                      +++++|.+++....                .+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||
T Consensus       123 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  202 (334)
T 2pvf_A          123 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG  202 (334)
T ss_dssp             CTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEcccc
Confidence            99999999997543                38889999999999999999999999999999999999999999999999


Q ss_pred             cceecCCC
Q psy3273         129 LACDFSKK  136 (145)
Q Consensus       129 ~~~~~~~~  136 (145)
                      ++..+...
T Consensus       203 ~~~~~~~~  210 (334)
T 2pvf_A          203 LARDINNI  210 (334)
T ss_dssp             TCEECTTT
T ss_pred             cccccccc
Confidence            99876543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.94  E-value=1.8e-26  Score=165.56  Aligned_cols=134  Identities=22%  Similarity=0.261  Sum_probs=114.4

Q ss_pred             eeeeeeeEEEEEEEcccCCee----eeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETL----ALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~----~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +|.|+||.||+|.+..+++.+    ++|.         ...+.++...++.++||||+++++++..+. .++++|+++++
T Consensus        23 lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g  101 (327)
T 3poz_A           23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFG  101 (327)
T ss_dssp             EEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTC
T ss_pred             EeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCC
Confidence            699999999999998887755    4442         334566777889999999999999999765 77899999999


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          69 DLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        69 ~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +|.+++.. ...+++..+..++.|++.++.|+|+.+++|+||||+||+++.++.++++|||+++.+...
T Consensus       102 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A          102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             BHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            99999976 456999999999999999999999999999999999999999999999999999866543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.94  E-value=1.4e-26  Score=166.00  Aligned_cols=132  Identities=23%  Similarity=0.339  Sum_probs=117.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH---------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI---------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||+|.+..+++.+++|...         .+.++...++.++||||+++++++..++..++||||+++ +|.+
T Consensus        10 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~   88 (324)
T 3mtl_A           10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQ   88 (324)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHH
T ss_pred             EcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHH
Confidence            699999999999999999999997432         223566778899999999999999999999999999975 8888


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++... ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++....
T Consensus        89 ~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           89 YLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             HHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            88754 458999999999999999999999999999999999999999999999999997554

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.94  E-value=5.2e-27  Score=170.97  Aligned_cols=132  Identities=19%  Similarity=0.186  Sum_probs=113.4

Q ss_pred             eeeeeeeEEEEEE-----EcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCS-----HVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~-----~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.     +..+++.+|+|..         ..+.++...++.++||||+++++++..++..++||||+++
T Consensus        79 LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~  158 (367)
T 3l9p_A           79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG  158 (367)
T ss_dssp             CCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCC
Confidence            6899999999999     4557778888742         2345667778899999999999999999999999999999


Q ss_pred             CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC---CCEEEeeeccceec
Q psy3273          68 GDLHYHLSQH-------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH---GHVRISDLGLACDF  133 (145)
Q Consensus        68 ~~l~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~---~~~~l~dfg~~~~~  133 (145)
                      ++|.+++...       ..+++..+..++.|++.|+.|+|+++++|+||+|+||+++..   ..++++|||+++.+
T Consensus       159 g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~  234 (367)
T 3l9p_A          159 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI  234 (367)
T ss_dssp             EEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred             CCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccccc
Confidence            9999999754       348899999999999999999999999999999999999844   45999999999754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.94  E-value=1.1e-25  Score=160.04  Aligned_cols=134  Identities=25%  Similarity=0.375  Sum_probs=113.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|++|.||+|.+..+++.+++|.           ...+.++...++.++||||+++++++..++..+++||++++++|
T Consensus        40 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  119 (310)
T 2wqm_A           40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL  119 (310)
T ss_dssp             EECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBH
T ss_pred             ecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCH
Confidence            6899999999999999999999873           23456677788999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++..    ...+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..+..
T Consensus       120 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             HHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            998863    45689999999999999999999999999999999999999999999999999876543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=3.9e-26  Score=161.21  Aligned_cols=134  Identities=21%  Similarity=0.265  Sum_probs=116.5

Q ss_pred             eeeeeeeEEEEEEEcccCC---eeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEE-EEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE---TLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKL-CFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~---~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~-~lv~e~~~~~   68 (145)
                      +|.|+||.||+|....+++   .+++|         ..+.+.++...++.++||||+++++++...+.. +++||++.++
T Consensus        29 lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~  108 (298)
T 3pls_A           29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHG  108 (298)
T ss_dssp             EEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTC
T ss_pred             eccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCC
Confidence            6999999999999866654   56665         234556777788999999999999999876654 9999999999


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++.. ...+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||+++.+..
T Consensus       109 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          109 DLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             BHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999976 45689999999999999999999999999999999999999999999999999975543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.94  E-value=5.3e-27  Score=171.29  Aligned_cols=132  Identities=14%  Similarity=0.089  Sum_probs=111.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhh---hhcccCCCCceeEee-------EEEEcCC----
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVS---TGIQMVDCPFIVCMT-------YAFHTPD----   56 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~---~~~~~l~hp~i~~~~-------~~~~~~~----   56 (145)
                      +|.|+||.||+|.+..+++.+|+|..           ..+.++.   ..++.++||||++++       ++++.++    
T Consensus        81 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~  160 (377)
T 3byv_A           81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM  160 (377)
T ss_dssp             EEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSE
T ss_pred             eecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccc
Confidence            68999999999999999999999752           4456666   566777999999998       7776554    


Q ss_pred             -------------EEEEEEEccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE
Q psy3273          57 -------------KLCFILDLMNGGDLHYHLSQHGVFNE-------DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL  116 (145)
Q Consensus        57 -------------~~~lv~e~~~~~~l~~~l~~~~~~~~-------~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~  116 (145)
                                   ..|++|||+ +|+|.+++.....+++       .....++.|++.|+.|+|+++++|+||||+||++
T Consensus       161 ~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll  239 (377)
T 3byv_A          161 IRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL  239 (377)
T ss_dssp             EEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             cccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence                         289999999 5799999986444444       7777899999999999999999999999999999


Q ss_pred             CCCCCEEEeeeccceecC
Q psy3273         117 DEHGHVRISDLGLACDFS  134 (145)
Q Consensus       117 ~~~~~~~l~dfg~~~~~~  134 (145)
                      +.++.++|+|||+++...
T Consensus       240 ~~~~~~kL~DFG~a~~~~  257 (377)
T 3byv_A          240 DQRGGVFLTGFEHLVRDG  257 (377)
T ss_dssp             CTTCCEEECCGGGCEETT
T ss_pred             cCCCCEEEEechhheecC
Confidence            999999999999998643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.94  E-value=9.6e-26  Score=159.86  Aligned_cols=134  Identities=23%  Similarity=0.364  Sum_probs=122.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|++|.||+|.+..+++.+++|.         ...+.++...++.++||||+++++++..++..++||||+++++|.+
T Consensus        30 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  109 (303)
T 3a7i_A           30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD  109 (303)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHH
T ss_pred             hcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHH
Confidence            6899999999999999999999873         3556677778889999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++.. ..+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..+...
T Consensus       110 ~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          110 LLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             HHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            8864 57899999999999999999999999999999999999999999999999999876543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.94  E-value=1e-25  Score=161.29  Aligned_cols=133  Identities=17%  Similarity=0.286  Sum_probs=118.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----HHHHHhhhhhcccCC-CCceeEeeEEEEc--CCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----RIMLSLVSTGIQMVD-CPFIVCMTYAFHT--PDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~-hp~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~   73 (145)
                      +|.|+||.||+|.+..+++.+++|.     ...+.++...++.++ ||||+++++++..  ....+++||++++++|.++
T Consensus        44 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~  123 (330)
T 3nsz_A           44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL  123 (330)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHH
T ss_pred             ecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHH
Confidence            6999999999999999999999974     455667777788886 9999999999997  5689999999999999888


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC-CEEEeeeccceecCCCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK  137 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~  137 (145)
                      +.   .+++..+..++.|++.++.|+|+++++|+||+|+||+++.++ .++++|||++..+....
T Consensus       124 ~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          124 YQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             GG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             HH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            75   388999999999999999999999999999999999998666 89999999998765443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.94  E-value=1e-25  Score=163.22  Aligned_cols=133  Identities=22%  Similarity=0.339  Sum_probs=115.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccC-----CCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMV-----DCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l-----~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|.+..+++.+|+|..       .....+...++.+     +||||+++++++...+..++|||++ +++
T Consensus        43 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~  121 (360)
T 3llt_A           43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPS  121 (360)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCB
T ss_pred             EcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCC
Confidence            69999999999999999999999742       2334455555555     4999999999999999999999999 889


Q ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-------------------------CCCE
Q psy3273          70 LHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-------------------------HGHV  122 (145)
Q Consensus        70 l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-------------------------~~~~  122 (145)
                      |.+++....  .+++..+..++.|++.|+.|+|+++++|+||||+||+++.                         ...+
T Consensus       122 L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (360)
T 3llt_A          122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI  201 (360)
T ss_dssp             HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCE
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCE
Confidence            999997643  5899999999999999999999999999999999999975                         6789


Q ss_pred             EEeeeccceecCC
Q psy3273         123 RISDLGLACDFSK  135 (145)
Q Consensus       123 ~l~dfg~~~~~~~  135 (145)
                      +++|||++.....
T Consensus       202 kl~DFG~a~~~~~  214 (360)
T 3llt_A          202 KLIDFGCATFKSD  214 (360)
T ss_dssp             EECCCTTCEETTS
T ss_pred             EEEeccCceecCC
Confidence            9999999986543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.94  E-value=8.7e-27  Score=167.04  Aligned_cols=134  Identities=19%  Similarity=0.247  Sum_probs=114.8

Q ss_pred             eeeeeeeEEEEEEEcccCCe----eeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGET----LALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +|.|+||.||+|.+..+++.    +++|..         ..+.++...++.++||||+++++++. ++..++||||++++
T Consensus        21 lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~   99 (325)
T 3kex_A           21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLG   99 (325)
T ss_dssp             EECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTC
T ss_pred             eeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCC
Confidence            69999999999999988876    444421         22345556677889999999999986 45689999999999


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          69 DLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        69 ~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +|.+++... ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++..+.++++|||+++.+...
T Consensus       100 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A          100 SLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             BSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             CHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            999998764 56889999999999999999999999999999999999999999999999999876543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.94  E-value=4.2e-28  Score=174.52  Aligned_cols=131  Identities=14%  Similarity=0.046  Sum_probs=106.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------------HHHHhhhhhcccCC---------CCceeEeeEE-----
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------------IMLSLVSTGIQMVD---------CPFIVCMTYA-----   51 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~l~---------hp~i~~~~~~-----   51 (145)
                      +|.|+||.||+|.+  +++.+|+|..                ..+.++...++.++         ||||+++.++     
T Consensus        28 lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~  105 (336)
T 2vuw_A           28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQG  105 (336)
T ss_dssp             EEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEES
T ss_pred             ecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecC
Confidence            69999999999998  6788888642                44555665555554         6666665555     


Q ss_pred             ------------EEc-------------CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hCCce
Q psy3273          52 ------------FHT-------------PDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH-RRYIV  105 (145)
Q Consensus        52 ------------~~~-------------~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~ii  105 (145)
                                  |.+             ++.+|+||||+++|++.+.+.. ..+++..+..++.|++.|+.|+| +++++
T Consensus       106 ~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~iv  184 (336)
T 2vuw_A          106 SYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFE  184 (336)
T ss_dssp             SCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCB
T ss_pred             CCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEe
Confidence                        333             6789999999999976666643 56899999999999999999999 99999


Q ss_pred             ecCCCCCcEEECCCC--------------------CEEEeeeccceecCC
Q psy3273         106 YRDLKPANILLDEHG--------------------HVRISDLGLACDFSK  135 (145)
Q Consensus       106 h~~l~~~nil~~~~~--------------------~~~l~dfg~~~~~~~  135 (145)
                      |+||||+||+++..+                    .+||+|||+|+.+..
T Consensus       185 HrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~  234 (336)
T 2vuw_A          185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD  234 (336)
T ss_dssp             CSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred             ECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence            999999999998776                    899999999987654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2.1e-26  Score=167.85  Aligned_cols=132  Identities=20%  Similarity=0.325  Sum_probs=112.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCC------EEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD------KLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~------~~~lv~e~~   65 (145)
                      +|.|+||.||+|.+..+++.+|+|..          ..+.++...++.++||||+++++++..++      .+|+|||++
T Consensus        33 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~  112 (367)
T 1cm8_A           33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM  112 (367)
T ss_dssp             C------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC
T ss_pred             eeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC
Confidence            68999999999999999999999743          34556777889999999999999998763      469999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                       +++|.+++.. ..+++..+..++.|++.|+.|+|+.+++|+||+|+||+++.++.++++|||+++....
T Consensus       113 -~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          113 -GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             -SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             -CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence             7799998876 5789999999999999999999999999999999999999999999999999987643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.94  E-value=1.8e-26  Score=178.44  Aligned_cols=134  Identities=22%  Similarity=0.263  Sum_probs=118.0

Q ss_pred             eeeeeeeEEEEEEE--cccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSH--VKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~--~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|..  ..+++.+|+|.          ...+.++...++.++||||+++++++.. +..++||||+++++
T Consensus       377 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~  455 (635)
T 4fl3_A          377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGP  455 (635)
T ss_dssp             EEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             eccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCC
Confidence            69999999999954  45667888763          3456677788899999999999999975 45889999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.+++.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++|+|||+++.+...
T Consensus       456 L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          456 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             HHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            9999988888999999999999999999999999999999999999999999999999999866443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.94  E-value=2.8e-26  Score=164.53  Aligned_cols=134  Identities=19%  Similarity=0.245  Sum_probs=118.1

Q ss_pred             eeeeeeeEEEEEEEcccCC-----eeeee---------HHHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE-----TLALN---------ERIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~-----~~~~~---------~~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +|.|+||.||+|.+..+++     .+++|         ....+.++...++.+ +||||+++++++..++..++||||++
T Consensus        54 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~  133 (333)
T 2i1m_A           54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC  133 (333)
T ss_dssp             EEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCC
Confidence            6899999999999987665     56665         234566777788888 89999999999999999999999999


Q ss_pred             CCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          67 GGDLHYHLSQH--------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        67 ~~~l~~~l~~~--------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      +++|.+++...              ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++..
T Consensus       134 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  213 (333)
T 2i1m_A          134 YGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD  213 (333)
T ss_dssp             TEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCC
T ss_pred             CCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccc
Confidence            99999998642              3578999999999999999999999999999999999999999999999999986


Q ss_pred             cCC
Q psy3273         133 FSK  135 (145)
Q Consensus       133 ~~~  135 (145)
                      +..
T Consensus       214 ~~~  216 (333)
T 2i1m_A          214 IMN  216 (333)
T ss_dssp             GGG
T ss_pred             ccc
Confidence            644

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.94  E-value=4.1e-26  Score=170.91  Aligned_cols=132  Identities=19%  Similarity=0.326  Sum_probs=111.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcC------CEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTP------DKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~------~~~~lv~e~~   65 (145)
                      +|.|+||.||+|.+..+++.+|+|..          ..+.++...++.++||||+++++++...      ..+|+||||+
T Consensus        70 lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~  149 (464)
T 3ttj_A           70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM  149 (464)
T ss_dssp             EEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECC
T ss_pred             eecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCC
Confidence            69999999999999999999999742          3345677778899999999999999754      4689999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++ ++...+.  ..+++..+..++.|++.|+.|+|+.+++|+||||+||+++.++.++|+|||+++.....
T Consensus       150 ~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  217 (464)
T 3ttj_A          150 DA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  217 (464)
T ss_dssp             SE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred             CC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence            76 5666654  34899999999999999999999999999999999999999999999999999876543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=5e-26  Score=163.69  Aligned_cols=134  Identities=17%  Similarity=0.176  Sum_probs=113.0

Q ss_pred             eeeeeeeEEEEEEEcccCC----eeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE----TLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +|.|+||.||+|....++.    .+++|.         ...+.++...++.++||||+++++++...+..++|||+++++
T Consensus        52 lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  131 (333)
T 1mqb_A           52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG  131 (333)
T ss_dssp             EEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred             EecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCC
Confidence            6899999999998876543    366652         334567777889999999999999999999999999999999


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++... ..+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..+..
T Consensus       132 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          132 ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999764 6799999999999999999999999999999999999999999999999999986643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.94  E-value=1.4e-25  Score=158.33  Aligned_cols=133  Identities=20%  Similarity=0.253  Sum_probs=118.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEc-------------CCEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHT-------------PDKLCFI   61 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~-------------~~~~~lv   61 (145)
                      +|.|+||.||+|.+..+++.+++|.       ...+.++...++.++||||+++++++..             ++..|++
T Consensus        14 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv   93 (303)
T 1zy4_A           14 LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQ   93 (303)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEE
T ss_pred             eccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEE
Confidence            6899999999999999999999873       3455677788899999999999998865             4579999


Q ss_pred             EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          62 LDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        62 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |||+++++|.+++... ..+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++..+.
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  167 (303)
T 1zy4_A           94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH  167 (303)
T ss_dssp             EECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTT
T ss_pred             EecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcc
Confidence            9999999999999854 357888999999999999999999999999999999999999999999999997654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.8e-26  Score=166.73  Aligned_cols=133  Identities=25%  Similarity=0.396  Sum_probs=118.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-------------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-------------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +|.|+||.||+|.+..+++.+++|...             .+.++...++.++||||+++++++..++..++||||+++ 
T Consensus        18 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-   96 (346)
T 1ua2_A           18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-   96 (346)
T ss_dssp             EEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-
T ss_pred             EeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-
Confidence            689999999999999999999997532             344667778899999999999999999999999999976 


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|...+... ..+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus        97 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A           97 DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  164 (346)
T ss_dssp             EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence            888887654 4588899999999999999999999999999999999999999999999999987644

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.94  E-value=6.2e-26  Score=162.80  Aligned_cols=135  Identities=20%  Similarity=0.377  Sum_probs=117.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+++|.          ...+.++...++.+ .||||+++++++..++..++||||+++++|
T Consensus        37 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  116 (327)
T 3lm5_A           37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI  116 (327)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEG
T ss_pred             eCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcH
Confidence            6899999999999999999999863          33445566666666 569999999999999999999999999999


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC---CCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE---HGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++...  ..+++..+..++.|++.++.++|+++++|+||+|+||+++.   .+.++++|||++..+...
T Consensus       117 ~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          117 FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             GGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence            9988543  66999999999999999999999999999999999999987   688999999999876544

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.94  E-value=4e-26  Score=165.93  Aligned_cols=134  Identities=16%  Similarity=0.147  Sum_probs=111.7

Q ss_pred             eeeeeeeEEEEEEEccc-----CCeeeeeH-----------HHHHHhhh--------hhcccCCCCceeEeeEEEEcC--
Q psy3273           2 FFIVGTGFLSNCSHVKQ-----GETLALNE-----------RIMLSLVS--------TGIQMVDCPFIVCMTYAFHTP--   55 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~-----~~~~~~~~-----------~~~~~~~~--------~~~~~l~hp~i~~~~~~~~~~--   55 (145)
                      +|.|+||.||+|.+..+     ++.+++|.           ...+++..        ..++.++||||+++++++...  
T Consensus        43 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  122 (364)
T 3op5_A           43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKN  122 (364)
T ss_dssp             CCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEET
T ss_pred             EecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccC
Confidence            68999999999988765     47777763           22222221        235678999999999998764  


Q ss_pred             --CEEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC--CCCCEEEeeeccc
Q psy3273          56 --DKLCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD--EHGHVRISDLGLA  130 (145)
Q Consensus        56 --~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~--~~~~~~l~dfg~~  130 (145)
                        ...|+||||+ +++|.+++... ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++  ....++|+|||++
T Consensus       123 ~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a  201 (364)
T 3op5_A          123 GKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA  201 (364)
T ss_dssp             TEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTC
T ss_pred             CcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcc
Confidence              4689999999 99999999765 6799999999999999999999999999999999999998  7889999999999


Q ss_pred             eecCCC
Q psy3273         131 CDFSKK  136 (145)
Q Consensus       131 ~~~~~~  136 (145)
                      +.+...
T Consensus       202 ~~~~~~  207 (364)
T 3op5_A          202 YRYCPE  207 (364)
T ss_dssp             EESSGG
T ss_pred             eecccC
Confidence            876543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.94  E-value=3.5e-26  Score=161.68  Aligned_cols=133  Identities=26%  Similarity=0.385  Sum_probs=108.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|++|.||+|.+..+++.+++|..         ..+.++...++.++||||+++++++..++..++||||+++++|.+
T Consensus        23 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  102 (303)
T 2vwi_A           23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD  102 (303)
T ss_dssp             CC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHH
T ss_pred             eccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHH
Confidence            68999999999999999999999742         234456667888999999999999999999999999999999999


Q ss_pred             HHHh--------cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          73 HLSQ--------HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        73 ~l~~--------~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ++..        ...+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++..+.
T Consensus       103 ~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A          103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             HHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             HHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            8863        3458999999999999999999999999999999999999999999999999987553

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.94  E-value=3.4e-26  Score=160.71  Aligned_cols=133  Identities=18%  Similarity=0.247  Sum_probs=108.8

Q ss_pred             eeeeeeeEEEEEEEccc---CCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQ---GETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|.+..+   +..+++|.         ...+.++...++.++||||+++++++. ++..|+||||+++++
T Consensus        23 lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~  101 (281)
T 1mp8_A           23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGE  101 (281)
T ss_dssp             EEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEE
T ss_pred             eeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCC
Confidence            68999999999998764   34577753         344667777888999999999999984 567899999999999


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |.+++... ..+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus       102 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A          102 LRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             HHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            99999764 4689999999999999999999999999999999999999999999999999986644

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.94  E-value=1.1e-25  Score=167.95  Aligned_cols=131  Identities=20%  Similarity=0.216  Sum_probs=116.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCCCceeEeeEEEEcCC-EEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD-KLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~-~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|+||.||++...  ++.+|+|.      ...+.++...++.++||||+++++++..++ ..|+||||+++++|.+++
T Consensus       201 lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l  278 (450)
T 1k9a_A          201 IGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL  278 (450)
T ss_dssp             EEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHH
T ss_pred             ecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHH
Confidence            689999999999875  66788863      345677888899999999999999987665 799999999999999999


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          75 SQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        75 ~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ...+  .+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||+++...
T Consensus       279 ~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          279 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             HHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            8643  37899999999999999999999999999999999999999999999999998653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.94  E-value=1.8e-26  Score=166.31  Aligned_cols=133  Identities=19%  Similarity=0.252  Sum_probs=120.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------------------------HHHHhhhhhcccCCCCceeEeeEEEEcCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------------------------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD   56 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~   56 (145)
                      +|.|++|.||+|.+  +++.+++|..                         ..+.++...++.++||||+++++++..++
T Consensus        39 lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  116 (348)
T 2pml_X           39 LNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYD  116 (348)
T ss_dssp             EECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSS
T ss_pred             EcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence            68999999999999  8888888632                         56677888899999999999999999999


Q ss_pred             EEEEEEEccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeee
Q psy3273          57 KLCFILDLMNGGDLHYH------LSQ--HGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDL  127 (145)
Q Consensus        57 ~~~lv~e~~~~~~l~~~------l~~--~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~df  127 (145)
                      ..|+||||+++++|.++      +..  ...+++..+..++.|++.++.|+|+ ++++|+||+|+||+++.++.++++||
T Consensus       117 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~df  196 (348)
T 2pml_X          117 EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDF  196 (348)
T ss_dssp             EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEecc
Confidence            99999999999999988      654  5679999999999999999999999 99999999999999999999999999


Q ss_pred             ccceecCCC
Q psy3273         128 GLACDFSKK  136 (145)
Q Consensus       128 g~~~~~~~~  136 (145)
                      |.+......
T Consensus       197 g~~~~~~~~  205 (348)
T 2pml_X          197 GESEYMVDK  205 (348)
T ss_dssp             TTCEECBTT
T ss_pred             ccccccccc
Confidence            999876443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.94  E-value=1.9e-25  Score=157.33  Aligned_cols=135  Identities=24%  Similarity=0.360  Sum_probs=121.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|++|.||+|.+..+++.+++|.          ...+.++...++.++||||+++++++..++..+++||++++++|.
T Consensus        30 lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  109 (287)
T 2wei_A           30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF  109 (287)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             EcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHH
Confidence            6899999999999999999999864          344567777889999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC---CCEEEeeeccceecCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH---GHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~---~~~~l~dfg~~~~~~~~  136 (145)
                      +.+.....+++..+..++.|++.++.++|+++++|+||+|+||+++..   ..++++|||++......
T Consensus       110 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A          110 DEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            998877789999999999999999999999999999999999999754   46999999999765443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.94  E-value=7.5e-26  Score=160.00  Aligned_cols=134  Identities=19%  Similarity=0.205  Sum_probs=113.8

Q ss_pred             eeeeeeeEEEEEEEcccC---Ceeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEE-cCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQG---ETLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFH-TPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~-~~~~~~lv~e~~~~~   68 (145)
                      +|.|+||.||+|....++   ..+++|         ....+.++...++.++||||+++++++. .++..+++||+++++
T Consensus        33 lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~  112 (298)
T 3f66_A           33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG  112 (298)
T ss_dssp             EEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTC
T ss_pred             eeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCC
Confidence            699999999999976544   235554         2345667778889999999999999864 556889999999999


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++.. ...+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus       113 ~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          113 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             BHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999975 45589999999999999999999999999999999999999999999999999986644

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.94  E-value=7.3e-26  Score=159.29  Aligned_cols=131  Identities=22%  Similarity=0.285  Sum_probs=116.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +|.|+||.||+|.+..+++.+++|..               ..+.++...++.++||||+++++++....  +++|||++
T Consensus        27 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~  104 (287)
T 4f0f_A           27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVP  104 (287)
T ss_dssp             CCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCT
T ss_pred             cccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecC
Confidence            68999999999999999999999753               56677888899999999999999998766  69999999


Q ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEECCCCC-----EEEeeeccceecC
Q psy3273          67 GGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRY--IVYRDLKPANILLDEHGH-----VRISDLGLACDFS  134 (145)
Q Consensus        67 ~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~--iih~~l~~~nil~~~~~~-----~~l~dfg~~~~~~  134 (145)
                      +++|.+.+.. ...+++.....++.|++.++.|+|+.+  ++|+||+|+||+++....     ++++|||+++...
T Consensus       105 ~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~  180 (287)
T 4f0f_A          105 CGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV  180 (287)
T ss_dssp             TCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS
T ss_pred             CCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccc
Confidence            9999888865 356999999999999999999999999  999999999999987665     9999999997543

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.94  E-value=9.8e-26  Score=159.35  Aligned_cols=133  Identities=23%  Similarity=0.370  Sum_probs=119.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|++|.||+|.+..+++.+++|..          ..+.++...++.++||||+++++++..++..|++||+++ ++|.
T Consensus        11 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~   89 (299)
T 2r3i_A           11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK   89 (299)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred             hccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEEccc-CCHH
Confidence            68999999999999999999999743          345567778899999999999999999999999999997 5999


Q ss_pred             HHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++...  ..+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..+..
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  155 (299)
T 2r3i_A           90 KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  155 (299)
T ss_dssp             HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             HHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence            988754  4689999999999999999999999999999999999999999999999999976543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.94  E-value=5.4e-26  Score=162.61  Aligned_cols=133  Identities=23%  Similarity=0.221  Sum_probs=118.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      +|.|+||.||+|.. .+++.+++|..         ..+.++...++.++||||+++++++..++..++||||+++++|.+
T Consensus        38 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  116 (326)
T 3uim_A           38 LGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS  116 (326)
T ss_dssp             EECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHH
T ss_pred             EecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHH
Confidence            68999999999974 46888888632         145677788899999999999999999999999999999999999


Q ss_pred             HHHhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          73 HLSQH----GVFNEDEMRFYAAEVILGLEHMHRR---YIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~---~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++...    ..+++..+..++.|++.++.|+|+.   +++|+||+|+||+++.++.++++|||++..+..
T Consensus       117 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  186 (326)
T 3uim_A          117 CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY  186 (326)
T ss_dssp             HHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCS
T ss_pred             HHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCc
Confidence            99753    2489999999999999999999999   999999999999999999999999999987653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.94  E-value=8.8e-26  Score=161.18  Aligned_cols=134  Identities=21%  Similarity=0.259  Sum_probs=117.8

Q ss_pred             eeeeeeeEEEEEEEc-----ccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHV-----KQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.+.     .+++.+++|.         ...+.++...++.++||||+++++++..++..++|||++++
T Consensus        33 lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  112 (322)
T 1p4o_A           33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR  112 (322)
T ss_dssp             EEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCC
Confidence            689999999999876     3567777763         33456777889999999999999999999999999999999


Q ss_pred             CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          68 GDLHYHLSQH----------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        68 ~~l~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++|.+++...          ..+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus       113 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~  190 (322)
T 1p4o_A          113 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE  190 (322)
T ss_dssp             CBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGG
T ss_pred             CcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcccccccc
Confidence            9999998642          3568899999999999999999999999999999999999999999999999976543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.94  E-value=5.2e-26  Score=158.76  Aligned_cols=134  Identities=24%  Similarity=0.391  Sum_probs=109.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|.+.  ++.+++|.            ...+.++...++.++||||+++++++..++..+++|||+++++
T Consensus        15 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   92 (271)
T 3dtc_A           15 IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGP   92 (271)
T ss_dssp             EEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEE
T ss_pred             eccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCC
Confidence            689999999999975  66777753            2445667778889999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC---ceecCCCCCcEEECC--------CCCEEEeeeccceecCCCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY---IVYRDLKPANILLDE--------HGHVRISDLGLACDFSKKKP  138 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---iih~~l~~~nil~~~--------~~~~~l~dfg~~~~~~~~~~  138 (145)
                      |.+++. ...+++..+..++.|++.++.++|+.+   ++|+||+|+||+++.        ...++++|||++..+.....
T Consensus        93 L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~  171 (271)
T 3dtc_A           93 LNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK  171 (271)
T ss_dssp             HHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------
T ss_pred             HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc
Confidence            988875 457899999999999999999999999   889999999999985        66799999999986654433

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.94  E-value=7.7e-26  Score=162.44  Aligned_cols=133  Identities=21%  Similarity=0.251  Sum_probs=113.9

Q ss_pred             eeeeeeeEEEEEEEcccCCee----eee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETL----ALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~----~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +|.|+||.||+|.+..+++.+    ++|         ....+.++...++.++||||+++++++..+. .+++++++.++
T Consensus        23 lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g  101 (327)
T 3lzb_A           23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFG  101 (327)
T ss_dssp             EEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSC
T ss_pred             eeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCC
Confidence            699999999999999888765    333         2455677888899999999999999999765 78899999999


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++.. ...+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||+++.+..
T Consensus       102 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A          102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            99999976 45699999999999999999999999999999999999999999999999999986643

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.93  E-value=1.5e-25  Score=160.14  Aligned_cols=134  Identities=21%  Similarity=0.263  Sum_probs=116.7

Q ss_pred             eeeeeeeEEEEEE----EcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCS----HVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~----~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~   66 (145)
                      +|.|+||.||++.    +..+++.+++|.         ...+.++...++.++||||+++++++...  ..+++||||++
T Consensus        39 lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~  118 (318)
T 3lxp_A           39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP  118 (318)
T ss_dssp             EEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCT
T ss_pred             ecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEeccc
Confidence            6899999997764    455788888863         34467788888999999999999999874  68999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +++|.+++... .+++..+..++.|++.++.++|+.+++|+||+|+||+++.+..++++|||++..+...
T Consensus       119 ~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          119 LGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             TCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             CCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            99999998764 4899999999999999999999999999999999999999999999999999877554

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=7.7e-26  Score=157.47  Aligned_cols=132  Identities=17%  Similarity=0.245  Sum_probs=118.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|++|.||++.+. +++.+++|.       .+.+.++...++.++||||+++++++..++..+++||++++++|.+++
T Consensus        16 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   94 (267)
T 3t9t_A           16 IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL   94 (267)
T ss_dssp             EEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHH
T ss_pred             ecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHH
Confidence            689999999999986 556677753       345667778889999999999999999999999999999999999999


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          75 SQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        75 ~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ... ..+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++....
T Consensus        95 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           95 RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             hhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccc
Confidence            764 568999999999999999999999999999999999999999999999999997653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.93  E-value=2.5e-25  Score=157.06  Aligned_cols=134  Identities=18%  Similarity=0.282  Sum_probs=118.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|++|.||+|.+..+++.+++|.      ...+.++...++.+ +|||++++++++..+...+++||++ +++|.+++
T Consensus        18 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l   96 (298)
T 1csn_A           18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLL   96 (298)
T ss_dssp             EEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHH
T ss_pred             EeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHH
Confidence            6899999999999999999999973      22345566666777 8999999999999999999999999 88999999


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCC-----EEEeeeccceecCCC
Q psy3273          75 SQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH-----VRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~-----~~l~dfg~~~~~~~~  136 (145)
                      ... ..+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.     ++++|||++..+..+
T Consensus        97 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           97 DLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             HHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence            864 45999999999999999999999999999999999999976655     999999999877554

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=6.7e-26  Score=165.58  Aligned_cols=134  Identities=19%  Similarity=0.212  Sum_probs=109.7

Q ss_pred             eeeeeeeEEEEEEEcccC---Ceeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEE-cCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQG---ETLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFH-TPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~-~~~~~~lv~e~~~~~   68 (145)
                      +|.|+||.||+|....++   ..+++|         +...+.++...++.++||||+++++++. .++..++||||++++
T Consensus        97 LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g  176 (373)
T 3c1x_A           97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG  176 (373)
T ss_dssp             EECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTC
T ss_pred             eeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCC
Confidence            689999999999886543   345554         3455677888899999999999999865 456889999999999


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++... ..+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||+++.+..
T Consensus       177 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          177 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             BHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999754 4588899999999999999999999999999999999999999999999999986543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.93  E-value=9.6e-26  Score=159.61  Aligned_cols=131  Identities=20%  Similarity=0.327  Sum_probs=117.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.||+|.+..+++.+++|.        ...+.++...++.++||||+++++++..++..+++||++++++|..+
T Consensus        27 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~  106 (302)
T 2j7t_A           27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI  106 (302)
T ss_dssp             EECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHH
T ss_pred             eccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHH
Confidence            6899999999999999999998863        34455677778889999999999999999999999999999999998


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273          74 LSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus        74 l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                      +.. ...+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..
T Consensus       107 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A          107 MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             HHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             HHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            865 56799999999999999999999999999999999999999999999999998753

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.93  E-value=2.7e-25  Score=157.75  Aligned_cols=132  Identities=25%  Similarity=0.234  Sum_probs=117.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|++|.||+|..  +++.+++|.            ...+.++...++.++||||+++++++..++..+++||++++++
T Consensus        39 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  116 (307)
T 2nru_A           39 MGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS  116 (307)
T ss_dssp             EEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             cccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCc
Confidence            68999999999986  566777752            3456677788899999999999999999999999999999999


Q ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQ---HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |.+++..   ...+++.....++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++.....
T Consensus       117 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             HHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             HHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence            9999863   34689999999999999999999999999999999999999999999999999986644

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.93  E-value=9.1e-26  Score=163.10  Aligned_cols=132  Identities=27%  Similarity=0.336  Sum_probs=115.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEc--------CCEEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHT--------PDKLCFILD   63 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~--------~~~~~lv~e   63 (145)
                      +|.|+||.||+|.+..+++.+++|..          ..+.++...++.++||||+++++++..        .+.+|+|||
T Consensus        25 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e  104 (351)
T 3mi9_A           25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD  104 (351)
T ss_dssp             CSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEE
T ss_pred             EecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEe
Confidence            68899999999999999999999732          234567778889999999999999987        446999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          64 LMNGGDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        64 ~~~~~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      |+++ ++...+.. ...+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+.
T Consensus       105 ~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A          105 FCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             CCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            9976 77776664 4569999999999999999999999999999999999999999999999999998764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.93  E-value=6.3e-26  Score=169.37  Aligned_cols=132  Identities=18%  Similarity=0.206  Sum_probs=116.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|+||.||++.... +..+|+|.       .+.+.++...++.++||||+++++++. ++..|+||||+++|+|.+++
T Consensus       196 lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l  273 (454)
T 1qcf_A          196 LGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFL  273 (454)
T ss_dssp             EECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHH
T ss_pred             cccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHH
Confidence            6899999999998864 56677763       455678888899999999999999986 66789999999999999999


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ...  ..++...+..++.|++.|+.|+|+++++|+||+|+||+++.+..+|++|||+++.+..
T Consensus       274 ~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          274 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             HSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             HhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            743  3688899999999999999999999999999999999999999999999999986543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.93  E-value=2e-25  Score=159.98  Aligned_cols=135  Identities=20%  Similarity=0.284  Sum_probs=118.7

Q ss_pred             eeeeeeeEEEEEE----EcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCC--EEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCS----HVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD--KLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~----~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~~   67 (145)
                      +|.|++|.||+|.    +..+++.+++|.        ...+.++...++.++||||+++++++...+  ..++|||++++
T Consensus        49 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~  128 (326)
T 2w1i_A           49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY  128 (326)
T ss_dssp             EECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTT
T ss_pred             eccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCC
Confidence            6899999999998    466888888863        345677888899999999999999987654  78999999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          68 GDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        68 ~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++|.+++... ..+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..+...
T Consensus       129 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          129 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             CBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence            9999999865 45899999999999999999999999999999999999999999999999999876544

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.93  E-value=2.2e-25  Score=162.49  Aligned_cols=131  Identities=19%  Similarity=0.316  Sum_probs=111.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCC------EEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD------KLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~------~~~lv~e~~   65 (145)
                      +|.|+||.||+|.+..+++.+|+|..          ..+.++...++.++||||+++++++...+      ..|+||||+
T Consensus        33 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~  112 (371)
T 2xrw_A           33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM  112 (371)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECC
T ss_pred             eEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcC
Confidence            68999999999999999999999742          33456777788999999999999998765      799999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++ +|.+.+.  ..+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||+++....
T Consensus       113 ~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          113 DA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             SE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             CC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            75 7877775  4589999999999999999999999999999999999999999999999999986643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.93  E-value=2e-25  Score=159.63  Aligned_cols=134  Identities=21%  Similarity=0.360  Sum_probs=117.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccC-CCCceeEeeEEEEc------CCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMV-DCPFIVCMTYAFHT------PDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~------~~~~~lv~e~~~~   67 (145)
                      +|.|++|.||+|.+..+++.+++|.       ...+.++...++.+ +||||+++++++..      ++..|+||||+++
T Consensus        32 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~  111 (326)
T 2x7f_A           32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGA  111 (326)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTT
T ss_pred             eccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCC
Confidence            6899999999999999999999874       34456666677777 89999999999987      5689999999999


Q ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          68 GDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        68 ~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++|.+++...  ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++..+..
T Consensus       112 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          112 GSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  181 (326)
T ss_dssp             EEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred             CcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence            9999999754  5689999999999999999999999999999999999999999999999999876543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.93  E-value=2.1e-25  Score=157.70  Aligned_cols=132  Identities=26%  Similarity=0.217  Sum_probs=110.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----HHHHhhhhhc--ccCCCCceeEeeEEEEc----CCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----IMLSLVSTGI--QMVDCPFIVCMTYAFHT----PDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~--~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|..  +++.+|+|..     .....+.+.+  ..++||||+++++++..    ....+++|||+++++|
T Consensus        16 lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L   93 (301)
T 3q4u_A           16 VGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSL   93 (301)
T ss_dssp             EEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBH
T ss_pred             eccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCH
Confidence            69999999999987  6788888732     2222333333  34799999999998654    3569999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMH--------RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.. ..+++..+..++.|++.|+.|+|        +.+++|+||||+||+++.++.++++|||+++.....
T Consensus        94 ~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  166 (301)
T 3q4u_A           94 YDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS  166 (301)
T ss_dssp             HHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             HHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccc
Confidence            999854 56899999999999999999999        999999999999999999999999999999765443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.93  E-value=1e-25  Score=166.79  Aligned_cols=135  Identities=20%  Similarity=0.246  Sum_probs=113.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----HHHHhhhhhcccCCCCceeEeeEEEEcC------CEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----IMLSLVSTGIQMVDCPFIVCMTYAFHTP------DKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~hp~i~~~~~~~~~~------~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+|+|..    ....++.+.++.++||||++++++|...      ..+++||||+++ ++.
T Consensus        62 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  140 (420)
T 1j1b_A           62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY  140 (420)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHH
T ss_pred             EeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHH
Confidence            69999999999999999999999743    2334677788899999999999998532      247799999976 666


Q ss_pred             HHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-CCEEEeeeccceecCCCC
Q psy3273          72 YHLS----QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK  137 (145)
Q Consensus        72 ~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~  137 (145)
                      ..+.    ....+++..+..++.|++.|+.|+|+.+++|+||||+||+++.+ ..+||+|||+++.+....
T Consensus       141 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~  211 (420)
T 1j1b_A          141 RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  211 (420)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             HHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence            5553    34679999999999999999999999999999999999999865 568999999998765443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.93  E-value=5.3e-26  Score=162.70  Aligned_cols=138  Identities=20%  Similarity=0.297  Sum_probs=120.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH--------------HHHhhhhhcccCC--CCceeEeeEEEEcCCEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI--------------MLSLVSTGIQMVD--CPFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~l~--hp~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      +|.|+||.||+|.+..+++.+++|...              .+..+...++.++  ||||+++++++..++..+++||++
T Consensus        51 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~  130 (320)
T 3a99_A           51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP  130 (320)
T ss_dssp             CSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECC
T ss_pred             EeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcC
Confidence            688999999999999999999997532              2234555566665  699999999999999999999999


Q ss_pred             CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC-CCCCEEEeeeccceecCCCCCc
Q psy3273          66 NG-GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH  139 (145)
Q Consensus        66 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~  139 (145)
                      .+ ++|.+++.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++ ..+.++++|||++..+......
T Consensus       131 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~  206 (320)
T 3a99_A          131 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT  206 (320)
T ss_dssp             SSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCBC
T ss_pred             CCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccccc
Confidence            76 89999998888899999999999999999999999999999999999998 6789999999999877654433

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.93  E-value=1.3e-25  Score=173.10  Aligned_cols=133  Identities=19%  Similarity=0.269  Sum_probs=116.2

Q ss_pred             eeeeeeeEEEEEEEcc--cCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVK--QGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~--~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++....  ++..+|+|.         ...+.++...++.++||||+++++++.. +.+++||||+++++|
T Consensus       344 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L  422 (613)
T 2ozo_A          344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL  422 (613)
T ss_dssp             EEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBH
T ss_pred             EecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcH
Confidence            5999999999997754  445677752         4556778888999999999999999986 569999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++... ..+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++|+|||+++.+..
T Consensus       423 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          423 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            9998753 5599999999999999999999999999999999999999999999999999986643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.93  E-value=1.3e-25  Score=162.14  Aligned_cols=132  Identities=17%  Similarity=0.188  Sum_probs=115.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCC--CceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDC--PFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~h--p~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||++.+. +++.+|+|.          ...+.++...++.++|  |||+++++++..++..|+||| +.+++
T Consensus        17 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~   94 (343)
T 3dbq_A           17 IGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID   94 (343)
T ss_dssp             ESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEE
T ss_pred             EecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCC
Confidence            689999999999884 578888863          2445677777888877  999999999999999999999 56789


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.+++.....+++.....++.|++.|+.|+|+.+++|+||+|+||+++ ++.++++|||++..+...
T Consensus        95 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           95 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             HHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            999999888899999999999999999999999999999999999996 577999999999876443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=8.7e-25  Score=156.70  Aligned_cols=132  Identities=26%  Similarity=0.237  Sum_probs=111.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----HHHHhhhhh--cccCCCCceeEeeEEEEcC----CEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----IMLSLVSTG--IQMVDCPFIVCMTYAFHTP----DKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~--~~~l~hp~i~~~~~~~~~~----~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|...  ++.+++|..     .....+.+.  ...++||||+++++++...    ...|+||||+++++|
T Consensus        45 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L  122 (337)
T 3mdy_A           45 IGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL  122 (337)
T ss_dssp             EEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBH
T ss_pred             eecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcH
Confidence            689999999999875  778888632     222222222  3345999999999999877    789999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR--------YIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.. ..+++..+..++.|++.++.|+|+.        +++|+||+|+||+++.++.++++|||++..+...
T Consensus       123 ~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~  195 (337)
T 3mdy_A          123 YDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD  195 (337)
T ss_dssp             HHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             HHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccc
Confidence            999975 4689999999999999999999998        9999999999999999999999999999876543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.93  E-value=5.6e-26  Score=161.65  Aligned_cols=137  Identities=21%  Similarity=0.306  Sum_probs=115.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH--------------HHHhhhhhcccC----CCCceeEeeEEEEcCCEEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI--------------MLSLVSTGIQMV----DCPFIVCMTYAFHTPDKLCFILD   63 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~l----~hp~i~~~~~~~~~~~~~~lv~e   63 (145)
                      +|.|+||.||+|.+..+++.+++|...              .+.++...++.+    +||||+++++++..++..+++||
T Consensus        39 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e  118 (312)
T 2iwi_A           39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE  118 (312)
T ss_dssp             EEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEE
T ss_pred             EEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEE
Confidence            689999999999999999999997532              122344445555    89999999999999999999999


Q ss_pred             c-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC-CCCCEEEeeeccceecCCCCC
Q psy3273          64 L-MNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKP  138 (145)
Q Consensus        64 ~-~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~  138 (145)
                      + +.+++|.+++.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++ .++.++++|||++..+.....
T Consensus       119 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~  195 (312)
T 2iwi_A          119 RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY  195 (312)
T ss_dssp             CCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCB
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcc
Confidence            9 78899999998878899999999999999999999999999999999999998 788999999999987765443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.93  E-value=8.5e-26  Score=158.27  Aligned_cols=134  Identities=26%  Similarity=0.368  Sum_probs=116.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEE--cCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFH--TPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~~~~   69 (145)
                      +|.|++|.||++.+..+++.+++|.          ...+.++...++.++||||+++++++.  .++..|++|||+++++
T Consensus        14 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~   93 (279)
T 2w5a_A           14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGD   93 (279)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEE
T ss_pred             ccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCC
Confidence            6899999999999999999998863          344567777888999999999999885  4578999999999999


Q ss_pred             HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCC-----ceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQH----GVFNEDEMRFYAAEVILGLEHMHRRY-----IVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~-----iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |.+++...    ..+++..+..++.|++.++.++|+.+     ++|+||+|+||+++.++.++++|||++..+..
T Consensus        94 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~  168 (279)
T 2w5a_A           94 LASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH  168 (279)
T ss_dssp             HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC--
T ss_pred             HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecc
Confidence            99998643    34899999999999999999999999     99999999999999999999999999976543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.93  E-value=1.6e-25  Score=159.35  Aligned_cols=134  Identities=19%  Similarity=0.193  Sum_probs=110.5

Q ss_pred             eeeeeeeEEEEEEEcc---cCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCC-----EEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVK---QGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD-----KLCFILD   63 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~---~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~-----~~~lv~e   63 (145)
                      .|.|+||.||+|....   +++.+++|.          ...+.++...++.++||||+++++++...+     ..+++||
T Consensus        42 lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e  121 (313)
T 3brb_A           42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP  121 (313)
T ss_dssp             EEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEE
T ss_pred             eeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEe
Confidence            6899999999998866   445777763          234566777889999999999999998765     3599999


Q ss_pred             ccCCCCHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          64 LMNGGDLHYHLS------QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        64 ~~~~~~l~~~l~------~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++++++|.+++.      ....+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus       122 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~  199 (313)
T 3brb_A          122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS  199 (313)
T ss_dssp             CCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC-----
T ss_pred             cccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            999999999984      235699999999999999999999999999999999999999999999999999986643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.93  E-value=7.5e-26  Score=164.05  Aligned_cols=131  Identities=23%  Similarity=0.340  Sum_probs=111.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------------------HHHHhhhhhcccCCCCceeEeeEEEEc-----CCE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------------------IMLSLVSTGIQMVDCPFIVCMTYAFHT-----PDK   57 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~l~hp~i~~~~~~~~~-----~~~   57 (145)
                      +|.|+||.||+|.+.. ++.+++|..                   ..+.++...++.++||||+++++++..     ...
T Consensus        30 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (362)
T 3pg1_A           30 ISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK  108 (362)
T ss_dssp             EEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCE
T ss_pred             eccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcce
Confidence            6999999999999865 888888743                   556778888899999999999999854     347


Q ss_pred             EEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          58 LCFILDLMNGGDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        58 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +|+|||+++ +++.+.+... ..+++..+..++.|++.++.|+|+++++|+||+|+||+++..+.++++|||++....
T Consensus       109 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (362)
T 3pg1_A          109 LYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT  185 (362)
T ss_dssp             EEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC-----
T ss_pred             EEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccc
Confidence            999999997 5888877653 469999999999999999999999999999999999999999999999999997543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.93  E-value=2.8e-25  Score=155.74  Aligned_cols=133  Identities=18%  Similarity=0.182  Sum_probs=115.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|++|.||+|... +++.+++|.       ...+.++...++.++||||+++++++. ++..+++||++++++|.+++
T Consensus        21 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l   98 (279)
T 1qpc_A           21 LGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFL   98 (279)
T ss_dssp             EEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHT
T ss_pred             ecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHH
Confidence            689999999999965 455677762       445667788889999999999999987 45689999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ...  ..+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..+...
T Consensus        99 ~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           99 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             TSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            643  26899999999999999999999999999999999999999999999999999876543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.93  E-value=2.4e-25  Score=173.28  Aligned_cols=132  Identities=23%  Similarity=0.321  Sum_probs=113.4

Q ss_pred             eeeeeeeEEEEEEEcc-cCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCE-----EEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVK-QGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDK-----LCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~-----~~lv~e~~~   66 (145)
                      +|.|+||.||++.+.. +++.+++|.         ...+.++...++.++||||+++++++...+.     .|+||||++
T Consensus        88 lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~  167 (681)
T 2pzi_A           88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVG  167 (681)
T ss_dssp             EEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCC
T ss_pred             EeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCC
Confidence            6899999999999987 788888873         2345677788899999999999999987654     799999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +++|.+++..  .+++..+..++.|++.++.|+|+.+++|+||||+||+++.+ .++++|||+++.+...
T Consensus       168 g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          168 GQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             CEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             CCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence            9999887654  78999999999999999999999999999999999999875 8999999999876543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.93  E-value=1.8e-25  Score=158.06  Aligned_cols=127  Identities=12%  Similarity=0.007  Sum_probs=112.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|.+..+++.+++|..           ..+.++...++.++||||+++++++..++..|+||||+++++|
T Consensus        39 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L  118 (286)
T 3uqc_A           39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL  118 (286)
T ss_dssp             EEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEH
T ss_pred             EcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCH
Confidence            68999999999999999999999732           4456666778899999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccc
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA  130 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~  130 (145)
                      .+++...  ....++..++.|++.++.|+|+++++|+||||+||+++.++.+++++++..
T Consensus       119 ~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~  176 (286)
T 3uqc_A          119 QEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM  176 (286)
T ss_dssp             HHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred             HHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc
Confidence            9998542  355678889999999999999999999999999999999999999876544

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.93  E-value=1e-25  Score=162.75  Aligned_cols=133  Identities=19%  Similarity=0.163  Sum_probs=109.2

Q ss_pred             eeeeeeeEEEEEEEcc---cCCeeeeeH-----------HHH--------HHhhhhhcccCCCCceeEeeEEEEc----C
Q psy3273           2 FFIVGTGFLSNCSHVK---QGETLALNE-----------RIM--------LSLVSTGIQMVDCPFIVCMTYAFHT----P   55 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~---~~~~~~~~~-----------~~~--------~~~~~~~~~~l~hp~i~~~~~~~~~----~   55 (145)
                      +|.|+||.||+|.+..   +++.+++|.           ...        +.++...++.++||||+++++++..    +
T Consensus        45 lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~  124 (345)
T 2v62_A           45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGR  124 (345)
T ss_dssp             C------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSC
T ss_pred             EeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCC
Confidence            6899999999999987   777777752           111        1233345677899999999999988    7


Q ss_pred             CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC--CEEEeeeccceec
Q psy3273          56 DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG--HVRISDLGLACDF  133 (145)
Q Consensus        56 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~--~~~l~dfg~~~~~  133 (145)
                      ...|+|||++ +++|.+++...+.+++..+..++.|++.|+.|+|+.+++|+||+|+||+++.+.  .++++|||+++.+
T Consensus       125 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~  203 (345)
T 2v62_A          125 SYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY  203 (345)
T ss_dssp             EEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEES
T ss_pred             cEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceec
Confidence            7899999999 889999998777899999999999999999999999999999999999998776  9999999999876


Q ss_pred             CC
Q psy3273         134 SK  135 (145)
Q Consensus       134 ~~  135 (145)
                      ..
T Consensus       204 ~~  205 (345)
T 2v62_A          204 CP  205 (345)
T ss_dssp             SG
T ss_pred             cc
Confidence            43

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=3.3e-25  Score=156.11  Aligned_cols=134  Identities=20%  Similarity=0.285  Sum_probs=115.9

Q ss_pred             eeeeeeeEEEEEEEc--ccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHV--KQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~--~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||+|...  .+++.+++|.         ...+.++...++.++||||+++++++. .+..++|||++++++|
T Consensus        18 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L   96 (287)
T 1u59_A           18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPL   96 (287)
T ss_dssp             EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEH
T ss_pred             ccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEEEeCCCCCH
Confidence            689999999999864  4566777753         344567777888999999999999994 5569999999999999


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.. ...+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++..+...
T Consensus        97 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           97 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             HHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            999864 356999999999999999999999999999999999999999999999999999877543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.93  E-value=1.2e-25  Score=159.89  Aligned_cols=134  Identities=25%  Similarity=0.274  Sum_probs=115.1

Q ss_pred             eeeeeeeEEEEEEE-----cccCCeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCC-EEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSH-----VKQGETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPD-KLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~-----~~~~~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~-~~~lv~e~~   65 (145)
                      +|.|+||.||+|.+     ..+++.+++|.         ...+.++...++.+ +||||+++++++..++ .++++|||+
T Consensus        35 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~  114 (316)
T 2xir_A           35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC  114 (316)
T ss_dssp             EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECC
T ss_pred             EcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcC
Confidence            68999999999985     34667788863         33455666777777 7899999999988654 599999999


Q ss_pred             CCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecc
Q psy3273          66 NGGDLHYHLSQHGV----------------FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL  129 (145)
Q Consensus        66 ~~~~l~~~l~~~~~----------------~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~  129 (145)
                      ++++|.+++.....                +++..+..++.|++.++.|+|+.+++|+||+|+||+++..+.++++|||+
T Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  194 (316)
T 2xir_A          115 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL  194 (316)
T ss_dssp             TTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGG
T ss_pred             CCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCcc
Confidence            99999999986443                78899999999999999999999999999999999999999999999999


Q ss_pred             ceecCC
Q psy3273         130 ACDFSK  135 (145)
Q Consensus       130 ~~~~~~  135 (145)
                      +..+..
T Consensus       195 ~~~~~~  200 (316)
T 2xir_A          195 ARDIYK  200 (316)
T ss_dssp             GSCTTT
T ss_pred             cccccc
Confidence            986644

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.93  E-value=3.2e-25  Score=161.17  Aligned_cols=132  Identities=20%  Similarity=0.284  Sum_probs=117.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcC-----CEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTP-----DKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.+..+++.+++|..         ..+.++...++.++||||+++++++...     ...|++||++.+
T Consensus        35 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~  114 (364)
T 3qyz_A           35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET  114 (364)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE
T ss_pred             eecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc
Confidence            69999999999999999999999742         4456777888999999999999999765     479999999975


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                       +|.+++.. ..+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++.....
T Consensus       115 -~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          115 -DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             -EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             -CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence             89888865 4689999999999999999999999999999999999999999999999999987654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.93  E-value=4.3e-25  Score=162.08  Aligned_cols=132  Identities=18%  Similarity=0.198  Sum_probs=114.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCC--CCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVD--CPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~--hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|.+.. ++.+|+|.          ...+.++...++.++  ||||+++++++..++.+|+||| +.+++
T Consensus        64 LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~  141 (390)
T 2zmd_A           64 IGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID  141 (390)
T ss_dssp             EECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEE
T ss_pred             EccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCC
Confidence            6899999999999875 88888863          244566777778886  5999999999999999999999 66889


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.+++.....+++.....++.|++.++.|+|+.+++|+||+|+||+++ ++.++|+|||+++.+...
T Consensus       142 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          142 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             HHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            999999888899999999999999999999999999999999999995 578999999999876543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.93  E-value=1.3e-25  Score=165.02  Aligned_cols=134  Identities=19%  Similarity=0.240  Sum_probs=110.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----HHHHHhhhhhcccCCCCceeEeeEEEEcCC------EEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD------KLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~------~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++ ++++.    .....++...++.++||||++++++|...+      .+++||||++++ +.
T Consensus        48 lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~  125 (394)
T 4e7w_A           48 IGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VY  125 (394)
T ss_dssp             EEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HH
T ss_pred             EeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HH
Confidence            6999999999999988776 55543    233446777888999999999999996543      388999999874 43


Q ss_pred             HHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC-CCCCEEEeeeccceecCCCC
Q psy3273          72 YHLS----QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        72 ~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~  137 (145)
                      ..+.    ....+++..+..++.|++.|+.|+|+++++|+||+|+||+++ ..+.++++|||+++.+..+.
T Consensus       126 ~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~  196 (394)
T 4e7w_A          126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE  196 (394)
T ss_dssp             HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence            3332    346799999999999999999999999999999999999998 78899999999998765443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.93  E-value=6.7e-25  Score=155.46  Aligned_cols=132  Identities=20%  Similarity=0.235  Sum_probs=114.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------------HHHHHhhhhhcccCCCCceeEeeEEEE--cCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------------RIMLSLVSTGIQMVDCPFIVCMTYAFH--TPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.+..+++.+++|.            ...+.++...++.++||||+++++++.  ..+..|+||||+++
T Consensus        13 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~   92 (305)
T 2wtk_C           13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVC   92 (305)
T ss_dssp             EEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSE
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccC
Confidence            6899999999999999999998863            234567778889999999999999984  44689999999987


Q ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          68 GDLHYHLSQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        68 ~~l~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      + +.+.+..  ...+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++..+.
T Consensus        93 ~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           93 G-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             E-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             C-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            5 6676654  3568999999999999999999999999999999999999999999999999998764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.93  E-value=1.3e-25  Score=165.39  Aligned_cols=134  Identities=22%  Similarity=0.350  Sum_probs=106.4

Q ss_pred             CeeeeeeeEEEEEEEc--ccCCeeeeeHH------HHHHhhhhhcccCCCCceeEeeEEEEc--CCEEEEEEEccCCCCH
Q psy3273           1 MFFIVGTGFLSNCSHV--KQGETLALNER------IMLSLVSTGIQMVDCPFIVCMTYAFHT--PDKLCFILDLMNGGDL   70 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~--~~~~~~~~~~~------~~~~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~l   70 (145)
                      ++|.|+||.||+|...  .+++.+|+|..      ..+.++...++.++||||+++++++..  +...|+||||+.+ +|
T Consensus        28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l  106 (405)
T 3rgf_A           28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DL  106 (405)
T ss_dssp             CCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EH
T ss_pred             EeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CH
Confidence            3689999999999966  57888988742      245677788899999999999999954  6789999999965 88


Q ss_pred             HHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE----CCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQH---------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL----DEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~----~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+.+...         ..+++..+..++.|++.|+.|+|+++++|+||+|+||++    +..+.++|+|||+++.+..
T Consensus       107 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  184 (405)
T 3rgf_A          107 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  184 (405)
T ss_dssp             HHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----
T ss_pred             HHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCC
Confidence            7777521         248999999999999999999999999999999999999    5668999999999986643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.93  E-value=1.3e-24  Score=151.40  Aligned_cols=130  Identities=18%  Similarity=0.221  Sum_probs=115.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcC--CEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTP--DKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||++.+.  ++.+++|.          ...+.++...++.++||||+++++++...  +..+++|||+++++
T Consensus        18 lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~   95 (271)
T 3kmu_A           18 LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGS   95 (271)
T ss_dssp             EEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCB
T ss_pred             hcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCc
Confidence            689999999999985  66677752          34567788889999999999999999887  78999999999999


Q ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRY--IVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~--iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |.+++....  .+++..+..++.|++.++.|+|+.+  ++|+|++|+||+++.++.+++.||+++...
T Consensus        96 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           96 LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             HHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999998654  4899999999999999999999999  999999999999999999999998877543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.93  E-value=1.6e-25  Score=167.16  Aligned_cols=132  Identities=18%  Similarity=0.173  Sum_probs=113.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|+||.||++....+ ..+|+|.       .+.+.++...++.++||||+++++++.. +..|+||||+++++|.+++
T Consensus       192 lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l  269 (452)
T 1fmk_A          192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL  269 (452)
T ss_dssp             EEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHH
T ss_pred             ecCCCCeEEEEEEECCC-ceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHH
Confidence            68999999999998754 4577763       3456778888999999999999999876 6789999999999999999


Q ss_pred             Hh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ..  ...+++..+..++.|++.|+.|+|+++++|+||+|+||+++.+..++++|||+++.+..
T Consensus       270 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             SHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            64  35689999999999999999999999999999999999999999999999999986643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.93  E-value=1.7e-25  Score=160.31  Aligned_cols=132  Identities=18%  Similarity=0.188  Sum_probs=111.0

Q ss_pred             eeeeeeeEEEEEE-----EcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCS-----HVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~-----~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.     +..+++.+++|.         ...+.++...++.++||||+++++++..++..|+||||+++
T Consensus        38 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  117 (327)
T 2yfx_A           38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAG  117 (327)
T ss_dssp             CC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCC
Confidence            6899999999999     566788888873         23455667778889999999999999999999999999999


Q ss_pred             CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC---CCCEEEeeeccceec
Q psy3273          68 GDLHYHLSQH-------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE---HGHVRISDLGLACDF  133 (145)
Q Consensus        68 ~~l~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~---~~~~~l~dfg~~~~~  133 (145)
                      ++|.+++...       ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++.   ...++++|||++..+
T Consensus       118 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~  193 (327)
T 2yfx_A          118 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI  193 (327)
T ss_dssp             EEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred             CcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccccccc
Confidence            9999999764       34889999999999999999999999999999999999983   456999999998754

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.93  E-value=8.1e-25  Score=156.66  Aligned_cols=133  Identities=23%  Similarity=0.398  Sum_probs=114.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+++|..          ....+....++.++||||+++++++..++..++|||++++ +|.
T Consensus        30 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~  108 (327)
T 3aln_A           30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFD  108 (327)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHH
T ss_pred             eccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChH
Confidence            68999999999999999999998732          2223333367788999999999999999999999999976 787


Q ss_pred             HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQ-----HGVFNEDEMRFYAAEVILGLEHMHRR-YIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~-~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++..     ...+++..+..++.|++.++.++|.. +++|+||+|+||+++.++.++++|||++..+..
T Consensus       109 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          109 KFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             HHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             HHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            77753     46789999999999999999999998 999999999999999999999999999976543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.92  E-value=1e-24  Score=157.35  Aligned_cols=132  Identities=20%  Similarity=0.367  Sum_probs=116.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcC-----CEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTP-----DKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.+..+++.+++|..         ..+.++...++.++||||+++++++..+     ...|++||++. 
T Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-   97 (353)
T 2b9h_A           19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-   97 (353)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-
T ss_pred             EcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-
Confidence            68999999999999999999999742         2345677788899999999999988754     67999999997 


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++|.+.+.. ..+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++..+..
T Consensus        98 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           98 TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            589888875 5789999999999999999999999999999999999999999999999999987643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.92  E-value=1.3e-24  Score=155.92  Aligned_cols=131  Identities=20%  Similarity=0.179  Sum_probs=108.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----HHH--HhhhhhcccCCCCceeEeeEEEEc-----CCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----IML--SLVSTGIQMVDCPFIVCMTYAFHT-----PDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----~~~--~~~~~~~~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||++..  +++.+|+|..     ...  +.+...++.++||||+++++.+..     ...+++||||+++++
T Consensus        21 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~   98 (336)
T 3g2f_A           21 IGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGS   98 (336)
T ss_dssp             EEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCB
T ss_pred             cccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCc
Confidence            69999999999966  6788888742     222  222233556899999999986542     236899999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC---------CceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRR---------YIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~---------~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |.+++... ..++.....++.|++.++.|+|+.         +++|+||||+||+++.++.++|+|||++..+..
T Consensus        99 L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~  172 (336)
T 3g2f_A           99 LXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG  172 (336)
T ss_dssp             HHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             HHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccc
Confidence            99999764 348888999999999999999999         999999999999999999999999999987654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.92  E-value=1.2e-25  Score=163.93  Aligned_cols=131  Identities=21%  Similarity=0.323  Sum_probs=102.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcC------CEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTP------DKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~------~~~~lv~e~~   65 (145)
                      +|.|+||.||+|.+..+++.+++|..          ..+.++...++.++||||+++++++...      ...|+++|++
T Consensus        37 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~  116 (367)
T 2fst_X           37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM  116 (367)
T ss_dssp             CC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC
T ss_pred             EeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc
Confidence            68999999999999999999999743          3445677788899999999999999754      5689999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                       +++|.+++.. ..+++..+..++.|++.|+.|+|+.+++|+||+|+||+++.++.++++|||+++...
T Consensus       117 -~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          117 -GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             -CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             -CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence             6789888765 578999999999999999999999999999999999999999999999999997654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.92  E-value=5.3e-25  Score=159.30  Aligned_cols=136  Identities=19%  Similarity=0.256  Sum_probs=103.7

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccCCCCceeEeeEEEEcCC-------EEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD-------KLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~-------~~~lv~e~~~   66 (145)
                      .+|.|+||.||+|.+..+++.+|+|..       ....++...++.++||||++++++|...+       .++++|||++
T Consensus        30 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~  109 (360)
T 3e3p_A           30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP  109 (360)
T ss_dssp             ---------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCS
T ss_pred             EEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeeccc
Confidence            368999999999999999999999742       12233344456779999999999997543       3899999998


Q ss_pred             CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHh--hCCceecCCCCCcEEECC-CCCEEEeeeccceecCCCC
Q psy3273          67 GGDLHYHLS----QHGVFNEDEMRFYAAEVILGLEHMH--RRYIVYRDLKPANILLDE-HGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        67 ~~~l~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh--~~~iih~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~  137 (145)
                      + ++...+.    ....+++..+..++.|++.++.|+|  +++++|+||+|+||+++. ++.++++|||++..+....
T Consensus       110 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~  186 (360)
T 3e3p_A          110 D-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE  186 (360)
T ss_dssp             C-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS
T ss_pred             c-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC
Confidence            7 5544433    4466899999999999999999999  999999999999999986 7899999999998765443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.92  E-value=2.3e-25  Score=161.20  Aligned_cols=133  Identities=18%  Similarity=0.169  Sum_probs=114.0

Q ss_pred             eeeeeeeEEEEEEEccc--------CCeeeeeHH---HHHHhhhhhcccCCCCceeE---------------eeEEEEc-
Q psy3273           2 FFIVGTGFLSNCSHVKQ--------GETLALNER---IMLSLVSTGIQMVDCPFIVC---------------MTYAFHT-   54 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~--------~~~~~~~~~---~~~~~~~~~~~~l~hp~i~~---------------~~~~~~~-   54 (145)
                      +|.|+||.||+|.+..+        ++.+++|..   ..+.++...++.++||||++               +++++.. 
T Consensus        50 lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~  129 (352)
T 2jii_A           50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ  129 (352)
T ss_dssp             EEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEET
T ss_pred             ecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccC
Confidence            68999999999999884        788888743   34566677778889988887               6777765 


Q ss_pred             CCEEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC--CEEEeeeccc
Q psy3273          55 PDKLCFILDLMNGGDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG--HVRISDLGLA  130 (145)
Q Consensus        55 ~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~--~~~l~dfg~~  130 (145)
                      ++..|+||||+ +++|.+++...  ..+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++  .++++|||++
T Consensus       130 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a  208 (352)
T 2jii_A          130 DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA  208 (352)
T ss_dssp             TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGC
T ss_pred             CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcce
Confidence            78999999999 89999999875  6799999999999999999999999999999999999999887  8999999999


Q ss_pred             eecCC
Q psy3273         131 CDFSK  135 (145)
Q Consensus       131 ~~~~~  135 (145)
                      +.+..
T Consensus       209 ~~~~~  213 (352)
T 2jii_A          209 FRYCP  213 (352)
T ss_dssp             BCSSG
T ss_pred             eeccC
Confidence            86654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.92  E-value=1.1e-24  Score=154.85  Aligned_cols=131  Identities=24%  Similarity=0.325  Sum_probs=109.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEE--------------cCCEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFH--------------TPDKLC   59 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~--------------~~~~~~   59 (145)
                      +|.|++|.||+|.+..+++.+++|.        ...+.++...++.++||||+++++++.              ..+..|
T Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~   98 (320)
T 2i6l_A           19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY   98 (320)
T ss_dssp             CC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEE
T ss_pred             eccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCcee
Confidence            6899999999999999999999973        345567778889999999999999874              346899


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC-CCCCEEEeeeccceecC
Q psy3273          60 FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLACDFS  134 (145)
Q Consensus        60 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~-~~~~~~l~dfg~~~~~~  134 (145)
                      ++|||++ ++|.+++.. ..+++..+..++.|++.++.++|+++++|+||+|+||+++ .+..++++|||++..+.
T Consensus        99 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~  172 (320)
T 2i6l_A           99 IVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD  172 (320)
T ss_dssp             EEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC-
T ss_pred             EEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccC
Confidence            9999997 599888864 5689999999999999999999999999999999999997 45689999999998654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.92  E-value=1.6e-24  Score=160.81  Aligned_cols=132  Identities=20%  Similarity=0.300  Sum_probs=112.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcc------cCCCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQ------MVDCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~------~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +|.|+||.||+|.+..+++.+|+|..       ....++...++      ..+||||+++++.+...+.++++||++. +
T Consensus       105 LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~  183 (429)
T 3kvw_A          105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-M  183 (429)
T ss_dssp             EEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-C
T ss_pred             cccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-C
Confidence            69999999999999999999999742       22233333333      3378899999999999999999999996 5


Q ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCC--EEEeeeccceecC
Q psy3273          69 DLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH--VRISDLGLACDFS  134 (145)
Q Consensus        69 ~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~--~~l~dfg~~~~~~  134 (145)
                      +|.+++...  ..+++..+..++.|++.|+.|+|+.+++|+||||+||+++..+.  ++|+|||+++...
T Consensus       184 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~  253 (429)
T 3kvw_A          184 NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH  253 (429)
T ss_dssp             BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred             CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence            899988754  34899999999999999999999999999999999999998876  9999999997654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.92  E-value=9.8e-25  Score=156.19  Aligned_cols=133  Identities=25%  Similarity=0.351  Sum_probs=114.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCC-CCceeEeeEEEE--------cCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVD-CPFIVCMTYAFH--------TPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~-hp~i~~~~~~~~--------~~~~~~lv~e~   64 (145)
                      +|.|+||.||+|.+..+++.+++|.        ...+.++...++.+. ||||+++++++.        ....++++||+
T Consensus        36 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~  115 (337)
T 3ll6_A           36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL  115 (337)
T ss_dssp             EECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEEC
T ss_pred             EccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEe
Confidence            6899999999999999999999973        234455666677775 999999999994        33468999999


Q ss_pred             cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          65 MNGGDLHYHLSQ---HGVFNEDEMRFYAAEVILGLEHMHRRY--IVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        65 ~~~~~l~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~--iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +. |+|.+++..   ...+++..+..++.|++.++.|+|+.+  ++|+||+|+||+++.++.++++|||++..+..
T Consensus       116 ~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  190 (337)
T 3ll6_A          116 CK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH  190 (337)
T ss_dssp             CS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSS
T ss_pred             cC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccc
Confidence            96 688888764   456999999999999999999999999  99999999999999999999999999976543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.92  E-value=1.2e-24  Score=152.71  Aligned_cols=133  Identities=17%  Similarity=0.177  Sum_probs=113.3

Q ss_pred             eeeeeeeEEEEEEEcccC---CeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQG---ETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~---~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|++|.||+|......   ..+++|.         ...+.++...++.++||||+++++++..+ ..|++||++++++
T Consensus        20 lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~   98 (281)
T 3cc6_A           20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGE   98 (281)
T ss_dssp             EEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCB
T ss_pred             EEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCC
Confidence            689999999999876533   3467752         34556677788889999999999998754 5689999999999


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |.+++... ..+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++.....
T Consensus        99 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           99 LGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             HHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             HHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            99999754 5599999999999999999999999999999999999999999999999999976543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.92  E-value=6.7e-25  Score=159.94  Aligned_cols=130  Identities=21%  Similarity=0.333  Sum_probs=112.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEE------EEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKL------CFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~------~lv~e~~   65 (145)
                      +|.|+||.||+|.+..+++.+|+|.          ...+.++...++.++||||+++++++...+..      |++||++
T Consensus        50 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~  129 (371)
T 4exu_A           50 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM  129 (371)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECC
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccc
Confidence            6999999999999999999999974          23455677788899999999999999877654      9999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      . ++|...+.  ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||+++...
T Consensus       130 ~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          130 Q-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             C-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             c-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence            7 48877764  358999999999999999999999999999999999999999999999999997654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.92  E-value=7.8e-25  Score=159.46  Aligned_cols=132  Identities=14%  Similarity=0.120  Sum_probs=97.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhh---hhcccCCCCceeEee-------EEEEcC-----
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVS---TGIQMVDCPFIVCMT-------YAFHTP-----   55 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~---~~~~~l~hp~i~~~~-------~~~~~~-----   55 (145)
                      +|.|+||.||+|.+..+++.+|+|.           ...++++.   ..++. +||||++++       +++..+     
T Consensus        70 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~  148 (371)
T 3q60_A           70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPF  148 (371)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSS
T ss_pred             ccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCe
Confidence            6899999999999999999999973           22334443   34455 799988755       455433     


Q ss_pred             ------------CEEEEEEEccCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHhhCCceecCCCCCcEEE
Q psy3273          56 ------------DKLCFILDLMNGGDLHYHLSQH-GVFNEDEM------RFYAAEVILGLEHMHRRYIVYRDLKPANILL  116 (145)
Q Consensus        56 ------------~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~------~~~~~~i~~~l~~lh~~~iih~~l~~~nil~  116 (145)
                                  ..+|+||||++ ++|.+++... ..++....      ..++.|++.|+.|+|+++++|+||||+||++
T Consensus       149 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll  227 (371)
T 3q60_A          149 AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI  227 (371)
T ss_dssp             SBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE
T ss_pred             eeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE
Confidence                        34899999998 7999999753 23344444      5667999999999999999999999999999


Q ss_pred             CCCCCEEEeeeccceecCC
Q psy3273         117 DEHGHVRISDLGLACDFSK  135 (145)
Q Consensus       117 ~~~~~~~l~dfg~~~~~~~  135 (145)
                      +.++.++|+|||+++....
T Consensus       228 ~~~~~~kL~DFG~a~~~~~  246 (371)
T 3q60_A          228 MPDGRLMLGDVSALWKVGT  246 (371)
T ss_dssp             CTTSCEEECCGGGEEETTC
T ss_pred             CCCCCEEEEecceeeecCC
Confidence            9999999999999986643

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.92  E-value=1.5e-24  Score=154.86  Aligned_cols=133  Identities=22%  Similarity=0.310  Sum_probs=111.4

Q ss_pred             eeeeeeeEEEEEEEc-ccCCeeeeeHHH----------HHHhhhhhcc---cCCCCceeEeeEEEE-----cCCEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHV-KQGETLALNERI----------MLSLVSTGIQ---MVDCPFIVCMTYAFH-----TPDKLCFIL   62 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~---~l~hp~i~~~~~~~~-----~~~~~~lv~   62 (145)
                      +|.|+||.||+|.+. .+++.+++|...          .+.++...++   .++||||+++++++.     .....+++|
T Consensus        19 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~   98 (326)
T 1blx_A           19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF   98 (326)
T ss_dssp             EEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEE
T ss_pred             ecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEE
Confidence            689999999999996 677888886321          2233344444   448999999999997     556899999


Q ss_pred             EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          63 DLMNGGDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        63 e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |+++ ++|.+++...  ..+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.++++|||++..+..
T Consensus        99 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  172 (326)
T 1blx_A           99 EHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF  172 (326)
T ss_dssp             ECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG
T ss_pred             ecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccC
Confidence            9997 5999998764  3489999999999999999999999999999999999999999999999999976543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.92  E-value=3.3e-24  Score=154.02  Aligned_cols=132  Identities=25%  Similarity=0.243  Sum_probs=113.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----HHHHHhhhhhccc--CCCCceeEeeEEEEcCC----EEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----RIMLSLVSTGIQM--VDCPFIVCMTYAFHTPD----KLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~--l~hp~i~~~~~~~~~~~----~~~lv~e~~~~~~l   70 (145)
                      +|.|+||.||++..  +++.+++|.     ...+.++.+.++.  ++||||+++++++..++    ..++||||+++++|
T Consensus        50 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L  127 (342)
T 1b6c_B           50 IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL  127 (342)
T ss_dssp             EEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBH
T ss_pred             ecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcH
Confidence            68999999999987  478888874     2233344444444  79999999999998876    89999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMH--------RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++.. ..+++..+..++.|++.++.|+|        +.+++|+||+|+||+++.++.++++|||++......
T Consensus       128 ~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  200 (342)
T 1b6c_B          128 FDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  200 (342)
T ss_dssp             HHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             HHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccc
Confidence            999975 46899999999999999999999        899999999999999999999999999999876544

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.92  E-value=8.7e-25  Score=153.26  Aligned_cols=132  Identities=20%  Similarity=0.221  Sum_probs=110.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee------HHHHHHhhhhhcccCCCCceeEeeEEEEcC-CEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTP-DKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|++|.||++...  ++.+++|      ....+.++...++.++||||+++++++... +..+++||++++++|.+++
T Consensus        29 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  106 (278)
T 1byg_A           29 IGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL  106 (278)
T ss_dssp             EEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHH
T ss_pred             EecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHH
Confidence            689999999999874  7777776      344566778889999999999999997654 5799999999999999999


Q ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ....  .+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++.....
T Consensus       107 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A          107 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             HHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             HhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            7543  388999999999999999999999999999999999999999999999999876543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.92  E-value=4.4e-25  Score=167.85  Aligned_cols=131  Identities=18%  Similarity=0.173  Sum_probs=115.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|+||.||++....+ ..+++|.       .+.+.++...++.++||||+++++++.. +..|+||||+++++|.+++
T Consensus       275 lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l  352 (535)
T 2h8h_A          275 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL  352 (535)
T ss_dssp             EEECSSEEEEEEEETTT-EEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHH
T ss_pred             cccCCCeEEEEEEECCC-ceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHH
Confidence            68999999999998754 4577753       3456778888999999999999999875 6789999999999999999


Q ss_pred             Hh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          75 SQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        75 ~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      ..  ...+++..+..++.|++.++.|+|+++++|+||+|+||+++.+..++|+|||+++.+.
T Consensus       353 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          353 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            64  2568999999999999999999999999999999999999999999999999997654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.92  E-value=1.2e-24  Score=153.44  Aligned_cols=129  Identities=22%  Similarity=0.250  Sum_probs=106.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee----------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||++....+   +++|          ....+.++...++.++||||++++++. ..+..+++|||+++++|.
T Consensus        32 lG~G~~g~Vy~~~~~~~---vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~  107 (289)
T 3og7_A           32 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLY  107 (289)
T ss_dssp             EEECSSEEEEEEESSSE---EEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHH
T ss_pred             ecCCCCeEEEEEEEcCc---eEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHH
Confidence            68999999999986543   5554          235567788889999999999999954 566789999999999999


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +++.. ...+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||++....
T Consensus       108 ~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A          108 HHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             HHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             HHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence            98864 4569999999999999999999999999999999999999999999999999997554

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.92  E-value=3.1e-24  Score=152.68  Aligned_cols=133  Identities=23%  Similarity=0.375  Sum_probs=105.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+++|..          ..+.++...++.++||||+++++++..++..+++||++ ++.+.
T Consensus        33 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~  111 (318)
T 2dyl_A           33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE  111 (318)
T ss_dssp             C------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHH
T ss_pred             eeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHH
Confidence            58899999999999999999999732          23334444567889999999999999999999999999 54665


Q ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRR-YIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~-~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ..... ...+++..+..++.|++.++.|+|.. +++|+||+|+||+++.++.++++|||++..+..
T Consensus       112 ~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          112 KLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             HHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             HHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            55543 56799999999999999999999985 999999999999999999999999999976543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.92  E-value=8.5e-24  Score=149.10  Aligned_cols=134  Identities=21%  Similarity=0.243  Sum_probs=115.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCCCceeEeeEE-EEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDCPFIVCMTYA-FHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~hp~i~~~~~~-~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|++|.||+|.+..+++.+++|.      ...+.++...++.++|++++..+.. +..++..+++||++ +++|.+++
T Consensus        17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~   95 (296)
T 3uzp_A           17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLF   95 (296)
T ss_dssp             EEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHH
T ss_pred             EccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHH
Confidence            6899999999999999999999973      2345667777788888876555444 56778899999999 88999999


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC---CCCCEEEeeeccceecCCC
Q psy3273          75 SQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD---EHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~---~~~~~~l~dfg~~~~~~~~  136 (145)
                      .. ...+++..+..++.|++.++.|+|+++++|+||+|+||+++   ....++++|||++..+...
T Consensus        96 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           96 NFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             HhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            74 46799999999999999999999999999999999999994   7789999999999876554

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.92  E-value=7.9e-25  Score=158.34  Aligned_cols=130  Identities=20%  Similarity=0.322  Sum_probs=113.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcCCE------EEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDK------LCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~------~~lv~e~~   65 (145)
                      +|.|+||.||+|.+..+++.+++|..          ..+.++...++.++||||+++++++...+.      +|++||++
T Consensus        32 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~  111 (353)
T 3coi_A           32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM  111 (353)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccc
Confidence            68999999999999999999999742          345567777889999999999999987654      59999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      . ++|.+.+.  ..+++..+..++.|++.++.|+|+++++|+||+|+||+++.++.++++|||++....
T Consensus       112 ~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          112 Q-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             S-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             c-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence            7 48877664  358999999999999999999999999999999999999999999999999997543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.92  E-value=5e-24  Score=150.20  Aligned_cols=134  Identities=21%  Similarity=0.244  Sum_probs=114.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCCCceeEeeEE-EEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDCPFIVCMTYA-FHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~hp~i~~~~~~-~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      +|.|+||.||+|.+..+++.+++|.      ...+.++...++.++|++++..+.. +..++..+++||++ +++|.+++
T Consensus        17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~   95 (296)
T 4hgt_A           17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLF   95 (296)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHH
T ss_pred             ecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHH
Confidence            6899999999999999999999973      2234556666777888876655554 56778999999999 88999998


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE---CCCCCEEEeeeccceecCCC
Q psy3273          75 SQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~---~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .. ...+++..+..++.|++.|+.|+|+.+++|+||+|+||++   +....++++|||++..+...
T Consensus        96 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           96 NFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             HHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            74 4679999999999999999999999999999999999999   67889999999999877554

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.91  E-value=2.5e-24  Score=167.05  Aligned_cols=133  Identities=18%  Similarity=0.243  Sum_probs=115.5

Q ss_pred             eeeeeeeEEEEEEEcccC---CeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQG---ETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~---~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|....++   ..+++|.         ...+.++...++.++||||+++++++. ++..|+||||+++++
T Consensus       398 LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~  476 (656)
T 2j0j_A          398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGE  476 (656)
T ss_dssp             EECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred             EeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCc
Confidence            689999999999986543   4566652         245667777888999999999999985 567899999999999


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |.+++... ..+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||+++.+..
T Consensus       477 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          477 LRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             HHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            99999754 4689999999999999999999999999999999999999999999999999986644

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.91  E-value=2.6e-24  Score=151.42  Aligned_cols=134  Identities=21%  Similarity=0.275  Sum_probs=110.5

Q ss_pred             eeeeeeeEEEEEEEcc-cCC--eeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVK-QGE--TLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-~~~--~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|++|.||+|.... +++  .+++|.           ...+.++...++.++||||+++++++..+. .+++||++++
T Consensus        26 lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~  104 (291)
T 1u46_A           26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPL  104 (291)
T ss_dssp             CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTT
T ss_pred             ecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccC
Confidence            5889999999998654 333  466653           234556777788899999999999998765 8899999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          68 GDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        68 ~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++|.+++... ..+++..+..++.|++.++.++|+++++|+||+|+||+++.++.++++|||++..+...
T Consensus       105 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A          105 GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             CBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             CCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            9999998753 56899999999999999999999999999999999999999999999999999876543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.91  E-value=9.2e-24  Score=158.85  Aligned_cols=136  Identities=20%  Similarity=0.235  Sum_probs=116.6

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCC-CceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDC-PFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .+|.|+||.||+|.+..+++.+|+|.      ...+..+...++.++| ++++.+..++...+..++||||+ +++|.++
T Consensus        14 ~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~l   92 (483)
T 3sv0_A           14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDL   92 (483)
T ss_dssp             CCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             EEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHH
Confidence            47999999999999999999999973      2234556666777777 56667777778889999999999 8899999


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE---CCCCCEEEeeeccceecCCCC
Q psy3273          74 LSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        74 l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~---~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      +.. ...+++..+..++.|++.++.|||.++++|+||||+||++   +....++|+|||+++.+....
T Consensus        93 l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           93 FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             HHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            975 5679999999999999999999999999999999999999   577899999999998776543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.91  E-value=9.4e-24  Score=151.08  Aligned_cols=132  Identities=20%  Similarity=0.273  Sum_probs=112.1

Q ss_pred             eeeeeeeEEEEEEE-cccCCeeeeeHH-------HHHHhhhhhcccCCC------CceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSH-VKQGETLALNER-------IMLSLVSTGIQMVDC------PFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~~~~l~h------p~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.+ ..+++.+++|..       ..+.++...++.++|      ++++++++++..++..++|||++ +
T Consensus        22 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~  100 (339)
T 1z57_A           22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-G  100 (339)
T ss_dssp             EEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-C
T ss_pred             EecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-C
Confidence            68999999999998 557888888732       334455555555554      45999999999999999999999 7


Q ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-------------------CCCEEEee
Q psy3273          68 GDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-------------------HGHVRISD  126 (145)
Q Consensus        68 ~~l~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-------------------~~~~~l~d  126 (145)
                      ++|.+++....  .+++..+..++.|++.|+.|+|+++++|+||+|+||+++.                   ...++++|
T Consensus       101 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D  180 (339)
T 1z57_A          101 LSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD  180 (339)
T ss_dssp             CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECC
T ss_pred             CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEee
Confidence            89999987654  6889999999999999999999999999999999999987                   56799999


Q ss_pred             eccceecC
Q psy3273         127 LGLACDFS  134 (145)
Q Consensus       127 fg~~~~~~  134 (145)
                      ||++....
T Consensus       181 fg~~~~~~  188 (339)
T 1z57_A          181 FGSATYDD  188 (339)
T ss_dssp             CSSCEETT
T ss_pred             CcccccCc
Confidence            99998654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.91  E-value=4.4e-24  Score=155.90  Aligned_cols=118  Identities=16%  Similarity=0.199  Sum_probs=98.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccCC--------CCceeEeeEEEE----cCCEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMVD--------CPFIVCMTYAFH----TPDKLCFIL   62 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~--------hp~i~~~~~~~~----~~~~~~lv~   62 (145)
                      +|.|+||.||+|.+..+++.+|+|..       ..+.++...++.++        ||||++++++|.    ....+|+||
T Consensus        45 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~  124 (397)
T 1wak_A           45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVF  124 (397)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEE
T ss_pred             eeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEE
Confidence            68999999999999999999999742       33445555555553        889999999998    556899999


Q ss_pred             EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEECCCC
Q psy3273          63 DLMNGGDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRR-YIVYRDLKPANILLDEHG  120 (145)
Q Consensus        63 e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~-~iih~~l~~~nil~~~~~  120 (145)
                      |++ ++++.+.+...  ..+++..+..++.|++.|+.|+|++ +++|+||||+||+++.++
T Consensus       125 e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          125 EVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             CCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred             ecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence            999 55776766543  5699999999999999999999998 999999999999998664

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.91  E-value=2.9e-24  Score=152.89  Aligned_cols=129  Identities=23%  Similarity=0.401  Sum_probs=107.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS   75 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~   75 (145)
                      +|.|+||.||++...  ++.+++|.      ...+.++...++.++||||+++++++.+  ..++||||+++++|.+++.
T Consensus        16 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~   91 (307)
T 2eva_A           16 VGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLH   91 (307)
T ss_dssp             EECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHH
T ss_pred             eecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHh
Confidence            689999999999875  56677763      4456677788899999999999998874  4789999999999999998


Q ss_pred             hcC---CCCHHHHHHHHHHHHHHHHHHhh---CCceecCCCCCcEEECCCCC-EEEeeeccceecC
Q psy3273          76 QHG---VFNEDEMRFYAAEVILGLEHMHR---RYIVYRDLKPANILLDEHGH-VRISDLGLACDFS  134 (145)
Q Consensus        76 ~~~---~~~~~~~~~~~~~i~~~l~~lh~---~~iih~~l~~~nil~~~~~~-~~l~dfg~~~~~~  134 (145)
                      ...   .++...+..++.|++.++.|+|+   ++++|+||+|+||+++.++. ++++|||++..+.
T Consensus        92 ~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           92 GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             CSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            654   37888999999999999999999   89999999999999987776 7999999997654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.91  E-value=1e-24  Score=168.78  Aligned_cols=136  Identities=26%  Similarity=0.362  Sum_probs=119.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEc------CCEEEEEEEcc
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHT------PDKLCFILDLM   65 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~------~~~~~lv~e~~   65 (145)
                      .+|.|+||.||+|.+..+++.+|+|.         ...+.++...++.++||||+++++++..      ++..|+||||+
T Consensus        21 ~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~  100 (676)
T 3qa8_A           21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYC  100 (676)
T ss_dssp             CCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECC
T ss_pred             EEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeC
Confidence            36899999999999999999999973         3456677888899999999999999765      67789999999


Q ss_pred             CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCC---EEEeeeccceecCCC
Q psy3273          66 NGGDLHYHLSQHG---VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGH---VRISDLGLACDFSKK  136 (145)
Q Consensus        66 ~~~~l~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~---~~l~dfg~~~~~~~~  136 (145)
                      ++++|.+++....   .+++..+..++.|++.++.|+|+.+++|+||+|+||+++.++.   ++++|||.+..+...
T Consensus       101 ~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~  177 (676)
T 3qa8_A          101 EGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG  177 (676)
T ss_dssp             SSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC
T ss_pred             CCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccc
Confidence            9999999998643   5888999999999999999999999999999999999986554   899999999876544

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.91  E-value=1.5e-23  Score=149.33  Aligned_cols=131  Identities=18%  Similarity=0.200  Sum_probs=113.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCC--CCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVD--CPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~--hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      +|.|+||.||+|.+. +++.+++|.          ...+.++...++.++  ||||+++++++..++..|++|| +.+++
T Consensus        36 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~  113 (313)
T 3cek_A           36 IGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNID  113 (313)
T ss_dssp             EECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEE
T ss_pred             ecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCc
Confidence            689999999999985 477888863          244566667777776  5999999999999999999999 56789


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |.+++.....+++..+..++.|++.++.|+|+.+++|+||+|+||+++. +.++++|||++..+..
T Consensus       114 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          114 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             HHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence            9999998888999999999999999999999999999999999999964 7899999999986643

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.90  E-value=3.1e-24  Score=152.90  Aligned_cols=128  Identities=22%  Similarity=0.251  Sum_probs=109.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.....   +++|.          ...+.++...++.++||||+++++++..++..+++||++++++|.
T Consensus        41 lg~G~~g~V~~~~~~~~---~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~  117 (319)
T 2y4i_B           41 IGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY  117 (319)
T ss_dssp             CCCSSSSEEEEEEESSS---EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHH
T ss_pred             eccCCceEEEEEEEcCe---EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHH
Confidence            68999999999987542   44432          234556777788999999999999999999999999999999999


Q ss_pred             HHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          72 YHLSQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        72 ~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      +++.... .+++..+..++.|++.++.++|+.+++|+||+|+||+++ ++.++++|||++...
T Consensus       118 ~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          118 SVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             HHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            9997644 689999999999999999999999999999999999998 678999999987644

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=4.1e-24  Score=162.68  Aligned_cols=124  Identities=14%  Similarity=0.045  Sum_probs=99.7

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH----------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE----------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      ++|.|+||.||++..  .++.+++|.                .+.+.++.+.++.++||||+++..++...+..|+||||
T Consensus       343 ~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~  420 (540)
T 3en9_A          343 LIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY  420 (540)
T ss_dssp             -----CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred             EEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence            368999999999933  344444432                23357788889999999999666666677778999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          65 MNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        65 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +++++|.+++..        ...++.|++.++.|+|+++++|+||||+||+++.  .++++|||+++.+...
T Consensus       421 ~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          421 INGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             CCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             CCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999998875        4678999999999999999999999999999998  9999999999987654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.90  E-value=5.9e-23  Score=147.87  Aligned_cols=132  Identities=22%  Similarity=0.299  Sum_probs=110.8

Q ss_pred             eeeeeeeEEEEEEEcccC-CeeeeeH-------HHHHHhhhhhcccCCCCc------eeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQG-ETLALNE-------RIMLSLVSTGIQMVDCPF------IVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~-~~~~~~~-------~~~~~~~~~~~~~l~hp~------i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +|.|+||.||+|.+..++ +.+++|.       ...+.++...++.++|++      ++.+.+++...+..+++||++ +
T Consensus        27 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~  105 (355)
T 2eu9_A           27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-G  105 (355)
T ss_dssp             EEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-C
T ss_pred             eeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-C
Confidence            689999999999998877 6788863       234455556666665554      999999999999999999999 5


Q ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE-------------------CCCCCEEEee
Q psy3273          68 GDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL-------------------DEHGHVRISD  126 (145)
Q Consensus        68 ~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~-------------------~~~~~~~l~d  126 (145)
                      +++.+.+...  ..+++..+..++.|++.|+.|+|+++++|+||+|+||++                   +....++++|
T Consensus       106 ~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~D  185 (355)
T 2eu9_A          106 KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD  185 (355)
T ss_dssp             CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECC
T ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEee
Confidence            5777777654  469999999999999999999999999999999999999                   4567899999


Q ss_pred             eccceecC
Q psy3273         127 LGLACDFS  134 (145)
Q Consensus       127 fg~~~~~~  134 (145)
                      ||++....
T Consensus       186 fg~~~~~~  193 (355)
T 2eu9_A          186 FGSATFDH  193 (355)
T ss_dssp             CTTCEETT
T ss_pred             cCcccccc
Confidence            99998644

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.90  E-value=9.9e-24  Score=156.75  Aligned_cols=133  Identities=23%  Similarity=0.237  Sum_probs=106.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS   75 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~   75 (145)
                      +|.|+||.||.+ ...+|+.+|+|.     .....++...++.+ +||||+++++++.+++..|+|||++. ++|.+++.
T Consensus        23 LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~  100 (434)
T 2rio_A           23 LGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVE  100 (434)
T ss_dssp             EEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHH
T ss_pred             EeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHh
Confidence            699999999865 455789999974     23345566666654 89999999999999999999999996 59999997


Q ss_pred             hcCCC-------CHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-------------CCEEEeeeccceecCC
Q psy3273          76 QHGVF-------NEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-------------GHVRISDLGLACDFSK  135 (145)
Q Consensus        76 ~~~~~-------~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-------------~~~~l~dfg~~~~~~~  135 (145)
                      .....       ++..+..++.|++.|+.|+|+++++|+||+|+||+++..             ..++++|||++..+..
T Consensus       101 ~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~  180 (434)
T 2rio_A          101 SKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS  180 (434)
T ss_dssp             TC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC
T ss_pred             ccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCC
Confidence            64332       222346799999999999999999999999999999643             4799999999987754


Q ss_pred             C
Q psy3273         136 K  136 (145)
Q Consensus       136 ~  136 (145)
                      +
T Consensus       181 ~  181 (434)
T 2rio_A          181 G  181 (434)
T ss_dssp             -
T ss_pred             C
Confidence            3

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.90  E-value=1.9e-23  Score=151.66  Aligned_cols=133  Identities=20%  Similarity=0.284  Sum_probs=111.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCC-----------CCceeEeeEEEEcCC----EEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVD-----------CPFIVCMTYAFHTPD----KLC   59 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~-----------hp~i~~~~~~~~~~~----~~~   59 (145)
                      +|.|+||.||+|.+..+++.+|+|.       ...+.++...++.++           ||||+++++++...+    .++
T Consensus        27 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  106 (373)
T 1q8y_A           27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV  106 (373)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEE
T ss_pred             eeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEE
Confidence            6899999999999999999999974       233444555555444           899999999998654    799


Q ss_pred             EEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhC-CceecCCCCCcEEEC------CCCCEEEeeeccc
Q psy3273          60 FILDLMNGGDLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMHRR-YIVYRDLKPANILLD------EHGHVRISDLGLA  130 (145)
Q Consensus        60 lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~-~iih~~l~~~nil~~------~~~~~~l~dfg~~  130 (145)
                      ++||++ +++|.+++...  ..+++..+..++.|++.|+.|+|++ +++|+||+|+||+++      ....++++|||++
T Consensus       107 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a  185 (373)
T 1q8y_A          107 MVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA  185 (373)
T ss_dssp             EEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTC
T ss_pred             EEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccc
Confidence            999999 88999998753  4599999999999999999999998 999999999999994      3347999999999


Q ss_pred             eecCC
Q psy3273         131 CDFSK  135 (145)
Q Consensus       131 ~~~~~  135 (145)
                      ..+..
T Consensus       186 ~~~~~  190 (373)
T 1q8y_A          186 CWYDE  190 (373)
T ss_dssp             EETTB
T ss_pred             cccCC
Confidence            87644

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.90  E-value=6.8e-24  Score=157.66  Aligned_cols=133  Identities=20%  Similarity=0.200  Sum_probs=107.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----HHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----MLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      ++|.|+||.|+ .....+++.+|+|...     ...++...++.+ +||||+++++++..++..|++||++. ++|.+++
T Consensus        31 ~LG~G~~G~V~-~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l  108 (432)
T 3p23_A           31 VLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV  108 (432)
T ss_dssp             EEEECGGGCEE-EEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHH
T ss_pred             eeecCcCEEEE-EEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHH
Confidence            36999999976 3555678889997432     234566667777 89999999999999999999999996 5999988


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-----CCCEEEeeeccceecCC
Q psy3273          75 SQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-----HGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-----~~~~~l~dfg~~~~~~~  135 (145)
                      .... ...+.....++.|++.|+.|+|+.+++|+||+|+||+++.     ...++++|||+++.+..
T Consensus       109 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          109 EQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             HSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             HhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            7543 3555566789999999999999999999999999999943     24688999999986643

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.90  E-value=8.7e-23  Score=149.24  Aligned_cols=133  Identities=20%  Similarity=0.271  Sum_probs=110.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccC------CCCceeEeeEEEEcCCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMV------DCPFIVCMTYAFHTPDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l------~hp~i~~~~~~~~~~~~~~lv~e~~~~~   68 (145)
                      +|.|+||.||+|.+..+++.+|+|..       .....+...++.+      .|++|+++++++..++..|+|||++.+ 
T Consensus        62 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-  140 (382)
T 2vx3_A           62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-  140 (382)
T ss_dssp             EEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-
T ss_pred             EeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-
Confidence            69999999999999999999999742       2223333344433      334699999999999999999999965 


Q ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh--hCCceecCCCCCcEEEC--CCCCEEEeeeccceecCC
Q psy3273          69 DLHYHLSQH--GVFNEDEMRFYAAEVILGLEHMH--RRYIVYRDLKPANILLD--EHGHVRISDLGLACDFSK  135 (145)
Q Consensus        69 ~l~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh--~~~iih~~l~~~nil~~--~~~~~~l~dfg~~~~~~~  135 (145)
                      +|.+++...  ..+++..+..++.|++.++.|+|  ..+++|+||||+||+++  ....++|+|||+++.+..
T Consensus       141 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~  213 (382)
T 2vx3_A          141 NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ  213 (382)
T ss_dssp             BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence            999998764  45899999999999999999999  57899999999999995  467899999999987643

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=3.6e-22  Score=140.99  Aligned_cols=122  Identities=11%  Similarity=0.114  Sum_probs=98.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH--------------------------HHHHhhhhhcccCCCCceeEeeEEEEcC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER--------------------------IMLSLVSTGIQMVDCPFIVCMTYAFHTP   55 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~   55 (145)
                      .|.|++|.||+|.+ .+++.+|+|..                          ..+.++...++.++|   +++.+++.. 
T Consensus        98 iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~~~-  172 (282)
T 1zar_A           98 MGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVYAW-  172 (282)
T ss_dssp             EEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEEEE-
T ss_pred             eccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEEec-
Confidence            68999999999999 88999999743                          235567777788874   455554443 


Q ss_pred             CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          56 DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        56 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +..|+||||+++++|.+ +..      .....++.|++.++.++|+.+++|+|++|+||+++ ++.++++|||+|+....
T Consensus       173 ~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~~~  244 (282)
T 1zar_A          173 EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE  244 (282)
T ss_dssp             ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEETTS
T ss_pred             cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeECCC
Confidence            45699999999999987 421      23446899999999999999999999999999999 99999999999987654


Q ss_pred             C
Q psy3273         136 K  136 (145)
Q Consensus       136 ~  136 (145)
                      +
T Consensus       245 ~  245 (282)
T 1zar_A          245 E  245 (282)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.84  E-value=5.5e-21  Score=141.19  Aligned_cols=132  Identities=14%  Similarity=0.084  Sum_probs=99.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCC-C---------------------ceeEe
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDC-P---------------------FIVCM   48 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~h-p---------------------~i~~~   48 (145)
                      +|.|+||.||+|.+..+++.+|+|.           .+.++++...++.+.| +                     +...+
T Consensus        86 LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (413)
T 3dzo_A           86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM  165 (413)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC----
T ss_pred             cccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCcc
Confidence            6999999999999999999999973           3345566666777766 1                     11112


Q ss_pred             eEEEEc-----CCEEEEEEEccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEE
Q psy3273          49 TYAFHT-----PDKLCFILDLMNGGDLHYHLSQ-------HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILL  116 (145)
Q Consensus        49 ~~~~~~-----~~~~~lv~e~~~~~~l~~~l~~-------~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~  116 (145)
                      ...+..     ...++++|+.+ +++|.+++..       ...+++.....++.|++.|+.|+|+.+++|+||||+||++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl  244 (413)
T 3dzo_A          166 IRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL  244 (413)
T ss_dssp             -----------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE
Confidence            222222     22477888866 5699988841       2336677888889999999999999999999999999999


Q ss_pred             CCCCCEEEeeeccceecC
Q psy3273         117 DEHGHVRISDLGLACDFS  134 (145)
Q Consensus       117 ~~~~~~~l~dfg~~~~~~  134 (145)
                      +.++.+||+|||+++...
T Consensus       245 ~~~~~~kL~DFG~a~~~~  262 (413)
T 3dzo_A          245 DQRGGVFLTGFEHLVRDG  262 (413)
T ss_dssp             CTTCCEEECCGGGCEETT
T ss_pred             ecCCeEEEEeccceeecC
Confidence            999999999999987654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=2.5e-20  Score=129.95  Aligned_cols=126  Identities=13%  Similarity=0.082  Sum_probs=97.6

Q ss_pred             eeeeeeeEEEEEEEcccCCe--eeeeHH--------------------------------HHHHhhhhhcccCCCCce--
Q psy3273           2 FFIVGTGFLSNCSHVKQGET--LALNER--------------------------------IMLSLVSTGIQMVDCPFI--   45 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~--~~~~~~--------------------------------~~~~~~~~~~~~l~hp~i--   45 (145)
                      .|.|++|.||+|.+..+|+.  +|+|..                                ..+.++...++.+.|+++  
T Consensus        55 ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~  134 (258)
T 1zth_A           55 ISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSV  134 (258)
T ss_dssp             EEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            68999999999999888888  888731                                145566667777777764  


Q ss_pred             eEeeEEEEcCCEEEEEEEccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hCCceecCCCCCcEEECCC
Q psy3273          46 VCMTYAFHTPDKLCFILDLMNG-G----DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMH-RRYIVYRDLKPANILLDEH  119 (145)
Q Consensus        46 ~~~~~~~~~~~~~~lv~e~~~~-~----~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~iih~~l~~~nil~~~~  119 (145)
                      +.+++.    +..++||||+.+ |    +|.+....   .++.....++.|++.++.++| .++++|+|++|.||+++. 
T Consensus       135 p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~-  206 (258)
T 1zth_A          135 PQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID-  206 (258)
T ss_dssp             CCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS-
T ss_pred             CeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC-
Confidence            344432    356899999942 3    66655432   224456788999999999999 999999999999999988 


Q ss_pred             CCEEEeeeccceecCCC
Q psy3273         120 GHVRISDLGLACDFSKK  136 (145)
Q Consensus       120 ~~~~l~dfg~~~~~~~~  136 (145)
                       .++++|||+|.....+
T Consensus       207 -~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          207 -KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             -SEEECCCTTCEETTST
T ss_pred             -cEEEEECcccccCCCc
Confidence             9999999999877544

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.63  E-value=5.4e-17  Score=118.73  Aligned_cols=128  Identities=11%  Similarity=0.090  Sum_probs=85.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHHH----------------------HHhhhhhcccCCCCceeEeeEEEEcC----
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERIM----------------------LSLVSTGIQMVDCPFIVCMTYAFHTP----   55 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~l~hp~i~~~~~~~~~~----   55 (145)
                      .|.|++|.||.|.+. +|+.+|+|....                      ...+...+....|+|+.+++.....-    
T Consensus       103 IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~  181 (397)
T 4gyi_A          103 IGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPI  181 (397)
T ss_dssp             EEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEE
T ss_pred             eeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeee
Confidence            689999999999985 688888873110                      00111111112234443333221111    


Q ss_pred             --CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC----------CEE
Q psy3273          56 --DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG----------HVR  123 (145)
Q Consensus        56 --~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~----------~~~  123 (145)
                        ...++||||+++++|.....    .  .....+..|++.++.++|.+|++|+|+||.||+++.++          .+.
T Consensus       182 ~~~~~~LVME~i~G~~L~~l~~----~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~  255 (397)
T 4gyi_A          182 AQSRHTIVMSLVDALPMRQVSS----V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPI  255 (397)
T ss_dssp             EEETTEEEEECCSCEEGGGCCC----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEE
T ss_pred             eccCceEEEEecCCccHhhhcc----c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceE
Confidence              11269999999888755432    1  23356788999999999999999999999999997554          388


Q ss_pred             EeeeccceecCCC
Q psy3273         124 ISDLGLACDFSKK  136 (145)
Q Consensus       124 l~dfg~~~~~~~~  136 (145)
                      ++||+.+.....+
T Consensus       256 iID~~Q~V~~~hp  268 (397)
T 4gyi_A          256 IIXFPQMVSMDHP  268 (397)
T ss_dssp             ECCCTTCEETTST
T ss_pred             EEEeCCcccCCCC
Confidence            9999988765433

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.18  E-value=7e-11  Score=81.83  Aligned_cols=120  Identities=11%  Similarity=-0.022  Sum_probs=86.4

Q ss_pred             eeeeEEEEEEEcccCCeeeeeHH--------HHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHH
Q psy3273           5 VGTGFLSNCSHVKQGETLALNER--------IMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS   75 (145)
Q Consensus         5 ~~~g~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~   75 (145)
                      ++.+.||++...  ++.+++|..        ..++++...++.+ .+..++++++++...+..|+|||+++|.++.+.+.
T Consensus        25 ~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~  102 (263)
T 3tm0_A           25 MSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE  102 (263)
T ss_dssp             CSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC
T ss_pred             CCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC
Confidence            455678887643  455555532        2355666666655 36778899999998999999999999988876531


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHhh------------------------------------------------------
Q psy3273          76 QHGVFNEDEMRFYAAEVILGLEHMHR------------------------------------------------------  101 (145)
Q Consensus        76 ~~~~~~~~~~~~~~~~i~~~l~~lh~------------------------------------------------------  101 (145)
                      .     ......+..++...+..+|+                                                      
T Consensus       103 ~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~  177 (263)
T 3tm0_A          103 D-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE  177 (263)
T ss_dssp             T-----TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHC
T ss_pred             C-----cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhc
Confidence            1     11223566778888888887                                                      


Q ss_pred             -----CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 -----RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 -----~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                           .+++|+|+++.|++++......++||+.+.
T Consensus       178 ~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                 448899999999999765556799999775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.93  E-value=3.1e-09  Score=73.00  Aligned_cols=118  Identities=12%  Similarity=0.040  Sum_probs=76.8

Q ss_pred             eeeEEEEEEEcccCCeeeeeH-----HHHHHhhhhhcccCCCCc--eeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcC
Q psy3273           6 GTGFLSNCSHVKQGETLALNE-----RIMLSLVSTGIQMVDCPF--IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG   78 (145)
Q Consensus         6 ~~g~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~hp~--i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~   78 (145)
                      ..+.+|++.. .+|+.+++|.     ...+..+...++.+.+.+  +++++.+...++..+++||+++|.++.  ..   
T Consensus        32 ~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---  105 (264)
T 1nd4_A           32 SDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---  105 (264)
T ss_dssp             SSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---
T ss_pred             CCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---
Confidence            4478888854 3455555542     122344555555554333  677899888888899999999998773  11   


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhC--------------------------------------------------------
Q psy3273          79 VFNEDEMRFYAAEVILGLEHMHRR--------------------------------------------------------  102 (145)
Q Consensus        79 ~~~~~~~~~~~~~i~~~l~~lh~~--------------------------------------------------------  102 (145)
                      ....   ..+..++...+..+|+.                                                        
T Consensus       106 ~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  182 (264)
T 1nd4_A          106 HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  182 (264)
T ss_dssp             CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCC
Confidence            1121   13344555555555543                                                        


Q ss_pred             --CceecCCCCCcEEECCCCCEEEeeecccee
Q psy3273         103 --YIVYRDLKPANILLDEHGHVRISDLGLACD  132 (145)
Q Consensus       103 --~iih~~l~~~nil~~~~~~~~l~dfg~~~~  132 (145)
                        +++|+|++|.||+++.+....++||+.+..
T Consensus       183 ~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          183 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence              289999999999997665567999998763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.89  E-value=4.7e-09  Score=75.84  Aligned_cols=125  Identities=11%  Similarity=0.033  Sum_probs=84.5

Q ss_pred             eeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCC--CCceeEeeEEEEcC---CEEEEEEEccC
Q psy3273           3 FIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVD--CPFIVCMTYAFHTP---DKLCFILDLMN   66 (145)
Q Consensus         3 g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~--hp~i~~~~~~~~~~---~~~~lv~e~~~   66 (145)
                      +-|.++.+|.+.... +.. +++.           ...+.++...++.+.  +..+++++..+.+.   +..|+|||+++
T Consensus        47 ~~G~sn~~y~v~~~~-~~~-vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~  124 (359)
T 3dxp_A           47 KGGQSNPTFKLVTPG-QTY-VMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVS  124 (359)
T ss_dssp             CC-CCSCEEEEECSS-CEE-EEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCC
T ss_pred             CCcccceEEEEEECC-ceE-EEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecC
Confidence            446667777776542 333 3321           123445555555555  45578888888766   45889999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh---------------------------------------------
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR---------------------------------------------  101 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~---------------------------------------------  101 (145)
                      |..+.+.  ....+++.....+..++...+..+|.                                             
T Consensus       125 G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (359)
T 3dxp_A          125 GRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMD  202 (359)
T ss_dssp             CBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHH
T ss_pred             CeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHH
Confidence            8766331  11235667777778888888888886                                             


Q ss_pred             -------------CCceecCCCCCcEEECCCCC--EEEeeeccce
Q psy3273         102 -------------RYIVYRDLKPANILLDEHGH--VRISDLGLAC  131 (145)
Q Consensus       102 -------------~~iih~~l~~~nil~~~~~~--~~l~dfg~~~  131 (145)
                                   .+++|+|+++.|++++.+..  +.++||+.+.
T Consensus       203 ~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          203 WLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             HGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             HHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence                         35899999999999986643  6899999876

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.16  E-value=3.8e-05  Score=52.97  Aligned_cols=119  Identities=13%  Similarity=0.109  Sum_probs=72.6

Q ss_pred             EEEEEEEcccCCeeeee-----HHHHHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCH
Q psy3273           9 FLSNCSHVKQGETLALN-----ERIMLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE   82 (145)
Q Consensus         9 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~   82 (145)
                      .+|+......++.+.+|     ....+..+...++.+. +--+++++.++.+++..|+|||++++.++.+......    
T Consensus        40 ~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~----  115 (272)
T 4gkh_A           40 TIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP----  115 (272)
T ss_dssp             EEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG----
T ss_pred             eEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH----
Confidence            57776666666555554     2233444444444332 2236788999999999999999999877655432210    


Q ss_pred             HHHHHHHHHHHHHHHHHhh----------------------------------------------------------CCc
Q psy3273          83 DEMRFYAAEVILGLEHMHR----------------------------------------------------------RYI  104 (145)
Q Consensus        83 ~~~~~~~~~i~~~l~~lh~----------------------------------------------------------~~i  104 (145)
                      .....+..++...+..+|.                                                          ..+
T Consensus       116 ~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l  195 (272)
T 4gkh_A          116 DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVV  195 (272)
T ss_dssp             GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEE
T ss_pred             HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEE
Confidence            0011122222222222221                                                          126


Q ss_pred             eecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         105 VYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       105 ih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      +|+|+.+.|++++.....-++||+.+.
T Consensus       196 ~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          196 THGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             ECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EcCCCCCCeEEEECCeEEEEEECcccc
Confidence            899999999999877666799998775

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.97  E-value=2.2e-05  Score=55.33  Aligned_cols=103  Identities=16%  Similarity=0.088  Sum_probs=63.0

Q ss_pred             HHHHhhhhhcccC-CCCc--eeEeeEEEEcCC---EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q psy3273          28 IMLSLVSTGIQMV-DCPF--IVCMTYAFHTPD---KLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHR  101 (145)
Q Consensus        28 ~~~~~~~~~~~~l-~hp~--i~~~~~~~~~~~---~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~  101 (145)
                      ..+.++...++.+ .+..  +++++.....++   ..|+|||+++|.++.....  ..++..+...+..++...+..+|+
T Consensus        55 ~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~  132 (304)
T 3sg8_A           55 TNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHS  132 (304)
T ss_dssp             HHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHc
Confidence            4455666666555 3333  445555443333   3588999999977654221  123444444444444444444442


Q ss_pred             ----------------------------------------------------------CCceecCCCCCcEEECC--CCC
Q psy3273         102 ----------------------------------------------------------RYIVYRDLKPANILLDE--HGH  121 (145)
Q Consensus       102 ----------------------------------------------------------~~iih~~l~~~nil~~~--~~~  121 (145)
                                                                                ..++|+|+.+.|++++.  ...
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~  212 (304)
T 3sg8_A          133 INISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTI  212 (304)
T ss_dssp             SCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEE
T ss_pred             CCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCE
Confidence                                                                      24799999999999987  456


Q ss_pred             EEEeeecccee
Q psy3273         122 VRISDLGLACD  132 (145)
Q Consensus       122 ~~l~dfg~~~~  132 (145)
                      +.++||+.+..
T Consensus       213 ~~~iD~~~~~~  223 (304)
T 3sg8_A          213 CGIIDFGDAAI  223 (304)
T ss_dssp             EEECCCTTCEE
T ss_pred             EEEEeCCCCcc
Confidence            78999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.93  E-value=0.00027  Score=49.94  Aligned_cols=45  Identities=11%  Similarity=-0.124  Sum_probs=30.4

Q ss_pred             HHHHhhhhhcccCCCC---ceeEeeEEEE-cCCEEEEEEEccCCCCHHH
Q psy3273          28 IMLSLVSTGIQMVDCP---FIVCMTYAFH-TPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus        28 ~~~~~~~~~~~~l~hp---~i~~~~~~~~-~~~~~~lv~e~~~~~~l~~   72 (145)
                      ..+..+...++.+.+.   .+++++.+.. ..+..+++||+++|..+..
T Consensus        54 ~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~  102 (306)
T 3tdw_A           54 DELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE  102 (306)
T ss_dssp             HHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence            4556666666666542   3567777764 4556789999999877654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.22  E-value=0.00079  Score=49.05  Aligned_cols=30  Identities=23%  Similarity=0.400  Sum_probs=25.2

Q ss_pred             hCCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         101 RRYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       101 ~~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      ...++|+|+.+.|++++.+ .+.++||..+.
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            4578999999999999765 48899998765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.73  E-value=0.0018  Score=46.40  Aligned_cols=31  Identities=16%  Similarity=0.351  Sum_probs=25.4

Q ss_pred             hCCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         101 RRYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       101 ~~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      ...++|+|+.+.|++++....+.++||..+.
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            3568999999999999854447899998775

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.67  E-value=0.024  Score=39.93  Aligned_cols=31  Identities=23%  Similarity=0.333  Sum_probs=27.5

Q ss_pred             hCCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         101 RRYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       101 ~~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      ..+++|+|+.+.|++++.+..+.++||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            3679999999999999877889999999775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=94.67  E-value=0.094  Score=36.52  Aligned_cols=28  Identities=21%  Similarity=0.084  Sum_probs=23.7

Q ss_pred             CceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         103 YIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       103 ~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .++|+|+.+.|++ ..++.+.++||..+.
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            4799999999999 556678999998775

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.53  E-value=0.048  Score=39.99  Aligned_cols=31  Identities=10%  Similarity=0.321  Sum_probs=26.8

Q ss_pred             hhCCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         100 HRRYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       100 h~~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      +...++|+|+.+.|++++.+. +.++||+.+.
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~  260 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSF  260 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence            467799999999999998765 9999998775

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=91.61  E-value=0.054  Score=37.98  Aligned_cols=30  Identities=20%  Similarity=0.280  Sum_probs=25.0

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .+++|+|+.+.|++++.+....++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            468999999999999876556799998765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=91.29  E-value=0.076  Score=37.50  Aligned_cols=31  Identities=26%  Similarity=0.250  Sum_probs=26.3

Q ss_pred             hCCceecCCCCCcEEECCC----CCEEEeeeccce
Q psy3273         101 RRYIVYRDLKPANILLDEH----GHVRISDLGLAC  131 (145)
Q Consensus       101 ~~~iih~~l~~~nil~~~~----~~~~l~dfg~~~  131 (145)
                      ...++|+|+.+.|++++.+    ..+.++||+.+.
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            3468999999999999864    678999998775

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=91.07  E-value=0.3  Score=34.22  Aligned_cols=28  Identities=25%  Similarity=0.122  Sum_probs=24.2

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      ..++|+|+.+.|++++ + .+.++||..+.
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            4578999999999998 4 89999998764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.59  E-value=2.5  Score=28.39  Aligned_cols=89  Identities=9%  Similarity=-0.019  Sum_probs=62.5

Q ss_pred             CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC
Q psy3273          41 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG  120 (145)
Q Consensus        41 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~  120 (145)
                      .||++  ...+-++++.+.+.++.-+++.-+..+.   ..+...-+.++.+++.... -|...-.+.-+.|+|++++.+.
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~~  121 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRAL  121 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTTC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCCC
Confidence            78888  5555588888888888665543333443   3566666777777766544 1234557888999999999999


Q ss_pred             CEEEeeeccceecCC
Q psy3273         121 HVRISDLGLACDFSK  135 (145)
Q Consensus       121 ~~~l~dfg~~~~~~~  135 (145)
                      .+++.-.|+-..+.+
T Consensus       122 ~p~i~hRGi~~~lpP  136 (219)
T 4ano_A          122 EPFFLHVGVKESLPP  136 (219)
T ss_dssp             CEEESCCEETTTBSS
T ss_pred             cEEEEEcCCcccCCC
Confidence            999999887655543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=89.04  E-value=1.9  Score=30.43  Aligned_cols=83  Identities=7%  Similarity=-0.011  Sum_probs=51.5

Q ss_pred             eeeeEEEEEEEcccCCeeeee-----HHHHHHhhhhhcccCC---CCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHh
Q psy3273           5 VGTGFLSNCSHVKQGETLALN-----ERIMLSLVSTGIQMVD---CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ   76 (145)
Q Consensus         5 ~~~g~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~---hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~   76 (145)
                      |....+|+...  .++.+++|     ....+..+...++.|.   ...+++++.+...++..++|||++++..+..    
T Consensus        47 G~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~----  120 (312)
T 3jr1_A           47 GEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQ----  120 (312)
T ss_dssp             SSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCT----
T ss_pred             ccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCc----
Confidence            33445565553  23344443     2344555555555442   3567889988888889999999999865411    


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCC
Q psy3273          77 HGVFNEDEMRFYAAEVILGLEHMHRRY  103 (145)
Q Consensus        77 ~~~~~~~~~~~~~~~i~~~l~~lh~~~  103 (145)
                                ....++...+..+|...
T Consensus       121 ----------~~~~~lG~~LA~LH~~~  137 (312)
T 3jr1_A          121 ----------SSFTIFAEKIAQLHQIQ  137 (312)
T ss_dssp             ----------THHHHHHHHHHHHHHCC
T ss_pred             ----------hhHHHHHHHHHHHHcCC
Confidence                      13356677778888764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=88.15  E-value=0.5  Score=33.56  Aligned_cols=30  Identities=17%  Similarity=0.265  Sum_probs=26.1

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .+++|+|+.+.|++++.+..+.++||..+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            458999999999999877789999997665

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=86.95  E-value=0.33  Score=34.77  Aligned_cols=28  Identities=21%  Similarity=0.323  Sum_probs=23.0

Q ss_pred             CceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         103 YIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       103 ~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      +++|+|+.+.|++++.+. +.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            589999999999987544 8999997665

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.35  E-value=2.1  Score=28.62  Aligned_cols=88  Identities=15%  Similarity=0.123  Sum_probs=59.9

Q ss_pred             CCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC
Q psy3273          41 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG  120 (145)
Q Consensus        41 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~  120 (145)
                      .||+++.. .+-++++.+.+-++.-+.+.-+..+.   ..+...-+.++.+++....++  ..-.+--+.|+|++++.+.
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~  116 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG  116 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence            77888755 56677788777777554322222222   356666677777777766433  3346788999999999999


Q ss_pred             CEEEeeeccceecC
Q psy3273         121 HVRISDLGLACDFS  134 (145)
Q Consensus       121 ~~~l~dfg~~~~~~  134 (145)
                      .+++.-.|+-..+.
T Consensus       117 ~p~i~~RGik~~l~  130 (215)
T 4ann_A          117 LPIAKTRGLQNVVD  130 (215)
T ss_dssp             CEEESCCEETTTBS
T ss_pred             CEEEEEccCccCCC
Confidence            99999888754443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=84.76  E-value=0.54  Score=35.12  Aligned_cols=15  Identities=27%  Similarity=0.290  Sum_probs=13.9

Q ss_pred             CceecCCCCCcEEEC
Q psy3273         103 YIVYRDLKPANILLD  117 (145)
Q Consensus       103 ~iih~~l~~~nil~~  117 (145)
                      .++|+|+.+.|++++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            478999999999998

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=84.48  E-value=0.36  Score=35.59  Aligned_cols=29  Identities=28%  Similarity=0.359  Sum_probs=23.4

Q ss_pred             CceecCCCCCcEEECCC----------------------------CCEEEeeeccce
Q psy3273         103 YIVYRDLKPANILLDEH----------------------------GHVRISDLGLAC  131 (145)
Q Consensus       103 ~iih~~l~~~nil~~~~----------------------------~~~~l~dfg~~~  131 (145)
                      .++|+|+.+.|++++.+                            ..+.++||..+.
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~  306 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS  306 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence            48999999999999764                            678999997665

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=83.53  E-value=0.59  Score=33.99  Aligned_cols=29  Identities=21%  Similarity=0.327  Sum_probs=25.3

Q ss_pred             CceecCCCCCcEEECCC----CCEEEeeeccce
Q psy3273         103 YIVYRDLKPANILLDEH----GHVRISDLGLAC  131 (145)
Q Consensus       103 ~iih~~l~~~nil~~~~----~~~~l~dfg~~~  131 (145)
                      .++|+|+.+.|++++.+    ..+.++||..+.
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            48999999999999765    689999998776

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=82.40  E-value=0.77  Score=33.45  Aligned_cols=28  Identities=25%  Similarity=0.383  Sum_probs=23.8

Q ss_pred             ceecCCCCCcEEE------CCCCCEEEeeeccce
Q psy3273         104 IVYRDLKPANILL------DEHGHVRISDLGLAC  131 (145)
Q Consensus       104 iih~~l~~~nil~------~~~~~~~l~dfg~~~  131 (145)
                      ++|+|+.+.||++      +....+.++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6799999999998      345679999998776

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	145
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-39
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-28
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-28
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-28
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-27
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-26
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-26
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-25
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-24
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-24
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-23
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-23
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-23
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-23
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-22
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-22
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-22
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-21
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-21
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-21
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-21
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-21
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-21
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-21
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-21
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-21
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-21
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-21
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-20
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-20
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-20
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-19
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-19
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-19
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-19
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-19
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-19
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-19
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-19
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-18
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-18
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-18
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-18
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-18
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-18
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-17
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-17
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-17
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-17
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-17
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-16
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-16
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-16
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-15
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-15
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-15
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-15
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-15
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-12
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-12
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-08
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-07

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  134 bits (337), Expect = 2e-39
 Identities = 114/127 (89%), Positives = 120/127 (94%), Gaps = 4/127 (3%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           KQGETLALNERIMLSLVSTG    DCPFIVCM+YAFHTPDKL FILDLMNGGDLHYHLSQ
Sbjct: 45  KQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 100

Query: 77  HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
           HGVF+E +MRFYAAE+ILGLEHMH R++VYRDLKPANILLDEHGHVRISDLGLACDFSKK
Sbjct: 101 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160

Query: 137 KPHASVG 143
           KPHASVG
Sbjct: 161 KPHASVG 167

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 4e-28
 Identities = 29/108 (26%), Positives = 58/108 (53%), Gaps = 1/108 (0%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +   + P+IV    AF++  ++   ++ M+GG L   L + G   E  +   +  VI GL
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117

Query: 97  EHMH-RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
            ++  +  I++RD+KP+NIL++  G +++ D G++        ++ VG
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 165

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (254), Expect = 4e-28
 Identities = 26/107 (24%), Positives = 49/107 (45%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
              +  P I+ +   FH   ++  IL+    G ++  L +   F+E     Y  E+   L
Sbjct: 60  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 119

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
            + H + +++RD+KP N+LL   G ++I+D G +      +     G
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 166

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 6e-28
 Identities = 40/107 (37%), Positives = 62/107 (57%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +  +D PF V + + F   +KL F L     G+L  ++ + G F+E   RFY AE++  L
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 121

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
           E++H + I++RDLKP NILL+E  H++I+D G A   S +   A   
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 1e-27
 Identities = 23/106 (21%), Positives = 49/106 (46%), Gaps = 1/106 (0%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILG 95
           +   D P IV +  AF+  + L  +++   GG +   +        E +++    + +  
Sbjct: 63  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122

Query: 96  LEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
           L ++H   I++RDLK  NIL    G ++++D G++   ++      
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 97.8 bits (243), Expect = 3e-26
 Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 6/131 (4%)

Query: 12  NCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH 71
           +   V++     L E  +L  VS        P I+ +   + T      + DLM  G+L 
Sbjct: 45  SAEEVQELREATLKEVDILRKVS------GHPNIIQLKDTYETNTFFFLVFDLMKKGELF 98

Query: 72  YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLAC 131
            +L++    +E E R     ++  +  +H+  IV+RDLKP NILLD+  +++++D G +C
Sbjct: 99  DYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158

Query: 132 DFSKKKPHASV 142
                +    V
Sbjct: 159 QLDPGEKLREV 169

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 98.1 bits (244), Expect = 3e-26
 Identities = 21/101 (20%), Positives = 39/101 (38%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +  P  +     +        +++   G              E E+       + GL
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 137
            ++H   +++RD+K  NILL E G V++ D G A   +   
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 95.9 bits (238), Expect = 4e-25
 Identities = 31/109 (28%), Positives = 52/109 (47%), Gaps = 3/109 (2%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILG 95
           + ++  P +V +  AF   +++  I + M+GG+L   +  +H   +EDE   Y  +V  G
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 96  LEHMHRRYIVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASV 142
           L HMH    V+ DLKP NI+        +++ D GL      K+     
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.5 bits (232), Expect = 1e-24
 Identities = 27/109 (24%), Positives = 48/109 (44%), Gaps = 2/109 (1%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILG 95
           ++      I+     + T  +L  +     G  L++HL      F   ++   A +   G
Sbjct: 58  LRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116

Query: 96  LEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGK 144
           ++++H + I++RDLK  NI L E   V+I D GLA   S+        +
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.8 bits (230), Expect = 2e-24
 Identities = 26/98 (26%), Positives = 50/98 (51%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
            +M++   +V         +     L+  +GG+L   +       E + + +  +++ G+
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 116

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS 134
            ++H   I +RD+KP N+LLDE  +++ISD GLA  F 
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 92.0 bits (228), Expect = 1e-23
 Identities = 29/106 (27%), Positives = 54/106 (50%), Gaps = 3/106 (2%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FNEDEMRFYAAEVILG 95
           +  +  P ++ +  AF    ++  IL+ ++GG+L   ++      +E E+  Y  +   G
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139

Query: 96  LEHMHRRYIVYRDLKPANILLD--EHGHVRISDLGLACDFSKKKPH 139
           L+HMH   IV+ D+KP NI+ +  +   V+I D GLA   +  +  
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.2 bits (226), Expect = 1e-23
 Identities = 28/125 (22%), Positives = 59/125 (47%), Gaps = 8/125 (6%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           +  + L +NE +++            P IV    ++   D+L  +++ + GG L   +++
Sbjct: 58  QPKKELIINEILVMR-------ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110

Query: 77  HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
               +E ++     E +  LE +H   +++RD+K  NILL   G V+++D G     + +
Sbjct: 111 TC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

Query: 137 KPHAS 141
           +   S
Sbjct: 170 QSKRS 174

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.3 bits (226), Expect = 1e-23
 Identities = 46/123 (37%), Positives = 68/123 (55%), Gaps = 6/123 (4%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
                  + E+ +LSL        + PF+  M   F T + L F+++ +NGGDL YH+  
Sbjct: 43  DDDVECTMVEKRVLSLA------WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS 96

Query: 77  HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
              F+     FYAAE+ILGL+ +H + IVYRDLK  NILLD+ GH++I+D G+  +    
Sbjct: 97  CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156

Query: 137 KPH 139
              
Sbjct: 157 DAK 159

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.0 bits (225), Expect = 2e-23
 Identities = 44/104 (42%), Positives = 68/104 (65%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q    PF+  + YAF T D+LCF+++  NGG+L +HLS+  VF E+  RFY AE++  L
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 118

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
           E++H R +VYRD+K  N++LD+ GH++I+D GL  +        
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 89.8 bits (222), Expect = 3e-23
 Identities = 22/133 (16%), Positives = 50/133 (37%), Gaps = 8/133 (6%)

Query: 14  SHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL-HY 72
            + ++     L+E  ++          D P ++ +         +  I + M  G L  +
Sbjct: 65  GYTEKQRRDFLSEASIMG-------QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 117

Query: 73  HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
                G F   ++      +  G++++     V+RDL   NIL++ +   ++SD GL+  
Sbjct: 118 LRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 133 FSKKKPHASVGKS 145
                   +   +
Sbjct: 178 LEDDTSDPTYTSA 190

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.4 bits (216), Expect = 2e-22
 Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 11/116 (9%)

Query: 37  IQMVDCPFIVCMTYAFH--TPDKLCFILDLMNGGDLHYHLSQH----GVFNEDEMRFYAA 90
           ++ +  P IV         T   L  +++   GGDL   +++        +E+ +     
Sbjct: 57  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116

Query: 91  EVILGLEHMHRRY-----IVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
           ++ L L+  HRR      +++RDLKPAN+ LD   +V++ D GLA   +     A 
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 172

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.5 bits (211), Expect = 8e-22
 Identities = 23/108 (21%), Positives = 47/108 (43%), Gaps = 1/108 (0%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFNEDEMRFYAAEVILG 95
           +  +    +V +         +  I + M  G L  +L      F   ++     +V   
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112

Query: 96  LEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
           +E++  +  ++RDL   N L+++ G V++SD GL+      +  +SVG
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.5 bits (211), Expect = 9e-22
 Identities = 24/109 (22%), Positives = 50/109 (45%), Gaps = 1/109 (0%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +D P+IV M       +    ++++   G L+ +L Q+    +  +     +V +G+
Sbjct: 62  MQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           +++     V+RDL   N+LL    + +ISD GL+      + +      
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.2 bits (213), Expect = 1e-21
 Identities = 24/129 (18%), Positives = 51/129 (39%), Gaps = 10/129 (7%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
              + L   E  +L        +     I+ +  +F + ++L  I + ++G D+   ++ 
Sbjct: 42  GTDQVLVKKEISIL-------NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT 94

Query: 77  HGV-FNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD--EHGHVRISDLGLACDF 133
                NE E+  Y  +V   L+ +H   I + D++P NI+        ++I + G A   
Sbjct: 95  SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154

Query: 134 SKKKPHASV 142
                   +
Sbjct: 155 KPGDNFRLL 163

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 85.5 bits (211), Expect = 1e-21
 Identities = 21/109 (19%), Positives = 48/109 (44%), Gaps = 2/109 (1%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFNEDEMRFYAAEVIL 94
           ++ +  P +V +            I + M  G+L  +L        +   + + A ++  
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126

Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
            +E++ ++  ++RDL   N L+ E+  V+++D GL+   +     A  G
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.7 bits (211), Expect = 1e-21
 Identities = 30/99 (30%), Positives = 51/99 (51%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q +  P I+ +  AF     +  + D M             V     ++ Y    + GL
Sbjct: 54  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 113

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK 135
           E++H+ +I++RDLKP N+LLDE+G ++++D GLA  F  
Sbjct: 114 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 86.4 bits (213), Expect = 1e-21
 Identities = 35/97 (36%), Positives = 64/97 (65%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +Q V+ PF+V + ++F     L  +++ + GG++  HL + G F+E   RFYAA+++L  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF 133
           E++H   ++YRDLKP N+L+D+ G+++++D G A   
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 85.5 bits (211), Expect = 2e-21
 Identities = 29/109 (26%), Positives = 54/109 (49%), Gaps = 3/109 (2%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +  +  P IV +   + +   L  I+ L++GG+L   + + G + E +      +V+  +
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120

Query: 97  EHMHRRYIVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASV 142
           +++H   IV+RDLKP N+L    DE   + ISD GL+         ++ 
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 169

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.6 bits (211), Expect = 2e-21
 Identities = 30/143 (20%), Positives = 52/143 (36%), Gaps = 29/143 (20%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH------ 77
           ++E  M++      Q+     IV +  A      +  I +    GDL  +L         
Sbjct: 88  MSELKMMT------QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141

Query: 78  -----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
                             V   +++  +A +V  G+E +  +  V+RDL   N+L+    
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 201

Query: 121 HVRISDLGLACDFSKKKPHASVG 143
            V+I D GLA D      +   G
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRG 224

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 84.8 bits (209), Expect = 3e-21
 Identities = 46/113 (40%), Positives = 66/113 (58%), Gaps = 7/113 (6%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNED 83
            +ER+MLS       +V  PFI+ M   F    ++  I+D + GG+L   L +   F   
Sbjct: 52  NDERLMLS-------IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP 104

Query: 84  EMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
             +FYAAEV L LE++H + I+YRDLKP NILLD++GH++I+D G A      
Sbjct: 105 VAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.1 bits (210), Expect = 4e-21
 Identities = 27/146 (18%), Positives = 56/146 (38%), Gaps = 13/146 (8%)

Query: 13  CSHVKQGETLAL----NERIMLSLVSTGIQMVDCPFIVCMTYAFHTP----DKLCFILDL 64
             + +  E  AL    +       V    +   CP IV +   +         L  +++ 
Sbjct: 31  IFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90

Query: 65  MNGGDLHYHLSQHG--VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH--- 119
           ++GG+L   +   G   F E E       +   ++++H   I +RD+KP N+L       
Sbjct: 91  LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 150

Query: 120 GHVRISDLGLACDFSKKKPHASVGKS 145
             ++++D G A + +      +   +
Sbjct: 151 AILKLTDFGFAKETTSHNSLTTPCYT 176

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.9 bits (207), Expect = 4e-21
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 7/114 (6%)

Query: 37  IQMVDCPFIVCMTYAFHTPDK----LCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEV 92
           ++ +  P IV    ++ +  K    +  + +LM  G L  +L +  V     +R +  ++
Sbjct: 62  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 121

Query: 93  ILGLEHMHRR--YIVYRDLKPANILL-DEHGHVRISDLGLACDFSKKKPHASVG 143
           + GL+ +H R   I++RDLK  NI +    G V+I DLGLA         A +G
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG 175

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.9 bits (209), Expect = 4e-21
 Identities = 50/117 (42%), Positives = 70/117 (59%), Gaps = 6/117 (5%)

Query: 23  ALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNE 82
              ER +L  +         PF+V + YAF T  KL  ILD +NGG+L  HLSQ   F E
Sbjct: 75  TRTERQVLEHIR------QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE 128

Query: 83  DEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
            E++ Y  E++L LEH+H+  I+YRD+K  NILLD +GHV ++D GL+ +F   +  
Sbjct: 129 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.6 bits (206), Expect = 6e-21
 Identities = 24/110 (21%), Positives = 50/110 (45%), Gaps = 2/110 (1%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAAEVILG 95
           +  +D P+IV +       + L  ++++  GG LH  L  +        +     +V +G
Sbjct: 63  MHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121

Query: 96  LEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           ++++  +  V+RDL   N+LL    + +ISD GL+        + +   +
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.1 bits (202), Expect = 3e-20
 Identities = 25/109 (22%), Positives = 51/109 (46%), Gaps = 3/109 (2%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL--HYHLSQHGVFNEDEMRFYAAEVIL 94
           ++ +    +V + YA  + + +  + + M+ G L               ++   AA++  
Sbjct: 66  MKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124

Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
           G+ ++ R   V+RDL+ ANIL+ E+   +++D GLA      +  A  G
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.2 bits (200), Expect = 4e-20
 Identities = 27/109 (24%), Positives = 50/109 (45%), Gaps = 3/109 (2%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVIL 94
           ++ +    +V + YA  T + +  I + M  G L   L          +++   AA++  
Sbjct: 62  MKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120

Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
           G+  +  R  ++RDL+ ANIL+ +    +I+D GLA      +  A  G
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.9 bits (199), Expect = 5e-20
 Identities = 23/108 (21%), Positives = 49/108 (45%), Gaps = 1/108 (0%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFNEDEMRFYAAEVILG 95
           +  +  P +V +         +C + + M  G L  Y  +Q G+F  + +     +V  G
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113

Query: 96  LEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 143
           + ++    +++RDL   N L+ E+  +++SD G+       +  +S G
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.1 bits (197), Expect = 1e-19
 Identities = 30/128 (23%), Positives = 54/128 (42%), Gaps = 7/128 (5%)

Query: 18  QGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG-DLHYHLSQ 76
              T    E ++L  VS+G        ++ +   F  PD    IL+      DL   +++
Sbjct: 49  PNGTRVPMEVVLLKKVSSG-----FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 103

Query: 77  HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSK 135
            G   E+  R +  +V+  + H H   +++RD+K  NIL+D + G +++ D G       
Sbjct: 104 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163

Query: 136 KKPHASVG 143
                  G
Sbjct: 164 TVYTDFDG 171

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (197), Expect = 2e-19
 Identities = 22/105 (20%), Positives = 41/105 (39%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           +  VD P +  +     T         +  G  L Y            +  +  ++  G+
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
            ++  R +V+RDL   N+L+    HV+I+D GLA     ++    
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.7 bits (196), Expect = 2e-19
 Identities = 23/107 (21%), Positives = 44/107 (41%), Gaps = 3/107 (2%)

Query: 37  IQMVDCPFIV-CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFNEDEMRFYAAEVI 93
           +  +    +V  +         L  + + M  G L  +L   G  V   D +  ++ +V 
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113

Query: 94  LGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 140
             +E++     V+RDL   N+L+ E    ++SD GL  + S  +   
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 2e-19
 Identities = 20/132 (15%), Positives = 46/132 (34%), Gaps = 8/132 (6%)

Query: 12  NCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD-L 70
              + ++     L E  ++              I+ +         +  I + M  G   
Sbjct: 45  KAGYTEKQRVDFLGEAGIMG-------QFSHHNIIRLEGVISKYKPMMIITEYMENGALD 97

Query: 71  HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
            +   + G F+  ++      +  G++++     V+RDL   NIL++ +   ++SD GL+
Sbjct: 98  KFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 157

Query: 131 CDFSKKKPHASV 142
                       
Sbjct: 158 RVLEDDPEATYT 169

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 3e-19
 Identities = 25/143 (17%), Positives = 52/143 (36%), Gaps = 22/143 (15%)

Query: 17  KQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ 76
           K        E  +L       ++   P I+ +  A      L   ++    G+L   L +
Sbjct: 51  KDDHRDFAGELEVLC------KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 104

Query: 77  H----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG 120
                               +  ++  +AA+V  G++++ ++  ++RDL   NIL+ E+ 
Sbjct: 105 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164

Query: 121 HVRISDLGLACDFSKKKPHASVG 143
             +I+D GL+             
Sbjct: 165 VAKIADFGLSRGQEVYVKKTMGR 187

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 3e-19
 Identities = 27/138 (19%), Positives = 49/138 (35%), Gaps = 24/138 (17%)

Query: 24  LNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG----- 78
           ++E  +LS       + +   IV +  A         I +    GDL   L +       
Sbjct: 74  MSELKVLS------YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 79  -------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRIS 125
                          + +++  ++ +V  G+  +  +  ++RDL   NILL      +I 
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187

Query: 126 DLGLACDFSKKKPHASVG 143
           D GLA D      +   G
Sbjct: 188 DFGLARDIKNDSNYVVKG 205

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 79.1 bits (194), Expect = 4e-19
 Identities = 28/131 (21%), Positives = 48/131 (36%), Gaps = 24/131 (18%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG------------------ 78
           +   D P IV +         +C + + M  GDL+  L                      
Sbjct: 70  MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 79  ------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACD 132
                   +  E    A +V  G+ ++  R  V+RDL   N L+ E+  V+I+D GL+ +
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 133 FSKKKPHASVG 143
                 + + G
Sbjct: 190 IYSADYYKADG 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.9 bits (191), Expect = 9e-19
 Identities = 25/106 (23%), Positives = 50/106 (47%), Gaps = 4/106 (3%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
           + +  P ++ +   +     +  IL+L+ GG+L   L++     E+E   +  +++ G+ 
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127

Query: 98  HMHRRYIVYRDLKPANILLDEHG----HVRISDLGLACDFSKKKPH 139
           ++H   I + DLKP NI+L +       ++I D GLA         
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.3 bits (187), Expect = 3e-18
 Identities = 21/106 (19%), Positives = 48/106 (45%), Gaps = 2/106 (1%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFNEDEMRFYAAEVILG 95
           ++  D P IV +     T + +  I++L   G+L  +   +    +   +  YA ++   
Sbjct: 62  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 96  LEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
           L ++  +  V+RD+   N+L+  +  V++ D GL+        + +
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 166

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 76.3 bits (187), Expect = 3e-18
 Identities = 21/107 (19%), Positives = 41/107 (38%), Gaps = 4/107 (3%)

Query: 37  IQMVDCPFIVCMTYAFHTPDK----LCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEV 92
              ++ P IV +                +++ ++G  L   +   G           A+ 
Sbjct: 61  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 120

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
              L   H+  I++RD+KPANI++     V++ D G+A   +     
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.5 bits (187), Expect = 3e-18
 Identities = 33/136 (24%), Positives = 53/136 (38%), Gaps = 17/136 (12%)

Query: 25  NERIMLSLVSTGIQMVDCPFIVCMTYAFHTPD-KLCFILDLMNGGDLHYHLSQHG----- 78
             R ++S +   I +     +V +  A   P   L  I++    G+L  +L         
Sbjct: 59  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118

Query: 79  -----------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDL 127
                          + +  Y+ +V  G+E +  R  ++RDL   NILL E   V+I D 
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 178

Query: 128 GLACDFSKKKPHASVG 143
           GLA D  K   +   G
Sbjct: 179 GLARDIYKDPDYVRKG 194

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.6 bits (185), Expect = 5e-18
 Identities = 23/110 (20%), Positives = 44/110 (40%), Gaps = 2/110 (1%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFNEDEMRFYAAEVILG 95
           +  +D   ++ + Y       +  + +L   G L        G F    +  YA +V  G
Sbjct: 65  MHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 96  LEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS 145
           + ++  +  ++RDL   N+LL     V+I D GL     +   H  + + 
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.1 bits (186), Expect = 5e-18
 Identities = 27/131 (20%), Positives = 53/131 (40%), Gaps = 1/131 (0%)

Query: 10  LSNCSHVKQGETLALNE-RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGG 68
           +   +  +     AL E +I+  L    +  +        +        +  + D     
Sbjct: 43  VLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD 102

Query: 69  DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG 128
                 +    F   E++     ++ GL ++HR  I++RD+K AN+L+   G ++++D G
Sbjct: 103 LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162

Query: 129 LACDFSKKKPH 139
           LA  FS  K  
Sbjct: 163 LARAFSLAKNS 173

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 75.6 bits (185), Expect = 8e-18
 Identities = 25/105 (23%), Positives = 50/105 (47%), Gaps = 6/105 (5%)

Query: 38  QMVDCPFIVCMTYAFHTPDK--LCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILG 95
            +   P I+ +      P       + + +N  D       +    + ++RFY  E++  
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKA 141

Query: 96  LEHMHRRYIVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH 139
           L++ H   I++RD+KP N+++D EH  +R+ D GLA  +   + +
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 74.5 bits (182), Expect = 2e-17
 Identities = 23/103 (22%), Positives = 48/103 (46%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +    IV +    HT  +L  + + ++           G       + +  +++ G+
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
            + H R +++RDLKP N+L++  G ++I+D GLA  F      
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.9 bits (183), Expect = 2e-17
 Identities = 26/118 (22%), Positives = 48/118 (40%), Gaps = 10/118 (8%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG----------VFNEDEMR 86
           ++  +C  +V +            I++LM  GDL  +L                +  +M 
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 87  FYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGK 144
             A E+  G+ +++    V+RDL   N ++ E   V+I D G+  D  +   +   GK
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.2 bits (181), Expect = 3e-17
 Identities = 25/105 (23%), Positives = 54/105 (51%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGL 96
           ++ +    IV +    H+  KL  + +  +     Y  S +G  + + ++ +  +++ GL
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114

Query: 97  EHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
              H R +++RDLKP N+L++ +G +++++ GLA  F       S
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.3 bits (179), Expect = 5e-17
 Identities = 30/121 (24%), Positives = 51/121 (42%), Gaps = 13/121 (10%)

Query: 37  IQMVDCPFIVCMTYAFHTPD----KLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEV 92
             M+    I+    A +  +    +L  + D    G L  +L+++ V  E  ++  A   
Sbjct: 51  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALST 109

Query: 93  ILGLEHMH--------RRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGK 144
             GL H+H        +  I +RDLK  NIL+ ++G   I+DLGLA           +  
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169

Query: 145 S 145
           +
Sbjct: 170 N 170

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.0 bits (178), Expect = 6e-17
 Identities = 28/128 (21%), Positives = 59/128 (46%), Gaps = 8/128 (6%)

Query: 10  LSNCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD 69
           +   +  +   + A+ E  +L       + ++ P IV +    HT +KL  + + ++   
Sbjct: 35  IRLDTETEGVPSTAIREISLL-------KELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87

Query: 70  LHY-HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG 128
             +   S         ++ Y  +++ GL   H   +++RDLKP N+L++  G ++++D G
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147

Query: 129 LACDFSKK 136
           LA  F   
Sbjct: 148 LARAFGVP 155

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.5 bits (177), Expect = 2e-16
 Identities = 28/136 (20%), Positives = 55/136 (40%), Gaps = 17/136 (12%)

Query: 16  VKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDK------LCFILDLMNGG- 68
           V Q +     E  ++         +D   IV + Y F++  +      L  +LD +    
Sbjct: 53  VLQDKRFKNRELQIMR-------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV 105

Query: 69  --DLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG-HVRIS 125
                ++           ++ Y  ++   L ++H   I +RD+KP N+LLD     +++ 
Sbjct: 106 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 165

Query: 126 DLGLACDFSKKKPHAS 141
           D G A    + +P+ S
Sbjct: 166 DFGSAKQLVRGEPNVS 181

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.8 bits (175), Expect = 2e-16
 Identities = 25/146 (17%), Positives = 55/146 (37%), Gaps = 22/146 (15%)

Query: 12  NCSHVKQGETLALNERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH 71
                ++  +  ++E  M+        +     I+ +  A      L  I++  + G+L 
Sbjct: 54  KSDATEKDLSDLISEMEMMK------MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107

Query: 72  YHLSQHG----------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANIL 115
            +L                      +  ++   A +V  G+E++  +  ++RDL   N+L
Sbjct: 108 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167

Query: 116 LDEHGHVRISDLGLACDFSKKKPHAS 141
           + E   ++I+D GLA D      +  
Sbjct: 168 VTEDNVMKIADFGLARDIHHIDYYKK 193

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.0 bits (173), Expect = 4e-16
 Identities = 25/107 (23%), Positives = 51/107 (47%), Gaps = 5/107 (4%)

Query: 37  IQMVDCPFIVCMTYAFHTPD----KLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEV 92
           +       I+ +      P     K  +++  + G D  Y L +    + D + ++  ++
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGAD-LYKLLKTQHLSNDHICYFLYQI 118

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
           + GL+++H   +++RDLKP+N+LL+    ++I D GLA        H
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.7 bits (167), Expect = 3e-15
 Identities = 23/107 (21%), Positives = 48/107 (44%), Gaps = 2/107 (1%)

Query: 37  IQMVDCPFIVCM-TYAFHTPDKLCFILDLMNGGDLH-YHLSQHGVFNEDEMRFYAAEVIL 94
           ++    P ++ +      +      +L  M  GDL  +  ++       ++  +  +V  
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 141

Query: 95  GLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 141
           G++ +  +  V+RDL   N +LDE   V+++D GLA D   K+  + 
Sbjct: 142 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.0 bits (165), Expect = 4e-15
 Identities = 26/112 (23%), Positives = 51/112 (45%), Gaps = 6/112 (5%)

Query: 37  IQMVDCPFIV-----CMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFNEDEMRFYAA 90
           ++  + P +V     C         KL  + + ++     Y           + ++    
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 142
           +++ GL+ +H   +V+RDLKP NIL+   G ++++D GLA  +S +    SV
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 175

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.3 bits (166), Expect = 5e-15
 Identities = 25/104 (24%), Positives = 48/104 (46%), Gaps = 4/104 (3%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLCFILDLM----NGGDLHYHLSQHGVFNEDEMRFYAAEV 92
           ++ +    ++ +   F   + L    D        G     L +H    ED ++F   ++
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
           + GL ++H   I++RDLKP N+ ++E   ++I D GLA     +
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 67.5 bits (164), Expect = 6e-15
 Identities = 18/110 (16%), Positives = 40/110 (36%), Gaps = 5/110 (4%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
            +  C  I  + Y          ++DL+              F+   +   A +++  ++
Sbjct: 56  LLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115

Query: 98  HMHRRYIVYRDLKPANILLDE-----HGHVRISDLGLACDFSKKKPHASV 142
            +H + +VYRD+KP N L+          + + D G+   +        +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 67.6 bits (164), Expect = 7e-15
 Identities = 22/106 (20%), Positives = 42/106 (39%), Gaps = 3/106 (2%)

Query: 38  QMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLE 97
            M     I  + +     D    +++L+              F+   +   A ++I  +E
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117

Query: 98  HMHRRYIVYRDLKPANIL---LDEHGHVRISDLGLACDFSKKKPHA 140
           ++H +  ++RD+KP N L     +   V I D GLA  +   + H 
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.8 bits (149), Expect = 1e-12
 Identities = 22/104 (21%), Positives = 49/104 (47%), Gaps = 4/104 (3%)

Query: 37  IQMVDCPFIVCMTYAFHTPDKLC----FILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEV 92
           ++ +    ++ +   F     L       L     G    ++ +     +D ++F   ++
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 93  ILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK 136
           + GL+++H   I++RDLKP+N+ ++E   ++I D GLA     +
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.7 bits (146), Expect = 2e-12
 Identities = 22/109 (20%), Positives = 49/109 (44%), Gaps = 9/109 (8%)

Query: 37  IQMVDCPFIVCMTYAFHTPDK------LCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAA 90
           ++ V+   I+ +   F           +  +++LM+         +    + + M +   
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLY 126

Query: 91  EVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 139
           +++ G++H+H   I++RDLKP+NI++     ++I D GLA         
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 47.1 bits (111), Expect = 7e-08
 Identities = 11/64 (17%), Positives = 22/64 (34%), Gaps = 1/64 (1%)

Query: 71  HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLA 130
                +      +        ++  +   + R IV+ DL   N+L+ E G   I D   +
Sbjct: 91  LIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII-DFPQS 149

Query: 131 CDFS 134
            +  
Sbjct: 150 VEVG 153

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 47.0 bits (110), Expect = 1e-07
 Identities = 22/112 (19%), Positives = 50/112 (44%), Gaps = 12/112 (10%)

Query: 40  VDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQHGVFNEDEMRFYAAEVIL 94
           +    I+ +   F+        + ++        L      +H       ++  + +++L
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 95  GLEHMH-RRYIVYRDLKPANILLDEHG------HVRISDLGLACDFSKKKPH 139
           GL++MH R  I++ D+KP N+L++          ++I+DLG AC + +   +
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	145
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.98
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.98
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.98
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.97
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.97
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.97
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.97
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.97
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.97
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.96
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.96
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.96
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.96
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.96
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.96
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.95
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.95
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.95
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.95
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.85
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.33
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.91
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.89
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.83
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	86.16

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-36  Score=207.71  Aligned_cols=143  Identities=22%  Similarity=0.282  Sum_probs=129.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+|+|.           ...+.++.+.++.++||||+++++++.+++.+|+||||+++|+|
T Consensus        14 iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L   93 (263)
T d2j4za1          14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV   93 (263)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             EecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcH
Confidence            6999999999999999999999973           23355677888999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccccCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGK  144 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  144 (145)
                      .+++.....+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+|++|||+|.....+......||
T Consensus        94 ~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~Gt  167 (263)
T d2j4za1          94 YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT  167 (263)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEETTEE
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCcccccCCC
Confidence            99998888899999999999999999999999999999999999999999999999999987765554444443

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-36  Score=209.66  Aligned_cols=134  Identities=22%  Similarity=0.242  Sum_probs=123.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|+||.||+|.+..+++.+|+|.         .+.+.++.+.++.++||||+++++++.+++.+|+||||+++|+|.+
T Consensus        13 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~   92 (271)
T d1nvra_          13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD   92 (271)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGG
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHH
Confidence            6999999999999999999999973         2345677888999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ++.....+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+||+|||+|+.+..
T Consensus        93 ~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          93 RIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             GSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            998778899999999999999999999999999999999999999999999999999987643

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-36  Score=212.50  Aligned_cols=143  Identities=24%  Similarity=0.385  Sum_probs=127.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|+||.||+|.+..+++.+|+|.         ...+.++.+.++.++||||++++++|.+++.+|+||||+++|+|.+
T Consensus        14 iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~   93 (322)
T d1s9ja_          14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ   93 (322)
T ss_dssp             EECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHH
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHH
Confidence            6999999999999999999999973         3456778889999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccccCC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGK  144 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  144 (145)
                      ++.+.+.+++..+..++.|++.|+.|+|+ ++++||||||+||+++.++.+|++|||+|+.+.+......+||
T Consensus        94 ~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~GT  166 (322)
T d1s9ja_          94 VLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT  166 (322)
T ss_dssp             HHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CCS
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccccCC
Confidence            99888889999999999999999999996 5999999999999999999999999999987655444444554

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-35  Score=206.13  Aligned_cols=134  Identities=21%  Similarity=0.379  Sum_probs=123.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.||+|.+..+|+.+|+|.        .+.+.++...++.++||||++++++|.+++.+|+||||+++|+|.++
T Consensus        28 iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~  107 (293)
T d1yhwa1          28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV  107 (293)
T ss_dssp             CCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHH
T ss_pred             EecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHH
Confidence            5899999999999999999999973        34567788889999999999999999999999999999999999987


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +.. ..+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+|++|||+|+.+..+
T Consensus       108 ~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1         108 VTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             HHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             hhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            765 57999999999999999999999999999999999999999999999999999987654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-35  Score=202.92  Aligned_cols=144  Identities=24%  Similarity=0.308  Sum_probs=125.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEc----CCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHT----PDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|.+..+++.+|+|.          .+.+.++.++++.++||||++++++|++    +..+|+||||+++
T Consensus        17 iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~   96 (270)
T d1t4ha_          17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS   96 (270)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCS
T ss_pred             EecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCC
Confidence            6999999999999999999998863          3456788889999999999999999975    3568999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--ceecCCCCCcEEECC-CCCEEEeeeccceecCCCCCccccCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRY--IVYRDLKPANILLDE-HGHVRISDLGLACDFSKKKPHASVGK  144 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--iih~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~  144 (145)
                      |+|.+++.....+++..+..++.|++.|+.|+|+++  ++||||||+||+++. ++.+|++|||+|+..........+||
T Consensus        97 g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT  176 (270)
T d1t4ha_          97 GTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT  176 (270)
T ss_dssp             CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSS
T ss_pred             CcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccC
Confidence            999999988888999999999999999999999998  999999999999964 67999999999976554444444555


Q ss_pred             C
Q psy3273         145 S  145 (145)
Q Consensus       145 ~  145 (145)
                      +
T Consensus       177 ~  177 (270)
T d1t4ha_         177 P  177 (270)
T ss_dssp             C
T ss_pred             c
Confidence            3

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.4e-34  Score=201.21  Aligned_cols=139  Identities=23%  Similarity=0.347  Sum_probs=126.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------------HHHHhhhhhcccCC-CCceeEeeEEEEcCCEEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------------IMLSLVSTGIQMVD-CPFIVCMTYAFHTPDKLCFILD   63 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~e   63 (145)
                      .|.|+||.||+|++..+++.+|+|..                 +.+.++...++.++ ||||++++++|.+++.+|+|||
T Consensus        11 iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE   90 (277)
T d1phka_          11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD   90 (277)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEE
Confidence            69999999999999999999999742                 23556777888887 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCcc
Q psy3273          64 LMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA  140 (145)
Q Consensus        64 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  140 (145)
                      |+++|+|.+++...+.+++..+..++.|++.|+.|+|.++++|+||+|+||+++.++.+|++|||+++.+.+.....
T Consensus        91 ~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~  167 (277)
T d1phka_          91 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR  167 (277)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBC
T ss_pred             cCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCCcee
Confidence            99999999999888899999999999999999999999999999999999999999999999999999876654433

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-34  Score=206.19  Aligned_cols=134  Identities=36%  Similarity=0.625  Sum_probs=124.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|++..+++.+|+|.           ...+.++..+++.++||||++++++|++++.+|+||||+++|+|
T Consensus        13 lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L   92 (337)
T d1o6la_          13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL   92 (337)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCch
Confidence            6999999999999999999999973           23345667788999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ..++...+.+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+|++|||+|+.+..
T Consensus        93 ~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          93 FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             hhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999888999999999999999999999999999999999999999999999999999987654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.3e-34  Score=206.42  Aligned_cols=140  Identities=23%  Similarity=0.379  Sum_probs=125.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.||+|.+..+|+.+|+|.        ...+.++...++.++||||++++++|++++.+|+|||||++|+|.+.
T Consensus        37 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~  116 (352)
T d1koba_          37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR  116 (352)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHH
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHH
Confidence            6999999999999999999999973        34556788889999999999999999999999999999999999988


Q ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC--CCCCEEEeeeccceecCCCCCccc
Q psy3273          74 LSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD--EHGHVRISDLGLACDFSKKKPHAS  141 (145)
Q Consensus        74 l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~--~~~~~~l~dfg~~~~~~~~~~~~~  141 (145)
                      +... ..+++.++..++.|++.|+.|+|+++++||||||+||+++  ..+.+||+|||+|..+..+.....
T Consensus       117 ~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~  187 (352)
T d1koba_         117 IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  187 (352)
T ss_dssp             TTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence            7654 4699999999999999999999999999999999999997  567899999999998876654443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.7e-34  Score=206.98  Aligned_cols=145  Identities=68%  Similarity=1.136  Sum_probs=128.5

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHH---hhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-----------MLS---LVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~---~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      +.|.|+||.||+|.+..+|+.+|+|...           ...   .+...++.++||||++++++|.+++.+|+||||++
T Consensus        11 ~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~   90 (364)
T d1omwa3          11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   90 (364)
T ss_dssp             EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecC
Confidence            3699999999999999999999997421           111   22445678899999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCCccccCCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGKS  145 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  145 (145)
                      +|+|.+++.....+++..+..++.|++.|+.|+|+++++||||||+||+++..+.+|++|||+|+.+.........||+
T Consensus        91 gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~  169 (364)
T d1omwa3          91 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH  169 (364)
T ss_dssp             SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCCCSCCSCG
T ss_pred             CCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCccccccccc
Confidence            9999999998888999999999999999999999999999999999999999999999999999988777666666653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-34  Score=203.23  Aligned_cols=134  Identities=30%  Similarity=0.443  Sum_probs=124.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+|+|.           ...+.++.++++.++||||++++++|.+++.+|+||||+++|+|
T Consensus        16 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L   95 (288)
T d1uu3a_          16 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL   95 (288)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCH
Confidence            6999999999999999999999973           22356777788999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      .+++...+.+++..+..++.|++.|+.|+|+++++||||||+||+++.++.++++|||+|+.+..
T Consensus        96 ~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          96 LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             HHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            99998888999999999999999999999999999999999999999999999999999987753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-34  Score=203.88  Aligned_cols=134  Identities=19%  Similarity=0.226  Sum_probs=123.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+++.+|+|.           ...+.++.++++.++||||+++++++.+++.+|+|||||++|++
T Consensus        23 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l  102 (309)
T d1u5ra_          23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS  102 (309)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHH
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCch
Confidence            6999999999999999999999963           23456788889999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ..++.....+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+|++|||+|.....
T Consensus       103 ~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_         103 DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             HHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            87777778899999999999999999999999999999999999999999999999999986543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-34  Score=199.96  Aligned_cols=139  Identities=21%  Similarity=0.339  Sum_probs=126.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|.+..+|+.+|+|.              .+.+.++...++.++||||++++++|++++.+|+|||||++
T Consensus        18 lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~g   97 (293)
T d1jksa_          18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAG   97 (293)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            6999999999999999999999973              34567888889999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC----CEEEeeeccceecCCCCCcc
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG----HVRISDLGLACDFSKKKPHA  140 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~  140 (145)
                      |+|.+++...+.+++..+..++.|++.|+.|+|+++++||||||+||+++..+    .+|++|||+|..+..+....
T Consensus        98 g~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~  174 (293)
T d1jksa_          98 GELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK  174 (293)
T ss_dssp             CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCS
T ss_pred             ccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCcccc
Confidence            99999998888899999999999999999999999999999999999997655    59999999998876554433

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-34  Score=201.49  Aligned_cols=133  Identities=19%  Similarity=0.267  Sum_probs=122.5

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.||+|.+..+++.+|+|.        .+.+.++.+.++.++||||+++++++.+++.+|+||||+++|+|.++
T Consensus        20 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~   99 (288)
T d2jfla1          20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV   99 (288)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHH
T ss_pred             EeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHH
Confidence            6999999999999999999999963        34566788889999999999999999999999999999999999998


Q ss_pred             HHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          74 LSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        74 l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +.. ...+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+|++|||+|+...
T Consensus       100 ~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1         100 MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             HHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccC
Confidence            764 5679999999999999999999999999999999999999999999999999997654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.1e-34  Score=205.27  Aligned_cols=140  Identities=24%  Similarity=0.409  Sum_probs=125.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH--------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE--------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.||+|.+..+|+.+|+|.        .+.+.++..+++.++||||++++++|++++.+|+|||||++|+|.++
T Consensus        34 lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~  113 (350)
T d1koaa2          34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK  113 (350)
T ss_dssp             EEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHH
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHH
Confidence            6999999999999999999999973        44566788889999999999999999999999999999999999998


Q ss_pred             HH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC--CCCEEEeeeccceecCCCCCccc
Q psy3273          74 LS-QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE--HGHVRISDLGLACDFSKKKPHAS  141 (145)
Q Consensus        74 l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~  141 (145)
                      +. ..+.+++..+..++.|++.|+.|+|+++++||||||+||++..  .+.+||+|||+|+.+.......+
T Consensus       114 l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  184 (350)
T d1koaa2         114 VADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  184 (350)
T ss_dssp             HTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEE
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccce
Confidence            85 4567999999999999999999999999999999999999964  57899999999998876554443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-34  Score=204.45  Aligned_cols=137  Identities=21%  Similarity=0.286  Sum_probs=115.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   72 (145)
                      .|.|+||.||+|.+..+++.+|+|.         ...+.++.++++.++||||++++++|.+++.+|+||||+++|+|.+
T Consensus        17 lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~   96 (307)
T d1a06a_          17 LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD   96 (307)
T ss_dssp             SBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             EeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHH
Confidence            6899999999999999999999974         2234567788999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEEC---CCCCEEEeeeccceecCCCCC
Q psy3273          73 HLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKP  138 (145)
Q Consensus        73 ~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~---~~~~~~l~dfg~~~~~~~~~~  138 (145)
                      ++...+.+++..+..++.|++.|+.|+|+++++||||||+||++.   .++.+|++|||+|+....+..
T Consensus        97 ~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          97 RIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             HHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             hhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence            998888899999999999999999999999999999999999995   467899999999987765543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-33  Score=200.57  Aligned_cols=135  Identities=33%  Similarity=0.501  Sum_probs=124.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+|+.+|+|.           .+.+.++..+++.++||||+++++++.+++.+|+||||++++++
T Consensus        12 lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l   91 (316)
T d1fota_          12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL   91 (316)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccc
Confidence            6999999999999999999999974           23455677788999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ...+.....+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+||+|||+|+.+...
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          92 FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             HHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             cccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            999998888999999999999999999999999999999999999999999999999999876543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=200.88  Aligned_cols=137  Identities=18%  Similarity=0.316  Sum_probs=123.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|+||.||+|.+..+++.+|+|.       ...+.++.++++.++||||++++++|++++.+|+|||||++++|.+++
T Consensus        13 lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i   92 (321)
T d1tkia_          13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI   92 (321)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHH
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHH
Confidence            5999999999999999999999973       345667888899999999999999999999999999999999999999


Q ss_pred             HhcC-CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC--CCEEEeeeccceecCCCCC
Q psy3273          75 SQHG-VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKP  138 (145)
Q Consensus        75 ~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~--~~~~l~dfg~~~~~~~~~~  138 (145)
                      ...+ .+++.++..++.|++.|+.|+|+.+++||||+|+||+++.+  ..++++|||+++.......
T Consensus        93 ~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          93 NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             TSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            7654 79999999999999999999999999999999999999744  5799999999987765443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-34  Score=202.06  Aligned_cols=136  Identities=17%  Similarity=0.179  Sum_probs=124.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|+||.||+|.+..+++.+|+|.       .+.+.++...++.++||||++++++|.+++.+|++|||+++|+|..++
T Consensus        25 iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l  104 (287)
T d1opja_          25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL  104 (287)
T ss_dssp             TTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred             EeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHh
Confidence            5889999999999999999999973       455678888999999999999999999999999999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      ...  ..+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+||+|||+|+....+.
T Consensus       105 ~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_         105 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             HHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             hhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            753  568999999999999999999999999999999999999999999999999998765543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=196.54  Aligned_cols=135  Identities=25%  Similarity=0.365  Sum_probs=113.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEc--CCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHT--PDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|.+..+|+.+|+|.          .+.+.++...++.++||||+++++++.+  ++.+|+|||||++|+
T Consensus        12 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~   91 (269)
T d2java1          12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGD   91 (269)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEE
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCc
Confidence            6999999999999999999999973          3456678888999999999999999964  457999999999999


Q ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCC-----ceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQ----HGVFNEDEMRFYAAEVILGLEHMHRRY-----IVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~-----iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.+++..    ...+++..+..++.|++.|+.|+|+.+     ++||||||+||+++.++.+|++|||+|+.+..+
T Consensus        92 L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  167 (269)
T d2java1          92 LASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD  167 (269)
T ss_dssp             HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence            9998853    467999999999999999999999866     999999999999999999999999999876544

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-33  Score=197.85  Aligned_cols=135  Identities=19%  Similarity=0.234  Sum_probs=112.3

Q ss_pred             eeeeeeeEEEEEEEcccCC---eeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE---TLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~---~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|....+++   .+++|         ....+.++...++.++||||+++++++..++.+|+||||+++|+
T Consensus        34 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~  113 (299)
T d1jpaa_          34 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS  113 (299)
T ss_dssp             EEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred             EeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCc
Confidence            6999999999999987664   35554         24456788889999999999999999999999999999999999


Q ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.+++.. .+.+++.++..++.|++.|+.|+|+++++||||||+||+++.++.+||+|||+|+.+.+.
T Consensus       114 L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         114 LDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             HHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             ceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            9998876 456999999999999999999999999999999999999999999999999999876543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-32  Score=197.44  Aligned_cols=135  Identities=29%  Similarity=0.545  Sum_probs=124.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----------HHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----------IMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|.+..+|+.+|+|.+           ..+.++..+++.++||||++++++|......++|||++.+|+|
T Consensus        49 lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l  128 (350)
T d1rdqe_          49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM  128 (350)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred             eecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccch
Confidence            69999999999999999999999742           2345677788999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ...+...+.+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+||+|||+|+.+...
T Consensus       129 ~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             hhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999988889999999999999999999999999999999999999999999999999999877543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-32  Score=196.02  Aligned_cols=135  Identities=33%  Similarity=0.533  Sum_probs=120.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHHH-----------HHHhhhh-hcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNERI-----------MLSLVST-GIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~-~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|.+..+++.+|+|...           ....+.. ..+.++||||+++++++.+++.+|+||||+++|+
T Consensus        10 iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~   89 (320)
T d1xjda_          10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD   89 (320)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             EecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCc
Confidence            699999999999999999999997532           1122222 2346899999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.+++.....+++..+..++.|++.|+.|+|+++++|+||||+||+++..+.++++|||+++.....
T Consensus        90 L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          90 LMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            9999998888999999999999999999999999999999999999999999999999999866543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=198.99  Aligned_cols=136  Identities=23%  Similarity=0.332  Sum_probs=122.0

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHH-------------HHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERI-------------MLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +.|.|+||.||+|.+..+++.+|+|...             .+.++...++.++||||++++++|..++.+|+||||+.+
T Consensus         5 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~   84 (299)
T d1ua2a_           5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET   84 (299)
T ss_dssp             EEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE
T ss_pred             EeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcc
Confidence            3799999999999999999999998432             345677888999999999999999999999999999998


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +++.........+++..+..++.|++.|+.|+|+++++||||||+||+++..+.+||+|||+|+....+
T Consensus        85 ~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          85 DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             hHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC
Confidence            777666666677999999999999999999999999999999999999999999999999999876554

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-32  Score=191.68  Aligned_cols=134  Identities=21%  Similarity=0.244  Sum_probs=119.3

Q ss_pred             eeeeeeeEEEEEEEcc--cCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVK--QGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~--~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|....  +++.+|+|.          .+.+.++...++.++||||+++++++.++ ..++||||+++|+
T Consensus        15 iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~   93 (277)
T d1xbba_          15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGP   93 (277)
T ss_dssp             EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEE
T ss_pred             cccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCc
Confidence            6999999999997643  456788762          34567788889999999999999999755 5789999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          70 LHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        70 l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |.+++.....+++..+..++.|++.|+.|+|+++++||||||+||+++..+.++++|||+|+.+...
T Consensus        94 L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          94 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             HHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            9999998888999999999999999999999999999999999999999999999999999877544

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.3e-32  Score=194.80  Aligned_cols=138  Identities=19%  Similarity=0.303  Sum_probs=118.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeH---HHHHHhhhhhc-ccCCCCceeEeeEEEEc----CCEEEEEEEccCCCCHHH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNE---RIMLSLVSTGI-QMVDCPFIVCMTYAFHT----PDKLCFILDLMNGGDLHY   72 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~-~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~~~~l~~   72 (145)
                      +.|.|+||.||+|.+..+++.+|+|.   ....+++...+ +..+||||++++++|++    +..+|+|||||++|+|.+
T Consensus        19 ~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~   98 (335)
T d2ozaa1          19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS   98 (335)
T ss_dssp             EEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHH
T ss_pred             EeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHH
Confidence            36999999999999999999999974   33455565554 45589999999999976    467999999999999999


Q ss_pred             HHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC---CCCEEEeeeccceecCCCCC
Q psy3273          73 HLSQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE---HGHVRISDLGLACDFSKKKP  138 (145)
Q Consensus        73 ~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~~~  138 (145)
                      ++...  ..+++..+..++.|++.|+.|+|+++++||||||+||+++.   ...+|++|||+|+.......
T Consensus        99 ~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~  169 (335)
T d2ozaa1          99 RIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS  169 (335)
T ss_dssp             HHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred             HHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCc
Confidence            99764  46999999999999999999999999999999999999975   45699999999987765443

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=5.5e-32  Score=190.81  Aligned_cols=134  Identities=23%  Similarity=0.367  Sum_probs=118.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      +|.|+||.||+|.+..+++.+|+|.          ...+.++.++++.++||||++++++|.+++.+|+||||+.+ ++.
T Consensus        10 lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~   88 (298)
T d1gz8a_          10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLK   88 (298)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHH
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chh
Confidence            6999999999999999999999974          33456778889999999999999999999999999999976 444


Q ss_pred             HHHH-h-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLS-Q-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~-~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +.+. . ...+++..+..++.|++.|+.|+|+++++||||||+||+++.+..++++|||.|+....+
T Consensus        89 ~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          89 KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             hhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            4443 3 456999999999999999999999999999999999999999999999999999876543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=8e-32  Score=188.98  Aligned_cols=135  Identities=19%  Similarity=0.274  Sum_probs=116.8

Q ss_pred             eeeeeeeEEEEEEEccc--CCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQ--GETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|....+  +..||+|.         ...+.++...++.++||||+++++++.+ +.+|+||||+++|+|
T Consensus        17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L   95 (285)
T d1u59a_          17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL   95 (285)
T ss_dssp             EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEH
T ss_pred             EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcH
Confidence            69999999999987543  44677752         3456778888999999999999999975 468999999999999


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          71 HYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        71 ~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      .+++.. ...+++..+..++.|++.|+.|+|+++++|+||||+||+++.++.+|++|||+|+.+....
T Consensus        96 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          96 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             HHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            998765 4679999999999999999999999999999999999999999999999999998775543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.1e-32  Score=190.00  Aligned_cols=144  Identities=20%  Similarity=0.287  Sum_probs=123.0

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHHHH--------------HHhhhhhcccCC--CCceeEeeEEEEcCCEEEEEEEc
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNERIM--------------LSLVSTGIQMVD--CPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~l~--hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      +.|.|+||.||+|.+..+++.+|+|....              +.++...++.++  ||||++++++|.+++..|+|||+
T Consensus        11 ~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~   90 (273)
T d1xwsa_          11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER   90 (273)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEEC
T ss_pred             EEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEe
Confidence            36999999999999999999999985321              335556666665  89999999999999999999999


Q ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-CCEEEeeeccceecCCCCCcccc
Q psy3273          65 MNG-GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHASV  142 (145)
Q Consensus        65 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~  142 (145)
                      +.+ +++.+++.....+++..+..++.|++.|+.|+|+++++||||||+||+++.+ ..++++|||+|+...........
T Consensus        91 ~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~  170 (273)
T d1xwsa_          91 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD  170 (273)
T ss_dssp             CSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCC
T ss_pred             ccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccccccccc
Confidence            976 5788888888889999999999999999999999999999999999999854 78999999999876655444445


Q ss_pred             CC
Q psy3273         143 GK  144 (145)
Q Consensus       143 ~~  144 (145)
                      ||
T Consensus       171 GT  172 (273)
T d1xwsa_         171 GT  172 (273)
T ss_dssp             SC
T ss_pred             cC
Confidence            54

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.5e-32  Score=188.84  Aligned_cols=134  Identities=16%  Similarity=0.252  Sum_probs=114.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|+||.||+|... +++.+|+|.       .+.+.++...++.++||||+++++++..++.+++||||+++|+|.+++
T Consensus        13 iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l   91 (263)
T d1sm2a_          13 IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL   91 (263)
T ss_dssp             EECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred             EeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHh
Confidence            699999999999976 466788863       345677888899999999999999999999999999999999999988


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          75 SQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ... ..+++.....++.|++.|+.|+|+++++||||||+||+++.++.+||+|||+++.+.+.
T Consensus        92 ~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          92 RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             HTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             hccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC
Confidence            754 56889999999999999999999999999999999999999999999999999876544

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.7e-32  Score=192.48  Aligned_cols=136  Identities=23%  Similarity=0.249  Sum_probs=116.3

Q ss_pred             eeeeeeeEEEEEEEcccCC-----eeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE-----TLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~-----~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      .|.|+||.||+|.+..+++     .+++|.         ...+.++...++.+ +||||+++++++.+++.+|+|||||+
T Consensus        45 lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~  124 (325)
T d1rjba_          45 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC  124 (325)
T ss_dssp             EEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             EeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCC
Confidence            6999999999999876554     456542         23455666677776 89999999999999999999999999


Q ss_pred             CCCHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEE
Q psy3273          67 GGDLHYHLSQH-----------------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR  123 (145)
Q Consensus        67 ~~~l~~~l~~~-----------------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~  123 (145)
                      +|+|.+++...                       ..+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+|
T Consensus       125 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~K  204 (325)
T d1rjba_         125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVK  204 (325)
T ss_dssp             TCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEE
T ss_pred             CCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEE
Confidence            99999999653                       2478889999999999999999999999999999999999999999


Q ss_pred             EeeeccceecCCCC
Q psy3273         124 ISDLGLACDFSKKK  137 (145)
Q Consensus       124 l~dfg~~~~~~~~~  137 (145)
                      ++|||+|+......
T Consensus       205 l~DFGla~~~~~~~  218 (325)
T d1rjba_         205 ICDFGLARDIMSDS  218 (325)
T ss_dssp             ECCCGGGSCGGGCT
T ss_pred             EeeccccccccCCC
Confidence            99999998765544

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2e-31  Score=185.79  Aligned_cols=133  Identities=18%  Similarity=0.181  Sum_probs=116.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|+||.||+|... +++.||+|.       .+.+.++...++.++||||+++++++. ++..|+||||+++|+|.+++
T Consensus        21 iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~   98 (272)
T d1qpca_          21 LGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFL   98 (272)
T ss_dssp             EEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHT
T ss_pred             EecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHH
Confidence            699999999999975 567788863       345678888899999999999999875 45679999999999999877


Q ss_pred             Hh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          75 SQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ..  ...+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+||+|||+|+.+.++
T Consensus        99 ~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          99 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             TSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            53  235899999999999999999999999999999999999999999999999999877654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.1e-31  Score=183.02  Aligned_cols=136  Identities=16%  Similarity=0.164  Sum_probs=121.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|+||.||+|+.. +++.+|+|.       .+.+.++...++.++||||+++++++.+++.+++||||+++|++..++
T Consensus        12 iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~   90 (258)
T d1k2pa_          12 LGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL   90 (258)
T ss_dssp             CCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHH
T ss_pred             EecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhh
Confidence            699999999999974 777888862       445677888899999999999999999999999999999999999987


Q ss_pred             Hh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCCC
Q psy3273          75 SQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  138 (145)
Q Consensus        75 ~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~  138 (145)
                      .. ...+++.....++.|++.|+.|+|+++++|+||+|+||+++.+..+|++|||+++.+.....
T Consensus        91 ~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          91 REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             HSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             hccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            64 46689999999999999999999999999999999999999999999999999987655433

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-31  Score=186.65  Aligned_cols=130  Identities=22%  Similarity=0.199  Sum_probs=112.9

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeee----------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALN----------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|+||.||+|+..   ..+|+|          +...+.++...++.++||||+++++++. ++.+++||||+++|+|.
T Consensus        16 lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~   91 (276)
T d1uwha_          16 IGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLY   91 (276)
T ss_dssp             EEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHH
T ss_pred             EeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHH
Confidence            699999999999753   346665          3456778889999999999999999865 55789999999999999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          72 YHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        72 ~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++... ..+++..+..++.|++.|+.|+|+++++||||||+||+++.+..+|++|||+|+....
T Consensus        92 ~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          92 HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             HHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             HHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            999754 5699999999999999999999999999999999999999999999999999976543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=3.7e-31  Score=184.78  Aligned_cols=134  Identities=17%  Similarity=0.249  Sum_probs=121.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCC----EEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD----KLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~----~~~lv~e~~~   66 (145)
                      .|.|+||.||+|.+..+++.+|+|.           ...+.++...++.++||||+++++++..++    .+|+||||++
T Consensus        15 lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~   94 (277)
T d1o6ya_          15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD   94 (277)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCC
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCC
Confidence            6999999999999999999999973           234567788889999999999999998654    4899999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++|..++...+.+++.++..++.|++.|+.|+|+++++||||||+||+++.....+++|||.+.....
T Consensus        95 g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          95 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             CCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence            999999998888999999999999999999999999999999999999999999999999999876543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6e-31  Score=184.32  Aligned_cols=135  Identities=17%  Similarity=0.176  Sum_probs=114.2

Q ss_pred             CeeeeeeeEEEEEEEcccC----CeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQG----ETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +.|.|+||.||+|....++    ..+|+|.         ...+.++...++.++||||+++++++..++..+++||++.+
T Consensus        14 ~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~   93 (283)
T d1mqba_          14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN   93 (283)
T ss_dssp             EEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             EEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEeccc
Confidence            4799999999999887655    3567652         33466788889999999999999999999999999999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          68 GDLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        68 ~~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++.+.+... ..+++.++..++.|++.|+.|+|+++++||||||+||+++.++.+||+|||+|+.+..
T Consensus        94 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          94 GALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             CcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            9998877654 6799999999999999999999999999999999999999999999999999987644

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.5e-31  Score=189.35  Aligned_cols=140  Identities=20%  Similarity=0.257  Sum_probs=116.5

Q ss_pred             CeeeeeeeEEEEEEEcccCCeeeeeHH----HHHHhhhhhcccCCCCceeEeeEEEEcC------CEEEEEEEccCCCCH
Q psy3273           1 MFFIVGTGFLSNCSHVKQGETLALNER----IMLSLVSTGIQMVDCPFIVCMTYAFHTP------DKLCFILDLMNGGDL   70 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~hp~i~~~~~~~~~~------~~~~lv~e~~~~~~l   70 (145)
                      +.|.|+||+||+|++..+++.+|+|..    ....++..+++.++||||++++++|...      .++|+||||++++.+
T Consensus        27 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~  106 (350)
T d1q5ka_          27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY  106 (350)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHH
T ss_pred             EEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccH
Confidence            379999999999999999999999753    2345677788899999999999998543      358999999987543


Q ss_pred             HHHH---HhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCC-CCEEEeeeccceecCCCCCcc
Q psy3273          71 HYHL---SQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHA  140 (145)
Q Consensus        71 ~~~l---~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~  140 (145)
                      ....   .....+++..+..++.|++.|+.|+|+++++||||||+||+++.+ ..+|++|||++..+.......
T Consensus       107 ~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~  180 (350)
T d1q5ka_         107 RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV  180 (350)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCC
T ss_pred             HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccc
Confidence            3332   234579999999999999999999999999999999999999876 489999999998876554333

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.8e-31  Score=185.76  Aligned_cols=135  Identities=19%  Similarity=0.240  Sum_probs=118.6

Q ss_pred             eeeeeeeEEEEEEEcccCCe--eeee---------HHHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGET--LALN---------ERIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~--~~~~---------~~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|....++..  +++|         ..+.+.++.+.++.+ +||||+++++++.+++.+|+||||+++|+
T Consensus        18 iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~   97 (309)
T d1fvra_          18 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN   97 (309)
T ss_dssp             EECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred             EeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCc
Confidence            69999999999999988864  4443         233466788888888 79999999999999999999999999999


Q ss_pred             HHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceec
Q psy3273          70 LHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDF  133 (145)
Q Consensus        70 l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~  133 (145)
                      |.+++...                ..+++.....++.|++.|+.|+|+++++|||++|+||+++....+|++|||+|+..
T Consensus        98 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~  177 (309)
T d1fvra_          98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ  177 (309)
T ss_dssp             HHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESS
T ss_pred             HHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccc
Confidence            99998643                45899999999999999999999999999999999999999999999999999765


Q ss_pred             CCC
Q psy3273         134 SKK  136 (145)
Q Consensus       134 ~~~  136 (145)
                      ...
T Consensus       178 ~~~  180 (309)
T d1fvra_         178 EVY  180 (309)
T ss_dssp             CEE
T ss_pred             ccc
Confidence            433

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.3e-30  Score=179.65  Aligned_cols=136  Identities=21%  Similarity=0.311  Sum_probs=125.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|+||.||+|++..+++.+|+|.          ...+.++...++.++||||++++++|...+..+++++++.++++.
T Consensus        10 LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~   89 (292)
T d1unla_          10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK   89 (292)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHH
T ss_pred             EecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccc
Confidence            6999999999999999999999974          345667888899999999999999999999999999999999998


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  137 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  137 (145)
                      .++.....+++..+..++.|++.|+.|+|.++++|+||||+||+++....++++|||.|+....+.
T Consensus        90 ~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          90 YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             HHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             cccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            888888889999999999999999999999999999999999999999999999999998775543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=1.4e-30  Score=182.53  Aligned_cols=134  Identities=22%  Similarity=0.305  Sum_probs=120.3

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH   71 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~   71 (145)
                      .|.|+||.||+|++. +++.+|+|.          ...+.++.++++.++||||++++++|..++..+++||++.++.+.
T Consensus        10 iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~   88 (286)
T d1ob3a_          10 IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKK   88 (286)
T ss_dssp             EEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHH
T ss_pred             EecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHH
Confidence            699999999999985 788999975          335667888899999999999999999999999999999887776


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          72 YHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        72 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ........+++..+..++.|++.|+.|+|+.+++||||||+||+++.++.+|++|||.|.....+
T Consensus        89 ~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          89 LLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             HHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             HHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            66666788999999999999999999999999999999999999999999999999999766543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.97  E-value=7.1e-30  Score=181.92  Aligned_cols=135  Identities=18%  Similarity=0.290  Sum_probs=117.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-----HHHHHhhhhhcccCC-CCceeEeeEEEEcC--CEEEEEEEccCCCCHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-----RIMLSLVSTGIQMVD-CPFIVCMTYAFHTP--DKLCFILDLMNGGDLHYH   73 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~-hp~i~~~~~~~~~~--~~~~lv~e~~~~~~l~~~   73 (145)
                      .|.|+||.||+|++..+++.+|+|.     ...+.++.+.++.+. ||||++++++|...  ..+++||||+.+++|...
T Consensus        43 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~  122 (328)
T d3bqca1          43 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL  122 (328)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHH
Confidence            6999999999999999999999974     445667777888884 99999999999854  579999999999998665


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCC-CEEEeeeccceecCCCCCc
Q psy3273          74 LSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHG-HVRISDLGLACDFSKKKPH  139 (145)
Q Consensus        74 l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  139 (145)
                      .   ..+++..+..++.|++.|+.|+|+++++|+||||+||+++.++ .++++|||+|+.+.+....
T Consensus       123 ~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~  186 (328)
T d3bqca1         123 Y---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  186 (328)
T ss_dssp             T---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence            3   4699999999999999999999999999999999999998665 5899999999877655433

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.8e-30  Score=179.30  Aligned_cols=133  Identities=18%  Similarity=0.239  Sum_probs=108.8

Q ss_pred             eeeeeeeEEEEEEEcccC---Ceeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQG---ETLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGD   69 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   69 (145)
                      .|.|+||.||+|....++   ..+++|         ....+.++...++.++||||+++++++. ++.+|+||||+++|+
T Consensus        15 iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~   93 (273)
T d1mp8a_          15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGE   93 (273)
T ss_dssp             EEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEE
T ss_pred             EeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCc
Confidence            699999999999887644   346664         2445677888899999999999999996 567899999999999


Q ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          70 LHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        70 l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +..++.. ...+++..+..++.|++.|+.|+|+++++|+||||+||+++..+.+|++|||+|+.+..
T Consensus        94 l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          94 LRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             HHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             HHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            9998764 45699999999999999999999999999999999999999999999999999987654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.6e-30  Score=181.26  Aligned_cols=132  Identities=18%  Similarity=0.172  Sum_probs=114.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH-------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE-------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|+||.||+|...++ +.+|+|.       .+.+.++...++.++||||+++++++. ++..++||||+++|++...+
T Consensus        25 iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~  102 (285)
T d1fmka3          25 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFL  102 (285)
T ss_dssp             EEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHH
T ss_pred             EeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhh
Confidence            69999999999998765 4588863       355778888899999999999999985 45689999999999999887


Q ss_pred             Hh--cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQ--HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ..  ...+++..+..++.|++.|+.|+|.++++|+||||+||+++.++.+||+|||+|+.+.+
T Consensus       103 ~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3         103 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             SHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             hhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence            53  35699999999999999999999999999999999999999999999999999986643

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=8.6e-30  Score=179.74  Aligned_cols=135  Identities=21%  Similarity=0.235  Sum_probs=119.2

Q ss_pred             eeeeeeeEEEEEEEc-----ccCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHV-----KQGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|+..     .+++.+|+|.         ...+.++...++.++||||+++++++..++..+++||++++
T Consensus        21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~  100 (301)
T d1lufa_          21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAY  100 (301)
T ss_dssp             EEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCC
Confidence            699999999999875     3556788863         34577888899999999999999999999999999999999


Q ss_pred             CCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEE
Q psy3273          68 GDLHYHLSQHG------------------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVR  123 (145)
Q Consensus        68 ~~l~~~l~~~~------------------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~  123 (145)
                      |+|.+++....                        .+++.....++.|++.|+.|+|+.+++|+||||+||+++.+..+|
T Consensus       101 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~K  180 (301)
T d1lufa_         101 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK  180 (301)
T ss_dssp             CBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             CcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEE
Confidence            99999986432                        378889999999999999999999999999999999999999999


Q ss_pred             EeeeccceecCCC
Q psy3273         124 ISDLGLACDFSKK  136 (145)
Q Consensus       124 l~dfg~~~~~~~~  136 (145)
                      |+|||+|+.+.+.
T Consensus       181 l~DFGls~~~~~~  193 (301)
T d1lufa_         181 IADFGLSRNIYSA  193 (301)
T ss_dssp             ECCCSCHHHHTGG
T ss_pred             EccchhheeccCC
Confidence            9999999866544

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.8e-29  Score=177.19  Aligned_cols=135  Identities=19%  Similarity=0.219  Sum_probs=116.3

Q ss_pred             eeeeeeeEEEEEEEcccCC---eeeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEc-CCEEEEEEEccCCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGE---TLALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHT-PDKLCFILDLMNGG   68 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~---~~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~~   68 (145)
                      .|.|+||.||++....++.   .+|+|         +...+.++.+.+++++||||+++++++.. ++..++|||||+++
T Consensus        35 iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g  114 (311)
T d1r0pa_          35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG  114 (311)
T ss_dssp             EEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTC
T ss_pred             EeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecC
Confidence            6999999999999876542   45665         34557788888999999999999999765 56899999999999


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          69 DLHYHLSQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        69 ~l~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +|.+++... ...++.....++.|++.|+.|+|+.+++|+||||+||+++....+||+|||+++.....
T Consensus       115 ~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         115 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             BHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             chhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            999988754 45778888999999999999999999999999999999999999999999999876544

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.3e-30  Score=180.74  Aligned_cols=135  Identities=21%  Similarity=0.254  Sum_probs=114.4

Q ss_pred             CeeeeeeeEEEEEEEcccCCe----eeee---------HHHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           1 MFFIVGTGFLSNCSHVKQGET----LALN---------ERIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         1 ~~g~~~~g~~~~~~~~~~~~~----~~~~---------~~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      +.|.|+||.||+|....+|+.    +|+|         ..+.+.++...++.++||||+++++++.++ ..++++|++.+
T Consensus        16 ~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~   94 (317)
T d1xkka_          16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPF   94 (317)
T ss_dssp             EEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             EEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccC
Confidence            369999999999999888864    4544         234567788889999999999999999865 56778899999


Q ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          68 GDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        68 ~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++|.+.+.. ...+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+|++|||+|+.+...
T Consensus        95 ~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          95 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             CBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            999988765 467999999999999999999999999999999999999999999999999999876543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.9e-29  Score=179.99  Aligned_cols=133  Identities=19%  Similarity=0.272  Sum_probs=112.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH---------HHHHhhhhhcccCCCCceeEeeEEEEcCC-----EEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER---------IMLSLVSTGIQMVDCPFIVCMTYAFHTPD-----KLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~hp~i~~~~~~~~~~~-----~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|.+..+++.+|+|.+         ..+.++..+++.++||||+++++++..++     .+|++ +++.+
T Consensus        16 LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~   94 (345)
T d1pmea_          16 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMG   94 (345)
T ss_dssp             CC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCC
T ss_pred             EeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecC
Confidence            69999999999999999999999742         24456788899999999999999997653     35555 55668


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          68 GDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        68 ~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ++|.+++.. ..+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+|++|||+|......
T Consensus        95 g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          95 ADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             Cchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            899999875 46899999999999999999999999999999999999999999999999999876443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.8e-29  Score=179.60  Aligned_cols=135  Identities=37%  Similarity=0.613  Sum_probs=121.7

Q ss_pred             eeeeeeeEEEEEEEcc---cCCeeeeeHH------------HHHHhhhhhcccCCC-CceeEeeEEEEcCCEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVK---QGETLALNER------------IMLSLVSTGIQMVDC-PFIVCMTYAFHTPDKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~---~~~~~~~~~~------------~~~~~~~~~~~~l~h-p~i~~~~~~~~~~~~~~lv~e~~   65 (145)
                      .|.|+||.||+|.+..   +|+.+|+|..            +.+.++.+.++.++| |||+++++++.+...++++|||+
T Consensus        32 IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~  111 (322)
T d1vzoa_          32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI  111 (322)
T ss_dssp             EEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             EecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecc
Confidence            6999999999999844   6889998742            345577777888877 89999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+++|.+++.....+++..+..++.|++.|+.|+|+.+++|+||+|+||+++.++.++++|||+++.+...
T Consensus       112 ~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~  182 (322)
T d1vzoa_         112 NGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  182 (322)
T ss_dssp             CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             cccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence            99999999998888999999999999999999999999999999999999999999999999999876543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.7e-29  Score=175.21  Aligned_cols=132  Identities=19%  Similarity=0.207  Sum_probs=111.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCCCceeEeeEEEEc-CCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDCPFIVCMTYAFHT-PDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|+||.||+|..  +|..+|+|.      .+.+.++.+.++.++||||+++++++.. ++.+|+||||+++|+|.+++
T Consensus        15 lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l   92 (262)
T d1byga_          15 IGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL   92 (262)
T ss_dssp             EEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHH
T ss_pred             EecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHH
Confidence            68999999999987  466788863      4567788899999999999999999854 56789999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          75 SQH--GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      ...  ..+++..+..++.|++.|+.|+|+++++|+||+|+||+++.++.++++|||+++...+
T Consensus        93 ~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          93 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             HHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             HhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence            653  3589999999999999999999999999999999999999999999999999986543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.2e-29  Score=175.51  Aligned_cols=134  Identities=21%  Similarity=0.253  Sum_probs=117.5

Q ss_pred             eeeeeeeEEEEEEEcc-----cCCeeeeeH---------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVK-----QGETLALNE---------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-----~~~~~~~~~---------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|....     .+..||+|.         ...+.++.+.++.++||||+++++++..++..++||||+++
T Consensus        28 lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~  107 (308)
T d1p4oa_          28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR  107 (308)
T ss_dssp             EEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCC
Confidence            6999999999998753     356777752         34567888899999999999999999999999999999999


Q ss_pred             CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          68 GDLHYHLSQH----------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        68 ~~l~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      |+|.+++...          ..++...+..++.|++.|+.|+|.++++|+||||+||+++.+..+||+|||+|+.+..
T Consensus       108 g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~  185 (308)
T d1p4oa_         108 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE  185 (308)
T ss_dssp             CBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGG
T ss_pred             CCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccC
Confidence            9999988632          2368888999999999999999999999999999999999999999999999986644

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.6e-29  Score=178.45  Aligned_cols=133  Identities=21%  Similarity=0.342  Sum_probs=111.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH----------HHHHHhhhhhcccCCCCceeEeeEEEEcCC------EEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPD------KLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~------~~~lv~e~~   65 (145)
                      .|.|+||.||+|.+..+|+.+|+|.          .....++.+.++.++||||++++++|...+      .+|+||||+
T Consensus        26 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~  105 (346)
T d1cm8a_          26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM  105 (346)
T ss_dssp             C------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc
Confidence            6999999999999999999999974          234556778889999999999999998664      579999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                       +.++..... ...+++..+..++.|++.|+.|+|+++++|+||||+||+++.++.++++|||+|+.....
T Consensus       106 -~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~  174 (346)
T d1cm8a_         106 -GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE  174 (346)
T ss_dssp             -SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             -cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc
Confidence             557766654 467999999999999999999999999999999999999999999999999999876543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.5e-28  Score=172.38  Aligned_cols=132  Identities=25%  Similarity=0.241  Sum_probs=112.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-----H--HHHhhhhhcccCCCCceeEeeEEEEcCC----EEEEEEEccCCCCH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-----I--MLSLVSTGIQMVDCPFIVCMTYAFHTPD----KLCFILDLMNGGDL   70 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-----~--~~~~~~~~~~~l~hp~i~~~~~~~~~~~----~~~lv~e~~~~~~l   70 (145)
                      .|.|+||.||+|+.  +|+.+|+|..     .  ..+.+...+..++||||+++++++.+++    .+|+||||+++|+|
T Consensus        11 iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L   88 (303)
T d1vjya_          11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL   88 (303)
T ss_dssp             EECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred             EeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCH
Confidence            69999999999985  6888998731     1  2233444566789999999999998653    68999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------CCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          71 HYHLSQHGVFNEDEMRFYAAEVILGLEHMHR--------RYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        71 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~--------~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      ..++.+. .+++.....++.|++.++.|+|.        ++++|+||||+||+++.++.+|++|||+++.+...
T Consensus        89 ~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~  161 (303)
T d1vjya_          89 FDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             HHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence            9999764 68888999999999999999996        58999999999999999999999999999877543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-28  Score=174.37  Aligned_cols=135  Identities=21%  Similarity=0.224  Sum_probs=116.9

Q ss_pred             eeeeeeeEEEEEEEc-----ccCCeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHV-----KQGETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~   66 (145)
                      .|.|+||.||+|...     .+++.+|+|.         ...+.++...++.+ +||||+++++++.+++..|++||||+
T Consensus        31 iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~  110 (311)
T d1t46a_          31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC  110 (311)
T ss_dssp             EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             EeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCC
Confidence            699999999999863     3556778863         33455666677777 79999999999999999999999999


Q ss_pred             CCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          67 GGDLHYHLSQHG------------------VFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        67 ~~~l~~~l~~~~------------------~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                      +|+|.+++....                  .+++..+..++.|++.|+.|+|+.+++|+||||+||+++..+.++++|||
T Consensus       111 ~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG  190 (311)
T d1t46a_         111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG  190 (311)
T ss_dssp             TEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCG
T ss_pred             CCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccc
Confidence            999999986432                  48889999999999999999999999999999999999999999999999


Q ss_pred             cceecCCC
Q psy3273         129 LACDFSKK  136 (145)
Q Consensus       129 ~~~~~~~~  136 (145)
                      .++.....
T Consensus       191 ~~~~~~~~  198 (311)
T d1t46a_         191 LARDIKND  198 (311)
T ss_dssp             GGSCTTSC
T ss_pred             hheeccCC
Confidence            99876543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-28  Score=174.97  Aligned_cols=134  Identities=23%  Similarity=0.276  Sum_probs=116.8

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcC--------CEEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTP--------DKLCFILD   63 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~--------~~~~lv~e   63 (145)
                      +|.|+||.||+|.+..+|+.+|+|..          ..+.++.+.++.++||||+++++++...        +.+|++||
T Consensus        18 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e   97 (318)
T d3blha1          18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD   97 (318)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEE
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEe
Confidence            69999999999999999999999842          2345677888999999999999998653        46899999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          64 LMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        64 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                      +++++.+.........+++..+..++.|++.|+.|+|+++++|+||||+||+++.++.++++|||+++.+..
T Consensus        98 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~  169 (318)
T d3blha1          98 FCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL  169 (318)
T ss_dssp             CCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred             ccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence            998876665555567799999999999999999999999999999999999999999999999999986653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.4e-29  Score=172.55  Aligned_cols=134  Identities=19%  Similarity=0.243  Sum_probs=110.4

Q ss_pred             eeeeeeeEEEEEEEcc-cCC--eeeeeH-----------HHHHHhhhhhcccCCCCceeEeeEEEEcCCEEEEEEEccCC
Q psy3273           2 FFIVGTGFLSNCSHVK-QGE--TLALNE-----------RIMLSLVSTGIQMVDCPFIVCMTYAFHTPDKLCFILDLMNG   67 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~-~~~--~~~~~~-----------~~~~~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   67 (145)
                      .|.|+||.||+|.... +++  .+|+|.           .+.+.++...++.++||||+++++++.+ ...++||||+++
T Consensus        16 iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~   94 (273)
T d1u46a_          16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPL   94 (273)
T ss_dssp             CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             EecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecC
Confidence            5899999999998654 333  456642           3345677788999999999999999975 467899999999


Q ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          68 GDLHYHLSQ-HGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        68 ~~l~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      +++.+.+.. ...+++.....++.|++.|+.|+|+++++|+||||+||+++.+..+|++|||+++.+...
T Consensus        95 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          95 GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             CBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             cchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            999987764 456999999999999999999999999999999999999999999999999999977544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-28  Score=173.22  Aligned_cols=135  Identities=20%  Similarity=0.229  Sum_probs=109.5

Q ss_pred             eeeeeeeEEEEEEEcccC-------CeeeeeH---------HHHHHhhhhhcccC-CCCceeEeeEEEEcCCEEEEEEEc
Q psy3273           2 FFIVGTGFLSNCSHVKQG-------ETLALNE---------RIMLSLVSTGIQMV-DCPFIVCMTYAFHTPDKLCFILDL   64 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~e~   64 (145)
                      .|.|+||.||+|....++       ..+|+|.         ...+.++...+..+ +||||+++++++.+++..++||||
T Consensus        21 iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~  100 (299)
T d1fgka_          21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY  100 (299)
T ss_dssp             CC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             EeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEc
Confidence            589999999999876654       3566652         23344455555555 899999999999999999999999


Q ss_pred             cCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeec
Q psy3273          65 MNGGDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLG  128 (145)
Q Consensus        65 ~~~~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg  128 (145)
                      +++|+|.+++...                ..+++.++..++.|++.|+.|+|+++++||||||+||+++.++.+|++|||
T Consensus       101 ~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg  180 (299)
T d1fgka_         101 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG  180 (299)
T ss_dssp             CTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTT
T ss_pred             cCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccch
Confidence            9999999999643                248999999999999999999999999999999999999999999999999


Q ss_pred             cceecCCC
Q psy3273         129 LACDFSKK  136 (145)
Q Consensus       129 ~~~~~~~~  136 (145)
                      +++.....
T Consensus       181 ~~~~~~~~  188 (299)
T d1fgka_         181 LARDIHHI  188 (299)
T ss_dssp             CCCCGGGC
T ss_pred             hhcccccc
Confidence            99876543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.1e-28  Score=171.49  Aligned_cols=135  Identities=24%  Similarity=0.269  Sum_probs=104.1

Q ss_pred             eeeeeeeEEEEEEEccc-----CCeeeeeHH---------HHHHhhhhhc-ccCCCCceeEeeEEEEcC-CEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQ-----GETLALNER---------IMLSLVSTGI-QMVDCPFIVCMTYAFHTP-DKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~-----~~~~~~~~~---------~~~~~~~~~~-~~l~hp~i~~~~~~~~~~-~~~~lv~e~~   65 (145)
                      .|.|+||.||+|.....     ++.+|+|..         ..+.++...+ +...||||+.+++++..+ ..++++||||
T Consensus        21 iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~  100 (299)
T d1ywna1          21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC  100 (299)
T ss_dssp             EEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECC
T ss_pred             EeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEec
Confidence            69999999999997553     456777632         1222333333 344789999999987654 5799999999


Q ss_pred             CCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeecc
Q psy3273          66 NGGDLHYHLSQH----------------GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGL  129 (145)
Q Consensus        66 ~~~~l~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~  129 (145)
                      ++|+|.+++...                ..+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+||+|||+
T Consensus       101 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGl  180 (299)
T d1ywna1         101 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL  180 (299)
T ss_dssp             TTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC---
T ss_pred             CCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcc
Confidence            999999999643                2378899999999999999999999999999999999999999999999999


Q ss_pred             ceecCCC
Q psy3273         130 ACDFSKK  136 (145)
Q Consensus       130 ~~~~~~~  136 (145)
                      |+.....
T Consensus       181 a~~~~~~  187 (299)
T d1ywna1         181 ARDIYKD  187 (299)
T ss_dssp             ---CCSC
T ss_pred             hhhcccc
Confidence            9866443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.95  E-value=3e-27  Score=166.08  Aligned_cols=133  Identities=17%  Similarity=0.249  Sum_probs=116.1

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCC-CceeEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDC-PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|+||.||+|.+..+++.+|+|.      ...++++.+.++.++| ||++.+++++..+...++|||++ +++|.+++
T Consensus        13 iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~   91 (293)
T d1csna_          13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLL   91 (293)
T ss_dssp             EEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHH
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHH
Confidence            6999999999999999999999973      2234556667777766 89999999999999999999999 67999888


Q ss_pred             Hhc-CCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC-----CCCEEEeeeccceecCC
Q psy3273          75 SQH-GVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE-----HGHVRISDLGLACDFSK  135 (145)
Q Consensus        75 ~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~-----~~~~~l~dfg~~~~~~~  135 (145)
                      ... ..++..+...++.|++.++.++|+.+++||||||+||+++.     .+.++++|||+|+.+..
T Consensus        92 ~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          92 DLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             HHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             HhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            754 46999999999999999999999999999999999999964     46799999999987654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.2e-28  Score=170.18  Aligned_cols=135  Identities=21%  Similarity=0.291  Sum_probs=109.6

Q ss_pred             eeeeeeeEEEEEEEccc-CCeeeeeHHH----------HHHhhhhhcc---cCCCCceeEeeEEEEc-----CCEEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQ-GETLALNERI----------MLSLVSTGIQ---MVDCPFIVCMTYAFHT-----PDKLCFIL   62 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~-~~~~~~~~~~----------~~~~~~~~~~---~l~hp~i~~~~~~~~~-----~~~~~lv~   62 (145)
                      +|.|+||.||+|.+.++ ++.+|+|...          ...++.++++   .++||||++++++|..     ...++++|
T Consensus        15 LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~   94 (305)
T d1blxa_          15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF   94 (305)
T ss_dssp             EEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEE
T ss_pred             EecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEE
Confidence            69999999999999776 5678886421          1223444444   4489999999999863     34799999


Q ss_pred             EccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          63 DLMNGGDLHYHLS-QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        63 e~~~~~~l~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      |++.++++..... ....+++..+..++.|++.|+.|+|+++++||||||+||+++..+.++++|||++......
T Consensus        95 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~  169 (305)
T d1blxa_          95 EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ  169 (305)
T ss_dssp             ECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG
T ss_pred             EeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhccc
Confidence            9998876654444 3456899999999999999999999999999999999999999999999999999765443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1e-27  Score=172.42  Aligned_cols=132  Identities=19%  Similarity=0.320  Sum_probs=108.4

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEc------CCEEEEEEEcc
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHT------PDKLCFILDLM   65 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~------~~~~~lv~e~~   65 (145)
                      .|.|+||+||+|.+..+|+.+|+|..          ..+.++..+++.++||||++++++|..      ...+|+||||+
T Consensus        25 LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~  104 (355)
T d2b1pa1          25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM  104 (355)
T ss_dssp             CSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECC
T ss_pred             eecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEecc
Confidence            68999999999999999999999742          235577778889999999999999964      36899999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCCC
Q psy3273          66 NGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSKK  136 (145)
Q Consensus        66 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  136 (145)
                      .+ ++.+.+  ...+++..+..++.|++.|+.|+|+.|++|+||||+||+++.+...+++|||+++.....
T Consensus       105 ~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1         105 DA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             SE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             ch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            76 444444  356899999999999999999999999999999999999999999999999998766544

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.2e-28  Score=173.83  Aligned_cols=132  Identities=20%  Similarity=0.279  Sum_probs=111.7

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH----------HHHHhhhhhcccCCCCceeEeeEEEEcC-----CEEEEEEEccC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER----------IMLSLVSTGIQMVDCPFIVCMTYAFHTP-----DKLCFILDLMN   66 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~   66 (145)
                      +|.|+||.||+|.+..+++.+|+|..          ..+.++..+++.++||||++++++|...     ...+++++++.
T Consensus        26 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~  105 (348)
T d2gfsa1          26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM  105 (348)
T ss_dssp             CGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECC
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeec
Confidence            68999999999999999999999742          2455777888999999999999999643     23456667788


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecC
Q psy3273          67 GGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFS  134 (145)
Q Consensus        67 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~  134 (145)
                      +++|.+++.. ..+++..+..++.|++.|+.|+|+++++||||||+||+++.++.++++|||++....
T Consensus       106 gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1         106 GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             SEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             CCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence            9999998854 579999999999999999999999999999999999999999999999999997554

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=9.9e-27  Score=163.64  Aligned_cols=134  Identities=20%  Similarity=0.246  Sum_probs=111.6

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeH------HHHHHhhhhhcccCCCCce-eEeeEEEEcCCEEEEEEEccCCCCHHHHH
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNE------RIMLSLVSTGIQMVDCPFI-VCMTYAFHTPDKLCFILDLMNGGDLHYHL   74 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~hp~i-~~~~~~~~~~~~~~lv~e~~~~~~l~~~l   74 (145)
                      .|.|+||.||+|.+..+++.+|+|.      ...+..+.+.++.++|+|+ +.+..++..++..++|||++.+ ++...+
T Consensus        15 iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~-~l~~~~   93 (299)
T d1ckia_          15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLF   93 (299)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC-BHHHHH
T ss_pred             EeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCC-chhhhh
Confidence            6999999999999999999999972      2235566777888887765 5556667888999999999954 666655


Q ss_pred             H-hcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECC---CCCEEEeeeccceecCCC
Q psy3273          75 S-QHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDE---HGHVRISDLGLACDFSKK  136 (145)
Q Consensus        75 ~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~---~~~~~l~dfg~~~~~~~~  136 (145)
                      . ....+++..+..++.|++.|+.|+|+++++||||||+||+++.   ...++++|||+|+.+...
T Consensus        94 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          94 NFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             hhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            4 4567999999999999999999999999999999999999753   457999999999987543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=6e-22  Score=130.87  Aligned_cols=122  Identities=12%  Similarity=0.051  Sum_probs=94.0

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH--------------------------HHHHhhhhhcccCCCCceeEeeEEEEcC
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER--------------------------IMLSLVSTGIQMVDCPFIVCMTYAFHTP   55 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~l~hp~i~~~~~~~~~~   55 (145)
                      .|.|+||.||+|.+. +|+.+|+|..                          .....+...+..+.|++++..++...  
T Consensus         8 IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~--   84 (191)
T d1zara2           8 MGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG--   84 (191)
T ss_dssp             EEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET--
T ss_pred             eeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC--
Confidence            699999999999885 6888888721                          11123344566789999998876532  


Q ss_pred             CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCceecCCCCCcEEECCCCCEEEeeeccceecCC
Q psy3273          56 DKLCFILDLMNGGDLHYHLSQHGVFNEDEMRFYAAEVILGLEHMHRRYIVYRDLKPANILLDEHGHVRISDLGLACDFSK  135 (145)
Q Consensus        56 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~iih~~l~~~nil~~~~~~~~l~dfg~~~~~~~  135 (145)
                        .+++||++++..+..       ++......++.|++.++.++|+++++|+|+||+||+++. ..++++|||.|.....
T Consensus        85 --~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~~~~liDFG~a~~~~~  154 (191)
T d1zara2          85 --NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGE  154 (191)
T ss_dssp             --TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-TEEEECCCTTCEETTS
T ss_pred             --CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-CCEEEEECCCcccCCC
Confidence              269999998865432       333445678899999999999999999999999999985 4589999999987754


Q ss_pred             C
Q psy3273         136 K  136 (145)
Q Consensus       136 ~  136 (145)
                      +
T Consensus       155 ~  155 (191)
T d1zara2         155 E  155 (191)
T ss_dssp             T
T ss_pred             C
Confidence            4

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.85  E-value=3.7e-21  Score=137.85  Aligned_cols=134  Identities=20%  Similarity=0.256  Sum_probs=103.2

Q ss_pred             eeeeeeeEEEEEEEcccCCeeeeeHH-------HHHHhhhhhcccC-----------CCCceeEeeEEEEc--CCEEEEE
Q psy3273           2 FFIVGTGFLSNCSHVKQGETLALNER-------IMLSLVSTGIQMV-----------DCPFIVCMTYAFHT--PDKLCFI   61 (145)
Q Consensus         2 ~g~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l-----------~hp~i~~~~~~~~~--~~~~~lv   61 (145)
                      +|.|+||+||+|++..+|+.+|+|..       +...++.+.++.+           .||||+++++++..  ....+++
T Consensus        21 LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~  100 (362)
T d1q8ya_          21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV  100 (362)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEE
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeee
Confidence            69999999999999999999999742       2233444444433           57899999999864  3567777


Q ss_pred             EEccCCCC-HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhh-CCceecCCCCCcEEECCCC------CEEEeeeccce
Q psy3273          62 LDLMNGGD-LHYHLS--QHGVFNEDEMRFYAAEVILGLEHMHR-RYIVYRDLKPANILLDEHG------HVRISDLGLAC  131 (145)
Q Consensus        62 ~e~~~~~~-l~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~iih~~l~~~nil~~~~~------~~~l~dfg~~~  131 (145)
                      ++++.... ......  ....+++..+..++.|++.|+.|+|+ .+++|+||||+||+++..+      .++++|||.+.
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~  180 (362)
T d1q8ya_         101 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC  180 (362)
T ss_dssp             EEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCE
T ss_pred             eeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccc
Confidence            77665543 333332  34568999999999999999999997 8899999999999997543      48999999998


Q ss_pred             ecCC
Q psy3273         132 DFSK  135 (145)
Q Consensus       132 ~~~~  135 (145)
                      ....
T Consensus       181 ~~~~  184 (362)
T d1q8ya_         181 WYDE  184 (362)
T ss_dssp             ETTB
T ss_pred             cccc
Confidence            6543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.33  E-value=0.00037  Score=46.03  Aligned_cols=28  Identities=25%  Similarity=0.293  Sum_probs=24.0

Q ss_pred             ceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         104 IVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       104 iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      ++|+|+.+.|++++......++||+.+.
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEeeccCcceeecCCceEEEeechhcc
Confidence            7899999999999876656799998775

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.91  E-value=0.0028  Score=44.62  Aligned_cols=29  Identities=24%  Similarity=0.421  Sum_probs=24.5

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      ..++|+|+.+.|++++.+ .++++|+..+.
T Consensus       223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~  251 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAF  251 (392)
T ss_dssp             CEEECSCCCGGGEEECSS-CEEECCCTTCE
T ss_pred             cceeccCCcCCceeEcCC-ceEEechhhcc
Confidence            358999999999999765 48999998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.89  E-value=0.00075  Score=44.25  Aligned_cols=28  Identities=18%  Similarity=0.165  Sum_probs=24.4

Q ss_pred             ceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         104 IVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       104 iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      ++|+|+.+.|++++.+....++||+.+.
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            7999999999999876667799998775

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.83  E-value=0.0031  Score=42.69  Aligned_cols=30  Identities=20%  Similarity=0.280  Sum_probs=26.8

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .|++|+|+.++|++++.+....++||+.++
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            468999999999999987777899999886

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=86.16  E-value=0.13  Score=34.67  Aligned_cols=28  Identities=25%  Similarity=0.150  Sum_probs=22.9

Q ss_pred             CCceecCCCCCcEEECCCCCEEEeeeccce
Q psy3273         102 RYIVYRDLKPANILLDEHGHVRISDLGLAC  131 (145)
Q Consensus       102 ~~iih~~l~~~nil~~~~~~~~l~dfg~~~  131 (145)
                      .+++|+|+.+.|++++.+  ..++||+-++
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            458999999999999743  4589998776